data_2lhf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lhf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.461 0.118 0 CA-C-O 120.809 0.337 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.9 138.86 56.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.762 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.5 m-85 -132.48 139.88 48.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 111.103 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 19.6 m -154.58 127.63 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.997 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.6 -146.47 4.66 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.846 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.8 153.97 45.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 0.0 110.821 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.37 135.9 52.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.05 113.24 11.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.29 131.36 10.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.523 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.871 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.8 p -95.01 126.58 40.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -128.31 132.73 48.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -156.35 -167.26 17.41 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.51 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 pt -107.15 172.54 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 111.027 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.87 141.44 34.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.639 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -174.87 123.2 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.315 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -160.96 -148.74 5.38 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.698 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -136.07 126.29 26.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.01 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -83.97 158.91 21.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.662 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -135.04 164.22 28.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.15 -24.08 65.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.365 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.32 24.38 5.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.27 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 174.61 178.21 44.32 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.202 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 54' ' ' ARG . 4.1 ptm85 -148.13 138.22 22.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 111.187 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -117.04 145.63 43.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.514 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.441 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 41.0 p90 -172.12 121.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 111.171 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.85 158.93 16.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.1 m -127.95 117.06 21.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.059 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -100.96 127.59 47.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.754 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -141.53 176.71 8.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.029 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.742 0.306 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -144.64 116.99 8.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.094 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.73 127.05 39.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.534 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.415 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.8 OUTLIER -146.32 137.72 24.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.963 0.411 . . . . 0.0 111.438 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.77 116.89 3.89 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.016 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.408 ' OG ' ' CE2' ' A' ' 56' ' ' TYR . 26.0 p -105.92 133.29 50.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.412 . . . . 0.0 111.279 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 55' ' ' TYR . 23.1 p90 -123.85 110.89 15.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.353 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.57 171.19 14.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.053 0.454 . . . . 0.0 111.383 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -117.54 120.6 38.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.919 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 42.1 p90 -97.86 164.38 12.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.133 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.26 139.03 1.44 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.636 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.84 119.51 4.88 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.514 2.142 . . . . 0.0 112.359 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.0 tp . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.03 179.921 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.734 0.302 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.78 153.09 31.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.569 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 1.7 tptp -126.58 92.53 3.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.824 0.345 . . . . 0.0 110.995 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.14 102.82 0.32 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.256 0.55 . . . . 0.0 110.508 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.452 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 35.9 p90 -111.04 156.0 21.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.758 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.27 134.7 3.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.732 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.53 -160.66 24.59 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.446 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.13 171.43 8.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 0.0 111.23 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.8 t -143.92 159.81 41.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.06 131.19 5.81 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -152.73 -153.31 6.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.806 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 pp -155.28 127.94 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.656 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.2 m -109.74 130.41 62.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.206 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.29 132.61 6.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -84.62 115.04 22.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 0.0 111.034 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -111.62 137.74 49.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.05 141.27 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.27 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.94 -139.56 2.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.603 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt -140.37 161.16 38.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.378 . . . . 0.0 110.831 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -150.04 157.78 43.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.796 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 178.68 142.39 0.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.371 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.452 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -168.01 -130.33 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.117 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 11.3 pt -159.45 121.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.77 0.319 . . . . 0.0 110.377 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.13 111.61 23.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.742 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -92.58 122.13 34.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.075 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.39 149.12 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.02 -47.26 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.001 0.429 . . . . 0.0 110.518 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -164.97 0.49 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.194 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 56.71 2.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.833 0.349 . . . . 0.0 110.6 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.76 -58.96 0.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.952 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -162.68 146.18 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.978 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.03 -179.9 4.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.4 mt -136.49 134.97 49.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 141.0 46.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.97 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -161.82 117.28 0.76 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.446 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -172.64 -138.95 2.7 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.094 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -121.19 161.16 22.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 110.843 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 121.71 12.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.107 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -118.18 131.3 56.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.463 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.29 146.96 32.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.935 0.398 . . . . 0.0 111.261 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.84 162.38 13.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.561 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.089 -179.822 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.813 0.339 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 m -106.97 117.58 34.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.816 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 155.18 51.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.724 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -103.49 165.2 11.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.21 0.528 . . . . 0.0 110.277 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.407 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -131.39 128.0 38.7 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.768 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.4 131.65 3.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.711 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.33 -152.04 15.95 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.648 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -131.61 172.01 12.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 0.0 111.058 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -152.22 115.49 4.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -109.21 113.62 26.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.94 163.56 22.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.142 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.524 -0.053 0 CA-C-O 120.643 0.258 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -109.71 128.39 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.785 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.8 OUTLIER -129.05 139.91 51.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 16.4 m -154.08 126.41 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.214 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.35 -141.92 3.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.641 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mt -142.93 162.01 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 t -139.07 136.38 35.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 111.263 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -130.62 113.02 13.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.59 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 172' ' ' TYR . . . -118.13 169.65 13.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.064 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.79 0.329 . . . . 0.0 110.837 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 p -138.62 107.99 6.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -125.11 137.36 54.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.707 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.15 -171.61 34.23 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.851 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 58' ' ' THR . 1.4 mp -106.95 164.05 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.578 0.227 . . . . 0.0 110.745 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.0 ttm-85 -132.39 139.71 48.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.646 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -174.81 122.43 0.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.443 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -169.92 -128.44 1.02 Allowed Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.516 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -143.22 154.91 44.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.65 109.84 11.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.7 145.71 29.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.547 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.22 -21.67 24.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.208 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -124.63 24.13 7.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.073 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.75 120.49 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.513 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 129.38 53.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 110.816 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.481 ' CD1' ' CD2' ' A' ' 80' ' ' TYR . 11.4 m-85 -124.24 147.03 48.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.772 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.469 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 31.9 p90 -177.3 125.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.039 0.447 . . . . 0.0 110.979 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.69 156.13 18.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.609 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 21.2 m -133.28 119.05 19.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.495 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -89.95 118.9 29.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.324 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.92 176.72 4.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.977 0.418 . . . . 0.0 111.397 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.641 179.985 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.7 0.286 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -122.71 110.87 16.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.108 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.42 114.96 28.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.467 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.468 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 4.5 mm? -123.91 142.38 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 111.297 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.96 116.89 4.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.989 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -93.18 125.43 37.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.913 0.387 . . . . 0.0 111.413 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.481 ' CD2' ' CD1' ' A' ' 55' ' ' TYR . 9.8 m-85 -127.09 110.94 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.068 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -150.26 172.18 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 111.692 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.92 122.84 47.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.623 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -97.21 169.67 9.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.641 -179.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tp -147.93 124.44 5.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.551 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.09 110.45 2.2 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.405 2.07 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.8 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.654 179.77 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 57.3 m-80 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.63 0.252 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -74.65 151.18 39.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.561 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.444 ' HG2' ' CD2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -130.51 93.59 3.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.052 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.81 103.08 0.18 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.595 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 44.0 p90 -111.02 153.53 25.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.913 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.72 133.84 2.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.613 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.75 -136.54 2.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.75 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -128.01 179.98 5.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.789 0.328 . . . . 0.0 111.353 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.7 p -146.73 157.09 43.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.73 131.15 6.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.678 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -150.56 -154.04 6.34 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.948 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -155.37 130.86 9.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.853 0.359 . . . . 0.0 110.301 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.6 122.1 63.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.322 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.929 0.395 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.45 168.53 13.04 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.83 116.25 31.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.54 148.38 22.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.03 141.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.963 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.68 -140.31 2.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 97' ' ' ALA . 22.5 mt -141.02 174.33 10.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.74 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.2 153.3 13.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.757 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.439 ' HA ' ' CD1' ' A' ' 94' ' ' PHE . . . 177.2 142.5 0.08 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.939 0.4 . . . . 0.0 110.633 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.448 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -172.37 -126.65 0.91 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.873 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.46 ' N ' ' CE2' ' A' ' 94' ' ' PHE . 1.3 pp -160.09 120.76 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.747 0.308 . . . . 0.0 110.236 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 6.3 tt -94.48 110.71 22.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.054 0.454 . . . . 0.0 110.428 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -91.62 161.12 15.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.058 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -120.81 146.73 46.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 19.6 mt -109.73 -30.37 7.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.743 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.62 -165.0 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.424 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.49 50.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.813 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.71 -33.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.246 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -104.22 146.71 28.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 111.241 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.0 m -151.74 -176.81 5.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.035 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 175' ' ' ALA . 11.8 pt -148.56 150.79 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.642 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 127.63 31.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.787 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 173' ' ' LEU . . . -151.84 158.34 27.72 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.583 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.09 -120.71 0.97 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.657 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -139.6 152.9 47.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.814 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.11 145.3 45.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 168' ' ' SER . 8.1 m-85 -121.48 145.74 47.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.348 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.64 147.19 27.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.031 0.443 . . . . 0.0 111.258 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -135.61 155.58 50.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.48 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.108 -179.809 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.416 ' O ' ' CD1' ' A' ' 143' ' ' TYR . 67.1 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.818 0.342 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.87 141.04 38.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -154.3 155.14 34.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -119.68 130.88 55.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.261 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.445 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 34.5 p90 -133.23 173.9 10.95 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.712 0.768 . . . . 0.0 111.725 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.447 ' HA ' ' CA ' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -163.76 134.31 4.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.847 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -154.56 -165.61 14.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.0 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -107.73 169.73 8.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.341 . . . . 0.0 110.985 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -158.0 117.44 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.87 118.4 31.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -89.02 160.22 17.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.023 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.3 t80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.828 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.46 0.053 0 CA-C-O 120.7 0.286 . . . . 0.0 110.858 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -112.51 141.98 45.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.678 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 28.2 p90 -146.43 167.23 24.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 111.23 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -156.33 144.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.475 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.68 -142.67 3.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mt -120.95 153.51 37.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.751 0.31 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -122.15 113.53 19.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.78 112.94 19.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.04 115.25 3.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.542 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.33 144.25 48.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.84 105.51 5.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.44 -164.83 10.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.513 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -106.69 158.95 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.695 0.283 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -121.99 131.92 54.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.001 0.429 . . . . 0.0 110.523 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.75 117.82 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.97 -143.56 3.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.621 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -153.66 126.09 8.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.955 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 3' ' ' ASP . 19.9 pt20 -95.09 109.54 21.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.487 . . . . 0.0 111.184 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 53' ' ' GLY . 1.7 t80 -98.82 159.43 14.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.159 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -55.41 -28.1 52.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.547 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.37 24.39 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 50' ' ' PHE . . . -174.8 132.85 2.31 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.802 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.444 ' NH1' ' CE2' ' A' ' 5' ' ' PHE . 2.7 ttt-85 -116.56 131.96 56.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 0.0 111.14 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.93 139.04 31.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.396 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.37 100.13 5.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 0.0 111.505 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.91 118.45 36.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.438 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 t -122.58 114.73 21.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.926 0.393 . . . . 0.0 111.224 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CD2' ' CD2' ' A' ' 76' ' ' LEU . 4.0 t80 -89.39 111.16 21.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.53 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.75 -179.91 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.104 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.854 0.359 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -127.91 110.96 13.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -105.64 116.84 32.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.651 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.44 122.65 47.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.184 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.59 120.73 4.61 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.89 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.4 ' CB ' ' HA ' ' A' ' 98' ' ' THR . 96.5 p -129.33 145.09 51.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 0.0 111.558 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 11.2 t80 -116.56 110.87 19.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.184 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -126.17 163.91 22.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.383 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -110.27 118.28 35.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.424 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 34.5 p90 -97.86 160.22 14.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.608 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 tp -165.85 124.69 1.14 Allowed Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.803 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' THR . 50.6 Cg_exo -55.55 108.34 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.458 2.106 . . . . 0.0 112.241 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.1 tp . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.153 -179.916 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 5.0 m120 . . . . . 0 C--O 1.232 0.142 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 2.6 t -79.64 153.22 29.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 7.1 mmtp -130.27 91.96 3.2 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.046 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 1.1 tt -67.79 102.81 1.29 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.886 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.435 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 41.5 p90 -110.59 150.85 28.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.71 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.38 132.15 2.5 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.802 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.85 -144.82 4.92 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.605 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.02 158.42 17.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 79' ' ' SER . 9.8 t -130.66 150.54 51.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.004 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.1 tt -160.07 127.01 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.729 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.35 -156.97 8.84 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.612 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.64 124.83 6.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.778 0.323 . . . . 0.0 110.737 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 t -109.88 125.47 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.6 mttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.5 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.806 0.336 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.0 -167.7 19.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.52 134.81 39.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -106.71 142.81 35.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.075 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.78 134.3 9.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.123 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -174.38 -138.98 2.84 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.627 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 pp -155.46 160.95 41.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -156.42 177.64 11.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.157 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.84 142.53 0.08 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.46 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.435 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -155.23 -140.56 3.03 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.005 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 3.5 pt -159.43 120.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.693 0.282 . . . . 0.0 110.262 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.79 109.28 21.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.728 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 3.0 mt-30 -101.08 141.64 33.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.006 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.98 149.21 40.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.769 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 pp -110.18 -39.67 4.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.016 0.436 . . . . 0.0 110.776 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -169.2 -164.87 0.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.368 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -84.88 52.98 2.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 110.603 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.407 ' O ' ' CE1' ' A' ' 177' ' ' TYR . 0.5 OUTLIER -133.06 -55.34 0.92 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.037 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.05 150.15 7.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.156 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.4 t -106.89 169.66 8.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.785 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 tt -132.7 134.7 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.661 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.61 152.32 35.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.984 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -161.79 118.09 0.8 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.29 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.68 -151.68 6.38 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.914 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.27 161.13 32.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 110.81 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -146.87 136.71 23.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.414 ' CD2' ' HA ' ' A' ' 169' ' ' SER . 11.5 m-85 -145.03 127.48 15.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.838 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 pp -156.2 162.47 40.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -103.19 157.72 16.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.849 0.357 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.414 ' HA ' ' CD2' ' A' ' 143' ' ' TYR . 15.7 m -106.87 122.98 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.64 155.15 46.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.742 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -111.71 164.1 13.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.121 0.486 . . . . 0.0 110.161 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.414 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -132.59 126.88 33.79 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.771 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.56 129.96 3.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.563 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.89 -152.94 15.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.831 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.95 172.09 10.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 111.114 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -155.59 119.18 4.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.407 ' CE1' ' O ' ' A' ' 134' ' ' ASN . 13.9 t80 -120.31 115.87 24.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.081 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.39 145.93 30.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.013 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.023 -179.801 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 49' ' ' GLN . 2.0 t0 . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 120.71 0.29 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 1.8 t30 -80.69 156.59 26.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.561 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.9 OUTLIER -156.12 164.56 38.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 111.592 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.4 m -158.02 128.22 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.953 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.73 -146.87 4.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.596 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.38 136.9 25.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.779 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -100.58 151.2 21.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -148.69 128.69 13.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.98 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.38 138.24 13.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.43 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.362 -0.295 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -94.99 110.08 22.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.823 0.344 . . . . 0.0 110.959 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.87 -178.96 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.567 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.59 ' HA2' ' HB2' ' A' ' 60' ' ' GLU . . . -178.17 158.17 22.78 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.081 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 58' ' ' THR . 25.7 mt -106.44 124.82 62.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.18 133.89 49.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.392 0.615 . . . . 0.0 111.084 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.34 111.11 1.21 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.448 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.45 -163.04 12.36 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.188 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -126.41 142.63 51.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.024 0.44 . . . . 0.0 111.298 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.403 ' HG2' ' HB3' ' A' ' 54' ' ' ARG . 0.7 OUTLIER -97.02 162.15 13.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.473 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.52 -169.38 1.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.977 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -32.51 73.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.509 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -127.33 -34.7 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -119.04 -166.05 13.33 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.702 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.403 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . 44.9 ptt85 -162.96 158.54 22.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.0 111.791 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.409 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 12.2 m-85 -118.84 144.26 46.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.846 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -159.12 119.09 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.963 0.411 . . . . 0.0 111.181 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.79 140.33 29.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.817 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 7.1 t -126.18 116.15 20.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -130.11 126.7 38.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 111.763 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.59 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -158.36 -179.91 8.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.948 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.397 179.464 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.79 0.329 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -146.0 119.44 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.106 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.29 145.12 50.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.642 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.06 157.98 33.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 111.342 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.97 116.79 4.23 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.054 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.3 t -98.78 133.69 42.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.97 0.414 . . . . 0.0 111.37 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 12.7 p90 -134.13 112.06 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.185 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -139.16 172.14 13.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.188 0.518 . . . . 0.0 111.558 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.513 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -112.22 118.72 36.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.839 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 20.3 p90 -99.74 166.42 11.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.257 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 tt -167.83 134.79 1.79 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.11 118.48 4.6 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.463 2.109 . . . . 0.0 112.345 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.057 179.925 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.765 0.316 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 p -136.29 151.89 50.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.547 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 5.4 mptt -122.81 92.42 3.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.906 0.384 . . . . 0.0 110.924 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tp -62.23 102.83 0.33 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.706 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 30.2 p90 -112.76 156.03 23.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.781 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.03 128.65 1.5 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -163.99 -132.75 1.38 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.65 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.411 ' HB1' ' CZ ' ' A' ' 80' ' ' TYR . . . -133.25 165.95 23.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.773 0.321 . . . . 0.0 111.235 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 p -136.65 154.94 50.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.89 130.67 5.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.023 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -161.92 -152.76 6.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.679 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mp -148.25 122.26 9.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.4 m -109.82 130.25 63.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.231 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.8 mttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.806 0.336 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -137.88 170.5 23.72 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -84.31 132.68 34.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.323 . . . . 0.0 110.853 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -115.18 143.37 45.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -169.31 137.98 1.96 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.47 -137.86 2.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mp -146.59 157.07 43.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 110.964 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.13 161.87 36.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.594 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 179.59 142.41 0.14 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.461 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -169.5 -135.08 1.84 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.948 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 2.8 pt -158.04 120.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.801 0.334 . . . . 0.0 110.383 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.408 ' CB ' ' HB2' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -94.82 112.99 24.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.551 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 137' ' ' ILE . 4.0 tt0 -96.45 123.94 40.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.147 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.23 149.12 32.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.572 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 tp -105.87 -47.19 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 110.542 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 m -165.72 -164.86 0.76 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -81.37 55.66 2.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.62 -59.13 0.72 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.99 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -154.89 151.36 28.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.101 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 m -113.72 174.28 6.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 129' ' ' GLN . 28.5 mm -134.17 134.9 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.96 141.52 46.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -163.07 121.41 1.02 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -174.85 -138.13 2.66 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.048 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.501 ' CE1' ' CE2' ' A' ' 171' ' ' PHE . 64.6 m-85 -132.76 161.09 34.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.756 0.312 . . . . 0.0 110.758 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -140.83 136.58 32.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -132.02 128.91 39.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.433 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.68 151.44 45.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.379 . . . . 0.0 111.154 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.5 ttt-85 -116.52 163.97 15.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.689 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.005 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.812 0.339 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.9 t -106.96 106.18 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.52 155.24 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.501 ' CE2' ' CE1' ' A' ' 141' ' ' TYR . 0.2 OUTLIER -94.2 165.36 12.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.199 0.523 . . . . 0.0 110.195 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.403 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -131.3 128.46 39.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.809 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.39 135.18 5.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.58 -142.74 6.96 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.774 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -142.88 171.99 13.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -155.59 117.6 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -102.61 111.62 24.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.83 147.01 29.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.083 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.925 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 1.5 t0 . . . . . 0 C--O 1.227 -0.086 0 CA-C-O 120.59 0.233 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.18 125.51 39.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.644 0.259 . . . . 0.0 110.686 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.2 OUTLIER -134.68 139.95 45.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.396 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 37.9 t -150.2 131.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.982 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.36 -162.49 10.76 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.799 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -118.24 142.7 47.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 0.0 110.61 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 p -111.33 118.61 36.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.06 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -128.35 112.88 14.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.696 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -106.97 153.9 16.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.644 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 179.944 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.561 -0.215 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 m -113.38 118.43 34.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -103.99 161.75 13.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.61 -169.36 35.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.605 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mp -134.9 160.0 41.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.026 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.07 139.32 39.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.95 0.405 . . . . 0.0 110.593 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -171.57 120.91 0.49 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.842 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.73 -141.73 3.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.832 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 15.5 pt20 -122.3 142.18 50.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.705 0.288 . . . . 0.0 110.785 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.81 109.68 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 111.089 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -130.57 165.01 23.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.509 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -19.2 65.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.36 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.63 24.09 12.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.31 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 155.98 142.56 3.45 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.526 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.466 ' CD ' ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -136.71 162.09 34.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.319 . . . . 0.0 110.946 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.466 ' CE1' ' CD ' ' A' ' 54' ' ' ARG . 8.9 m-85 77.05 -175.81 0.1 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 79' ' ' SER . 3.4 t80 178.65 -43.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.902 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.43 136.96 55.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 111.396 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.13 119.69 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.565 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -113.55 149.98 33.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.01 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.34 155.91 44.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.985 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.758 0.313 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.74 119.37 24.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.43 114.93 17.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.324 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.472 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.5 OUTLIER -142.93 168.87 18.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 111.399 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.97 116.74 4.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.903 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 56' ' ' TYR . 3.5 m -104.67 126.59 51.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.971 0.415 . . . . 0.0 111.484 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -136.57 110.89 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.198 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -129.21 171.87 12.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.029 0.442 . . . . 0.0 111.651 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.81 119.76 35.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.565 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 50.3 p90 -97.76 172.17 7.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.098 0.475 . . . . 0.0 111.809 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tp -165.09 135.45 3.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.391 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.54 119.26 4.89 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.548 2.165 . . . . 0.0 112.203 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.9 tt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.785 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.815 0.341 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.86 145.09 54.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.348 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 3.6 mmpt? -126.63 92.32 3.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 111.272 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.8 tp -60.54 103.25 0.23 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.051 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 16.6 p90 -110.73 161.76 15.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.292 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.44 126.57 1.05 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.559 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.06 -134.38 1.64 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.621 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.06 157.81 44.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.883 0.373 . . . . 0.0 111.324 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -134.79 161.86 33.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.732 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.29 132.76 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -158.68 -144.69 4.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.986 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.21 130.09 9.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 110.388 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.63 132.84 56.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.178 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.816 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.762 0.315 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -136.51 131.61 5.73 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.546 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -84.17 117.73 23.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.803 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.86 145.13 37.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 141.32 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.954 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.01 -137.08 2.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.541 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mp -145.2 153.31 41.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.195 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.71 172.55 12.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.622 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.89 142.49 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.054 0.454 . . . . 0.0 110.69 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.446 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -169.41 -134.33 1.72 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.721 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 10.8 pt -161.22 120.48 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.318 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tt -95.88 113.32 24.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 111.201 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -100.31 139.27 36.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.756 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -93.34 149.15 21.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.002 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.41 -43.89 2.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 110.584 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 m -142.2 -164.72 1.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.361 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.41 28.8 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.162 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 177.84 34.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.773 0.32 . . . . 0.0 111.132 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.23 129.09 1.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.815 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.1 m -142.97 169.71 17.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.004 0.431 . . . . 0.0 111.29 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -132.52 134.78 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.247 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -128.18 149.19 50.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.925 0.393 . . . . 0.0 111.162 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -165.8 152.8 22.33 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.378 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.13 -131.72 2.22 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.698 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -135.82 152.56 51.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.762 0.315 . . . . 0.0 110.793 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -140.36 123.75 16.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 3.2 m-85 -116.98 124.28 48.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.0 171.39 16.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.182 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.1 ttt85 -152.39 144.32 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.765 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.5 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.408 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 10.6 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.798 0.332 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.83 140.65 39.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.746 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.35 155.28 33.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.081 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.58 141.57 41.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.095 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -119.84 127.51 52.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.989 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.45 129.87 3.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.465 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.76 -156.94 20.1 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.658 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.25 171.98 8.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.84 0.352 . . . . 0.0 111.159 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.451 ' ND2' ' CD1' ' A' ' 5' ' ' PHE . 2.0 t30 -150.8 114.96 5.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -115.38 122.17 45.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.162 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.93 162.91 22.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.224 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.942 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.46 0.075 0 CA-C-O 120.697 0.284 . . . . 0.0 110.667 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.82 118.53 37.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.785 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 1.7 m-85 -124.02 145.11 49.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.003 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.427 HG23 ' CE1' ' A' ' 179' ' ' PHE . 13.3 m -158.15 125.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.181 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.02 -149.06 5.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.64 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.1 159.66 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.819 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.61 127.72 35.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 36.9 t90 -128.33 112.99 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.687 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.83 168.58 13.99 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 110.868 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.439 -0.265 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.8 m -137.16 107.86 6.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.943 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.426 ' CE3' ' CD1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -120.35 146.55 46.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.27 -164.83 25.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.512 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.0 161.16 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.446 ' NE ' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -130.8 137.17 49.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.996 0.427 . . . . 0.0 110.693 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -174.16 122.51 0.3 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.825 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.64 -145.47 4.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.656 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -146.45 126.1 13.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.0 111.009 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.416 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -94.13 109.6 21.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.096 0.474 . . . . 0.0 111.278 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -105.09 155.2 19.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.474 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.38 -18.6 65.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.384 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -130.68 24.26 5.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.318 . . . . 0.0 111.172 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 50' ' ' PHE . . . 168.72 163.62 23.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.931 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -145.0 141.04 28.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.93 0.395 . . . . 0.0 111.532 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.35 146.61 26.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.035 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CD1' ' NE ' ' A' ' 45' ' ' ARG . 6.7 m-85 -143.87 96.9 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.381 . . . . 0.0 111.683 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.87 139.25 30.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.099 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.75 124.93 18.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.067 0.461 . . . . 0.0 111.714 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 76' ' ' LEU . 3.3 t80 -101.5 104.67 15.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.846 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.95 153.63 19.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.086 0.47 . . . . 0.0 111.489 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.461 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.785 0.326 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -124.89 111.06 15.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.002 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.409 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -118.96 116.95 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.654 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 pp -135.38 146.3 48.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 0.0 111.405 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.18 116.9 4.23 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.956 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.4 p -105.9 119.95 40.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.629 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.45 110.88 23.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.963 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.41 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 1.7 m-20 -128.08 161.11 29.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.147 0.499 . . . . 0.0 111.842 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.85 119.12 38.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.221 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 35.1 p90 -97.32 158.11 15.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.994 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -165.33 125.98 1.33 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.733 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.99 100.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.614 2.209 . . . . 0.0 112.229 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 93' ' ' LEU . 18.8 tt . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.113 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 18.4 m120 . . . . . 0 CA--C 1.527 0.081 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -79.47 153.29 29.72 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -130.73 92.1 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.999 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -64.26 102.06 0.48 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.771 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 46.3 p90 -111.92 120.94 43.63 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.604 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.41 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -140.72 147.35 18.99 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.777 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.46 -139.08 3.52 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.813 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.57 176.2 5.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.891 0.377 . . . . 0.0 111.182 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 p -146.48 145.54 30.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.07 131.15 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.53 -151.89 5.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.652 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.07 125.82 7.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.797 0.332 . . . . 0.0 110.746 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.1 p -110.31 142.83 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.252 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 179.874 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.815 0.341 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -142.72 149.6 21.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.335 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -119.24 114.97 23.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.02 139.23 48.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.75 130.61 5.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -175.43 -138.19 2.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mp -148.04 171.31 16.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -152.17 168.74 24.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.957 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . -175.15 142.06 0.6 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.96 0.41 . . . . 0.0 110.554 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 93' ' ' LEU . . . -168.28 -146.74 5.08 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.783 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 1.8 pp -161.04 120.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 2.1 tt -95.95 113.41 25.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.942 0.401 . . . . 0.0 111.19 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 3.0 tt0 -95.17 115.84 27.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.14 149.21 24.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mp -107.66 -39.67 5.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.691 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.1 p -169.05 -164.88 0.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.395 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -83.55 55.16 3.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.865 0.364 . . . . 0.0 110.73 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -140.35 -59.99 0.53 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.002 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.47 157.33 27.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.1 p -135.4 -177.3 4.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.128 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 175' ' ' ALA . 2.4 pt -129.65 134.82 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.617 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -123.86 140.62 52.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.46 143.94 9.2 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.392 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.07 -144.94 5.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.649 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.75 158.38 40.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -144.67 140.26 28.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 2.8 p90 -145.06 105.06 4.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.969 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.85 153.97 47.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -108.58 147.86 31.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.839 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.961 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.805 0.336 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 72.3 p -106.94 120.55 42.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.694 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -146.66 155.15 42.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.985 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -104.58 165.38 11.1 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.14 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.47 127.27 37.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.044 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.52 129.95 3.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.471 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.84 -152.74 15.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.747 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -124.86 171.9 9.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 111.218 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.65 114.92 5.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -106.2 114.22 28.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.0 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.95 163.39 22.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.024 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.427 ' CE1' HG23 ' A' ' 6' ' ' VAL . 4.2 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.714 0.292 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -112.08 132.88 54.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.801 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -131.41 139.59 49.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.973 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.1 t -156.14 125.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.081 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.98 -128.12 1.0 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.739 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -159.19 167.91 27.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.748 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.45 150.22 35.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.982 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -110.47 117.09 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.823 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.5 137.51 13.73 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.529 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 0.0 110.917 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.1 p -137.72 107.99 6.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -91.6 131.22 37.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.682 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.9 -175.81 20.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.796 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.417 HG21 HD11 ' A' ' 44' ' ' ILE . 4.0 mt -106.94 168.6 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.56 0.219 . . . . 0.0 110.698 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.458 ' CZ ' ' CE1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -138.4 142.78 39.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.051 0.453 . . . . 0.0 110.828 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -170.48 120.23 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.965 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -161.57 -156.8 8.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.577 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.461 ' HB2' ' CE2' ' A' ' 55' ' ' TYR . 5.9 mt-30 -141.44 133.39 27.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.087 0.47 . . . . 0.0 111.074 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.441 ' HA ' ' CB ' ' A' ' 54' ' ' ARG . 8.1 tt0 -83.55 162.06 20.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.849 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.02 -169.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.647 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -67.24 -40.37 86.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.237 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -123.18 -26.61 4.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.732 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -124.29 -159.83 10.56 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.689 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' CB ' ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -171.64 168.09 6.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.632 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -141.23 166.68 24.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.424 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.586 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 41.3 p90 177.92 135.73 0.08 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.092 0.473 . . . . 0.0 110.888 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.51 155.78 18.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.257 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.1 p -137.58 123.78 20.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.055 0.455 . . . . 0.0 111.454 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.89 108.69 19.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.173 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -105.99 178.68 4.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.092 0.472 . . . . 0.0 111.503 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.54 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.758 0.313 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.02 110.87 17.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.805 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.17 115.72 30.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.638 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.414 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 1.8 mp -133.12 133.66 43.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.4 . . . . 0.0 111.298 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.89 116.91 4.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.944 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.6 t -105.25 135.6 46.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 111.576 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -128.71 110.95 12.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.899 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -136.52 172.13 13.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.233 0.54 . . . . 0.0 111.866 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.469 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -115.42 121.89 44.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.547 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 18.9 p90 -97.71 164.66 12.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.737 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.04 128.15 1.23 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.389 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.57 106.92 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.445 2.097 . . . . 0.0 112.362 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.2 mt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.988 179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.6 p30 . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.659 0.266 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.5 p -136.59 130.51 32.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.714 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -117.31 92.82 3.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.896 0.379 . . . . 0.0 110.881 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.17 103.02 0.09 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.596 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 22.6 p90 -110.93 156.17 21.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.802 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.43 135.21 2.94 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.712 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.91 -137.59 2.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.653 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -124.87 161.74 25.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.855 0.359 . . . . 0.0 111.19 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.7 m -139.49 148.63 42.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.5 mp -157.1 130.82 8.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -141.46 -162.7 9.26 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.121 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 mp -155.6 142.54 19.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.407 ' CG2' ' HA3' ' A' ' 118' ' ' GLY . 35.0 m -109.56 145.41 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.416 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.86 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.821 0.343 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.407 ' HA3' ' CG2' ' A' ' 102' ' ' VAL . . . -161.11 132.4 2.86 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.275 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -113.97 114.97 26.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.876 0.37 . . . . 0.0 111.05 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.73 138.24 54.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.746 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.96 132.75 5.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.448 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.39 -140.05 3.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.765 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.3 mt -147.64 164.78 32.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -149.74 170.54 18.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.704 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.92 142.56 0.08 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.988 0.423 . . . . 0.0 110.851 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.453 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -164.53 -128.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.759 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.452 ' N ' ' CE2' ' A' ' 94' ' ' PHE . 12.6 pt -160.59 121.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 120.794 0.33 . . . . 0.0 110.296 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 5.0 tt -94.48 113.28 25.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.008 0.432 . . . . 0.0 110.857 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -95.63 124.18 39.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -111.56 149.14 31.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.7 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.6 tp -108.24 -45.9 3.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.118 0.485 . . . . 0.0 110.635 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.7 p -169.21 -164.85 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.189 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.55 54.96 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.913 0.387 . . . . 0.0 110.569 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -138.25 -58.2 0.65 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.16 171.95 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.197 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.9 m -141.03 167.73 21.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.4 mt -129.26 134.87 63.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.444 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -127.95 132.09 49.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . -155.28 144.49 11.08 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.554 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 171' ' ' PHE . . . 176.14 -151.41 11.58 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.366 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 170' ' ' GLN . 0.2 OUTLIER -119.75 153.45 35.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.902 0.382 . . . . 0.0 110.916 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.415 ' HB3' ' CE1' ' A' ' 172' ' ' TYR . 29.1 ptt180 -131.89 129.99 41.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 169' ' ' SER . 7.3 t80 -128.59 102.23 6.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.779 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.72 164.04 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.196 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.2 153.89 18.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.718 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.789 0.328 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.422 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 83.4 p -107.9 122.59 47.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.805 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . 0.407 ' O ' ' CD1' ' A' ' 141' ' ' TYR . 1.6 mt-30 -141.58 152.11 43.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.417 ' CD1' HD23 ' A' ' 173' ' ' LEU . 2.7 t80 -100.04 120.55 40.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.265 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 142' ' ' ARG . 9.7 p90 -125.07 126.44 45.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.234 0.54 . . . . 0.0 111.428 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.581 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 1.4 pt? -147.46 155.47 41.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.858 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -176.73 -132.73 1.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.401 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.85 169.41 16.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 0.0 111.128 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -158.05 118.35 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.022 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -101.57 118.27 36.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 154.79 20.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 110.661 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -112.28 119.19 37.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.744 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 29.0 p90 -124.05 155.29 38.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.256 0.55 . . . . 0.0 111.469 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 7.5 p -151.91 128.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.732 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.74 -141.6 3.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.373 -0.917 . . . . 0.0 112.754 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.5 165.54 23.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.896 0.379 . . . . 0.0 110.799 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.1 p -129.17 143.95 51.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -140.9 112.96 7.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.689 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.88 135.24 10.98 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.6 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 110.823 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.2 p -119.2 139.43 51.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 111.028 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -148.45 139.94 23.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -177.3 -164.89 31.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.605 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -106.86 161.74 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.584 0.23 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.99 148.7 40.74 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.606 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -177.22 124.38 0.14 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -161.57 -163.11 13.84 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.308 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 3.4 mp0 -118.34 125.97 51.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 0.0 111.001 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.461 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 37.5 tt0 -111.79 109.97 20.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.196 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -119.41 160.11 22.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.521 179.339 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.75 -23.29 64.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.197 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -99.29 24.09 8.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.242 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 50' ' ' PHE . . . 133.4 164.57 10.83 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.337 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.401 ' NE ' ' CZ ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -139.44 146.03 39.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.918 0.39 . . . . 0.0 111.314 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -129.78 161.23 31.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.408 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.553 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 15.9 p90 -176.97 126.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.166 0.508 . . . . 0.0 111.525 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.71 139.06 31.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.284 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.3 m -129.57 117.29 20.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 111.529 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -94.32 117.17 29.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.319 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -111.82 175.4 5.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 111.266 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.731 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.777 0.323 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -114.57 112.54 23.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 tt -98.28 114.95 27.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.49 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.11 113.58 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.278 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.01 116.95 4.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.623 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 12.3 m -126.41 143.02 51.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 0.0 111.831 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -131.79 110.67 11.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.502 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.44 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 15.8 m-20 -130.55 166.06 21.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.214 0.531 . . . . 0.0 112.017 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.08 127.95 53.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.045 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 94' ' ' PHE . 45.4 p90 -97.36 168.72 10.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.143 0.497 . . . . 0.0 111.778 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tp -158.9 132.4 4.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.235 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.17 106.04 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.32 2.014 . . . . 0.0 112.401 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.7 mm . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.002 179.807 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.979 0.418 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 p -136.48 142.7 43.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.463 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 13.6 mmtt -123.52 98.92 6.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 7.8 tt -55.32 104.54 0.13 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.381 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -109.42 145.88 35.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.606 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.21 140.54 6.47 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.067 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 179.45 -146.82 7.29 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.004 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -109.07 -178.02 3.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 111.257 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.51 161.44 39.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.4 mt -147.86 130.27 15.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.34 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.37 123.64 4.02 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.378 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tp -143.87 120.9 11.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.845 0.355 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.9 m -109.8 145.26 16.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.138 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.956 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.458 -0.037 0 CA-C-O 120.9 0.381 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.62 149.42 19.23 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.48 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -114.25 127.93 56.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -133.86 148.82 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.11 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -171.98 134.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.85 -124.9 0.74 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.615 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 97' ' ' ALA . 86.7 mt -141.05 169.65 17.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -158.65 153.49 24.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.376 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -178.26 142.57 0.26 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.131 0.491 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -163.12 -125.0 0.74 Allowed Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.553 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 1.7 pt -160.79 120.62 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.708 0.29 . . . . 0.0 110.351 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 1.2 tt -95.0 115.21 27.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.446 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -94.58 152.97 18.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.215 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -108.13 149.08 28.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 tp -121.0 -39.1 2.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.929 0.395 . . . . 0.0 110.824 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 t -158.96 -164.57 1.44 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.353 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.41 30.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.102 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.6 p30 178.32 34.96 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.16 119.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.74 172.1 11.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.989 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.9 mp -137.64 135.55 46.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.764 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 127.57 51.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -146.74 122.77 1.66 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.291 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.98 -147.61 5.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.885 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -135.85 161.13 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 0.0 110.922 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -133.25 149.03 52.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.667 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.76 109.97 5.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -151.89 164.6 36.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.068 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -112.35 146.61 37.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.846 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.762 0.315 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 11.7 m -107.0 131.23 54.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.774 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -138.68 155.2 48.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -114.21 165.17 12.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.056 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -138.35 129.34 26.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.252 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.66 129.89 3.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.596 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.35 -156.0 18.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.775 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -129.6 171.96 12.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 111.008 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -151.56 116.1 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.91 111.77 24.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.712 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 3.7 mttp -81.86 150.91 27.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.226 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.767 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.804 0.335 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -112.13 142.03 45.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.815 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CD1' ' NH2' ' A' ' 54' ' ' ARG . 18.0 m-85 -131.24 142.18 50.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.773 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -159.52 121.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.156 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.56 -140.33 2.89 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.652 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.21 146.93 49.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.2 m -116.74 129.36 56.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -124.75 112.97 17.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.682 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.1 134.41 11.71 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.719 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.834 0.349 . . . . 0.0 110.777 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.05 127.92 53.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -125.34 123.59 39.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.79 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.36 -164.85 16.09 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.553 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 pt -107.04 162.03 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 111.087 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.31 138.94 51.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.759 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -168.61 119.86 0.78 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.62 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.49 -159.33 8.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.945 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -143.26 116.67 9.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 0.0 110.74 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.412 ' HA ' ' CG ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -83.79 148.34 27.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.22 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -132.42 -166.74 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.291 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.62 -47.18 84.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.225 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -135.91 12.01 3.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.821 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -148.1 153.58 25.36 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.561 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.469 ' NH2' ' CD1' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -141.72 144.65 34.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.607 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -89.29 153.71 20.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.012 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.439 ' CE1' ' HD2' ' A' ' 54' ' ' ARG . 58.2 m-85 -133.24 103.34 5.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.362 . . . . 0.0 111.422 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.29 122.74 48.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.318 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 p -141.1 128.96 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.048 0.451 . . . . 0.0 111.268 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.411 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 3.1 m-85 -89.42 119.27 29.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.078 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -101.92 163.51 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.943 0.402 . . . . 0.0 111.54 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.637 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.665 0.269 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -144.65 112.6 6.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.411 HD11 ' CZ ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -82.99 136.92 34.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.601 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.72 142.52 47.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 111.205 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.1 116.8 0.74 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.73 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.5 p -139.25 143.21 37.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.468 . . . . 0.0 111.614 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 110.96 21.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.826 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -127.91 172.06 11.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.208 0.528 . . . . 0.0 111.787 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -119.11 118.8 32.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.44 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 21.9 p90 -97.73 161.53 13.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.086 0.47 . . . . 0.0 111.659 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.04 138.57 3.86 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.493 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.8 117.74 4.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.38 2.053 . . . . 0.0 112.532 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.5 mm . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.933 179.686 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.75 0.31 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 p -75.85 153.13 37.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.435 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -131.5 92.49 3.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 111.047 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.2 103.12 0.35 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.316 0.579 . . . . 0.0 110.497 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.459 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 24.0 p90 -110.96 154.53 23.99 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.477 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.03 139.9 4.84 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.815 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.68 -135.31 2.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.73 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.86 155.66 20.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.9 m -128.34 148.34 50.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.121 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 120.99 3.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.682 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.98 -155.92 8.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.63 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.19 127.0 7.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.822 0.344 . . . . 0.0 110.661 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -109.83 122.06 63.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 -179.954 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.826 0.346 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.33 162.75 12.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.82 130.28 56.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.47 140.6 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.75 131.27 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -176.28 -131.03 1.41 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.605 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mp -148.93 157.72 43.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.346 . . . . 0.0 111.004 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -143.12 164.97 28.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.748 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . 179.53 142.59 0.14 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.99 0.424 . . . . 0.0 110.699 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.459 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -164.03 -136.19 1.95 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.994 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 5.1 pt -161.92 120.97 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.408 ' CD1' ' NH2' ' A' ' 54' ' ' ARG . 9.2 tt -94.46 111.31 23.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 110.745 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -97.07 116.85 30.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.944 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.09 148.98 21.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.995 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.8 -30.02 8.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.611 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -165.34 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.491 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -89.45 52.34 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.8 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.63 -35.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.22 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.78 125.95 49.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.871 0.367 . . . . 0.0 111.216 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 m -126.46 163.63 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.4 mt -135.48 134.93 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.817 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.49 139.19 48.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.95 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -160.74 111.14 0.47 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.333 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -162.48 -150.18 5.92 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.07 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -139.18 161.03 38.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.402 ' O ' ' CD1' ' A' ' 143' ' ' TYR . 5.7 ttp-105 -137.73 140.55 40.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 142' ' ' ARG . 15.7 m-85 -140.3 115.27 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.53 174.01 14.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -132.82 160.38 37.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.861 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.812 0.339 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.9 t -106.93 115.9 31.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -124.01 155.09 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -126.53 140.47 52.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.447 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.424 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -122.3 126.95 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.738 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.42 130.02 3.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.62 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.02 -153.39 18.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.849 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -122.19 172.18 8.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.32 . . . . 0.0 111.065 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -155.18 117.67 4.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.152 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -107.39 111.87 24.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.694 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.427 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . 8.8 pttt -86.87 157.96 19.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.081 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.829 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.46 0.062 0 CA-C-O 120.763 0.315 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -112.02 140.53 46.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.476 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 52.6 p90 -148.54 167.53 25.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.126 0.489 . . . . 0.0 111.661 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 46.2 t -155.85 137.4 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.791 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.49 -147.17 4.88 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.803 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.34 163.05 32.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.657 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.67 141.5 44.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -126.29 112.93 16.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.63 136.01 15.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.404 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 110.942 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.7 p -142.99 107.99 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -89.78 124.97 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.764 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.19 -169.24 12.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.688 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 58' ' ' THR . 13.9 tt -119.66 162.39 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.52 0.2 . . . . 0.0 110.897 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.1 142.69 46.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.924 0.392 . . . . 0.0 110.73 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -169.34 119.32 0.68 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.253 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -170.61 -139.06 2.65 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.673 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.1 143.53 25.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.805 0.336 . . . . 0.0 110.985 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 14.1 pt20 -118.13 109.84 16.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.215 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -87.69 166.83 14.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.805 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.15 -21.42 65.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.329 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.12 24.25 11.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.42 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.43 169.15 28.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.454 ' CZ ' ' CD2' ' A' ' 83' ' ' PHE . 11.7 ttp180 -141.0 125.85 18.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.367 . . . . 0.0 111.231 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -117.6 150.07 39.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.346 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.506 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 28.2 p90 -177.97 127.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.079 0.466 . . . . 0.0 111.222 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.72 142.93 27.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.222 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 9.4 t -132.92 120.73 21.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 0.0 111.608 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CD1' HD11 ' A' ' 76' ' ' LEU . 4.1 m-85 -91.14 123.97 34.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.194 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.03 170.44 7.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.951 0.405 . . . . 0.0 111.305 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.685 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.789 0.328 . . . . 0.0 110.697 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -121.91 110.93 16.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.102 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.426 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -119.31 121.01 38.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.66 157.8 44.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 111.264 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.66 116.76 3.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.266 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.92 122.23 40.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.879 0.371 . . . . 0.0 111.065 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -117.06 110.87 18.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.475 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.61 161.42 31.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 111.289 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -113.29 120.23 40.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.376 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 48.3 p90 -97.58 161.04 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.575 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.93 122.63 1.7 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.585 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.51 116.52 3.14 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.501 2.134 . . . . 0.0 112.308 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.6 tt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.089 179.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 120.95 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.551 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.59 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 17.3 mmtm -119.5 92.78 3.87 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.212 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 tp -59.54 103.34 0.19 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.344 0.592 . . . . 0.0 110.758 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 36.3 p90 -110.73 159.06 17.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.885 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.81 142.11 5.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.11 -141.07 3.7 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.725 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.95 169.08 15.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.865 0.364 . . . . 0.0 111.147 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.6 p -138.66 150.84 46.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.806 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 mp -160.15 132.08 6.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.29 -154.54 6.5 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.822 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -155.21 128.0 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.8 m -109.85 145.0 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.237 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.836 0.35 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.47 134.52 3.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.41 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -93.49 131.72 38.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.89 149.16 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.082 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.47 135.48 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -157.97 -140.46 2.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.573 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.1 mp -153.06 172.02 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.906 0.384 . . . . 0.0 110.806 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.41 161.97 40.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.821 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 141' ' ' TYR . . . 176.94 142.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.773 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.92 -130.41 1.25 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.736 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -156.65 120.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -94.91 115.52 27.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.191 0.52 . . . . 0.0 111.14 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -98.94 114.87 27.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.618 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.45 144.35 34.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.75 -30.53 8.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 110.431 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.24 -170.39 1.68 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.017 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -85.96 53.78 2.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.81 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 176.31 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -122.38 143.69 49.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.982 0.42 . . . . 0.0 111.731 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.0 m -156.08 164.83 37.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.687 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.9 pt -143.64 136.35 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -126.28 176.88 6.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . -174.98 143.37 6.76 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.583 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.89 -139.35 3.95 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.016 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 125' ' ' ALA . 19.1 p90 -120.03 161.08 21.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 0.0 111.051 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -151.11 140.36 21.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.01 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -112.01 162.9 14.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.532 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 tt -153.68 145.72 23.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.173 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.3 ttm-85 -126.12 152.88 45.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.64 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.071 -179.791 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.788 0.327 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 m -107.02 136.16 47.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -152.24 155.07 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 141' ' ' TYR . 88.5 m-85 -113.97 125.56 54.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.671 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -127.97 126.67 41.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.14 0.495 . . . . 0.0 111.263 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.528 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 3.1 pp -150.73 145.97 26.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.702 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.33 -149.02 6.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.674 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -121.0 168.74 11.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -153.89 116.14 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -99.14 114.87 27.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.038 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -81.42 153.78 26.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.063 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t70 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -75.26 131.3 40.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 10.3 t80 -126.9 139.61 52.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.802 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.4 m -159.56 126.15 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.247 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -147.95 -144.57 4.01 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.87 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mt -126.9 158.86 35.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.745 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 m -125.61 139.28 53.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.034 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -153.1 112.98 3.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.753 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.18 131.48 9.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.516 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 0.0 110.845 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.9 m -95.18 118.62 32.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -123.51 126.24 46.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.02 -174.42 22.66 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.685 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.42 176.83 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.605 0.241 . . . . 0.0 111.054 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 -135.97 145.88 46.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.042 0.449 . . . . 0.0 110.723 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -175.37 119.95 0.18 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.075 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.82 -136.91 2.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.577 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.78 113.0 8.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.39 . . . . 0.0 110.902 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -134.57 128.73 33.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.081 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' O ' ' CZ ' ' A' ' 83' ' ' PHE . 1.2 t80 -105.23 -166.96 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.41 -27.48 6.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 0.0 110.945 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -115.27 24.16 11.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.845 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 82' ' ' ALA . . . 71.82 -155.55 52.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.274 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER 161.73 -82.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.684 0.278 . . . . 0.0 110.965 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -142.46 163.19 33.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.999 0.428 . . . . 0.0 111.23 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 79' ' ' SER . 2.3 p90 -166.01 117.86 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.743 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.72 147.65 23.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.709 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.9 p -139.1 123.49 18.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.965 0.412 . . . . 0.0 111.071 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -91.9 124.61 36.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.5 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -117.49 163.91 15.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 111.105 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.778 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.744 0.307 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -138.04 125.73 22.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.995 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mt -106.98 114.9 29.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.61 118.3 34.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.956 0.408 . . . . 0.0 111.45 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.28 116.86 3.45 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 66.1 m -130.91 134.16 46.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.481 . . . . 0.0 112.231 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 7.5 t80 -105.52 110.7 23.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.105 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 94' ' ' PHE . 3.5 m-20 -136.59 172.16 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.22 0.533 . . . . 0.0 112.084 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.481 ' HA ' ' HA3' ' A' ' 53' ' ' GLY . . . -137.62 124.18 20.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.637 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.466 ' HB3' ' CD1' ' A' ' 94' ' ' PHE . 55.1 p90 -97.78 162.8 13.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.344 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.27 137.77 5.54 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.657 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.59 112.06 3.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.462 2.108 . . . . 0.0 112.296 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.082 179.993 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.669 0.271 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.5 p -136.16 144.16 44.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.639 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 34.5 mttp -122.38 102.05 7.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 0.0 110.729 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 7.3 tp -55.34 102.95 0.08 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.406 0.622 . . . . 0.0 110.347 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 81' ' ' ASP . 5.2 t80 -110.58 142.09 42.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.175 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.31 156.02 20.26 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.425 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 168.68 -140.57 6.25 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.732 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.85 172.94 6.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.609 0.242 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.6 p -142.16 170.04 16.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.175 0.512 . . . . 0.0 111.631 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.44 131.99 11.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.982 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.82 123.41 4.47 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.668 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -136.27 120.62 18.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.955 0.407 . . . . 0.0 110.304 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.88 142.57 21.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.271 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 mttp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.828 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.805 0.336 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.38 178.28 19.92 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.52 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.75 117.86 21.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.44 151.23 40.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.15 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.03 131.55 0.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.038 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -163.24 -124.94 0.73 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.55 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mp -154.36 174.33 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.961 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.48 170.5 20.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.687 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . 177.0 142.48 0.08 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.991 0.424 . . . . 0.0 110.928 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -163.3 -132.27 1.32 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.726 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 0.8 OUTLIER -161.78 120.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -98.17 116.29 30.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.044 0.45 . . . . 0.0 110.979 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -95.15 143.32 26.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -110.27 149.08 30.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.69 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.92 -48.79 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.015 0.436 . . . . 0.0 110.593 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.16 -164.97 0.49 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.193 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.09 57.74 2.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.888 0.375 . . . . 0.0 110.501 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -142.12 -61.06 0.45 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.29 171.98 15.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.118 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.85 167.92 20.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.027 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.1 tt -132.74 134.67 58.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.63 172.22 12.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.018 0.437 . . . . 0.0 111.402 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.31 146.79 7.61 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.992 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.43 -147.7 5.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.057 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.41 ' OH ' ' CZ ' ' A' ' 171' ' ' PHE . 30.5 m-85 -126.13 146.91 49.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.96 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -125.51 132.74 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.726 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.77 116.36 20.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 pp -156.45 159.21 38.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.844 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.67 137.57 52.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.859 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.88 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 10.4 m . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.841 0.353 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.3 t -106.97 123.29 47.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.51 155.29 47.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.997 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.41 ' CZ ' ' OH ' ' A' ' 141' ' ' TYR . 1.1 m-85 -96.85 165.24 12.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.265 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.18 129.26 15.52 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.08 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.2 tt -163.42 129.99 3.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.572 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.58 -165.14 26.48 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.566 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.67 172.16 6.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.767 0.317 . . . . 0.0 111.013 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.413 ' ND2' ' CE1' ' A' ' 5' ' ' PHE . 17.4 t-20 -145.23 114.5 7.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.682 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -143.23 111.8 6.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.254 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -85.9 157.03 20.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.624 0.249 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -83.22 128.08 34.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 0.0 110.712 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.2 m-85 -127.52 140.0 52.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.8 128.07 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.38 -151.63 6.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.718 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mt -132.01 149.43 52.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -110.39 149.3 30.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -152.77 113.04 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.748 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.07 133.77 11.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.436 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.909 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.7 p -119.57 107.92 13.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 110.975 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -119.29 129.88 55.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.94 -164.99 21.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.573 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 58' ' ' THR . 12.2 pt -107.67 162.48 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.66 0.267 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -132.78 138.11 47.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.55 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 5' ' ' PHE . . . -173.14 122.08 0.38 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.005 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.14 -137.8 2.38 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.87 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -145.48 120.4 9.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.431 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 2.3 tt0 -101.67 112.07 24.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.371 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.436 ' CE2' ' HA3' ' A' ' 53' ' ' GLY . 0.9 OUTLIER -119.57 163.82 16.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.741 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -17.76 65.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.494 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.12 24.37 13.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.642 0.258 . . . . 0.0 111.286 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.436 ' HA3' ' CE2' ' A' ' 50' ' ' PHE . . . 145.86 167.33 12.5 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.333 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -134.09 115.26 14.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 0.0 111.285 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -91.87 126.33 36.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.901 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.455 ' CE1' ' ND2' ' A' ' 176' ' ' ASN . 0.5 OUTLIER -133.4 103.08 5.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 0.0 111.815 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.32 119.62 36.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.861 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 1.6 t -128.6 122.74 31.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.147 0.498 . . . . 0.0 111.438 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -86.79 124.52 33.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.474 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.04 166.96 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 0.0 111.216 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.754 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.424 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 3.1 pm0 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.666 0.27 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -143.98 111.01 5.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.139 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.417 ' HG ' ' CZ ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -85.46 145.94 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.406 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mp -139.54 107.91 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 111.385 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.78 119.67 4.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.746 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.427 ' CB ' ' HA ' ' A' ' 98' ' ' THR . 24.3 p -130.5 150.44 51.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.869 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.51 110.86 18.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.904 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.448 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 1.8 m-20 -124.17 153.35 41.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 111.622 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -100.65 118.56 37.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.231 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 43.8 p90 -97.54 153.75 17.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.826 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.34 143.07 10.84 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.731 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.64 91.71 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.691 2.261 . . . . 0.0 112.262 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.0 tt . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.014 -179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.101 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.12 153.22 28.84 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -131.18 92.42 3.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.99 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 1.4 tt -61.74 102.22 0.25 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.279 0.562 . . . . 0.0 110.1 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 23.0 p90 -111.01 120.79 43.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.518 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.448 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -142.78 151.42 23.1 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.815 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.33 -140.09 4.66 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.561 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.43 150.66 47.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 0.0 111.091 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.427 ' HA ' ' CB ' ' A' ' 79' ' ' SER . 11.6 t -118.93 153.36 34.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.18 129.09 4.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.589 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.74 -149.18 4.97 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.856 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tt -155.21 129.21 8.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 0.0 110.49 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 m -109.76 128.44 65.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.245 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.786 0.327 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.67 -163.33 13.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.566 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -96.0 123.09 39.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.98 146.82 23.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -168.85 140.81 2.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.941 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -163.74 -136.91 2.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.71 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.08 155.03 40.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.788 0.328 . . . . 0.0 110.882 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . 0.44 ' NE2' ' CE2' ' A' ' 172' ' ' TYR . 0.5 OUTLIER -138.57 158.37 44.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.996 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . -176.36 141.98 0.44 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.471 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 93' ' ' LEU . . . -175.08 -146.57 5.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.923 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 9.5 pt -162.26 120.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 122.69 0.396 . . . . 0.0 110.01 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 7.8 tp -94.73 111.92 23.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.969 0.414 . . . . 0.0 110.851 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 4.3 tt0 -102.5 131.16 49.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -97.28 149.17 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.66 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.75 -45.07 4.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.98 0.419 . . . . 0.0 110.613 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -164.86 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.105 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.52 55.77 2.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.391 . . . . 0.0 110.69 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -139.06 -58.68 0.6 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.024 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.06 163.01 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.987 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.7 t -116.15 170.4 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 129' ' ' GLN . 2.1 mp -129.98 134.75 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.568 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.422 ' CG ' ' CE1' ' A' ' 94' ' ' PHE . 8.1 tt0 -123.83 147.04 47.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.961 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.62 141.66 7.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.402 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.51 -135.83 2.75 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.464 -0.875 . . . . 0.0 112.778 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -133.79 161.21 35.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 0.0 110.881 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.72 147.49 29.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.85 140.51 50.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.643 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 tt -117.35 137.09 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.144 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.05 117.8 3.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.633 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.008 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.8 0.333 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.9 129.5 54.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -139.52 155.2 47.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.41 165.14 11.21 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.159 0.504 . . . . 0.0 110.28 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.44 ' CE2' ' NE2' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -138.29 129.47 27.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.889 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.1 tp -163.32 135.15 5.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.93 -152.69 16.74 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.64 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -130.26 171.31 13.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.455 ' ND2' ' CE1' ' A' ' 56' ' ' TYR . 14.5 m120 -151.57 114.98 4.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.082 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -116.72 117.71 30.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.674 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.86 162.41 22.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.205 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 49' ' ' GLN . 10.8 m-20 . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 120.786 0.327 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 178' ' ' LYS . 2.8 t30 -71.41 131.58 43.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.584 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.1 m-85 -123.98 139.9 53.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 21.4 t -150.48 122.34 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.08 -135.33 1.84 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.619 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mp -144.95 166.66 24.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.743 0.306 . . . . 0.0 110.819 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -136.83 146.52 45.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.165 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -153.0 117.54 4.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.664 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 172' ' ' TYR . . . -136.1 -176.08 14.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.466 -0.874 . . . . 0.0 113.021 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.91 -179.896 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.9 p -140.61 107.93 5.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 0.0 111.016 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -135.15 158.32 44.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.814 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.06 -166.95 32.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.768 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 58' ' ' THR . 9.4 mt -107.63 163.74 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.428 0.156 . . . . 0.0 110.828 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -135.87 138.52 42.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.934 0.397 . . . . 0.0 110.834 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -171.05 119.8 0.51 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.255 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -162.5 -133.63 1.51 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.683 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -155.73 148.81 24.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 111.0 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.451 ' NE2' ' CZ ' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -100.7 162.57 12.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.756 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -133.29 165.78 24.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.915 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -24.65 65.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.371 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.2 24.13 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.448 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.77 177.49 46.61 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.447 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.413 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . 13.2 ttp-105 -143.91 140.58 29.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 111.074 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -124.43 149.44 46.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.578 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.509 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 34.0 p90 -178.28 126.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.75 162.77 14.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.527 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 49.7 p -141.05 124.46 16.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.07 0.462 . . . . 0.0 111.517 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.45 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 9.2 m-85 -92.51 116.57 29.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.957 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.06 178.37 4.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.029 0.442 . . . . 0.0 111.569 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.51 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.834 0.349 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -120.87 114.64 21.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.45 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -98.32 128.94 44.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.496 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.408 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 2.2 mt -138.87 131.07 28.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.891 0.377 . . . . 0.0 111.183 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.76 116.82 4.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.578 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.65 126.28 52.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.956 0.408 . . . . 0.0 111.768 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 20.1 p90 -125.39 110.7 14.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.758 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -133.31 166.1 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.036 0.446 . . . . 0.0 111.507 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -109.63 118.33 36.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.173 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 48.5 p90 -97.85 167.62 10.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.827 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.7 tp -160.56 121.08 1.65 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.577 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.53 114.69 1.43 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.493 2.129 . . . . 0.0 112.541 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.152 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.786 0.326 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.04 150.71 16.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.483 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 2.4 mptm? -132.06 92.48 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.334 . . . . 0.0 111.45 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 9.0 tt -63.23 102.96 0.44 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.137 0.494 . . . . 0.0 109.848 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 45.6 p90 -110.71 159.7 17.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.34 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.26 126.79 1.31 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.783 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.99 -140.29 2.89 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.415 ' HB1' ' CZ ' ' A' ' 80' ' ' TYR . . . -128.74 178.83 6.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 111.156 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.3 p -144.08 152.13 40.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.238 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.11 131.37 5.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.59 -140.56 3.05 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.909 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.14 125.94 7.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 110.734 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.86 140.18 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.824 179.961 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.812 0.339 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.51 175.56 38.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.96 136.19 34.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.94 139.68 30.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.93 132.01 3.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.952 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.86 -140.83 2.97 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.628 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 mt -143.89 170.28 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.13 150.02 18.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 94' ' ' PHE . . . 178.21 142.39 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.377 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' LEU . . . -175.32 -126.74 0.96 Allowed Glycine 0 C--O 1.229 -0.192 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.806 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 1.3 pp -161.07 120.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.512 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 2.2 tt -104.01 116.09 31.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.634 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.428 ' CG ' ' CG2' ' A' ' 137' ' ' ILE . 18.8 pt20 -116.85 126.22 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.775 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -69.24 147.88 50.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.273 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 -30.68 7.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.338 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 t -160.93 -165.02 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.196 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -90.28 50.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.371 . . . . 0.0 110.771 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 174.14 -28.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.6 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.5 157.19 29.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.361 . . . . 0.0 111.393 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.2 m -155.92 169.05 25.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.994 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.428 ' CG2' ' CG ' ' A' ' 129' ' ' GLN . 18.3 tt -131.49 135.0 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.417 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -133.52 167.64 20.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.544 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . 174.09 153.65 10.05 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.665 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.3 -125.95 1.26 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.971 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 171' ' ' PHE . 5.3 m-85 -133.77 161.15 35.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.96 147.33 19.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -108.29 147.81 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.754 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.87 134.9 48.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.92 147.0 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.841 0.353 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.2 p -119.88 117.73 28.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -134.07 155.38 50.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.43 ' HB3' ' CE2' ' A' ' 141' ' ' TYR . 43.2 p90 -111.12 124.41 52.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.382 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.467 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 7.4 p90 -124.68 179.2 5.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.643 0.735 . . . . 0.0 111.966 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.475 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 0.4 OUTLIER -163.45 147.88 10.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.872 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.3 -162.86 21.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.809 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -123.23 171.74 9.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.861 0.363 . . . . 0.0 111.047 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -156.29 117.1 3.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.65 112.01 24.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.59 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.95 154.06 25.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.109 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 1.3 m-85 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 120.763 0.316 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -63.51 137.75 58.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.826 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.3 m-85 -129.0 139.75 51.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.057 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.7 t -154.94 124.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.012 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.98 -144.06 3.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.58 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mt -139.76 142.86 36.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.822 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -112.15 142.4 44.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.994 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.33 114.55 13.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.74 132.54 11.01 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.426 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -139.17 138.31 36.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.327 . . . . 0.0 110.899 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -162.03 129.42 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.44 -167.56 19.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 mt -109.28 161.07 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.745 0.307 . . . . 0.0 110.964 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 133.02 47.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.665 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -169.2 120.02 0.71 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.106 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.51 -136.95 2.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.593 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -153.85 136.37 15.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 0.0 110.99 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -89.52 162.29 15.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.66 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -134.95 167.21 21.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.929 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -67.11 -25.9 66.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 24.26 3.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.01 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -174.44 179.97 45.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.192 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.01 130.3 7.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 0.0 111.276 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' A' ' 80' ' ' TYR . 4.1 m-85 -107.7 159.83 16.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.489 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -173.59 123.89 0.37 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.912 0.387 . . . . 0.0 111.198 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.88 153.12 20.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.602 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.3 m -130.93 118.77 21.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.18 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 4.6 m-85 -99.23 118.34 35.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.507 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -110.82 141.85 43.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.753 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.727 0.299 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -129.61 117.8 20.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.175 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.452 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 1.5 tm? -124.38 114.92 20.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.391 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.403 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.5 OUTLIER -134.1 126.21 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 111.593 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.39 116.8 4.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.645 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 0.8 OUTLIER -111.72 156.71 21.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.075 0.464 . . . . 0.0 111.702 -179.248 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.414 ' HB3' ' CD2' ' A' ' 55' ' ' TYR . 23.6 p90 -130.86 110.94 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.308 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.81 155.25 34.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 111.494 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.412 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -105.6 119.25 38.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.533 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -97.59 156.14 16.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.139 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tp -155.49 140.32 12.04 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.805 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.85 113.0 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.451 2.101 . . . . 0.0 112.178 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 120.985 0.422 . . . . 0.0 111.085 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 37.3 p-10 . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.447 ' CG2' ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -136.55 130.0 31.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 9.9 mttt -123.15 92.66 3.75 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.142 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.88 102.72 0.63 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -115.75 155.05 28.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.77 142.92 7.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.558 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.73 -143.73 4.58 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.657 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.09 162.23 29.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 111.083 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 79' ' ' SER . 5.2 t -129.2 155.73 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 mp -160.11 130.87 5.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.713 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -156.63 -150.39 5.65 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.866 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.05 127.28 7.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.618 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.88 133.67 54.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.948 -179.925 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.7 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.762 0.315 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.4 -179.27 33.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.553 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.21 118.41 36.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.31 143.41 26.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 137.94 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -165.66 -143.43 3.73 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.498 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.11 160.46 38.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.966 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.88 165.74 35.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.047 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.91 142.49 0.08 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.272 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.52 -127.0 0.85 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.263 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 14.6 pt -156.93 120.78 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -94.43 112.74 24.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.188 0.518 . . . . 0.0 111.019 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 6.4 mt-30 -102.46 115.54 30.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.024 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -73.4 149.18 42.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.4 tp -108.01 -31.82 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.409 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -169.04 -173.98 1.92 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.131 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -81.98 55.64 2.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.791 0.329 . . . . 0.0 110.696 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -178.45 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.277 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.79 155.87 33.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.895 0.378 . . . . 0.0 111.201 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.08 -178.64 5.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.876 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 28.9 mt -138.78 134.95 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.968 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.96 131.53 54.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.708 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -155.35 124.29 1.48 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.66 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.28 -144.08 4.67 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.803 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -126.2 161.11 28.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 110.749 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -153.18 145.67 24.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.052 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.74 138.94 52.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.618 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mt -121.86 132.58 54.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.089 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.97 111.96 4.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.057 -179.82 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.6 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.792 0.33 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.97 123.17 47.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.767 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -113.08 155.24 25.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -106.36 153.3 22.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.203 0.525 . . . . 0.0 110.144 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.57 126.78 47.27 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.583 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.52 129.91 3.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.548 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 171.66 -152.2 17.06 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.891 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.23 172.17 11.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.091 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -149.87 114.94 5.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -108.09 111.93 24.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.753 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -83.52 159.72 21.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.129 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.444 ' CB ' ' HB3' ' A' ' 49' ' ' GLN . 1.5 t0 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.797 0.332 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -109.77 134.45 52.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.689 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 10.0 m-85 -133.47 139.99 47.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.865 0.364 . . . . 0.0 111.044 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 11.1 p -155.3 122.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.199 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.31 -139.91 2.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.541 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -140.19 164.03 31.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.727 0.298 . . . . 0.0 110.759 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.42 155.66 41.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.354 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -153.08 128.13 9.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.602 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.74 160.83 12.99 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.579 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.868 -179.954 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.01 131.47 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -139.6 117.69 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.82 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -151.81 -165.06 12.7 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.624 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -116.33 161.92 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.673 0.273 . . . . 0.0 110.956 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -126.54 138.89 53.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.601 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -170.4 120.32 0.59 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.12 -139.32 2.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.611 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -159.14 140.19 12.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 111.128 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 3' ' ' ASP . 33.0 tt0 -83.77 162.47 20.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.413 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.418 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -131.08 -166.9 1.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.88 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.85 -45.16 93.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.219 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.97 -20.47 3.83 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -118.19 179.59 17.07 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.886 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.411 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 8.4 mtt180 -142.36 143.55 32.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 111.4 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 80' ' ' TYR . 6.0 t80 -100.73 153.56 19.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.961 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 70.4 m-85 -157.66 115.44 3.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 111.585 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.09 132.52 38.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.398 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.2 p -119.28 112.18 19.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.945 0.402 . . . . 0.0 111.253 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -106.19 111.27 23.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.677 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -110.41 179.96 3.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.872 0.367 . . . . 0.0 111.132 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.792 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.688 0.28 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -130.42 119.59 22.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.177 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.04 114.97 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.431 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 pp -145.16 152.5 40.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.399 . . . . 0.0 111.519 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.99 125.68 6.64 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.972 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -104.09 132.28 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 111.637 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.414 ' HB2' ' CE1' ' A' ' 55' ' ' TYR . 14.0 t80 -122.9 110.99 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.957 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.43 172.05 13.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.181 0.515 . . . . 0.0 111.869 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.457 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -107.99 118.77 37.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.219 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 50.4 p90 -97.38 162.97 13.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.84 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 130.7 2.12 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.444 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.54 115.94 2.95 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.446 2.097 . . . . 0.0 112.36 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 86' ' ' ILE . 23.0 mt . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.089 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.775 0.321 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.89 152.71 42.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.459 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 2.5 mttt -132.47 92.85 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 111.079 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.29 102.88 0.19 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.312 0.577 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 20.0 p90 -112.1 154.18 25.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.33 133.79 2.72 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.75 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -170.14 -133.51 1.61 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.654 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.98 162.97 28.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 111.29 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.93 156.85 47.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.822 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.06 132.48 6.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.85 -149.45 5.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.825 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 mt -154.93 126.87 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.668 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 p -109.95 133.73 54.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.978 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.022 -179.854 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.802 0.334 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -152.9 134.31 4.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.349 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -84.07 116.44 22.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.917 0.389 . . . . 0.0 111.078 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.23 135.8 41.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.994 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.07 142.34 1.42 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.177 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.35 -138.33 2.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.588 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.7 mt -142.99 159.83 41.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.714 0.293 . . . . 0.0 110.688 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.28 173.11 17.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.14 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.87 142.67 0.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.648 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.415 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -159.52 -130.89 1.18 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.7 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 1.1 pt -161.13 120.38 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.0 110.67 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.82 115.16 27.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.672 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -104.31 118.15 35.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.945 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.82 149.3 28.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.02 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.53 -31.71 11.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.2 p -169.01 -164.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.329 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.71 56.02 3.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.886 0.374 . . . . 0.0 110.658 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -142.73 -67.5 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.061 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.68 171.49 13.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.041 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.3 p -156.02 173.98 16.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.942 0.401 . . . . 0.0 111.204 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 175' ' ' ALA . 5.2 pt -134.95 134.79 53.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.699 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -127.58 172.49 10.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.131 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.19 145.4 6.21 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.35 -135.96 2.53 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.657 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.85 158.04 27.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.712 0.291 . . . . 0.0 110.693 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 172' ' ' TYR . 0.0 OUTLIER -142.68 130.96 22.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.189 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 2.3 m-85 -122.77 133.92 54.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.453 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 mt -142.43 145.39 33.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 111.114 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 159.73 16.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.594 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.41 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.41 136.84 51.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -156.02 155.35 32.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.022 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.9 152.58 20.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.15 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -135.04 129.4 33.99 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.152 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.7 mt -163.56 129.87 3.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.479 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.79 -158.84 21.57 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.909 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -126.79 172.05 10.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.8 116.68 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.935 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -108.98 112.82 25.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.819 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 11.2 pttt -82.01 164.07 21.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.888 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -100.95 130.03 46.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.786 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.439 ' CE1' ' NE2' ' A' ' 49' ' ' GLN . 3.9 m-85 -132.33 139.94 48.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.379 . . . . 0.0 111.115 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 8.3 p -154.77 130.4 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.08 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.22 -147.17 4.87 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.716 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -126.41 166.72 16.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.345 . . . . 0.0 110.909 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -139.61 140.43 37.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -137.9 115.91 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.22 137.64 13.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.536 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 0.0 110.952 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -127.81 124.05 36.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -117.75 115.47 25.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.4 -173.8 13.43 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.767 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 58' ' ' THR . 18.0 mt -106.98 162.03 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.561 0.219 . . . . 0.0 111.041 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.402 ' NH2' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -132.6 136.07 46.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.681 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -170.84 120.55 0.55 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.377 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -166.91 -142.34 3.41 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.755 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -131.92 130.65 41.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.681 0.277 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.439 ' NE2' ' CE1' ' A' ' 5' ' ' PHE . 32.3 tt0 -109.52 112.53 24.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.225 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -96.01 176.42 6.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.589 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -29.15 68.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.2 24.19 3.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.346 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.2 110.03 0.39 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -103.8 112.74 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 111.187 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -106.2 150.71 25.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.155 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.521 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 34.2 p90 -179.09 129.35 0.1 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.125 0.488 . . . . 0.0 111.198 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.42 148.58 22.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.15 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 2.6 m -129.24 118.43 22.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.979 0.418 . . . . 0.0 111.599 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -94.52 109.18 21.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.071 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -103.65 175.2 5.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.032 0.444 . . . . 0.0 111.566 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.567 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.659 0.266 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.4 110.93 20.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tt -115.6 117.02 29.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.755 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.6 144.46 39.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.228 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.93 116.9 4.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.033 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.2 t -99.18 134.12 42.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 111.374 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -122.41 110.89 16.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.155 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -133.11 163.39 29.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.93 0.395 . . . . 0.0 111.486 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.22 118.7 36.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 54.2 p90 -97.58 161.29 13.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.645 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.12 121.01 1.26 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.63 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.89 114.98 2.04 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.469 2.113 . . . . 0.0 112.329 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.859 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.741 0.305 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -136.55 145.08 44.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.806 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 9.0 tttt -121.31 92.69 3.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.371 . . . . 0.0 110.702 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.28 102.85 0.12 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.339 0.59 . . . . 0.0 110.772 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.451 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 32.6 p90 -112.3 153.21 27.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.862 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.12 140.66 6.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.856 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.11 -137.62 2.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.388 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.91 177.63 7.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 111.172 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -146.2 151.65 37.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.978 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 130.65 5.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.775 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.35 -153.86 6.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.885 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.28 131.43 10.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.1 p -109.59 122.83 64.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.262 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.735 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.805 0.336 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.79 118.83 2.03 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.267 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.09 131.78 34.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.966 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -123.57 145.41 48.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -170.99 140.48 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.177 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -165.6 -136.72 2.06 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.453 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mp -138.36 170.27 16.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 110.727 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -159.71 152.29 21.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.94 142.48 0.08 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.612 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.451 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -169.75 -127.09 0.9 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.938 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 3.4 pt -161.19 120.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.681 0.277 . . . . 0.0 110.436 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 1.3 tp -94.5 114.1 26.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.069 0.462 . . . . 0.0 110.725 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -98.08 122.93 41.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.09 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -95.91 149.02 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.825 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.78 -30.29 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.058 0.456 . . . . 0.0 110.584 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.08 -172.07 2.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.108 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.74 54.73 3.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.791 0.329 . . . . 0.0 110.833 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -177.28 -37.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.436 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.26 135.82 51.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 111.519 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.8 m -132.84 168.7 17.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.753 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.1 mt -138.25 135.86 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -119.5 132.64 55.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -157.1 128.41 2.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.502 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.86 -134.74 2.28 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.847 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.86 161.19 25.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.848 0.356 . . . . 0.0 110.859 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.11 121.96 9.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.029 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.67 139.42 49.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.648 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 mp -157.93 142.88 16.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.207 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -114.23 163.69 14.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.629 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.0 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.135 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 93.5 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.876 0.37 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.01 124.89 50.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.63 155.18 47.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -91.54 165.27 13.44 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.264 0.554 . . . . 0.0 110.29 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.24 129.98 34.5 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.78 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.6 tt -163.41 133.26 4.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.739 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.47 -156.41 18.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.613 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -124.24 172.15 9.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -150.06 114.95 5.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.982 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -117.26 111.9 20.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 2.3 ptpt -82.18 161.4 22.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.773 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.828 0.346 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -60.62 140.86 57.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.0 m-85 -131.07 139.86 49.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.973 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.3 m -154.74 129.27 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.266 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.33 -143.59 3.78 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.676 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -140.14 165.42 27.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -135.05 144.86 47.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.079 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -136.73 118.58 15.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.741 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.96 143.65 16.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.683 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 0.0 110.922 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.96 142.81 31.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -132.94 131.58 41.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.86 -173.26 31.36 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.665 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.35 177.12 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 111.157 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -142.55 142.73 32.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.603 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -175.68 123.06 0.2 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.255 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -163.33 -136.31 1.97 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.581 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -153.41 127.31 8.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 111.102 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB2' ' CD1' ' A' ' 5' ' ' PHE . 1.5 tt0 -83.94 152.52 24.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.58 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -127.28 165.68 19.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.817 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -24.79 66.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.372 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -126.13 24.57 6.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.266 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 172.61 -177.29 45.25 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.357 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.36 122.29 7.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 80' ' ' TYR . 34.9 t80 -101.74 146.41 27.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.376 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.44 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 25.0 p90 -173.55 124.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.035 0.445 . . . . 0.0 111.036 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.67 162.86 14.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.584 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.4 m -139.92 125.25 18.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.221 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -102.88 100.93 10.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.295 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.94 174.95 5.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.548 179.905 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.793 0.33 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.409 ' ND2' ' CG2' ' A' ' 102' ' ' VAL . 6.3 t-20 -131.31 116.01 17.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.821 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.436 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 68.7 tp -124.96 123.06 39.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.551 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.427 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.6 OUTLIER -144.98 157.46 44.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.334 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.99 117.47 4.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.049 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.2 p -99.15 121.73 41.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.938 0.399 . . . . 0.0 111.586 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 55' ' ' TYR . 47.6 m-85 -104.25 110.86 23.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.893 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.408 ' OD1' ' CE1' ' A' ' 56' ' ' TYR . 1.9 p-10 -136.48 172.1 13.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 111.664 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.484 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -122.3 125.51 46.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.602 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 55.7 p90 -97.51 156.68 16.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 tp -158.25 135.57 6.97 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.62 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.57 116.65 3.31 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.552 2.168 . . . . 0.0 112.174 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.5 HD13 HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.046 0.45 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 . . . . . 0 N--CA 1.46 0.036 0 CA-C-O 120.614 0.245 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.07 153.09 51.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 9.8 mmtp -126.99 92.73 3.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 110.849 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -56.28 102.8 0.08 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.038 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.451 ' CE2' ' N ' ' A' ' 127' ' ' ILE . 37.3 p90 -111.49 151.81 28.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.613 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.06 142.14 6.89 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.992 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.72 -142.88 5.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.685 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.23 179.59 5.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.802 0.334 . . . . 0.0 111.214 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.4 t -159.01 154.94 26.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.059 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 pp -160.23 131.96 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.68 -129.98 1.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.946 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -155.08 128.09 8.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.393 . . . . 0.0 110.557 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.409 ' CG2' ' ND2' ' A' ' 75' ' ' ASN . 21.6 t -109.63 115.59 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.166 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.97 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.25 164.2 24.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.406 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.82 114.99 26.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.06 136.7 39.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.006 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -168.63 138.69 2.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.353 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.36 -140.68 2.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.66 163.95 35.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.36 . . . . 0.0 110.805 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.91 171.22 18.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.207 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.9 142.52 0.08 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.588 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -170.08 -134.44 1.75 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.732 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -158.71 120.62 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.744 0.307 . . . . 0.0 110.441 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -95.07 117.69 30.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.936 0.398 . . . . 0.0 110.859 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.414 ' HB2' ' CG1' ' A' ' 137' ' ' ILE . 27.9 mt-30 -95.08 121.34 36.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -112.57 149.1 33.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.662 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mp -106.18 -42.37 5.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 110.509 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.11 -166.71 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.026 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -82.78 54.28 2.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.789 0.328 . . . . 0.0 110.44 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -141.9 -56.62 0.46 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.146 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.36 152.39 34.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.934 0.397 . . . . 0.0 111.303 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.2 t -142.17 179.12 7.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.538 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.414 ' CG1' ' HB2' ' A' ' 129' ' ' GLN . 19.2 pt -140.71 144.96 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 128' ' ' LEU . 41.0 tt0 -130.54 136.25 48.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.87 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -155.82 149.98 21.2 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.547 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.09 -131.24 2.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.642 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -119.9 160.76 22.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.799 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.72 123.12 13.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.198 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -119.55 133.91 55.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.441 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -141.64 154.12 45.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 111.3 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -117.67 163.41 16.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.477 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 111.203 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 91.8 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.792 0.33 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 18.8 t -107.02 130.17 54.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.744 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.24 155.21 46.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -106.19 143.7 33.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.133 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.54 127.02 46.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.102 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.9 tt -163.66 129.73 3.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.501 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.34 -155.45 15.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.87 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -114.98 172.04 7.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.119 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -155.9 117.52 3.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 3.9 m-85 -115.98 117.19 29.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.074 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -84.58 163.98 18.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.126 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.781 0.324 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.05 132.71 54.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.708 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 13.6 m-85 -134.51 139.96 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.028 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 7.6 p -151.16 129.36 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.965 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.7 -147.85 5.31 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.843 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 4.8 mp -138.99 160.06 40.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.352 . . . . 0.0 110.903 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -129.54 167.5 17.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -149.11 137.18 20.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.96 122.03 5.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.474 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.853 0.359 . . . . 0.0 110.941 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 m -112.83 125.73 54.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -108.34 174.31 5.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.798 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.5 157.94 21.41 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.603 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 2.1 mp -109.8 158.89 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.511 0.196 . . . . 0.0 110.907 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -143.31 149.77 38.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.042 0.448 . . . . 0.0 110.839 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -177.35 123.56 0.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.583 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -163.85 -137.6 2.23 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.592 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.66 130.42 38.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.782 0.325 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 40.0 tt0 -105.66 110.71 23.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.029 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 53' ' ' GLY . 1.9 p90 -121.06 166.99 13.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.727 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -19.95 65.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.4 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -92.14 15.86 12.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.553 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . 133.02 176.0 14.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.56 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.437 ' HD2' ' CD2' ' A' ' 83' ' ' PHE . 47.3 mtp180 -116.14 117.13 29.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.865 0.364 . . . . 0.0 111.2 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -100.36 136.36 40.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.209 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.586 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 44.0 p90 179.84 132.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.836 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . -90.34 136.65 32.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.158 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 m -113.68 111.72 22.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.98 0.419 . . . . 0.0 111.543 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.88 124.34 29.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.148 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -101.88 155.12 18.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 111.501 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.48 179.908 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -133.41 120.67 21.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.093 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tt -114.94 114.99 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.443 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.553 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 2.1 mp -122.45 153.79 38.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.991 0.424 . . . . 0.0 111.498 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.73 116.7 4.24 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.81 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.42 ' HB2' ' CE2' ' A' ' 56' ' ' TYR . 54.5 m -90.53 140.72 29.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.07 0.462 . . . . 0.0 111.568 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -148.34 110.78 4.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.031 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -146.36 172.18 13.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.421 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.31 118.66 35.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -97.81 167.12 11.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.665 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.44 134.25 1.53 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.71 95.06 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.474 2.116 . . . . 0.0 112.102 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 tt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.991 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 38.1 p-10 . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.828 0.347 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.63 148.48 47.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.124 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -126.64 92.31 3.53 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.078 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.4 tt -61.59 102.73 0.27 Allowed 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.482 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 15.2 p90 -113.35 154.2 27.27 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.88 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.84 130.56 1.97 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.671 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.65 -139.99 2.86 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.589 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -135.64 170.11 16.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 111.155 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -138.03 163.16 32.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.27 133.81 6.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -155.63 -144.31 3.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.995 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.14 130.84 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.256 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 t -109.65 128.84 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.225 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.853 179.886 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.715 0.293 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -140.53 143.61 13.73 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.642 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -90.49 120.33 31.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.746 0.308 . . . . 0.0 110.753 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.04 140.05 30.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.211 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.02 134.72 0.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.72 -141.99 3.27 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.601 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 mp -149.65 162.44 40.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.89 0.376 . . . . 0.0 110.985 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -154.01 159.71 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 177.01 142.51 0.08 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.729 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.461 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -174.58 -125.69 0.88 Allowed Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.733 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 5.3 pt -161.13 120.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 110.366 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 1.1 tp -95.42 114.69 26.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.971 0.415 . . . . 0.0 110.833 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 21.5 mt-30 -99.52 147.48 25.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.247 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -128.72 149.11 50.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.52 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.4 mt -109.43 -45.38 3.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.089 0.471 . . . . 0.0 110.76 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.09 -164.89 0.49 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.274 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -80.12 57.41 2.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.879 0.371 . . . . 0.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -138.72 -60.28 0.6 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' A' ' 177' ' ' TYR . . . -163.2 158.24 21.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.993 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.3 m -125.72 168.66 13.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.08 134.7 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.778 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -124.21 149.99 45.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -154.76 128.8 2.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.365 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.25 -136.74 2.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.8 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -135.16 161.07 36.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.77 146.32 29.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -112.47 145.79 39.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.85 122.56 39.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -145.52 111.99 5.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.704 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.1 p . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.834 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.734 0.302 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.0 p -107.09 122.47 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.05 155.2 49.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.3 165.16 11.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.139 0.495 . . . . 0.0 110.239 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -137.92 128.5 26.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.805 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.6 129.98 3.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.87 -156.66 18.41 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.696 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -125.07 172.09 9.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.114 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -149.98 114.94 5.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 135' ' ' ALA . 39.9 m-85 -107.02 116.92 32.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.987 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -83.87 162.85 20.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 40.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.969 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.228 -0.06 0 CA-C-O 120.571 0.224 . . . . 0.0 110.665 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.24 138.1 49.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.512 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 28.4 p90 -148.95 161.86 41.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.01 0.433 . . . . 0.0 111.454 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 34.3 m -150.33 141.18 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.02 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.1 -157.91 9.04 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 119.966 -1.112 . . . . 0.0 113.135 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -126.97 154.94 43.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.795 0.331 . . . . 0.0 110.786 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 p -128.02 149.6 50.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.413 ' CD2' ' HB3' ' A' ' 42' ' ' TRP . 1.7 t-105 -153.09 115.9 4.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.45 137.96 13.73 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 179.999 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.96 149.79 38.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.413 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 68.0 p-90 -152.92 162.91 40.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.757 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.94 -165.99 35.34 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.706 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 18.0 tt -123.56 159.84 27.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.491 0.186 . . . . 0.0 110.803 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -137.88 158.53 44.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.24 0.543 . . . . 0.0 110.669 179.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -177.04 123.74 0.14 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.107 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -167.02 -142.69 3.52 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.603 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 1.5 mp0 -129.78 139.39 51.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.822 0.344 . . . . 0.0 111.048 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.445 ' HG2' ' CD1' ' A' ' 5' ' ' PHE . 2.2 pt20 -121.25 112.33 18.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -119.92 157.22 29.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.6 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.28 -22.28 29.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.255 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -95.66 21.66 8.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.257 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.67 158.85 8.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.494 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -121.22 130.85 53.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.851 0.358 . . . . 0.0 111.061 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -117.67 152.52 35.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.471 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.492 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 36.2 p90 179.67 129.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.156 0.503 . . . . 0.0 111.25 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . -90.59 128.91 36.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.022 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.0 p -117.39 115.05 24.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.165 0.507 . . . . 0.0 111.486 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -92.9 130.64 38.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.116 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.9 171.73 8.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.051 0.453 . . . . 0.0 111.441 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.628 179.833 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.724 0.297 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -143.76 131.11 20.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.69 114.91 6.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.469 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.418 ' CB ' ' HA3' ' A' ' 100' ' ' GLY . 0.2 OUTLIER -145.73 154.62 42.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.041 0.448 . . . . 0.0 111.472 -179.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.93 116.8 4.24 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.823 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.415 ' OG ' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -98.45 134.0 42.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.974 0.416 . . . . 0.0 111.447 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -124.52 110.86 14.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.061 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -130.79 166.42 20.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 111.415 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.77 118.46 35.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.396 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 55.4 p90 -97.78 166.94 11.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.574 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.68 136.14 1.65 Allowed Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.468 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.12 118.11 4.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.417 2.078 . . . . 0.0 112.377 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.8 mt . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.919 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.788 0.327 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.97 149.14 50.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.536 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -127.21 92.47 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 0.0 111.114 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.02 103.17 0.15 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 110.319 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 40.7 p90 -110.7 157.66 19.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.053 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.98 129.96 1.61 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.835 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.3 -138.33 2.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.581 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.93 -177.82 4.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.143 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -148.99 155.98 41.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.2 132.2 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.699 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 77' ' ' LEU . . . -160.52 -148.16 5.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.918 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 mp -155.34 133.6 11.66 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.241 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.2 p -109.35 131.31 60.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.137 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.966 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.903 0.383 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -148.57 -157.79 7.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.428 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -116.05 115.0 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.09 144.04 37.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 141.33 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.263 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.46 -142.74 3.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.517 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mp -145.58 161.97 38.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.834 0.349 . . . . 0.0 110.771 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -149.13 160.47 43.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.794 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.95 142.44 0.08 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.598 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.427 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -174.86 -130.69 1.33 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.748 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 10.7 pt -160.94 120.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 110.492 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -94.7 112.21 23.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.684 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -103.91 124.31 48.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.75 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -86.05 149.35 25.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.02 -29.61 10.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.048 0.452 . . . . 0.0 110.163 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.01 -165.48 0.55 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.824 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -91.27 48.01 1.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.705 0.288 . . . . 0.0 110.596 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -155.95 -44.07 0.08 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.647 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -130.19 170.67 13.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.012 0.434 . . . . 0.0 111.566 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.7 m -156.1 -175.8 5.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.73 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.8 pt -154.18 152.61 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.701 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.87 156.56 47.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.041 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -167.54 146.4 10.63 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.95 -125.2 1.19 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.644 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -136.09 161.2 36.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.766 0.317 . . . . 0.0 110.732 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.444 ' HB2' ' CD2' ' A' ' 172' ' ' TYR . 0.2 OUTLIER -162.44 140.28 8.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.246 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -119.78 162.7 18.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.1 tp -159.48 146.93 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.957 0.408 . . . . 0.0 111.306 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.6 mmm-85 -118.65 154.22 33.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.544 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 -179.823 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.734 0.302 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 30.3 t -107.11 142.41 36.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.02 155.2 35.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -102.5 165.27 11.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.2 0.524 . . . . 0.0 110.367 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.444 ' CD2' ' HB2' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -134.26 128.7 34.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.957 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 9.8 tp -163.67 129.89 3.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.588 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.77 -158.57 22.12 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.737 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.52 172.02 8.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.798 0.332 . . . . 0.0 111.046 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -153.96 114.93 4.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -116.23 111.34 20.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 1.7 ptpt -84.43 163.17 19.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.164 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.795 0.331 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 1.6 t-20 -77.79 145.56 36.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.651 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 18.0 p90 -148.57 152.11 36.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.124 0.488 . . . . 0.0 111.421 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 9.1 p -151.29 135.64 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.158 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.86 -133.69 1.57 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mp -143.86 167.96 21.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 110.829 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -135.01 143.38 46.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 42' ' ' TRP . 0.6 OUTLIER -134.53 117.84 16.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.708 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.2 151.2 17.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.597 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.847 179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.0 p -124.11 108.03 11.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TRP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 6.6 p-90 -126.27 164.51 20.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.691 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.61 -169.43 35.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.832 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 58' ' ' THR . 1.7 mt -107.79 163.21 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.551 0.215 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.92 139.82 38.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.932 0.396 . . . . 0.0 110.923 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -170.02 117.73 0.57 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.771 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.597 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -157.63 -167.25 18.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.457 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 3.9 pt20 -131.72 125.52 32.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 110.839 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 50' ' ' PHE . 5.3 tt0 -83.84 151.95 24.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.412 ' N ' ' HG2' ' A' ' 49' ' ' GLN . 0.8 OUTLIER -127.66 166.48 18.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -24.98 65.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.441 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -133.12 24.26 4.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.691 0.281 . . . . 0.0 111.475 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.99 170.96 42.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.4 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -141.5 142.68 33.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.851 0.358 . . . . 0.0 111.329 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -129.89 151.73 50.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.242 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.597 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 36.2 p90 179.49 129.19 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.191 0.52 . . . . 0.0 111.246 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.82 152.41 20.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.426 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 73.0 p -137.13 121.22 17.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 111.546 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.444 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 8.3 m-85 -85.67 117.62 24.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.926 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -101.96 158.04 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 111.469 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 m120 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.494 179.884 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.713 0.292 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -144.08 114.82 7.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.175 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.444 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 2.5 mp -107.62 131.11 54.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.397 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.43 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 1.9 mp -141.72 147.41 37.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.027 0.441 . . . . 0.0 111.565 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.99 116.75 4.21 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.072 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.418 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 1.9 t -87.71 136.32 33.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.983 0.42 . . . . 0.0 111.259 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -133.07 110.82 10.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.258 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -147.78 172.08 14.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.031 0.444 . . . . 0.0 111.589 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.44 124.97 50.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.485 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 45.6 p90 -97.51 165.43 12.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.497 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.0 tp -140.52 117.85 8.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.417 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.52 108.66 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.37 2.047 . . . . 0.0 112.354 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.7 mm . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.789 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 31.4 m120 . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.922 0.391 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.6 148.64 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.672 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -123.25 92.49 3.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.931 0.396 . . . . 0.0 110.781 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.51 103.01 0.28 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.666 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 46.6 p90 -111.37 154.59 24.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.817 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.35 132.83 2.34 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.819 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.6 -139.43 2.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.687 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.89 177.11 7.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.756 0.312 . . . . 0.0 111.183 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.8 p -146.37 159.04 43.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mp -159.25 130.8 6.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.646 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -150.71 -155.91 7.1 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.124 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.9 mt -155.2 130.51 9.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.794 0.33 . . . . 0.0 110.168 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.5 p -109.72 119.78 59.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.297 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 tttm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.934 -179.946 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.837 0.351 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -113.95 -177.62 19.22 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.507 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -91.71 125.44 36.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.4 137.46 51.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -171.17 140.42 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.001 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.28 -139.86 2.76 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.643 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 143' ' ' TYR . 24.9 mt -145.39 165.64 27.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.798 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -157.14 159.27 37.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 94' ' ' PHE . . . 176.94 142.46 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.81 -130.69 1.26 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.656 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 4.7 pt -158.68 120.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.52 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 8.5 tt -95.19 114.32 26.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.117 0.484 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 29.0 mt-30 -99.14 139.63 34.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.268 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -118.78 149.11 42.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.556 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.92 -51.22 2.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.626 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -169.11 -164.9 0.49 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.093 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -76.47 58.32 1.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.786 0.326 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -136.88 -60.17 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.03 156.66 12.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.75 165.34 13.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.63 134.73 61.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.514 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.95 143.36 50.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.051 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -160.08 149.88 19.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.297 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 173.8 -133.98 2.73 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.729 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.62 161.05 23.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.82 0.343 . . . . 0.0 110.98 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.0 ttt-85 -149.91 125.27 10.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 13.1 m-85 -101.09 138.71 37.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.763 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.06 134.06 55.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.7 mmm-85 -151.64 112.14 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.987 -179.876 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.832 0.349 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.88 119.8 40.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -147.7 155.16 41.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -102.51 165.27 11.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.154 0.502 . . . . 0.0 110.163 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.75 129.75 30.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.113 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.4 tp -163.42 131.56 3.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.721 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 176.94 -155.17 17.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.681 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.19 172.04 13.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.986 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -158.05 121.81 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -98.71 115.77 29.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.833 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.63 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.4 147.28 29.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.112 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.724 0.297 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.76 139.84 17.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.232 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.9 138.86 56.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.762 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.5 m-85 -132.48 139.88 48.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 111.103 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 19.6 m -154.58 127.63 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.997 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.6 -146.47 4.66 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.846 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.8 153.97 45.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 0.0 110.821 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.37 135.9 52.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.05 113.24 11.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.29 131.36 10.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.523 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.61 119.46 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.871 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -122.49 105.59 10.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.984 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.3 p -150.05 102.79 3.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -88.59 -46.14 9.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -86.6 140.53 29.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 29.5 mm -128.39 97.69 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.113 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -144.03 171.05 14.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.77 144.18 51.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 p -140.77 165.99 26.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -148.89 132.26 16.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.77 127.52 45.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.46 129.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -106.34 -31.4 8.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.863 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -58.41 -23.6 57.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 62.33 105.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.962 0.411 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.55 -47.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.811 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -93.51 128.22 39.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 t -140.95 87.34 11.02 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.027 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.86 -174.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.581 2.187 . . . . 0.0 112.228 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -127.1 68.79 1.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -138.2 101.31 4.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.994 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -140.76 90.97 2.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 178.46 -34.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.036 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.5 m -152.2 92.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.174 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -130.72 103.99 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.092 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -136.47 -167.88 2.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.716 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -146.09 -47.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.45 140.04 51.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.87 134.55 1.79 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.53 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.8 p -95.01 126.58 40.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -128.31 132.73 48.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -156.35 -167.26 17.41 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.51 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 pt -107.15 172.54 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 111.027 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.87 141.44 34.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.639 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -174.87 123.2 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.315 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.441 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -160.96 -148.74 5.38 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.698 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -136.07 126.29 26.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.01 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -83.97 158.91 21.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.662 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -135.04 164.22 28.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.15 -24.08 65.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.365 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.32 24.38 5.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.27 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 174.61 178.21 44.32 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.202 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 54' ' ' ARG . 4.1 ptm85 -148.13 138.22 22.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 111.187 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -117.04 145.63 43.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.514 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.441 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 41.0 p90 -172.12 121.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 111.171 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.85 158.93 16.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.1 m -127.95 117.06 21.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.059 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -100.96 127.59 47.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.754 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -141.53 176.71 8.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.029 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -137.29 -78.41 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -159.99 137.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.081 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.0 126.02 25.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -73.91 153.46 39.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.001 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.8 172.8 16.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -81.05 -35.86 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 p -105.1 27.16 8.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.025 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -70.82 111.15 3.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.517 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -111.77 128.35 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.836 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt 60.55 82.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mt -130.58 115.25 16.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.964 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -176.91 106.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.95 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -162.25 -178.8 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -128.41 150.24 50.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.835 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -144.64 116.99 8.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.094 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.73 127.05 39.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.534 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.415 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.8 OUTLIER -146.32 137.72 24.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.963 0.411 . . . . 0.0 111.438 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.77 116.89 3.89 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.016 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.408 ' OG ' ' CE2' ' A' ' 56' ' ' TYR . 26.0 p -105.92 133.29 50.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.412 . . . . 0.0 111.279 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 55' ' ' TYR . 23.1 p90 -123.85 110.89 15.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.353 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.57 171.19 14.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.053 0.454 . . . . 0.0 111.383 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -117.54 120.6 38.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.919 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 42.1 p90 -97.86 164.38 12.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.133 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.26 139.03 1.44 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.636 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.84 119.51 4.88 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.514 2.142 . . . . 0.0 112.359 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.0 tp -119.71 104.85 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.03 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.88 -75.53 0.26 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.55 -68.64 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 110.868 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 t30 179.71 37.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.959 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -121.48 -59.98 1.65 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.81 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.78 153.09 31.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.569 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 1.7 tptp -126.58 92.53 3.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.824 0.345 . . . . 0.0 110.995 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.14 102.82 0.32 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.256 0.55 . . . . 0.0 110.508 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.452 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 35.9 p90 -111.04 156.0 21.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.758 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.27 134.7 3.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.732 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -177.53 -160.66 24.59 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.446 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.13 171.43 8.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 0.0 111.23 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.8 t -143.92 159.81 41.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.06 131.19 5.81 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -152.73 -153.31 6.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.806 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 pp -155.28 127.94 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.656 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.2 m -109.74 130.41 62.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.206 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.63 126.95 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.93 127.14 47.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.87 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -122.94 143.65 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -131.64 170.95 14.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.29 115.31 21.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.95 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.41 -46.06 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.656 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.24 116.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.905 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.65 -78.02 1.62 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.454 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -97.4 104.79 16.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 110.845 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.56 122.93 28.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -87.99 -52.14 5.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.02 136.65 57.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 23.5 p -83.63 -22.19 32.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.19 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 64.24 31.84 12.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.4 p -148.94 110.81 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.29 132.61 6.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -84.62 115.04 22.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 0.0 111.034 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -111.62 137.74 49.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.05 141.27 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.27 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.94 -139.56 2.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.603 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mt -140.37 161.16 38.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.378 . . . . 0.0 110.831 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -150.04 157.78 43.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.796 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 178.68 142.39 0.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.371 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.452 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -168.01 -130.33 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.117 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 11.3 pt -159.45 121.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.77 0.319 . . . . 0.0 110.377 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.13 111.61 23.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.742 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -92.58 122.13 34.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.075 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.39 149.12 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.02 -47.26 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.001 0.429 . . . . 0.0 110.518 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -164.97 0.49 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.194 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 56.71 2.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.833 0.349 . . . . 0.0 110.6 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.76 -58.96 0.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.952 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -162.68 146.18 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.978 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.03 -179.9 4.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.4 mt -136.49 134.97 49.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 141.0 46.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.97 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -161.82 117.28 0.76 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.446 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -172.64 -138.95 2.7 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.094 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -121.19 161.16 22.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 110.843 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 121.71 12.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.107 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -118.18 131.3 56.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.463 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.29 146.96 32.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.935 0.398 . . . . 0.0 111.261 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.84 162.38 13.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.561 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p -108.91 172.04 7.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.089 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -56.17 115.56 2.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.079 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.32 80.0 1.45 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 t -116.98 119.97 36.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.959 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 m 59.38 162.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -115.63 159.36 21.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -88.33 -63.51 1.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.2 p -110.88 99.04 40.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.59 116.38 4.22 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.447 2.098 . . . . 0.0 112.328 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -87.21 -63.01 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 80.84 130.97 1.04 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.524 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -141.26 -108.58 0.73 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.548 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.18 161.75 41.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.846 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -101.88 80.22 1.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.65 108.26 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.68 -127.48 39.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.534 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.58 162.51 38.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.804 0.335 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.6 pp -156.53 162.37 39.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -76.69 139.29 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.54 176.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -93.78 100.16 12.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.69 160.85 29.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.69 150.56 22.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.791 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 m -106.97 117.58 34.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.816 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 155.18 51.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.724 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -103.49 165.2 11.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.21 0.528 . . . . 0.0 110.277 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.407 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -131.39 128.0 38.7 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.768 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.4 131.65 3.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.711 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.33 -152.04 15.95 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.648 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -131.61 172.01 12.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 0.0 111.058 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -152.22 115.49 4.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -109.21 113.62 26.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.94 163.56 22.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.142 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' CB ' ' CD2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.79 0.329 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.92 168.12 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.863 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -109.71 128.39 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.785 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.8 OUTLIER -129.05 139.91 51.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 16.4 m -154.08 126.41 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.214 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.35 -141.92 3.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.641 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mt -142.93 162.01 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.749 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.4 t -139.07 136.38 35.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 111.263 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -130.62 113.02 13.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.59 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 172' ' ' TYR . . . -118.13 169.65 13.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.064 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.97 133.84 54.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.79 0.329 . . . . 0.0 110.837 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 p -135.67 110.04 8.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 p -150.17 102.76 3.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.848 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.51 -69.02 0.32 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.95 162.84 10.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.43 142.32 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.088 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.92 101.98 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.875 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -72.85 136.68 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 p -143.65 137.39 28.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -106.71 -64.8 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.99 166.19 19.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -44.89 69.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -78.81 179.68 7.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -145.71 -176.96 5.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 t30 65.96 80.45 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.24 -62.15 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.796 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -127.38 -46.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.84 163.6 27.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.22 -179.75 3.35 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.6 2.2 . . . . 0.0 112.344 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -107.38 31.51 5.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.97 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 tp -168.35 153.3 6.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 60.26 76.73 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -79.46 -43.76 22.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.2 m -147.83 -46.22 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 pp -155.29 -175.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.726 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -131.69 120.12 22.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.2 146.32 26.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.5 p -114.72 -61.73 1.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.803 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.12 -142.28 9.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.545 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 p -138.62 107.99 6.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -125.11 137.36 54.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.707 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.15 -171.61 34.23 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.851 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 58' ' ' THR . 1.4 mp -106.95 164.05 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.578 0.227 . . . . 0.0 110.745 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.0 ttm-85 -132.39 139.71 48.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.646 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -174.81 122.43 0.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.443 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -169.92 -128.44 1.02 Allowed Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.516 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -143.22 154.91 44.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.65 109.84 11.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.456 ' CD2' ' CB ' ' A' ' 2' ' ' ALA . 0.6 OUTLIER -103.7 145.71 29.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.547 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.22 -21.67 24.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.208 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -124.63 24.13 7.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.073 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.75 120.49 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.513 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 129.38 53.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 110.816 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.481 ' CD1' ' CD2' ' A' ' 80' ' ' TYR . 11.4 m-85 -124.24 147.03 48.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.772 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.469 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 31.9 p90 -177.3 125.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.039 0.447 . . . . 0.0 110.979 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.69 156.13 18.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.609 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 21.2 m -133.28 119.05 19.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.495 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -89.95 118.9 29.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.324 179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.92 176.72 4.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.977 0.418 . . . . 0.0 111.397 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -150.47 -165.87 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.641 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 mp -129.48 111.11 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.097 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 t -118.76 113.24 20.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -140.49 -50.17 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -70.08 115.6 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.0 m -68.68 -34.42 75.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.2 p -66.5 -31.44 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.883 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.73 61.83 1.83 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.569 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -122.22 129.09 51.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 61.8 116.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 tt -163.09 100.85 0.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.62 83.54 1.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.846 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -151.73 157.91 42.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.994 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -146.44 131.81 18.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.796 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -122.71 110.87 16.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.108 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.42 114.96 28.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.467 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.468 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 4.5 mm? -123.91 142.38 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 111.297 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.96 116.89 4.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.989 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 56' ' ' TYR . 0.1 OUTLIER -93.18 125.43 37.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.913 0.387 . . . . 0.0 111.413 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.481 ' CD2' ' CD1' ' A' ' 55' ' ' TYR . 9.8 m-85 -127.09 110.94 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.068 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -150.26 172.18 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 111.692 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.92 122.84 47.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.623 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -97.21 169.67 9.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.641 -179.349 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tp -147.93 124.44 5.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.551 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.09 110.45 2.2 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.405 2.07 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 88' ' ' ASP . 33.8 mt -99.89 97.82 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.654 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.09 74.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.77 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -148.05 -47.34 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 110.63 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -149.37 30.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.614 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 57.3 m-80 62.85 15.9 8.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.406 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -74.65 151.18 39.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.561 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.444 ' HG2' ' CD2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -130.51 93.59 3.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.052 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.81 103.08 0.18 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.595 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.523 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 44.0 p90 -111.02 153.53 25.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.913 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.72 133.84 2.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.613 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.75 -136.54 2.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.75 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -128.01 179.98 5.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.789 0.328 . . . . 0.0 111.353 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 48.7 p -146.73 157.09 43.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -158.73 131.15 6.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.678 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.468 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -150.56 -154.04 6.34 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.948 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -155.37 130.86 9.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.853 0.359 . . . . 0.0 110.301 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.1 t -109.6 122.1 63.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.322 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.48 138.12 53.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.73 132.33 38.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -136.66 164.27 28.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -138.3 169.3 18.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -158.22 150.16 21.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.898 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 141.03 -152.61 23.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 106.71 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.45 88.83 1.85 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.531 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -76.11 122.91 24.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.84 139.51 21.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.17 82.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.16 106.06 18.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.4 t -150.86 124.75 9.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -144.74 85.1 1.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.0 m -84.56 118.08 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.189 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.45 168.53 13.04 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.83 116.25 31.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.54 148.38 22.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.03 141.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.963 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.68 -140.31 2.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 97' ' ' ALA . 22.5 mt -141.02 174.33 10.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.74 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.2 153.3 13.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.757 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.439 ' HA ' ' CD1' ' A' ' 94' ' ' PHE . . . 177.2 142.5 0.08 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.939 0.4 . . . . 0.0 110.633 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.448 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -172.37 -126.65 0.91 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.873 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.46 ' N ' ' CE2' ' A' ' 94' ' ' PHE . 1.3 pp -160.09 120.76 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.747 0.308 . . . . 0.0 110.236 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.431 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 6.3 tt -94.48 110.71 22.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.054 0.454 . . . . 0.0 110.428 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -91.62 161.12 15.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.058 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -120.81 146.73 46.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 19.6 mt -109.73 -30.37 7.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.743 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.62 -165.0 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.424 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.49 50.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.813 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.71 -33.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.246 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -104.22 146.71 28.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 111.241 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.0 m -151.74 -176.81 5.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.035 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.404 ' HA ' ' HA ' ' A' ' 175' ' ' ALA . 11.8 pt -148.56 150.79 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.642 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 127.63 31.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.787 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 173' ' ' LEU . . . -151.84 158.34 27.72 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.583 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 161.09 -120.71 0.97 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.657 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -139.6 152.9 47.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.814 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.11 145.3 45.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.416 ' CD1' ' O ' ' A' ' 168' ' ' SER . 8.1 m-85 -121.48 145.74 47.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.348 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.64 147.19 27.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.031 0.443 . . . . 0.0 111.258 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -135.61 155.58 50.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.48 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 p -108.89 123.76 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.108 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.14 114.85 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.823 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.99 -33.57 7.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.066 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 71.7 m -159.02 -75.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 59.31 101.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.47 -44.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 8.9 mtt -64.88 95.82 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 80.8 p -117.22 97.6 50.95 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.02 -61.69 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.479 2.119 . . . . 0.0 112.411 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -178.06 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.901 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.03 -141.91 17.96 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.455 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.74 178.82 41.64 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -78.98 110.88 14.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -76.2 -25.42 55.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mt 69.51 -66.84 0.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.63 -135.92 1.94 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.574 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.2 p -68.01 127.41 32.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.1 tp -148.1 105.89 3.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -113.84 108.34 16.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.35 84.7 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.857 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.05 -49.27 0.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.81 148.64 40.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.416 ' O ' ' CD1' ' A' ' 143' ' ' TYR . 67.1 m -109.66 147.22 33.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.87 141.04 38.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -154.3 155.14 34.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -119.68 130.88 55.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.261 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.445 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 34.5 p90 -133.23 173.9 10.95 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.712 0.768 . . . . 0.0 111.725 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.447 ' HA ' ' CA ' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -163.76 134.31 4.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.847 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -154.56 -165.61 14.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.0 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -107.73 169.73 8.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.341 . . . . 0.0 110.985 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -158.0 117.44 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -117.87 118.4 31.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -89.02 160.22 17.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.023 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.3 t80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.828 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.469 ' CB ' ' CE2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.676 0.274 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER -132.05 163.1 29.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.858 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -112.51 141.98 45.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.678 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 28.2 p90 -146.43 167.23 24.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 111.23 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -156.33 144.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.475 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.68 -142.67 3.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mt -120.95 153.51 37.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.751 0.31 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -122.15 113.53 19.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.78 112.94 19.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.04 115.25 3.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.542 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.73 120.03 35.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.9 t -92.85 103.58 15.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -150.12 102.76 3.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -93.59 76.01 4.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -86.9 118.93 26.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.0 tp -72.75 65.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.022 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.77 -173.87 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -178.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 m -139.09 125.43 20.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -88.58 159.13 18.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.3 m -147.28 143.9 28.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mt -116.81 31.14 6.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -74.72 -167.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.814 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.14 42.73 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -177.23 158.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.859 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.03 -51.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -95.63 79.19 3.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -160.64 137.59 6.63 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.846 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.41 158.28 7.83 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.537 2.158 . . . . 0.0 112.317 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -133.06 149.32 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 tp -111.03 49.49 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.817 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -110.59 78.55 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.67 -49.31 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.3 p 44.38 29.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.763 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 mm 62.43 143.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.159 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -161.82 118.08 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.947 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -133.24 129.18 37.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.953 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 t -178.17 150.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.27 -136.71 5.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.485 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.33 144.25 48.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.84 105.51 5.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.44 -164.83 10.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.513 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mt -106.69 158.95 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.695 0.283 . . . . 0.0 110.898 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -121.99 131.92 54.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.001 0.429 . . . . 0.0 110.523 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.75 117.82 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.97 -143.56 3.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.621 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -153.66 126.09 8.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.955 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 3' ' ' ASP . 19.9 pt20 -95.09 109.54 21.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.487 . . . . 0.0 111.184 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.469 ' CE2' ' CB ' ' A' ' 2' ' ' ALA . 1.7 t80 -98.82 159.43 14.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.159 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -55.41 -28.1 52.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.547 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.37 24.39 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.415 ' HA3' ' CE1' ' A' ' 80' ' ' TYR . . . -174.8 132.85 2.31 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.802 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.444 ' NH1' ' CE2' ' A' ' 5' ' ' PHE . 2.7 ttt-85 -116.56 131.96 56.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 0.0 111.14 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.93 139.04 31.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.396 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.37 100.13 5.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 0.0 111.505 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -105.91 118.45 36.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.438 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 t -122.58 114.73 21.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.926 0.393 . . . . 0.0 111.224 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CD2' ' CD2' ' A' ' 76' ' ' LEU . 4.0 t80 -89.39 111.16 21.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.53 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.75 -179.91 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.104 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -149.97 -75.49 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.882 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.8 pp -158.61 140.48 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.133 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.1 t -106.16 -32.48 8.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -115.39 134.23 55.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.6 p -121.93 31.71 6.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -69.53 -31.38 69.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -36.0 76.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.955 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.58 -134.12 2.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.447 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -113.62 132.94 55.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -154.78 158.81 40.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp -170.77 -66.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.54 92.4 1.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.736 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -153.15 144.67 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -138.41 125.15 20.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -127.91 110.96 13.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -105.64 116.84 32.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.651 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.44 122.65 47.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.184 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.59 120.73 4.61 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.89 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.4 ' CB ' ' HA ' ' A' ' 98' ' ' THR . 96.5 p -129.33 145.09 51.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 0.0 111.558 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 11.2 t80 -116.56 110.87 19.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.184 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -126.17 163.91 22.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.383 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -110.27 118.28 35.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.424 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.428 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 34.5 p90 -97.86 160.22 14.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.608 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 tp -165.85 124.69 1.14 Allowed Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.803 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 91' ' ' THR . 50.6 Cg_exo -55.55 108.34 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.458 2.106 . . . . 0.0 112.241 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.1 tp -157.07 127.23 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.7 -96.71 0.41 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.809 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.39 -74.39 0.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 111.016 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -173.15 -39.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 5.0 m120 -116.22 15.1 15.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.537 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 2.6 t -79.64 153.22 29.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 7.1 mmtp -130.27 91.96 3.2 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.046 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 1.1 tt -67.79 102.81 1.29 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.886 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.435 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 41.5 p90 -110.59 150.85 28.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.71 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.38 132.15 2.5 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.802 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.85 -144.82 4.92 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.605 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.02 158.42 17.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 79' ' ' SER . 9.8 t -130.66 150.54 51.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.004 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.1 tt -160.07 127.01 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.729 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.35 -156.97 8.84 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.612 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.64 124.83 6.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.778 0.323 . . . . 0.0 110.737 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 t -109.88 125.47 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -140.12 144.98 37.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.26 158.35 28.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.13 127.84 43.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 159.41 19.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -162.84 133.26 4.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 159.49 -88.16 0.11 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.466 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -179.83 -37.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.773 0.32 . . . . 0.0 110.889 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.53 -100.34 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.661 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -92.5 136.18 33.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.58 174.07 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.784 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 60.49 -175.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.9 t0 70.38 -64.68 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.4 p 62.88 150.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.84 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.92 65.01 2.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.983 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.5 m -88.31 153.69 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.077 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.0 -167.7 19.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.52 134.81 39.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -106.71 142.81 35.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.075 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.78 134.3 9.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.123 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -174.38 -138.98 2.84 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.627 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 pp -155.46 160.95 41.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -156.42 177.64 11.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.157 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.84 142.53 0.08 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.46 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.435 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -155.23 -140.56 3.03 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.005 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.522 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 3.5 pt -159.43 120.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.693 0.282 . . . . 0.0 110.262 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.79 109.28 21.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.728 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 3.0 mt-30 -101.08 141.64 33.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.006 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.98 149.21 40.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.769 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 pp -110.18 -39.67 4.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.016 0.436 . . . . 0.0 110.776 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -169.2 -164.87 0.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.368 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -84.88 52.98 2.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 110.603 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.407 ' O ' ' CE1' ' A' ' 177' ' ' TYR . 0.5 OUTLIER -133.06 -55.34 0.92 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.037 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.05 150.15 7.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.156 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 6.4 t -106.89 169.66 8.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.785 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.5 tt -132.7 134.7 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.661 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.61 152.32 35.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.984 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -161.79 118.09 0.8 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.29 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.68 -151.68 6.38 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.914 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.27 161.13 32.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 110.81 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -146.87 136.71 23.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.414 ' CD2' ' HA ' ' A' ' 169' ' ' SER . 11.5 m-85 -145.03 127.48 15.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.838 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 pp -156.2 162.47 40.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -103.19 157.72 16.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.8 m -109.0 129.13 55.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -128.8 151.15 49.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -131.49 -46.16 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.012 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.1 m -128.66 -175.78 3.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.39 -66.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -79.34 89.91 4.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.938 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -47.17 86.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.6 p -116.22 144.86 33.76 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.19 -43.72 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.468 2.112 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -116.47 159.25 22.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.37 -28.5 12.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.6 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.93 -163.51 18.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.584 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.34 131.24 56.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -127.11 -70.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.59 90.73 5.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 167.92 41.99 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.463 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.1 t -163.45 164.11 24.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 0.0 110.894 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 68.03 -70.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -66.24 77.62 0.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 mt -109.92 -35.01 6.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 61.22 154.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.81 154.12 46.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.0 168.37 10.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.414 ' HA ' ' CD2' ' A' ' 143' ' ' TYR . 15.7 m -106.87 122.98 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.64 155.15 46.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.742 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -111.71 164.1 13.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.121 0.486 . . . . 0.0 110.161 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.414 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -132.59 126.88 33.79 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.771 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.56 129.96 3.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.563 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.89 -152.94 15.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.831 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.95 172.09 10.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 111.114 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -155.59 119.18 4.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.407 ' CE1' ' O ' ' A' ' 134' ' ' ASN . 13.9 t80 -120.31 115.87 24.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.081 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.39 145.93 30.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.013 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.023 -179.801 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.842 0.353 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 49' ' ' GLN . 2.0 t0 -163.06 138.92 6.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 1.8 t30 -80.69 156.59 26.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.561 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.515 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.9 OUTLIER -156.12 164.56 38.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 111.592 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.4 m -158.02 128.22 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.953 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -150.73 -146.87 4.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.596 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.38 136.9 25.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.779 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.6 p -100.58 151.2 21.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -148.69 128.69 13.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.98 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.38 138.24 13.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.43 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 109.97 17.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.8 p -110.26 147.05 34.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.821 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.11 102.89 3.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 62.35 94.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -92.52 150.14 20.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 pt -139.19 31.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -105.61 -57.65 2.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 151.34 31.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 m 60.54 110.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -121.87 -54.89 1.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.1 m 61.15 155.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.3 156.86 40.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -115.01 -177.23 3.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.823 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.71 -45.42 1.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -131.9 -69.69 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.4 tp 61.05 101.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -111.9 46.62 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m -131.85 95.9 21.6 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.846 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.01 -41.8 7.04 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.435 2.09 . . . . 0.0 112.356 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -84.06 58.22 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.44 -48.9 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.83 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.3 87.27 1.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -74.97 -73.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.1 m -134.27 -46.67 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 mt -121.98 103.25 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -126.76 -63.24 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -116.73 30.92 7.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.6 t -118.71 117.94 30.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.75 138.86 4.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.362 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -94.99 110.08 22.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.823 0.344 . . . . 0.0 110.959 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.87 -178.96 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.567 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.59 ' HA2' ' HB2' ' A' ' 60' ' ' GLU . . . -178.17 158.17 22.78 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.081 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 58' ' ' THR . 25.7 mt -106.44 124.82 62.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.18 133.89 49.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.392 0.615 . . . . 0.0 111.084 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -163.34 111.11 1.21 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.448 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.45 -163.04 12.36 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.188 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -126.41 142.63 51.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.024 0.44 . . . . 0.0 111.298 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.403 ' HG2' ' HB3' ' A' ' 54' ' ' ARG . 0.7 OUTLIER -97.02 162.15 13.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.473 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.52 -169.38 1.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.977 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -32.51 73.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.509 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -127.33 -34.7 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -119.04 -166.05 13.33 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.702 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.403 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . 44.9 ptt85 -162.96 158.54 22.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.0 111.791 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.409 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 12.2 m-85 -118.84 144.26 46.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.846 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -159.12 119.09 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.963 0.411 . . . . 0.0 111.181 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.79 140.33 29.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.817 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 7.1 t -126.18 116.15 20.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.1 p90 -130.11 126.7 38.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 111.763 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.59 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -158.36 -179.91 8.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.948 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -93.26 -166.22 1.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.397 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.0 tp -137.38 121.53 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 111.196 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.2 m 57.72 91.79 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.999 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -163.84 177.24 8.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.3 p -107.83 -177.65 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.6 t -89.8 -42.44 11.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.05 27.07 5.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.991 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -93.46 -151.79 28.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.493 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.01 141.71 27.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.778 0.323 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -70.99 168.59 16.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.3 -67.71 0.73 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.7 37.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.959 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -134.89 142.68 46.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.49 159.91 10.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -146.0 119.44 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.106 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.29 145.12 50.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.642 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.06 157.98 33.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 111.342 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.97 116.79 4.23 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.054 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 23.3 t -98.78 133.69 42.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.97 0.414 . . . . 0.0 111.37 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 12.7 p90 -134.13 112.06 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.185 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -139.16 172.14 13.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.188 0.518 . . . . 0.0 111.558 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.513 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -112.22 118.72 36.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.839 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 20.3 p90 -99.74 166.42 11.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.257 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 tt -167.83 134.79 1.79 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.11 118.48 4.6 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.463 2.109 . . . . 0.0 112.345 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 tt -121.24 105.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.057 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.9 -96.43 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.59 51.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 110.827 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.0 m120 60.27 29.44 19.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -108.13 -24.03 11.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 p -136.29 151.89 50.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.547 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 5.4 mptt -122.81 92.42 3.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.906 0.384 . . . . 0.0 110.924 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tp -62.23 102.83 0.33 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.706 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 30.2 p90 -112.76 156.03 23.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.781 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.03 128.65 1.5 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -163.99 -132.75 1.38 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.65 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.411 ' HB1' ' CZ ' ' A' ' 80' ' ' TYR . . . -133.25 165.95 23.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.773 0.321 . . . . 0.0 111.235 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 p -136.65 154.94 50.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.89 130.67 5.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.023 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -161.92 -152.76 6.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.679 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mp -148.25 122.26 9.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.4 m -109.82 130.25 63.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.231 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -114.55 134.93 54.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mt -131.74 142.66 49.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -109.39 147.92 31.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.858 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.24 151.74 37.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -171.49 35.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.42 73.46 0.25 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.499 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -63.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.347 . . . . 0.0 110.841 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.43 -74.49 0.35 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.429 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.08 162.47 24.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.825 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -83.61 96.15 8.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.968 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -88.42 168.77 12.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.72 116.91 12.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.72 88.97 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -147.98 -68.66 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.2 p -163.64 137.21 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -137.88 170.5 23.72 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -84.31 132.68 34.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.323 . . . . 0.0 110.853 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -115.18 143.37 45.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -169.31 137.98 1.96 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.47 -137.86 2.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mp -146.59 157.07 43.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 110.964 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.13 161.87 36.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.594 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 179.59 142.41 0.14 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.461 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -169.5 -135.08 1.84 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.948 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 2.8 pt -158.04 120.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.801 0.334 . . . . 0.0 110.383 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.408 ' CB ' ' HB2' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -94.82 112.99 24.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.551 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 137' ' ' ILE . 4.0 tt0 -96.45 123.94 40.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.147 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.23 149.12 32.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.572 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 tp -105.87 -47.19 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 110.542 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 m -165.72 -164.86 0.76 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -81.37 55.66 2.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.62 -59.13 0.72 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.99 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -154.89 151.36 28.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.101 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.4 m -113.72 174.28 6.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 129' ' ' GLN . 28.5 mm -134.17 134.9 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.96 141.52 46.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.897 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -163.07 121.41 1.02 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -174.85 -138.13 2.66 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.048 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.501 ' CE1' ' CE2' ' A' ' 171' ' ' PHE . 64.6 m-85 -132.76 161.09 34.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.756 0.312 . . . . 0.0 110.758 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -140.83 136.58 32.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -132.02 128.91 39.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.433 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.68 151.44 45.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.379 . . . . 0.0 111.154 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.5 ttt-85 -116.52 163.97 15.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.689 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.3 m -108.83 134.29 51.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.005 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -135.01 153.23 52.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.54 -50.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.04 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 61.02 91.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 p -107.74 -47.17 3.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.804 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -106.47 121.38 44.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.23 -43.18 8.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.94 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.52 139.61 31.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.27 145.66 30.81 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.468 2.112 . . . . 0.0 112.287 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -169.47 149.21 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.73 164.87 32.95 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.441 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -105.26 46.72 1.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.458 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.07 135.47 16.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.81 0.338 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -114.61 150.18 35.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -35.15 16.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 129.18 114.09 1.72 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.497 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.5 p -118.15 163.35 16.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.972 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 59.59 20.81 9.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 t70 178.79 82.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.856 0.36 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.14 151.2 28.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.955 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.96 175.27 10.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.889 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.45 173.22 11.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.95 119.72 37.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.9 t -106.96 106.18 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.52 155.24 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.501 ' CE2' ' CE1' ' A' ' 141' ' ' TYR . 0.2 OUTLIER -94.2 165.36 12.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.199 0.523 . . . . 0.0 110.195 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.403 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -131.3 128.46 39.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.809 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.39 135.18 5.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.58 -142.74 6.96 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.774 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -142.88 171.99 13.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -155.59 117.6 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -102.61 111.62 24.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.83 147.01 29.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.083 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.925 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.805 0.336 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 1.5 t0 -113.48 168.18 9.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.583 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.18 125.51 39.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.644 0.259 . . . . 0.0 110.686 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.2 OUTLIER -134.68 139.95 45.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.396 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 37.9 t -150.2 131.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.982 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.36 -162.49 10.76 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.799 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -118.24 142.7 47.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 0.0 110.61 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 p -111.33 118.61 36.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.06 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -128.35 112.88 14.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.696 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -106.97 153.9 16.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.644 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -94.84 133.2 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.26 108.58 20.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.971 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.07 102.84 3.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.853 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -93.62 125.31 38.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -65.79 138.38 57.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.7 pp -146.12 -46.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.175 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 55.68 89.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.039 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.5 tttm -140.94 116.12 9.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.017 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.7 m -124.97 83.64 2.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -96.64 97.8 9.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 m -102.1 82.74 2.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.94 -64.68 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -130.03 161.01 31.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.27 110.79 18.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -104.76 132.01 51.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.78 -71.02 0.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.866 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 61.22 83.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.3 p 62.17 148.64 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.042 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.24 -19.39 22.54 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.599 2.199 . . . . 0.0 112.529 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 63.02 89.12 0.09 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.957 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.72 -39.88 9.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.44 -30.08 65.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt 62.37 105.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 m -61.69 -26.44 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.212 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.4 mt 67.39 138.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.68 -27.71 12.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.975 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.22 91.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 m -117.92 95.51 4.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.02 141.1 3.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.561 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 m -113.38 118.43 34.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -103.99 161.75 13.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.61 -169.36 35.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.605 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.7 mp -134.9 160.0 41.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.026 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.07 139.32 39.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.95 0.405 . . . . 0.0 110.593 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -171.57 120.91 0.49 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.842 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.73 -141.73 3.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.832 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.473 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 15.5 pt20 -122.3 142.18 50.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.705 0.288 . . . . 0.0 110.785 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -116.81 109.68 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 111.089 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -130.57 165.01 23.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.509 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -19.2 65.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.36 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.63 24.09 12.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.31 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 155.98 142.56 3.45 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.526 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.466 ' CD ' ' CE1' ' A' ' 55' ' ' TYR . 0.0 OUTLIER -136.71 162.09 34.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.319 . . . . 0.0 110.946 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.466 ' CE1' ' CD ' ' A' ' 54' ' ' ARG . 8.9 m-85 77.05 -175.81 0.1 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 79' ' ' SER . 3.4 t80 178.65 -43.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.902 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -122.43 136.96 55.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 111.396 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.13 119.69 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.565 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -113.55 149.98 33.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.01 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.34 155.91 44.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -166.8 124.92 1.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.985 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -126.91 134.85 65.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.129 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.82 -67.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.3 -74.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.979 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 t -69.55 147.11 51.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -86.03 -24.57 26.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -95.71 26.93 3.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.119 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.7 91.31 0.11 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.476 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.01 138.07 53.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.91 27.68 16.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.981 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 tp -177.84 85.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.94 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.1 -42.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.894 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -142.2 124.87 15.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.992 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -118.75 130.5 55.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.689 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.74 119.37 24.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.43 114.93 17.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.324 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.472 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.5 OUTLIER -142.93 168.87 18.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 111.399 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.97 116.74 4.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.903 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 56' ' ' TYR . 3.5 m -104.67 126.59 51.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.971 0.415 . . . . 0.0 111.484 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -136.57 110.89 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.198 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -129.21 171.87 12.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.029 0.442 . . . . 0.0 111.651 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.81 119.76 35.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.565 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 50.3 p90 -97.76 172.17 7.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.098 0.475 . . . . 0.0 111.809 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tp -165.09 135.45 3.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.391 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.54 119.26 4.89 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.548 2.165 . . . . 0.0 112.203 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 8.9 tt -128.13 108.74 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.2 -57.57 0.57 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -166.57 -59.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.754 0.311 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.74 38.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.793 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -129.77 -68.01 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.733 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.86 145.09 54.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.348 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 3.6 mmpt? -126.63 92.32 3.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 111.272 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.8 tp -60.54 103.25 0.23 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.051 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 16.6 p90 -110.73 161.76 15.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.292 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.44 126.57 1.05 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.559 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.06 -134.38 1.64 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.621 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.06 157.81 44.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.883 0.373 . . . . 0.0 111.324 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -134.79 161.86 33.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.732 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.29 132.76 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -158.68 -144.69 4.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.986 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.21 130.09 9.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 110.388 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.63 132.84 56.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.178 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.12 130.22 52.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.816 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.8 tp -114.5 136.14 53.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -161.17 136.34 7.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -137.17 129.81 30.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.39 110.61 2.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.872 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.34 157.5 27.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.441 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -114.98 89.86 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.93 -65.19 0.32 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -90.16 171.76 9.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.312 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -140.87 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.14 170.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.163 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.0 p30 -135.19 27.65 3.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.3 p -167.75 -78.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 79.89 -8.73 1.51 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.777 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.8 m -162.77 117.87 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.762 0.315 . . . . 0.0 110.993 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -136.51 131.61 5.73 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.546 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -84.17 117.73 23.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.803 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.86 145.13 37.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 141.32 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.954 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.01 -137.08 2.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.541 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 mp -145.2 153.31 41.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.195 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -133.71 172.55 12.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.622 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.89 142.49 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.054 0.454 . . . . 0.0 110.69 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.446 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -169.41 -134.33 1.72 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.721 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 10.8 pt -161.22 120.48 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.318 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.8 tt -95.88 113.32 24.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 111.201 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -100.31 139.27 36.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.756 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -93.34 149.15 21.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.002 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.41 -43.89 2.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 110.584 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 m -142.2 -164.72 1.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.361 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.41 28.8 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.162 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 177.84 34.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.773 0.32 . . . . 0.0 111.132 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.23 129.09 1.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.815 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.1 m -142.97 169.71 17.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.004 0.431 . . . . 0.0 111.29 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -132.52 134.78 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.247 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -128.18 149.19 50.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.925 0.393 . . . . 0.0 111.162 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -165.8 152.8 22.33 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.378 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.13 -131.72 2.22 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.698 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -135.82 152.56 51.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.762 0.315 . . . . 0.0 110.793 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -140.36 123.75 16.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 3.2 m-85 -116.98 124.28 48.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.0 171.39 16.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.182 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.1 ttt85 -152.39 144.32 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.765 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.5 p -108.99 128.88 55.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.93 115.62 9.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.04 -176.58 3.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.079 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 77.6 p -99.2 175.25 5.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -61.93 172.11 1.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.992 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.94 -31.38 7.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -172.74 -47.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.5 p -126.82 148.59 65.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.995 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.95 152.95 63.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.294 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -174.36 -42.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -80.92 97.86 1.79 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.515 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -139.46 117.51 1.37 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.465 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -138.93 133.04 31.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.804 0.335 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.21 164.96 11.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.9 92.99 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -116.21 32.54 5.55 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.496 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 81.2 p -147.51 167.88 23.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.892 0.377 . . . . 0.0 110.845 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.1 mt -101.99 31.59 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -131.13 122.07 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.88 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.55 158.13 15.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -96.71 92.88 6.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.3 m -140.89 152.47 45.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.838 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.408 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 10.6 t -107.4 150.85 26.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.953 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.83 140.65 39.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.746 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.35 155.28 33.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.081 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.58 141.57 41.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.095 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -119.84 127.51 52.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.989 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.45 129.87 3.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.465 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.76 -156.94 20.1 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.658 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.25 171.98 8.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.84 0.352 . . . . 0.0 111.159 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.451 ' ND2' ' CD1' ' A' ' 5' ' ' PHE . 2.0 t30 -150.8 114.96 5.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -115.38 122.17 45.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.162 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.93 162.91 22.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.224 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.942 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' HB1' ' CG ' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.888 0.375 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -97.29 168.47 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.667 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.82 118.53 37.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.785 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 1.7 m-85 -124.02 145.11 49.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.003 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.427 HG23 ' CE1' ' A' ' 179' ' ' PHE . 13.3 m -158.15 125.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.181 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.02 -149.06 5.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.64 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.1 159.66 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.819 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.61 127.72 35.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 36.9 t90 -128.33 112.99 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.687 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.83 168.58 13.99 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -110.48 130.61 55.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.8 t -102.21 113.82 27.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.973 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.08 102.88 3.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.746 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -105.36 101.64 11.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -92.27 134.38 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.855 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 pp -138.28 173.94 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.65 108.78 1.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -131.34 -46.57 0.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -82.53 161.46 22.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.53 132.46 10.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.1 t 61.48 30.5 18.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.38 -39.55 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -140.67 -177.97 5.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -166.3 163.74 17.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -99.77 34.8 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.31 73.94 1.43 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -176.67 -66.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 p -148.25 95.08 4.14 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.14 98.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.469 2.113 . . . . 0.0 112.313 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -92.89 -73.19 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.77 -78.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.37 97.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.815 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -128.04 -71.1 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.5 p -176.21 -41.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pt -156.76 27.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 57.82 64.49 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m120 60.71 156.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.31 -67.41 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.879 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.38 -161.77 22.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.439 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.8 m -137.16 107.86 6.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.943 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.426 ' CE3' ' CD1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -120.35 146.55 46.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.27 -164.83 25.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.512 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mp -107.0 161.16 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 110.95 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.446 ' NE ' ' CD1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -130.8 137.17 49.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.996 0.427 . . . . 0.0 110.693 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -174.16 122.51 0.3 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.825 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.64 -145.47 4.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.656 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -146.45 126.1 13.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.0 111.009 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -94.13 109.6 21.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.096 0.474 . . . . 0.0 111.278 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.2 OUTLIER -105.09 155.2 19.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.474 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.38 -18.6 65.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.384 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -130.68 24.26 5.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.318 . . . . 0.0 111.172 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.41 ' O ' ' N ' ' A' ' 50' ' ' PHE . . . 168.72 163.62 23.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.931 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -145.0 141.04 28.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.93 0.395 . . . . 0.0 111.532 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.35 146.61 26.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.035 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CD1' ' NE ' ' A' ' 45' ' ' ARG . 6.7 m-85 -143.87 96.9 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.381 . . . . 0.0 111.683 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.87 139.25 30.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.099 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.75 124.93 18.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.067 0.461 . . . . 0.0 111.714 -179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 76' ' ' LEU . 3.3 t80 -101.5 104.67 15.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.846 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.95 153.63 19.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.086 0.47 . . . . 0.0 111.489 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.99 -164.78 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.461 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 pt -109.34 108.92 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.148 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m 58.94 -84.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.067 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -179.65 -176.93 0.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -101.31 33.85 2.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.911 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.0 t -90.93 -11.45 39.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.393 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t -96.08 27.02 3.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.717 0.294 . . . . 0.0 111.131 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.41 -142.87 42.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.606 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.56 121.68 41.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -176.7 -39.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -137.1 146.67 45.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.92 123.75 6.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.803 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.54 155.09 48.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -140.81 121.06 13.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -124.89 111.06 15.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.002 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.409 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -118.96 116.95 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.654 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 pp -135.38 146.3 48.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 0.0 111.405 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.18 116.9 4.23 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.956 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.4 p -105.9 119.95 40.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.629 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.45 110.88 23.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.963 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.41 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 1.7 m-20 -128.08 161.11 29.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.147 0.499 . . . . 0.0 111.842 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.85 119.12 38.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.221 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 35.1 p90 -97.32 158.11 15.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.994 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -165.33 125.98 1.33 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.733 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -52.99 100.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.614 2.209 . . . . 0.0 112.229 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 93' ' ' LEU . 18.8 tt -157.28 127.1 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.113 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.0 -83.25 0.2 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.786 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.95 -63.13 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.991 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -169.44 -40.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.986 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 18.4 m120 -121.86 17.98 11.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.539 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.6 p -79.47 153.29 29.72 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -130.73 92.1 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.999 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -64.26 102.06 0.48 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.771 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 46.3 p90 -111.92 120.94 43.63 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.604 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.41 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -140.72 147.35 18.99 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.777 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.46 -139.08 3.52 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.813 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.57 176.2 5.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.891 0.377 . . . . 0.0 111.182 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 p -146.48 145.54 30.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.07 131.15 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.53 -151.89 5.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.652 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.07 125.82 7.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.797 0.332 . . . . 0.0 110.746 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.1 p -110.31 142.83 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.252 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -153.48 138.23 17.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.97 146.01 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.945 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.28 133.48 14.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.83 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.56 138.59 43.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.2 p30 -176.73 -178.16 0.86 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -114.27 -39.59 1.02 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.498 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -126.01 -63.01 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.52 37.22 0.68 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.465 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -89.12 173.05 8.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.855 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.48 132.64 9.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -134.13 -65.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -114.43 102.85 10.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.952 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.6 t -177.41 133.82 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.78 -83.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.9 m -164.04 169.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.815 0.341 . . . . 0.0 111.245 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -142.72 149.6 21.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.335 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -119.24 114.97 23.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.02 139.23 48.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.75 130.61 5.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -175.43 -138.19 2.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mp -148.04 171.31 16.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -152.17 168.74 24.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.957 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . -175.15 142.06 0.6 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.96 0.41 . . . . 0.0 110.554 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 93' ' ' LEU . . . -168.28 -146.74 5.08 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.783 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 1.8 pp -161.04 120.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.419 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 2.1 tt -95.95 113.41 25.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.942 0.401 . . . . 0.0 111.19 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.421 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 3.0 tt0 -95.17 115.84 27.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.14 149.21 24.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mp -107.66 -39.67 5.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.691 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.1 p -169.05 -164.88 0.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.395 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -83.55 55.16 3.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.865 0.364 . . . . 0.0 110.73 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -140.35 -59.99 0.53 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.002 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.47 157.33 27.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.1 p -135.4 -177.3 4.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.128 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 175' ' ' ALA . 2.4 pt -129.65 134.82 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.617 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -123.86 140.62 52.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.46 143.94 9.2 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.392 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.07 -144.94 5.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.649 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.75 158.38 40.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -144.67 140.26 28.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 2.8 p90 -145.06 105.06 4.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.969 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.85 153.97 47.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -108.58 147.86 31.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.839 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.84 126.7 50.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.961 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -141.04 115.12 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.73 157.68 17.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.118 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.7 t -82.92 79.49 9.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.94 -64.7 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -161.56 152.44 18.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -67.44 167.49 12.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.6 t -117.59 132.71 23.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.33 164.88 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.427 2.084 . . . . 0.0 112.284 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -139.72 130.92 26.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -136.16 -117.0 1.63 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -134.52 -147.25 5.55 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.497 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -145.77 -178.74 6.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 110.92 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -130.36 -54.57 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.1 167.13 22.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -95.94 37.2 3.5 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.2 m -152.28 153.49 33.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.754 0.311 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.78 -173.23 4.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.94 100.65 2.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.41 130.58 47.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -99.9 30.39 3.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 2.0 m -78.4 175.39 10.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.898 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.61 125.16 50.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.964 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 72.3 p -106.94 120.55 42.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.694 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -146.66 155.15 42.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.985 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -104.58 165.38 11.1 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.14 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.47 127.27 37.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.044 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.52 129.95 3.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.471 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.84 -152.74 15.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.747 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -124.86 171.9 9.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 111.218 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.65 114.92 5.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -106.2 114.22 28.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.0 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.95 163.39 22.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.024 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.427 ' CE1' HG23 ' A' ' 6' ' ' VAL . 4.2 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.2 168.17 11.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.862 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -112.08 132.88 54.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.801 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -131.41 139.59 49.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.973 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.1 t -156.14 125.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.081 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -170.98 -128.12 1.0 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.739 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -159.19 167.91 27.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.748 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.45 150.22 35.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.982 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -110.47 117.09 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.823 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.5 137.51 13.73 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.529 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.05 116.94 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 0.0 110.917 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.3 p -121.9 106.43 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.11 102.87 3.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.84 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -117.24 136.97 52.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.793 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -91.23 124.6 35.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.428 ' N ' ' CD1' ' A' ' 17' ' ' ILE . 0.2 OUTLIER -131.12 -37.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.374 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -164.17 -176.81 4.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.331 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -107.79 153.72 22.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.3 p -151.41 177.09 10.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.815 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.63 133.31 16.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.9 t -109.99 92.11 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tp -100.95 31.54 3.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.808 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -99.49 -67.14 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.818 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -77.14 114.99 16.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.65 -68.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 60.58 161.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -131.3 102.67 6.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.978 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.7 t -149.55 137.98 12.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.734 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.62 -49.85 15.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.406 2.071 . . . . 0.0 112.297 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.49 -179.77 6.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.81 91.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -177.53 -45.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -97.04 -14.03 21.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.329 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.5 m -96.07 28.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.312 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.94 84.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.126 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -103.16 -76.06 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -105.72 115.02 29.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -72.71 -54.22 9.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.68 -138.49 9.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.435 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.1 p -137.72 107.99 6.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -91.6 131.22 37.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.682 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.9 -175.81 20.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.796 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.417 HG21 HD11 ' A' ' 44' ' ' ILE . 4.0 mt -106.94 168.6 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.56 0.219 . . . . 0.0 110.698 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.458 ' CZ ' ' CE1' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -138.4 142.78 39.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.051 0.453 . . . . 0.0 110.828 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -170.48 120.23 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.965 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -161.57 -156.8 8.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.577 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.461 ' HB2' ' CE2' ' A' ' 55' ' ' TYR . 5.9 mt-30 -141.44 133.39 27.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.087 0.47 . . . . 0.0 111.074 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.441 ' HA ' ' CB ' ' A' ' 54' ' ' ARG . 8.1 tt0 -83.55 162.06 20.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.849 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.02 -169.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.647 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -67.24 -40.37 86.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.237 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -123.18 -26.61 4.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.732 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -124.29 -159.83 10.56 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.689 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' CB ' ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -171.64 168.09 6.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.632 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -141.23 166.68 24.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.424 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.586 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 41.3 p90 177.92 135.73 0.08 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.092 0.473 . . . . 0.0 110.888 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.51 155.78 18.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.257 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 77.1 p -137.58 123.78 20.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.055 0.455 . . . . 0.0 111.454 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.89 108.69 19.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.173 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -105.99 178.68 4.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.092 0.472 . . . . 0.0 111.503 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -164.36 -164.67 0.87 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.54 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -121.47 117.65 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 111.199 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.82 82.9 1.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.84 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -90.84 -65.19 1.04 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 t -99.09 140.56 33.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.97 -31.95 34.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.24 -29.82 24.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.48 46.47 2.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.467 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -76.65 122.13 24.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.861 0.363 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -161.84 147.54 13.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.8 87.18 6.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -105.27 -30.39 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.977 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -116.49 169.09 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.936 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -151.21 131.34 13.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -120.02 110.87 17.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.805 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.17 115.72 30.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.638 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 1.8 mp -133.12 133.66 43.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.4 . . . . 0.0 111.298 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.89 116.91 4.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.944 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.6 t -105.25 135.6 46.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 111.576 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -128.71 110.95 12.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.899 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -136.52 172.13 13.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.233 0.54 . . . . 0.0 111.866 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.469 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -115.42 121.89 44.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.547 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 18.9 p90 -97.71 164.66 12.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.737 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -167.04 128.15 1.23 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.389 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.57 106.92 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.445 2.097 . . . . 0.0 112.362 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.2 mt -150.23 120.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.988 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 149.22 -78.72 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.422 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.02 -72.99 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.794 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -170.43 31.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.144 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -172.31 31.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.295 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.5 p -136.59 130.51 32.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.714 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -117.31 92.82 3.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.896 0.379 . . . . 0.0 110.881 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.17 103.02 0.09 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.596 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 22.6 p90 -110.93 156.17 21.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.802 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.43 135.21 2.94 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.712 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.91 -137.59 2.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.653 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -124.87 161.74 25.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.855 0.359 . . . . 0.0 111.19 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.7 m -139.49 148.63 42.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.5 mp -157.1 130.82 8.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -141.46 -162.7 9.26 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.121 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 mp -155.6 142.54 19.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.407 ' CG2' ' HA3' ' A' ' 118' ' ' GLY . 35.0 m -109.56 145.41 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.416 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.88 145.06 39.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.84 103.63 9.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.883 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.31 166.39 11.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.65 177.98 7.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.39 158.16 44.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.84 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.77 46.11 1.06 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.497 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm 59.52 32.44 21.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.55 111.26 3.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.448 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -103.77 149.71 24.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.72 155.39 40.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -87.59 -63.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.66 118.46 9.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.808 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.5 p -173.87 154.14 2.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.1 t0 61.73 76.67 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.955 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.58 100.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.407 ' HA3' ' CG2' ' A' ' 102' ' ' VAL . . . -161.11 132.4 2.86 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.275 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -113.97 114.97 26.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.876 0.37 . . . . 0.0 111.05 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.73 138.24 54.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.746 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.96 132.75 5.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.448 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.39 -140.05 3.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.765 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.3 mt -147.64 164.78 32.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -149.74 170.54 18.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.704 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.92 142.56 0.08 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.988 0.423 . . . . 0.0 110.851 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.453 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -164.53 -128.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.759 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.452 ' N ' ' CE2' ' A' ' 94' ' ' PHE . 12.6 pt -160.59 121.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 120.794 0.33 . . . . 0.0 110.296 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 5.0 tt -94.48 113.28 25.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.008 0.432 . . . . 0.0 110.857 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -95.63 124.18 39.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -111.56 149.14 31.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.7 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.6 tp -108.24 -45.9 3.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.118 0.485 . . . . 0.0 110.635 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.7 p -169.21 -164.85 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.189 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.55 54.96 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.913 0.387 . . . . 0.0 110.569 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -138.25 -58.2 0.65 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.16 171.95 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.197 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.9 m -141.03 167.73 21.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 5.4 mt -129.26 134.87 63.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.444 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -127.95 132.09 49.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . -155.28 144.49 11.08 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.554 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 171' ' ' PHE . . . 176.14 -151.41 11.58 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.366 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 170' ' ' GLN . 0.2 OUTLIER -119.75 153.45 35.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.902 0.382 . . . . 0.0 110.916 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.415 ' HB3' ' CE1' ' A' ' 172' ' ' TYR . 29.1 ptt180 -131.89 129.99 41.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 169' ' ' SER . 7.3 t80 -128.59 102.23 6.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.779 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.72 164.04 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.196 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.2 153.89 18.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.718 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.3 t -108.89 172.12 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -56.15 115.21 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.84 95.57 8.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 60.83 172.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.7 p -135.95 -55.25 0.77 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -150.71 135.71 17.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.99 104.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.3 p -108.25 91.87 8.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.97 92.78 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.484 2.122 . . . . 0.0 112.317 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.28 153.24 43.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -76.18 -65.82 1.96 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.53 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 107.33 98.96 2.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.459 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -76.31 -179.32 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 30.83 6.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.852 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mt -147.07 -49.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 176.48 177.78 45.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.2 p -152.28 129.44 11.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.762 0.315 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 60.52 178.71 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.69 -64.26 0.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.1 tp -128.71 143.87 51.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.93 33.57 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' SER . . . . . 0.415 ' HB3' ' CE1' ' A' ' 143' ' ' TYR . 4.6 m -110.05 176.05 5.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.807 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.5 m -157.53 132.48 8.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.422 ' HB3' ' CE2' ' A' ' 143' ' ' TYR . 83.4 p -107.9 122.59 47.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.805 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . 0.407 ' O ' ' CD1' ' A' ' 141' ' ' TYR . 1.6 mt-30 -141.58 152.11 43.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.417 ' CD1' HD23 ' A' ' 173' ' ' LEU . 2.7 t80 -100.04 120.55 40.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.265 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.415 ' CE1' ' HB3' ' A' ' 142' ' ' ARG . 9.7 p90 -125.07 126.44 45.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.234 0.54 . . . . 0.0 111.428 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.581 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 1.4 pt? -147.46 155.47 41.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.858 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -176.73 -132.73 1.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.401 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.85 169.41 16.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 0.0 111.128 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -158.05 118.35 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.022 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -101.57 118.27 36.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.16 154.79 20.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.402 ' HA ' ' HB3' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.798 0.333 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.8 OUTLIER -110.06 151.53 27.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.661 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -112.28 119.19 37.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.744 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 29.0 p90 -124.05 155.29 38.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.256 0.55 . . . . 0.0 111.469 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 7.5 p -151.91 128.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.732 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.74 -141.6 3.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.373 -0.917 . . . . 0.0 112.754 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.5 165.54 23.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.896 0.379 . . . . 0.0 110.799 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.1 p -129.17 143.95 51.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -140.9 112.96 7.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.689 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.88 135.24 10.98 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.6 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -79.93 125.42 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 110.823 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -110.75 119.16 38.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -150.12 102.79 3.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.717 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.06 -64.53 1.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -74.51 131.9 41.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.11 124.54 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -173.39 164.29 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.857 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.21 124.69 45.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -136.54 31.57 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.5 129.22 19.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -90.17 118.09 29.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.975 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.65 173.78 8.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.973 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -120.77 138.14 54.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 mtt-85 -115.51 -178.37 3.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -176.83 -52.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -162.92 -44.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -88.78 115.58 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.6 116.19 60.38 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.801 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.06 93.39 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.341 2.027 . . . . 0.0 112.306 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -118.07 127.54 53.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 60.78 74.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -110.81 -49.89 3.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -158.1 78.07 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.92 -66.15 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.176 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 mp 69.18 -67.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.22 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.3 153.29 0.93 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -136.94 -56.87 0.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.73 142.72 33.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.31 -159.18 23.73 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.2 p -119.2 139.43 51.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 111.028 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -148.45 139.94 23.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -177.3 -164.89 31.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.605 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mt -106.86 161.74 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.584 0.23 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.99 148.7 40.74 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.606 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -177.22 124.38 0.14 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -161.57 -163.11 13.84 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.308 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 3.4 mp0 -118.34 125.97 51.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 0.0 111.001 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.461 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 37.5 tt0 -111.79 109.97 20.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.196 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -119.41 160.11 22.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.521 179.339 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.75 -23.29 64.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.197 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -99.29 24.09 8.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.242 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 50' ' ' PHE . . . 133.4 164.57 10.83 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.337 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.401 ' NE ' ' CZ ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -139.44 146.03 39.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.918 0.39 . . . . 0.0 111.314 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -129.78 161.23 31.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.408 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.553 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 15.9 p90 -176.97 126.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.166 0.508 . . . . 0.0 111.525 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.71 139.06 31.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.284 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.3 m -129.57 117.29 20.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 111.529 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -94.32 117.17 29.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.319 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -111.82 175.4 5.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 111.266 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.08 -166.85 1.35 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.731 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.7 mt -100.1 118.86 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.101 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.0 m -82.86 -55.17 4.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.87 137.71 46.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 3.5 t -128.25 106.43 9.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 t -68.65 -40.24 80.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -61.0 -36.96 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.29 42.37 83.16 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.561 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -100.05 171.76 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -102.83 81.52 2.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.1 tt -163.86 136.43 5.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -135.89 151.9 50.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.999 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -127.25 -178.43 4.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -121.38 139.53 53.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -114.57 112.54 23.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 tt -98.28 114.95 27.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.49 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.11 113.58 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.278 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.01 116.95 4.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.623 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 12.3 m -126.41 143.02 51.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 0.0 111.831 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -131.79 110.67 11.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.502 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 15.8 m-20 -130.55 166.06 21.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.214 0.531 . . . . 0.0 112.017 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.08 127.95 53.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.045 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 94' ' ' PHE . 45.4 p90 -97.36 168.72 10.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.143 0.497 . . . . 0.0 111.778 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 tp -158.9 132.4 4.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.235 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.17 106.04 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.32 2.014 . . . . 0.0 112.401 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 42.7 mm -119.08 103.39 14.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.002 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 119.29 -95.08 0.59 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.537 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -169.5 59.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 64.23 25.2 13.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.63 -36.37 6.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 14.5 p -136.48 142.7 43.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.463 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 13.6 mmtt -123.52 98.92 6.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 7.8 tt -55.32 104.54 0.13 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.381 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -109.42 145.88 35.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.606 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.21 140.54 6.47 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.067 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 179.45 -146.82 7.29 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.004 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -109.07 -178.02 3.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 111.257 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -145.51 161.44 39.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 12.4 mt -147.86 130.27 15.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.34 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.37 123.64 4.02 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.378 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.0 tp -143.87 120.9 11.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.845 0.355 . . . . 0.0 110.743 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 4.9 m -109.8 145.26 16.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.138 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.24 137.18 52.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.956 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -118.09 131.44 56.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -145.01 149.74 35.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -113.88 155.21 26.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.57 -173.87 2.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.22 159.99 1.59 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.508 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.83 148.85 39.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 146.44 -165.51 28.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -92.54 124.97 36.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.88 102.86 4.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -124.83 -40.5 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.87 161.9 1.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.161 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.0 p -169.74 154.81 5.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.63 83.3 2.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.56 106.58 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.62 149.42 19.23 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.48 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -114.25 127.93 56.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -133.86 148.82 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.11 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -171.98 134.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.85 -124.9 0.74 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.615 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 97' ' ' ALA . 86.7 mt -141.05 169.65 17.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -158.65 153.49 24.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.376 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -178.26 142.57 0.26 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.131 0.491 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -163.12 -125.0 0.74 Allowed Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.553 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 1.7 pt -160.79 120.62 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.708 0.29 . . . . 0.0 110.351 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 1.2 tt -95.0 115.21 27.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.446 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -94.58 152.97 18.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.215 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -108.13 149.08 28.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 tp -121.0 -39.1 2.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.929 0.395 . . . . 0.0 110.824 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 t -158.96 -164.57 1.44 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.353 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.41 30.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.102 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.6 p30 178.32 34.96 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.16 119.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.74 172.1 11.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.989 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.9 mp -137.64 135.55 46.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.764 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 127.57 51.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -146.74 122.77 1.66 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.291 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.98 -147.61 5.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.885 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -135.85 161.13 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 0.0 110.922 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -133.25 149.03 52.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.667 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.76 109.97 5.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -151.89 164.6 36.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.068 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -112.35 146.61 37.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.846 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.28 130.39 55.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -141.14 125.16 17.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.26 95.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.46 174.87 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 t -141.55 -50.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.826 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -96.33 89.46 5.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 8.5 mmt -97.91 140.3 32.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 40.1 p -94.67 105.9 21.24 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.92 132.85 27.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.383 2.055 . . . . 0.0 112.374 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -95.8 144.92 25.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.79 -79.71 0.11 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.547 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.07 28.38 18.1 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.527 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -172.92 -44.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.851 0.358 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -147.99 118.85 7.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.4 147.32 36.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -155.48 161.1 30.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.436 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.3 t -73.45 142.15 46.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.36 -178.7 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -87.01 130.51 34.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.6 tp -158.27 -178.3 7.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.817 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -131.84 156.74 45.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.4 m -111.35 174.81 5.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.813 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -128.16 157.24 41.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.958 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 11.7 m -107.0 131.23 54.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.774 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -138.68 155.2 48.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -114.21 165.17 12.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.056 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -138.35 129.34 26.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.252 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.66 129.89 3.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.596 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.35 -156.0 18.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.775 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -129.6 171.96 12.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 111.008 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -151.56 116.1 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.91 111.77 24.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.712 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 3.7 mttp -81.86 150.91 27.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.226 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.767 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.874 0.369 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.52 168.09 10.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -112.13 142.03 45.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.815 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.469 ' CD1' ' NH2' ' A' ' 54' ' ' ARG . 18.0 m-85 -131.24 142.18 50.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.773 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -159.52 121.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.156 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.56 -140.33 2.89 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.652 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.21 146.93 49.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.2 m -116.74 129.36 56.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -124.75 112.97 17.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.682 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.1 134.41 11.71 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.719 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.02 117.57 31.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.834 0.349 . . . . 0.0 110.777 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 m -113.96 147.09 39.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 m -150.05 102.86 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -155.22 146.89 23.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -78.54 103.18 8.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 pt -113.59 30.86 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -155.62 110.74 2.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.32 146.74 52.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.838 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -143.82 172.4 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -92.06 -32.94 14.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.57 136.19 35.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mt -151.74 167.73 27.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -141.18 147.64 38.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.23 35.19 3.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -147.54 -56.87 0.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.06 136.32 37.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -97.16 139.5 33.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.409 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -71.19 -58.84 3.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 29' ' ' SER . 59.8 Cg_endo -72.68 114.85 4.13 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.426 2.084 . . . . 0.0 112.342 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -106.57 156.63 18.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.11 82.31 7.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.5 26.86 3.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.87 43.5 18.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.034 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.3 t -120.09 -66.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.428 HD12 HG22 ' A' ' 36' ' ' ILE . 29.9 mt -118.62 90.63 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.158 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -107.24 -55.97 2.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -177.31 -178.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.58 -170.32 3.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.846 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.91 144.85 5.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.57 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.05 127.92 53.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -125.34 123.59 39.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.79 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.36 -164.85 16.09 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.553 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 pt -107.04 162.03 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 111.087 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.31 138.94 51.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.759 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -168.61 119.86 0.78 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.62 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.49 -159.33 8.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.945 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -143.26 116.67 9.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 0.0 110.74 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' HA ' ' CG ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -83.79 148.34 27.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.22 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -132.42 -166.74 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.291 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.62 -47.18 84.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.225 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -135.91 12.01 3.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.821 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.501 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -148.1 153.58 25.36 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.561 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.469 ' NH2' ' CD1' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -141.72 144.65 34.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.607 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -89.29 153.71 20.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.012 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.439 ' CE1' ' HD2' ' A' ' 54' ' ' ARG . 58.2 m-85 -133.24 103.34 5.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.362 . . . . 0.0 111.422 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -113.29 122.74 48.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.318 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 2.2 p -141.1 128.96 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.048 0.451 . . . . 0.0 111.268 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.411 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 3.1 m-85 -89.42 119.27 29.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.078 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -101.92 163.51 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.943 0.402 . . . . 0.0 111.54 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -145.08 -171.04 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.637 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.1 mm -100.1 118.26 46.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.179 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.7 t -102.23 107.1 18.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -153.87 125.05 7.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.55 -28.9 8.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.949 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 p -56.73 -31.62 64.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.079 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.3 p -107.92 -30.7 8.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.44 140.25 5.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -59.5 97.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.74 84.93 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.34 81.51 5.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.873 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.28 -32.35 11.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.66 167.47 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.99 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.16 163.19 35.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.709 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -144.65 112.6 6.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.411 HD11 ' CZ ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -82.99 136.92 34.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.601 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.72 142.52 47.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 111.205 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -160.1 116.8 0.74 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.73 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.5 p -139.25 143.21 37.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.468 . . . . 0.0 111.614 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 110.96 21.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.826 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -127.91 172.06 11.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.208 0.528 . . . . 0.0 111.787 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -119.11 118.8 32.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.44 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.429 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 21.9 p90 -97.73 161.53 13.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.086 0.47 . . . . 0.0 111.659 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -165.04 138.57 3.86 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.493 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.8 117.74 4.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.38 2.053 . . . . 0.0 112.532 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.5 mm -123.0 105.76 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.933 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.11 -47.67 1.01 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.411 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -175.64 -67.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 111.003 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -179.68 37.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -124.27 -63.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.786 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 p -75.85 153.13 37.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.435 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -131.5 92.49 3.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 111.047 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 tt -62.2 103.12 0.35 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.316 0.579 . . . . 0.0 110.497 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.459 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 24.0 p90 -110.96 154.53 23.99 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.477 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.03 139.9 4.84 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.815 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.68 -135.31 2.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.73 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.86 155.66 20.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.9 m -128.34 148.34 50.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.121 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 120.99 3.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.682 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.98 -155.92 8.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.63 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.19 127.0 7.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.822 0.344 . . . . 0.0 110.661 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 29.1 m -109.83 122.06 63.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -141.13 144.64 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.95 160.69 33.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -129.48 135.13 48.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -107.37 146.87 31.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.58 110.66 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -161.08 -171.2 26.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -145.51 97.8 3.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.77 -159.09 28.57 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.73 91.18 6.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.843 0.354 . . . . 0.0 110.876 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -118.25 140.52 49.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -144.24 -47.83 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -114.03 128.53 56.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.9 t -137.85 -60.6 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.964 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.89 46.39 1.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.4 t -74.59 109.37 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.33 162.75 12.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.82 130.28 56.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.47 140.6 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.75 131.27 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -176.28 -131.03 1.41 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.605 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mp -148.93 157.72 43.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.346 . . . . 0.0 111.004 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -143.12 164.97 28.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.748 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . 179.53 142.59 0.14 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.99 0.424 . . . . 0.0 110.699 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.459 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -164.03 -136.19 1.95 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.994 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.468 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 5.1 pt -161.92 120.97 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.408 ' CD1' ' NH2' ' A' ' 54' ' ' ARG . 9.2 tt -94.46 111.31 23.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 110.745 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -97.07 116.85 30.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.944 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.09 148.98 21.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.995 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.8 -30.02 8.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.611 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -165.34 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.491 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -89.45 52.34 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.8 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.63 -35.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.22 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.78 125.95 49.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.871 0.367 . . . . 0.0 111.216 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 1.2 m -126.46 163.63 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.4 mt -135.48 134.93 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.817 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.49 139.19 48.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.95 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -160.74 111.14 0.47 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.333 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.451 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -162.48 -150.18 5.92 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.07 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -139.18 161.03 38.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.402 ' O ' ' CD1' ' A' ' 143' ' ' TYR . 5.7 ttp-105 -137.73 140.55 40.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 142' ' ' ARG . 15.7 m-85 -140.3 115.27 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.53 174.01 14.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -132.82 160.38 37.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.1 m -109.01 127.37 54.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -140.98 132.1 26.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.92 -62.38 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.068 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.7 t -157.93 -49.22 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.961 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.5 p -158.46 163.18 37.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -153.73 -69.05 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.24 31.27 20.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.0 p -83.36 154.55 66.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.33 -179.53 2.78 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.605 2.203 . . . . 0.0 112.339 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 -55.84 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.947 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 59.69 77.11 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.559 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -64.16 -50.1 62.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -123.31 -69.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.918 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -138.3 -53.77 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.73 125.13 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 91.22 35.51 7.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.517 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.9 132.22 26.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.49 -52.09 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.84 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.7 t0 60.52 -179.63 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.62 119.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -117.37 -44.31 2.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.2 t -154.63 175.38 13.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.2 t -98.73 162.39 13.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.9 t -106.93 115.9 31.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -124.01 155.09 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -126.53 140.47 52.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.447 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.424 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -122.3 126.95 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.738 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.42 130.02 3.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.62 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.02 -153.39 18.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.849 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -122.19 172.18 8.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.32 . . . . 0.0 111.065 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -155.18 117.67 4.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.152 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -107.39 111.87 24.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.694 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.427 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . 8.8 pttt -86.87 157.96 19.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.081 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.829 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.419 ' CB ' ' CD2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.743 0.306 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -138.22 159.69 41.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.019 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -112.02 140.53 46.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.476 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 52.6 p90 -148.54 167.53 25.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.126 0.489 . . . . 0.0 111.661 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 46.2 t -155.85 137.4 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.791 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.49 -147.17 4.88 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.803 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.34 163.05 32.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.657 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.67 141.5 44.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -126.29 112.93 16.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.63 136.01 15.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.404 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.0 110.01 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 110.942 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.3 m -83.63 131.72 34.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 t -150.05 102.76 3.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.31 32.39 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -83.06 163.12 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 mt 66.21 89.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -165.34 35.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.05 171.82 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.3 p -91.42 137.08 32.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.1 mmtm -75.48 178.03 6.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 t -154.48 151.78 29.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.73 118.04 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -122.25 -59.93 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -138.94 -65.28 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -135.84 150.06 49.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.93 151.72 46.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -104.44 146.03 29.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.5 t -112.34 85.31 6.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.71 174.51 10.21 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.464 2.11 . . . . 0.0 112.336 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -83.36 -55.52 4.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.35 111.7 7.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -94.17 -31.45 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -100.25 81.4 2.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.84 79.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.074 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 pt -148.36 129.39 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.11 -34.68 12.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 m120 60.05 160.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 p -135.76 -76.5 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.46 -141.4 14.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.7 p -142.99 107.99 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -89.78 124.97 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.764 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.19 -169.24 12.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.688 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 58' ' ' THR . 13.9 tt -119.66 162.39 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.52 0.2 . . . . 0.0 110.897 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.1 142.69 46.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.924 0.392 . . . . 0.0 110.73 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -169.34 119.32 0.68 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.253 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -170.61 -139.06 2.65 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.673 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.1 143.53 25.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.805 0.336 . . . . 0.0 110.985 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 14.1 pt20 -118.13 109.84 16.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.215 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.419 ' CD2' ' CB ' ' A' ' 2' ' ' ALA . 73.8 m-85 -87.69 166.83 14.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.805 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.15 -21.42 65.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.329 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.12 24.25 11.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.42 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.43 169.15 28.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.454 ' CZ ' ' CD2' ' A' ' 83' ' ' PHE . 11.7 ttp180 -141.0 125.85 18.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.367 . . . . 0.0 111.231 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -117.6 150.07 39.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.346 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.506 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 28.2 p90 -177.97 127.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.079 0.466 . . . . 0.0 111.222 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.72 142.93 27.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.222 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 9.4 t -132.92 120.73 21.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 0.0 111.608 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CD1' HD11 ' A' ' 76' ' ' LEU . 4.1 m-85 -91.14 123.97 34.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.194 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.03 170.44 7.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.951 0.405 . . . . 0.0 111.305 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.05 -164.94 1.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.685 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.0 pp -115.99 118.91 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.12 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.46 62.85 5.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.12 -170.46 3.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.02 162.48 29.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 t -68.62 -51.33 43.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 t -87.43 -31.03 20.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.74 68.89 1.85 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.498 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.66 159.34 31.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.296 . . . . 0.0 110.884 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -170.17 -42.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.62 175.71 5.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.12 137.6 8.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.855 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -141.62 163.71 32.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.003 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -130.32 131.56 45.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.697 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -121.91 110.93 16.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.102 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.426 ' CD2' ' N ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -119.31 121.01 38.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.66 157.8 44.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 111.264 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.66 116.76 3.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.266 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -97.92 122.23 40.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.879 0.371 . . . . 0.0 111.065 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -117.06 110.87 18.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.475 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.61 161.42 31.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 111.289 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -113.29 120.23 40.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.376 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 48.3 p90 -97.58 161.04 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.575 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.93 122.63 1.7 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.585 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.51 116.52 3.14 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.501 2.134 . . . . 0.0 112.308 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.6 tt -148.54 120.59 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.089 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 125.5 -43.71 1.34 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.457 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.26 -62.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 110.905 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 175.56 -30.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -89.58 18.5 5.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.668 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 120.95 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.551 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.59 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 17.3 mmtm -119.5 92.78 3.87 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.212 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 tp -59.54 103.34 0.19 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.344 0.592 . . . . 0.0 110.758 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 36.3 p90 -110.73 159.06 17.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.885 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.81 142.11 5.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.11 -141.07 3.7 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.725 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.95 169.08 15.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.865 0.364 . . . . 0.0 111.147 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.6 p -138.66 150.84 46.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.806 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 3.3 mp -160.15 132.08 6.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.29 -154.54 6.5 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.822 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -155.21 128.0 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 27.8 m -109.85 145.0 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.237 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.06 145.03 51.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.1 148.85 29.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -131.54 158.83 39.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.93 155.09 37.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -143.71 124.16 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.47 -93.7 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -163.59 109.25 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.13 114.71 2.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.503 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.64 99.13 10.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 86.14 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.76 161.02 34.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.03 30.61 1.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.02 -77.22 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.9 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.4 p30 44.3 31.04 0.52 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.455 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 p -170.01 151.47 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.47 134.52 3.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.41 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -93.49 131.72 38.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.89 149.16 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.082 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.47 135.48 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -157.97 -140.46 2.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.573 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.1 mp -153.06 172.02 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.906 0.384 . . . . 0.0 110.806 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.41 161.97 40.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.821 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 141' ' ' TYR . . . 176.94 142.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.773 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.92 -130.41 1.25 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.736 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.494 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -156.65 120.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.59 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -94.91 115.52 27.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.191 0.52 . . . . 0.0 111.14 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -98.94 114.87 27.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.618 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.45 144.35 34.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.8 mp -108.75 -30.53 8.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 110.431 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.24 -170.39 1.68 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.017 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -85.96 53.78 2.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.81 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 176.31 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -122.38 143.69 49.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.982 0.42 . . . . 0.0 111.731 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.0 m -156.08 164.83 37.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.687 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 29.9 pt -143.64 136.35 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -126.28 176.88 6.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . -174.98 143.37 6.76 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.583 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.89 -139.35 3.95 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.016 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.413 ' CZ ' ' HB2' ' A' ' 125' ' ' ALA . 19.1 p90 -120.03 161.08 21.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 0.0 111.051 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -151.11 140.36 21.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.01 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -112.01 162.9 14.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.532 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.8 tt -153.68 145.72 23.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.173 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.3 ttm-85 -126.12 152.88 45.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.64 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 p -108.84 124.88 51.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.071 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -140.96 151.49 44.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.26 166.29 33.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.79 77.49 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.832 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.7 p -111.74 175.47 5.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.97 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.9 -46.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -32.61 56.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.94 91.97 19.62 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.82 -175.82 1.3 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.528 2.152 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -124.91 -47.63 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 126.34 144.08 6.04 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.504 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -148.96 59.55 0.45 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.78 -172.39 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.351 . . . . 0.0 110.892 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.9 34.12 2.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.46 89.14 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 102.76 46.88 1.44 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.6 p -103.03 152.32 21.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.13 161.7 32.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -66.76 -42.13 86.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.98 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 7.8 mp -125.9 179.86 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.971 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.39 31.13 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.0 t -117.09 175.26 5.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 m -151.44 166.75 30.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 m -107.02 136.16 47.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -152.24 155.07 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 141' ' ' TYR . 88.5 m-85 -113.97 125.56 54.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.671 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -127.97 126.67 41.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.14 0.495 . . . . 0.0 111.263 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.528 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 3.1 pp -150.73 145.97 26.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.702 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.33 -149.02 6.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.674 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -121.0 168.74 11.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -153.89 116.14 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -99.14 114.87 27.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.038 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -81.42 153.78 26.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.063 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.72 168.02 12.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -75.26 131.3 40.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.485 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 10.3 t80 -126.9 139.61 52.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.802 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.4 m -159.56 126.15 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.247 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -147.95 -144.57 4.01 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.87 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mt -126.9 158.86 35.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.745 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 m -125.61 139.28 53.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.034 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -153.1 112.98 3.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.753 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.18 131.48 9.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.516 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 109.96 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 0.0 110.845 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 m -105.26 128.42 53.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.9 t -150.06 102.81 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -160.98 -55.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -96.13 94.95 7.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.831 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.58 99.53 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.097 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -104.8 -177.47 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 60.58 94.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -123.72 -63.05 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 tppm? -115.71 38.28 3.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m 61.22 164.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.05 61.47 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m120 60.05 -175.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -117.95 138.5 52.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -155.64 153.87 30.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.2 177.07 8.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 59.87 31.63 20.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.6 p -129.64 101.47 18.68 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.15 120.14 5.23 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.562 2.175 . . . . 0.0 112.376 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -98.03 133.43 42.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -149.85 -59.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -170.32 -69.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.46 82.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 t -117.6 34.62 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.027 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -126.61 118.68 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 60.16 100.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -93.01 173.38 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.44 111.04 8.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.21 135.3 3.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.462 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.9 m -95.18 118.62 32.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -123.51 126.24 46.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -152.02 -174.42 22.66 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.685 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.42 176.83 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.605 0.241 . . . . 0.0 111.054 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.2 mtp85 -135.97 145.88 46.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.042 0.449 . . . . 0.0 110.723 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -175.37 119.95 0.18 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.075 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.82 -136.91 2.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.577 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.78 113.0 8.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.39 . . . . 0.0 110.902 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -134.57 128.73 33.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.081 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' O ' ' CZ ' ' A' ' 83' ' ' PHE . 1.2 t80 -105.23 -166.96 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.41 -27.48 6.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 0.0 110.945 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -115.27 24.16 11.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.845 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 82' ' ' ALA . . . 71.82 -155.55 52.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.274 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER 161.73 -82.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.684 0.278 . . . . 0.0 110.965 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -142.46 163.19 33.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.999 0.428 . . . . 0.0 111.23 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 79' ' ' SER . 2.3 p90 -166.01 117.86 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.743 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.72 147.65 23.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.709 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.9 p -139.1 123.49 18.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.965 0.412 . . . . 0.0 111.071 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -91.9 124.61 36.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.5 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -117.49 163.91 15.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 111.105 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -149.17 -178.18 6.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.778 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.86 122.2 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.2 m 61.15 96.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.066 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.42 81.37 0.53 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.757 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.5 m -150.03 -61.8 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.9 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -83.97 -45.42 13.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -62.23 -35.03 77.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.53 -58.51 4.99 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.481 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.79 151.5 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 0.0 110.934 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.53 159.07 2.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mt -160.14 81.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.793 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.9 -38.23 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -172.67 148.59 1.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.48 167.53 10.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -138.04 125.73 22.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.995 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mt -106.98 114.9 29.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.61 118.3 34.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.956 0.408 . . . . 0.0 111.45 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.28 116.86 3.45 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 66.1 m -130.91 134.16 46.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.481 . . . . 0.0 112.231 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 7.5 t80 -105.52 110.7 23.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.105 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 94' ' ' PHE . 3.5 m-20 -136.59 172.16 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.22 0.533 . . . . 0.0 112.084 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.481 ' HA ' ' HA3' ' A' ' 53' ' ' GLY . . . -137.62 124.18 20.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.637 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.466 ' HB3' ' CD1' ' A' ' 94' ' ' PHE . 55.1 p90 -97.78 162.8 13.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.344 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.27 137.77 5.54 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.657 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.59 112.06 3.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.462 2.108 . . . . 0.0 112.296 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 40.7 mm -117.11 102.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.54 -60.43 0.67 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.355 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -177.25 -65.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.674 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -177.61 36.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.812 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.13 -30.53 5.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.11 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 82.5 p -136.16 144.16 44.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.639 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 34.5 mttp -122.38 102.05 7.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 0.0 110.729 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 7.3 tp -55.34 102.95 0.08 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.406 0.622 . . . . 0.0 110.347 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 81' ' ' ASP . 5.2 t80 -110.58 142.09 42.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.175 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.31 156.02 20.26 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.425 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 168.68 -140.57 6.25 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.732 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.85 172.94 6.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.609 0.242 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.6 p -142.16 170.04 16.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.175 0.512 . . . . 0.0 111.631 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.44 131.99 11.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.982 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.82 123.41 4.47 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.668 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -136.27 120.62 18.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.955 0.407 . . . . 0.0 110.304 179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.88 142.57 21.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.271 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -125.61 132.67 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.828 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.4 tt -98.12 148.09 23.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -115.45 147.05 41.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -78.05 143.98 36.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.15 -50.91 17.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 126.62 -27.76 4.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.4 141.07 52.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.362 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.04 127.85 3.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.531 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -87.07 93.96 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -126.09 177.71 6.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.72 97.37 7.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.822 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.46 -176.1 4.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.1 m 63.39 125.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.975 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -168.47 78.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.6 p -96.12 132.68 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.145 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.38 178.28 19.92 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.52 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.75 117.86 21.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.44 151.23 40.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.15 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.03 131.55 0.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.038 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -163.24 -124.94 0.73 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.55 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.2 mp -154.36 174.33 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.961 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -153.48 170.5 20.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.687 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . 177.0 142.48 0.08 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.991 0.424 . . . . 0.0 110.928 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -163.3 -132.27 1.32 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.726 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 0.8 OUTLIER -161.78 120.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -98.17 116.29 30.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.044 0.45 . . . . 0.0 110.979 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -95.15 143.32 26.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -110.27 149.08 30.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.69 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.92 -48.79 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.015 0.436 . . . . 0.0 110.593 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.16 -164.97 0.49 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.193 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.09 57.74 2.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.888 0.375 . . . . 0.0 110.501 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -142.12 -61.06 0.45 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.29 171.98 15.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.118 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.85 167.92 20.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.027 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.1 tt -132.74 134.67 58.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.63 172.22 12.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.018 0.437 . . . . 0.0 111.402 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.31 146.79 7.61 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.992 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.43 -147.7 5.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.057 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.41 ' OH ' ' CZ ' ' A' ' 171' ' ' PHE . 30.5 m-85 -126.13 146.91 49.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.96 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -125.51 132.74 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.726 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.77 116.36 20.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.3 pp -156.45 159.21 38.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.844 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.67 137.57 52.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.859 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.9 t -118.85 134.27 55.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -139.49 117.12 11.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.28 32.2 5.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.6 t -159.7 168.22 26.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.98 118.84 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -161.47 158.06 26.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.82 -36.31 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.33 145.02 39.12 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.909 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.13 165.79 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.513 2.142 . . . . 0.0 112.325 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -142.9 35.87 1.4 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.74 146.52 8.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.448 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 162.89 156.28 8.47 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -107.43 -53.24 2.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.819 0.342 . . . . 0.0 110.944 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -79.44 -177.57 5.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.5 pp -134.95 -46.34 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.973 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -128.94 48.46 0.97 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.508 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.2 t -79.42 176.08 10.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.351 . . . . 0.0 110.825 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.5 tt -112.47 -40.37 4.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.98 40.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.92 -43.67 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -69.04 -52.37 29.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 m -94.25 159.59 15.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 10.4 m -123.64 158.91 30.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.3 t -106.97 123.29 47.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.51 155.29 47.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.997 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.41 ' CZ ' ' OH ' ' A' ' 141' ' ' TYR . 1.1 m-85 -96.85 165.24 12.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.265 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.18 129.26 15.52 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.08 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.2 tt -163.42 129.99 3.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.572 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.58 -165.14 26.48 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.566 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.67 172.16 6.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.767 0.317 . . . . 0.0 111.013 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.413 ' ND2' ' CE1' ' A' ' 5' ' ' PHE . 17.4 t-20 -145.23 114.5 7.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.682 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -143.23 111.8 6.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.254 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.485 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -85.9 157.03 20.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.833 0.349 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -107.64 149.79 27.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.775 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -83.22 128.08 34.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 0.0 110.712 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.2 m-85 -127.52 140.0 52.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.8 128.07 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.38 -151.63 6.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.718 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mt -132.01 149.43 52.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.89 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -110.39 149.3 30.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -152.77 113.04 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.748 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.07 133.77 11.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.436 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.97 109.94 22.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.909 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.2 t -121.5 128.58 52.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -150.12 102.77 3.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.776 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -155.26 -46.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.74 126.03 25.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.58 112.66 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.158 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -102.65 36.74 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -146.95 121.41 9.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.79 26.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.84 -30.33 6.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 p -92.63 46.44 1.24 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.959 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mt 58.41 177.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.066 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -85.42 171.57 11.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -167.42 131.83 1.88 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.838 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -139.0 -46.84 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.13 83.48 6.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.43 -43.04 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 85.4 p -176.48 139.85 0.5 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.77 -29.08 10.88 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.428 2.086 . . . . 0.0 112.334 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.63 158.32 33.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 pp -112.53 101.58 9.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.848 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -112.17 -41.62 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -115.7 89.55 3.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.27 -56.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 pt -107.81 101.8 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -71.34 -68.45 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -134.11 33.52 3.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 m -137.66 156.39 48.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.58 165.98 11.32 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.409 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.7 p -119.57 107.92 13.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 110.975 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -119.29 129.88 55.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -164.94 -164.99 21.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.573 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 58' ' ' THR . 12.2 pt -107.67 162.48 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.66 0.267 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.9 ttt85 -132.78 138.11 47.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.55 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 5' ' ' PHE . . . -173.14 122.08 0.38 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.005 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.14 -137.8 2.38 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.87 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -145.48 120.4 9.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.431 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 2.3 tt0 -101.67 112.07 24.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.371 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.436 ' CE2' ' HA3' ' A' ' 53' ' ' GLY . 0.9 OUTLIER -119.57 163.82 16.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.741 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -17.76 65.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.494 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.12 24.37 13.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.642 0.258 . . . . 0.0 111.286 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.436 ' HA3' ' CE2' ' A' ' 50' ' ' PHE . . . 145.86 167.33 12.5 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.333 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -134.09 115.26 14.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 0.0 111.285 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -91.87 126.33 36.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.901 179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.455 ' CE1' ' ND2' ' A' ' 176' ' ' ASN . 0.5 OUTLIER -133.4 103.08 5.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 0.0 111.815 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -97.32 119.62 36.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.861 178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 1.6 t -128.6 122.74 31.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.147 0.498 . . . . 0.0 111.438 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -86.79 124.52 33.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.474 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.04 166.96 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 0.0 111.216 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.42 -166.33 1.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.754 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.6 mp -100.16 113.29 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.147 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.6 -43.25 12.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.24 87.76 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 t -78.43 142.57 37.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -90.95 -54.06 4.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.4 m -108.55 -35.88 6.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.23 49.06 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -143.17 137.36 28.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.746 0.307 . . . . 0.0 110.833 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -149.01 120.3 7.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -139.6 -60.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -105.85 53.83 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.7 mm-40 -132.64 122.37 24.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.973 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.424 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 3.1 pm0 -162.97 153.75 16.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.799 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -143.98 111.01 5.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.139 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.417 ' HG ' ' CZ ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -85.46 145.94 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.406 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mp -139.54 107.91 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 111.385 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.78 119.67 4.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.746 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.427 ' CB ' ' HA ' ' A' ' 98' ' ' THR . 24.3 p -130.5 150.44 51.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.869 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.51 110.86 18.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.904 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.448 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 1.8 m-20 -124.17 153.35 41.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 111.622 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -100.65 118.56 37.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.231 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 43.8 p90 -97.54 153.75 17.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.826 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.34 143.07 10.84 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.731 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -63.64 91.71 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.691 2.261 . . . . 0.0 112.262 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 19.0 tt -157.12 126.57 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.014 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.76 -56.87 0.36 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.719 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -154.01 -46.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.754 0.311 . . . . 0.0 111.067 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -169.33 -46.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.254 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 0.7 OUTLIER -126.17 20.82 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.651 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.12 153.22 28.84 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -131.18 92.42 3.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.99 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.497 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 1.4 tt -61.74 102.22 0.25 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.279 0.562 . . . . 0.0 110.1 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 23.0 p90 -111.01 120.79 43.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.518 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.448 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -142.78 151.42 23.1 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.815 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.33 -140.09 4.66 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.561 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.43 150.66 47.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 0.0 111.091 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.427 ' HA ' ' CB ' ' A' ' 79' ' ' SER . 11.6 t -118.93 153.36 34.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.18 129.09 4.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.589 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.74 -149.18 4.97 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.856 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tt -155.21 129.21 8.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 0.0 110.49 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 11.2 m -109.76 128.44 65.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.245 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -122.89 127.34 48.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.3 mt -132.15 131.79 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.66 140.59 21.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -89.52 169.83 11.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.07 135.25 28.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.846 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.81 -137.74 6.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.468 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.45 105.7 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.969 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.51 -76.75 0.25 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.475 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.68 172.23 1.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.856 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.8 -179.95 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.79 146.35 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.91 161.18 23.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -153.77 70.4 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -108.31 31.02 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.036 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 25.1 t -84.45 125.08 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.67 -163.33 13.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.566 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -96.0 123.09 39.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.98 146.82 23.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -168.85 140.81 2.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.941 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -163.74 -136.91 2.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.71 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.08 155.03 40.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.788 0.328 . . . . 0.0 110.882 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . 0.44 ' NE2' ' CE2' ' A' ' 172' ' ' TYR . 0.5 OUTLIER -138.57 158.37 44.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.996 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . -176.36 141.98 0.44 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.471 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 93' ' ' LEU . . . -175.08 -146.57 5.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.923 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 9.5 pt -162.26 120.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 122.69 0.396 . . . . 0.0 110.01 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 7.8 tp -94.73 111.92 23.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.969 0.414 . . . . 0.0 110.851 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.414 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 4.3 tt0 -102.5 131.16 49.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -97.28 149.17 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.66 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.75 -45.07 4.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.98 0.419 . . . . 0.0 110.613 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -164.86 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.105 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.52 55.77 2.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.391 . . . . 0.0 110.69 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -139.06 -58.68 0.6 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.024 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.06 163.01 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.987 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.7 t -116.15 170.4 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 129' ' ' GLN . 2.1 mp -129.98 134.75 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.568 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.422 ' CG ' ' CE1' ' A' ' 94' ' ' PHE . 8.1 tt0 -123.83 147.04 47.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.961 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.62 141.66 7.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.402 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.51 -135.83 2.75 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.464 -0.875 . . . . 0.0 112.778 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -133.79 161.21 35.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 0.0 110.881 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.72 147.49 29.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.85 140.51 50.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.643 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 tt -117.35 137.09 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.144 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.05 117.8 3.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.633 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.95 131.84 54.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.008 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.08 114.86 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.79 -72.51 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.6 m -162.26 160.66 27.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 18.0 p -159.63 39.17 0.2 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -132.79 -46.62 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.0 mmt -76.76 -25.44 53.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 60.5 p -111.61 93.25 19.11 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.97 174.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 59.48 -175.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -153.71 -109.19 0.36 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.545 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 107.22 147.9 14.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.51 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -135.26 103.66 5.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.947 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -178.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mt -92.33 168.9 11.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 150.54 -48.79 0.57 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.478 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 75.3 m -131.16 176.04 8.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.851 0.357 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.9 mt -99.6 -51.25 3.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.58 159.96 15.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.26 106.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.22 -63.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 96.4 p -155.38 161.73 40.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t -118.02 160.57 21.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.9 129.5 54.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -139.52 155.2 47.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.41 165.14 11.21 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.159 0.504 . . . . 0.0 110.28 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.44 ' CE2' ' NE2' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -138.29 129.47 27.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.889 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.1 tp -163.32 135.15 5.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.93 -152.69 16.74 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.64 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -130.26 171.31 13.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.455 ' ND2' ' CE1' ' A' ' 56' ' ' TYR . 14.5 m120 -151.57 114.98 4.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.082 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -116.72 117.71 30.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.674 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.86 162.41 22.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.205 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.71 0.29 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 49' ' ' GLN . 10.8 m-20 -152.18 137.82 17.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.194 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 178' ' ' LYS . 2.8 t30 -71.41 131.58 43.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.584 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.1 m-85 -123.98 139.9 53.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 21.4 t -150.48 122.34 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.08 -135.33 1.84 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.619 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mp -144.95 166.66 24.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.743 0.306 . . . . 0.0 110.819 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -136.83 146.52 45.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.165 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -153.0 117.54 4.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.664 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 172' ' ' TYR . . . -136.1 -176.08 14.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.466 -0.874 . . . . 0.0 113.021 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -98.15 149.02 22.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.91 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.08 131.42 37.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.893 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.3 p -150.14 102.79 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -157.75 142.74 16.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.13 97.23 10.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 pp -142.55 151.39 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -104.29 138.21 41.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -74.84 -31.79 61.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.51 136.17 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.22 134.1 39.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.1 p -114.7 111.5 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -48.53 23.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -149.02 102.85 3.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.41 165.3 7.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.5 164.13 23.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.49 83.86 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -122.11 78.04 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.69 156.17 55.93 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.948 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.23 -45.34 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.533 2.155 . . . . 0.0 112.283 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -149.37 149.32 30.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mt -142.53 32.29 1.47 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.16 -74.18 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.78 -72.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.8 m -156.85 82.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.41 ' CD1' ' N ' ' A' ' 37' ' ' ASP . 2.5 pp -63.74 -47.99 88.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.355 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.41 ' N ' ' CD1' ' A' ' 36' ' ' ILE . 0.4 OUTLIER 176.29 40.22 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.838 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -144.5 38.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.976 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.9 143.01 10.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.933 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.97 156.37 17.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.453 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.9 p -140.61 107.93 5.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 0.0 111.016 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -135.15 158.32 44.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.814 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.06 -166.95 32.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.768 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 58' ' ' THR . 9.4 mt -107.63 163.74 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.428 0.156 . . . . 0.0 110.828 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -135.87 138.52 42.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.934 0.397 . . . . 0.0 110.834 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -171.05 119.8 0.51 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.255 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -162.5 -133.63 1.51 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.683 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -155.73 148.81 24.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 111.0 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.451 ' NE2' ' CZ ' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -100.7 162.57 12.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.756 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -133.29 165.78 24.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.915 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -24.65 65.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.371 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.2 24.13 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.448 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 177.77 177.49 46.61 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.447 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.413 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . 13.2 ttp-105 -143.91 140.58 29.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 111.074 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -124.43 149.44 46.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.578 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.509 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 34.0 p90 -178.28 126.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.75 162.77 14.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.527 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 49.7 p -141.05 124.46 16.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.07 0.462 . . . . 0.0 111.517 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.45 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 9.2 m-85 -92.51 116.57 29.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.957 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.06 178.37 4.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.029 0.442 . . . . 0.0 111.569 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -164.98 154.4 12.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.51 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 tt -100.02 130.28 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.176 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.1 t -96.68 108.71 21.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -116.43 -66.14 1.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.1 p -85.72 89.9 7.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 t -69.63 -33.07 72.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 p -112.63 -35.86 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.822 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.57 -146.12 0.23 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.623 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -114.0 130.07 56.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.785 0.326 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 136.59 34.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 mp -78.66 162.41 26.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.944 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -67.06 124.95 24.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.828 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -155.79 160.76 40.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.21 135.88 3.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.779 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -120.87 114.64 21.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.45 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -98.32 128.94 44.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.496 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 2.2 mt -138.87 131.07 28.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.891 0.377 . . . . 0.0 111.183 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.76 116.82 4.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.578 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.65 126.28 52.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.956 0.408 . . . . 0.0 111.768 -179.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.415 ' CZ ' ' HB1' ' A' ' 97' ' ' ALA . 20.1 p90 -125.39 110.7 14.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.758 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -133.31 166.1 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.036 0.446 . . . . 0.0 111.507 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -109.63 118.33 36.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.173 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 48.5 p90 -97.85 167.62 10.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.827 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.7 tp -160.56 121.08 1.65 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.577 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.53 114.69 1.43 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.493 2.129 . . . . 0.0 112.541 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -156.29 123.74 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.152 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.46 -95.64 0.3 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.658 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.6 33.23 5.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 110.87 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 63.56 24.82 14.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.711 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -141.36 -44.58 0.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.732 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.04 150.71 16.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.483 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 2.4 mptm? -132.06 92.48 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.334 . . . . 0.0 111.45 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 9.0 tt -63.23 102.96 0.44 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.137 0.494 . . . . 0.0 109.848 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 45.6 p90 -110.71 159.7 17.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.34 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.26 126.79 1.31 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.783 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.99 -140.29 2.89 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.415 ' HB1' ' CZ ' ' A' ' 80' ' ' TYR . . . -128.74 178.83 6.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 111.156 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 44.3 p -144.08 152.13 40.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.238 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.11 131.37 5.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.59 -140.56 3.05 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.909 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.14 125.94 7.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 110.734 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.86 140.18 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -141.76 136.94 31.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.824 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.96 158.45 44.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.2 172.65 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.26 163.14 33.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -130.64 37.52 3.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.52 -156.82 0.47 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.592 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -123.15 88.81 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.74 -176.93 33.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.486 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.65 96.58 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.777 0.322 . . . . 0.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -101.55 138.18 38.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 -59.33 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -119.09 110.04 16.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.5 m -80.93 -64.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -149.43 80.91 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 t -130.38 120.89 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.51 175.56 38.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.96 136.19 34.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.94 139.68 30.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.93 132.01 3.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.952 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.86 -140.83 2.97 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.628 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 mt -143.89 170.28 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.13 150.02 18.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 94' ' ' PHE . . . 178.21 142.39 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.377 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 93' ' ' LEU . . . -175.32 -126.74 0.96 Allowed Glycine 0 C--O 1.229 -0.192 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.806 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 1.3 pp -161.07 120.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.512 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.411 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 2.2 tt -104.01 116.09 31.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.634 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.428 ' CG ' ' CG2' ' A' ' 137' ' ' ILE . 18.8 pt20 -116.85 126.22 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.775 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -69.24 147.88 50.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.273 -179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 -30.68 7.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.338 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 t -160.93 -165.02 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.196 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -90.28 50.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.371 . . . . 0.0 110.771 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 174.14 -28.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.6 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.5 157.19 29.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.361 . . . . 0.0 111.393 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 15.2 m -155.92 169.05 25.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.994 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.428 ' CG2' ' CG ' ' A' ' 129' ' ' GLN . 18.3 tt -131.49 135.0 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.417 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -133.52 167.64 20.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.544 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . 174.09 153.65 10.05 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.665 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.3 -125.95 1.26 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.971 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.43 ' CE2' ' HB3' ' A' ' 171' ' ' PHE . 5.3 m-85 -133.77 161.15 35.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.96 147.33 19.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -108.29 147.81 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.754 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.87 134.9 48.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.92 147.0 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -121.98 125.86 47.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -140.79 115.67 9.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -153.2 31.24 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 93.5 p -86.11 162.7 18.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.12 81.55 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.7 122.95 19.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.956 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -121.6 -43.01 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.7 p -86.71 149.26 48.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.68 176.04 8.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.552 2.168 . . . . 0.0 112.311 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 60.31 110.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 149.42 84.85 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.558 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -174.4 -42.02 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.585 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 34.3 m120 59.83 29.45 19.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 110.97 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -178.14 125.37 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.907 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mt -88.57 129.11 35.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -116.82 113.13 2.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.503 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.9 165.29 6.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.892 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.74 109.47 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.04 170.31 15.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.999 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.5 tt 64.54 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.019 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.2 t60 65.87 -70.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 111.124 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.07 166.6 25.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.707 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 62.2 m -127.44 136.99 52.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.977 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.2 p -119.88 117.73 28.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -134.07 155.38 50.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.43 ' HB3' ' CE2' ' A' ' 141' ' ' TYR . 43.2 p90 -111.12 124.41 52.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.382 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.467 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 7.4 p90 -124.68 179.2 5.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.643 0.735 . . . . 0.0 111.966 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.475 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 0.4 OUTLIER -163.45 147.88 10.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.872 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.3 -162.86 21.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.809 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -123.23 171.74 9.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.861 0.363 . . . . 0.0 111.047 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -156.29 117.1 3.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.65 112.01 24.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.59 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.95 154.06 25.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.109 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.405 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 1.3 m-85 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.895 0.379 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.62 123.82 13.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -63.51 137.75 58.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.826 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.3 m-85 -129.0 139.75 51.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.057 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.7 t -154.94 124.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.012 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.98 -144.06 3.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.58 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mt -139.76 142.86 36.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.822 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.7 t -112.15 142.4 44.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.994 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.33 114.55 13.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.74 132.54 11.01 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.426 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.25 110.0 20.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.64 135.33 31.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.82 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 t -150.06 102.88 3.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.84 -39.24 24.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -85.6 162.09 19.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 pt -115.35 165.74 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.149 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -145.42 109.76 4.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.8 33.04 3.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.9 m -153.18 110.77 3.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.51 -48.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 p -157.28 129.8 7.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.08 -68.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -95.94 123.73 39.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.01 150.61 49.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -141.99 146.92 36.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.9 tp -117.34 90.5 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -145.96 -52.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 30' ' ' PRO . 1.5 t -114.48 -68.54 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 29' ' ' SER . 60.6 Cg_endo -72.42 -178.18 3.17 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.136 1.89 . . . . 0.0 112.393 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.47 -173.08 3.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.49 103.21 15.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.11 -30.96 61.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.987 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt 61.29 92.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.93 56.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.058 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.05 111.59 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.117 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -148.72 134.91 19.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.973 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -144.3 157.16 44.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.5 p -108.04 130.74 55.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.76 -68.57 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.6 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -139.17 138.31 36.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.327 . . . . 0.0 110.899 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -162.03 129.42 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.44 -167.56 19.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 mt -109.28 161.07 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.745 0.307 . . . . 0.0 110.964 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.02 133.02 47.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.665 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -169.2 120.02 0.71 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.106 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.51 -136.95 2.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.593 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -153.85 136.37 15.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 0.0 110.99 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -89.52 162.29 15.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.66 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -134.95 167.21 21.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.929 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -67.11 -25.9 66.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 24.26 3.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.01 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -174.44 179.97 45.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.192 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.01 130.3 7.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 0.0 111.276 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.414 ' CD2' ' HB3' ' A' ' 80' ' ' TYR . 4.1 m-85 -107.7 159.83 16.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.489 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -173.59 123.89 0.37 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.912 0.387 . . . . 0.0 111.198 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.88 153.12 20.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.602 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.3 m -130.93 118.77 21.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.18 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 4.6 m-85 -99.23 118.34 35.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.507 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -110.82 141.85 43.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.25 -69.54 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.753 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.1 mt -151.89 127.64 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.7 p -87.66 55.17 3.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -153.45 152.22 30.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 p -109.19 -35.79 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -48.66 17.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.5 p -112.27 27.11 9.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.994 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -107.61 75.37 0.22 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -132.59 177.02 7.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.883 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt 60.59 163.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.89 88.92 3.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.826 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -87.39 -30.63 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.58 139.67 29.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.988 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.55 135.6 53.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.71 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -129.61 117.8 20.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.175 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 1.5 tm? -124.38 114.92 20.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.391 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.403 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.5 OUTLIER -134.1 126.21 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 111.593 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.39 116.8 4.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.645 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 0.8 OUTLIER -111.72 156.71 21.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.075 0.464 . . . . 0.0 111.702 -179.248 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.414 ' HB3' ' CD2' ' A' ' 55' ' ' TYR . 23.6 p90 -130.86 110.94 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.308 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -120.81 155.25 34.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 111.494 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.412 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -105.6 119.25 38.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.533 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -97.59 156.14 16.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.139 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tp -155.49 140.32 12.04 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.805 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.85 113.0 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.451 2.101 . . . . 0.0 112.178 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.8 tp -119.12 97.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.985 0.422 . . . . 0.0 111.085 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.02 -73.68 0.25 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.614 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -153.77 -49.6 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.648 0.261 . . . . 0.0 111.233 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 174.62 -27.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.391 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 37.3 p-10 -73.99 3.06 7.4 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.447 ' CG2' ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -136.55 130.0 31.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 9.9 mttt -123.15 92.66 3.75 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.142 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.88 102.72 0.63 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 17.7 p90 -115.75 155.05 28.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.905 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.77 142.92 7.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.558 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.73 -143.73 4.58 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.657 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.09 162.23 29.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 111.083 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 79' ' ' SER . 5.2 t -129.2 155.73 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.9 mp -160.11 130.87 5.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.713 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -156.63 -150.39 5.65 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.866 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.05 127.28 7.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.618 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.88 133.67 54.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 5.4 mtpp -120.98 129.97 53.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.948 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.6 tt -121.45 153.67 37.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.828 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -169.61 172.09 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.943 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -100.71 156.01 17.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.02 104.43 12.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -135.74 -55.48 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -111.03 -33.13 6.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.817 0.341 . . . . 0.0 110.843 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.46 33.87 1.68 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.555 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.36 106.45 10.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 110.842 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -73.11 83.26 1.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.65 112.22 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.89 126.69 47.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.971 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.34 -29.02 8.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.02 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -81.68 59.95 4.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.7 m -98.66 161.76 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.067 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.4 -179.27 33.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.553 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -103.21 118.41 36.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.31 143.41 26.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 137.94 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -165.66 -143.43 3.73 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.498 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.11 160.46 38.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.966 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.88 165.74 35.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.047 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.91 142.49 0.08 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.272 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.52 -127.0 0.85 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.263 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 14.6 pt -156.93 120.78 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.43 ' CB ' ' HB2' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -94.43 112.74 24.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.188 0.518 . . . . 0.0 111.019 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 6.4 mt-30 -102.46 115.54 30.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.024 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -73.4 149.18 42.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.4 tp -108.01 -31.82 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.409 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -169.04 -173.98 1.92 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.131 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -81.98 55.64 2.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.791 0.329 . . . . 0.0 110.696 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -178.45 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.277 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.79 155.87 33.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.895 0.378 . . . . 0.0 111.201 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.08 -178.64 5.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.876 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 28.9 mt -138.78 134.95 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.968 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.96 131.53 54.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.708 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -155.35 124.29 1.48 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.66 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.28 -144.08 4.67 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.803 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -126.2 161.11 28.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 110.749 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -153.18 145.67 24.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.052 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.74 138.94 52.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.618 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mt -121.86 132.58 54.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.089 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.97 111.96 4.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 6.9 p -111.75 142.78 43.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.057 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -141.02 115.16 9.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.76 -69.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.171 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.17 149.55 41.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.7 p -132.89 -177.94 4.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.18 56.26 3.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 69.15 -65.63 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.935 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.71 108.94 45.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.02 -45.71 18.66 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.509 2.139 . . . . 0.0 112.112 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -104.86 175.52 5.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.96 117.27 4.31 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.495 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.56 36.9 21.91 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.537 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -91.5 88.24 6.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.37 -46.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.4 pp -137.59 127.96 26.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 135.15 162.92 9.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.512 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.2 t -62.55 157.42 20.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.83 0.347 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.05 102.54 7.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -60.39 -46.18 90.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.53 130.13 37.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -160.93 93.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.95 171.88 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.6 p -149.24 179.76 7.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.97 123.17 47.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.767 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -113.08 155.24 25.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -106.36 153.3 22.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.203 0.525 . . . . 0.0 110.144 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.57 126.78 47.27 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.583 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.52 129.91 3.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.548 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 171.66 -152.2 17.06 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.891 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.23 172.17 11.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.091 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -149.87 114.94 5.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -108.09 111.93 24.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.753 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -83.52 159.72 21.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.129 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.778 0.323 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.444 ' CB ' ' HB3' ' A' ' 49' ' ' GLN . 1.5 t0 -112.03 168.57 9.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.096 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -109.77 134.45 52.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.689 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 10.0 m-85 -133.47 139.99 47.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.865 0.364 . . . . 0.0 111.044 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 11.1 p -155.3 122.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.199 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.31 -139.91 2.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.541 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -140.19 164.03 31.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.727 0.298 . . . . 0.0 110.759 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.42 155.66 41.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.354 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -153.08 128.13 9.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.602 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.74 160.83 12.99 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.579 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -98.65 115.55 28.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.868 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.9 p -140.75 113.01 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -150.12 102.87 3.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.769 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -102.89 90.64 3.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -64.01 123.84 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.915 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.9 mp -91.93 130.93 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.17 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -104.19 100.84 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -137.89 84.62 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.959 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.82 107.42 18.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.7 -49.64 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.72 156.53 35.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.33 49.42 2.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.887 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -98.04 -61.23 1.41 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -105.43 128.01 53.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -176.04 143.74 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.828 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -169.69 36.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.869 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -129.94 153.05 48.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.55 131.82 6.84 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.91 -41.13 77.46 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.427 2.085 . . . . 0.0 112.23 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 61.11 86.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.953 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -130.22 120.37 24.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.13 -66.61 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.011 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 179.56 45.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.014 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 17.3 m -145.41 -46.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.153 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 tt -129.89 106.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -71.03 -57.53 4.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.022 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.71 29.9 19.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.987 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.5 t -177.08 94.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.52 -134.69 2.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.01 131.47 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -139.6 117.69 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.82 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -151.81 -165.06 12.7 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.624 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.0 mt -116.33 161.92 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.673 0.273 . . . . 0.0 110.956 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -126.54 138.89 53.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.601 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -170.4 120.32 0.59 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.12 -139.32 2.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.611 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -159.14 140.19 12.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 111.128 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 3' ' ' ASP . 33.0 tt0 -83.77 162.47 20.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.413 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.418 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -131.08 -166.9 1.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.88 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.85 -45.16 93.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.219 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.97 -20.47 3.83 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -118.19 179.59 17.07 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.886 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.411 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 8.4 mtt180 -142.36 143.55 32.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 111.4 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 80' ' ' TYR . 6.0 t80 -100.73 153.56 19.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.961 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 70.4 m-85 -157.66 115.44 3.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 111.585 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.09 132.52 38.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.398 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.2 p -119.28 112.18 19.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.945 0.402 . . . . 0.0 111.253 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -106.19 111.27 23.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.677 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -110.41 179.96 3.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.872 0.367 . . . . 0.0 111.132 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -162.09 -74.33 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.792 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 7.3 pt -142.81 125.77 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.091 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.54 -32.54 12.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.986 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -59.28 -49.84 76.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.986 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 p 49.57 78.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.234 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.82 -52.05 6.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -104.46 -31.1 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.23 -75.82 0.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.58 124.59 44.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.775 0.321 . . . . 0.0 110.843 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.0 mtpt -146.26 82.64 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.883 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -71.96 72.79 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.775 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -118.99 -39.47 2.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.013 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -130.38 143.16 50.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 111.109 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -141.68 134.55 28.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.675 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -130.42 119.59 22.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.177 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.04 114.97 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.431 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 pp -145.16 152.5 40.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.399 . . . . 0.0 111.519 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.99 125.68 6.64 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.972 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -104.09 132.28 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 111.637 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.414 ' HB2' ' CE1' ' A' ' 55' ' ' TYR . 14.0 t80 -122.9 110.99 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.957 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -134.43 172.05 13.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.181 0.515 . . . . 0.0 111.869 -178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.457 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -107.99 118.77 37.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.219 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 50.4 p90 -97.38 162.97 13.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.84 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 130.7 2.12 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.444 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.54 115.94 2.95 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.446 2.097 . . . . 0.0 112.36 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 86' ' ' ILE . 23.0 mt -153.9 122.12 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.089 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 138.97 -90.38 0.2 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.632 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -131.24 35.91 3.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.804 0.335 . . . . 0.0 110.836 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 65.13 29.02 12.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.654 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -143.58 -45.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.735 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.89 152.71 42.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.459 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 2.5 mttt -132.47 92.85 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 111.079 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.29 102.88 0.19 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.312 0.577 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 20.0 p90 -112.1 154.18 25.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.33 133.79 2.72 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.75 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -170.14 -133.51 1.61 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.654 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.98 162.97 28.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 111.29 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -133.93 156.85 47.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.822 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -160.06 132.48 6.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.849 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.85 -149.45 5.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.825 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 mt -154.93 126.87 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.668 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 p -109.95 133.73 54.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.978 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -131.4 145.07 51.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.0 tp -127.01 127.05 44.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.78 133.72 20.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -85.33 160.98 19.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -70.27 -48.2 57.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.93 -99.97 0.23 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -71.37 178.72 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.84 0.352 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.21 71.38 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -84.84 163.13 19.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -90.89 78.3 6.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.79 31.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -154.53 73.85 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.11 -79.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.4 t0 75.37 -58.79 0.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.37 141.1 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -152.9 134.31 4.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.349 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -84.07 116.44 22.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.917 0.389 . . . . 0.0 111.078 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.23 135.8 41.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.994 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.07 142.34 1.42 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.177 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.35 -138.33 2.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.588 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.7 mt -142.99 159.83 41.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.714 0.293 . . . . 0.0 110.688 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.28 173.11 17.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.14 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.87 142.67 0.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.648 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.415 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -159.52 -130.89 1.18 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.7 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 1.1 pt -161.13 120.38 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.0 110.67 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.82 115.16 27.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.672 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -104.31 118.15 35.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.945 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -107.82 149.3 28.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.02 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.53 -31.71 11.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.2 p -169.01 -164.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.329 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.71 56.02 3.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.886 0.374 . . . . 0.0 110.658 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -142.73 -67.5 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.061 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.68 171.49 13.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.041 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 36.3 p -156.02 173.98 16.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.942 0.401 . . . . 0.0 111.204 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 175' ' ' ALA . 5.2 pt -134.95 134.79 53.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.699 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -127.58 172.49 10.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.131 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.19 145.4 6.21 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.35 -135.96 2.53 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.657 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.85 158.04 27.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.712 0.291 . . . . 0.0 110.693 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.416 ' HG3' ' CZ ' ' A' ' 172' ' ' TYR . 0.0 OUTLIER -142.68 130.96 22.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.189 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 2.3 m-85 -122.77 133.92 54.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.453 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 mt -142.43 145.39 33.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 111.114 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 159.73 16.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.594 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.82 152.14 25.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -131.93 163.27 28.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.725 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 65.19 -176.12 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.885 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.59 80.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 p -109.94 80.19 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.89 108.23 16.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.938 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -107.8 143.39 36.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.6 p -114.47 148.2 39.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.0 -30.37 16.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.558 2.172 . . . . 0.0 112.284 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -92.01 85.92 5.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.782 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.89 -178.64 15.4 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 150.01 -148.2 19.22 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.555 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.36 142.47 41.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.99 -46.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.0 mt -81.18 -36.01 30.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.817 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.6 -118.81 1.56 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 42.8 t -120.52 128.37 53.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.99 145.89 35.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.18 111.13 17.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.71 123.93 13.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -136.6 -55.64 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.862 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.7 m -145.49 176.04 9.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.971 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.41 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -115.98 165.6 12.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.878 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.41 136.84 51.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -156.02 155.35 32.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.022 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.9 152.58 20.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.15 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.416 ' CZ ' ' HG3' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -135.04 129.4 33.99 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.152 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.7 mt -163.56 129.87 3.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.479 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -177.79 -158.84 21.57 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.909 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -126.79 172.05 10.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.8 116.68 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.935 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -108.98 112.82 25.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.819 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 11.2 pttt -82.01 164.07 21.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.888 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.447 ' CB ' ' CE2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.805 0.336 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -111.37 168.16 9.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -100.95 130.03 46.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.786 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.439 ' CE1' ' NE2' ' A' ' 49' ' ' GLN . 3.9 m-85 -132.33 139.94 48.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.379 . . . . 0.0 111.115 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 8.3 p -154.77 130.4 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.08 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.22 -147.17 4.87 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.716 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -126.41 166.72 16.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.345 . . . . 0.0 110.909 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -139.61 140.43 37.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -137.9 115.91 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.22 137.64 13.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.536 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -111.65 134.21 53.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 0.0 110.952 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.7 125.68 35.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -150.02 102.89 3.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -136.53 40.95 2.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -85.6 120.0 26.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 pt -111.77 -30.55 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.238 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.43 176.07 7.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.016 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.2 mttt 60.84 156.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.13 -177.88 3.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 85.08 2.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.2 m -114.2 -175.44 2.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.6 pp -168.3 -43.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -123.94 -61.9 1.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.84 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.55 87.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -136.94 125.31 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -168.01 33.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.816 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.76 -69.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -91.54 138.93 25.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.01 -43.67 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.522 2.148 . . . . 0.0 112.428 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -103.83 -37.19 7.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.69 89.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -157.6 73.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -100.1 -46.21 5.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.7 t 69.48 -66.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.18 -45.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.254 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 t70 76.05 111.76 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.963 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -157.05 29.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 m -118.87 137.31 53.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.0 172.66 12.71 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.582 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -127.81 124.05 36.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -117.75 115.47 25.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.4 -173.8 13.43 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.767 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.428 ' O ' ' HA ' ' A' ' 58' ' ' THR . 18.0 mt -106.98 162.03 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.561 0.219 . . . . 0.0 111.041 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.402 ' NH2' ' HB3' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -132.6 136.07 46.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.681 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -170.84 120.55 0.55 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.377 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -166.91 -142.34 3.41 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.755 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -131.92 130.65 41.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.681 0.277 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.439 ' NE2' ' CE1' ' A' ' 5' ' ' PHE . 32.3 tt0 -109.52 112.53 24.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.225 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.447 ' CE2' ' CB ' ' A' ' 2' ' ' ALA . 4.2 m-85 -96.01 176.42 6.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -29.15 68.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.2 24.19 3.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.346 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.2 110.03 0.39 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -103.8 112.74 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 111.187 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -106.2 150.71 25.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.155 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.521 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 34.2 p90 -179.09 129.35 0.1 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.125 0.488 . . . . 0.0 111.198 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.42 148.58 22.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.15 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 2.6 m -129.24 118.43 22.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.979 0.418 . . . . 0.0 111.599 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -94.52 109.18 21.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.071 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -103.65 175.2 5.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.032 0.444 . . . . 0.0 111.566 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -149.1 171.9 15.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.567 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.3 mt -99.97 119.51 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.228 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -91.03 -35.86 14.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -146.94 126.05 12.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.2 p -100.16 109.81 22.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -87.3 -38.52 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 p -101.91 -34.28 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.0 -178.97 29.09 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.518 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -102.3 145.14 29.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -73.34 123.58 24.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 tp -158.12 -67.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -177.39 158.28 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.71 159.33 1.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -142.5 122.97 14.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.4 110.93 20.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 tt -115.6 117.02 29.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.755 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.6 144.46 39.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.228 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.93 116.9 4.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.033 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 5.2 t -99.18 134.12 42.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 111.374 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -122.41 110.89 16.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.155 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -133.11 163.39 29.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.93 0.395 . . . . 0.0 111.486 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.22 118.7 36.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 54.2 p90 -97.58 161.29 13.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.645 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.12 121.01 1.26 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.63 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.89 114.98 2.04 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.469 2.113 . . . . 0.0 112.329 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pt -108.08 97.97 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.47 -58.24 0.57 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.44 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -169.19 -75.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -169.46 34.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.66 -30.18 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 16.5 p -136.55 145.08 44.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.806 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 9.0 tttt -121.31 92.69 3.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.371 . . . . 0.0 110.702 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.28 102.85 0.12 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.339 0.59 . . . . 0.0 110.772 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.451 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 32.6 p90 -112.3 153.21 27.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.862 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.12 140.66 6.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.856 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.11 -137.62 2.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.388 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.91 177.63 7.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 111.172 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.2 m -146.2 151.65 37.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.978 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 130.65 5.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.775 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.35 -153.86 6.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.885 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.28 131.43 10.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.1 p -109.59 122.83 64.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.262 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.01 145.07 50.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.735 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 tt -105.16 131.16 53.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.814 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.43 150.6 34.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -175.68 172.09 2.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.74 95.9 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.43 -80.82 1.36 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.437 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -126.66 -68.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -110.77 -117.01 3.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.453 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -110.42 169.09 8.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.13 149.39 32.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 125.79 43.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.43 -71.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 p -121.46 -61.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 76.68 -57.91 0.53 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.118 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.33 123.88 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.298 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.79 118.83 2.03 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.267 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.09 131.78 34.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.966 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -123.57 145.41 48.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -170.99 140.48 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.177 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -165.6 -136.72 2.06 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.453 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 mp -138.36 170.27 16.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 110.727 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -159.71 152.29 21.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.881 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.94 142.48 0.08 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.612 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.451 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -169.75 -127.09 0.9 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.938 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.454 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 3.4 pt -161.19 120.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.681 0.277 . . . . 0.0 110.436 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 1.3 tp -94.5 114.1 26.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.069 0.462 . . . . 0.0 110.725 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -98.08 122.93 41.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.09 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -95.91 149.02 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.825 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.78 -30.29 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.058 0.456 . . . . 0.0 110.584 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.08 -172.07 2.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.108 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.74 54.73 3.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.791 0.329 . . . . 0.0 110.833 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -177.28 -37.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.436 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.26 135.82 51.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 111.519 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.8 m -132.84 168.7 17.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.753 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 25.1 mt -138.25 135.86 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -119.5 132.64 55.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -157.1 128.41 2.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.502 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.86 -134.74 2.28 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.847 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.86 161.19 25.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.848 0.356 . . . . 0.0 110.859 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.11 121.96 9.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.029 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.67 139.42 49.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.648 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 mp -157.93 142.88 16.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.207 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -114.23 163.69 14.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.629 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.0 m -119.39 123.88 45.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -141.15 114.87 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.03 -33.83 63.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.133 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.1 m 61.19 167.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 82.0 p -112.77 -73.7 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -131.03 42.03 3.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.794 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 3.6 mmt 59.99 31.98 20.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.933 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.2 t -89.73 147.42 37.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.14 145.67 79.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.465 2.11 . . . . 0.0 112.244 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -179.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -80.79 138.76 19.93 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.565 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -153.37 71.47 0.28 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.458 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -144.33 95.98 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 110.865 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.5 tttm 68.38 -69.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.941 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.56 176.73 9.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.927 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.9 -144.31 4.97 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.652 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.7 m -103.36 162.25 13.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.794 0.331 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.6 mt -135.03 31.74 3.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -146.59 102.41 3.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.6 mt -77.08 97.85 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -89.87 60.67 5.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.08 150.45 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 93.5 p -144.04 163.09 34.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.01 124.89 50.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.63 155.18 47.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -91.54 165.27 13.44 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.264 0.554 . . . . 0.0 110.29 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.24 129.98 34.5 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.78 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.6 tt -163.41 133.26 4.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.739 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.47 -156.41 18.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.613 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -124.24 172.15 9.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -150.06 114.95 5.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.982 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -117.26 111.9 20.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 2.3 ptpt -82.18 161.4 22.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.773 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.797 0.332 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -163.09 136.34 5.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.199 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -60.62 140.86 57.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.0 m-85 -131.07 139.86 49.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.973 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.3 m -154.74 129.27 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.266 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.33 -143.59 3.78 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.676 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -140.14 165.42 27.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -135.05 144.86 47.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.079 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -136.73 118.58 15.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.741 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.96 143.65 16.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.683 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.6 110.41 19.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.1 p -102.29 117.94 35.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -150.14 102.82 3.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.807 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.04 -56.6 2.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.841 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -75.27 124.27 26.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -82.56 -178.98 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.143 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 64.72 111.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.13 -35.24 5.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m 61.9 157.43 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.894 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -143.12 -176.36 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.4 m -88.16 166.57 14.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.37 148.07 24.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -159.51 -43.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.031 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.6 ttt-85 68.82 94.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -162.87 117.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -51.47 13.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -92.74 80.68 4.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -99.98 100.26 11.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.83 60.1 3.58 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.487 2.124 . . . . 0.0 112.43 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 179.11 102.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -80.4 103.94 10.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -129.08 87.4 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 21.92 9.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.0 t 61.96 117.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.217 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mt -63.58 -27.18 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.053 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 63.6 87.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.014 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 m120 58.3 171.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.047 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.8 p -102.46 -73.57 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.58 -92.27 0.41 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.563 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.96 142.81 31.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -132.94 131.58 41.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.86 -173.26 31.36 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.665 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.35 177.12 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 111.157 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -142.55 142.73 32.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.603 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -175.68 123.06 0.2 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.255 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -163.33 -136.31 1.97 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.581 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -153.41 127.31 8.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 111.102 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB2' ' CD1' ' A' ' 5' ' ' PHE . 1.5 tt0 -83.94 152.52 24.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.58 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -127.28 165.68 19.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.817 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -24.79 66.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.372 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -126.13 24.57 6.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.266 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 172.61 -177.29 45.25 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.357 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.36 122.29 7.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 111.297 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 80' ' ' TYR . 34.9 t80 -101.74 146.41 27.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.376 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.44 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 25.0 p90 -173.55 124.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.035 0.445 . . . . 0.0 111.036 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.67 162.86 14.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.584 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.4 m -139.92 125.25 18.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.221 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.436 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -102.88 100.93 10.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.295 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.94 174.95 5.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -151.77 -164.84 2.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.548 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.5 tp -114.3 123.45 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.182 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 p -78.44 102.18 7.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -107.31 -169.99 1.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 p -68.03 144.26 55.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -33.0 72.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.984 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 m -72.28 -31.9 66.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.7 -174.41 36.14 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.441 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.07 131.72 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.873 0.368 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -78.95 -68.67 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.977 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.18 81.82 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.828 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.81 -53.72 2.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -107.11 166.61 10.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -162.25 125.12 2.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.409 ' ND2' ' CG2' ' A' ' 102' ' ' VAL . 6.3 t-20 -131.31 116.01 17.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.821 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.436 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 68.7 tp -124.96 123.06 39.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.551 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.427 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.6 OUTLIER -144.98 157.46 44.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.334 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.99 117.47 4.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.049 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.2 p -99.15 121.73 41.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.938 0.399 . . . . 0.0 111.586 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 55' ' ' TYR . 47.6 m-85 -104.25 110.86 23.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.893 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.408 ' OD1' ' CE1' ' A' ' 56' ' ' TYR . 1.9 p-10 -136.48 172.1 13.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 111.664 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.484 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -122.3 125.51 46.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.602 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 55.7 p90 -97.51 156.68 16.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 tp -158.25 135.57 6.97 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.62 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.57 116.65 3.31 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.552 2.168 . . . . 0.0 112.174 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.5 HD13 HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -117.43 103.45 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.046 0.45 . . . . 0.0 110.999 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.91 -66.42 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.25 -75.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -169.33 33.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -112.65 -22.62 10.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.19 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.07 153.09 51.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 9.8 mmtp -126.99 92.73 3.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 110.849 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.7 OUTLIER -56.28 102.8 0.08 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.038 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.451 ' CE2' ' N ' ' A' ' 127' ' ' ILE . 37.3 p90 -111.49 151.81 28.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.613 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.06 142.14 6.89 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.992 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 178.72 -142.88 5.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.685 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.23 179.59 5.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.802 0.334 . . . . 0.0 111.214 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.4 t -159.01 154.94 26.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.059 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 pp -160.23 131.96 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.427 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.68 -129.98 1.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.946 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 tt -155.08 128.09 8.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.393 . . . . 0.0 110.557 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.409 ' CG2' ' ND2' ' A' ' 75' ' ' ASN . 21.6 t -109.63 115.59 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.166 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.15 130.79 55.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.97 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.91 165.6 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.51 135.29 55.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.58 141.56 32.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -126.01 114.34 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.93 154.7 21.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.59 31.21 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 0.0 110.857 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.37 -98.09 2.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.541 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.78 138.04 58.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 0.0 110.907 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.76 143.32 28.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -146.41 168.86 20.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -92.26 86.85 5.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 67.3 m -129.56 95.04 3.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -161.47 -74.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.1 p -160.76 122.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.127 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.25 164.2 24.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.406 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.82 114.99 26.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -100.06 136.7 39.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.006 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -168.63 138.69 2.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.353 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.36 -140.68 2.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.66 163.95 35.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.36 . . . . 0.0 110.805 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.91 171.22 18.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.207 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.9 142.52 0.08 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.588 179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -170.08 -134.44 1.75 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.732 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 127' ' ' ILE . 0.1 OUTLIER -158.71 120.62 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.744 0.307 . . . . 0.0 110.441 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -95.07 117.69 30.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.936 0.398 . . . . 0.0 110.859 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.414 ' HB2' ' CG1' ' A' ' 137' ' ' ILE . 27.9 mt-30 -95.08 121.34 36.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -112.57 149.1 33.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.662 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mp -106.18 -42.37 5.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 110.509 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.11 -166.71 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.026 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -82.78 54.28 2.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.789 0.328 . . . . 0.0 110.44 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -141.9 -56.62 0.46 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.146 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.36 152.39 34.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.934 0.397 . . . . 0.0 111.303 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.2 t -142.17 179.12 7.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.538 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.414 ' CG1' ' HB2' ' A' ' 129' ' ' GLN . 19.2 pt -140.71 144.96 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 128' ' ' LEU . 41.0 tt0 -130.54 136.25 48.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.87 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -155.82 149.98 21.2 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.547 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.09 -131.24 2.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.642 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -119.9 160.76 22.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.799 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.72 123.12 13.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.198 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -119.55 133.91 55.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.441 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -141.64 154.12 45.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 111.3 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -117.67 163.41 16.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.477 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.86 172.07 7.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 111.203 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -56.65 117.23 3.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.142 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -113.75 113.29 24.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.077 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.9 p 62.58 146.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.031 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 p -147.24 65.48 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 62.51 128.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.118 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 41.0 mtm -99.22 -178.78 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 63.5 p -114.93 135.44 22.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.992 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.19 -62.3 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.515 2.144 . . . . 0.0 112.323 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -75.86 137.6 40.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.22 174.98 50.77 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.493 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 176.8 165.4 32.23 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.443 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -128.12 -178.56 4.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 110.802 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 89.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -77.31 155.68 31.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 109.18 60.18 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.7 m -134.41 129.42 35.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.37 97.58 2.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -150.84 33.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.44 -52.34 9.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 3.5 m170 60.31 166.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 57.9 m -91.35 167.69 12.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 91.8 p -115.16 157.34 23.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 18.8 t -107.02 130.17 54.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.744 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.24 155.21 46.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -106.19 143.7 33.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.133 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.54 127.02 46.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.102 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.9 tt -163.66 129.73 3.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.501 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.34 -155.45 15.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.87 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -114.98 172.04 7.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.119 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -155.9 117.52 3.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 3.9 m-85 -115.98 117.19 29.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.074 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.525 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -84.58 163.98 18.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.126 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.922 0.391 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -123.07 168.11 12.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.05 132.71 54.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.708 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 13.6 m-85 -134.51 139.96 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.028 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 7.6 p -151.16 129.36 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.965 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.7 -147.85 5.31 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.843 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 4.8 mp -138.99 160.06 40.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.352 . . . . 0.0 110.903 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.8 t -129.54 167.5 17.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.0 t-105 -149.11 137.18 20.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.96 122.03 5.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.474 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -87.26 122.83 31.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.853 0.359 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.09 137.84 52.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.0 m -150.06 102.83 3.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -138.27 36.52 2.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.24 150.87 48.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.33 31.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.14 129.74 43.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 60.07 31.21 20.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.89 129.6 53.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mttt 62.43 117.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.957 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 m -119.23 24.45 10.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mt -155.49 58.99 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.94 0.4 . . . . 0.0 110.724 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -119.96 167.57 12.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.2 mtm-85 -84.5 -73.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.24 -177.96 3.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mp -142.0 -72.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -67.06 178.82 1.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.421 ' CB ' ' CD ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -178.44 -61.77 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 29' ' ' SER . 44.9 Cg_endo -68.31 145.97 67.57 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.534 2.156 . . . . 0.0 112.306 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -60.07 147.18 40.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.946 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 mp -116.78 116.35 27.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.38 -45.78 4.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -147.79 -65.64 0.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.0 p -121.41 -45.61 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.051 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.453 ' O ' HG13 ' A' ' 36' ' ' ILE . 4.4 tp 44.19 33.34 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.47 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.26 111.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.919 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -107.08 170.42 7.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.4 p -144.72 29.48 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.48 96.68 0.1 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.466 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 m -112.83 125.73 54.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -108.34 174.31 5.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.798 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.5 157.94 21.41 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.603 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 2.1 mp -109.8 158.89 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.511 0.196 . . . . 0.0 110.907 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -143.31 149.77 38.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.042 0.448 . . . . 0.0 110.839 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -177.35 123.56 0.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.583 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.586 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -163.85 -137.6 2.23 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.592 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.66 130.42 38.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.782 0.325 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.435 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 40.0 tt0 -105.66 110.71 23.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.029 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 53' ' ' GLY . 1.9 p90 -121.06 166.99 13.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.727 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -19.95 65.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.4 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -92.14 15.86 12.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.553 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . 133.02 176.0 14.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.56 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.437 ' HD2' ' CD2' ' A' ' 83' ' ' PHE . 47.3 mtp180 -116.14 117.13 29.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.865 0.364 . . . . 0.0 111.2 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -100.36 136.36 40.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.209 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.586 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 44.0 p90 179.84 132.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.836 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.482 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . -90.34 136.65 32.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.158 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.8 m -113.68 111.72 22.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.98 0.419 . . . . 0.0 111.543 -179.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.88 124.34 29.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.148 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -101.88 155.12 18.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 111.501 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -166.43 114.92 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.48 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.0 pt -99.86 145.11 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 m 64.62 127.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.007 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.6 -177.25 5.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.26 177.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 83.8 p -81.75 -33.58 30.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -62.04 -37.08 83.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.5 -107.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.49 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -138.02 172.99 12.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.779 0.323 . . . . 0.0 110.952 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -144.48 93.36 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mp -119.88 146.08 46.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -90.16 55.01 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.99 177.17 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.9 158.09 5.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.807 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -133.41 120.67 21.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.093 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.1 tt -114.94 114.99 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.443 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.553 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 2.1 mp -122.45 153.79 38.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.991 0.424 . . . . 0.0 111.498 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.73 116.7 4.24 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.81 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.42 ' HB2' ' CE2' ' A' ' 56' ' ' TYR . 54.5 m -90.53 140.72 29.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.07 0.462 . . . . 0.0 111.568 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -148.34 110.78 4.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.031 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -146.36 172.18 13.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.421 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.31 118.66 35.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -97.81 167.12 11.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.665 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -168.44 134.25 1.53 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.71 95.06 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.474 2.116 . . . . 0.0 112.102 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.7 tt -156.42 125.43 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.14 -56.7 0.36 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.623 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.67 -53.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -177.53 -38.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.08 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 38.1 p-10 -125.59 57.53 1.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.294 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.63 148.48 47.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.124 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -126.64 92.31 3.53 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.078 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.4 tt -61.59 102.73 0.27 Allowed 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.482 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 15.2 p90 -113.35 154.2 27.27 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.88 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.84 130.56 1.97 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.671 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -169.65 -139.99 2.86 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.589 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -135.64 170.11 16.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 111.155 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -138.03 163.16 32.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.27 133.81 6.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -155.63 -144.31 3.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.995 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.14 130.84 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.256 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 14.9 t -109.65 128.84 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.225 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -127.32 131.88 50.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.853 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.4 tp -118.58 146.09 44.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -110.42 173.61 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.92 177.73 10.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.49 96.94 6.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.86 168.48 44.48 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.516 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.16 122.37 46.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 0.0 110.907 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -151.18 -48.29 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.545 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.94 163.74 26.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.53 161.55 30.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -73.47 129.41 37.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -176.35 -39.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.075 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.91 -165.77 1.42 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.982 0.42 . . . . 0.0 110.755 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 t0 69.09 10.12 7.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.35 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.0 m -163.32 104.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.715 0.293 . . . . 0.0 110.973 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -140.53 143.61 13.73 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.642 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -90.49 120.33 31.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.746 0.308 . . . . 0.0 110.753 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -95.04 140.05 30.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.211 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.02 134.72 0.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.72 -141.99 3.27 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.601 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 mp -149.65 162.44 40.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.89 0.376 . . . . 0.0 110.985 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -154.01 159.71 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 177.01 142.51 0.08 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.729 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.461 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -174.58 -125.69 0.88 Allowed Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.733 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 5.3 pt -161.13 120.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 110.366 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.509 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 1.1 tp -95.42 114.69 26.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.971 0.415 . . . . 0.0 110.833 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 21.5 mt-30 -99.52 147.48 25.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.247 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -128.72 149.11 50.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.52 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.4 mt -109.43 -45.38 3.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.089 0.471 . . . . 0.0 110.76 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.09 -164.89 0.49 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.274 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -80.12 57.41 2.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.879 0.371 . . . . 0.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -138.72 -60.28 0.6 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.412 ' HB3' ' CE1' ' A' ' 177' ' ' TYR . . . -163.2 158.24 21.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.993 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.3 m -125.72 168.66 13.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.0 mp -134.08 134.7 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.778 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -124.21 149.99 45.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -154.76 128.8 2.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.365 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.25 -136.74 2.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.8 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -135.16 161.07 36.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.77 146.32 29.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -112.47 145.79 39.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.85 122.56 39.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -145.52 111.99 5.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.704 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.1 p -115.87 135.29 54.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -141.07 114.91 9.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.854 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.73 178.58 8.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.7 m 59.68 28.31 17.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 m 58.27 164.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -93.21 77.18 4.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 24.1 ttt -60.48 -52.76 63.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 10.6 t -79.55 114.71 47.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.22 124.52 10.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.363 2.042 . . . . 0.0 112.201 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -101.06 160.75 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 132.35 -70.03 0.52 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.536 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.68 -98.73 1.7 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.426 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -172.47 -44.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -78.79 179.72 7.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.37 138.14 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -124.62 -89.63 0.83 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.452 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.02 140.44 24.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.02 95.74 5.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -160.03 31.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.1 -66.58 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.05 40.44 3.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.16 159.14 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.2 m -107.92 148.78 29.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.0 p -107.09 122.47 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.05 155.2 49.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.3 165.16 11.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.139 0.495 . . . . 0.0 110.239 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -137.92 128.5 26.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.805 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.6 129.98 3.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.87 -156.66 18.41 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.696 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -125.07 172.09 9.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.114 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -149.98 114.94 5.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.412 ' CE1' ' HB3' ' A' ' 135' ' ' ALA . 39.9 m-85 -107.02 116.92 32.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.987 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -83.87 162.85 20.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 40.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.969 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.45 ' HA ' ' CD1' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.876 0.369 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -106.12 160.6 15.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.665 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.24 138.1 49.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.512 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.566 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 28.4 p90 -148.95 161.86 41.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.01 0.433 . . . . 0.0 111.454 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 34.3 m -150.33 141.18 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.02 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.1 -157.91 9.04 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 119.966 -1.112 . . . . 0.0 113.135 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -126.97 154.94 43.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.795 0.331 . . . . 0.0 110.786 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 p -128.02 149.6 50.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.413 ' CD2' ' HB3' ' A' ' 42' ' ' TRP . 1.7 t-105 -153.09 115.9 4.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.45 137.96 13.73 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -84.06 135.61 34.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 m -99.66 121.5 41.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -150.18 102.84 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.67 -60.56 2.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.954 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -65.94 114.06 4.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 tt -150.86 142.9 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -134.52 153.51 51.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.95 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -167.98 -67.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -114.69 -44.4 3.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.3 mtmm -121.88 160.2 25.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.0 t -97.41 113.85 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.81 125.6 29.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.23 135.28 50.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.8 81.59 8.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -65.28 172.74 2.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.5 tt -130.26 97.61 4.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -96.45 -36.83 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.42 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.5 OUTLIER 180.0 -55.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.42 ' HD3' ' CB ' ' A' ' 29' ' ' SER . 53.2 Cg_exo -52.37 178.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.488 2.126 . . . . 0.0 112.219 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -172.75 147.7 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.12 71.93 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.027 0.441 . . . . 0.0 110.745 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -113.17 -36.23 5.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.01 -57.52 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 m -71.63 73.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.2 mt -100.51 -30.52 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.123 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -110.73 -55.07 2.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.827 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.33 138.61 33.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.6 t -170.62 104.42 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.33 -175.02 30.87 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.491 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.96 149.79 38.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.413 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 68.0 p-90 -152.92 162.91 40.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.757 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.94 -165.99 35.34 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.706 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' LEU . 18.0 tt -123.56 159.84 27.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.491 0.186 . . . . 0.0 110.803 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.415 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -137.88 158.53 44.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.24 0.543 . . . . 0.0 110.669 179.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -177.04 123.74 0.14 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.107 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -167.02 -142.69 3.52 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.603 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.423 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 1.5 mp0 -129.78 139.39 51.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.822 0.344 . . . . 0.0 111.048 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.445 ' HG2' ' CD1' ' A' ' 5' ' ' PHE . 2.2 pt20 -121.25 112.33 18.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CD1' ' HA ' ' A' ' 2' ' ' ALA . 24.2 t80 -119.92 157.22 29.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.6 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.28 -22.28 29.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.255 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -95.66 21.66 8.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.257 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.67 158.85 8.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.494 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -121.22 130.85 53.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.851 0.358 . . . . 0.0 111.061 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -117.67 152.52 35.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.471 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.492 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 36.2 p90 179.67 129.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.156 0.503 . . . . 0.0 111.25 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . -90.59 128.91 36.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.022 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.0 p -117.39 115.05 24.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.165 0.507 . . . . 0.0 111.486 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -92.9 130.64 38.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.116 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.9 171.73 8.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.051 0.453 . . . . 0.0 111.441 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -157.67 -176.09 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.628 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.2 mt -113.23 136.8 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 111.076 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.2 m -161.97 148.64 13.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -115.88 -41.47 3.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.943 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.9 t -89.39 173.69 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.4 m -63.6 -60.91 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -67.55 -30.06 69.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.933 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 102.99 135.96 8.92 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.454 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -119.72 96.9 5.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.753 0.311 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt 56.66 -179.3 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.57 -168.08 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.806 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -161.51 -44.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.961 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 mp0 -142.64 151.99 42.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.972 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.24 165.02 11.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.718 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -143.76 131.11 20.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -147.69 114.91 6.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.469 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.418 ' CB ' ' HA3' ' A' ' 100' ' ' GLY . 0.2 OUTLIER -145.73 154.62 42.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.041 0.448 . . . . 0.0 111.472 -179.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.93 116.8 4.24 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.823 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.415 ' OG ' ' CE2' ' A' ' 56' ' ' TYR . 0.3 OUTLIER -98.45 134.0 42.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.974 0.416 . . . . 0.0 111.447 -179.407 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -124.52 110.86 14.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.061 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -130.79 166.42 20.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 111.415 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.77 118.46 35.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.396 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 55.4 p90 -97.78 166.94 11.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.574 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.68 136.14 1.65 Allowed Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.468 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.12 118.11 4.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.417 2.078 . . . . 0.0 112.377 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 27.8 mt -155.72 109.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.86 -95.17 0.17 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -130.57 35.44 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 110.812 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 67.06 29.87 7.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.683 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -142.34 -44.64 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.808 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.97 149.14 50.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.536 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -127.21 92.47 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 0.0 111.114 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.02 103.17 0.15 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 110.319 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 40.7 p90 -110.7 157.66 19.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.053 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.98 129.96 1.61 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.835 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.3 -138.33 2.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.581 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.93 -177.82 4.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.143 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -148.99 155.98 41.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.2 132.2 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.699 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 77' ' ' LEU . . . -160.52 -148.16 5.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.918 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 mp -155.34 133.6 11.66 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.241 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.2 p -109.35 131.31 60.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.137 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.12 121.04 28.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.966 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.9 144.38 33.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.815 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -123.3 164.47 18.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -151.41 178.02 9.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.03 -174.79 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.753 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -122.99 41.41 1.8 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -144.7 -47.26 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.58 -127.67 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.504 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -88.59 153.91 20.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.807 0.336 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -153.17 100.99 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -125.78 -65.98 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.07 119.75 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.835 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.5 p -152.54 79.77 1.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -150.22 -67.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.9 m -160.1 172.99 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -148.57 -157.79 7.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.428 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -116.05 115.0 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.09 144.04 37.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 141.33 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.263 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.46 -142.74 3.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.517 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mp -145.58 161.97 38.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.834 0.349 . . . . 0.0 110.771 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -149.13 160.47 43.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.794 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 176.95 142.44 0.08 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.598 179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.427 ' N ' ' CE1' ' A' ' 94' ' ' PHE . . . -174.86 -130.69 1.33 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.748 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 10.7 pt -160.94 120.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 110.492 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 92' ' ' LYS . 0.4 OUTLIER -94.7 112.21 23.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.684 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -103.91 124.31 48.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.75 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -86.05 149.35 25.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.02 -29.61 10.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.048 0.452 . . . . 0.0 110.163 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.01 -165.48 0.55 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.824 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -91.27 48.01 1.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.705 0.288 . . . . 0.0 110.596 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -155.95 -44.07 0.08 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.647 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -130.19 170.67 13.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.012 0.434 . . . . 0.0 111.566 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.7 m -156.1 -175.8 5.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.73 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.8 pt -154.18 152.61 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.701 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.87 156.56 47.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.041 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -167.54 146.4 10.63 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.95 -125.2 1.19 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.644 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -136.09 161.2 36.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.766 0.317 . . . . 0.0 110.732 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.444 ' HB2' ' CD2' ' A' ' 172' ' ' TYR . 0.2 OUTLIER -162.44 140.28 8.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.246 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -119.78 162.7 18.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 12.1 tp -159.48 146.93 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.957 0.408 . . . . 0.0 111.306 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.6 mmm-85 -118.65 154.22 33.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.544 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.8 p -108.99 172.03 7.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -55.44 114.99 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.23 -43.94 8.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.6 m -170.75 166.12 7.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.0 p -142.35 146.35 34.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.56 86.75 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.49 -58.9 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.4 p -107.87 150.32 40.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.59 62.89 2.26 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.591 2.194 . . . . 0.0 112.241 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.13 -66.71 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 67.52 135.88 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.565 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.68 96.34 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -153.05 36.37 0.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.93 123.61 4.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.785 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.34 30.52 19.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.825 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -148.31 154.91 26.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.461 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.4 m -83.53 157.2 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.84 123.01 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.956 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.34 -178.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.3 tp -113.93 175.73 5.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.89 141.39 34.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.09 149.25 29.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.811 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.55 -177.46 3.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 30.3 t -107.11 142.41 36.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.02 155.2 35.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -102.5 165.27 11.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.2 0.524 . . . . 0.0 110.367 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.444 ' CD2' ' HB2' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -134.26 128.7 34.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.957 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 9.8 tp -163.67 129.89 3.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.588 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.77 -158.57 22.12 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.737 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.52 172.02 8.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.798 0.332 . . . . 0.0 111.046 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 39.6 t-20 -153.96 114.93 4.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -116.23 111.34 20.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 1.7 ptpt -84.43 163.17 19.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.164 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.737 0.303 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.79 129.07 3.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.25 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 1.6 t-20 -77.79 145.56 36.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.651 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.63 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 18.0 p90 -148.57 152.11 36.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.124 0.488 . . . . 0.0 111.421 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 9.1 p -151.29 135.64 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.158 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.86 -133.69 1.57 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mp -143.86 167.96 21.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 110.829 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -135.01 143.38 46.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 42' ' ' TRP . 0.6 OUTLIER -134.53 117.84 16.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.708 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.2 151.2 17.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.597 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -86.24 124.28 32.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 m -81.94 135.31 35.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.14 102.81 3.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.783 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.9 m120 61.79 116.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.16 147.36 49.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 mp -74.66 110.34 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 156.99 31.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -105.93 40.83 1.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.32 105.16 15.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.982 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -64.66 0.86 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.864 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.6 m -146.36 88.37 1.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 tp -173.55 110.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 60.85 164.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.72 50.9 1.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.74 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -99.91 130.67 46.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.877 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.4 pp -111.54 -34.27 6.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -129.18 110.22 11.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -72.39 -60.41 2.16 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.872 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 29' ' ' SER . 58.9 Cg_endo -72.07 176.43 8.45 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.538 2.158 . . . . 0.0 112.317 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -67.8 179.81 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mp -118.93 124.76 47.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.991 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -171.04 -55.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.31 -65.21 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.3 p 43.51 43.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.624 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.8 pt -85.34 87.51 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.19 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.34 121.89 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -157.83 156.07 30.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.952 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.0 m -108.02 -71.83 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.24 151.73 8.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.0 p -124.11 108.03 11.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TRP . . . . . 0.426 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 6.6 p-90 -126.27 164.51 20.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.691 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.61 -169.43 35.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.832 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 58' ' ' THR . 1.7 mt -107.79 163.21 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.551 0.215 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -138.92 139.82 38.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.932 0.396 . . . . 0.0 110.923 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -170.02 117.73 0.57 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.771 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.597 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -157.63 -167.25 18.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.457 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 3.9 pt20 -131.72 125.52 32.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 110.839 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 50' ' ' PHE . 5.3 tt0 -83.84 151.95 24.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.412 ' N ' ' HG2' ' A' ' 49' ' ' GLN . 0.8 OUTLIER -127.66 166.48 18.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -24.98 65.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.441 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -133.12 24.26 4.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.691 0.281 . . . . 0.0 111.475 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.99 170.96 42.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.4 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -141.5 142.68 33.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.851 0.358 . . . . 0.0 111.329 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -129.89 151.73 50.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.242 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.597 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 36.2 p90 179.49 129.19 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.191 0.52 . . . . 0.0 111.246 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.82 152.41 20.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.426 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 73.0 p -137.13 121.22 17.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 111.546 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.444 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 8.3 m-85 -85.67 117.62 24.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.926 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -101.96 158.04 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 111.469 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -165.32 107.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.494 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.2 mm -99.87 144.26 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.205 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 m -120.98 120.45 35.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -159.19 33.99 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -99.06 178.73 4.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 m -74.19 -54.21 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -34.46 78.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 -45.95 1.24 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.579 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -122.88 123.02 40.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.392 . . . . 0.0 110.955 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.4 mtpp -112.07 -35.31 5.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.21 31.91 19.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.08 33.0 2.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -152.66 128.61 10.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.93 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.88 156.66 41.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.718 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -144.08 114.82 7.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.175 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.444 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 2.5 mp -107.62 131.11 54.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.397 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.43 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 1.9 mp -141.72 147.41 37.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.027 0.441 . . . . 0.0 111.565 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.99 116.75 4.21 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.072 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.418 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 1.9 t -87.71 136.32 33.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.983 0.42 . . . . 0.0 111.259 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -133.07 110.82 10.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.258 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -147.78 172.08 14.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.031 0.444 . . . . 0.0 111.589 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.44 124.97 50.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.485 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 45.6 p90 -97.51 165.43 12.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.497 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.0 tp -140.52 117.85 8.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.417 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.52 108.66 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.37 2.047 . . . . 0.0 112.354 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 31.7 mm -103.76 97.73 5.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.76 62.34 2.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.534 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.09 -43.83 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.883 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -155.07 33.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 31.4 m120 60.93 66.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.023 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.6 148.64 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.672 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -123.25 92.49 3.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.931 0.396 . . . . 0.0 110.781 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.51 103.01 0.28 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.666 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 46.6 p90 -111.37 154.59 24.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.817 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.35 132.83 2.34 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.819 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.6 -139.43 2.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.687 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.89 177.11 7.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.756 0.312 . . . . 0.0 111.183 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 47.8 p -146.37 159.04 43.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mp -159.25 130.8 6.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.646 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.43 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -150.71 -155.91 7.1 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.124 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.9 mt -155.2 130.51 9.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.794 0.33 . . . . 0.0 110.168 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 12.5 p -109.72 119.78 59.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.297 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -93.52 122.92 36.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.934 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.09 145.73 51.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.37 156.2 19.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -154.48 154.86 33.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.812 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -60.85 -42.22 97.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.75 124.74 5.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.486 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.61 -68.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.831 0.348 . . . . 0.0 110.873 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.29 -99.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.99 158.24 32.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.764 0.316 . . . . 0.0 110.947 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.8 103.75 16.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.98 163.43 20.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.04 -67.61 0.97 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.7 m -61.16 85.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.986 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.33 60.06 5.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 p -93.29 133.49 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.176 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -113.95 -177.62 19.22 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.507 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -91.71 125.44 36.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.4 137.46 51.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -171.17 140.42 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.001 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.28 -139.86 2.76 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.643 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.419 ' HB2' ' CD1' ' A' ' 143' ' ' TYR . 24.9 mt -145.39 165.64 27.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.798 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -157.14 159.27 37.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 94' ' ' PHE . . . 176.94 142.46 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.81 -130.69 1.26 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.656 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 4.7 pt -158.68 120.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.52 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 8.5 tt -95.19 114.32 26.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.117 0.484 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 29.0 mt-30 -99.14 139.63 34.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.268 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -118.78 149.11 42.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.556 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.92 -51.22 2.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.626 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -169.11 -164.9 0.49 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.093 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -76.47 58.32 1.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.786 0.326 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -136.88 -60.17 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.03 156.66 12.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.75 165.34 13.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.63 134.73 61.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.514 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.95 143.36 50.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.051 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -160.08 149.88 19.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.297 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 173.8 -133.98 2.73 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.729 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.62 161.05 23.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.82 0.343 . . . . 0.0 110.98 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.0 ttt-85 -149.91 125.27 10.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.419 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 13.1 m-85 -101.09 138.71 37.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.763 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.06 134.06 55.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.7 mmm-85 -151.64 112.14 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.1 p -118.49 129.78 55.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.987 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -140.95 115.02 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.793 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.64 116.09 17.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.3 m -88.78 153.37 21.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 61.3 p -132.55 -46.84 0.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -62.37 154.21 28.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 4.1 ttp -108.78 37.26 2.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.796 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.6 t -109.77 96.23 23.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.72 96.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.519 2.146 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.92 148.35 22.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.8 161.95 32.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.51 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -175.47 -63.37 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.459 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 60.57 98.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.77 0.319 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -127.49 149.95 49.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.39 119.32 38.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 162.63 -92.27 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.524 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.3 m -160.08 142.86 13.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.27 97.34 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 62.64 126.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.007 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.6 mt -98.37 34.5 1.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -98.41 33.49 2.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.5 m -71.25 170.12 13.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.49 141.2 43.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.88 119.8 40.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -147.7 155.16 41.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -102.51 165.27 11.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.154 0.502 . . . . 0.0 110.163 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.75 129.75 30.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.113 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.4 tp -163.42 131.56 3.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.721 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 176.94 -155.17 17.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.681 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.19 172.04 13.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.986 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -158.05 121.81 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -98.71 115.77 29.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.833 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.63 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.4 147.28 29.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.112 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.461 0.118 0 CA-C-O 120.809 0.337 . . . . 0.0 111.232 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.9 138.86 56.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.762 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.5 m-85 -132.48 139.88 48.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 111.103 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.605 HG12 ' CB ' ' A' ' 46' ' ' ALA . 19.6 m -154.58 127.63 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.997 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.6 -146.47 4.66 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.846 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 43' ' ' GLY . 0.5 OUTLIER -127.8 153.97 45.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 0.0 110.821 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.662 ' OG1' HG23 ' A' ' 58' ' ' THR . 1.0 OUTLIER -125.37 135.9 52.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.05 113.24 11.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.29 131.36 10.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.523 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.871 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.8 p -95.01 126.58 40.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -128.31 132.73 48.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.705 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -156.35 -167.26 17.41 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.51 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 pt -107.15 172.54 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 111.027 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.87 141.44 34.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.639 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.605 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -174.87 123.2 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.315 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -160.96 -148.74 5.38 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.698 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -136.07 126.29 26.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.01 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 1.1 tm0? -83.97 158.91 21.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.662 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -135.04 164.22 28.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.15 -24.08 65.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.365 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.32 24.38 5.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.27 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 174.61 178.21 44.32 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.202 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 54' ' ' ARG . 4.1 ptm85 -148.13 138.22 22.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 111.187 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -117.04 145.63 43.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.514 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.457 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 41.0 p90 -172.12 121.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 111.171 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.85 158.93 16.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.662 HG23 ' OG1' ' A' ' 9' ' ' THR . 68.1 m -127.95 117.06 21.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.059 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.466 ' HD2' HD23 ' A' ' 76' ' ' LEU . 28.3 t80 -100.96 127.59 47.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.754 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -141.53 176.71 8.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.029 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.742 0.306 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.431 ' OD1' HD12 ' A' ' 77' ' ' LEU . 21.7 t-20 -144.64 116.99 8.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.094 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.5 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -129.73 127.05 39.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.534 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.652 HD22 HD21 ' A' ' 144' ' ' LEU . 0.8 OUTLIER -146.32 137.72 24.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.963 0.411 . . . . 0.0 111.438 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.77 116.89 3.89 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.016 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.408 ' OG ' ' CE2' ' A' ' 56' ' ' TYR . 26.0 p -105.92 133.29 50.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.412 . . . . 0.0 111.279 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 55' ' ' TYR . 23.1 p90 -123.85 110.89 15.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.353 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.57 171.19 14.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.053 0.454 . . . . 0.0 111.383 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -117.54 120.6 38.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.919 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 42.1 p90 -97.86 164.38 12.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.133 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.721 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.2 OUTLIER -170.26 139.03 1.44 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.636 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.721 ' HD2' HD23 ' A' ' 84' ' ' LEU . 76.3 Cg_exo -49.84 119.51 4.88 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.514 2.142 . . . . 0.0 112.359 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 86' ' ' ILE . 5.0 tp . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.03 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.734 0.302 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.78 153.09 31.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.569 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 1.7 tptp -126.58 92.53 3.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.824 0.345 . . . . 0.0 110.995 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.14 102.82 0.32 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.256 0.55 . . . . 0.0 110.508 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.452 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 35.9 p90 -111.04 156.0 21.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.758 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.27 134.7 3.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.732 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.418 ' O ' HD23 ' A' ' 123' ' ' LEU . . . -177.53 -160.66 24.59 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.446 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.13 171.43 8.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 0.0 111.23 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.8 t -143.92 159.81 41.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.06 131.19 5.81 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.456 ' N ' HD23 ' A' ' 77' ' ' LEU . . . -152.73 -153.31 6.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.806 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.7 pp -155.28 127.94 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.656 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.2 m -109.74 130.41 62.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.206 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 117' ' ' VAL . 11.4 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.29 132.61 6.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -84.62 115.04 22.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 0.0 111.034 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -111.62 137.74 49.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.05 141.27 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.27 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.94 -139.56 2.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.603 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 96' ' ' GLY . 1.9 mt -140.37 161.16 38.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.378 . . . . 0.0 110.831 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -150.04 157.78 43.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.796 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 178.68 142.39 0.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.371 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -168.01 -130.33 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.117 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.523 HG23 ' O ' ' A' ' 126' ' ' GLY . 11.3 pt -159.45 121.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.77 0.319 . . . . 0.0 110.377 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.13 111.61 23.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.742 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -92.58 122.13 34.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.075 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.39 149.12 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.02 -47.26 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.001 0.429 . . . . 0.0 110.518 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -164.97 0.49 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.194 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 56.71 2.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.833 0.349 . . . . 0.0 110.6 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.76 -58.96 0.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.952 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -162.68 146.18 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.978 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.03 -179.9 4.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.4 mt -136.49 134.97 49.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 141.0 46.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.97 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -161.82 117.28 0.76 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.446 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -172.64 -138.95 2.7 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.094 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -121.19 161.16 22.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 110.843 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.724 ' HD3' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -143.28 121.71 12.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.107 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -118.18 131.3 56.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.463 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.724 HD12 ' HD3' ' A' ' 142' ' ' ARG . 0.8 OUTLIER -144.29 146.96 32.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.935 0.398 . . . . 0.0 111.261 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.84 162.38 13.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.561 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.089 -179.822 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.813 0.339 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 m -106.97 117.58 34.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.816 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 155.18 51.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.724 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -103.49 165.2 11.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.21 0.528 . . . . 0.0 110.277 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.413 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -131.39 128.0 38.7 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.768 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.4 131.65 3.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.711 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.33 -152.04 15.95 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.648 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -131.61 172.01 12.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 0.0 111.058 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -152.22 115.49 4.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -109.21 113.62 26.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.94 163.56 22.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.142 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.524 -0.053 0 CA-C-O 120.643 0.258 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -109.71 128.39 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.785 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.8 OUTLIER -129.05 139.91 51.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 46' ' ' ALA . 16.4 m -154.08 126.41 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.214 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.35 -141.92 3.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.641 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.769 HD23 ' HA ' ' A' ' 44' ' ' ILE . 4.6 mt -142.93 162.01 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.749 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.412 HG21 HG21 ' A' ' 58' ' ' THR . 8.4 t -139.07 136.38 35.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 111.263 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -130.62 113.02 13.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.59 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 172' ' ' TYR . . . -118.13 169.65 13.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.064 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.79 0.329 . . . . 0.0 110.837 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 p -138.62 107.99 6.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -125.11 137.36 54.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.707 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.15 -171.61 34.23 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.851 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.769 ' HA ' HD23 ' A' ' 8' ' ' LEU . 1.4 mp -106.95 164.05 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.578 0.227 . . . . 0.0 110.745 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 44' ' ' ILE . 4.0 ttm-85 -132.39 139.71 48.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.646 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.571 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -174.81 122.43 0.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.443 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -169.92 -128.44 1.02 Allowed Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.516 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -143.22 154.91 44.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.65 109.84 11.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.7 145.71 29.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.547 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.22 -21.67 24.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.208 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -124.63 24.13 7.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.073 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.75 120.49 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.513 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 129.38 53.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 110.816 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.481 ' CD1' ' CD2' ' A' ' 80' ' ' TYR . 11.4 m-85 -124.24 147.03 48.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.772 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.486 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 31.9 p90 -177.3 125.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.039 0.447 . . . . 0.0 110.979 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.69 156.13 18.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.609 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 21.2 m -133.28 119.05 19.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.495 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.509 ' CZ ' HD23 ' A' ' 76' ' ' LEU . 27.9 m-85 -89.95 118.9 29.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.324 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.92 176.72 4.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.977 0.418 . . . . 0.0 111.397 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.641 179.985 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.7 0.286 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.597 ' OD1' HG22 ' A' ' 102' ' ' VAL . 2.5 t-20 -122.71 110.87 16.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.108 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.536 ' O ' HD22 ' A' ' 77' ' ' LEU . 4.2 mp -111.42 114.96 28.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.467 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.721 HD13 ' HA3' ' A' ' 100' ' ' GLY . 4.5 mm? -123.91 142.38 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 111.297 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.96 116.89 4.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.989 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.49 ' HA ' HG22 ' A' ' 98' ' ' THR . 0.1 OUTLIER -93.18 125.43 37.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.913 0.387 . . . . 0.0 111.413 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.481 ' CD2' ' CD1' ' A' ' 55' ' ' TYR . 9.8 m-85 -127.09 110.94 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.068 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 1.6 p30 -150.26 172.18 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 111.692 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.92 122.84 47.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.623 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -97.21 169.67 9.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.641 -179.349 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tp -147.93 124.44 5.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.551 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.09 110.45 2.2 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.405 2.07 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.917 HD11 ' HB2' ' A' ' 93' ' ' LEU . 33.8 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.654 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 57.3 m-80 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.63 0.252 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.682 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -74.65 151.18 39.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.561 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.467 ' HG2' ' CD2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -130.51 93.59 3.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.052 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.917 ' HB2' HD11 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -59.81 103.08 0.18 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.595 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 44.0 p90 -111.02 153.53 25.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.913 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.72 133.84 2.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.613 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.403 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -174.75 -136.54 2.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.75 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -128.01 179.98 5.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.789 0.328 . . . . 0.0 111.353 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.775 ' O ' HD12 ' A' ' 99' ' ' LEU . 48.7 p -146.73 157.09 43.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 98' ' ' THR . 0.6 OUTLIER -158.73 131.15 6.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.678 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.721 ' HA3' HD13 ' A' ' 77' ' ' LEU . . . -150.56 -154.04 6.34 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.948 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.578 ' N ' HD23 ' A' ' 101' ' ' LEU . 2.0 pt? -155.37 130.86 9.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.853 0.359 . . . . 0.0 110.301 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.597 HG22 ' OD1' ' A' ' 75' ' ' ASN . 21.1 t -109.6 122.1 63.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.322 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.929 0.395 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.45 168.53 13.04 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.83 116.25 31.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.54 148.38 22.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.03 141.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.963 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.68 -140.31 2.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 97' ' ' ALA . 22.5 mt -141.02 174.33 10.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.74 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -164.2 153.3 13.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.757 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.851 ' HB3' ' CZ ' ' A' ' 141' ' ' TYR . . . 177.2 142.5 0.08 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.939 0.4 . . . . 0.0 110.633 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -172.37 -126.65 0.91 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.873 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.3 pp -160.09 120.76 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.747 0.308 . . . . 0.0 110.236 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.699 HD12 ' HG3' ' A' ' 138' ' ' GLU . 6.3 tt -94.48 110.71 22.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.054 0.454 . . . . 0.0 110.428 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.438 ' HB3' HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -91.62 161.12 15.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.058 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -120.81 146.73 46.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 19.6 mt -109.73 -30.37 7.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.743 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.62 -165.0 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.424 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.49 50.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.813 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.71 -33.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.246 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 177' ' ' TYR . . . -104.22 146.71 28.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 111.241 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.0 m -151.74 -176.81 5.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.035 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' A' ' 175' ' ' ALA . 11.8 pt -148.56 150.79 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.642 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.699 ' HG3' HD12 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -134.87 127.63 31.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.787 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 173' ' ' LEU . . . -151.84 158.34 27.72 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.583 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 171' ' ' PHE . . . 161.09 -120.71 0.97 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.657 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.851 ' CZ ' ' HB3' ' A' ' 125' ' ' ALA . 50.6 p90 -139.6 152.9 47.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.814 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.11 145.3 45.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.721 ' O ' HD22 ' A' ' 144' ' ' LEU . 8.1 m-85 -121.48 145.74 47.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.348 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.721 HD22 ' O ' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -149.64 147.19 27.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.031 0.443 . . . . 0.0 111.258 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -135.61 155.58 50.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.48 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.108 -179.809 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.416 ' O ' ' CD1' ' A' ' 143' ' ' TYR . 67.1 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.818 0.342 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.87 141.04 38.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -154.3 155.14 34.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 14.8 m-85 -119.68 130.88 55.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.261 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.449 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 34.5 p90 -133.23 173.9 10.95 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.712 0.768 . . . . 0.0 111.725 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.459 ' HA ' ' CA ' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -163.76 134.31 4.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.847 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -154.56 -165.61 14.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.0 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.532 ' HA ' HG22 ' A' ' 137' ' ' ILE . . . -107.73 169.73 8.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.341 . . . . 0.0 110.985 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -158.0 117.44 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -117.87 118.4 31.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -89.02 160.22 17.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.023 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.3 t80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.828 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.46 0.053 0 CA-C-O 120.7 0.286 . . . . 0.0 110.858 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.51 141.98 45.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.678 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 28.2 p90 -146.43 167.23 24.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 111.23 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.539 HG12 ' CB ' ' A' ' 46' ' ' ALA . 35.5 m -156.33 144.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.475 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.68 -142.67 3.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mt -120.95 153.51 37.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.751 0.31 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -122.15 113.53 19.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.78 112.94 19.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.04 115.25 3.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.542 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.33 144.25 48.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.84 105.51 5.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.44 -164.83 10.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.513 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 45' ' ' ARG . 3.9 mt -106.69 158.95 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.695 0.283 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 44' ' ' ILE . 7.7 ttm180 -121.99 131.92 54.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.001 0.429 . . . . 0.0 110.523 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.843 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -163.75 117.82 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.97 -143.56 3.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.621 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 4.8 mt-30 -153.66 126.09 8.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.955 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 3' ' ' ASP . 19.9 pt20 -95.09 109.54 21.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.487 . . . . 0.0 111.184 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 1.7 t80 -98.82 159.43 14.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.159 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -55.41 -28.1 52.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.547 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.37 24.39 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 80' ' ' TYR . . . -174.8 132.85 2.31 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.802 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.444 ' NH1' ' CE2' ' A' ' 5' ' ' PHE . 2.7 ttt-85 -116.56 131.96 56.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 0.0 111.14 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.93 139.04 31.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.396 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.37 100.13 5.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 0.0 111.505 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -105.91 118.45 36.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.438 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 t -122.58 114.73 21.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.926 0.393 . . . . 0.0 111.224 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CD2' ' CD2' ' A' ' 76' ' ' LEU . 4.0 t80 -89.39 111.16 21.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.53 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.75 -179.91 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.104 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.854 0.359 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -127.91 110.96 13.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -105.64 116.84 32.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.651 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.445 HD21 HD21 ' A' ' 144' ' ' LEU . 0.8 OUTLIER -108.44 122.65 47.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.184 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.59 120.73 4.61 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.89 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.404 ' CB ' ' HA ' ' A' ' 98' ' ' THR . 96.5 p -129.33 145.09 51.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 0.0 111.558 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.431 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 11.2 t80 -116.56 110.87 19.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.184 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.405 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 31.1 m-20 -126.17 163.91 22.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.383 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -110.27 118.28 35.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.424 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 34.5 p90 -97.86 160.22 14.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.608 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 tp -165.85 124.69 1.14 Allowed Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.803 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' THR . 50.6 Cg_exo -55.55 108.34 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.458 2.106 . . . . 0.0 112.241 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 86' ' ' ILE . 9.1 tp . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 5.0 m120 . . . . . 0 C--O 1.232 0.142 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 2.6 t -79.64 153.22 29.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 7.1 mmtp -130.27 91.96 3.2 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.046 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 1.1 tt -67.79 102.81 1.29 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.886 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 82' ' ' ALA . 41.5 p90 -110.59 150.85 28.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.71 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -168.38 132.15 2.5 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.802 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.85 -144.82 4.92 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.605 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.02 158.42 17.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.404 ' HA ' ' CB ' ' A' ' 79' ' ' SER . 9.8 t -130.66 150.54 51.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.004 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.1 tt -160.07 127.01 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.729 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 120' ' ' ALA . . . -130.35 -156.97 8.84 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.612 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.64 124.83 6.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.778 0.323 . . . . 0.0 110.737 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 t -109.88 125.47 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 117' ' ' VAL . 17.6 mttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.501 HG12 ' HG2' ' A' ' 103' ' ' LYS . 8.5 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.806 0.336 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.0 -167.7 19.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.52 134.81 39.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 100' ' ' GLY . . . -106.71 142.81 35.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.075 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.78 134.3 9.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.123 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -174.38 -138.98 2.84 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.627 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 pp -155.46 160.95 41.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 6.0 pt20 -156.42 177.64 11.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.157 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 94' ' ' PHE . . . 176.84 142.53 0.08 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.46 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -155.23 -140.56 3.03 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.005 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 3.5 pt -159.43 120.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.693 0.282 . . . . 0.0 110.262 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 176' ' ' ASN . 0.4 OUTLIER -95.79 109.28 21.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.728 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 3.0 mt-30 -101.08 141.64 33.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.006 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.98 149.21 40.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.769 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 pp -110.18 -39.67 4.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.016 0.436 . . . . 0.0 110.776 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -169.2 -164.87 0.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.368 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -84.88 52.98 2.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 110.603 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.407 ' O ' ' CE1' ' A' ' 177' ' ' TYR . 0.5 OUTLIER -133.06 -55.34 0.92 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.037 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.05 150.15 7.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.156 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.582 ' OG ' HD22 ' A' ' 128' ' ' LEU . 6.4 t -106.89 169.66 8.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.785 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.463 ' O ' HD23 ' A' ' 128' ' ' LEU . 11.5 tt -132.7 134.7 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.661 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.61 152.32 35.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.984 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -161.79 118.09 0.8 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.29 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.68 -151.68 6.38 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.914 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.27 161.13 32.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 110.81 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.551 ' HD3' HD23 ' A' ' 144' ' ' LEU . 9.4 ttm180 -146.87 136.71 23.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.983 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.423 ' CD2' ' HA ' ' A' ' 169' ' ' SER . 11.5 m-85 -145.03 127.48 15.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.838 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.551 HD23 ' HD3' ' A' ' 142' ' ' ARG . 4.3 pp -156.2 162.47 40.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -103.19 157.72 16.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.849 0.357 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.423 ' HA ' ' CD2' ' A' ' 143' ' ' TYR . 15.7 m -106.87 122.98 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.64 155.15 46.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.742 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -111.71 164.1 13.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.121 0.486 . . . . 0.0 110.161 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.422 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -132.59 126.88 33.79 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.771 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.56 129.96 3.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.563 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.89 -152.94 15.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.831 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.95 172.09 10.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 111.114 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.586 ' HB2' HD21 ' A' ' 128' ' ' LEU . 23.8 m-20 -155.59 119.18 4.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.407 ' CE1' ' O ' ' A' ' 134' ' ' ASN . 13.9 t80 -120.31 115.87 24.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.081 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.39 145.93 30.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.013 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.023 -179.801 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 49' ' ' GLN . 2.0 t0 . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 120.71 0.29 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 1.8 t30 -80.69 156.59 26.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.561 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.9 OUTLIER -156.12 164.56 38.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 111.592 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' A' ' 46' ' ' ALA . 27.4 m -158.02 128.22 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.953 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 176' ' ' ASN . . . -150.73 -146.87 4.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.596 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.38 136.9 25.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.779 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.776 HG22 ' OE2' ' A' ' 138' ' ' GLU . 35.6 p -100.58 151.2 21.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -148.69 128.69 13.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.98 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.38 138.24 13.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.43 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.362 -0.295 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -94.99 110.08 22.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.823 0.344 . . . . 0.0 110.959 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.87 -178.96 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.567 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.602 ' HA2' ' HB2' ' A' ' 60' ' ' GLU . . . -178.17 158.17 22.78 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.081 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.793 HD12 ' CE2' ' A' ' 59' ' ' TYR . 25.7 mt -106.44 124.82 62.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.18 133.89 49.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.392 0.615 . . . . 0.0 111.084 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -163.34 111.11 1.21 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.448 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.45 -163.04 12.36 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.188 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -126.41 142.63 51.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.024 0.44 . . . . 0.0 111.298 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -97.02 162.15 13.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.473 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.52 -169.38 1.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.977 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -32.51 73.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.509 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -127.33 -34.7 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -119.04 -166.05 13.33 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.702 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.452 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . 44.9 ptt85 -162.96 158.54 22.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.0 111.791 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.409 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 12.2 m-85 -118.84 144.26 46.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.846 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -159.12 119.09 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.963 0.411 . . . . 0.0 111.181 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.79 140.33 29.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.817 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 7.1 t -126.18 116.15 20.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.793 ' CE2' HD12 ' A' ' 44' ' ' ILE . 40.1 p90 -130.11 126.7 38.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 111.763 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.602 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -158.36 -179.91 8.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.948 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.397 179.464 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.79 0.329 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.72 ' HB2' HG12 ' A' ' 102' ' ' VAL . 8.0 p30 -146.0 119.44 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.106 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.29 145.12 50.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.642 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.402 ' CB ' ' HA3' ' A' ' 100' ' ' GLY . 0.9 OUTLIER -158.06 157.98 33.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 111.342 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.97 116.79 4.23 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.054 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.625 ' CB ' HG22 ' A' ' 98' ' ' THR . 23.3 t -98.78 133.69 42.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.97 0.414 . . . . 0.0 111.37 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.755 ' CZ ' ' HB3' ' A' ' 97' ' ' ALA . 12.7 p90 -134.13 112.06 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.185 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 6.1 p30 -139.16 172.14 13.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.188 0.518 . . . . 0.0 111.558 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.554 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -112.22 118.72 36.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.839 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 20.3 p90 -99.74 166.42 11.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.257 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 tt -167.83 134.79 1.79 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.11 118.48 4.6 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.463 2.109 . . . . 0.0 112.345 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 86' ' ' ILE . 1.1 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.057 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.765 0.316 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.452 HG22 HD12 ' A' ' 127' ' ' ILE . 3.3 p -136.29 151.89 50.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.547 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 5.4 mptt -122.81 92.42 3.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.906 0.384 . . . . 0.0 110.924 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tp -62.23 102.83 0.33 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.706 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 30.2 p90 -112.76 156.03 23.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.781 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.03 128.65 1.5 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.403 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -163.99 -132.75 1.38 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.65 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.755 ' HB3' ' CZ ' ' A' ' 80' ' ' TYR . . . -133.25 165.95 23.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.773 0.321 . . . . 0.0 111.235 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.625 HG22 ' CB ' ' A' ' 79' ' ' SER . 2.7 p -136.65 154.94 50.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.89 130.67 5.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.023 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 77' ' ' LEU . . . -161.92 -152.76 6.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.679 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mp -148.25 122.26 9.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.72 HG12 ' HB2' ' A' ' 75' ' ' ASN . 31.4 m -109.82 130.25 63.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.231 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.8 mttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.806 0.336 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -137.88 170.5 23.72 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -84.31 132.68 34.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.323 . . . . 0.0 110.853 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.714 ' HB1' ' CD2' ' A' ' 144' ' ' LEU . . . -115.18 143.37 45.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -169.31 137.98 1.96 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.47 -137.86 2.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mp -146.59 157.07 43.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 110.964 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' A' ' 142' ' ' ARG . 0.0 OUTLIER -141.13 161.87 36.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.594 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 179.59 142.41 0.14 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -169.5 -135.08 1.84 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.948 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 2.8 pt -158.04 120.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.801 0.334 . . . . 0.0 110.383 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -94.82 112.99 24.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.551 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 137' ' ' ILE . 4.0 tt0 -96.45 123.94 40.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.147 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.23 149.12 32.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.572 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 tp -105.87 -47.19 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 110.542 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 m -165.72 -164.86 0.76 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -81.37 55.66 2.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.62 -59.13 0.72 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.99 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -154.89 151.36 28.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.101 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.758 ' O ' HD13 ' A' ' 137' ' ' ILE . 1.4 m -113.72 174.28 6.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.758 HD13 ' O ' ' A' ' 136' ' ' SER . 28.5 mm -134.17 134.9 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.776 ' OE2' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.96 141.52 46.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.897 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -163.07 121.41 1.02 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -174.85 -138.13 2.66 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.048 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.501 ' CE1' ' CE2' ' A' ' 171' ' ' PHE . 64.6 m-85 -132.76 161.09 34.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.756 0.312 . . . . 0.0 110.758 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.409 ' HA ' ' HG2' ' A' ' 124' ' ' GLN . 14.3 ptm180 -140.83 136.58 32.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -132.02 128.91 39.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.433 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.714 ' CD2' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -139.68 151.44 45.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.379 . . . . 0.0 111.154 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.5 ttt-85 -116.52 163.97 15.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.689 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.005 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.812 0.339 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.9 t -106.96 106.18 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.52 155.24 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.501 ' CE2' ' CE1' ' A' ' 141' ' ' TYR . 0.2 OUTLIER -94.2 165.36 12.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.199 0.523 . . . . 0.0 110.195 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.412 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -131.3 128.46 39.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.809 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.39 135.18 5.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.58 -142.74 6.96 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.774 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -142.88 171.99 13.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.41 ' HA ' ' HA3' ' A' ' 7' ' ' GLY . 7.8 t-20 -155.59 117.6 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -102.61 111.62 24.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.83 147.01 29.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.083 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.925 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 1.5 t0 . . . . . 0 C--O 1.227 -0.086 0 CA-C-O 120.59 0.233 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.18 125.51 39.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.644 0.259 . . . . 0.0 110.686 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.2 OUTLIER -134.68 139.95 45.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.396 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 46' ' ' ALA . 37.9 t -150.2 131.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.982 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.36 -162.49 10.76 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.799 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -118.24 142.7 47.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 0.0 110.61 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 p -111.33 118.61 36.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.06 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -128.35 112.88 14.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.696 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -106.97 153.9 16.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.644 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 179.944 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.561 -0.215 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 m -113.38 118.43 34.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -103.99 161.75 13.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.61 -169.36 35.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.605 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 45' ' ' ARG . 2.7 mp -134.9 160.0 41.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.602 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -138.07 139.32 39.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.95 0.405 . . . . 0.0 110.593 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.696 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -171.57 120.91 0.49 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.842 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 56' ' ' TYR . . . -167.73 -141.73 3.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.832 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 15.5 pt20 -122.3 142.18 50.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.705 0.288 . . . . 0.0 110.785 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.418 ' CG ' ' HG3' ' A' ' 54' ' ' ARG . 0.8 OUTLIER -116.81 109.68 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 111.089 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -130.57 165.01 23.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.509 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -19.2 65.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.36 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.63 24.09 12.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.31 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 80' ' ' TYR . . . 155.98 142.56 3.45 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.526 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.648 ' NH2' HD22 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -136.71 162.09 34.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.319 . . . . 0.0 110.946 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.466 ' CE1' ' CD ' ' A' ' 54' ' ' ARG . 8.9 m-85 77.05 -175.81 0.1 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 3.4 t80 178.65 -43.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.902 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -122.43 136.96 55.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 111.396 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.13 119.69 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.565 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -113.55 149.98 33.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.01 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.34 155.91 44.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.985 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.758 0.313 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.74 119.37 24.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.43 114.93 17.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.324 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.487 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.5 OUTLIER -142.93 168.87 18.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 111.399 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.97 116.74 4.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.903 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 56' ' ' TYR . 3.5 m -104.67 126.59 51.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.971 0.415 . . . . 0.0 111.484 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 63.4 t80 -136.57 110.89 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.198 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -129.21 171.87 12.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.029 0.442 . . . . 0.0 111.651 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.81 119.76 35.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.565 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 50.3 p90 -97.76 172.17 7.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.098 0.475 . . . . 0.0 111.809 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tp -165.09 135.45 3.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.391 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.54 119.26 4.89 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.548 2.165 . . . . 0.0 112.203 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.597 ' O ' HG23 ' A' ' 86' ' ' ILE . 8.9 tt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.815 0.341 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.571 HG23 ' HG2' ' A' ' 129' ' ' GLN . 0.5 OUTLIER -67.86 145.09 54.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.348 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 3.6 mmpt? -126.63 92.32 3.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 111.272 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.585 HD13 HD13 ' A' ' 86' ' ' ILE . 1.8 tp -60.54 103.25 0.23 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.051 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 16.6 p90 -110.73 161.76 15.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.292 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.44 126.57 1.05 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.559 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.06 -134.38 1.64 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.621 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -141.06 157.81 44.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.883 0.373 . . . . 0.0 111.324 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -134.79 161.86 33.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.732 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.29 132.76 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -158.68 -144.69 4.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.986 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.21 130.09 9.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 110.388 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.63 132.84 56.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.178 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.816 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.762 0.315 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -136.51 131.61 5.73 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.546 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -84.17 117.73 23.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.803 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.678 ' HB2' HG22 ' A' ' 146' ' ' THR . . . -109.86 145.13 37.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 141.32 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.954 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.01 -137.08 2.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.541 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 97' ' ' ALA . 3.8 mp -145.2 153.31 41.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.195 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -133.71 172.55 12.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.622 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.89 142.49 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.054 0.454 . . . . 0.0 110.69 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.597 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -169.41 -134.33 1.72 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.721 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 126' ' ' GLY . 10.8 pt -161.22 120.48 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.318 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.648 HD22 ' NH2' ' A' ' 54' ' ' ARG . 1.8 tt -95.88 113.32 24.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 111.201 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.571 ' HG2' HG23 ' A' ' 91' ' ' THR . 30.7 mt-30 -100.31 139.27 36.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.756 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -93.34 149.15 21.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.002 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.41 -43.89 2.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 110.584 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 m -142.2 -164.72 1.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.361 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.41 28.8 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.162 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 177.84 34.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.773 0.32 . . . . 0.0 111.132 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.23 129.09 1.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.815 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.1 m -142.97 169.71 17.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.004 0.431 . . . . 0.0 111.29 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 129' ' ' GLN . 0.6 OUTLIER -132.52 134.78 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.247 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -128.18 149.19 50.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.925 0.393 . . . . 0.0 111.162 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.647 ' HA3' HD22 ' A' ' 173' ' ' LEU . . . -165.8 152.8 22.33 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.378 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.13 -131.72 2.22 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.698 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -135.82 152.56 51.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.762 0.315 . . . . 0.0 110.793 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -140.36 123.75 16.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 3.2 m-85 -116.98 124.28 48.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.0 171.39 16.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.182 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.1 ttt85 -152.39 144.32 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.765 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.678 HG22 ' HB2' ' A' ' 120' ' ' ALA . 82.5 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.408 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 10.6 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.798 0.332 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.83 140.65 39.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.746 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.35 155.28 33.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.081 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.58 141.57 41.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.095 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -119.84 127.51 52.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.989 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.647 HD22 ' HA3' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -163.45 129.87 3.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.465 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.76 -156.94 20.1 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.658 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.25 171.98 8.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.84 0.352 . . . . 0.0 111.159 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.451 ' ND2' ' CD1' ' A' ' 5' ' ' PHE . 2.0 t30 -150.8 114.96 5.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -115.38 122.17 45.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.162 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.93 162.91 22.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.224 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.942 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.46 0.075 0 CA-C-O 120.697 0.284 . . . . 0.0 110.667 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.82 118.53 37.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.785 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 1.7 m-85 -124.02 145.11 49.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.003 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 5' ' ' PHE . 13.3 m -158.15 125.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.181 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.02 -149.06 5.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.64 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.1 159.66 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.819 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.61 127.72 35.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 36.9 t90 -128.33 112.99 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.687 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.83 168.58 13.99 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 110.868 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.439 -0.265 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.602 HG21 ' OE1' ' A' ' 170' ' ' GLN . 33.8 m -137.16 107.86 6.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.426 ' CE3' ' CD1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -120.35 146.55 46.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.27 -164.83 25.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.512 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.649 HD12 ' HB3' ' A' ' 59' ' ' TYR . 3.0 mp -107.0 161.16 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 110.95 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.684 HH11 HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -130.8 137.17 49.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.996 0.427 . . . . 0.0 110.693 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -174.16 122.51 0.3 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.825 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.64 -145.47 4.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.656 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -146.45 126.1 13.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.0 111.009 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -94.13 109.6 21.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.096 0.474 . . . . 0.0 111.278 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.09 155.2 19.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.474 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.38 -18.6 65.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.384 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -130.68 24.26 5.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.318 . . . . 0.0 111.172 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.72 163.62 23.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.931 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -145.0 141.04 28.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.93 0.395 . . . . 0.0 111.532 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.35 146.61 26.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.035 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CD1' ' NE ' ' A' ' 45' ' ' ARG . 6.7 m-85 -143.87 96.9 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.381 . . . . 0.0 111.683 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -90.87 139.25 30.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.099 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.684 HG23 HH11 ' A' ' 45' ' ' ARG . 0.2 OUTLIER -139.75 124.93 18.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.067 0.461 . . . . 0.0 111.714 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.649 ' HB3' HD12 ' A' ' 44' ' ' ILE . 3.3 t80 -101.5 104.67 15.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.846 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.95 153.63 19.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.086 0.47 . . . . 0.0 111.489 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.461 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.785 0.326 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.461 ' CG ' HG23 ' A' ' 102' ' ' VAL . 1.5 m-20 -124.89 111.06 15.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.002 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -118.96 116.95 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.654 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.4 ' CB ' ' HA3' ' A' ' 100' ' ' GLY . 3.9 pp -135.38 146.3 48.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 0.0 111.405 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.18 116.9 4.23 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.956 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.4 p -105.9 119.95 40.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.629 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.45 110.88 23.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.963 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.419 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 1.7 m-20 -128.08 161.11 29.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.147 0.499 . . . . 0.0 111.842 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.85 119.12 38.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.221 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 35.1 p90 -97.32 158.11 15.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.994 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.518 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -165.33 125.98 1.33 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.733 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 91' ' ' THR . 52.7 Cg_exo -52.99 100.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.614 2.209 . . . . 0.0 112.229 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 84' ' ' LEU . 18.8 tt . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.113 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 18.4 m120 . . . . . 0 CA--C 1.527 0.081 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 7.6 p -79.47 153.29 29.72 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -130.73 92.1 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.999 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -64.26 102.06 0.48 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.771 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 46.3 p90 -111.92 120.94 43.63 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.604 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -140.72 147.35 18.99 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.777 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.46 -139.08 3.52 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.813 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.57 176.2 5.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.891 0.377 . . . . 0.0 111.182 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 p -146.48 145.54 30.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.07 131.15 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 77' ' ' LEU . . . -154.53 -151.89 5.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.652 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.07 125.82 7.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.797 0.332 . . . . 0.0 110.746 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.461 HG23 ' CG ' ' A' ' 75' ' ' ASN . 11.1 p -110.31 142.83 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.252 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 179.874 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.815 0.341 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -142.72 149.6 21.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.335 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -119.24 114.97 23.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.02 139.23 48.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.75 130.61 5.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -175.43 -138.19 2.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.407 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 1.7 mp -148.04 171.31 16.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -152.17 168.74 24.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.957 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . -175.15 142.06 0.6 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.96 0.41 . . . . 0.0 110.554 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -168.28 -146.74 5.08 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.783 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.8 pp -161.04 120.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.773 HD12 ' HB3' ' A' ' 138' ' ' GLU . 2.1 tt -95.95 113.41 25.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.942 0.401 . . . . 0.0 111.19 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 2.4 tt0 -95.17 115.84 27.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.14 149.21 24.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mp -107.66 -39.67 5.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.691 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.1 p -169.05 -164.88 0.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.395 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -83.55 55.16 3.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.865 0.364 . . . . 0.0 110.73 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -140.35 -59.99 0.53 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.002 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.47 157.33 27.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.414 ' OG ' HD21 ' A' ' 128' ' ' LEU . 51.1 p -135.4 -177.3 4.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 175' ' ' ALA . 2.4 pt -129.65 134.82 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.617 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.773 ' HB3' HD12 ' A' ' 128' ' ' LEU . 1.6 pt-20 -123.86 140.62 52.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -162.46 143.94 9.2 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.392 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.07 -144.94 5.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.649 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.75 158.38 40.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.402 ' CZ ' HD21 ' A' ' 144' ' ' LEU . 4.3 ptm180 -144.67 140.26 28.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 2.8 p90 -145.06 105.06 4.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.969 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.402 HD21 ' CZ ' ' A' ' 142' ' ' ARG . 0.2 OUTLIER -139.85 153.97 47.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -108.58 147.86 31.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.839 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.961 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.805 0.336 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 72.3 p -106.94 120.55 42.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.694 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.602 ' OE1' HG21 ' A' ' 41' ' ' THR . 1.7 mt-30 -146.66 155.15 42.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.985 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -104.58 165.38 11.1 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.14 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.431 ' OH ' HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -131.47 127.27 37.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.044 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.52 129.95 3.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.471 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.84 -152.74 15.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.747 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -124.86 171.9 9.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 111.218 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.442 HD21 ' HD1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -149.65 114.92 5.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -106.2 114.22 28.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.0 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.95 163.39 22.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.024 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 6' ' ' VAL . 4.2 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.412 ' CB ' ' HB3' ' A' ' 49' ' ' GLN . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.714 0.292 . . . . 0.0 110.862 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -112.08 132.88 54.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.801 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 8.7 m-85 -131.41 139.59 49.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.973 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 27.1 t -156.14 125.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.081 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 176' ' ' ASN . . . -170.98 -128.12 1.0 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.739 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -159.19 167.91 27.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.748 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.45 150.22 35.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.982 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -110.47 117.09 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.823 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.5 137.51 13.73 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.529 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 0.0 110.917 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.1 p -137.72 107.99 6.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -91.6 131.22 37.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.682 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.9 -175.81 20.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.796 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.526 HG22 ' H ' ' A' ' 45' ' ' ARG . 4.0 mt -106.94 168.6 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.56 0.219 . . . . 0.0 110.698 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.526 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -138.4 142.78 39.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.051 0.453 . . . . 0.0 110.828 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -170.48 120.23 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -161.57 -156.8 8.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.577 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.46 ' HB2' ' CE2' ' A' ' 55' ' ' TYR . 5.9 mt-30 -141.44 133.39 27.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.087 0.47 . . . . 0.0 111.074 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.453 ' CG ' ' HB3' ' A' ' 54' ' ' ARG . 2.8 tt0 -83.55 162.06 20.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.849 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.02 -169.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.647 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -67.24 -40.37 86.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.237 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -123.18 -26.61 4.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.732 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -124.29 -159.83 10.56 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.689 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.453 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -171.64 168.09 6.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.632 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -141.23 166.68 24.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.424 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.613 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 41.3 p90 177.92 135.73 0.08 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.092 0.473 . . . . 0.0 110.888 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.51 155.78 18.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.257 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 77.1 p -137.58 123.78 20.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.055 0.455 . . . . 0.0 111.454 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.495 ' HD2' HD12 ' A' ' 44' ' ' ILE . 9.4 m-85 -89.89 108.69 19.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.173 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -105.99 178.68 4.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.092 0.472 . . . . 0.0 111.503 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.54 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.758 0.313 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.503 ' OD1' HG12 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -120.02 110.87 17.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.805 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.17 115.72 30.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.638 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.436 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 1.8 mp -133.12 133.66 43.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.4 . . . . 0.0 111.298 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.89 116.91 4.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.944 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.6 t -105.25 135.6 46.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 111.576 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -128.71 110.95 12.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.899 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 1.6 p30 -136.52 172.13 13.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.233 0.54 . . . . 0.0 111.866 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.508 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -115.42 121.89 44.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.547 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 18.9 p90 -97.71 164.66 12.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.737 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.664 ' CD2' HD11 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -167.04 128.15 1.23 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.389 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.57 106.92 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.445 2.097 . . . . 0.0 112.362 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.664 HD11 ' CD2' ' A' ' 84' ' ' LEU . 37.2 mt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.988 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.6 p30 . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.659 0.266 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.5 p -136.59 130.51 32.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.714 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -117.31 92.82 3.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.896 0.379 . . . . 0.0 110.881 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.585 HD12 HG22 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -56.17 103.02 0.09 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.596 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 22.6 p90 -110.93 156.17 21.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.802 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.43 135.21 2.94 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.712 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.404 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -168.91 -137.59 2.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.653 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -124.87 161.74 25.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.855 0.359 . . . . 0.0 111.19 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.512 ' C ' HD12 ' A' ' 99' ' ' LEU . 23.7 m -139.49 148.63 42.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.512 HD12 ' C ' ' A' ' 98' ' ' THR . 4.5 mp -157.1 130.82 8.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.667 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -141.46 -162.7 9.26 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.121 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' ' 100' ' ' GLY . 5.5 mp -155.6 142.54 19.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.885 HG22 ' HA3' ' A' ' 118' ' ' GLY . 35.0 m -109.56 145.41 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.416 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.86 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.821 0.343 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.885 ' HA3' HG22 ' A' ' 102' ' ' VAL . . . -161.11 132.4 2.86 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.275 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -113.97 114.97 26.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.876 0.37 . . . . 0.0 111.05 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.73 138.24 54.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.746 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.96 132.75 5.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.448 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.65 ' O ' HD23 ' A' ' 123' ' ' LEU . . . -173.39 -140.05 3.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.765 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 122' ' ' GLY . 13.3 mt -147.64 164.78 32.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 14.9 mt-30 -149.74 170.54 18.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.704 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.92 142.56 0.08 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.988 0.423 . . . . 0.0 110.851 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -164.53 -128.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.759 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.585 HG22 HD12 ' A' ' 93' ' ' LEU . 12.6 pt -160.59 121.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 120.794 0.33 . . . . 0.0 110.296 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 128' ' ' LEU . 5.0 tt -94.48 113.28 25.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.008 0.432 . . . . 0.0 110.857 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -95.63 124.18 39.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -111.56 149.14 31.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.7 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.6 tp -108.24 -45.9 3.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.118 0.485 . . . . 0.0 110.635 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.7 p -169.21 -164.85 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.189 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.55 54.96 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.913 0.387 . . . . 0.0 110.569 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -138.25 -58.2 0.65 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.16 171.95 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.197 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.9 m -141.03 167.73 21.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.764 HG23 ' O ' ' A' ' 174' ' ' GLY . 5.4 mt -129.26 134.87 63.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.444 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -127.95 132.09 49.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . -155.28 144.49 11.08 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.554 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 171' ' ' PHE . . . 176.14 -151.41 11.58 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.366 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 170' ' ' GLN . 0.2 OUTLIER -119.75 153.45 35.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.902 0.382 . . . . 0.0 110.916 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.424 ' HB3' ' CE1' ' A' ' 172' ' ' TYR . 29.1 ptt180 -131.89 129.99 41.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' A' ' 169' ' ' SER . 7.3 t80 -128.59 102.23 6.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.779 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.404 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 0.6 OUTLIER -150.72 164.04 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.196 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.2 153.89 18.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.718 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.789 0.328 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.438 ' HB3' ' CD2' ' A' ' 143' ' ' TYR . 83.4 p -107.9 122.59 47.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.805 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.407 ' O ' ' CD1' ' A' ' 141' ' ' TYR . 1.6 mt-30 -141.58 152.11 43.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 140' ' ' GLY . 2.7 t80 -100.04 120.55 40.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.265 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 142' ' ' ARG . 9.7 p90 -125.07 126.44 45.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.234 0.54 . . . . 0.0 111.428 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.612 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 1.4 pt? -147.46 155.47 41.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.858 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 137' ' ' ILE . . . -176.73 -132.73 1.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.401 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.85 169.41 16.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 0.0 111.128 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.41 ' HA ' ' HA3' ' A' ' 7' ' ' GLY . 4.3 t-20 -158.05 118.35 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.022 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -101.57 118.27 36.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -87.16 154.79 20.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 110.661 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -112.28 119.19 37.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.744 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 29.0 p90 -124.05 155.29 38.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.256 0.55 . . . . 0.0 111.469 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 46' ' ' ALA . 7.5 p -151.91 128.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.732 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.74 -141.6 3.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.373 -0.917 . . . . 0.0 112.754 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.5 165.54 23.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.896 0.379 . . . . 0.0 110.799 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.632 HG23 ' HB2' ' A' ' 45' ' ' ARG . 24.1 p -129.17 143.95 51.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -140.9 112.96 7.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.689 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.88 135.24 10.98 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.6 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 110.823 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.2 p -119.2 139.43 51.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 111.028 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -148.45 139.94 23.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -177.3 -164.89 31.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.605 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 45' ' ' ARG . 3.2 mt -106.86 161.74 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.584 0.23 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.632 ' HB2' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -140.99 148.7 40.74 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.606 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.865 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -177.22 124.38 0.14 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -161.57 -163.11 13.84 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.308 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 3.4 mp0 -118.34 125.97 51.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 0.0 111.001 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.477 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 37.5 tt0 -111.79 109.97 20.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.196 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -119.41 160.11 22.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.521 179.339 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.75 -23.29 64.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.197 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -99.29 24.09 8.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.242 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 50' ' ' PHE . . . 133.4 164.57 10.83 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.337 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.401 ' NE ' ' CZ ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -139.44 146.03 39.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.918 0.39 . . . . 0.0 111.314 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -129.78 161.23 31.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.408 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.576 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 15.9 p90 -176.97 126.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.166 0.508 . . . . 0.0 111.525 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.71 139.06 31.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.284 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 51.3 m -129.57 117.29 20.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 111.529 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -94.32 117.17 29.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.319 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -111.82 175.4 5.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 111.266 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.731 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.777 0.323 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.578 ' HA ' HG12 ' A' ' 102' ' ' VAL . 4.1 m120 -114.57 112.54 23.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 tt -98.28 114.95 27.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.49 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -118.11 113.58 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.278 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.01 116.95 4.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.623 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.798 ' OG ' HG22 ' A' ' 98' ' ' THR . 12.3 m -126.41 143.02 51.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 0.0 111.831 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -131.79 110.67 11.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.502 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.451 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 15.8 m-20 -130.55 166.06 21.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.214 0.531 . . . . 0.0 112.017 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.08 127.95 53.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.045 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 45.4 p90 -97.36 168.72 10.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.143 0.497 . . . . 0.0 111.778 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 86' ' ' ILE . 7.4 tp -158.9 132.4 4.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.235 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.17 106.04 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.32 2.014 . . . . 0.0 112.401 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.704 HD11 HD23 ' A' ' 84' ' ' LEU . 42.7 mm . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.002 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.979 0.418 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.545 HG22 HD12 ' A' ' 127' ' ' ILE . 14.5 p -136.48 142.7 43.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.463 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 13.6 mmtt -123.52 98.92 6.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 7.8 tt -55.32 104.54 0.13 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.381 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -109.42 145.88 35.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.606 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.21 140.54 6.47 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.067 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 179.45 -146.82 7.29 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.004 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.444 ' HA ' HD23 ' A' ' 123' ' ' LEU . . . -109.07 -178.02 3.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 111.257 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.798 HG22 ' OG ' ' A' ' 79' ' ' SER . 0.8 OUTLIER -145.51 161.44 39.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 12.4 mt -147.86 130.27 15.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.34 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 120' ' ' ALA . . . -130.37 123.64 4.02 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.378 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.591 HD11 ' CD2' ' A' ' 119' ' ' TYR . 2.0 tp -143.87 120.9 11.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.845 0.355 . . . . 0.0 110.743 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 75' ' ' ASN . 4.9 m -109.8 145.26 16.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.138 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.956 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.458 -0.037 0 CA-C-O 120.9 0.381 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.62 149.42 19.23 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.48 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.591 ' CD2' HD11 ' A' ' 101' ' ' LEU . 64.3 m-85 -114.25 127.93 56.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.719 ' HB1' HD12 ' A' ' 144' ' ' LEU . . . -133.86 148.82 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.11 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -171.98 134.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.85 -124.9 0.74 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.615 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 97' ' ' ALA . 86.7 mt -141.05 169.65 17.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.65 153.49 24.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.376 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -178.26 142.57 0.26 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.131 0.491 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -163.12 -125.0 0.74 Allowed Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.553 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.7 pt -160.79 120.62 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.708 0.29 . . . . 0.0 110.351 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 136' ' ' SER . 1.2 tt -95.0 115.21 27.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.446 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -94.58 152.97 18.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.215 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -108.13 149.08 28.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 tp -121.0 -39.1 2.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.929 0.395 . . . . 0.0 110.824 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 t -158.96 -164.57 1.44 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.353 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.41 30.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.102 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.6 p30 178.32 34.96 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.16 119.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.714 ' HB3' HD21 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -128.74 172.1 11.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.989 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 174' ' ' GLY . 3.9 mp -137.64 135.55 46.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 127.57 51.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -146.74 122.77 1.66 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.291 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.98 -147.61 5.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.885 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -135.85 161.13 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 0.0 110.922 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -133.25 149.03 52.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.667 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.76 109.97 5.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.719 HD12 ' HB1' ' A' ' 120' ' ' ALA . 1.2 pt? -151.89 164.6 36.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.068 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -112.35 146.61 37.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.846 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.762 0.315 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 11.7 m -107.0 131.23 54.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.774 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -138.68 155.2 48.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -114.21 165.17 12.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.056 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.508 ' O ' HD12 ' A' ' 173' ' ' LEU . 8.3 t80 -138.35 129.34 26.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.252 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 172' ' ' TYR . 0.3 OUTLIER -163.66 129.89 3.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.596 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 137' ' ' ILE . . . 178.35 -156.0 18.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.775 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -129.6 171.96 12.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 111.008 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -151.56 116.1 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.91 111.77 24.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.712 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 3.7 mttp -81.86 150.91 27.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.226 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.767 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.804 0.335 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -112.13 142.03 45.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.815 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.555 ' O ' HG13 ' A' ' 6' ' ' VAL . 18.0 m-85 -131.24 142.18 50.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.773 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 5' ' ' PHE . 5.0 m -159.52 121.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.156 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.56 -140.33 2.89 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.652 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.21 146.93 49.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.2 m -116.74 129.36 56.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -124.75 112.97 17.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.682 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.1 134.41 11.71 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.719 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.834 0.349 . . . . 0.0 110.777 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.05 127.92 53.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -125.34 123.59 39.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.79 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.36 -164.85 16.09 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.553 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 pt -107.04 162.03 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 111.087 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.709 ' HG2' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -129.31 138.94 51.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.759 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.802 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -168.61 119.86 0.78 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.62 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.49 -159.33 8.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.945 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -143.26 116.67 9.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 0.0 110.74 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' HA ' ' CG ' ' A' ' 54' ' ' ARG . 0.8 OUTLIER -83.79 148.34 27.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.22 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -132.42 -166.74 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.291 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.62 -47.18 84.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.225 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -135.91 12.01 3.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.821 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -148.1 153.58 25.36 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.561 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.469 ' NH2' ' CD1' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -141.72 144.65 34.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.607 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -89.29 153.71 20.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.012 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.456 ' CE1' ' HD2' ' A' ' 54' ' ' ARG . 58.2 m-85 -133.24 103.34 5.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.362 . . . . 0.0 111.422 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -113.29 122.74 48.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.318 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.709 HG22 ' HG2' ' A' ' 45' ' ' ARG . 2.2 p -141.1 128.96 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.048 0.451 . . . . 0.0 111.268 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.639 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 3.1 m-85 -89.42 119.27 29.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.078 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -101.92 163.51 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.943 0.402 . . . . 0.0 111.54 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.637 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.665 0.269 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -144.65 112.6 6.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.639 HD11 ' CZ ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -82.99 136.92 34.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.601 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -118.72 142.52 47.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 111.205 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.612 ' H ' HD23 ' A' ' 77' ' ' LEU . . . -160.1 116.8 0.74 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.73 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.775 ' HB3' HG23 ' A' ' 98' ' ' THR . 49.5 p -139.25 143.21 37.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.468 . . . . 0.0 111.614 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 110.96 21.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.826 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -127.91 172.06 11.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.208 0.528 . . . . 0.0 111.787 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.53 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -119.11 118.8 32.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.44 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 21.9 p90 -97.73 161.53 13.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.086 0.47 . . . . 0.0 111.659 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.517 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -165.04 138.57 3.86 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.493 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.517 ' HD2' HD23 ' A' ' 84' ' ' LEU . 31.6 Cg_exo -58.8 117.74 4.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.38 2.053 . . . . 0.0 112.532 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 85' ' ' PRO . 37.5 mm . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.933 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 82.3 m-20 . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.75 0.31 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 p -75.85 153.13 37.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.435 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -131.5 92.49 3.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 111.047 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.418 ' CB ' HG13 ' A' ' 86' ' ' ILE . 6.3 tt -62.2 103.12 0.35 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.316 0.579 . . . . 0.0 110.497 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.459 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 24.0 p90 -110.96 154.53 23.99 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.477 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.03 139.9 4.84 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.815 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.68 -135.31 2.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.73 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.86 155.66 20.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.775 HG23 ' HB3' ' A' ' 79' ' ' SER . 6.9 m -128.34 148.34 50.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.121 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 120.99 3.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.682 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.664 ' H ' ' HB3' ' A' ' 120' ' ' ALA . . . -127.98 -155.92 8.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.63 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.19 127.0 7.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.822 0.344 . . . . 0.0 110.661 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 102' ' ' VAL . 29.1 m -109.83 122.06 63.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HE3' HG22 ' A' ' 117' ' ' VAL . 2.1 ttmp? . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.418 HG22 ' HE3' ' A' ' 103' ' ' LYS . 21.4 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.826 0.346 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.33 162.75 12.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.82 130.28 56.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.744 ' HB1' ' CD1' ' A' ' 144' ' ' LEU . . . -100.47 140.6 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.75 131.27 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -176.28 -131.03 1.41 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.605 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mp -148.93 157.72 43.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.346 . . . . 0.0 111.004 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -143.12 164.97 28.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.748 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . 179.53 142.59 0.14 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.99 0.424 . . . . 0.0 110.699 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -164.03 -136.19 1.95 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.994 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 126' ' ' GLY . 5.1 pt -161.92 120.97 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.593 HD21 ' HB3' ' A' ' 136' ' ' SER . 9.2 tt -94.46 111.31 23.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 110.745 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 36.1 tt0 -97.07 116.85 30.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.944 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.09 148.98 21.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.995 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.8 -30.02 8.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.611 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -165.34 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.491 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.42 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 2.6 mmmt -89.45 52.34 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.8 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER 178.63 -35.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.22 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.78 125.95 49.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.871 0.367 . . . . 0.0 111.216 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.593 ' HB3' HD21 ' A' ' 128' ' ' LEU . 1.2 m -126.46 163.63 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.4 mt -135.48 134.93 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.817 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.49 139.19 48.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.95 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -160.74 111.14 0.47 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.333 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -162.48 -150.18 5.92 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.07 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -139.18 161.03 38.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.433 ' HD2' HG21 ' A' ' 98' ' ' THR . 5.7 ttp-105 -137.73 140.55 40.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 142' ' ' ARG . 15.7 m-85 -140.3 115.27 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.744 ' CD1' ' HB1' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -160.53 174.01 14.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -132.82 160.38 37.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.407 HG21 HG21 ' A' ' 102' ' ' VAL . 1.1 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.812 0.339 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.9 t -106.93 115.9 31.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -124.01 155.09 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -126.53 140.47 52.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.447 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.431 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -122.3 126.95 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.738 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.42 130.02 3.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.62 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.02 -153.39 18.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.849 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -122.19 172.18 8.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.32 . . . . 0.0 111.065 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -155.18 117.67 4.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.152 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -107.39 111.87 24.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.694 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . 8.8 pttt -86.87 157.96 19.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.081 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.829 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.46 0.062 0 CA-C-O 120.763 0.315 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 5.3 m-80 -112.02 140.53 46.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.476 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 52.6 p90 -148.54 167.53 25.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.126 0.489 . . . . 0.0 111.661 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.673 HG13 ' HB2' ' A' ' 46' ' ' ALA . 46.2 t -155.85 137.4 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.791 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.49 -147.17 4.88 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.803 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.34 163.05 32.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.657 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.67 141.5 44.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -126.29 112.93 16.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.63 136.01 15.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.404 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 110.942 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.7 p -142.99 107.99 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -89.78 124.97 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.764 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.19 -169.24 12.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.688 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 58' ' ' THR . 13.9 tt -119.66 162.39 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.52 0.2 . . . . 0.0 110.897 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.644 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -135.1 142.69 46.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.924 0.392 . . . . 0.0 110.73 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -169.34 119.32 0.68 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.253 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -170.61 -139.06 2.65 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.673 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -150.1 143.53 25.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.805 0.336 . . . . 0.0 110.985 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 14.1 pt20 -118.13 109.84 16.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.215 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -87.69 166.83 14.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.805 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.15 -21.42 65.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.329 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.12 24.25 11.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.42 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.43 169.15 28.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.774 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 11.7 ttp180 -141.0 125.85 18.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.367 . . . . 0.0 111.231 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -117.6 150.07 39.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.346 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.525 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 28.2 p90 -177.97 127.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.079 0.466 . . . . 0.0 111.222 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.72 142.93 27.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.222 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 9.4 t -132.92 120.73 21.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 0.0 111.608 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.575 ' CD1' HD12 ' A' ' 76' ' ' LEU . 4.1 m-85 -91.14 123.97 34.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.194 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.03 170.44 7.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.951 0.405 . . . . 0.0 111.305 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.685 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.583 ' HG3' HD11 ' A' ' 76' ' ' LEU . 33.1 tp60 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.789 0.328 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.625 ' C ' HD13 ' A' ' 76' ' ' LEU . 1.4 m120 -121.91 110.93 16.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.102 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.664 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -119.31 121.01 38.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.2 OUTLIER -142.66 157.8 44.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 111.264 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.66 116.76 3.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.266 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.66 ' HB3' HG22 ' A' ' 98' ' ' THR . 0.0 OUTLIER -97.92 122.23 40.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.879 0.371 . . . . 0.0 111.065 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -117.06 110.87 18.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.475 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.61 161.42 31.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 111.289 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -113.29 120.23 40.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.376 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 48.3 p90 -97.58 161.04 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.575 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.93 122.63 1.7 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.585 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.51 116.52 3.14 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.501 2.134 . . . . 0.0 112.308 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 86' ' ' ILE . 9.6 tt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.089 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.633 HG22 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -136.35 120.95 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.551 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.617 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 17.3 mmtm -119.5 92.78 3.87 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.212 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 tp -59.54 103.34 0.19 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.344 0.592 . . . . 0.0 110.758 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 36.3 p90 -110.73 159.06 17.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.885 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.81 142.11 5.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.11 -141.07 3.7 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.725 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -129.95 169.08 15.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.865 0.364 . . . . 0.0 111.147 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.66 HG22 ' HB3' ' A' ' 79' ' ' SER . 11.6 p -138.66 150.84 46.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.806 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 98' ' ' THR . 3.3 mp -160.15 132.08 6.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -150.29 -154.54 6.5 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.822 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -155.21 128.0 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 75' ' ' ASN . 27.8 m -109.85 145.0 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.237 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.836 0.35 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.47 134.52 3.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.41 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -93.49 131.72 38.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.89 149.16 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.082 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.47 135.48 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.607 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -157.97 -140.46 2.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.573 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 122' ' ' GLY . 1.1 mp -153.06 172.02 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.906 0.384 . . . . 0.0 110.806 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -155.41 161.97 40.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.821 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.707 ' HB3' ' CE1' ' A' ' 141' ' ' TYR . . . 176.94 142.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.773 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.92 -130.41 1.25 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.736 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.633 ' HB ' HG22 ' A' ' 91' ' ' THR . 1.0 OUTLIER -156.65 120.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -94.91 115.52 27.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.191 0.52 . . . . 0.0 111.14 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -98.94 114.87 27.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.618 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.45 144.35 34.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.565 HD11 HG12 ' A' ' 137' ' ' ILE . 4.8 mp -108.75 -30.53 8.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 110.431 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.24 -170.39 1.68 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.017 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -85.96 53.78 2.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.81 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 176.31 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -122.38 143.69 49.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.982 0.42 . . . . 0.0 111.731 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.46 ' HA ' HD12 ' A' ' 131' ' ' LEU . 51.0 m -156.08 164.83 37.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.687 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.565 HG12 HD11 ' A' ' 131' ' ' LEU . 29.9 pt -143.64 136.35 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.4 ' HB3' ' CG ' ' A' ' 128' ' ' LEU . 2.2 pt-20 -126.28 176.88 6.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . -174.98 143.37 6.76 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.583 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.89 -139.35 3.95 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.016 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.707 ' CE1' ' HB3' ' A' ' 125' ' ' ALA . 19.1 p90 -120.03 161.08 21.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 0.0 111.051 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.513 ' NH2' HD12 ' A' ' 144' ' ' LEU . 0.9 OUTLIER -151.11 140.36 21.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.01 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -112.01 162.9 14.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.532 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.513 HD12 ' NH2' ' A' ' 142' ' ' ARG . 5.8 tt -153.68 145.72 23.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.3 ttm-85 -126.12 152.88 45.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.64 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.071 -179.791 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.788 0.327 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 m -107.02 136.16 47.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -152.24 155.07 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 141' ' ' TYR . 88.5 m-85 -113.97 125.56 54.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.671 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -127.97 126.67 41.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.14 0.495 . . . . 0.0 111.263 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.548 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 3.1 pp -150.73 145.97 26.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.702 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.33 -149.02 6.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.674 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' A' ' 137' ' ' ILE . . . -121.0 168.74 11.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 111.175 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -153.89 116.14 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -99.14 114.87 27.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.038 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -81.42 153.78 26.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.063 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t70 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 179' ' ' PHE . 2.1 m120 -75.26 131.3 40.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.544 ' O ' HG13 ' A' ' 6' ' ' VAL . 10.3 t80 -126.9 139.61 52.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.802 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 5' ' ' PHE . 6.4 m -159.56 126.15 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.247 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -147.95 -144.57 4.01 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.87 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 43' ' ' GLY . 1.8 mt -126.9 158.86 35.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 m -125.61 139.28 53.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.034 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -153.1 112.98 3.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.753 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.18 131.48 9.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.516 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 0.0 110.845 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.9 m -95.18 118.62 32.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -123.51 126.24 46.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.49 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -152.02 -174.42 22.66 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.685 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.42 176.83 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.605 0.241 . . . . 0.0 111.054 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.894 ' HG3' HG22 ' A' ' 58' ' ' THR . 3.2 mtp85 -135.97 145.88 46.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.042 0.449 . . . . 0.0 110.723 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -175.37 119.95 0.18 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.075 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.82 -136.91 2.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.577 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.78 113.0 8.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.39 . . . . 0.0 110.902 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.417 ' HA ' ' HB2' ' A' ' 54' ' ' ARG . 10.0 mt-30 -134.57 128.73 33.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.081 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' O ' ' CZ ' ' A' ' 83' ' ' PHE . 1.2 t80 -105.23 -166.96 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.41 -27.48 6.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 0.0 110.945 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.416 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 4.7 mt-30 -115.27 24.16 11.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.845 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 82' ' ' ALA . . . 71.82 -155.55 52.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.274 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER 161.73 -82.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.684 0.278 . . . . 0.0 110.965 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -142.46 163.19 33.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.999 0.428 . . . . 0.0 111.23 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 79' ' ' SER . 2.3 p90 -166.01 117.86 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.743 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -90.72 147.65 23.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.709 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.894 HG22 ' HG3' ' A' ' 45' ' ' ARG . 44.9 p -139.1 123.49 18.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.965 0.412 . . . . 0.0 111.071 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -91.9 124.61 36.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.5 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -117.49 163.91 15.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 111.105 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.778 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.744 0.307 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.57 ' ND2' HG13 ' A' ' 102' ' ' VAL . 19.4 m120 -138.04 125.73 22.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.995 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mt -106.98 114.9 29.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.61 118.3 34.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.956 0.408 . . . . 0.0 111.45 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.28 116.86 3.45 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 98' ' ' THR . 66.1 m -130.91 134.16 46.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.481 . . . . 0.0 112.231 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 7.5 t80 -105.52 110.7 23.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.105 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 94' ' ' PHE . 3.5 m-20 -136.59 172.16 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.22 0.533 . . . . 0.0 112.084 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.495 ' HA ' ' HA3' ' A' ' 53' ' ' GLY . . . -137.62 124.18 20.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.637 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.477 ' HB3' ' CD1' ' A' ' 94' ' ' PHE . 55.1 p90 -97.78 162.8 13.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.344 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.549 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.2 OUTLIER -162.27 137.77 5.54 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.657 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.549 ' HD2' HD23 ' A' ' 84' ' ' LEU . 58.5 Cg_endo -71.59 112.06 3.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.462 2.108 . . . . 0.0 112.296 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.406 ' CG1' ' HB2' ' A' ' 93' ' ' LEU . 40.7 mm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.669 0.271 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.435 ' HB ' ' HB ' ' A' ' 127' ' ' ILE . 82.5 p -136.16 144.16 44.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.783 ' CB ' HD12 ' A' ' 128' ' ' LEU . 34.5 mttp -122.38 102.05 7.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 0.0 110.729 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 7.3 tp -55.34 102.95 0.08 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.406 0.622 . . . . 0.0 110.347 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 81' ' ' ASP . 5.2 t80 -110.58 142.09 42.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.175 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.31 156.02 20.26 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.425 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 168.68 -140.57 6.25 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.732 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.85 172.94 6.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.609 0.242 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.648 HG22 ' OG ' ' A' ' 79' ' ' SER . 36.6 p -142.16 170.04 16.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.175 0.512 . . . . 0.0 111.631 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.448 ' CD1' HD23 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -154.44 131.99 11.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.982 179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.615 ' O ' HD22 ' A' ' 101' ' ' LEU . . . -127.82 123.41 4.47 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.668 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.615 HD22 ' O ' ' A' ' 100' ' ' GLY . 1.1 mm? -136.27 120.62 18.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.955 0.407 . . . . 0.0 110.304 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.57 HG13 ' ND2' ' A' ' 75' ' ' ASN . 21.3 t -109.88 142.57 21.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.271 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 mttp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.828 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.805 0.336 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.562 ' O ' HD13 ' A' ' 101' ' ' LEU . . . -110.38 178.28 19.92 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.52 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.75 117.86 21.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.722 ' HB1' HD13 ' A' ' 144' ' ' LEU . . . -121.44 151.23 40.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.15 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.03 131.55 0.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.038 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.506 ' C ' HD12 ' A' ' 123' ' ' LEU . . . -163.24 -124.94 0.73 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.55 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.506 HD12 ' C ' ' A' ' 122' ' ' GLY . 4.2 mp -154.36 174.33 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.8 OUTLIER -153.48 170.5 20.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.687 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . 177.0 142.48 0.08 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.991 0.424 . . . . 0.0 110.928 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.597 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -163.3 -132.27 1.32 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.726 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 126' ' ' GLY . 0.8 OUTLIER -161.78 120.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.783 HD12 ' CB ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -98.17 116.29 30.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.044 0.45 . . . . 0.0 110.979 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -95.15 143.32 26.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -110.27 149.08 30.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.69 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.92 -48.79 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.015 0.436 . . . . 0.0 110.593 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.16 -164.97 0.49 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.193 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.09 57.74 2.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.888 0.375 . . . . 0.0 110.501 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -142.12 -61.06 0.45 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.29 171.98 15.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.118 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.85 167.92 20.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.027 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.1 tt -132.74 134.67 58.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.607 ' HG2' HD23 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -130.63 172.22 12.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.018 0.437 . . . . 0.0 111.402 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.31 146.79 7.61 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.992 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.43 -147.7 5.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.057 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -126.13 146.91 49.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.96 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.55 ' HD2' HD23 ' A' ' 144' ' ' LEU . 26.9 ttp180 -125.51 132.74 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.77 116.36 20.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.722 HD13 ' HB1' ' A' ' 120' ' ' ALA . 4.3 pp -156.45 159.21 38.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.844 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.67 137.57 52.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.859 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.88 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 10.4 m . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.841 0.353 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.3 t -106.97 123.29 47.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.51 155.29 47.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.997 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -96.85 165.24 12.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.265 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.18 129.26 15.52 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.08 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.2 tt -163.42 129.99 3.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.572 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.58 -165.14 26.48 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.566 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.67 172.16 6.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.767 0.317 . . . . 0.0 111.013 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.413 ' ND2' ' CE1' ' A' ' 5' ' ' PHE . 17.4 t-20 -145.23 114.5 7.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.682 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -143.23 111.8 6.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.254 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -85.9 157.03 20.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 4' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.624 0.249 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -83.22 128.08 34.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 0.0 110.712 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.2 m-85 -127.52 140.0 52.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' A' ' 46' ' ' ALA . 21.9 t -152.8 128.07 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.38 -151.63 6.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.718 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 43' ' ' GLY . 5.3 mt -132.01 149.43 52.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.654 HG23 ' HD2' ' A' ' 45' ' ' ARG . 1.3 p -110.39 149.3 30.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.018 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -152.77 113.04 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.748 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.07 133.77 11.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.436 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.909 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.7 p -119.57 107.92 13.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 110.975 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -119.29 129.88 55.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.45 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -164.94 -164.99 21.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.573 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' THR . 12.2 pt -107.67 162.48 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.66 0.267 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.654 ' HD2' HG23 ' A' ' 9' ' ' THR . 15.9 ttt85 -132.78 138.11 47.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.55 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -173.14 122.08 0.38 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.005 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.14 -137.8 2.38 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.87 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -145.48 120.4 9.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 2.3 tt0 -101.67 112.07 24.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.371 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -119.57 163.82 16.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.741 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -17.76 65.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.494 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.12 24.37 13.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.642 0.258 . . . . 0.0 111.286 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 50' ' ' PHE . . . 145.86 167.33 12.5 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.333 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.753 ' NH2' HD22 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -134.09 115.26 14.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 0.0 111.285 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.606 ' HE1' ' HB2' ' A' ' 57' ' ' ALA . 13.5 t80 -91.87 126.33 36.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.901 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.455 ' CE1' ' ND2' ' A' ' 176' ' ' ASN . 0.5 OUTLIER -133.4 103.08 5.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 0.0 111.815 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB2' ' HE1' ' A' ' 55' ' ' TYR . . . -97.32 119.62 36.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.861 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 77' ' ' LEU . 1.6 t -128.6 122.74 31.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.147 0.498 . . . . 0.0 111.438 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -86.79 124.52 33.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.474 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.04 166.96 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 0.0 111.216 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.754 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 3.1 pm0 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.666 0.27 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.791 ' HB3' HG12 ' A' ' 102' ' ' VAL . 43.2 m-20 -143.98 111.01 5.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.139 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.426 ' HG ' ' CZ ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -85.46 145.94 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.406 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HB2' HG23 ' A' ' 58' ' ' THR . 5.5 mp -139.54 107.91 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 111.385 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.78 119.67 4.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.746 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.43 ' CB ' ' HA ' ' A' ' 98' ' ' THR . 24.3 p -130.5 150.44 51.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.869 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.51 110.86 18.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.904 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.455 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 1.8 m-20 -124.17 153.35 41.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 111.622 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -100.65 118.56 37.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.231 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 43.8 p90 -97.54 153.75 17.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.826 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.34 143.07 10.84 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.731 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' THR . 31.9 Cg_endo -63.64 91.71 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.691 2.261 . . . . 0.0 112.262 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.545 HG23 ' HB2' ' A' ' 93' ' ' LEU . 19.0 tt . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.014 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.101 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.423 HG23 ' HG3' ' A' ' 129' ' ' GLN . 0.1 OUTLIER -80.12 153.22 28.84 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -131.18 92.42 3.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.99 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' A' ' 86' ' ' ILE . 1.4 tt -61.74 102.22 0.25 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.279 0.562 . . . . 0.0 110.1 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 23.0 p90 -111.01 120.79 43.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.518 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.455 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -142.78 151.42 23.1 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.815 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.33 -140.09 4.66 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.561 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.43 150.66 47.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 0.0 111.091 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.43 ' HA ' ' CB ' ' A' ' 79' ' ' SER . 11.6 t -118.93 153.36 34.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -160.18 129.09 4.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.589 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.74 -149.18 4.97 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.856 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tt -155.21 129.21 8.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 0.0 110.49 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.791 HG12 ' HB3' ' A' ' 75' ' ' ASN . 11.2 m -109.76 128.44 65.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.245 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HA ' HG22 ' A' ' 117' ' ' VAL . 6.3 mmtt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 103' ' ' LYS . 25.1 t . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.786 0.327 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.67 -163.33 13.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.566 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -96.0 123.09 39.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.688 ' O ' HD23 ' A' ' 99' ' ' LEU . . . -94.98 146.82 23.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -168.85 140.81 2.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.941 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -163.74 -136.91 2.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.71 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.08 155.03 40.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.788 0.328 . . . . 0.0 110.882 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.44 ' NE2' ' CE2' ' A' ' 172' ' ' TYR . 0.5 OUTLIER -138.57 158.37 44.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.996 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . -176.36 141.98 0.44 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.471 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.589 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -175.08 -146.57 5.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.923 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 126' ' ' GLY . 9.5 pt -162.26 120.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 122.69 0.396 . . . . 0.0 110.01 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.753 HD22 ' NH2' ' A' ' 54' ' ' ARG . 7.8 tp -94.73 111.92 23.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.969 0.414 . . . . 0.0 110.851 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 4.3 tt0 -102.5 131.16 49.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -97.28 149.17 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.66 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.75 -45.07 4.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.98 0.419 . . . . 0.0 110.613 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -164.86 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.105 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.52 55.77 2.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.391 . . . . 0.0 110.69 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -139.06 -58.68 0.6 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.024 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.06 163.01 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.987 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.7 t -116.15 170.4 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 129' ' ' GLN . 2.1 mp -129.98 134.75 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.568 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.43 ' HG2' ' CE1' ' A' ' 94' ' ' PHE . 8.1 tt0 -123.83 147.04 47.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.961 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.62 141.66 7.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.402 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.51 -135.83 2.75 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.464 -0.875 . . . . 0.0 112.778 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -133.79 161.21 35.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 0.0 110.881 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.402 ' HG2' ' CG ' ' A' ' 124' ' ' GLN . 0.3 OUTLIER -147.72 147.49 29.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.85 140.51 50.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.643 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 tt -117.35 137.09 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.144 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.05 117.8 3.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.633 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.008 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.8 0.333 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.9 129.5 54.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -139.52 155.2 47.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.41 165.14 11.21 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.159 0.504 . . . . 0.0 110.28 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.44 ' CE2' ' NE2' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -138.29 129.47 27.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.889 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.1 tp -163.32 135.15 5.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.93 -152.69 16.74 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.64 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -130.26 171.31 13.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.455 ' ND2' ' CE1' ' A' ' 56' ' ' TYR . 14.5 m120 -151.57 114.98 4.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.082 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -116.72 117.71 30.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.674 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.86 162.41 22.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.205 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 49' ' ' GLN . 10.8 m-20 . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 120.786 0.327 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 179' ' ' PHE . 2.8 t30 -71.41 131.58 43.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.584 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.1 m-85 -123.98 139.9 53.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.684 HG13 ' HB2' ' A' ' 46' ' ' ALA . 21.4 t -150.48 122.34 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.08 -135.33 1.84 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.619 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mp -144.95 166.66 24.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.743 0.306 . . . . 0.0 110.819 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -136.83 146.52 45.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.165 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -153.0 117.54 4.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.664 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 172' ' ' TYR . . . -136.1 -176.08 14.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.466 -0.874 . . . . 0.0 113.021 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.91 -179.896 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.9 p -140.61 107.93 5.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 0.0 111.016 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -135.15 158.32 44.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.814 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.06 -166.95 32.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.768 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 45' ' ' ARG . 9.4 mt -107.63 163.74 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.428 0.156 . . . . 0.0 110.828 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' N ' HG22 ' A' ' 44' ' ' ILE . 1.6 ttt180 -135.87 138.52 42.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.934 0.397 . . . . 0.0 110.834 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.684 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -171.05 119.8 0.51 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.255 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -162.5 -133.63 1.51 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.683 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -155.73 148.81 24.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 111.0 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.451 ' NE2' ' CZ ' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -100.7 162.57 12.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.756 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -133.29 165.78 24.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.915 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -24.65 65.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.371 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.2 24.13 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.448 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 177.77 177.49 46.61 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.447 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . 13.2 ttp-105 -143.91 140.58 29.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 111.074 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -124.43 149.44 46.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.578 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.529 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 34.0 p90 -178.28 126.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.75 162.77 14.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.527 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 49.7 p -141.05 124.46 16.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.07 0.462 . . . . 0.0 111.517 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.45 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 9.2 m-85 -92.51 116.57 29.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.957 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.06 178.37 4.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.029 0.442 . . . . 0.0 111.569 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.51 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.834 0.349 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -120.87 114.64 21.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -98.32 128.94 44.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.496 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.634 HD11 HD11 ' A' ' 144' ' ' LEU . 2.2 mt -138.87 131.07 28.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.891 0.377 . . . . 0.0 111.183 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.76 116.82 4.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.578 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.686 ' HB3' HG22 ' A' ' 98' ' ' THR . 0.9 OUTLIER -106.65 126.28 52.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.956 0.408 . . . . 0.0 111.768 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -125.39 110.7 14.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.758 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -133.31 166.1 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.036 0.446 . . . . 0.0 111.507 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -109.63 118.33 36.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.173 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 48.5 p90 -97.85 167.62 10.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.827 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.7 tp -160.56 121.08 1.65 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.577 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.53 114.69 1.43 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.493 2.129 . . . . 0.0 112.541 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.152 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.786 0.326 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.04 150.71 16.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.483 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 2.4 mptm? -132.06 92.48 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.334 . . . . 0.0 111.45 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.43 ' O ' HD23 ' A' ' 93' ' ' LEU . 9.0 tt -63.23 102.96 0.44 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.137 0.494 . . . . 0.0 109.848 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 45.6 p90 -110.71 159.7 17.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.34 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.26 126.79 1.31 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.783 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.99 -140.29 2.89 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.74 178.83 6.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 111.156 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 79' ' ' SER . 44.3 p -144.08 152.13 40.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.238 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.11 131.37 5.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.59 -140.56 3.05 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.909 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.14 125.94 7.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 110.734 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.86 140.18 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.824 179.961 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.812 0.339 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.51 175.56 38.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.96 136.19 34.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.94 139.68 30.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.93 132.01 3.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.952 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.86 -140.83 2.97 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.628 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 mt -143.89 170.28 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.722 HE21 ' HB3' ' A' ' 142' ' ' ARG . 0.6 OUTLIER -160.13 150.02 18.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 94' ' ' PHE . . . 178.21 142.39 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.377 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.592 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -175.32 -126.74 0.96 Allowed Glycine 0 C--O 1.229 -0.192 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.806 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.3 pp -161.07 120.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.512 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.48 HD12 ' HG3' ' A' ' 138' ' ' GLU . 2.2 tt -104.01 116.09 31.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.634 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.625 ' HG2' HG23 ' A' ' 137' ' ' ILE . 18.8 pt20 -116.85 126.22 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.775 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 136' ' ' SER . 25.2 tt0 -69.24 147.88 50.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.273 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 -30.68 7.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.338 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 t -160.93 -165.02 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.196 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -90.28 50.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.371 . . . . 0.0 110.771 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 174.14 -28.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.6 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.5 157.19 29.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.361 . . . . 0.0 111.393 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.41 ' CB ' ' HA ' ' A' ' 130' ' ' GLU . 15.2 m -155.92 169.05 25.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.994 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 129' ' ' GLN . 18.3 tt -131.49 135.0 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.417 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.48 ' HG3' HD12 ' A' ' 128' ' ' LEU . 1.3 tm-20 -133.52 167.64 20.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.544 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . 174.09 153.65 10.05 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.665 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.3 -125.95 1.26 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.971 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.444 ' CE2' ' HB3' ' A' ' 171' ' ' PHE . 5.3 m-85 -133.77 161.15 35.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.722 ' HB3' HE21 ' A' ' 124' ' ' GLN . 0.0 OUTLIER -157.96 147.33 19.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -108.29 147.81 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.754 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.634 HD11 HD11 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -128.87 134.9 48.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.92 147.0 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.841 0.353 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.2 p -119.88 117.73 28.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -134.07 155.38 50.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.444 ' HB3' ' CE2' ' A' ' 141' ' ' TYR . 43.2 p90 -111.12 124.41 52.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.382 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.478 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 7.4 p90 -124.68 179.2 5.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.643 0.735 . . . . 0.0 111.966 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.506 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 0.4 OUTLIER -163.45 147.88 10.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.872 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.3 -162.86 21.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.809 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -123.23 171.74 9.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.861 0.363 . . . . 0.0 111.047 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.439 HD22 HD11 ' A' ' 128' ' ' LEU . 1.6 t30 -156.29 117.1 3.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.65 112.01 24.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.59 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.95 154.06 25.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.109 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 1.3 m-85 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 120.763 0.316 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -63.51 137.75 58.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.826 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.3 m-85 -129.0 139.75 51.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.057 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 46' ' ' ALA . 25.7 t -154.94 124.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.012 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.98 -144.06 3.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.58 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mt -139.76 142.86 36.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.822 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.477 HG21 HG23 ' A' ' 58' ' ' THR . 9.7 t -112.15 142.4 44.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.994 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.33 114.55 13.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.74 132.54 11.01 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.426 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -139.17 138.31 36.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.327 . . . . 0.0 110.899 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -162.03 129.42 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.44 -167.56 19.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 45' ' ' ARG . 21.0 mt -109.28 161.07 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.745 0.307 . . . . 0.0 110.964 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -129.02 133.02 47.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.665 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.524 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -169.2 120.02 0.71 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.106 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.51 -136.95 2.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.593 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -153.85 136.37 15.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 0.0 110.99 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 50' ' ' PHE . 36.5 tt0 -89.52 162.29 15.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.66 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.4 ' N ' ' HG2' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -134.95 167.21 21.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.929 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -67.11 -25.9 66.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 24.26 3.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.01 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -174.44 179.97 45.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.192 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.01 130.3 7.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 0.0 111.276 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 80' ' ' TYR . 4.1 m-85 -107.7 159.83 16.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.489 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -173.59 123.89 0.37 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.912 0.387 . . . . 0.0 111.198 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.88 153.12 20.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.602 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.477 HG23 HG21 ' A' ' 9' ' ' THR . 91.3 m -130.93 118.77 21.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.18 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 4.6 m-85 -99.23 118.34 35.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.507 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -110.82 141.85 43.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.753 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.727 0.299 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.479 ' ND2' HG13 ' A' ' 102' ' ' VAL . 6.1 m-80 -129.61 117.8 20.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.175 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.452 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 1.5 tm? -124.38 114.92 20.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.391 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -134.1 126.21 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 111.593 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.39 116.8 4.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.645 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 0.8 OUTLIER -111.72 156.71 21.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.075 0.464 . . . . 0.0 111.702 -179.248 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.434 ' HB3' ' CD2' ' A' ' 55' ' ' TYR . 23.6 p90 -130.86 110.94 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.308 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 2.4 m-20 -120.81 155.25 34.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 111.494 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.425 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -105.6 119.25 38.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.533 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 39.1 p90 -97.59 156.14 16.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.139 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tp -155.49 140.32 12.04 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.805 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.85 113.0 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.451 2.101 . . . . 0.0 112.178 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.733 HG23 ' HB ' ' A' ' 91' ' ' THR . 7.8 tp . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 120.985 0.422 . . . . 0.0 111.085 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 37.3 p-10 . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.733 ' HB ' HG23 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -136.55 130.0 31.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 9.9 mttt -123.15 92.66 3.75 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.142 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.422 HD12 ' CG2' ' A' ' 127' ' ' ILE . 4.7 tp -64.88 102.72 0.63 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 17.7 p90 -115.75 155.05 28.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.404 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -172.77 142.92 7.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.558 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.73 -143.73 4.58 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.657 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.09 162.23 29.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 111.083 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.513 ' C ' HD12 ' A' ' 99' ' ' LEU . 5.2 t -129.2 155.73 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.513 HD12 ' C ' ' A' ' 98' ' ' THR . 2.9 mp -160.11 130.87 5.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.713 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.476 ' N ' HD23 ' A' ' 77' ' ' LEU . . . -156.63 -150.39 5.65 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.866 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.05 127.28 7.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.618 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.479 HG13 ' ND2' ' A' ' 75' ' ' ASN . 21.4 t -109.88 133.67 54.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.048 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 117' ' ' VAL . 5.4 mtpp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.948 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.474 HG12 ' HG2' ' A' ' 103' ' ' LYS . 10.7 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.762 0.315 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.4 -179.27 33.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.553 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TYR . . . . . 0.457 ' HE1' HD23 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -103.21 118.41 36.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.723 ' HA ' HG22 ' A' ' 146' ' ' THR . . . -95.31 143.41 26.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 137.94 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -165.66 -143.43 3.73 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.498 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.11 160.46 38.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.966 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -156.88 165.74 35.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.047 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.91 142.49 0.08 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.272 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -162.52 -127.0 0.85 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.263 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 14.6 pt -156.93 120.78 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -94.43 112.74 24.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.188 0.518 . . . . 0.0 111.019 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.42 HE21 HD12 ' A' ' 127' ' ' ILE . 6.4 mt-30 -102.46 115.54 30.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.024 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 136' ' ' SER . 23.6 mt-10 -73.4 149.18 42.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.872 HD13 HD11 ' A' ' 137' ' ' ILE . 8.4 tp -108.01 -31.82 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.409 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -169.04 -173.98 1.92 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.131 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -81.98 55.64 2.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.791 0.329 . . . . 0.0 110.696 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -178.45 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.277 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.79 155.87 33.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.895 0.378 . . . . 0.0 111.201 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.3 OUTLIER -140.08 -178.64 5.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.876 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.872 HD11 HD13 ' A' ' 131' ' ' LEU . 28.9 mt -138.78 134.95 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.968 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.96 131.53 54.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.708 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -155.35 124.29 1.48 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.66 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.28 -144.08 4.67 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.803 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -126.2 161.11 28.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 110.749 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -153.18 145.67 24.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.052 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.74 138.94 52.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.618 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mt -121.86 132.58 54.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.089 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.97 111.96 4.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.723 HG22 ' HA ' ' A' ' 120' ' ' ALA . 6.9 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.057 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.6 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.792 0.33 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.97 123.17 47.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.767 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -113.08 155.24 25.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -106.36 153.3 22.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.203 0.525 . . . . 0.0 110.144 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.402 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -123.57 126.78 47.27 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.583 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.52 129.91 3.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.548 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 171.66 -152.2 17.06 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.891 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.23 172.17 11.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.091 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -149.87 114.94 5.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -108.09 111.93 24.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.753 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -83.52 159.72 21.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.129 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.459 ' CB ' ' HB3' ' A' ' 49' ' ' GLN . 1.5 t0 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.797 0.332 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -109.77 134.45 52.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.689 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 10.0 m-85 -133.47 139.99 47.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.865 0.364 . . . . 0.0 111.044 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 46' ' ' ALA . 11.1 p -155.3 122.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.199 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.31 -139.91 2.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.541 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -140.19 164.03 31.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.727 0.298 . . . . 0.0 110.759 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.656 HG21 HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -148.42 155.66 41.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.354 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -153.08 128.13 9.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.602 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.74 160.83 12.99 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.579 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.868 -179.954 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.01 131.47 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -139.6 117.69 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.82 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -151.81 -165.06 12.7 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.624 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 45' ' ' ARG . 2.0 mt -116.33 161.92 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.673 0.273 . . . . 0.0 110.956 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.656 HH11 HG21 ' A' ' 9' ' ' THR . 4.0 ttt180 -126.54 138.89 53.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.601 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.537 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -170.4 120.32 0.59 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.12 -139.32 2.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.611 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -159.14 140.19 12.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 111.128 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB3' ' CB ' ' A' ' 3' ' ' ASP . 33.0 tt0 -83.77 162.47 20.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.413 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.418 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -131.08 -166.9 1.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.88 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.85 -45.16 93.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.219 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.97 -20.47 3.83 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -118.19 179.59 17.07 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.886 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 8.4 mtt180 -142.36 143.55 32.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 111.4 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 80' ' ' TYR . 6.0 t80 -100.73 153.56 19.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.961 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 70.4 m-85 -157.66 115.44 3.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 111.585 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.09 132.52 38.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.398 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.457 HG21 ' OH ' ' A' ' 172' ' ' TYR . 16.2 p -119.28 112.18 19.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.945 0.402 . . . . 0.0 111.253 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -106.19 111.27 23.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.677 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -110.41 179.96 3.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.872 0.367 . . . . 0.0 111.132 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.792 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.688 0.28 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -130.42 119.59 22.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.177 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.04 114.97 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.431 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.618 HD13 ' OG1' ' A' ' 98' ' ' THR . 3.4 pp -145.16 152.5 40.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.399 . . . . 0.0 111.519 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.99 125.68 6.64 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.972 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -104.09 132.28 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 111.637 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' HB2' ' CE1' ' A' ' 55' ' ' TYR . 14.0 t80 -122.9 110.99 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.957 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 0.5 OUTLIER -134.43 172.05 13.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.181 0.515 . . . . 0.0 111.869 -178.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.498 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -107.99 118.77 37.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.219 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 50.4 p90 -97.38 162.97 13.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.84 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 130.7 2.12 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.444 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.54 115.94 2.95 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.446 2.097 . . . . 0.0 112.36 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.0 mt . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.089 180.0 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.775 0.321 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.408 HG22 HD12 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -64.89 152.71 42.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.459 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 2.5 mttt -132.47 92.85 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 111.079 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.29 102.88 0.19 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.312 0.577 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 20.0 p90 -112.1 154.18 25.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.33 133.79 2.72 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.75 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.612 ' O ' HD23 ' A' ' 123' ' ' LEU . . . -170.14 -133.51 1.61 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.654 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -130.98 162.97 28.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 111.29 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.618 ' OG1' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -133.93 156.85 47.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.822 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -160.06 132.48 6.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.849 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.85 -149.45 5.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.825 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 mt -154.93 126.87 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.668 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 p -109.95 133.73 54.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.978 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.49 ' CD ' HG22 ' A' ' 117' ' ' VAL . 6.2 mmtt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.49 HG22 ' CD ' ' A' ' 103' ' ' LYS . 21.4 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.802 0.334 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -152.9 134.31 4.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.349 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -84.07 116.44 22.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.917 0.389 . . . . 0.0 111.078 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.51 ' HB1' HD22 ' A' ' 144' ' ' LEU . . . -100.23 135.8 41.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.994 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.07 142.34 1.42 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.177 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.35 -138.33 2.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.588 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 96' ' ' GLY . 5.7 mt -142.99 159.83 41.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.714 0.293 . . . . 0.0 110.688 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -157.28 173.11 17.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.14 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.87 142.67 0.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.588 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -159.52 -130.89 1.18 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.7 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.1 pt -161.13 120.38 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.0 110.67 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -94.82 115.16 27.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.672 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.415 ' N ' HD12 ' A' ' 128' ' ' LEU . 13.5 tt0 -104.31 118.15 35.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.945 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 136' ' ' SER . 1.8 pt-20 -107.82 149.3 28.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.02 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.53 -31.71 11.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.2 p -169.01 -164.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.329 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.71 56.02 3.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.886 0.374 . . . . 0.0 110.658 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -142.73 -67.5 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.061 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.68 171.49 13.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.041 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.403 ' CB ' ' HA ' ' A' ' 130' ' ' GLU . 36.3 p -156.02 173.98 16.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.942 0.401 . . . . 0.0 111.204 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 175' ' ' ALA . 5.2 pt -134.95 134.79 53.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.699 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -127.58 172.49 10.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.131 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.19 145.4 6.21 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.35 -135.96 2.53 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.657 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.85 158.04 27.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.712 0.291 . . . . 0.0 110.693 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.512 ' NH2' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.68 130.96 22.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.189 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 2.3 m-85 -122.77 133.92 54.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.453 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.51 HD22 ' HB1' ' A' ' 120' ' ' ALA . 3.7 mt -142.43 145.39 33.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 159.73 16.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.594 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.41 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.41 136.84 51.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -156.02 155.35 32.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.022 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.9 152.58 20.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.15 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.457 ' OH ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -135.04 129.4 33.99 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.152 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.7 mt -163.56 129.87 3.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.479 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 9' ' ' THR . . . -177.79 -158.84 21.57 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.909 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -126.79 172.05 10.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.8 116.68 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.935 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -108.98 112.82 25.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.819 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 11.2 pttt -82.01 164.07 21.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.888 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -100.95 130.03 46.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.786 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.9 m-85 -132.33 139.94 48.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.379 . . . . 0.0 111.115 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.699 HG23 ' HB2' ' A' ' 46' ' ' ALA . 8.3 p -154.77 130.4 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.08 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.62 ' C ' HD22 ' A' ' 8' ' ' LEU . . . -161.22 -147.17 4.87 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.716 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.62 HD22 ' C ' ' A' ' 7' ' ' GLY . 3.9 mm? -126.41 166.72 16.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.345 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.459 HG21 HG23 ' A' ' 58' ' ' THR . 27.9 p -139.61 140.43 37.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -137.9 115.91 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.22 137.64 13.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.536 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 0.0 110.952 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -127.81 124.05 36.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -117.75 115.47 25.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.4 -173.8 13.43 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.767 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.545 ' HA ' HD13 ' A' ' 8' ' ' LEU . 18.0 mt -106.98 162.03 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.561 0.219 . . . . 0.0 111.041 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -132.6 136.07 46.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.681 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -170.84 120.55 0.55 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.377 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -166.91 -142.34 3.41 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.755 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -131.92 130.65 41.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.681 0.277 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.429 ' CB ' ' CD1' ' A' ' 5' ' ' PHE . 29.1 tt0 -109.52 112.53 24.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.225 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -96.01 176.42 6.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.589 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -29.15 68.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.2 24.19 3.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.346 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.2 110.03 0.39 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -103.8 112.74 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 111.187 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -106.2 150.71 25.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.155 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.541 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 34.2 p90 -179.09 129.35 0.1 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.125 0.488 . . . . 0.0 111.198 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.42 148.58 22.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.15 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.459 HG23 HG21 ' A' ' 9' ' ' THR . 2.6 m -129.24 118.43 22.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.979 0.418 . . . . 0.0 111.599 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.632 ' CE2' HD12 ' A' ' 76' ' ' LEU . 14.8 m-85 -94.52 109.18 21.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.071 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -103.65 175.2 5.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.032 0.444 . . . . 0.0 111.566 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.567 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.659 0.266 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.4 110.93 20.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.632 HD12 ' CE2' ' A' ' 59' ' ' TYR . 9.3 tt -115.6 117.02 29.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.755 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.6 144.46 39.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.228 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.93 116.9 4.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.033 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.464 ' CB ' HG23 ' A' ' 98' ' ' THR . 5.2 t -99.18 134.12 42.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 111.374 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -122.41 110.89 16.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.155 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -133.11 163.39 29.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.93 0.395 . . . . 0.0 111.486 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -112.22 118.7 36.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 54.2 p90 -97.58 161.29 13.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.645 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.12 121.01 1.26 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.63 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.89 114.98 2.04 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.469 2.113 . . . . 0.0 112.329 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.859 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.741 0.305 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.531 HG22 HD12 ' A' ' 127' ' ' ILE . 16.5 p -136.55 145.08 44.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.806 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 9.0 tttt -121.31 92.69 3.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.371 . . . . 0.0 110.702 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.28 102.85 0.12 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.339 0.59 . . . . 0.0 110.772 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.451 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 32.6 p90 -112.3 153.21 27.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.862 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.12 140.66 6.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.856 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.11 -137.62 2.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.388 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.91 177.63 7.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 111.172 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.464 HG23 ' CB ' ' A' ' 79' ' ' SER . 1.2 m -146.2 151.65 37.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.978 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 130.65 5.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.775 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.35 -153.86 6.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.885 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.28 131.43 10.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 102' ' ' VAL . 12.1 p -109.59 122.83 64.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.262 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.735 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.805 0.336 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.79 118.83 2.03 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.267 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.09 131.78 34.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.966 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -123.57 145.41 48.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -170.99 140.48 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.177 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.632 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -165.6 -136.72 2.06 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.453 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.632 HD12 ' O ' ' A' ' 122' ' ' GLY . 1.7 mp -138.36 170.27 16.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 110.727 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 5.7 tt0 -159.71 152.29 21.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.881 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.94 142.48 0.08 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.612 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.596 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -169.75 -127.09 0.9 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.938 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 126' ' ' GLY . 3.4 pt -161.19 120.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.681 0.277 . . . . 0.0 110.436 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.67 HD12 ' HB3' ' A' ' 138' ' ' GLU . 1.3 tp -94.5 114.1 26.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.069 0.462 . . . . 0.0 110.725 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -98.08 122.93 41.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.09 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -95.91 149.02 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.825 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.668 HD12 HD11 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -109.78 -30.29 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.058 0.456 . . . . 0.0 110.584 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.08 -172.07 2.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.108 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.74 54.73 3.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.791 0.329 . . . . 0.0 110.833 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -177.28 -37.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.436 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.26 135.82 51.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 111.519 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.8 m -132.84 168.7 17.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.753 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.668 HD11 HD12 ' A' ' 131' ' ' LEU . 25.1 mt -138.25 135.86 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.67 ' HB3' HD12 ' A' ' 128' ' ' LEU . 13.2 pt-20 -119.5 132.64 55.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -157.1 128.41 2.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.502 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -179.86 -134.74 2.28 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.847 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.86 161.19 25.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.848 0.356 . . . . 0.0 110.859 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.11 121.96 9.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.029 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.67 139.42 49.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.648 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 mp -157.93 142.88 16.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.207 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -114.23 163.69 14.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.629 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.0 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.135 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 93.5 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.876 0.37 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.01 124.89 50.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.63 155.18 47.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -91.54 165.27 13.44 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.264 0.554 . . . . 0.0 110.29 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.24 129.98 34.5 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.78 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.6 tt -163.41 133.26 4.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.739 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.47 -156.41 18.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.613 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -124.24 172.15 9.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -150.06 114.95 5.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.982 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 6' ' ' VAL . 11.5 t80 -117.26 111.9 20.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 2.3 ptpt -82.18 161.4 22.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.773 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 2.6 m-20 . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.828 0.346 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -60.62 140.86 57.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.0 m-85 -131.07 139.86 49.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.973 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.415 HG12 ' CB ' ' A' ' 46' ' ' ALA . 27.3 m -154.74 129.27 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.266 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.33 -143.59 3.78 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.676 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -140.14 165.42 27.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -135.05 144.86 47.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.079 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -136.73 118.58 15.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.741 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.96 143.65 16.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.683 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 0.0 110.922 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.96 142.81 31.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -132.94 131.58 41.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.86 -173.26 31.36 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.665 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.35 177.12 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 111.157 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -142.55 142.73 32.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.603 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -175.68 123.06 0.2 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.255 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -163.33 -136.31 1.97 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.581 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -153.41 127.31 8.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 111.102 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 5' ' ' PHE . 1.5 tt0 -83.94 152.52 24.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.58 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -127.28 165.68 19.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.817 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -24.79 66.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.372 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -126.13 24.57 6.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.266 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 172.61 -177.29 45.25 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.357 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.748 ' NH2' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.36 122.29 7.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 111.297 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 80' ' ' TYR . 34.9 t80 -101.74 146.41 27.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.376 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.461 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 25.0 p90 -173.55 124.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.035 0.445 . . . . 0.0 111.036 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.67 162.86 14.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.584 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.4 m -139.92 125.25 18.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.221 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -102.88 100.93 10.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.295 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.94 174.95 5.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.548 179.905 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.793 0.33 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.749 ' OD1' HG22 ' A' ' 102' ' ' VAL . 30.8 t30 -131.31 116.01 17.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.821 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 68.7 tp -124.96 123.06 39.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.551 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -144.98 157.46 44.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.334 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.99 117.47 4.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.049 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.2 p -99.15 121.73 41.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.938 0.399 . . . . 0.0 111.586 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 55' ' ' TYR . 47.6 m-85 -104.25 110.86 23.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.893 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.408 ' OD1' ' CE1' ' A' ' 56' ' ' TYR . 1.9 p-10 -136.48 172.1 13.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 111.664 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.511 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -122.3 125.51 46.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.602 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 55.7 p90 -97.51 156.68 16.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 tp -158.25 135.57 6.97 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.62 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.57 116.65 3.31 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.552 2.168 . . . . 0.0 112.174 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.046 0.45 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 . . . . . 0 N--CA 1.46 0.036 0 CA-C-O 120.614 0.245 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.07 153.09 51.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 9.8 mmtp -126.99 92.73 3.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 110.849 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 126' ' ' GLY . 0.7 OUTLIER -56.28 102.8 0.08 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.038 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 37.3 p90 -111.49 151.81 28.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.613 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.06 142.14 6.89 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.992 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 178.72 -142.88 5.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.685 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -125.23 179.59 5.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.802 0.334 . . . . 0.0 111.214 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.479 HG21 ' NH1' ' A' ' 142' ' ' ARG . 9.4 t -159.01 154.94 26.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.059 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 pp -160.23 131.96 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.68 -129.98 1.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.946 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.846 HD21 HG23 ' A' ' 117' ' ' VAL . 4.4 tt -155.08 128.09 8.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.393 . . . . 0.0 110.557 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.782 HG23 ' HB2' ' A' ' 120' ' ' ALA . 21.6 t -109.63 115.59 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.166 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.97 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.846 HG23 HD21 ' A' ' 101' ' ' LEU . 10.1 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.25 164.2 24.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.406 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.82 114.99 26.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.782 ' HB2' HG23 ' A' ' 102' ' ' VAL . . . -100.06 136.7 39.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.006 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -168.63 138.69 2.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.353 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.36 -140.68 2.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 143' ' ' TYR . 0.4 OUTLIER -147.66 163.95 35.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.36 . . . . 0.0 110.805 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -151.91 171.22 18.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.207 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.9 142.52 0.08 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.588 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.58 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -170.08 -134.44 1.75 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.732 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.695 ' N ' HD13 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -158.71 120.62 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.744 0.307 . . . . 0.0 110.441 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -95.07 117.69 30.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.936 0.398 . . . . 0.0 110.859 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.418 ' HB2' ' CG1' ' A' ' 137' ' ' ILE . 27.9 mt-30 -95.08 121.34 36.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -112.57 149.1 33.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.662 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mp -106.18 -42.37 5.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 110.509 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.11 -166.71 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.026 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -82.78 54.28 2.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.789 0.328 . . . . 0.0 110.44 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -141.9 -56.62 0.46 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.146 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.36 152.39 34.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.934 0.397 . . . . 0.0 111.303 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.2 t -142.17 179.12 7.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.538 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.418 ' CG1' ' HB2' ' A' ' 129' ' ' GLN . 19.2 pt -140.71 144.96 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.801 ' HB2' HD12 ' A' ' 128' ' ' LEU . 41.0 tt0 -130.54 136.25 48.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.87 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -155.82 149.98 21.2 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.547 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 172' ' ' TYR . . . 171.09 -131.24 2.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.642 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -119.9 160.76 22.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.799 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.479 ' NH1' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -142.72 123.12 13.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.198 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.864 ' O ' HD22 ' A' ' 144' ' ' LEU . 93.4 m-85 -119.55 133.91 55.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.441 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.864 HD22 ' O ' ' A' ' 143' ' ' TYR . 2.0 mm? -141.64 154.12 45.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 111.3 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -117.67 163.41 16.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.477 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 111.203 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 91.8 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.792 0.33 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 18.8 t -107.02 130.17 54.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.744 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.24 155.21 46.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -106.19 143.7 33.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.133 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -124.54 127.02 46.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.102 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.9 tt -163.66 129.73 3.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.501 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.34 -155.45 15.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.87 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -114.98 172.04 7.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -155.9 117.52 3.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 3.9 m-85 -115.98 117.19 29.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.074 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -84.58 163.98 18.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.126 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.781 0.324 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.05 132.71 54.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.708 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 13.6 m-85 -134.51 139.96 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.028 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 1.063 HG23 ' HB2' ' A' ' 46' ' ' ALA . 7.6 p -151.16 129.36 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.965 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.7 -147.85 5.31 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.843 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 4.8 mp -138.99 160.06 40.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.352 . . . . 0.0 110.903 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.505 HG21 ' CG2' ' A' ' 58' ' ' THR . 4.8 t -129.54 167.5 17.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.791 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.48 ' HB3' HD12 ' A' ' 173' ' ' LEU . 5.0 t-105 -149.11 137.18 20.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.96 122.03 5.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.474 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.853 0.359 . . . . 0.0 110.941 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 m -112.83 125.73 54.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -108.34 174.31 5.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.798 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.5 157.94 21.41 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.603 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 45' ' ' ARG . 2.1 mp -109.8 158.89 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.511 0.196 . . . . 0.0 110.907 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -143.31 149.77 38.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.042 0.448 . . . . 0.0 110.839 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 1.063 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -177.35 123.56 0.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.583 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -163.85 -137.6 2.23 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.592 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.66 130.42 38.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.782 0.325 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 40.0 tt0 -105.66 110.71 23.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.029 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 53' ' ' GLY . 1.9 p90 -121.06 166.99 13.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.727 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -19.95 65.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.4 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -92.14 15.86 12.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.553 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . 133.02 176.0 14.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.56 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.444 ' HD2' ' CD2' ' A' ' 83' ' ' PHE . 47.3 mtp180 -116.14 117.13 29.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.865 0.364 . . . . 0.0 111.2 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -100.36 136.36 40.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.209 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.612 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 44.0 p90 179.84 132.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.836 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . -90.34 136.65 32.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.158 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.505 ' CG2' HG21 ' A' ' 9' ' ' THR . 25.8 m -113.68 111.72 22.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.98 0.419 . . . . 0.0 111.543 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.88 124.34 29.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.148 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -101.88 155.12 18.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 111.501 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.48 179.908 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.656 ' CG ' HG22 ' A' ' 102' ' ' VAL . 51.5 t-20 -133.41 120.67 21.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.093 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.41 ' C ' HD23 ' A' ' 76' ' ' LEU . 6.1 tt -114.94 114.99 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.443 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 120' ' ' ALA . 2.1 mp -122.45 153.79 38.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.991 0.424 . . . . 0.0 111.498 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.73 116.7 4.24 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.81 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.429 ' HB2' ' CE2' ' A' ' 56' ' ' TYR . 54.5 m -90.53 140.72 29.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.07 0.462 . . . . 0.0 111.568 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -148.34 110.78 4.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.031 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.414 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 3.9 p30 -146.36 172.18 13.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.421 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.31 118.66 35.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -97.81 167.12 11.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.665 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.494 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.1 OUTLIER -168.44 134.25 1.53 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 84' ' ' LEU . 36.9 Cg_endo -65.71 95.06 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.474 2.116 . . . . 0.0 112.102 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 86' ' ' ILE . 1.7 tt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 38.1 p-10 . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.828 0.347 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.598 HG22 HD12 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -136.63 148.48 47.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.124 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -126.64 92.31 3.53 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.078 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 6.4 tt -61.59 102.73 0.27 Allowed 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.482 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.511 ' HE1' HE22 ' A' ' 124' ' ' GLN . 15.2 p90 -113.35 154.2 27.27 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.88 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.84 130.56 1.97 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.671 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.414 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -169.65 -139.99 2.86 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.589 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -135.64 170.11 16.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 111.155 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -138.03 163.16 32.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.27 133.81 6.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -155.63 -144.31 3.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.995 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.14 130.84 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.256 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.656 HG22 ' CG ' ' A' ' 75' ' ' ASN . 14.9 t -109.65 128.84 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.225 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.853 179.886 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.715 0.293 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -140.53 143.61 13.73 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.642 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -90.49 120.33 31.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.746 0.308 . . . . 0.0 110.753 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.87 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -95.04 140.05 30.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.211 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.02 134.72 0.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.72 -141.99 3.27 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.601 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 mp -149.65 162.44 40.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.89 0.376 . . . . 0.0 110.985 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.511 HE22 ' HE1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -154.01 159.71 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 177.01 142.51 0.08 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.729 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -174.58 -125.69 0.88 Allowed Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.733 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.598 HD12 HG22 ' A' ' 91' ' ' THR . 5.3 pt -161.13 120.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 110.366 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.825 HD12 ' HB3' ' A' ' 138' ' ' GLU . 1.1 tp -95.42 114.69 26.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.971 0.415 . . . . 0.0 110.833 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 21.5 mt-30 -99.52 147.48 25.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.247 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -128.72 149.11 50.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.52 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.4 mt -109.43 -45.38 3.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.089 0.471 . . . . 0.0 110.76 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.09 -164.89 0.49 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.274 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -80.12 57.41 2.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.879 0.371 . . . . 0.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -138.72 -60.28 0.6 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.2 158.24 21.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.993 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.3 m -125.72 168.66 13.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 174' ' ' GLY . 4.0 mp -134.08 134.7 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.778 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.825 ' HB3' HD12 ' A' ' 128' ' ' LEU . 8.7 pm0 -124.21 149.99 45.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -154.76 128.8 2.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.365 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.25 -136.74 2.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.8 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -135.16 161.07 36.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.402 ' HG2' ' CG ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -147.77 146.32 29.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -112.47 145.79 39.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.85 122.56 39.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -145.52 111.99 5.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.704 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 120' ' ' ALA . 82.1 p . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.734 0.302 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.0 p -107.09 122.47 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.05 155.2 49.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.3 165.16 11.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.139 0.495 . . . . 0.0 110.239 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -137.92 128.5 26.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.805 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -163.6 129.98 3.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 137' ' ' ILE . . . -179.87 -156.66 18.41 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.696 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -125.07 172.09 9.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.114 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -149.98 114.94 5.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.419 ' O ' HG12 ' A' ' 6' ' ' VAL . 39.9 m-85 -107.02 116.92 32.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.987 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -83.87 162.85 20.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 40.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.969 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.228 -0.06 0 CA-C-O 120.571 0.224 . . . . 0.0 110.665 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.24 138.1 49.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.512 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 28.4 p90 -148.95 161.86 41.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.01 0.433 . . . . 0.0 111.454 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.885 HG12 ' HB1' ' A' ' 46' ' ' ALA . 34.3 m -150.33 141.18 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.02 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.1 -157.91 9.04 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 119.966 -1.112 . . . . 0.0 113.135 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -126.97 154.94 43.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.795 0.331 . . . . 0.0 110.786 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 p -128.02 149.6 50.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.437 ' CD2' ' HB3' ' A' ' 42' ' ' TRP . 1.7 t-105 -153.09 115.9 4.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.45 137.96 13.73 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 179.999 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.96 149.79 38.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.437 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 68.0 p-90 -152.92 162.91 40.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.757 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.94 -165.99 35.34 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.706 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.422 HG12 ' N ' ' A' ' 45' ' ' ARG . 18.0 tt -123.56 159.84 27.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.491 0.186 . . . . 0.0 110.803 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -137.88 158.53 44.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.24 0.543 . . . . 0.0 110.669 179.639 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.885 ' HB1' HG12 ' A' ' 6' ' ' VAL . . . -177.04 123.74 0.14 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.107 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -167.02 -142.69 3.52 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.603 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 1.5 mp0 -129.78 139.39 51.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.822 0.344 . . . . 0.0 111.048 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' CD1' ' A' ' 5' ' ' PHE . 2.2 pt20 -121.25 112.33 18.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -119.92 157.22 29.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.6 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.28 -22.28 29.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.255 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -95.66 21.66 8.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.257 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.67 158.85 8.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.494 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' HG3' ' HB3' ' A' ' 49' ' ' GLN . 47.5 ttm-85 -121.22 130.85 53.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.851 0.358 . . . . 0.0 111.061 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -117.67 152.52 35.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.471 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.514 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 36.2 p90 179.67 129.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.156 0.503 . . . . 0.0 111.25 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . -90.59 128.91 36.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.022 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.0 p -117.39 115.05 24.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.165 0.507 . . . . 0.0 111.486 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 75' ' ' ASN . 35.3 m-85 -92.9 130.64 38.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.116 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.9 171.73 8.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.051 0.453 . . . . 0.0 111.441 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.628 179.833 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.699 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.724 0.297 . . . . 0.0 110.718 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 5.6 m-80 -143.76 131.11 20.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -147.69 114.91 6.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.469 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -145.73 154.62 42.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.041 0.448 . . . . 0.0 111.472 -179.538 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.93 116.8 4.24 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.823 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.45 134.0 42.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.974 0.416 . . . . 0.0 111.447 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -124.52 110.86 14.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.061 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -130.79 166.42 20.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 111.415 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.77 118.46 35.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.396 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 55.4 p90 -97.78 166.94 11.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.574 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.68 136.14 1.65 Allowed Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.468 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.12 118.11 4.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.417 2.078 . . . . 0.0 112.377 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.475 HD12 ' CB ' ' A' ' 93' ' ' LEU . 27.8 mt . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.788 0.327 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.575 HG22 ' HG3' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -67.97 149.14 50.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.536 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -127.21 92.47 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 0.0 111.114 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.569 HD22 ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -59.02 103.17 0.15 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 110.319 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 40.7 p90 -110.7 157.66 19.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.053 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.98 129.96 1.61 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.835 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.3 -138.33 2.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.581 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.93 -177.82 4.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.143 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -148.99 155.98 41.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.2 132.2 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.699 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.63 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -160.52 -148.16 5.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.918 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.63 HD12 ' C ' ' A' ' 100' ' ' GLY . 5.5 mp -155.34 133.6 11.66 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.241 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 74' ' ' GLN . 12.2 p -109.35 131.31 60.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.137 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.966 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.903 0.383 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -148.57 -157.79 7.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.428 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -116.05 115.0 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.09 144.04 37.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 141.33 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.263 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.46 -142.74 3.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.517 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mp -145.58 161.97 38.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.834 0.349 . . . . 0.0 110.771 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.675 HE21 ' HE ' ' A' ' 142' ' ' ARG . 7.7 mt-30 -149.13 160.47 43.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.794 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.75 ' HB3' ' CZ ' ' A' ' 141' ' ' TYR . . . 176.95 142.44 0.08 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.598 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.586 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -174.86 -130.69 1.33 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.748 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 126' ' ' GLY . 10.7 pt -160.94 120.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 110.492 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.693 HD11 HD22 ' A' ' 176' ' ' ASN . 0.4 OUTLIER -94.7 112.21 23.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.684 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . 0.575 ' HG3' HG22 ' A' ' 91' ' ' THR . 8.6 mp0 -103.91 124.31 48.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.75 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -86.05 149.35 25.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -104.02 -29.61 10.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.048 0.452 . . . . 0.0 110.163 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.01 -165.48 0.55 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.824 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -91.27 48.01 1.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.705 0.288 . . . . 0.0 110.596 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -155.95 -44.07 0.08 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.647 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -130.19 170.67 13.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.012 0.434 . . . . 0.0 111.566 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.7 m -156.1 -175.8 5.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.73 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.8 pt -154.18 152.61 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.701 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.87 156.56 47.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.041 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -167.54 146.4 10.63 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.95 -125.2 1.19 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.644 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.75 ' CZ ' ' HB3' ' A' ' 125' ' ' ALA . 13.7 p90 -136.09 161.2 36.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.766 0.317 . . . . 0.0 110.732 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.675 ' HE ' HE21 ' A' ' 124' ' ' GLN . 0.2 OUTLIER -162.44 140.28 8.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.246 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -119.78 162.7 18.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.54 HD21 ' CD2' ' A' ' 77' ' ' LEU . 12.1 tp -159.48 146.93 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.957 0.408 . . . . 0.0 111.306 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.6 mmm-85 -118.65 154.22 33.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.544 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 -179.823 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.734 0.302 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 30.3 t -107.11 142.41 36.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.02 155.2 35.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -102.5 165.27 11.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.2 0.524 . . . . 0.0 110.367 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -134.26 128.7 34.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.957 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 9.8 tp -163.67 129.89 3.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.588 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.77 -158.57 22.12 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.737 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.52 172.02 8.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.798 0.332 . . . . 0.0 111.046 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.693 HD22 HD11 ' A' ' 128' ' ' LEU . 39.6 t-20 -153.96 114.93 4.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -116.23 111.34 20.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 1.7 ptpt -84.43 163.17 19.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.164 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.795 0.331 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 1.6 t-20 -77.79 145.56 36.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.651 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 18.0 p90 -148.57 152.11 36.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.124 0.488 . . . . 0.0 111.421 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.672 HG23 ' HB2' ' A' ' 46' ' ' ALA . 9.1 p -151.29 135.64 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.158 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.86 -133.69 1.57 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mp -143.86 167.96 21.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 110.829 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -135.01 143.38 46.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.451 ' CD1' ' HB3' ' A' ' 42' ' ' TRP . 0.6 OUTLIER -134.53 117.84 16.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.708 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.2 151.2 17.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.597 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.847 179.993 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.0 p -124.11 108.03 11.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TRP . . . . . 0.451 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 6.6 p-90 -126.27 164.51 20.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.691 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.61 -169.43 35.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.832 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.754 HD12 ' HB2' ' A' ' 59' ' ' TYR . 1.7 mt -107.79 163.21 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.551 0.215 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.618 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -138.92 139.82 38.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.932 0.396 . . . . 0.0 110.923 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.672 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -170.02 117.73 0.57 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.771 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -157.63 -167.25 18.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.457 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 3.9 pt20 -131.72 125.52 32.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 110.839 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.415 ' HG2' ' N ' ' A' ' 50' ' ' PHE . 5.3 tt0 -83.84 151.95 24.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' N ' ' HG2' ' A' ' 49' ' ' GLN . 0.8 OUTLIER -127.66 166.48 18.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -24.98 65.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.441 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -133.12 24.26 4.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.691 0.281 . . . . 0.0 111.475 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.99 170.96 42.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.4 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -141.5 142.68 33.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.851 0.358 . . . . 0.0 111.329 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -129.89 151.73 50.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.242 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.619 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 36.2 p90 179.49 129.19 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.191 0.52 . . . . 0.0 111.246 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.82 152.41 20.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.426 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 73.0 p -137.13 121.22 17.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 111.546 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.817 ' CE2' HD21 ' A' ' 76' ' ' LEU . 8.3 m-85 -85.67 117.62 24.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.926 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -101.96 158.04 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 111.469 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 m120 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.494 179.884 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.713 0.292 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -144.08 114.82 7.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.175 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.817 HD21 ' CE2' ' A' ' 59' ' ' TYR . 2.5 mp -107.62 131.11 54.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.397 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.446 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 1.9 mp -141.72 147.41 37.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.027 0.441 . . . . 0.0 111.565 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.99 116.75 4.21 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.072 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.566 ' OG ' HG22 ' A' ' 98' ' ' THR . 1.9 t -87.71 136.32 33.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.983 0.42 . . . . 0.0 111.259 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -133.07 110.82 10.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.258 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -147.78 172.08 14.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.031 0.444 . . . . 0.0 111.589 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.44 124.97 50.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.485 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 45.6 p90 -97.51 165.43 12.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.497 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.638 HD23 HD11 ' A' ' 86' ' ' ILE . 26.0 tp -140.52 117.85 8.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.417 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.52 108.66 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.37 2.047 . . . . 0.0 112.354 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.638 HD11 HD23 ' A' ' 84' ' ' LEU . 31.7 mm . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.4 m120 . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.922 0.391 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.643 HG22 HD12 ' A' ' 127' ' ' ILE . 0.8 OUTLIER -136.6 148.64 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.672 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -123.25 92.49 3.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.931 0.396 . . . . 0.0 110.781 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.51 103.01 0.28 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.666 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 46.6 p90 -111.37 154.59 24.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.817 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.35 132.83 2.34 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.819 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.6 -139.43 2.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.687 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.89 177.11 7.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.756 0.312 . . . . 0.0 111.183 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.566 HG22 ' OG ' ' A' ' 79' ' ' SER . 47.8 p -146.37 159.04 43.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mp -159.25 130.8 6.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.646 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -150.71 -155.91 7.1 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.124 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.9 mt -155.2 130.51 9.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.794 0.33 . . . . 0.0 110.168 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 102' ' ' VAL . 12.5 p -109.72 119.78 59.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.297 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 tttm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.934 -179.946 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.837 0.351 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -113.95 -177.62 19.22 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.507 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -91.71 125.44 36.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.4 137.46 51.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -171.17 140.42 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.001 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.28 -139.86 2.76 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.643 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 143' ' ' TYR . 24.9 mt -145.39 165.64 27.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.798 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 8.0 tt0 -157.14 159.27 37.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 94' ' ' PHE . . . 176.94 142.46 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -171.81 -130.69 1.26 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.656 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.643 HD12 HG22 ' A' ' 91' ' ' THR . 4.7 pt -158.68 120.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.52 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.701 HD11 ' OD1' ' A' ' 176' ' ' ASN . 8.5 tt -95.19 114.32 26.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.117 0.484 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -99.14 139.63 34.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.268 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -118.78 149.11 42.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.556 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.92 -51.22 2.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.626 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -169.11 -164.9 0.49 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.093 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -76.47 58.32 1.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.786 0.326 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -136.88 -60.17 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HB2' ' CE2' ' A' ' 177' ' ' TYR . . . -166.03 156.66 12.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.75 165.34 13.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.63 134.73 61.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.514 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.95 143.36 50.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.051 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -160.08 149.88 19.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.297 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 173.8 -133.98 2.73 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.729 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.62 161.05 23.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.82 0.343 . . . . 0.0 110.98 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.0 ttt-85 -149.91 125.27 10.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.43 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 13.1 m-85 -101.09 138.71 37.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.763 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.06 134.06 55.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.7 mmm-85 -151.64 112.14 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.987 -179.876 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.832 0.349 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.88 119.8 40.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -147.7 155.16 41.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -102.51 165.27 11.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.154 0.502 . . . . 0.0 110.163 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.75 129.75 30.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.113 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.4 tp -163.42 131.56 3.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.721 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 176.94 -155.17 17.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.681 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.19 172.04 13.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.986 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.701 ' OD1' HD11 ' A' ' 128' ' ' LEU . 1.1 p30 -158.05 121.81 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.544 ' CE2' ' HB2' ' A' ' 135' ' ' ALA . 36.3 m-85 -98.71 115.77 29.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.4 147.28 29.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.112 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.724 0.297 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -154.76 139.84 17.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.232 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.9 138.86 56.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.762 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.5 m-85 -132.48 139.88 48.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 111.103 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.605 HG12 ' CB ' ' A' ' 46' ' ' ALA . 19.6 m -154.58 127.63 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.997 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.6 -146.47 4.66 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.846 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 43' ' ' GLY . 0.5 OUTLIER -127.8 153.97 45.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 0.0 110.821 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.662 ' OG1' HG23 ' A' ' 58' ' ' THR . 1.0 OUTLIER -125.37 135.9 52.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.05 113.24 11.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.29 131.36 10.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.523 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.61 119.46 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.871 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -122.49 105.59 10.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.984 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.3 p -150.05 102.79 3.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -88.59 -46.14 9.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.551 ' O ' HD13 ' A' ' 17' ' ' ILE . 19.2 p-10 -86.6 140.53 29.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.551 HD13 ' O ' ' A' ' 16' ' ' ASN . 29.5 mm -128.39 97.69 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.113 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -144.03 171.05 14.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.77 144.18 51.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 p -140.77 165.99 26.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -148.89 132.26 16.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.77 127.52 45.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.46 129.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -106.34 -31.4 8.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.863 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -58.41 -23.6 57.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 62.33 105.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.962 0.411 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.55 -47.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.811 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -93.51 128.22 39.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 t -140.95 87.34 11.02 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.027 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.86 -174.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.581 2.187 . . . . 0.0 112.228 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -127.1 68.79 1.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -138.2 101.31 4.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.994 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -140.76 90.97 2.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.715 ' HD2' HG22 ' A' ' 35' ' ' VAL . 0.2 OUTLIER 178.46 -34.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.036 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.715 HG22 ' HD2' ' A' ' 34' ' ' LYS . 15.5 m -152.2 92.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.174 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -130.72 103.99 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.092 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -136.47 -167.88 2.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.716 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -146.09 -47.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.45 140.04 51.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.87 134.55 1.79 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.53 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.8 p -95.01 126.58 40.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -128.31 132.73 48.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.705 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -156.35 -167.26 17.41 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.51 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 pt -107.15 172.54 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 111.027 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.87 141.44 34.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.639 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.605 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -174.87 123.2 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.315 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -160.96 -148.74 5.38 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.698 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -136.07 126.29 26.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.01 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 1.1 tm0? -83.97 158.91 21.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.662 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -135.04 164.22 28.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.15 -24.08 65.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.365 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.32 24.38 5.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.27 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 174.61 178.21 44.32 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.202 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 54' ' ' ARG . 4.1 ptm85 -148.13 138.22 22.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 111.187 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -117.04 145.63 43.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.514 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.457 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 41.0 p90 -172.12 121.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 111.171 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.85 158.93 16.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.662 HG23 ' OG1' ' A' ' 9' ' ' THR . 68.1 m -127.95 117.06 21.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.059 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.466 ' HD2' HD23 ' A' ' 76' ' ' LEU . 28.3 t80 -100.96 127.59 47.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.754 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -141.53 176.71 8.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.029 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -137.29 -78.41 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.685 HG21 ' HB3' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -159.99 137.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.081 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.0 126.02 25.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -73.91 153.46 39.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.001 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.8 172.8 16.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -81.05 -35.86 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 p -105.1 27.16 8.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.025 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.612 ' HA3' HD11 ' A' ' 71' ' ' LEU . . . -70.82 111.15 3.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.517 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 69' ' ' ASN . 0.5 OUTLIER -111.77 128.35 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.836 -179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt 60.55 82.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.685 ' HB3' HG21 ' A' ' 62' ' ' ILE . 3.1 mt -130.58 115.25 16.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.964 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -176.91 106.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.95 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -162.25 -178.8 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -128.41 150.24 50.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.835 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.431 ' OD1' HD12 ' A' ' 77' ' ' LEU . 21.7 t-20 -144.64 116.99 8.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.094 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.5 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -129.73 127.05 39.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.534 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.652 HD22 HD21 ' A' ' 144' ' ' LEU . 0.8 OUTLIER -146.32 137.72 24.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.963 0.411 . . . . 0.0 111.438 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.77 116.89 3.89 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.016 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.408 ' OG ' ' CE2' ' A' ' 56' ' ' TYR . 26.0 p -105.92 133.29 50.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.412 . . . . 0.0 111.279 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 55' ' ' TYR . 23.1 p90 -123.85 110.89 15.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.353 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.57 171.19 14.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.053 0.454 . . . . 0.0 111.383 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -117.54 120.6 38.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.919 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 42.1 p90 -97.86 164.38 12.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.133 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.721 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.2 OUTLIER -170.26 139.03 1.44 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.636 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.721 ' HD2' HD23 ' A' ' 84' ' ' LEU . 76.3 Cg_exo -49.84 119.51 4.88 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.514 2.142 . . . . 0.0 112.359 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 86' ' ' ILE . 5.0 tp -119.71 104.85 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.03 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.88 -75.53 0.26 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.55 -68.64 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 110.868 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 t30 179.71 37.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.959 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -121.48 -59.98 1.65 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.81 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.78 153.09 31.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.569 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 1.7 tptp -126.58 92.53 3.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.824 0.345 . . . . 0.0 110.995 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.14 102.82 0.32 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.256 0.55 . . . . 0.0 110.508 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.452 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 35.9 p90 -111.04 156.0 21.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.758 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.27 134.7 3.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.732 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.418 ' O ' HD23 ' A' ' 123' ' ' LEU . . . -177.53 -160.66 24.59 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.446 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.13 171.43 8.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 0.0 111.23 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.8 t -143.92 159.81 41.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.06 131.19 5.81 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.456 ' N ' HD23 ' A' ' 77' ' ' LEU . . . -152.73 -153.31 6.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.806 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.7 pp -155.28 127.94 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.656 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.2 m -109.74 130.41 62.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.206 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.63 126.95 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.93 127.14 47.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.87 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -122.94 143.65 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -131.64 170.95 14.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.29 115.31 21.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.95 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.41 -46.06 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.656 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.24 116.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.905 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.65 -78.02 1.62 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.454 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -97.4 104.79 16.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 110.845 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.56 122.93 28.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -87.99 -52.14 5.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.02 136.65 57.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.43 ' HB2' HG12 ' A' ' 117' ' ' VAL . 23.5 p -83.63 -22.19 32.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 64.24 31.84 12.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 117' ' ' VAL . 11.4 p -148.94 110.81 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.29 132.61 6.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -84.62 115.04 22.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 0.0 111.034 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -111.62 137.74 49.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.05 141.27 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.27 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.94 -139.56 2.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.603 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 96' ' ' GLY . 1.9 mt -140.37 161.16 38.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.378 . . . . 0.0 110.831 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -150.04 157.78 43.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.796 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 178.68 142.39 0.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.371 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -168.01 -130.33 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.117 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.523 HG23 ' O ' ' A' ' 126' ' ' GLY . 11.3 pt -159.45 121.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.77 0.319 . . . . 0.0 110.377 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.13 111.61 23.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.742 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -92.58 122.13 34.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.075 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.39 149.12 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.02 -47.26 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.001 0.429 . . . . 0.0 110.518 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -164.97 0.49 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.194 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 56.71 2.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.833 0.349 . . . . 0.0 110.6 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.76 -58.96 0.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.952 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -162.68 146.18 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.978 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.03 -179.9 4.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.4 mt -136.49 134.97 49.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 141.0 46.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.97 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -161.82 117.28 0.76 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.446 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -172.64 -138.95 2.7 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.094 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -121.19 161.16 22.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 110.843 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.724 ' HD3' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -143.28 121.71 12.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.107 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -118.18 131.3 56.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.463 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.724 HD12 ' HD3' ' A' ' 142' ' ' ARG . 0.8 OUTLIER -144.29 146.96 32.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.935 0.398 . . . . 0.0 111.261 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.84 162.38 13.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.561 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p -108.91 172.04 7.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.089 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -56.17 115.56 2.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.079 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.32 80.0 1.45 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 t -116.98 119.97 36.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.959 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 m 59.38 162.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -115.63 159.36 21.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -88.33 -63.51 1.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.2 p -110.88 99.04 40.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.59 116.38 4.22 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.447 2.098 . . . . 0.0 112.328 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -87.21 -63.01 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 80.84 130.97 1.04 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.524 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -141.26 -108.58 0.73 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.548 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.18 161.75 41.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.846 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -101.88 80.22 1.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.65 108.26 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.68 -127.48 39.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.534 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.58 162.51 38.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.804 0.335 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.6 pp -156.53 162.37 39.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -76.69 139.29 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.403 ' C ' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -56.54 176.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -93.78 100.16 12.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.69 160.85 29.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.69 150.56 22.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.791 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 m -106.97 117.58 34.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.816 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 155.18 51.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.724 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -103.49 165.2 11.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.21 0.528 . . . . 0.0 110.277 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.413 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -131.39 128.0 38.7 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.768 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.4 131.65 3.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.711 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.33 -152.04 15.95 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.648 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -131.61 172.01 12.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 0.0 111.058 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -152.22 115.49 4.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -109.21 113.62 26.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.94 163.56 22.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.142 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.85 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.79 0.329 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.92 168.12 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.863 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -109.71 128.39 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.785 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.8 OUTLIER -129.05 139.91 51.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 46' ' ' ALA . 16.4 m -154.08 126.41 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.214 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.35 -141.92 3.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.641 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.769 HD23 ' HA ' ' A' ' 44' ' ' ILE . 4.6 mt -142.93 162.01 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.749 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.412 HG21 HG21 ' A' ' 58' ' ' THR . 8.4 t -139.07 136.38 35.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 111.263 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -130.62 113.02 13.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.59 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 172' ' ' TYR . . . -118.13 169.65 13.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.064 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.97 133.84 54.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.79 0.329 . . . . 0.0 110.837 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 p -135.67 110.04 8.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 p -150.17 102.76 3.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.848 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.51 -69.02 0.32 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.95 162.84 10.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.43 142.32 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.088 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.92 101.98 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.875 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -72.85 136.68 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 p -143.65 137.39 28.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -106.71 -64.8 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.99 166.19 19.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -44.89 69.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -78.81 179.68 7.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -145.71 -176.96 5.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 t30 65.96 80.45 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.24 -62.15 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.796 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -127.38 -46.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.84 163.6 27.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.22 -179.75 3.35 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.6 2.2 . . . . 0.0 112.344 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -107.38 31.51 5.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.97 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 tp -168.35 153.3 6.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 60.26 76.73 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -79.46 -43.76 22.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.499 HG23 HG13 ' A' ' 36' ' ' ILE . 13.2 m -147.83 -46.22 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.499 HG13 HG23 ' A' ' 35' ' ' VAL . 2.6 pp -155.29 -175.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.726 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -131.69 120.12 22.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.2 146.32 26.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.5 p -114.72 -61.73 1.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.803 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.12 -142.28 9.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.545 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 p -138.62 107.99 6.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -125.11 137.36 54.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.707 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.15 -171.61 34.23 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.851 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.769 ' HA ' HD23 ' A' ' 8' ' ' LEU . 1.4 mp -106.95 164.05 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.578 0.227 . . . . 0.0 110.745 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 44' ' ' ILE . 4.0 ttm-85 -132.39 139.71 48.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.646 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.571 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -174.81 122.43 0.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.443 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -169.92 -128.44 1.02 Allowed Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.516 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -143.22 154.91 44.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.65 109.84 11.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.85 ' CD2' ' HB2' ' A' ' 2' ' ' ALA . 0.6 OUTLIER -103.7 145.71 29.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.547 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.22 -21.67 24.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.208 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -124.63 24.13 7.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.073 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.75 120.49 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.513 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 129.38 53.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 110.816 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.481 ' CD1' ' CD2' ' A' ' 80' ' ' TYR . 11.4 m-85 -124.24 147.03 48.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.772 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.486 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 31.9 p90 -177.3 125.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.039 0.447 . . . . 0.0 110.979 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.69 156.13 18.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.609 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 21.2 m -133.28 119.05 19.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.495 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.509 ' CZ ' HD23 ' A' ' 76' ' ' LEU . 27.9 m-85 -89.95 118.9 29.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.324 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.92 176.72 4.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.977 0.418 . . . . 0.0 111.397 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.595 ' OD1' HD21 ' A' ' 71' ' ' LEU . 1.1 t-20 -150.47 -165.87 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.641 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.9 mp -129.48 111.11 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.097 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 t -118.76 113.24 20.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -140.49 -50.17 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -70.08 115.6 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.0 m -68.68 -34.42 75.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.2 p -66.5 -31.44 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.883 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.73 61.83 1.83 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.569 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -122.22 129.09 51.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 61.8 116.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.595 HD21 ' OD1' ' A' ' 61' ' ' ASN . 2.2 tt -163.09 100.85 0.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.62 83.54 1.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.846 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.465 ' CB ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -151.73 157.91 42.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.994 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -146.44 131.81 18.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.796 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.597 ' OD1' HG22 ' A' ' 102' ' ' VAL . 2.5 t-20 -122.71 110.87 16.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.108 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.536 ' O ' HD22 ' A' ' 77' ' ' LEU . 4.2 mp -111.42 114.96 28.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.467 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.721 HD13 ' HA3' ' A' ' 100' ' ' GLY . 4.5 mm? -123.91 142.38 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 111.297 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.96 116.89 4.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.989 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.49 ' HA ' HG22 ' A' ' 98' ' ' THR . 0.1 OUTLIER -93.18 125.43 37.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.913 0.387 . . . . 0.0 111.413 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.481 ' CD2' ' CD1' ' A' ' 55' ' ' TYR . 9.8 m-85 -127.09 110.94 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.068 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 1.6 p30 -150.26 172.18 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 111.692 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.92 122.84 47.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.623 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -97.21 169.67 9.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.641 -179.349 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tp -147.93 124.44 5.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.551 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.09 110.45 2.2 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.405 2.07 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.917 HD11 ' HB2' ' A' ' 93' ' ' LEU . 33.8 mt -99.89 97.82 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.654 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.09 74.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.77 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -148.05 -47.34 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 110.63 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -149.37 30.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.614 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 57.3 m-80 62.85 15.9 8.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.406 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.682 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -74.65 151.18 39.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.561 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.467 ' HG2' ' CD2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -130.51 93.59 3.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.052 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.917 ' HB2' HD11 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -59.81 103.08 0.18 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.595 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 44.0 p90 -111.02 153.53 25.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.913 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.72 133.84 2.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.613 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.403 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -174.75 -136.54 2.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.75 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -128.01 179.98 5.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.789 0.328 . . . . 0.0 111.353 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.775 ' O ' HD12 ' A' ' 99' ' ' LEU . 48.7 p -146.73 157.09 43.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 98' ' ' THR . 0.6 OUTLIER -158.73 131.15 6.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.678 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.721 ' HA3' HD13 ' A' ' 77' ' ' LEU . . . -150.56 -154.04 6.34 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.948 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.578 ' N ' HD23 ' A' ' 101' ' ' LEU . 2.0 pt? -155.37 130.86 9.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.853 0.359 . . . . 0.0 110.301 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.597 HG22 ' OD1' ' A' ' 75' ' ' ASN . 21.1 t -109.6 122.1 63.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.322 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.48 138.12 53.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.73 132.33 38.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -136.66 164.27 28.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -138.3 169.3 18.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -158.22 150.16 21.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.898 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 141.03 -152.61 23.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 106.71 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.45 88.83 1.85 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.531 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -76.11 122.91 24.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.84 139.51 21.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.17 82.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.16 106.06 18.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.4 t -150.86 124.75 9.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -144.74 85.1 1.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.0 m -84.56 118.08 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.189 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.45 168.53 13.04 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.83 116.25 31.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.54 148.38 22.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.03 141.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.963 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.68 -140.31 2.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 97' ' ' ALA . 22.5 mt -141.02 174.33 10.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.74 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -164.2 153.3 13.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.757 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.851 ' HB3' ' CZ ' ' A' ' 141' ' ' TYR . . . 177.2 142.5 0.08 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.939 0.4 . . . . 0.0 110.633 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -172.37 -126.65 0.91 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.873 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.3 pp -160.09 120.76 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.747 0.308 . . . . 0.0 110.236 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.699 HD12 ' HG3' ' A' ' 138' ' ' GLU . 6.3 tt -94.48 110.71 22.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.054 0.454 . . . . 0.0 110.428 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.438 ' HB3' HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -91.62 161.12 15.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.058 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -120.81 146.73 46.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 19.6 mt -109.73 -30.37 7.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.743 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.62 -165.0 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.424 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.49 50.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.813 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.71 -33.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.246 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 177' ' ' TYR . . . -104.22 146.71 28.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 111.241 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.0 m -151.74 -176.81 5.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.035 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' A' ' 175' ' ' ALA . 11.8 pt -148.56 150.79 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.642 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.699 ' HG3' HD12 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -134.87 127.63 31.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.787 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 173' ' ' LEU . . . -151.84 158.34 27.72 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.583 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 171' ' ' PHE . . . 161.09 -120.71 0.97 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.657 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.851 ' CZ ' ' HB3' ' A' ' 125' ' ' ALA . 50.6 p90 -139.6 152.9 47.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.814 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.11 145.3 45.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.721 ' O ' HD22 ' A' ' 144' ' ' LEU . 8.1 m-85 -121.48 145.74 47.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.348 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.721 HD22 ' O ' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -149.64 147.19 27.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.031 0.443 . . . . 0.0 111.258 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -135.61 155.58 50.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.48 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 p -108.89 123.76 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.108 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.14 114.85 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.823 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.99 -33.57 7.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.066 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 71.7 m -159.02 -75.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 59.31 101.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.47 -44.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 8.9 mtt -64.88 95.82 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 80.8 p -117.22 97.6 50.95 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.02 -61.69 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.479 2.119 . . . . 0.0 112.411 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -178.06 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.901 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.03 -141.91 17.96 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.455 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.74 178.82 41.64 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -78.98 110.88 14.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -76.2 -25.42 55.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mt 69.51 -66.84 0.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.63 -135.92 1.94 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.574 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.2 p -68.01 127.41 32.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.1 tp -148.1 105.89 3.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -113.84 108.34 16.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.35 84.7 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.857 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.05 -49.27 0.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.81 148.64 40.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.416 ' O ' ' CD1' ' A' ' 143' ' ' TYR . 67.1 m -109.66 147.22 33.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.87 141.04 38.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -154.3 155.14 34.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 14.8 m-85 -119.68 130.88 55.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.261 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.449 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 34.5 p90 -133.23 173.9 10.95 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.712 0.768 . . . . 0.0 111.725 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.459 ' HA ' ' CA ' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -163.76 134.31 4.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.847 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -154.56 -165.61 14.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.0 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.532 ' HA ' HG22 ' A' ' 137' ' ' ILE . . . -107.73 169.73 8.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.341 . . . . 0.0 110.985 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -158.0 117.44 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -117.87 118.4 31.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -89.02 160.22 17.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.023 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.3 t80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.828 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.9 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.676 0.274 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER -132.05 163.1 29.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.858 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.51 141.98 45.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.678 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 28.2 p90 -146.43 167.23 24.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 111.23 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.539 HG12 ' CB ' ' A' ' 46' ' ' ALA . 35.5 m -156.33 144.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.475 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.68 -142.67 3.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mt -120.95 153.51 37.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.751 0.31 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -122.15 113.53 19.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.78 112.94 19.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.04 115.25 3.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.542 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.73 120.03 35.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 13' ' ' THR . 3.9 t -92.85 103.58 15.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -150.12 102.76 3.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -93.59 76.01 4.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -86.9 118.93 26.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 17' ' ' ILE . 2.0 tp -72.75 65.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.022 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.77 -173.87 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -178.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 m -139.09 125.43 20.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -88.58 159.13 18.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.3 m -147.28 143.9 28.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mt -116.81 31.14 6.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -74.72 -167.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.814 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.14 42.73 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -177.23 158.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.859 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.03 -51.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -95.63 79.19 3.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -160.64 137.59 6.63 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.846 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.41 158.28 7.83 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.537 2.158 . . . . 0.0 112.317 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -133.06 149.32 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 tp -111.03 49.49 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.817 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -110.59 78.55 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.67 -49.31 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 35' ' ' VAL . 12.3 p 44.38 29.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.763 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 mm 62.43 143.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.159 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -161.82 118.08 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.947 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -133.24 129.18 37.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.953 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 t -178.17 150.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.27 -136.71 5.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.485 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.33 144.25 48.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.84 105.51 5.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.44 -164.83 10.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.513 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 45' ' ' ARG . 3.9 mt -106.69 158.95 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.695 0.283 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 44' ' ' ILE . 7.7 ttm180 -121.99 131.92 54.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.001 0.429 . . . . 0.0 110.523 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.843 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -163.75 117.82 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.97 -143.56 3.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.621 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 4.8 mt-30 -153.66 126.09 8.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.955 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 3' ' ' ASP . 19.9 pt20 -95.09 109.54 21.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.487 . . . . 0.0 111.184 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.9 ' CE2' ' HB2' ' A' ' 2' ' ' ALA . 1.7 t80 -98.82 159.43 14.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.159 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -55.41 -28.1 52.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.547 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.37 24.39 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 80' ' ' TYR . . . -174.8 132.85 2.31 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.802 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.444 ' NH1' ' CE2' ' A' ' 5' ' ' PHE . 2.7 ttt-85 -116.56 131.96 56.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 0.0 111.14 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.93 139.04 31.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.396 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.37 100.13 5.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 0.0 111.505 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -105.91 118.45 36.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.438 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 t -122.58 114.73 21.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.926 0.393 . . . . 0.0 111.224 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CD2' ' CD2' ' A' ' 76' ' ' LEU . 4.0 t80 -89.39 111.16 21.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.53 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.75 -179.91 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.104 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.499 ' O ' HG23 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -149.97 -75.49 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.882 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.605 HD13 HG22 ' A' ' 65' ' ' THR . 1.8 pp -158.61 140.48 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.133 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.1 t -106.16 -32.48 8.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -115.39 134.23 55.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.605 HG22 HD13 ' A' ' 62' ' ' ILE . 30.6 p -121.93 31.71 6.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -69.53 -31.38 69.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -36.0 76.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.955 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.58 -134.12 2.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.447 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -113.62 132.94 55.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -154.78 158.81 40.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp -170.77 -66.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.54 92.4 1.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.736 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.41 ' OE1' HD11 ' A' ' 104' ' ' LEU . 12.2 tt0 -153.15 144.67 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -138.41 125.15 20.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -127.91 110.96 13.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -105.64 116.84 32.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.651 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.445 HD21 HD21 ' A' ' 144' ' ' LEU . 0.8 OUTLIER -108.44 122.65 47.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.184 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.59 120.73 4.61 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.89 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.404 ' CB ' ' HA ' ' A' ' 98' ' ' THR . 96.5 p -129.33 145.09 51.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 0.0 111.558 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.431 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 11.2 t80 -116.56 110.87 19.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.184 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.405 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 31.1 m-20 -126.17 163.91 22.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.383 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -110.27 118.28 35.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.424 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 34.5 p90 -97.86 160.22 14.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.608 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 tp -165.85 124.69 1.14 Allowed Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.803 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' THR . 50.6 Cg_exo -55.55 108.34 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.458 2.106 . . . . 0.0 112.241 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 86' ' ' ILE . 9.1 tp -157.07 127.23 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.153 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.7 -96.71 0.41 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.809 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.39 -74.39 0.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 111.016 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -173.15 -39.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 5.0 m120 -116.22 15.1 15.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.537 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 2.6 t -79.64 153.22 29.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 7.1 mmtp -130.27 91.96 3.2 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.046 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 1.1 tt -67.79 102.81 1.29 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.886 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 82' ' ' ALA . 41.5 p90 -110.59 150.85 28.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.71 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -168.38 132.15 2.5 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.802 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.85 -144.82 4.92 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.605 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.02 158.42 17.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.404 ' HA ' ' CB ' ' A' ' 79' ' ' SER . 9.8 t -130.66 150.54 51.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.004 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.1 tt -160.07 127.01 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.729 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 120' ' ' ALA . . . -130.35 -156.97 8.84 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.612 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.64 124.83 6.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.778 0.323 . . . . 0.0 110.737 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 t -109.88 125.47 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 117' ' ' VAL . 17.6 mttt -140.12 144.98 37.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.41 HD11 ' OE1' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -121.26 158.35 28.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.13 127.84 43.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 159.41 19.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -162.84 133.26 4.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 159.49 -88.16 0.11 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.466 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -179.83 -37.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.773 0.32 . . . . 0.0 110.889 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.53 -100.34 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.661 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -92.5 136.18 33.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.58 174.07 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.784 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 60.49 -175.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.9 t0 70.38 -64.68 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.4 p 62.88 150.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.84 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.92 65.01 2.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.983 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.501 HG12 ' HG2' ' A' ' 103' ' ' LYS . 8.5 m -88.31 153.69 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.077 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.0 -167.7 19.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.52 134.81 39.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 100' ' ' GLY . . . -106.71 142.81 35.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.075 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.78 134.3 9.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.123 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -174.38 -138.98 2.84 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.627 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 pp -155.46 160.95 41.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 6.0 pt20 -156.42 177.64 11.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.157 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 94' ' ' PHE . . . 176.84 142.53 0.08 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.46 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -155.23 -140.56 3.03 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.005 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 3.5 pt -159.43 120.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.693 0.282 . . . . 0.0 110.262 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 176' ' ' ASN . 0.4 OUTLIER -95.79 109.28 21.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.728 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 3.0 mt-30 -101.08 141.64 33.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.006 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.98 149.21 40.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.769 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 pp -110.18 -39.67 4.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.016 0.436 . . . . 0.0 110.776 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -169.2 -164.87 0.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.368 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -84.88 52.98 2.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 110.603 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.407 ' O ' ' CE1' ' A' ' 177' ' ' TYR . 0.5 OUTLIER -133.06 -55.34 0.92 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.037 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.05 150.15 7.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.156 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.582 ' OG ' HD22 ' A' ' 128' ' ' LEU . 6.4 t -106.89 169.66 8.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.785 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.463 ' O ' HD23 ' A' ' 128' ' ' LEU . 11.5 tt -132.7 134.7 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.661 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.61 152.32 35.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.984 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -161.79 118.09 0.8 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.29 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.68 -151.68 6.38 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.914 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.27 161.13 32.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 110.81 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.551 ' HD3' HD23 ' A' ' 144' ' ' LEU . 9.4 ttm180 -146.87 136.71 23.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.983 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.423 ' CD2' ' HA ' ' A' ' 169' ' ' SER . 11.5 m-85 -145.03 127.48 15.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.838 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.551 HD23 ' HD3' ' A' ' 142' ' ' ARG . 4.3 pp -156.2 162.47 40.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -103.19 157.72 16.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.8 m -109.0 129.13 55.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -128.8 151.15 49.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -131.49 -46.16 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.012 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.1 m -128.66 -175.78 3.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.39 -66.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -79.34 89.91 4.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.938 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -47.17 86.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.6 p -116.22 144.86 33.76 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.19 -43.72 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.468 2.112 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -116.47 159.25 22.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.37 -28.5 12.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.6 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.93 -163.51 18.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.584 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.34 131.24 56.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -127.11 -70.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.59 90.73 5.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 167.92 41.99 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.463 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.1 t -163.45 164.11 24.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 0.0 110.894 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 68.03 -70.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -66.24 77.62 0.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 mt -109.92 -35.01 6.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 61.22 154.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.81 154.12 46.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.0 168.37 10.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.423 ' HA ' ' CD2' ' A' ' 143' ' ' TYR . 15.7 m -106.87 122.98 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.64 155.15 46.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.742 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -111.71 164.1 13.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.121 0.486 . . . . 0.0 110.161 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.422 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -132.59 126.88 33.79 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.771 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.56 129.96 3.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.563 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.89 -152.94 15.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.831 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.95 172.09 10.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 111.114 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.586 ' HB2' HD21 ' A' ' 128' ' ' LEU . 23.8 m-20 -155.59 119.18 4.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.407 ' CE1' ' O ' ' A' ' 134' ' ' ASN . 13.9 t80 -120.31 115.87 24.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.081 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.39 145.93 30.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.013 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.023 -179.801 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.842 0.353 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 49' ' ' GLN . 2.0 t0 -163.06 138.92 6.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 1.8 t30 -80.69 156.59 26.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.561 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.9 OUTLIER -156.12 164.56 38.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 111.592 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' A' ' 46' ' ' ALA . 27.4 m -158.02 128.22 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.953 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 176' ' ' ASN . . . -150.73 -146.87 4.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.596 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.38 136.9 25.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.779 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.776 HG22 ' OE2' ' A' ' 138' ' ' GLU . 35.6 p -100.58 151.2 21.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -148.69 128.69 13.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.98 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.38 138.24 13.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.43 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 109.97 17.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.8 p -110.26 147.05 34.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.821 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.11 102.89 3.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 62.35 94.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -92.52 150.14 20.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 pt -139.19 31.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -105.61 -57.65 2.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 151.34 31.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 m 60.54 110.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -121.87 -54.89 1.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.1 m 61.15 155.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.3 156.86 40.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.411 ' OD1' HD13 ' A' ' 27' ' ' LEU . 1.3 m-80 -115.01 -177.23 3.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.823 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.71 -45.42 1.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -131.9 -69.69 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.411 HD13 ' OD1' ' A' ' 24' ' ' ASN . 12.4 tp 61.05 101.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -111.9 46.62 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m -131.85 95.9 21.6 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.846 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.01 -41.8 7.04 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.435 2.09 . . . . 0.0 112.356 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -84.06 58.22 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.44 -48.9 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.83 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.3 87.27 1.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -74.97 -73.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.461 HG23 ' N ' ' A' ' 36' ' ' ILE . 15.1 m -134.27 -46.67 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.461 ' N ' HG23 ' A' ' 35' ' ' VAL . 5.0 mt -121.98 103.25 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -126.76 -63.24 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -116.73 30.92 7.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 39' ' ' THR . 9.6 t -118.71 117.94 30.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.75 138.86 4.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.362 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -94.99 110.08 22.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.823 0.344 . . . . 0.0 110.959 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.87 -178.96 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.567 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.602 ' HA2' ' HB2' ' A' ' 60' ' ' GLU . . . -178.17 158.17 22.78 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.081 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.793 HD12 ' CE2' ' A' ' 59' ' ' TYR . 25.7 mt -106.44 124.82 62.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.18 133.89 49.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.392 0.615 . . . . 0.0 111.084 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -163.34 111.11 1.21 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.448 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.45 -163.04 12.36 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.188 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -126.41 142.63 51.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.024 0.44 . . . . 0.0 111.298 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -97.02 162.15 13.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.473 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.52 -169.38 1.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.977 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -32.51 73.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.509 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -127.33 -34.7 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -119.04 -166.05 13.33 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.702 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.452 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . 44.9 ptt85 -162.96 158.54 22.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.0 111.791 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.409 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 12.2 m-85 -118.84 144.26 46.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.846 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -159.12 119.09 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.963 0.411 . . . . 0.0 111.181 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.79 140.33 29.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.817 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 7.1 t -126.18 116.15 20.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.793 ' CE2' HD12 ' A' ' 44' ' ' ILE . 40.1 p90 -130.11 126.7 38.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 111.763 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.602 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -158.36 -179.91 8.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.948 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -93.26 -166.22 1.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.397 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 62' ' ' ILE . 9.0 tp -137.38 121.53 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 111.196 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.2 m 57.72 91.79 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.999 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -163.84 177.24 8.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.3 p -107.83 -177.65 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.6 t -89.8 -42.44 11.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.05 27.07 5.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.991 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -93.46 -151.79 28.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.493 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.01 141.71 27.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.778 0.323 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -70.99 168.59 16.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.3 -67.71 0.73 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.7 37.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.959 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -134.89 142.68 46.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.49 159.91 10.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.72 ' HB2' HG12 ' A' ' 102' ' ' VAL . 8.0 p30 -146.0 119.44 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.106 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.29 145.12 50.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.642 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.402 ' CB ' ' HA3' ' A' ' 100' ' ' GLY . 0.9 OUTLIER -158.06 157.98 33.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 111.342 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.97 116.79 4.23 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.054 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.625 ' CB ' HG22 ' A' ' 98' ' ' THR . 23.3 t -98.78 133.69 42.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.97 0.414 . . . . 0.0 111.37 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.755 ' CZ ' ' HB3' ' A' ' 97' ' ' ALA . 12.7 p90 -134.13 112.06 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.185 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 6.1 p30 -139.16 172.14 13.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.188 0.518 . . . . 0.0 111.558 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.554 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -112.22 118.72 36.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.839 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 20.3 p90 -99.74 166.42 11.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.257 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 tt -167.83 134.79 1.79 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.11 118.48 4.6 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.463 2.109 . . . . 0.0 112.345 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 86' ' ' ILE . 1.1 tt -121.24 105.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.057 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.9 -96.43 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.59 51.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 110.827 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.0 m120 60.27 29.44 19.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -108.13 -24.03 11.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.452 HG22 HD12 ' A' ' 127' ' ' ILE . 3.3 p -136.29 151.89 50.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.547 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 5.4 mptt -122.81 92.42 3.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.906 0.384 . . . . 0.0 110.924 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tp -62.23 102.83 0.33 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.706 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 30.2 p90 -112.76 156.03 23.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.781 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.03 128.65 1.5 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.403 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -163.99 -132.75 1.38 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.65 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.755 ' HB3' ' CZ ' ' A' ' 80' ' ' TYR . . . -133.25 165.95 23.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.773 0.321 . . . . 0.0 111.235 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.625 HG22 ' CB ' ' A' ' 79' ' ' SER . 2.7 p -136.65 154.94 50.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.89 130.67 5.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.023 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 77' ' ' LEU . . . -161.92 -152.76 6.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.679 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mp -148.25 122.26 9.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.72 HG12 ' HB2' ' A' ' 75' ' ' ASN . 31.4 m -109.82 130.25 63.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.231 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -114.55 134.93 54.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mt -131.74 142.66 49.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -109.39 147.92 31.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.858 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.24 151.74 37.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -171.49 35.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.42 73.46 0.25 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.499 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -63.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.347 . . . . 0.0 110.841 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.43 -74.49 0.35 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.429 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.08 162.47 24.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.825 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -83.61 96.15 8.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.968 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -88.42 168.77 12.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.72 116.91 12.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.72 88.97 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -147.98 -68.66 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.2 p -163.64 137.21 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -137.88 170.5 23.72 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -84.31 132.68 34.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.323 . . . . 0.0 110.853 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.714 ' HB1' ' CD2' ' A' ' 144' ' ' LEU . . . -115.18 143.37 45.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -169.31 137.98 1.96 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.47 -137.86 2.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mp -146.59 157.07 43.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 110.964 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' A' ' 142' ' ' ARG . 0.0 OUTLIER -141.13 161.87 36.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.594 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 179.59 142.41 0.14 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -169.5 -135.08 1.84 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.948 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 2.8 pt -158.04 120.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.801 0.334 . . . . 0.0 110.383 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -94.82 112.99 24.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.551 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 137' ' ' ILE . 4.0 tt0 -96.45 123.94 40.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.147 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.23 149.12 32.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.572 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 tp -105.87 -47.19 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 110.542 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 m -165.72 -164.86 0.76 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -81.37 55.66 2.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.62 -59.13 0.72 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.99 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -154.89 151.36 28.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.101 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.758 ' O ' HD13 ' A' ' 137' ' ' ILE . 1.4 m -113.72 174.28 6.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.758 HD13 ' O ' ' A' ' 136' ' ' SER . 28.5 mm -134.17 134.9 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.776 ' OE2' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.96 141.52 46.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.897 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -163.07 121.41 1.02 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -174.85 -138.13 2.66 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.048 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.501 ' CE1' ' CE2' ' A' ' 171' ' ' PHE . 64.6 m-85 -132.76 161.09 34.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.756 0.312 . . . . 0.0 110.758 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.409 ' HA ' ' HG2' ' A' ' 124' ' ' GLN . 14.3 ptm180 -140.83 136.58 32.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -132.02 128.91 39.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.433 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.714 ' CD2' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -139.68 151.44 45.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.379 . . . . 0.0 111.154 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.596 HH21 HD22 ' A' ' 165' ' ' LEU . 26.5 ttt-85 -116.52 163.97 15.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.689 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.3 m -108.83 134.29 51.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.005 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -135.01 153.23 52.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.54 -50.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.04 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 61.02 91.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 p -107.74 -47.17 3.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.804 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -106.47 121.38 44.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.23 -43.18 8.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.94 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.52 139.61 31.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.27 145.66 30.81 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.468 2.112 . . . . 0.0 112.287 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -169.47 149.21 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.73 164.87 32.95 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.441 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -105.26 46.72 1.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.458 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -152.07 135.47 16.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.81 0.338 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -114.61 150.18 35.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -35.15 16.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 129.18 114.09 1.72 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.497 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.5 p -118.15 163.35 16.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.972 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 59.59 20.81 9.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 t70 178.79 82.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.856 0.36 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.596 HD22 HH21 ' A' ' 145' ' ' ARG . 1.0 OUTLIER -111.14 151.2 28.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.955 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.96 175.27 10.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.889 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.45 173.22 11.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.95 119.72 37.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.9 t -106.96 106.18 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.52 155.24 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.501 ' CE2' ' CE1' ' A' ' 141' ' ' TYR . 0.2 OUTLIER -94.2 165.36 12.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.199 0.523 . . . . 0.0 110.195 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.412 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -131.3 128.46 39.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.809 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.39 135.18 5.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.58 -142.74 6.96 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.774 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -142.88 171.99 13.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.41 ' HA ' ' HA3' ' A' ' 7' ' ' GLY . 7.8 t-20 -155.59 117.6 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -102.61 111.62 24.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.83 147.01 29.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.083 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.925 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.805 0.336 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 1.5 t0 -113.48 168.18 9.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.583 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.18 125.51 39.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.644 0.259 . . . . 0.0 110.686 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.2 OUTLIER -134.68 139.95 45.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.396 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 46' ' ' ALA . 37.9 t -150.2 131.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.982 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.36 -162.49 10.76 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.799 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -118.24 142.7 47.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 0.0 110.61 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 p -111.33 118.61 36.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.06 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -128.35 112.88 14.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.696 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -106.97 153.9 16.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.644 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -94.84 133.2 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.26 108.58 20.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.971 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.07 102.84 3.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.853 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -93.62 125.31 38.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -65.79 138.38 57.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 18' ' ' GLN . 1.7 pp -146.12 -46.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.175 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.504 ' N ' HD12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER 55.68 89.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.039 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.5 tttm -140.94 116.12 9.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.017 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.7 m -124.97 83.64 2.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -96.64 97.8 9.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 m -102.1 82.74 2.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.94 -64.68 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -130.03 161.01 31.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.27 110.79 18.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -104.76 132.01 51.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.78 -71.02 0.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.866 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 61.22 83.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.3 p 62.17 148.64 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.042 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.24 -19.39 22.54 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.599 2.199 . . . . 0.0 112.529 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.1 m120 63.02 89.12 0.09 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.957 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.72 -39.88 9.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.44 -30.08 65.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt 62.37 105.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 m -61.69 -26.44 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.212 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.4 mt 67.39 138.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.68 -27.71 12.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.975 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.22 91.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 m -117.92 95.51 4.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.02 141.1 3.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.561 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.739 HG23 ' CG1' ' A' ' 62' ' ' ILE . 7.8 m -113.38 118.43 34.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -103.99 161.75 13.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.61 -169.36 35.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.605 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 45' ' ' ARG . 2.7 mp -134.9 160.0 41.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.602 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -138.07 139.32 39.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.95 0.405 . . . . 0.0 110.593 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.696 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -171.57 120.91 0.49 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.842 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 56' ' ' TYR . . . -167.73 -141.73 3.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.832 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 15.5 pt20 -122.3 142.18 50.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.705 0.288 . . . . 0.0 110.785 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.418 ' CG ' ' HG3' ' A' ' 54' ' ' ARG . 0.8 OUTLIER -116.81 109.68 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 111.089 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -130.57 165.01 23.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.509 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -19.2 65.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.36 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.63 24.09 12.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.31 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 80' ' ' TYR . . . 155.98 142.56 3.45 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.526 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.648 ' NH2' HD22 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -136.71 162.09 34.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.319 . . . . 0.0 110.946 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.466 ' CE1' ' CD ' ' A' ' 54' ' ' ARG . 8.9 m-85 77.05 -175.81 0.1 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 3.4 t80 178.65 -43.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.902 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -122.43 136.96 55.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 111.396 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.13 119.69 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.565 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -113.55 149.98 33.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.01 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.34 155.91 44.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -166.8 124.92 1.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.985 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.739 ' CG1' HG23 ' A' ' 41' ' ' THR . 3.5 mt -126.91 134.85 65.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.129 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.82 -67.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.3 -74.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.979 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 t -69.55 147.11 51.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -86.03 -24.57 26.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -95.71 26.93 3.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.119 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.7 91.31 0.11 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.476 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.01 138.07 53.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.91 27.68 16.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.981 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 tp -177.84 85.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.94 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.528 ' NH2' HD21 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -170.1 -42.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.894 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -142.2 124.87 15.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.992 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -118.75 130.5 55.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.689 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.74 119.37 24.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.43 114.93 17.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.324 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.487 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.5 OUTLIER -142.93 168.87 18.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 111.399 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.97 116.74 4.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.903 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 56' ' ' TYR . 3.5 m -104.67 126.59 51.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.971 0.415 . . . . 0.0 111.484 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 63.4 t80 -136.57 110.89 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.198 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -129.21 171.87 12.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.029 0.442 . . . . 0.0 111.651 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.81 119.76 35.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.565 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 50.3 p90 -97.76 172.17 7.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.098 0.475 . . . . 0.0 111.809 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tp -165.09 135.45 3.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.391 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.54 119.26 4.89 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.548 2.165 . . . . 0.0 112.203 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.597 ' O ' HG23 ' A' ' 86' ' ' ILE . 8.9 tt -128.13 108.74 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.2 -57.57 0.57 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -166.57 -59.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.754 0.311 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.74 38.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.793 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -129.77 -68.01 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.733 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.571 HG23 ' HG2' ' A' ' 129' ' ' GLN . 0.5 OUTLIER -67.86 145.09 54.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.348 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 3.6 mmpt? -126.63 92.32 3.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 111.272 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.585 HD13 HD13 ' A' ' 86' ' ' ILE . 1.8 tp -60.54 103.25 0.23 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.051 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 16.6 p90 -110.73 161.76 15.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.292 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.44 126.57 1.05 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.559 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.06 -134.38 1.64 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.621 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -141.06 157.81 44.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.883 0.373 . . . . 0.0 111.324 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -134.79 161.86 33.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.732 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.29 132.76 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -158.68 -144.69 4.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.986 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.21 130.09 9.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 110.388 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.63 132.84 56.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.178 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.12 130.22 52.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.816 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.528 HD21 ' NH2' ' A' ' 72' ' ' ARG . 6.8 tp -114.5 136.14 53.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -161.17 136.34 7.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -137.17 129.81 30.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.39 110.61 2.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.872 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.34 157.5 27.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.441 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -114.98 89.86 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.93 -65.19 0.32 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -90.16 171.76 9.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.312 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -140.87 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.14 170.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.163 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.0 p30 -135.19 27.65 3.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.3 p -167.75 -78.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.639 ' O ' HG13 ' A' ' 117' ' ' VAL . 1.0 OUTLIER 79.89 -8.73 1.51 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.777 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 116' ' ' ASP . 2.8 m -162.77 117.87 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.762 0.315 . . . . 0.0 110.993 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -136.51 131.61 5.73 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.546 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -84.17 117.73 23.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.803 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.678 ' HB2' HG22 ' A' ' 146' ' ' THR . . . -109.86 145.13 37.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 141.32 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.954 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.01 -137.08 2.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.541 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 97' ' ' ALA . 3.8 mp -145.2 153.31 41.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.195 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -133.71 172.55 12.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.622 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.89 142.49 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.054 0.454 . . . . 0.0 110.69 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.597 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -169.41 -134.33 1.72 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.721 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 126' ' ' GLY . 10.8 pt -161.22 120.48 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.318 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.648 HD22 ' NH2' ' A' ' 54' ' ' ARG . 1.8 tt -95.88 113.32 24.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 111.201 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.571 ' HG2' HG23 ' A' ' 91' ' ' THR . 30.7 mt-30 -100.31 139.27 36.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.756 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -93.34 149.15 21.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.002 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.41 -43.89 2.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 110.584 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 m -142.2 -164.72 1.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.361 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.41 28.8 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.162 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 177.84 34.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.773 0.32 . . . . 0.0 111.132 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.23 129.09 1.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.815 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.1 m -142.97 169.71 17.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.004 0.431 . . . . 0.0 111.29 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 129' ' ' GLN . 0.6 OUTLIER -132.52 134.78 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.247 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -128.18 149.19 50.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.925 0.393 . . . . 0.0 111.162 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.647 ' HA3' HD22 ' A' ' 173' ' ' LEU . . . -165.8 152.8 22.33 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.378 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.13 -131.72 2.22 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.698 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -135.82 152.56 51.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.762 0.315 . . . . 0.0 110.793 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -140.36 123.75 16.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 3.2 m-85 -116.98 124.28 48.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.0 171.39 16.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.182 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.1 ttt85 -152.39 144.32 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.765 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.678 HG22 ' HB2' ' A' ' 120' ' ' ALA . 82.5 p -108.99 128.88 55.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.93 115.62 9.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.04 -176.58 3.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.079 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 77.6 p -99.2 175.25 5.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -61.93 172.11 1.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.992 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.94 -31.38 7.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -172.74 -47.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.5 p -126.82 148.59 65.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.995 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.95 152.95 63.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.294 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -174.36 -42.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -80.92 97.86 1.79 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.515 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -139.46 117.51 1.37 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.465 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -138.93 133.04 31.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.804 0.335 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.21 164.96 11.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.9 92.99 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -116.21 32.54 5.55 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.496 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 81.2 p -147.51 167.88 23.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.892 0.377 . . . . 0.0 110.845 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.1 mt -101.99 31.59 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -131.13 122.07 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.88 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.55 158.13 15.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -96.71 92.88 6.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.3 m -140.89 152.47 45.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.838 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.408 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 10.6 t -107.4 150.85 26.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.953 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.83 140.65 39.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.746 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.35 155.28 33.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.081 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.58 141.57 41.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.095 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -119.84 127.51 52.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.989 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.647 HD22 ' HA3' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -163.45 129.87 3.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.465 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.76 -156.94 20.1 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.658 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.25 171.98 8.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.84 0.352 . . . . 0.0 111.159 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.451 ' ND2' ' CD1' ' A' ' 5' ' ' PHE . 2.0 t30 -150.8 114.96 5.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -115.38 122.17 45.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.162 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.93 162.91 22.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.224 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.942 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.888 0.375 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -97.29 168.47 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.667 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.82 118.53 37.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.785 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 1.7 m-85 -124.02 145.11 49.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.003 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 5' ' ' PHE . 13.3 m -158.15 125.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.181 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.02 -149.06 5.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.64 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.1 159.66 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.819 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.61 127.72 35.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 36.9 t90 -128.33 112.99 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.687 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.83 168.58 13.99 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -110.48 130.61 55.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 13' ' ' THR . 9.8 t -102.21 113.82 27.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.973 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.08 102.88 3.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.746 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -105.36 101.64 11.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -92.27 134.38 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.855 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 pp -138.28 173.94 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.65 108.78 1.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -131.34 -46.57 0.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -82.53 161.46 22.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.53 132.46 10.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.1 t 61.48 30.5 18.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.38 -39.55 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -140.67 -177.97 5.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -166.3 163.74 17.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -99.77 34.8 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.31 73.94 1.43 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -176.67 -66.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 p -148.25 95.08 4.14 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.14 98.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.469 2.113 . . . . 0.0 112.313 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -92.89 -73.19 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.77 -78.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.37 97.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.815 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -128.04 -71.1 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 36' ' ' ILE . 10.5 p -176.21 -41.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.781 HD11 ' OG1' ' A' ' 39' ' ' THR . 1.7 pt -156.76 27.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 57.82 64.49 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m120 60.71 156.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.781 ' OG1' HD11 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -134.31 -67.41 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.879 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.407 ' HA2' HG22 ' A' ' 13' ' ' THR . . . 129.38 -161.77 22.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.439 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.602 HG21 ' OE1' ' A' ' 170' ' ' GLN . 33.8 m -137.16 107.86 6.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.426 ' CE3' ' CD1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -120.35 146.55 46.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.27 -164.83 25.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.512 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.649 HD12 ' HB3' ' A' ' 59' ' ' TYR . 3.0 mp -107.0 161.16 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 110.95 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.684 HH11 HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -130.8 137.17 49.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.996 0.427 . . . . 0.0 110.693 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -174.16 122.51 0.3 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.825 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.64 -145.47 4.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.656 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -146.45 126.1 13.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.0 111.009 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -94.13 109.6 21.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.096 0.474 . . . . 0.0 111.278 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 0.2 OUTLIER -105.09 155.2 19.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.474 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.38 -18.6 65.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.384 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -130.68 24.26 5.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.318 . . . . 0.0 111.172 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.72 163.62 23.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.931 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -145.0 141.04 28.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.93 0.395 . . . . 0.0 111.532 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.35 146.61 26.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.035 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CD1' ' NE ' ' A' ' 45' ' ' ARG . 6.7 m-85 -143.87 96.9 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.381 . . . . 0.0 111.683 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -90.87 139.25 30.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.099 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.684 HG23 HH11 ' A' ' 45' ' ' ARG . 0.2 OUTLIER -139.75 124.93 18.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.067 0.461 . . . . 0.0 111.714 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.649 ' HB3' HD12 ' A' ' 44' ' ' ILE . 3.3 t80 -101.5 104.67 15.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.846 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.95 153.63 19.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.086 0.47 . . . . 0.0 111.489 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.99 -164.78 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.461 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.491 HG23 ' CB ' ' A' ' 73' ' ' GLN . 1.2 pt -109.34 108.92 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.148 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m 58.94 -84.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.067 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -179.65 -176.93 0.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -101.31 33.85 2.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.911 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.0 t -90.93 -11.45 39.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.393 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t -96.08 27.02 3.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.717 0.294 . . . . 0.0 111.131 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.41 -142.87 42.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.606 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.56 121.68 41.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -176.7 -39.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -137.1 146.67 45.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.92 123.75 6.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.803 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.491 ' CB ' HG23 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -131.54 155.09 48.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -140.81 121.06 13.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.461 ' CG ' HG23 ' A' ' 102' ' ' VAL . 1.5 m-20 -124.89 111.06 15.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.002 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -118.96 116.95 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.654 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.4 ' CB ' ' HA3' ' A' ' 100' ' ' GLY . 3.9 pp -135.38 146.3 48.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 0.0 111.405 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.18 116.9 4.23 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.956 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.4 p -105.9 119.95 40.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.629 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.45 110.88 23.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.963 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.419 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 1.7 m-20 -128.08 161.11 29.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.147 0.499 . . . . 0.0 111.842 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.85 119.12 38.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.221 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 35.1 p90 -97.32 158.11 15.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.994 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.518 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -165.33 125.98 1.33 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.733 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 91' ' ' THR . 52.7 Cg_exo -52.99 100.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.614 2.209 . . . . 0.0 112.229 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 84' ' ' LEU . 18.8 tt -157.28 127.1 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.113 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.0 -83.25 0.2 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.786 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.95 -63.13 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.991 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -169.44 -40.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.986 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 18.4 m120 -121.86 17.98 11.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.539 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 7.6 p -79.47 153.29 29.72 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -130.73 92.1 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.999 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -64.26 102.06 0.48 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.771 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 46.3 p90 -111.92 120.94 43.63 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.604 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -140.72 147.35 18.99 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.777 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.46 -139.08 3.52 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.813 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.57 176.2 5.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.891 0.377 . . . . 0.0 111.182 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 p -146.48 145.54 30.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.07 131.15 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 77' ' ' LEU . . . -154.53 -151.89 5.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.652 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.07 125.82 7.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.797 0.332 . . . . 0.0 110.746 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.461 HG23 ' CG ' ' A' ' 75' ' ' ASN . 11.1 p -110.31 142.83 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.252 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -153.48 138.23 17.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.97 146.01 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.945 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.28 133.48 14.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.83 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.56 138.59 43.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.2 p30 -176.73 -178.16 0.86 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -114.27 -39.59 1.02 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.498 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -126.01 -63.01 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.52 37.22 0.68 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.465 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -89.12 173.05 8.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.855 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.48 132.64 9.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -134.13 -65.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -114.43 102.85 10.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.952 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.6 t -177.41 133.82 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.676 ' O ' HG13 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -149.78 -83.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 116' ' ' ASP . 1.9 m -164.04 169.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.815 0.341 . . . . 0.0 111.245 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -142.72 149.6 21.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.335 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -119.24 114.97 23.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.02 139.23 48.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.75 130.61 5.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -175.43 -138.19 2.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.407 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 1.7 mp -148.04 171.31 16.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -152.17 168.74 24.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.957 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . -175.15 142.06 0.6 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.96 0.41 . . . . 0.0 110.554 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -168.28 -146.74 5.08 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.783 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.8 pp -161.04 120.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.773 HD12 ' HB3' ' A' ' 138' ' ' GLU . 2.1 tt -95.95 113.41 25.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.942 0.401 . . . . 0.0 111.19 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.435 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 2.4 tt0 -95.17 115.84 27.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.14 149.21 24.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mp -107.66 -39.67 5.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.691 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.1 p -169.05 -164.88 0.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.395 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -83.55 55.16 3.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.865 0.364 . . . . 0.0 110.73 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -140.35 -59.99 0.53 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.002 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.47 157.33 27.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.414 ' OG ' HD21 ' A' ' 128' ' ' LEU . 51.1 p -135.4 -177.3 4.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 175' ' ' ALA . 2.4 pt -129.65 134.82 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.617 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.773 ' HB3' HD12 ' A' ' 128' ' ' LEU . 1.6 pt-20 -123.86 140.62 52.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -162.46 143.94 9.2 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.392 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.07 -144.94 5.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.649 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.75 158.38 40.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.402 ' CZ ' HD21 ' A' ' 144' ' ' LEU . 4.3 ptm180 -144.67 140.26 28.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 2.8 p90 -145.06 105.06 4.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.969 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.402 HD21 ' CZ ' ' A' ' 142' ' ' ARG . 0.2 OUTLIER -139.85 153.97 47.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -108.58 147.86 31.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.839 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.84 126.7 50.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.961 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -141.04 115.12 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.73 157.68 17.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.118 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.7 t -82.92 79.49 9.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.94 -64.7 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -161.56 152.44 18.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -67.44 167.49 12.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.6 t -117.59 132.71 23.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.33 164.88 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.427 2.084 . . . . 0.0 112.284 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -139.72 130.92 26.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -136.16 -117.0 1.63 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -134.52 -147.25 5.55 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.497 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -145.77 -178.74 6.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 110.92 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -130.36 -54.57 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.1 167.13 22.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -95.94 37.2 3.5 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.2 m -152.28 153.49 33.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.754 0.311 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.78 -173.23 4.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.94 100.65 2.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.785 HD23 ' HB2' ' A' ' 167' ' ' SER . 1.2 tp -59.41 130.58 47.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -99.9 30.39 3.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.785 ' HB2' HD23 ' A' ' 165' ' ' LEU . 2.0 m -78.4 175.39 10.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.898 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.61 125.16 50.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.964 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 72.3 p -106.94 120.55 42.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.694 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.602 ' OE1' HG21 ' A' ' 41' ' ' THR . 1.7 mt-30 -146.66 155.15 42.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.985 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -104.58 165.38 11.1 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.14 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.431 ' OH ' HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -131.47 127.27 37.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.044 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.52 129.95 3.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.471 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.84 -152.74 15.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.747 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -124.86 171.9 9.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 111.218 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.442 HD21 ' HD1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -149.65 114.92 5.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -106.2 114.22 28.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.0 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.95 163.39 22.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.024 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 6' ' ' VAL . 4.2 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.412 ' CB ' ' HB3' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -94.2 168.17 11.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.862 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -112.08 132.88 54.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.801 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 8.7 m-85 -131.41 139.59 49.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.973 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 27.1 t -156.14 125.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.081 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 176' ' ' ASN . . . -170.98 -128.12 1.0 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.739 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -159.19 167.91 27.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.748 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.45 150.22 35.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.982 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -110.47 117.09 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.823 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.5 137.51 13.73 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.529 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.05 116.94 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 0.0 110.917 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.517 HG22 ' OE1' ' A' ' 170' ' ' GLN . 73.3 p -121.9 106.43 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.962 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.11 102.87 3.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.84 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -117.24 136.97 52.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.793 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -91.23 124.6 35.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.67 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -131.12 -37.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.374 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -164.17 -176.81 4.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.331 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -107.79 153.72 22.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.3 p -151.41 177.09 10.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.815 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.63 133.31 16.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.9 t -109.99 92.11 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tp -100.95 31.54 3.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.808 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -99.49 -67.14 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.818 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -77.14 114.99 16.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.65 -68.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 60.58 161.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.405 ' H ' HD23 ' A' ' 27' ' ' LEU . 13.4 m-80 -131.3 102.67 6.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.978 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.7 t -149.55 137.98 12.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.734 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.62 -49.85 15.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.406 2.071 . . . . 0.0 112.297 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.49 -179.77 6.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.81 91.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -177.53 -45.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -97.04 -14.03 21.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.329 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.5 m -96.07 28.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.312 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.614 ' O ' HD12 ' A' ' 36' ' ' ILE . 1.3 pp -143.94 84.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.126 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -103.16 -76.06 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -105.72 115.02 29.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -72.71 -54.22 9.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.68 -138.49 9.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.435 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.1 p -137.72 107.99 6.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -91.6 131.22 37.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.682 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.9 -175.81 20.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.796 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.526 HG22 ' H ' ' A' ' 45' ' ' ARG . 4.0 mt -106.94 168.6 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.56 0.219 . . . . 0.0 110.698 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.526 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -138.4 142.78 39.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.051 0.453 . . . . 0.0 110.828 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -170.48 120.23 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -161.57 -156.8 8.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.577 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.46 ' HB2' ' CE2' ' A' ' 55' ' ' TYR . 5.9 mt-30 -141.44 133.39 27.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.087 0.47 . . . . 0.0 111.074 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.453 ' CG ' ' HB3' ' A' ' 54' ' ' ARG . 2.8 tt0 -83.55 162.06 20.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.849 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.02 -169.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.647 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -67.24 -40.37 86.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.237 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -123.18 -26.61 4.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.732 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -124.29 -159.83 10.56 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.689 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.453 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -171.64 168.09 6.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.632 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -141.23 166.68 24.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.424 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.613 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 41.3 p90 177.92 135.73 0.08 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.092 0.473 . . . . 0.0 110.888 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.51 155.78 18.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.257 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 77.1 p -137.58 123.78 20.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.055 0.455 . . . . 0.0 111.454 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.495 ' HD2' HD12 ' A' ' 44' ' ' ILE . 9.4 m-85 -89.89 108.69 19.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.173 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -105.99 178.68 4.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.092 0.472 . . . . 0.0 111.503 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -164.36 -164.67 0.87 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.54 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.578 HD11 ' OE1' ' A' ' 73' ' ' GLN . 1.3 pt -121.47 117.65 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 111.199 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.82 82.9 1.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.84 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -90.84 -65.19 1.04 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 t -99.09 140.56 33.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.97 -31.95 34.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.24 -29.82 24.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.48 46.47 2.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.467 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -76.65 122.13 24.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.861 0.363 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -161.84 147.54 13.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.8 87.18 6.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -105.27 -30.39 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.977 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.578 ' OE1' HD11 ' A' ' 62' ' ' ILE . 2.7 mt-30 -116.49 169.09 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -151.21 131.34 13.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.503 ' OD1' HG12 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -120.02 110.87 17.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.805 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.17 115.72 30.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.638 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.436 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 1.8 mp -133.12 133.66 43.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.4 . . . . 0.0 111.298 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.89 116.91 4.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.944 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.6 t -105.25 135.6 46.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 111.576 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -128.71 110.95 12.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.899 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 1.6 p30 -136.52 172.13 13.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.233 0.54 . . . . 0.0 111.866 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.508 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -115.42 121.89 44.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.547 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 18.9 p90 -97.71 164.66 12.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.737 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.664 ' CD2' HD11 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -167.04 128.15 1.23 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.389 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.57 106.92 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.445 2.097 . . . . 0.0 112.362 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.664 HD11 ' CD2' ' A' ' 84' ' ' LEU . 37.2 mt -150.23 120.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.988 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 149.22 -78.72 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.422 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.02 -72.99 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.794 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -170.43 31.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.144 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -172.31 31.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.295 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.5 p -136.59 130.51 32.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.714 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -117.31 92.82 3.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.896 0.379 . . . . 0.0 110.881 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.585 HD12 HG22 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -56.17 103.02 0.09 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.596 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 22.6 p90 -110.93 156.17 21.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.802 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.43 135.21 2.94 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.712 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.404 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -168.91 -137.59 2.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.653 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -124.87 161.74 25.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.855 0.359 . . . . 0.0 111.19 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.512 ' C ' HD12 ' A' ' 99' ' ' LEU . 23.7 m -139.49 148.63 42.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.512 HD12 ' C ' ' A' ' 98' ' ' THR . 4.5 mp -157.1 130.82 8.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.667 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -141.46 -162.7 9.26 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.121 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' ' 100' ' ' GLY . 5.5 mp -155.6 142.54 19.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.885 HG22 ' HA3' ' A' ' 118' ' ' GLY . 35.0 m -109.56 145.41 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.416 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.88 145.06 39.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.553 HD21 ' HG2' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -118.84 103.63 9.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.883 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.31 166.39 11.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.65 177.98 7.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.39 158.16 44.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.84 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.77 46.11 1.06 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.497 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm 59.52 32.44 21.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.55 111.26 3.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.448 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -103.77 149.71 24.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.72 155.39 40.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -87.59 -63.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.66 118.46 9.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.808 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.5 p -173.87 154.14 2.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.1 t0 61.73 76.67 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.955 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.58 100.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.885 ' HA3' HG22 ' A' ' 102' ' ' VAL . . . -161.11 132.4 2.86 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.275 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -113.97 114.97 26.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.876 0.37 . . . . 0.0 111.05 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.73 138.24 54.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.746 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.96 132.75 5.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.448 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.65 ' O ' HD23 ' A' ' 123' ' ' LEU . . . -173.39 -140.05 3.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.765 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 122' ' ' GLY . 13.3 mt -147.64 164.78 32.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 14.9 mt-30 -149.74 170.54 18.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.704 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.92 142.56 0.08 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.988 0.423 . . . . 0.0 110.851 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -164.53 -128.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.759 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.585 HG22 HD12 ' A' ' 93' ' ' LEU . 12.6 pt -160.59 121.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 120.794 0.33 . . . . 0.0 110.296 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 128' ' ' LEU . 5.0 tt -94.48 113.28 25.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.008 0.432 . . . . 0.0 110.857 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -95.63 124.18 39.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -111.56 149.14 31.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.7 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.6 tp -108.24 -45.9 3.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.118 0.485 . . . . 0.0 110.635 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.7 p -169.21 -164.85 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.189 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.55 54.96 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.913 0.387 . . . . 0.0 110.569 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -138.25 -58.2 0.65 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.16 171.95 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.197 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.9 m -141.03 167.73 21.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.764 HG23 ' O ' ' A' ' 174' ' ' GLY . 5.4 mt -129.26 134.87 63.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.444 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -127.95 132.09 49.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . -155.28 144.49 11.08 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.554 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 171' ' ' PHE . . . 176.14 -151.41 11.58 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.366 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 170' ' ' GLN . 0.2 OUTLIER -119.75 153.45 35.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.902 0.382 . . . . 0.0 110.916 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.424 ' HB3' ' CE1' ' A' ' 172' ' ' TYR . 29.1 ptt180 -131.89 129.99 41.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' A' ' 169' ' ' SER . 7.3 t80 -128.59 102.23 6.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.779 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.404 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 0.6 OUTLIER -150.72 164.04 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.196 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.2 153.89 18.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.718 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.3 t -108.89 172.12 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -56.15 115.21 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.84 95.57 8.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.419 ' OG ' HG22 ' A' ' 153' ' ' THR . 0.2 OUTLIER 60.83 172.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.7 p -135.95 -55.25 0.77 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -150.71 135.71 17.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.99 104.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.419 HG22 ' OG ' ' A' ' 149' ' ' SER . 44.3 p -108.25 91.87 8.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.97 92.78 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.484 2.122 . . . . 0.0 112.317 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.28 153.24 43.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -76.18 -65.82 1.96 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.53 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 107.33 98.96 2.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.459 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -76.31 -179.32 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 30.83 6.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.852 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mt -147.07 -49.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 176.48 177.78 45.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.2 p -152.28 129.44 11.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.762 0.315 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 60.52 178.71 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.69 -64.26 0.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.1 tp -128.71 143.87 51.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.93 33.57 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 143' ' ' TYR . 4.6 m -110.05 176.05 5.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.807 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.5 m -157.53 132.48 8.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.438 ' HB3' ' CD2' ' A' ' 143' ' ' TYR . 83.4 p -107.9 122.59 47.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.805 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.517 ' OE1' HG22 ' A' ' 13' ' ' THR . 1.6 mt-30 -141.58 152.11 43.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 140' ' ' GLY . 2.7 t80 -100.04 120.55 40.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.265 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 142' ' ' ARG . 9.7 p90 -125.07 126.44 45.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.234 0.54 . . . . 0.0 111.428 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.612 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 1.4 pt? -147.46 155.47 41.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.858 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 137' ' ' ILE . . . -176.73 -132.73 1.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.401 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.85 169.41 16.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 0.0 111.128 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.41 ' HA ' ' HA3' ' A' ' 7' ' ' GLY . 4.3 t-20 -158.05 118.35 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.022 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -101.57 118.27 36.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -87.16 154.79 20.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.798 0.333 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.8 OUTLIER -110.06 151.53 27.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.661 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -112.28 119.19 37.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.744 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 29.0 p90 -124.05 155.29 38.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.256 0.55 . . . . 0.0 111.469 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 46' ' ' ALA . 7.5 p -151.91 128.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.732 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.74 -141.6 3.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.373 -0.917 . . . . 0.0 112.754 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.5 165.54 23.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.896 0.379 . . . . 0.0 110.799 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.632 HG23 ' HB2' ' A' ' 45' ' ' ARG . 24.1 p -129.17 143.95 51.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -140.9 112.96 7.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.689 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.88 135.24 10.98 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.6 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -79.93 125.42 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 110.823 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -110.75 119.16 38.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -150.12 102.79 3.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.717 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.06 -64.53 1.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -74.51 131.9 41.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.11 124.54 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -173.39 164.29 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.857 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.21 124.69 45.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -136.54 31.57 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.5 129.22 19.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -90.17 118.09 29.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.975 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.708 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.65 173.78 8.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.973 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -120.77 138.14 54.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 mtt-85 -115.51 -178.37 3.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -176.83 -52.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -162.92 -44.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -88.78 115.58 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.6 116.19 60.38 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.801 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.06 93.39 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.341 2.027 . . . . 0.0 112.306 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -118.07 127.54 53.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 60.78 74.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -110.81 -49.89 3.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -158.1 78.07 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.663 ' C ' HD12 ' A' ' 36' ' ' ILE . 21.4 t -121.92 -66.15 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.176 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.663 HD12 ' C ' ' A' ' 35' ' ' VAL . 3.3 mp 69.18 -67.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.22 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.3 153.29 0.93 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -136.94 -56.87 0.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.73 142.72 33.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.31 -159.18 23.73 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.2 p -119.2 139.43 51.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 111.028 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -148.45 139.94 23.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -177.3 -164.89 31.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.605 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 45' ' ' ARG . 3.2 mt -106.86 161.74 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.584 0.23 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.632 ' HB2' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -140.99 148.7 40.74 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.606 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.865 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -177.22 124.38 0.14 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -161.57 -163.11 13.84 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.308 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 3.4 mp0 -118.34 125.97 51.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 0.0 111.001 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.477 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 37.5 tt0 -111.79 109.97 20.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.196 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -119.41 160.11 22.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.521 179.339 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.75 -23.29 64.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.197 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -99.29 24.09 8.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.242 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 50' ' ' PHE . . . 133.4 164.57 10.83 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.337 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.401 ' NE ' ' CZ ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -139.44 146.03 39.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.918 0.39 . . . . 0.0 111.314 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -129.78 161.23 31.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.408 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.576 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 15.9 p90 -176.97 126.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.166 0.508 . . . . 0.0 111.525 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.71 139.06 31.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.284 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 51.3 m -129.57 117.29 20.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 111.529 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -94.32 117.17 29.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.319 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -111.82 175.4 5.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 111.266 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.08 -166.85 1.35 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.731 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.7 mt -100.1 118.86 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.101 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.0 m -82.86 -55.17 4.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.87 137.71 46.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 65' ' ' THR . 3.5 t -128.25 106.43 9.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 t -68.65 -40.24 80.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -61.0 -36.96 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.29 42.37 83.16 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.561 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -100.05 171.76 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -102.83 81.52 2.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.743 HD21 HD21 ' A' ' 104' ' ' LEU . 4.1 tt -163.86 136.43 5.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -135.89 151.9 50.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.999 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -127.25 -178.43 4.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -121.38 139.53 53.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.578 ' HA ' HG12 ' A' ' 102' ' ' VAL . 4.1 m120 -114.57 112.54 23.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 tt -98.28 114.95 27.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.49 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -118.11 113.58 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.278 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.01 116.95 4.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.623 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.798 ' OG ' HG22 ' A' ' 98' ' ' THR . 12.3 m -126.41 143.02 51.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 0.0 111.831 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -131.79 110.67 11.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.502 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.451 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 15.8 m-20 -130.55 166.06 21.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.214 0.531 . . . . 0.0 112.017 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.08 127.95 53.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.045 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 45.4 p90 -97.36 168.72 10.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.143 0.497 . . . . 0.0 111.778 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 86' ' ' ILE . 7.4 tp -158.9 132.4 4.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.235 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.17 106.04 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.32 2.014 . . . . 0.0 112.401 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.704 HD11 HD23 ' A' ' 84' ' ' LEU . 42.7 mm -119.08 103.39 14.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.002 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 119.29 -95.08 0.59 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.537 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -169.5 59.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 64.23 25.2 13.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.63 -36.37 6.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.545 HG22 HD12 ' A' ' 127' ' ' ILE . 14.5 p -136.48 142.7 43.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.463 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 13.6 mmtt -123.52 98.92 6.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 7.8 tt -55.32 104.54 0.13 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.381 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -109.42 145.88 35.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.606 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.21 140.54 6.47 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.067 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 179.45 -146.82 7.29 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.004 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.444 ' HA ' HD23 ' A' ' 123' ' ' LEU . . . -109.07 -178.02 3.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 111.257 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.798 HG22 ' OG ' ' A' ' 79' ' ' SER . 0.8 OUTLIER -145.51 161.44 39.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 12.4 mt -147.86 130.27 15.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.34 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 120' ' ' ALA . . . -130.37 123.64 4.02 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.378 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.591 HD11 ' CD2' ' A' ' 119' ' ' TYR . 2.0 tp -143.87 120.9 11.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.845 0.355 . . . . 0.0 110.743 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 75' ' ' ASN . 4.9 m -109.8 145.26 16.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.138 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.24 137.18 52.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.956 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.743 HD21 HD21 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -118.09 131.44 56.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -145.01 149.74 35.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -113.88 155.21 26.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.57 -173.87 2.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.22 159.99 1.59 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.508 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.83 148.85 39.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 146.44 -165.51 28.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -92.54 124.97 36.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.88 102.86 4.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -124.83 -40.5 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.87 161.9 1.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.161 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.0 p -169.74 154.81 5.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.63 83.3 2.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.56 106.58 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.62 149.42 19.23 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.48 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.591 ' CD2' HD11 ' A' ' 101' ' ' LEU . 64.3 m-85 -114.25 127.93 56.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.719 ' HB1' HD12 ' A' ' 144' ' ' LEU . . . -133.86 148.82 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.11 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -171.98 134.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.85 -124.9 0.74 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.615 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 97' ' ' ALA . 86.7 mt -141.05 169.65 17.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.65 153.49 24.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.376 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -178.26 142.57 0.26 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.131 0.491 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -163.12 -125.0 0.74 Allowed Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.553 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.7 pt -160.79 120.62 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.708 0.29 . . . . 0.0 110.351 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 136' ' ' SER . 1.2 tt -95.0 115.21 27.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.446 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -94.58 152.97 18.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.215 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -108.13 149.08 28.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 tp -121.0 -39.1 2.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.929 0.395 . . . . 0.0 110.824 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 t -158.96 -164.57 1.44 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.353 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.41 30.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.102 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.6 p30 178.32 34.96 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.16 119.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.714 ' HB3' HD21 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -128.74 172.1 11.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.989 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 174' ' ' GLY . 3.9 mp -137.64 135.55 46.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 127.57 51.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -146.74 122.77 1.66 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.291 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.98 -147.61 5.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.885 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -135.85 161.13 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 0.0 110.922 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -133.25 149.03 52.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.667 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.76 109.97 5.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.719 HD12 ' HB1' ' A' ' 120' ' ' ALA . 1.2 pt? -151.89 164.6 36.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.068 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -112.35 146.61 37.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.846 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.28 130.39 55.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -141.14 125.16 17.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.26 95.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.46 174.87 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 t -141.55 -50.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.826 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -96.33 89.46 5.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 8.5 mmt -97.91 140.3 32.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 40.1 p -94.67 105.9 21.24 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.92 132.85 27.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.383 2.055 . . . . 0.0 112.374 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -95.8 144.92 25.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.79 -79.71 0.11 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.547 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.07 28.38 18.1 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.527 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -172.92 -44.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.851 0.358 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -147.99 118.85 7.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.4 147.32 36.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -155.48 161.1 30.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.436 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.3 t -73.45 142.15 46.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.36 -178.7 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -87.01 130.51 34.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.6 tp -158.27 -178.3 7.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.817 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -131.84 156.74 45.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.4 m -111.35 174.81 5.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.813 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -128.16 157.24 41.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.958 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 11.7 m -107.0 131.23 54.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.774 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -138.68 155.2 48.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -114.21 165.17 12.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.056 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.508 ' O ' HD12 ' A' ' 173' ' ' LEU . 8.3 t80 -138.35 129.34 26.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.252 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 172' ' ' TYR . 0.3 OUTLIER -163.66 129.89 3.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.596 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 137' ' ' ILE . . . 178.35 -156.0 18.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.775 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -129.6 171.96 12.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 111.008 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -151.56 116.1 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.91 111.77 24.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.712 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 3.7 mttp -81.86 150.91 27.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.226 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.767 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.874 0.369 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.52 168.09 10.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -112.13 142.03 45.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.815 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.555 ' O ' HG13 ' A' ' 6' ' ' VAL . 18.0 m-85 -131.24 142.18 50.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.773 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 5' ' ' PHE . 5.0 m -159.52 121.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.156 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.56 -140.33 2.89 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.652 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.21 146.93 49.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.2 m -116.74 129.36 56.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -124.75 112.97 17.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.682 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.1 134.41 11.71 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.719 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.02 117.57 31.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.834 0.349 . . . . 0.0 110.777 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 m -113.96 147.09 39.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 m -150.05 102.86 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -155.22 146.89 23.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -78.54 103.18 8.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 pt -113.59 30.86 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -155.62 110.74 2.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.32 146.74 52.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.838 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -143.82 172.4 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -92.06 -32.94 14.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.57 136.19 35.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mt -151.74 167.73 27.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -141.18 147.64 38.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.23 35.19 3.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -147.54 -56.87 0.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.06 136.32 37.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -97.16 139.5 33.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.423 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -71.19 -58.84 3.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 29' ' ' SER . 59.8 Cg_endo -72.68 114.85 4.13 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.426 2.084 . . . . 0.0 112.342 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -106.57 156.63 18.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.11 82.31 7.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.5 26.86 3.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.87 43.5 18.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.034 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.3 t -120.09 -66.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.9 mt -118.62 90.63 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.158 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -107.24 -55.97 2.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -177.31 -178.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -84.58 -170.32 3.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.846 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' H ' HG22 ' A' ' 39' ' ' THR . . . 176.91 144.85 5.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.57 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.05 127.92 53.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -125.34 123.59 39.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.79 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.36 -164.85 16.09 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.553 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 pt -107.04 162.03 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 111.087 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.709 ' HG2' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -129.31 138.94 51.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.759 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.802 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -168.61 119.86 0.78 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.62 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.49 -159.33 8.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.945 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -143.26 116.67 9.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 0.0 110.74 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' HA ' ' CG ' ' A' ' 54' ' ' ARG . 0.8 OUTLIER -83.79 148.34 27.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.22 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -132.42 -166.74 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.291 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.62 -47.18 84.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.225 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -135.91 12.01 3.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.821 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -148.1 153.58 25.36 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.561 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.469 ' NH2' ' CD1' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -141.72 144.65 34.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.607 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -89.29 153.71 20.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.012 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.456 ' CE1' ' HD2' ' A' ' 54' ' ' ARG . 58.2 m-85 -133.24 103.34 5.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.362 . . . . 0.0 111.422 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -113.29 122.74 48.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.318 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.709 HG22 ' HG2' ' A' ' 45' ' ' ARG . 2.2 p -141.1 128.96 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.048 0.451 . . . . 0.0 111.268 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.639 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 3.1 m-85 -89.42 119.27 29.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.078 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -101.92 163.51 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.943 0.402 . . . . 0.0 111.54 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -145.08 -171.04 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.637 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.526 HD11 ' HG3' ' A' ' 73' ' ' GLN . 33.1 mm -100.1 118.26 46.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.179 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.7 t -102.23 107.1 18.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -153.87 125.05 7.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.55 -28.9 8.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.949 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 p -56.73 -31.62 64.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.079 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.3 p -107.92 -30.7 8.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.44 140.25 5.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -59.5 97.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.74 84.93 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -79.34 81.51 5.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.873 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.28 -32.35 11.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.526 ' HG3' HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -110.66 167.47 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.99 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.16 163.19 35.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.709 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -144.65 112.6 6.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.639 HD11 ' CZ ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -82.99 136.92 34.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.601 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -118.72 142.52 47.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 111.205 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.612 ' H ' HD23 ' A' ' 77' ' ' LEU . . . -160.1 116.8 0.74 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.73 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.775 ' HB3' HG23 ' A' ' 98' ' ' THR . 49.5 p -139.25 143.21 37.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.468 . . . . 0.0 111.614 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 110.96 21.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.826 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -127.91 172.06 11.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.208 0.528 . . . . 0.0 111.787 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.53 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -119.11 118.8 32.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.44 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 21.9 p90 -97.73 161.53 13.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.086 0.47 . . . . 0.0 111.659 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.517 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -165.04 138.57 3.86 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.493 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.517 ' HD2' HD23 ' A' ' 84' ' ' LEU . 31.6 Cg_exo -58.8 117.74 4.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.38 2.053 . . . . 0.0 112.532 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 85' ' ' PRO . 37.5 mm -123.0 105.76 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.933 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.11 -47.67 1.01 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.411 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -175.64 -67.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 111.003 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -179.68 37.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 82.3 m-20 -124.27 -63.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.786 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 p -75.85 153.13 37.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.435 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -131.5 92.49 3.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 111.047 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.418 ' CB ' HG13 ' A' ' 86' ' ' ILE . 6.3 tt -62.2 103.12 0.35 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.316 0.579 . . . . 0.0 110.497 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.459 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 24.0 p90 -110.96 154.53 23.99 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.477 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.03 139.9 4.84 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.815 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.68 -135.31 2.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.73 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.86 155.66 20.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.775 HG23 ' HB3' ' A' ' 79' ' ' SER . 6.9 m -128.34 148.34 50.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.121 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 120.99 3.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.682 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.664 ' H ' ' HB3' ' A' ' 120' ' ' ALA . . . -127.98 -155.92 8.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.63 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.19 127.0 7.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.822 0.344 . . . . 0.0 110.661 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 102' ' ' VAL . 29.1 m -109.83 122.06 63.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HE3' HG22 ' A' ' 117' ' ' VAL . 2.1 ttmp? -141.13 144.64 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.499 HD23 ' CB ' ' A' ' 73' ' ' GLN . 0.6 OUTLIER -130.95 160.69 33.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -129.48 135.13 48.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -107.37 146.87 31.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.58 110.66 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -161.08 -171.2 26.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -145.51 97.8 3.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.77 -159.09 28.57 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.73 91.18 6.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.843 0.354 . . . . 0.0 110.876 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -118.25 140.52 49.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -144.24 -47.83 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -114.03 128.53 56.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.9 t -137.85 -60.6 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.964 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.89 46.39 1.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.418 HG22 ' HE3' ' A' ' 103' ' ' LYS . 21.4 t -74.59 109.37 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.33 162.75 12.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.82 130.28 56.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.744 ' HB1' ' CD1' ' A' ' 144' ' ' LEU . . . -100.47 140.6 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.75 131.27 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -176.28 -131.03 1.41 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.605 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mp -148.93 157.72 43.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.346 . . . . 0.0 111.004 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -143.12 164.97 28.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.748 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . 179.53 142.59 0.14 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.99 0.424 . . . . 0.0 110.699 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -164.03 -136.19 1.95 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.994 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 126' ' ' GLY . 5.1 pt -161.92 120.97 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.593 HD21 ' HB3' ' A' ' 136' ' ' SER . 9.2 tt -94.46 111.31 23.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 110.745 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 36.1 tt0 -97.07 116.85 30.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.944 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.09 148.98 21.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.995 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.8 -30.02 8.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.611 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -165.34 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.491 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.42 ' O ' ' ND2' ' A' ' 134' ' ' ASN . 2.6 mmmt -89.45 52.34 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.8 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER 178.63 -35.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.22 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.78 125.95 49.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.871 0.367 . . . . 0.0 111.216 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.593 ' HB3' HD21 ' A' ' 128' ' ' LEU . 1.2 m -126.46 163.63 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.4 mt -135.48 134.93 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.817 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.49 139.19 48.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.95 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -160.74 111.14 0.47 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.333 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -162.48 -150.18 5.92 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.07 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -139.18 161.03 38.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.433 ' HD2' HG21 ' A' ' 98' ' ' THR . 5.7 ttp-105 -137.73 140.55 40.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 142' ' ' ARG . 15.7 m-85 -140.3 115.27 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.744 ' CD1' ' HB1' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -160.53 174.01 14.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -132.82 160.38 37.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.407 HG21 HG21 ' A' ' 102' ' ' VAL . 1.1 m -109.01 127.37 54.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -140.98 132.1 26.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.92 -62.38 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.068 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 150' ' ' THR . 42.7 t -157.93 -49.22 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.961 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 149' ' ' SER . 4.5 p -158.46 163.18 37.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -153.73 -69.05 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.24 31.27 20.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 154' ' ' PRO . 81.0 p -83.36 154.55 66.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 153' ' ' THR . 52.2 Cg_endo -69.33 -179.53 2.78 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.605 2.203 . . . . 0.0 112.339 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 -55.84 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.947 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 59.69 77.11 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.559 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -64.16 -50.1 62.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -123.31 -69.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.918 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -138.3 -53.77 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.73 125.13 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 91.22 35.51 7.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.517 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.9 132.22 26.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.49 -52.09 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.84 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.7 t0 60.52 -179.63 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.62 119.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -117.37 -44.31 2.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.2 t -154.63 175.38 13.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.2 t -98.73 162.39 13.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.9 t -106.93 115.9 31.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -124.01 155.09 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -126.53 140.47 52.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.447 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.431 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -122.3 126.95 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.738 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.42 130.02 3.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.62 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.02 -153.39 18.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.849 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -122.19 172.18 8.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.32 . . . . 0.0 111.065 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -155.18 117.67 4.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.152 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -107.39 111.87 24.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.694 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . 8.8 pttt -86.87 157.96 19.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.081 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.829 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.463 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.743 0.306 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -138.22 159.69 41.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.019 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 5.3 m-80 -112.02 140.53 46.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.476 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 52.6 p90 -148.54 167.53 25.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.126 0.489 . . . . 0.0 111.661 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.673 HG13 ' HB2' ' A' ' 46' ' ' ALA . 46.2 t -155.85 137.4 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.791 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.49 -147.17 4.88 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.803 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.34 163.05 32.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.657 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.67 141.5 44.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -126.29 112.93 16.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.63 136.01 15.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.404 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.0 110.01 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 110.942 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.3 m -83.63 131.72 34.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 t -150.05 102.76 3.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.31 32.39 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -83.06 163.12 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 mt 66.21 89.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -165.34 35.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.05 171.82 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.3 p -91.42 137.08 32.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.1 mmtm -75.48 178.03 6.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 t -154.48 151.78 29.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.73 118.04 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -122.25 -59.93 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -138.94 -65.28 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -135.84 150.06 49.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.93 151.72 46.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -104.44 146.03 29.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.5 t -112.34 85.31 6.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.71 174.51 10.21 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.464 2.11 . . . . 0.0 112.336 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.655 ' O ' HD22 ' A' ' 32' ' ' LEU . 78.3 m-20 -83.36 -55.52 4.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.655 HD22 ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -139.35 111.7 7.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -94.17 -31.45 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -100.25 81.4 2.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.84 79.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.074 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 pt -148.36 129.39 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.11 -34.68 12.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 m120 60.05 160.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 p -135.76 -76.5 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.46 -141.4 14.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.7 p -142.99 107.99 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -89.78 124.97 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.764 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.19 -169.24 12.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.688 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 58' ' ' THR . 13.9 tt -119.66 162.39 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.52 0.2 . . . . 0.0 110.897 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.644 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -135.1 142.69 46.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.924 0.392 . . . . 0.0 110.73 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -169.34 119.32 0.68 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.253 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -170.61 -139.06 2.65 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.673 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -150.1 143.53 25.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.805 0.336 . . . . 0.0 110.985 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 14.1 pt20 -118.13 109.84 16.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.215 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.463 ' CD2' ' HB2' ' A' ' 2' ' ' ALA . 73.8 m-85 -87.69 166.83 14.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.805 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.15 -21.42 65.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.329 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.12 24.25 11.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.42 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.43 169.15 28.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.774 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 11.7 ttp180 -141.0 125.85 18.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.367 . . . . 0.0 111.231 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -117.6 150.07 39.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.346 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.525 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 28.2 p90 -177.97 127.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.079 0.466 . . . . 0.0 111.222 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.72 142.93 27.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.222 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 9.4 t -132.92 120.73 21.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 0.0 111.608 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.575 ' CD1' HD12 ' A' ' 76' ' ' LEU . 4.1 m-85 -91.14 123.97 34.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.194 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.03 170.44 7.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.951 0.405 . . . . 0.0 111.305 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.05 -164.94 1.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.685 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.446 ' O ' HD12 ' A' ' 62' ' ' ILE . 2.0 pp -115.99 118.91 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.12 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.46 62.85 5.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.12 -170.46 3.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.02 162.48 29.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 t -68.62 -51.33 43.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 t -87.43 -31.03 20.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.74 68.89 1.85 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.498 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.66 159.34 31.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.296 . . . . 0.0 110.884 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -170.17 -42.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.812 HD21 HD21 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -112.62 175.71 5.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.12 137.6 8.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.855 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -141.62 163.71 32.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.003 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.583 ' HG3' HD11 ' A' ' 76' ' ' LEU . 33.1 tp60 -130.32 131.56 45.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.697 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.625 ' C ' HD13 ' A' ' 76' ' ' LEU . 1.4 m120 -121.91 110.93 16.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.102 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.664 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -119.31 121.01 38.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.2 OUTLIER -142.66 157.8 44.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 111.264 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.66 116.76 3.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.266 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.66 ' HB3' HG22 ' A' ' 98' ' ' THR . 0.0 OUTLIER -97.92 122.23 40.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.879 0.371 . . . . 0.0 111.065 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -117.06 110.87 18.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.475 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.61 161.42 31.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 111.289 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -113.29 120.23 40.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.376 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 48.3 p90 -97.58 161.04 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.575 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.93 122.63 1.7 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.585 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.51 116.52 3.14 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.501 2.134 . . . . 0.0 112.308 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 86' ' ' ILE . 9.6 tt -148.54 120.59 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.089 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 125.5 -43.71 1.34 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.457 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.26 -62.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 110.905 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 175.56 -30.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -89.58 18.5 5.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.668 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.633 HG22 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -136.35 120.95 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.551 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.617 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 17.3 mmtm -119.5 92.78 3.87 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.212 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 tp -59.54 103.34 0.19 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.344 0.592 . . . . 0.0 110.758 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 36.3 p90 -110.73 159.06 17.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.885 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.81 142.11 5.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.11 -141.07 3.7 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.725 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -129.95 169.08 15.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.865 0.364 . . . . 0.0 111.147 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.66 HG22 ' HB3' ' A' ' 79' ' ' SER . 11.6 p -138.66 150.84 46.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.806 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 98' ' ' THR . 3.3 mp -160.15 132.08 6.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -150.29 -154.54 6.5 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.822 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -155.21 128.0 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 75' ' ' ASN . 27.8 m -109.85 145.0 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.237 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.06 145.03 51.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.812 HD21 HD21 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -108.1 148.85 29.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -131.54 158.83 39.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.93 155.09 37.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -143.71 124.16 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.47 -93.7 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -163.59 109.25 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.13 114.71 2.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.503 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.64 99.13 10.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 86.14 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.76 161.02 34.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.03 30.61 1.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.781 ' O ' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -116.02 -77.22 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.9 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.4 p30 44.3 31.04 0.52 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.455 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 115' ' ' SER . 11.5 p -170.01 151.47 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.47 134.52 3.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.41 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -93.49 131.72 38.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.89 149.16 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.082 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.47 135.48 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.607 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -157.97 -140.46 2.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.573 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 122' ' ' GLY . 1.1 mp -153.06 172.02 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.906 0.384 . . . . 0.0 110.806 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -155.41 161.97 40.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.821 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.707 ' HB3' ' CE1' ' A' ' 141' ' ' TYR . . . 176.94 142.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.773 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.92 -130.41 1.25 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.736 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.633 ' HB ' HG22 ' A' ' 91' ' ' THR . 1.0 OUTLIER -156.65 120.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -94.91 115.52 27.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.191 0.52 . . . . 0.0 111.14 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -98.94 114.87 27.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.618 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.45 144.35 34.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.565 HD11 HG12 ' A' ' 137' ' ' ILE . 4.8 mp -108.75 -30.53 8.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 110.431 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.24 -170.39 1.68 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.017 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -85.96 53.78 2.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.81 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 176.31 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -122.38 143.69 49.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.982 0.42 . . . . 0.0 111.731 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.46 ' HA ' HD12 ' A' ' 131' ' ' LEU . 51.0 m -156.08 164.83 37.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.687 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.565 HG12 HD11 ' A' ' 131' ' ' LEU . 29.9 pt -143.64 136.35 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.4 ' HB3' ' CG ' ' A' ' 128' ' ' LEU . 2.2 pt-20 -126.28 176.88 6.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . -174.98 143.37 6.76 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.583 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.89 -139.35 3.95 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.016 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.707 ' CE1' ' HB3' ' A' ' 125' ' ' ALA . 19.1 p90 -120.03 161.08 21.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 0.0 111.051 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.513 ' NH2' HD12 ' A' ' 144' ' ' LEU . 0.9 OUTLIER -151.11 140.36 21.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.01 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -112.01 162.9 14.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.532 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.513 HD12 ' NH2' ' A' ' 142' ' ' ARG . 5.8 tt -153.68 145.72 23.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.3 ttm-85 -126.12 152.88 45.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.64 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 p -108.84 124.88 51.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.071 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -140.96 151.49 44.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.26 166.29 33.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.79 77.49 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.832 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.7 p -111.74 175.47 5.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.97 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.9 -46.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -32.61 56.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.94 91.97 19.62 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.82 -175.82 1.3 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.528 2.152 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -124.91 -47.63 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 126.34 144.08 6.04 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.504 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -148.96 59.55 0.45 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.78 -172.39 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.351 . . . . 0.0 110.892 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.9 34.12 2.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.46 89.14 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 102.76 46.88 1.44 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.6 p -103.03 152.32 21.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.13 161.7 32.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.421 ' C ' HD12 ' A' ' 165' ' ' LEU . 4.5 t0 -66.76 -42.13 86.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.98 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.421 HD12 ' C ' ' A' ' 164' ' ' ASP . 7.8 mp -125.9 179.86 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.39 31.13 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.0 t -117.09 175.26 5.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 m -151.44 166.75 30.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 m -107.02 136.16 47.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -152.24 155.07 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 141' ' ' TYR . 88.5 m-85 -113.97 125.56 54.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.671 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -127.97 126.67 41.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.14 0.495 . . . . 0.0 111.263 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.548 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 3.1 pp -150.73 145.97 26.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.702 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.33 -149.02 6.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.674 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' A' ' 137' ' ' ILE . . . -121.0 168.74 11.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 111.175 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -153.89 116.14 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -99.14 114.87 27.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.038 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -81.42 153.78 26.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.063 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.72 168.02 12.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 179' ' ' PHE . 2.1 m120 -75.26 131.3 40.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.544 ' O ' HG13 ' A' ' 6' ' ' VAL . 10.3 t80 -126.9 139.61 52.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.802 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 5' ' ' PHE . 6.4 m -159.56 126.15 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.247 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -147.95 -144.57 4.01 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.87 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 43' ' ' GLY . 1.8 mt -126.9 158.86 35.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 m -125.61 139.28 53.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.034 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -153.1 112.98 3.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.753 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.18 131.48 9.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.516 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 109.96 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 0.0 110.845 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 m -105.26 128.42 53.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.9 t -150.06 102.81 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -160.98 -55.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -96.13 94.95 7.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.831 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.58 99.53 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.097 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -104.8 -177.47 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 60.58 94.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -123.72 -63.05 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 tppm? -115.71 38.28 3.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m 61.22 164.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.05 61.47 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m120 60.05 -175.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -117.95 138.5 52.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -155.64 153.87 30.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.2 177.07 8.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 59.87 31.63 20.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.6 p -129.64 101.47 18.68 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.15 120.14 5.23 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.562 2.175 . . . . 0.0 112.376 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -98.03 133.43 42.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -149.85 -59.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -170.32 -69.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.46 82.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 35' ' ' VAL . 14.2 t -117.6 34.62 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.027 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -126.61 118.68 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 60.16 100.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 -93.01 173.38 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.44 111.04 8.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.21 135.3 3.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.462 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.9 m -95.18 118.62 32.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -123.51 126.24 46.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.49 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -152.02 -174.42 22.66 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.685 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.42 176.83 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.605 0.241 . . . . 0.0 111.054 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.894 ' HG3' HG22 ' A' ' 58' ' ' THR . 3.2 mtp85 -135.97 145.88 46.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.042 0.449 . . . . 0.0 110.723 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -175.37 119.95 0.18 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.075 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.82 -136.91 2.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.577 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.78 113.0 8.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.39 . . . . 0.0 110.902 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.417 ' HA ' ' HB2' ' A' ' 54' ' ' ARG . 10.0 mt-30 -134.57 128.73 33.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.081 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' O ' ' CZ ' ' A' ' 83' ' ' PHE . 1.2 t80 -105.23 -166.96 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.41 -27.48 6.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 0.0 110.945 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.416 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 4.7 mt-30 -115.27 24.16 11.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.845 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 82' ' ' ALA . . . 71.82 -155.55 52.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.274 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER 161.73 -82.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.684 0.278 . . . . 0.0 110.965 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -142.46 163.19 33.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.999 0.428 . . . . 0.0 111.23 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 79' ' ' SER . 2.3 p90 -166.01 117.86 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.743 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -90.72 147.65 23.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.709 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.894 HG22 ' HG3' ' A' ' 45' ' ' ARG . 44.9 p -139.1 123.49 18.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.965 0.412 . . . . 0.0 111.071 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -91.9 124.61 36.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.5 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -117.49 163.91 15.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 111.105 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -149.17 -178.18 6.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.778 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.86 122.2 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.2 m 61.15 96.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.066 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.42 81.37 0.53 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.757 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.5 m -150.03 -61.8 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.9 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -83.97 -45.42 13.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -62.23 -35.03 77.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.53 -58.51 4.99 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.481 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.79 151.5 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 0.0 110.934 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.53 159.07 2.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mt -160.14 81.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.793 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.9 -38.23 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -172.67 148.59 1.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.48 167.53 10.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.57 ' ND2' HG13 ' A' ' 102' ' ' VAL . 19.4 m120 -138.04 125.73 22.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.995 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mt -106.98 114.9 29.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.61 118.3 34.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.956 0.408 . . . . 0.0 111.45 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.28 116.86 3.45 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 98' ' ' THR . 66.1 m -130.91 134.16 46.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.481 . . . . 0.0 112.231 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 7.5 t80 -105.52 110.7 23.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.105 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 94' ' ' PHE . 3.5 m-20 -136.59 172.16 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.22 0.533 . . . . 0.0 112.084 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.495 ' HA ' ' HA3' ' A' ' 53' ' ' GLY . . . -137.62 124.18 20.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.637 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.477 ' HB3' ' CD1' ' A' ' 94' ' ' PHE . 55.1 p90 -97.78 162.8 13.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.344 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.549 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.2 OUTLIER -162.27 137.77 5.54 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.657 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.549 ' HD2' HD23 ' A' ' 84' ' ' LEU . 58.5 Cg_endo -71.59 112.06 3.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.462 2.108 . . . . 0.0 112.296 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.406 ' CG1' ' HB2' ' A' ' 93' ' ' LEU . 40.7 mm -117.11 102.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.082 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.54 -60.43 0.67 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.355 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -177.25 -65.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.674 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -177.61 36.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.812 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.13 -30.53 5.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.11 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.435 ' HB ' ' HB ' ' A' ' 127' ' ' ILE . 82.5 p -136.16 144.16 44.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.783 ' CB ' HD12 ' A' ' 128' ' ' LEU . 34.5 mttp -122.38 102.05 7.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 0.0 110.729 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 7.3 tp -55.34 102.95 0.08 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.406 0.622 . . . . 0.0 110.347 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 81' ' ' ASP . 5.2 t80 -110.58 142.09 42.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.175 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.31 156.02 20.26 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.425 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 168.68 -140.57 6.25 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.732 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.85 172.94 6.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.609 0.242 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.648 HG22 ' OG ' ' A' ' 79' ' ' SER . 36.6 p -142.16 170.04 16.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.175 0.512 . . . . 0.0 111.631 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.448 ' CD1' HD23 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -154.44 131.99 11.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.982 179.659 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.615 ' O ' HD22 ' A' ' 101' ' ' LEU . . . -127.82 123.41 4.47 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.668 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.615 HD22 ' O ' ' A' ' 100' ' ' GLY . 1.1 mm? -136.27 120.62 18.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.955 0.407 . . . . 0.0 110.304 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.57 HG13 ' ND2' ' A' ' 75' ' ' ASN . 21.3 t -109.88 142.57 21.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.271 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -125.61 132.67 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.828 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.4 tt -98.12 148.09 23.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -115.45 147.05 41.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -78.05 143.98 36.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.15 -50.91 17.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 126.62 -27.76 4.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.4 141.07 52.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.362 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.04 127.85 3.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.531 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -87.07 93.96 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -126.09 177.71 6.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.72 97.37 7.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.822 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.46 -176.1 4.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.1 m 63.39 125.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.975 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -168.47 78.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.6 p -96.12 132.68 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.145 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.562 ' O ' HD13 ' A' ' 101' ' ' LEU . . . -110.38 178.28 19.92 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.52 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.75 117.86 21.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.722 ' HB1' HD13 ' A' ' 144' ' ' LEU . . . -121.44 151.23 40.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.15 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.03 131.55 0.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.038 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.506 ' C ' HD12 ' A' ' 123' ' ' LEU . . . -163.24 -124.94 0.73 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.55 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.506 HD12 ' C ' ' A' ' 122' ' ' GLY . 4.2 mp -154.36 174.33 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.8 OUTLIER -153.48 170.5 20.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.687 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . 177.0 142.48 0.08 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.991 0.424 . . . . 0.0 110.928 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.597 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -163.3 -132.27 1.32 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.726 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 126' ' ' GLY . 0.8 OUTLIER -161.78 120.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.783 HD12 ' CB ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -98.17 116.29 30.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.044 0.45 . . . . 0.0 110.979 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -95.15 143.32 26.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -110.27 149.08 30.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.69 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.92 -48.79 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.015 0.436 . . . . 0.0 110.593 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.16 -164.97 0.49 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.193 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.09 57.74 2.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.888 0.375 . . . . 0.0 110.501 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -142.12 -61.06 0.45 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.29 171.98 15.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.118 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.85 167.92 20.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.027 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.1 tt -132.74 134.67 58.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.607 ' HG2' HD23 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -130.63 172.22 12.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.018 0.437 . . . . 0.0 111.402 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.31 146.79 7.61 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.992 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.43 -147.7 5.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.057 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -126.13 146.91 49.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.96 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.55 ' HD2' HD23 ' A' ' 144' ' ' LEU . 26.9 ttp180 -125.51 132.74 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.77 116.36 20.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.722 HD13 ' HB1' ' A' ' 120' ' ' ALA . 4.3 pp -156.45 159.21 38.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.844 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.67 137.57 52.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.859 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.9 t -118.85 134.27 55.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -139.49 117.12 11.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.28 32.2 5.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.6 t -159.7 168.22 26.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.98 118.84 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -161.47 158.06 26.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.82 -36.31 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.697 HG22 ' HD2' ' A' ' 154' ' ' PRO . 0.2 OUTLIER -86.33 145.02 39.12 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.909 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.697 ' HD2' HG22 ' A' ' 153' ' ' THR . 51.3 Cg_exo -53.13 165.79 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.513 2.142 . . . . 0.0 112.325 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -142.9 35.87 1.4 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.74 146.52 8.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.448 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 162.89 156.28 8.47 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -107.43 -53.24 2.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.819 0.342 . . . . 0.0 110.944 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -79.44 -177.57 5.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 161' ' ' GLY . 1.5 pp -134.95 -46.34 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.973 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.625 ' N ' HD12 ' A' ' 160' ' ' LEU . . . -128.94 48.46 0.97 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.508 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.483 ' CB ' HD23 ' A' ' 165' ' ' LEU . 32.2 t -79.42 176.08 10.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.351 . . . . 0.0 110.825 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.5 tt -112.47 -40.37 4.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.98 40.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.483 HD23 ' CB ' ' A' ' 162' ' ' SER . 0.5 OUTLIER -105.92 -43.67 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.887 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -69.04 -52.37 29.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 m -94.25 159.59 15.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 10.4 m -123.64 158.91 30.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.3 t -106.97 123.29 47.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.51 155.29 47.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.997 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -96.85 165.24 12.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.265 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.18 129.26 15.52 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.08 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.2 tt -163.42 129.99 3.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.572 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.58 -165.14 26.48 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.566 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.67 172.16 6.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.767 0.317 . . . . 0.0 111.013 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.413 ' ND2' ' CE1' ' A' ' 5' ' ' PHE . 17.4 t-20 -145.23 114.5 7.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.682 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -143.23 111.8 6.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.254 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -85.9 157.03 20.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 4' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.833 0.349 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -107.64 149.79 27.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.775 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -83.22 128.08 34.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 0.0 110.712 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.2 m-85 -127.52 140.0 52.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' A' ' 46' ' ' ALA . 21.9 t -152.8 128.07 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.38 -151.63 6.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.718 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 43' ' ' GLY . 5.3 mt -132.01 149.43 52.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.654 HG23 ' HD2' ' A' ' 45' ' ' ARG . 1.3 p -110.39 149.3 30.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.018 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -152.77 113.04 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.748 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.07 133.77 11.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.436 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HG3' HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -104.97 109.94 22.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.909 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.519 HG23 HG22 ' A' ' 39' ' ' THR . 2.2 t -121.5 128.58 52.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -150.12 102.77 3.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.776 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -155.26 -46.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.74 126.03 25.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.58 112.66 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.158 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -102.65 36.74 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -146.95 121.41 9.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.79 26.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.84 -30.33 6.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 p -92.63 46.44 1.24 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.959 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mt 58.41 177.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.066 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -85.42 171.57 11.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -167.42 131.83 1.88 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.838 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -139.0 -46.84 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.13 83.48 6.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.43 -43.04 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 85.4 p -176.48 139.85 0.5 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.77 -29.08 10.88 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.428 2.086 . . . . 0.0 112.334 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.63 158.32 33.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 32' ' ' LEU . 2.0 pp -112.53 101.58 9.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.848 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -112.17 -41.62 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -115.7 89.55 3.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.27 -56.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.498 HG23 ' HG3' ' A' ' 12' ' ' GLU . 3.6 pt -107.81 101.8 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -71.34 -68.45 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -134.11 33.52 3.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 13' ' ' THR . 2.5 m -137.66 156.39 48.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.58 165.98 11.32 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.409 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.7 p -119.57 107.92 13.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 110.975 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -119.29 129.88 55.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.45 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -164.94 -164.99 21.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.573 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' THR . 12.2 pt -107.67 162.48 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.66 0.267 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.654 ' HD2' HG23 ' A' ' 9' ' ' THR . 15.9 ttt85 -132.78 138.11 47.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.55 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -173.14 122.08 0.38 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.005 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.14 -137.8 2.38 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.87 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -145.48 120.4 9.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 2.3 tt0 -101.67 112.07 24.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.371 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -119.57 163.82 16.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.741 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -17.76 65.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.494 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.12 24.37 13.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.642 0.258 . . . . 0.0 111.286 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 50' ' ' PHE . . . 145.86 167.33 12.5 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.333 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.753 ' NH2' HD22 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -134.09 115.26 14.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 0.0 111.285 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.606 ' HE1' ' HB2' ' A' ' 57' ' ' ALA . 13.5 t80 -91.87 126.33 36.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.901 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.455 ' CE1' ' ND2' ' A' ' 176' ' ' ASN . 0.5 OUTLIER -133.4 103.08 5.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 0.0 111.815 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB2' ' HE1' ' A' ' 55' ' ' TYR . . . -97.32 119.62 36.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.861 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 77' ' ' LEU . 1.6 t -128.6 122.74 31.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.147 0.498 . . . . 0.0 111.438 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -86.79 124.52 33.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.474 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.04 166.96 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 0.0 111.216 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.42 -166.33 1.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.754 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.876 HD11 ' HB3' ' A' ' 73' ' ' GLN . 3.6 mp -100.16 113.29 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.147 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.6 -43.25 12.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.24 87.76 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 t -78.43 142.57 37.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -90.95 -54.06 4.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.4 m -108.55 -35.88 6.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.23 49.06 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -143.17 137.36 28.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.746 0.307 . . . . 0.0 110.833 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -149.01 120.3 7.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -139.6 -60.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -105.85 53.83 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.876 ' HB3' HD11 ' A' ' 62' ' ' ILE . 3.7 mm-40 -132.64 122.37 24.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.973 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 3.1 pm0 -162.97 153.75 16.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.799 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.791 ' HB3' HG12 ' A' ' 102' ' ' VAL . 43.2 m-20 -143.98 111.01 5.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.139 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.426 ' HG ' ' CZ ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -85.46 145.94 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.406 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HB2' HG23 ' A' ' 58' ' ' THR . 5.5 mp -139.54 107.91 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 111.385 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.78 119.67 4.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.746 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.43 ' CB ' ' HA ' ' A' ' 98' ' ' THR . 24.3 p -130.5 150.44 51.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.869 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.51 110.86 18.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.904 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 1.8 m-20 -124.17 153.35 41.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 111.622 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -100.65 118.56 37.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.231 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 43.8 p90 -97.54 153.75 17.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.826 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.34 143.07 10.84 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.731 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' THR . 31.9 Cg_endo -63.64 91.71 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.691 2.261 . . . . 0.0 112.262 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.545 HG23 ' HB2' ' A' ' 93' ' ' LEU . 19.0 tt -157.12 126.57 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.014 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.76 -56.87 0.36 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.719 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -154.01 -46.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.754 0.311 . . . . 0.0 111.067 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -169.33 -46.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.254 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 0.7 OUTLIER -126.17 20.82 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.651 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.423 HG23 ' HG3' ' A' ' 129' ' ' GLN . 0.1 OUTLIER -80.12 153.22 28.84 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -131.18 92.42 3.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.99 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' A' ' 86' ' ' ILE . 1.4 tt -61.74 102.22 0.25 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.279 0.562 . . . . 0.0 110.1 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 23.0 p90 -111.01 120.79 43.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.518 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.455 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -142.78 151.42 23.1 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.815 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.33 -140.09 4.66 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.561 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.43 150.66 47.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 0.0 111.091 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.43 ' HA ' ' CB ' ' A' ' 79' ' ' SER . 11.6 t -118.93 153.36 34.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -160.18 129.09 4.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.589 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.74 -149.18 4.97 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.856 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tt -155.21 129.21 8.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 0.0 110.49 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.791 HG12 ' HB3' ' A' ' 75' ' ' ASN . 11.2 m -109.76 128.44 65.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.245 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HA ' HG22 ' A' ' 117' ' ' VAL . 6.3 mmtt -122.89 127.34 48.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.593 HD12 ' HB2' ' A' ' 116' ' ' ASP . 3.3 mt -132.15 131.79 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.66 140.59 21.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -89.52 169.83 11.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.07 135.25 28.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.846 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.81 -137.74 6.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.468 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.45 105.7 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.969 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.51 -76.75 0.25 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.475 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.68 172.23 1.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.856 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.8 -179.95 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.79 146.35 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.91 161.18 23.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -153.77 70.4 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.593 ' HB2' HD12 ' A' ' 104' ' ' LEU . 1.8 m-20 -108.31 31.02 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 103' ' ' LYS . 25.1 t -84.45 125.08 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.67 -163.33 13.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.566 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -96.0 123.09 39.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.688 ' O ' HD23 ' A' ' 99' ' ' LEU . . . -94.98 146.82 23.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -168.85 140.81 2.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.941 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -163.74 -136.91 2.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.71 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.08 155.03 40.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.788 0.328 . . . . 0.0 110.882 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.44 ' NE2' ' CE2' ' A' ' 172' ' ' TYR . 0.5 OUTLIER -138.57 158.37 44.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.996 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . -176.36 141.98 0.44 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.471 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.589 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -175.08 -146.57 5.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.923 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 126' ' ' GLY . 9.5 pt -162.26 120.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 122.69 0.396 . . . . 0.0 110.01 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.753 HD22 ' NH2' ' A' ' 54' ' ' ARG . 7.8 tp -94.73 111.92 23.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.969 0.414 . . . . 0.0 110.851 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 4.3 tt0 -102.5 131.16 49.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -97.28 149.17 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.66 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.75 -45.07 4.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.98 0.419 . . . . 0.0 110.613 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -164.86 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.105 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.52 55.77 2.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.391 . . . . 0.0 110.69 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -139.06 -58.68 0.6 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.024 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.06 163.01 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.987 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.7 t -116.15 170.4 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 129' ' ' GLN . 2.1 mp -129.98 134.75 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.568 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.43 ' HG2' ' CE1' ' A' ' 94' ' ' PHE . 8.1 tt0 -123.83 147.04 47.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.961 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.62 141.66 7.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.402 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.51 -135.83 2.75 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.464 -0.875 . . . . 0.0 112.778 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -133.79 161.21 35.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 0.0 110.881 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.402 ' HG2' ' CG ' ' A' ' 124' ' ' GLN . 0.3 OUTLIER -147.72 147.49 29.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.85 140.51 50.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.643 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 tt -117.35 137.09 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.144 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.05 117.8 3.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.633 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.95 131.84 54.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.008 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.08 114.86 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.79 -72.51 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 150' ' ' THR . 3.6 m -162.26 160.66 27.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 149' ' ' SER . 18.0 p -159.63 39.17 0.2 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -132.79 -46.62 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.0 mmt -76.76 -25.44 53.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 60.5 p -111.61 93.25 19.11 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.97 174.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 59.48 -175.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -153.71 -109.19 0.36 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.545 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 107.22 147.9 14.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.51 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -135.26 103.66 5.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.947 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -178.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mt -92.33 168.9 11.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 150.54 -48.79 0.57 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.478 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 75.3 m -131.16 176.04 8.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.851 0.357 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.9 mt -99.6 -51.25 3.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.58 159.96 15.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.26 106.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.22 -63.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 96.4 p -155.38 161.73 40.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t -118.02 160.57 21.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.9 129.5 54.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -139.52 155.2 47.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.41 165.14 11.21 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.159 0.504 . . . . 0.0 110.28 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.44 ' CE2' ' NE2' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -138.29 129.47 27.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.889 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.1 tp -163.32 135.15 5.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.93 -152.69 16.74 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.64 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -130.26 171.31 13.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.455 ' ND2' ' CE1' ' A' ' 56' ' ' TYR . 14.5 m120 -151.57 114.98 4.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.082 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -116.72 117.71 30.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.674 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.86 162.41 22.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.205 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.71 0.29 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 49' ' ' GLN . 10.8 m-20 -152.18 137.82 17.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.194 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 179' ' ' PHE . 2.8 t30 -71.41 131.58 43.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.584 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.1 m-85 -123.98 139.9 53.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.684 HG13 ' HB2' ' A' ' 46' ' ' ALA . 21.4 t -150.48 122.34 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.08 -135.33 1.84 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.619 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mp -144.95 166.66 24.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.743 0.306 . . . . 0.0 110.819 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -136.83 146.52 45.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.165 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -153.0 117.54 4.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.664 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 172' ' ' TYR . . . -136.1 -176.08 14.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.466 -0.874 . . . . 0.0 113.021 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.571 ' OE2' HG21 ' A' ' 35' ' ' VAL . 2.0 tm-20 -98.15 149.02 22.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.453 HG22 HD21 ' A' ' 15' ' ' ASN . 0.9 OUTLIER -92.08 131.42 37.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.893 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.3 p -150.14 102.79 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.453 HD21 HG22 ' A' ' 13' ' ' THR . 3.0 p30 -157.75 142.74 16.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.13 97.23 10.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 pp -142.55 151.39 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -104.29 138.21 41.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -74.84 -31.79 61.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.51 136.17 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.22 134.1 39.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.1 p -114.7 111.5 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -48.53 23.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -149.02 102.85 3.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.41 165.3 7.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.5 164.13 23.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.49 83.86 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -122.11 78.04 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.69 156.17 55.93 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.948 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.23 -45.34 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.533 2.155 . . . . 0.0 112.283 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -149.37 149.32 30.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mt -142.53 32.29 1.47 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.16 -74.18 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -162.78 -72.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.571 HG21 ' OE2' ' A' ' 12' ' ' GLU . 8.8 m -156.85 82.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 37' ' ' ASP . 2.5 pp -63.74 -47.99 88.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.355 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.728 ' N ' HD12 ' A' ' 36' ' ' ILE . 0.4 OUTLIER 176.29 40.22 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.838 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -144.5 38.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.976 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.4 HG22 ' CB ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -161.9 143.01 10.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.933 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.97 156.37 17.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.453 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.9 p -140.61 107.93 5.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 0.0 111.016 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -135.15 158.32 44.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.814 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.06 -166.95 32.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.768 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 45' ' ' ARG . 9.4 mt -107.63 163.74 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.428 0.156 . . . . 0.0 110.828 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' N ' HG22 ' A' ' 44' ' ' ILE . 1.6 ttt180 -135.87 138.52 42.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.934 0.397 . . . . 0.0 110.834 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.684 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -171.05 119.8 0.51 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.255 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -162.5 -133.63 1.51 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.683 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -155.73 148.81 24.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 111.0 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.451 ' NE2' ' CZ ' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -100.7 162.57 12.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.756 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -133.29 165.78 24.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.915 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -24.65 65.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.371 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.2 24.13 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.448 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 177.77 177.49 46.61 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.447 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . 13.2 ttp-105 -143.91 140.58 29.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 111.074 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -124.43 149.44 46.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.578 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.529 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 34.0 p90 -178.28 126.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.75 162.77 14.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.527 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 49.7 p -141.05 124.46 16.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.07 0.462 . . . . 0.0 111.517 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.45 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 9.2 m-85 -92.51 116.57 29.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.957 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.06 178.37 4.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.029 0.442 . . . . 0.0 111.569 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -164.98 154.4 12.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.51 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 tt -100.02 130.28 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.176 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.1 t -96.68 108.71 21.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -116.43 -66.14 1.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.1 p -85.72 89.9 7.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 t -69.63 -33.07 72.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 p -112.63 -35.86 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.822 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.57 -146.12 0.23 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.623 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -114.0 130.07 56.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.785 0.326 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 136.59 34.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 mp -78.66 162.41 26.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.944 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -67.06 124.95 24.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.828 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -155.79 160.76 40.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.21 135.88 3.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.779 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -120.87 114.64 21.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -98.32 128.94 44.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.496 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.634 HD11 HD11 ' A' ' 144' ' ' LEU . 2.2 mt -138.87 131.07 28.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.891 0.377 . . . . 0.0 111.183 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.76 116.82 4.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.578 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.686 ' HB3' HG22 ' A' ' 98' ' ' THR . 0.9 OUTLIER -106.65 126.28 52.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.956 0.408 . . . . 0.0 111.768 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -125.39 110.7 14.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.758 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -133.31 166.1 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.036 0.446 . . . . 0.0 111.507 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -109.63 118.33 36.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.173 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 48.5 p90 -97.85 167.62 10.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.827 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.7 tp -160.56 121.08 1.65 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.577 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.53 114.69 1.43 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.493 2.129 . . . . 0.0 112.541 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -156.29 123.74 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.152 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.46 -95.64 0.3 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.658 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.6 33.23 5.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 110.87 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 63.56 24.82 14.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.711 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -141.36 -44.58 0.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.732 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.04 150.71 16.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.483 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 2.4 mptm? -132.06 92.48 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.334 . . . . 0.0 111.45 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.43 ' O ' HD23 ' A' ' 93' ' ' LEU . 9.0 tt -63.23 102.96 0.44 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.137 0.494 . . . . 0.0 109.848 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 45.6 p90 -110.71 159.7 17.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.34 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.26 126.79 1.31 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.783 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.99 -140.29 2.89 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.74 178.83 6.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 111.156 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 79' ' ' SER . 44.3 p -144.08 152.13 40.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.238 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.11 131.37 5.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.59 -140.56 3.05 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.909 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.14 125.94 7.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 110.734 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.86 140.18 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -141.76 136.94 31.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.824 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -148.96 158.45 44.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.959 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.488 ' H ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -122.2 172.65 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.26 163.14 33.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -130.64 37.52 3.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.52 -156.82 0.47 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.592 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -123.15 88.81 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.74 -176.93 33.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.486 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.65 96.58 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.777 0.322 . . . . 0.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -101.55 138.18 38.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 -59.33 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -119.09 110.04 16.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.5 m -80.93 -64.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -149.43 80.91 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 t -130.38 120.89 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 148' ' ' ALA . . . -161.51 175.56 38.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.61 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.96 136.19 34.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.94 139.68 30.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.93 132.01 3.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.952 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.86 -140.83 2.97 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.628 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 mt -143.89 170.28 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.722 HE21 ' HB3' ' A' ' 142' ' ' ARG . 0.6 OUTLIER -160.13 150.02 18.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 94' ' ' PHE . . . 178.21 142.39 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.377 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.592 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -175.32 -126.74 0.96 Allowed Glycine 0 C--O 1.229 -0.192 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.806 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.3 pp -161.07 120.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.512 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.48 HD12 ' HG3' ' A' ' 138' ' ' GLU . 2.2 tt -104.01 116.09 31.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.634 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.625 ' HG2' HG23 ' A' ' 137' ' ' ILE . 18.8 pt20 -116.85 126.22 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.775 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 136' ' ' SER . 25.2 tt0 -69.24 147.88 50.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.273 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 -30.68 7.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.338 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 t -160.93 -165.02 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.196 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -90.28 50.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.371 . . . . 0.0 110.771 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 174.14 -28.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.6 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.5 157.19 29.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.361 . . . . 0.0 111.393 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.41 ' CB ' ' HA ' ' A' ' 130' ' ' GLU . 15.2 m -155.92 169.05 25.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.994 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 129' ' ' GLN . 18.3 tt -131.49 135.0 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.417 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.48 ' HG3' HD12 ' A' ' 128' ' ' LEU . 1.3 tm-20 -133.52 167.64 20.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.544 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . 174.09 153.65 10.05 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.665 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.3 -125.95 1.26 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.971 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.444 ' CE2' ' HB3' ' A' ' 171' ' ' PHE . 5.3 m-85 -133.77 161.15 35.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.722 ' HB3' HE21 ' A' ' 124' ' ' GLN . 0.0 OUTLIER -157.96 147.33 19.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -108.29 147.81 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.754 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.634 HD11 HD11 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -128.87 134.9 48.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.92 147.0 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -121.98 125.86 47.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -140.79 115.67 9.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.406 ' HB2' ' HA2' ' A' ' 118' ' ' GLY . . . -153.2 31.24 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 93.5 p -86.11 162.7 18.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.12 81.55 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.7 122.95 19.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.956 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -121.6 -43.01 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.7 p -86.71 149.26 48.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.68 176.04 8.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.552 2.168 . . . . 0.0 112.311 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 60.31 110.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 149.42 84.85 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.558 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -174.4 -42.02 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.585 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 34.3 m120 59.83 29.45 19.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 110.97 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -178.14 125.37 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.907 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mt -88.57 129.11 35.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -116.82 113.13 2.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.503 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.9 165.29 6.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.892 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.74 109.47 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.04 170.31 15.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.999 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 166' ' ' HIS . 9.5 tt 64.54 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.019 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.465 ' N ' HD23 ' A' ' 165' ' ' LEU . 1.2 t60 65.87 -70.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 111.124 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.6 OUTLIER -162.07 166.6 25.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.707 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 62.2 m -127.44 136.99 52.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.977 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.2 p -119.88 117.73 28.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -134.07 155.38 50.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.444 ' HB3' ' CE2' ' A' ' 141' ' ' TYR . 43.2 p90 -111.12 124.41 52.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.382 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.478 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 7.4 p90 -124.68 179.2 5.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.643 0.735 . . . . 0.0 111.966 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.506 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 0.4 OUTLIER -163.45 147.88 10.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.872 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.3 -162.86 21.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.809 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -123.23 171.74 9.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.861 0.363 . . . . 0.0 111.047 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.439 HD22 HD11 ' A' ' 128' ' ' LEU . 1.6 t30 -156.29 117.1 3.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.65 112.01 24.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.59 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.95 154.06 25.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.109 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 1.3 m-85 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.895 0.379 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.62 123.82 13.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -63.51 137.75 58.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.826 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.3 m-85 -129.0 139.75 51.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.057 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 46' ' ' ALA . 25.7 t -154.94 124.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.012 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.98 -144.06 3.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.58 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mt -139.76 142.86 36.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.822 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.477 HG21 HG23 ' A' ' 58' ' ' THR . 9.7 t -112.15 142.4 44.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.994 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.33 114.55 13.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.74 132.54 11.01 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.426 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.25 110.0 20.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.64 135.33 31.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.82 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 t -150.06 102.88 3.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.84 -39.24 24.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -85.6 162.09 19.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 pt -115.35 165.74 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.149 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -145.42 109.76 4.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.8 33.04 3.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.9 m -153.18 110.77 3.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.51 -48.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 p -157.28 129.8 7.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.08 -68.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -95.94 123.73 39.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.01 150.61 49.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -141.99 146.92 36.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.9 tp -117.34 90.5 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -145.96 -52.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 30' ' ' PRO . 1.5 t -114.48 -68.54 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 29' ' ' SER . 60.6 Cg_endo -72.42 -178.18 3.17 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.136 1.89 . . . . 0.0 112.393 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.47 -173.08 3.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.49 103.21 15.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.11 -30.96 61.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.987 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt 61.29 92.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 35' ' ' VAL . 7.9 p -102.93 56.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.058 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' O ' HD12 ' A' ' 36' ' ' ILE . 1.8 pp -107.05 111.59 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.117 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -148.72 134.91 19.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.973 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -144.3 157.16 44.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.5 p -108.04 130.74 55.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.76 -68.57 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.6 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -139.17 138.31 36.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.327 . . . . 0.0 110.899 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -162.03 129.42 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.44 -167.56 19.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 45' ' ' ARG . 21.0 mt -109.28 161.07 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.745 0.307 . . . . 0.0 110.964 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -129.02 133.02 47.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.665 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.524 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -169.2 120.02 0.71 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.106 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.51 -136.95 2.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.593 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -153.85 136.37 15.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 0.0 110.99 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 50' ' ' PHE . 36.5 tt0 -89.52 162.29 15.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.66 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.4 ' N ' ' HG2' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -134.95 167.21 21.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.929 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -67.11 -25.9 66.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 24.26 3.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.01 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -174.44 179.97 45.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.192 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.01 130.3 7.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 0.0 111.276 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 80' ' ' TYR . 4.1 m-85 -107.7 159.83 16.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.489 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -173.59 123.89 0.37 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.912 0.387 . . . . 0.0 111.198 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.88 153.12 20.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.602 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.477 HG23 HG21 ' A' ' 9' ' ' THR . 91.3 m -130.93 118.77 21.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.18 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 4.6 m-85 -99.23 118.34 35.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.507 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -110.82 141.85 43.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.25 -69.54 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.753 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.1 mt -151.89 127.64 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.7 p -87.66 55.17 3.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -153.45 152.22 30.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 p -109.19 -35.79 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -48.66 17.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.5 p -112.27 27.11 9.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.994 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -107.61 75.37 0.22 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -132.59 177.02 7.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.883 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt 60.59 163.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.89 88.92 3.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.826 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -87.39 -30.63 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.58 139.67 29.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.988 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.55 135.6 53.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.71 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.479 ' ND2' HG13 ' A' ' 102' ' ' VAL . 6.1 m-80 -129.61 117.8 20.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.175 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 1.5 tm? -124.38 114.92 20.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.391 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -134.1 126.21 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 111.593 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.39 116.8 4.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.645 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 0.8 OUTLIER -111.72 156.71 21.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.075 0.464 . . . . 0.0 111.702 -179.248 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.434 ' HB3' ' CD2' ' A' ' 55' ' ' TYR . 23.6 p90 -130.86 110.94 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.308 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 2.4 m-20 -120.81 155.25 34.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 111.494 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.425 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -105.6 119.25 38.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.533 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 39.1 p90 -97.59 156.14 16.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.139 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tp -155.49 140.32 12.04 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.805 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.85 113.0 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.451 2.101 . . . . 0.0 112.178 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.733 HG23 ' HB ' ' A' ' 91' ' ' THR . 7.8 tp -119.12 97.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.985 0.422 . . . . 0.0 111.085 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.02 -73.68 0.25 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.614 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -153.77 -49.6 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.648 0.261 . . . . 0.0 111.233 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 174.62 -27.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.391 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 37.3 p-10 -73.99 3.06 7.4 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.733 ' HB ' HG23 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -136.55 130.0 31.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 9.9 mttt -123.15 92.66 3.75 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.142 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.422 HD12 ' CG2' ' A' ' 127' ' ' ILE . 4.7 tp -64.88 102.72 0.63 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 17.7 p90 -115.75 155.05 28.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.404 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -172.77 142.92 7.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.558 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.73 -143.73 4.58 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.657 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.09 162.23 29.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 111.083 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.513 ' C ' HD12 ' A' ' 99' ' ' LEU . 5.2 t -129.2 155.73 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.513 HD12 ' C ' ' A' ' 98' ' ' THR . 2.9 mp -160.11 130.87 5.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.713 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.476 ' N ' HD23 ' A' ' 77' ' ' LEU . . . -156.63 -150.39 5.65 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.866 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.05 127.28 7.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.618 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.479 HG13 ' ND2' ' A' ' 75' ' ' ASN . 21.4 t -109.88 133.67 54.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.048 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 117' ' ' VAL . 5.4 mtpp -120.98 129.97 53.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.948 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 105' ' ' GLU . 6.6 tt -121.45 153.67 37.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.828 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.666 ' N ' HD23 ' A' ' 104' ' ' LEU . 4.5 pt-20 -169.61 172.09 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.943 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -100.71 156.01 17.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.02 104.43 12.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -135.74 -55.48 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -111.03 -33.13 6.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.817 0.341 . . . . 0.0 110.843 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.46 33.87 1.68 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.555 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.36 106.45 10.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 110.842 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -73.11 83.26 1.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.65 112.22 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.89 126.69 47.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.971 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.34 -29.02 8.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.02 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -81.68 59.95 4.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.474 HG12 ' HG2' ' A' ' 103' ' ' LYS . 10.7 m -98.66 161.76 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.067 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.4 -179.27 33.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.553 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TYR . . . . . 0.457 ' HE1' HD23 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -103.21 118.41 36.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.723 ' HA ' HG22 ' A' ' 146' ' ' THR . . . -95.31 143.41 26.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 137.94 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -165.66 -143.43 3.73 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.498 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.11 160.46 38.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.966 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -156.88 165.74 35.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.047 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.91 142.49 0.08 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.272 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -162.52 -127.0 0.85 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.263 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 14.6 pt -156.93 120.78 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -94.43 112.74 24.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.188 0.518 . . . . 0.0 111.019 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.42 HE21 HD12 ' A' ' 127' ' ' ILE . 6.4 mt-30 -102.46 115.54 30.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.024 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 136' ' ' SER . 23.6 mt-10 -73.4 149.18 42.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.872 HD13 HD11 ' A' ' 137' ' ' ILE . 8.4 tp -108.01 -31.82 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.409 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -169.04 -173.98 1.92 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.131 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -81.98 55.64 2.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.791 0.329 . . . . 0.0 110.696 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -178.45 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.277 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.79 155.87 33.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.895 0.378 . . . . 0.0 111.201 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.3 OUTLIER -140.08 -178.64 5.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.876 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.872 HD11 HD13 ' A' ' 131' ' ' LEU . 28.9 mt -138.78 134.95 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.968 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.96 131.53 54.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.708 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -155.35 124.29 1.48 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.66 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.28 -144.08 4.67 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.803 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -126.2 161.11 28.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 110.749 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -153.18 145.67 24.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.052 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.74 138.94 52.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.618 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mt -121.86 132.58 54.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.089 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.97 111.96 4.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.723 HG22 ' HA ' ' A' ' 120' ' ' ALA . 6.9 p -111.75 142.78 43.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.057 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -141.02 115.16 9.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.76 -69.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.171 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.17 149.55 41.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.7 p -132.89 -177.94 4.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.18 56.26 3.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 69.15 -65.63 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.935 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.71 108.94 45.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.02 -45.71 18.66 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.509 2.139 . . . . 0.0 112.112 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -104.86 175.52 5.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.96 117.27 4.31 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.495 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.56 36.9 21.91 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.537 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -91.5 88.24 6.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.37 -46.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 160' ' ' LEU . 3.4 pp -137.59 127.96 26.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 135.15 162.92 9.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.512 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.2 t -62.55 157.42 20.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.83 0.347 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.05 102.54 7.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -60.39 -46.18 90.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.53 130.13 37.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -160.93 93.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.95 171.88 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.6 p -149.24 179.76 7.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.97 123.17 47.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.767 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -113.08 155.24 25.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -106.36 153.3 22.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.203 0.525 . . . . 0.0 110.144 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.402 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -123.57 126.78 47.27 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.583 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.52 129.91 3.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.548 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 171.66 -152.2 17.06 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.891 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.23 172.17 11.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.091 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -149.87 114.94 5.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -108.09 111.93 24.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.753 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -83.52 159.72 21.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.129 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.778 0.323 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' CB ' ' HB3' ' A' ' 49' ' ' GLN . 1.5 t0 -112.03 168.57 9.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.096 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -109.77 134.45 52.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.689 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 10.0 m-85 -133.47 139.99 47.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.865 0.364 . . . . 0.0 111.044 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 46' ' ' ALA . 11.1 p -155.3 122.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.199 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.31 -139.91 2.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.541 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -140.19 164.03 31.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.727 0.298 . . . . 0.0 110.759 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.656 HG21 HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -148.42 155.66 41.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.354 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -153.08 128.13 9.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.602 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.74 160.83 12.99 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.579 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -98.65 115.55 28.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.868 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.9 p -140.75 113.01 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -150.12 102.87 3.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.769 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -102.89 90.64 3.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -64.01 123.84 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.915 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 17' ' ' ILE . 3.9 mp -91.93 130.93 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.17 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -104.19 100.84 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -137.89 84.62 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.959 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.82 107.42 18.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.7 -49.64 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.72 156.53 35.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.33 49.42 2.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.887 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -98.04 -61.23 1.41 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -105.43 128.01 53.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.41 ' C ' HD23 ' A' ' 27' ' ' LEU . 8.4 t-20 -176.04 143.74 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.828 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -169.69 36.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.869 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -129.94 153.05 48.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.55 131.82 6.84 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.91 -41.13 77.46 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.427 2.085 . . . . 0.0 112.23 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.704 ' O ' HD22 ' A' ' 32' ' ' LEU . 97.8 m-20 61.11 86.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 31' ' ' ASN . 4.4 mm? -130.22 120.37 24.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.503 ' OD1' HG22 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -136.13 -66.61 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.011 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 179.56 45.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.014 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.503 HG22 ' OD1' ' A' ' 33' ' ' ASP . 17.3 m -145.41 -46.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.153 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 36' ' ' ILE . 2.2 tt -129.89 106.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.631 ' O ' HG22 ' A' ' 39' ' ' THR . 1.5 t0 -71.03 -57.53 4.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.022 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.71 29.9 19.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.987 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 37' ' ' ASP . 2.5 t -177.08 94.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.52 -134.69 2.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.01 131.47 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -139.6 117.69 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.82 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -151.81 -165.06 12.7 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.624 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 45' ' ' ARG . 2.0 mt -116.33 161.92 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.673 0.273 . . . . 0.0 110.956 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.656 HH11 HG21 ' A' ' 9' ' ' THR . 4.0 ttt180 -126.54 138.89 53.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.601 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.537 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -170.4 120.32 0.59 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.12 -139.32 2.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.611 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -159.14 140.19 12.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 111.128 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB3' ' CB ' ' A' ' 3' ' ' ASP . 33.0 tt0 -83.77 162.47 20.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.413 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.418 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -131.08 -166.9 1.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.88 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.85 -45.16 93.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.219 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.97 -20.47 3.83 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -118.19 179.59 17.07 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.886 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 8.4 mtt180 -142.36 143.55 32.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 111.4 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 80' ' ' TYR . 6.0 t80 -100.73 153.56 19.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.961 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 70.4 m-85 -157.66 115.44 3.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 111.585 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.09 132.52 38.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.398 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.457 HG21 ' OH ' ' A' ' 172' ' ' TYR . 16.2 p -119.28 112.18 19.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.945 0.402 . . . . 0.0 111.253 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -106.19 111.27 23.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.677 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -110.41 179.96 3.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.872 0.367 . . . . 0.0 111.132 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -162.09 -74.33 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.792 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.553 HD13 ' HB2' ' A' ' 70' ' ' LYS . 7.3 pt -142.81 125.77 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.091 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.54 -32.54 12.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.986 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -59.28 -49.84 76.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.986 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 p 49.57 78.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.234 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.82 -52.05 6.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -104.46 -31.1 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.23 -75.82 0.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.58 124.59 44.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.775 0.321 . . . . 0.0 110.843 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HB2' HD13 ' A' ' 62' ' ' ILE . 15.0 mtpt -146.26 82.64 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 71' ' ' LEU . 4.7 mp -71.96 72.79 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.775 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -118.99 -39.47 2.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.013 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.409 ' HG3' HD12 ' A' ' 104' ' ' LEU . 1.1 tt0 -130.38 143.16 50.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 111.109 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -141.68 134.55 28.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.675 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -130.42 119.59 22.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.177 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.04 114.97 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.431 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.618 HD13 ' OG1' ' A' ' 98' ' ' THR . 3.4 pp -145.16 152.5 40.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.399 . . . . 0.0 111.519 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.99 125.68 6.64 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.972 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -104.09 132.28 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 111.637 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' HB2' ' CE1' ' A' ' 55' ' ' TYR . 14.0 t80 -122.9 110.99 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.957 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 0.5 OUTLIER -134.43 172.05 13.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.181 0.515 . . . . 0.0 111.869 -178.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.498 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -107.99 118.77 37.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.219 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 50.4 p90 -97.38 162.97 13.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.84 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 130.7 2.12 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.444 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.54 115.94 2.95 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.446 2.097 . . . . 0.0 112.36 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.0 mt -153.9 122.12 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.089 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 138.97 -90.38 0.2 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.632 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -131.24 35.91 3.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.804 0.335 . . . . 0.0 110.836 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 65.13 29.02 12.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.654 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -143.58 -45.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.735 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.408 HG22 HD12 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -64.89 152.71 42.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.459 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 2.5 mttt -132.47 92.85 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 111.079 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.29 102.88 0.19 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.312 0.577 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 20.0 p90 -112.1 154.18 25.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.33 133.79 2.72 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.75 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.612 ' O ' HD23 ' A' ' 123' ' ' LEU . . . -170.14 -133.51 1.61 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.654 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -130.98 162.97 28.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 111.29 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.618 ' OG1' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -133.93 156.85 47.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.822 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -160.06 132.48 6.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.849 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.85 -149.45 5.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.825 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 mt -154.93 126.87 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.668 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 p -109.95 133.73 54.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.978 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.49 ' CD ' HG22 ' A' ' 117' ' ' VAL . 6.2 mmtt -131.4 145.07 51.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.409 HD12 ' HG3' ' A' ' 73' ' ' GLN . 4.0 tp -127.01 127.05 44.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.78 133.72 20.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -85.33 160.98 19.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -70.27 -48.2 57.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.93 -99.97 0.23 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -71.37 178.72 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.84 0.352 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.21 71.38 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -84.84 163.13 19.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -90.89 78.3 6.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.79 31.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -154.53 73.85 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.11 -79.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.4 t0 75.37 -58.79 0.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.49 HG22 ' CD ' ' A' ' 103' ' ' LYS . 21.4 t -135.37 141.1 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -152.9 134.31 4.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.349 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -84.07 116.44 22.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.917 0.389 . . . . 0.0 111.078 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.51 ' HB1' HD22 ' A' ' 144' ' ' LEU . . . -100.23 135.8 41.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.994 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.07 142.34 1.42 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.177 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.35 -138.33 2.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.588 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 96' ' ' GLY . 5.7 mt -142.99 159.83 41.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.714 0.293 . . . . 0.0 110.688 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -157.28 173.11 17.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.14 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.87 142.67 0.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.588 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -159.52 -130.89 1.18 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.7 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.1 pt -161.13 120.38 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.0 110.67 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -94.82 115.16 27.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.672 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.415 ' N ' HD12 ' A' ' 128' ' ' LEU . 13.5 tt0 -104.31 118.15 35.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.945 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 136' ' ' SER . 1.8 pt-20 -107.82 149.3 28.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.02 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.53 -31.71 11.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.2 p -169.01 -164.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.329 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.71 56.02 3.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.886 0.374 . . . . 0.0 110.658 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -142.73 -67.5 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.061 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.68 171.49 13.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.041 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.403 ' CB ' ' HA ' ' A' ' 130' ' ' GLU . 36.3 p -156.02 173.98 16.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.942 0.401 . . . . 0.0 111.204 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 175' ' ' ALA . 5.2 pt -134.95 134.79 53.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.699 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -127.58 172.49 10.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.131 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.19 145.4 6.21 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.35 -135.96 2.53 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.657 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.85 158.04 27.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.712 0.291 . . . . 0.0 110.693 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.512 ' NH2' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.68 130.96 22.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.189 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 2.3 m-85 -122.77 133.92 54.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.453 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.51 HD22 ' HB1' ' A' ' 120' ' ' ALA . 3.7 mt -142.43 145.39 33.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 159.73 16.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.594 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.82 152.14 25.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -131.93 163.27 28.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.725 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 65.19 -176.12 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.885 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.59 80.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 p -109.94 80.19 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.89 108.23 16.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.938 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -107.8 143.39 36.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.6 p -114.47 148.2 39.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.0 -30.37 16.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.558 2.172 . . . . 0.0 112.284 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -92.01 85.92 5.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.782 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.89 -178.64 15.4 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 150.01 -148.2 19.22 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.555 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.36 142.47 41.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.99 -46.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.0 mt -81.18 -36.01 30.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.817 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.6 -118.81 1.56 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 42.8 t -120.52 128.37 53.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.99 145.89 35.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.18 111.13 17.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.71 123.93 13.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -136.6 -55.64 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.862 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.7 m -145.49 176.04 9.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.971 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.41 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -115.98 165.6 12.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.878 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.41 136.84 51.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -156.02 155.35 32.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.022 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.9 152.58 20.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.15 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.457 ' OH ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -135.04 129.4 33.99 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.152 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.7 mt -163.56 129.87 3.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.479 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 9' ' ' THR . . . -177.79 -158.84 21.57 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.909 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -126.79 172.05 10.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.8 116.68 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.935 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -108.98 112.82 25.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.819 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 11.2 pttt -82.01 164.07 21.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.888 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.724 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.805 0.336 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -111.37 168.16 9.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -100.95 130.03 46.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.786 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.9 m-85 -132.33 139.94 48.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.379 . . . . 0.0 111.115 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.699 HG23 ' HB2' ' A' ' 46' ' ' ALA . 8.3 p -154.77 130.4 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.08 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.62 ' C ' HD22 ' A' ' 8' ' ' LEU . . . -161.22 -147.17 4.87 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.716 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.62 HD22 ' C ' ' A' ' 7' ' ' GLY . 3.9 mm? -126.41 166.72 16.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.345 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.459 HG21 HG23 ' A' ' 58' ' ' THR . 27.9 p -139.61 140.43 37.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -137.9 115.91 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.22 137.64 13.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.536 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -111.65 134.21 53.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 0.0 110.952 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.7 125.68 35.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -150.02 102.89 3.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -136.53 40.95 2.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -85.6 120.0 26.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 pt -111.77 -30.55 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.238 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.43 176.07 7.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.016 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.2 mttt 60.84 156.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.13 -177.88 3.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 85.08 2.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.2 m -114.2 -175.44 2.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.779 HD12 ' HB2' ' A' ' 24' ' ' ASN . 1.6 pp -168.3 -43.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.779 ' HB2' HD12 ' A' ' 23' ' ' LEU . 1.4 t30 -123.94 -61.9 1.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.84 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.55 87.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -136.94 125.31 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -168.01 33.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.816 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.76 -69.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -91.54 138.93 25.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.01 -43.67 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.522 2.148 . . . . 0.0 112.428 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -103.83 -37.19 7.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.69 89.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -157.6 73.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -100.1 -46.21 5.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.7 t 69.48 -66.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -144.18 -45.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.254 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.49 ' N ' HG23 ' A' ' 36' ' ' ILE . 3.2 t70 76.05 111.76 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.963 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -157.05 29.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 m -118.87 137.31 53.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.0 172.66 12.71 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.582 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -127.81 124.05 36.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -117.75 115.47 25.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.4 -173.8 13.43 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.767 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.545 ' HA ' HD13 ' A' ' 8' ' ' LEU . 18.0 mt -106.98 162.03 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.561 0.219 . . . . 0.0 111.041 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -132.6 136.07 46.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.681 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -170.84 120.55 0.55 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.377 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -166.91 -142.34 3.41 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.755 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -131.92 130.65 41.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.681 0.277 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' CB ' ' CD1' ' A' ' 5' ' ' PHE . 29.1 tt0 -109.52 112.53 24.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.225 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.724 ' CE2' ' HB2' ' A' ' 2' ' ' ALA . 4.2 m-85 -96.01 176.42 6.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -29.15 68.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.2 24.19 3.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.346 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.2 110.03 0.39 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -103.8 112.74 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 111.187 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -106.2 150.71 25.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.155 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.541 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 34.2 p90 -179.09 129.35 0.1 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.125 0.488 . . . . 0.0 111.198 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.42 148.58 22.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.15 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.459 HG23 HG21 ' A' ' 9' ' ' THR . 2.6 m -129.24 118.43 22.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.979 0.418 . . . . 0.0 111.599 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.632 ' CE2' HD12 ' A' ' 76' ' ' LEU . 14.8 m-85 -94.52 109.18 21.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.071 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -103.65 175.2 5.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.032 0.444 . . . . 0.0 111.566 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -149.1 171.9 15.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.567 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.586 HG21 HG22 ' A' ' 65' ' ' THR . 29.3 mt -99.97 119.51 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.228 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -91.03 -35.86 14.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -146.94 126.05 12.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.586 HG22 HG21 ' A' ' 62' ' ' ILE . 46.2 p -100.16 109.81 22.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -87.3 -38.52 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 p -101.91 -34.28 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.0 -178.97 29.09 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.518 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -102.3 145.14 29.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -73.34 123.58 24.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 tp -158.12 -67.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -177.39 158.28 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.463 ' HB2' HD12 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -176.71 159.33 1.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -142.5 122.97 14.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.4 110.93 20.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.632 HD12 ' CE2' ' A' ' 59' ' ' TYR . 9.3 tt -115.6 117.02 29.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.755 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.6 144.46 39.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.228 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.93 116.9 4.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.033 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.464 ' CB ' HG23 ' A' ' 98' ' ' THR . 5.2 t -99.18 134.12 42.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 111.374 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -122.41 110.89 16.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.155 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -133.11 163.39 29.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.93 0.395 . . . . 0.0 111.486 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -112.22 118.7 36.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 54.2 p90 -97.58 161.29 13.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.645 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.12 121.01 1.26 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.63 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.89 114.98 2.04 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.469 2.113 . . . . 0.0 112.329 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pt -108.08 97.97 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.47 -58.24 0.57 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.44 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -169.19 -75.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -169.46 34.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.66 -30.18 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.531 HG22 HD12 ' A' ' 127' ' ' ILE . 16.5 p -136.55 145.08 44.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.806 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 9.0 tttt -121.31 92.69 3.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.371 . . . . 0.0 110.702 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.28 102.85 0.12 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.339 0.59 . . . . 0.0 110.772 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.451 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 32.6 p90 -112.3 153.21 27.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.862 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.12 140.66 6.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.856 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.11 -137.62 2.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.388 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.91 177.63 7.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 111.172 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.464 HG23 ' CB ' ' A' ' 79' ' ' SER . 1.2 m -146.2 151.65 37.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.978 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 130.65 5.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.775 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.35 -153.86 6.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.885 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.28 131.43 10.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 102' ' ' VAL . 12.1 p -109.59 122.83 64.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.262 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.01 145.07 50.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.735 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 tt -105.16 131.16 53.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.814 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.43 150.6 34.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -175.68 172.09 2.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.74 95.9 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.43 -80.82 1.36 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.437 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -126.66 -68.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -110.77 -117.01 3.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.453 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -110.42 169.09 8.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.13 149.39 32.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 125.79 43.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.43 -71.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 p -121.46 -61.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 76.68 -57.91 0.53 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.118 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.33 123.88 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.298 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.79 118.83 2.03 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.267 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.09 131.78 34.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.966 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -123.57 145.41 48.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -170.99 140.48 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.177 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.632 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -165.6 -136.72 2.06 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.453 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.632 HD12 ' O ' ' A' ' 122' ' ' GLY . 1.7 mp -138.36 170.27 16.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 110.727 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 5.7 tt0 -159.71 152.29 21.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.881 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.94 142.48 0.08 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.612 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.596 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -169.75 -127.09 0.9 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.938 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 126' ' ' GLY . 3.4 pt -161.19 120.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.681 0.277 . . . . 0.0 110.436 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.67 HD12 ' HB3' ' A' ' 138' ' ' GLU . 1.3 tp -94.5 114.1 26.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.069 0.462 . . . . 0.0 110.725 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -98.08 122.93 41.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.09 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -95.91 149.02 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.825 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.668 HD12 HD11 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -109.78 -30.29 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.058 0.456 . . . . 0.0 110.584 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.08 -172.07 2.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.108 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.74 54.73 3.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.791 0.329 . . . . 0.0 110.833 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -177.28 -37.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.436 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.26 135.82 51.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 111.519 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.8 m -132.84 168.7 17.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.753 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.668 HD11 HD12 ' A' ' 131' ' ' LEU . 25.1 mt -138.25 135.86 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.67 ' HB3' HD12 ' A' ' 128' ' ' LEU . 13.2 pt-20 -119.5 132.64 55.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -157.1 128.41 2.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.502 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -179.86 -134.74 2.28 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.847 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.86 161.19 25.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.848 0.356 . . . . 0.0 110.859 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.11 121.96 9.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.029 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.67 139.42 49.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.648 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 mp -157.93 142.88 16.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.207 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -114.23 163.69 14.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.629 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.0 m -119.39 123.88 45.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -141.15 114.87 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.03 -33.83 63.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.133 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.1 m 61.19 167.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 82.0 p -112.77 -73.7 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -131.03 42.03 3.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.794 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 3.6 mmt 59.99 31.98 20.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.933 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.2 t -89.73 147.42 37.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.14 145.67 79.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.465 2.11 . . . . 0.0 112.244 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -179.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -80.79 138.76 19.93 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.565 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -153.37 71.47 0.28 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.458 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -144.33 95.98 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 110.865 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.5 tttm 68.38 -69.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.941 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.56 176.73 9.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.927 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.9 -144.31 4.97 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.652 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.7 m -103.36 162.25 13.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.794 0.331 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.6 mt -135.03 31.74 3.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -146.59 102.41 3.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.6 mt -77.08 97.85 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -89.87 60.67 5.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.08 150.45 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 93.5 p -144.04 163.09 34.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.01 124.89 50.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.63 155.18 47.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -91.54 165.27 13.44 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.264 0.554 . . . . 0.0 110.29 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.24 129.98 34.5 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.78 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.6 tt -163.41 133.26 4.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.739 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.47 -156.41 18.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.613 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -124.24 172.15 9.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -150.06 114.95 5.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.982 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 6' ' ' VAL . 11.5 t80 -117.26 111.9 20.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 2.3 ptpt -82.18 161.4 22.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.773 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.797 0.332 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 2.6 m-20 -163.09 136.34 5.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.199 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -60.62 140.86 57.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.0 m-85 -131.07 139.86 49.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.973 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.415 HG12 ' CB ' ' A' ' 46' ' ' ALA . 27.3 m -154.74 129.27 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.266 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.33 -143.59 3.78 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.676 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -140.14 165.42 27.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -135.05 144.86 47.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.079 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -136.73 118.58 15.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.741 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.96 143.65 16.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.683 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.6 110.41 19.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.1 p -102.29 117.94 35.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -150.14 102.82 3.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.807 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.04 -56.6 2.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.841 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -75.27 124.27 26.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -82.56 -178.98 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.143 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 64.72 111.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.13 -35.24 5.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m 61.9 157.43 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.894 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -143.12 -176.36 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.4 m -88.16 166.57 14.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.715 HD13 ' H ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -88.37 148.07 24.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.715 ' H ' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -159.51 -43.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.031 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.6 ttt-85 68.82 94.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -162.87 117.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -51.47 13.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -92.74 80.68 4.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -99.98 100.26 11.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.83 60.1 3.58 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.487 2.124 . . . . 0.0 112.43 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 179.11 102.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -80.4 103.94 10.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -129.08 87.4 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 21.92 9.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 37' ' ' ASP . 16.0 t 61.96 117.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.217 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mt -63.58 -27.18 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.053 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.405 ' H ' HG12 ' A' ' 35' ' ' VAL . 3.8 m-20 63.6 87.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.014 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 m120 58.3 171.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.047 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.8 p -102.46 -73.57 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.58 -92.27 0.41 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.563 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.96 142.81 31.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -132.94 131.58 41.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.86 -173.26 31.36 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.665 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.35 177.12 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 111.157 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -142.55 142.73 32.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.603 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -175.68 123.06 0.2 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.255 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -163.33 -136.31 1.97 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.581 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -153.41 127.31 8.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 111.102 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 5' ' ' PHE . 1.5 tt0 -83.94 152.52 24.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.58 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -127.28 165.68 19.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.817 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -24.79 66.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.372 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -126.13 24.57 6.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.266 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 172.61 -177.29 45.25 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.357 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.748 ' NH2' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.36 122.29 7.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 111.297 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 80' ' ' TYR . 34.9 t80 -101.74 146.41 27.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.376 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.461 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 25.0 p90 -173.55 124.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.035 0.445 . . . . 0.0 111.036 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.67 162.86 14.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.584 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.4 m -139.92 125.25 18.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.221 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -102.88 100.93 10.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.295 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.94 174.95 5.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -151.77 -164.84 2.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.548 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.528 HG22 ' HB2' ' A' ' 73' ' ' GLN . 1.5 tp -114.3 123.45 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.182 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 p -78.44 102.18 7.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -107.31 -169.99 1.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 p -68.03 144.26 55.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -33.0 72.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.984 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 m -72.28 -31.9 66.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.7 -174.41 36.14 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.441 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.07 131.72 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.873 0.368 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -78.95 -68.67 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.977 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.18 81.82 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.828 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.81 -53.72 2.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.528 ' HB2' HG22 ' A' ' 62' ' ' ILE . 3.5 mt-30 -107.11 166.61 10.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -162.25 125.12 2.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.749 ' OD1' HG22 ' A' ' 102' ' ' VAL . 30.8 t30 -131.31 116.01 17.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.821 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 68.7 tp -124.96 123.06 39.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.551 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -144.98 157.46 44.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.334 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.99 117.47 4.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.049 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.2 p -99.15 121.73 41.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.938 0.399 . . . . 0.0 111.586 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 55' ' ' TYR . 47.6 m-85 -104.25 110.86 23.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.893 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.408 ' OD1' ' CE1' ' A' ' 56' ' ' TYR . 1.9 p-10 -136.48 172.1 13.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 111.664 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.511 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -122.3 125.51 46.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.602 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 55.7 p90 -97.51 156.68 16.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 tp -158.25 135.57 6.97 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.62 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.57 116.65 3.31 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.552 2.168 . . . . 0.0 112.174 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -117.43 103.45 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.046 0.45 . . . . 0.0 110.999 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.91 -66.42 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.25 -75.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -169.33 33.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -112.65 -22.62 10.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.19 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.07 153.09 51.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 9.8 mmtp -126.99 92.73 3.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 110.849 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 126' ' ' GLY . 0.7 OUTLIER -56.28 102.8 0.08 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.038 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 37.3 p90 -111.49 151.81 28.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.613 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.06 142.14 6.89 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.992 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 178.72 -142.88 5.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.685 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -125.23 179.59 5.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.802 0.334 . . . . 0.0 111.214 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.479 HG21 ' NH1' ' A' ' 142' ' ' ARG . 9.4 t -159.01 154.94 26.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.059 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 pp -160.23 131.96 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.68 -129.98 1.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.946 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.846 HD21 HG23 ' A' ' 117' ' ' VAL . 4.4 tt -155.08 128.09 8.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.393 . . . . 0.0 110.557 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.782 HG23 ' HB2' ' A' ' 120' ' ' ALA . 21.6 t -109.63 115.59 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.166 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.15 130.79 55.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.97 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.415 HD22 ' OG ' ' A' ' 115' ' ' SER . 0.4 OUTLIER -116.91 165.6 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.51 135.29 55.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.58 141.56 32.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -126.01 114.34 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.93 154.7 21.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.59 31.21 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 0.0 110.857 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.37 -98.09 2.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.541 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.78 138.04 58.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 0.0 110.907 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.76 143.32 28.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -146.41 168.86 20.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -92.26 86.85 5.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.415 ' OG ' HD22 ' A' ' 104' ' ' LEU . 67.3 m -129.56 95.04 3.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -161.47 -74.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.846 HG23 HD21 ' A' ' 101' ' ' LEU . 10.1 p -160.76 122.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.127 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.25 164.2 24.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.406 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.82 114.99 26.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.782 ' HB2' HG23 ' A' ' 102' ' ' VAL . . . -100.06 136.7 39.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.006 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -168.63 138.69 2.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.353 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.36 -140.68 2.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 143' ' ' TYR . 0.4 OUTLIER -147.66 163.95 35.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.36 . . . . 0.0 110.805 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -151.91 171.22 18.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.207 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.9 142.52 0.08 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.588 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.58 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -170.08 -134.44 1.75 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.732 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.695 ' N ' HD13 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -158.71 120.62 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.744 0.307 . . . . 0.0 110.441 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -95.07 117.69 30.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.936 0.398 . . . . 0.0 110.859 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.418 ' HB2' ' CG1' ' A' ' 137' ' ' ILE . 27.9 mt-30 -95.08 121.34 36.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -112.57 149.1 33.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.662 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mp -106.18 -42.37 5.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 110.509 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.11 -166.71 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.026 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -82.78 54.28 2.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.789 0.328 . . . . 0.0 110.44 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -141.9 -56.62 0.46 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.146 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.36 152.39 34.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.934 0.397 . . . . 0.0 111.303 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.2 t -142.17 179.12 7.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.538 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.418 ' CG1' ' HB2' ' A' ' 129' ' ' GLN . 19.2 pt -140.71 144.96 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.801 ' HB2' HD12 ' A' ' 128' ' ' LEU . 41.0 tt0 -130.54 136.25 48.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.87 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -155.82 149.98 21.2 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.547 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 172' ' ' TYR . . . 171.09 -131.24 2.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.642 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -119.9 160.76 22.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.799 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.479 ' NH1' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -142.72 123.12 13.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.198 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.864 ' O ' HD22 ' A' ' 144' ' ' LEU . 93.4 m-85 -119.55 133.91 55.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.441 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.864 HD22 ' O ' ' A' ' 143' ' ' TYR . 2.0 mm? -141.64 154.12 45.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 111.3 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -117.67 163.41 16.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.477 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.86 172.07 7.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 111.203 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -56.65 117.23 3.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.142 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -113.75 113.29 24.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.077 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.9 p 62.58 146.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.031 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 p -147.24 65.48 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 62.51 128.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.118 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 41.0 mtm -99.22 -178.78 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 63.5 p -114.93 135.44 22.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.992 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 153' ' ' THR . 52.0 Cg_exo -54.19 -62.3 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.515 2.144 . . . . 0.0 112.323 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -75.86 137.6 40.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.22 174.98 50.77 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.493 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 176.8 165.4 32.23 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.443 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -128.12 -178.56 4.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 110.802 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 89.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -77.31 155.68 31.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 109.18 60.18 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.7 m -134.41 129.42 35.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.37 97.58 2.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -150.84 33.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.44 -52.34 9.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 3.5 m170 60.31 166.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 57.9 m -91.35 167.69 12.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 91.8 p -115.16 157.34 23.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 18.8 t -107.02 130.17 54.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.744 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.24 155.21 46.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -106.19 143.7 33.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.133 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -124.54 127.02 46.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.102 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.9 tt -163.66 129.73 3.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.501 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.34 -155.45 15.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.87 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -114.98 172.04 7.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -155.9 117.52 3.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 3.9 m-85 -115.98 117.19 29.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.074 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -84.58 163.98 18.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.126 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.922 0.391 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -123.07 168.11 12.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.05 132.71 54.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.708 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 13.6 m-85 -134.51 139.96 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.028 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 1.063 HG23 ' HB2' ' A' ' 46' ' ' ALA . 7.6 p -151.16 129.36 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.965 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.7 -147.85 5.31 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.843 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 4.8 mp -138.99 160.06 40.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.352 . . . . 0.0 110.903 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.505 HG21 ' CG2' ' A' ' 58' ' ' THR . 4.8 t -129.54 167.5 17.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.791 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.48 ' HB3' HD12 ' A' ' 173' ' ' LEU . 5.0 t-105 -149.11 137.18 20.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.96 122.03 5.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.474 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -87.26 122.83 31.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.853 0.359 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.09 137.84 52.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.0 m -150.06 102.83 3.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -138.27 36.52 2.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.24 150.87 48.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.33 31.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.14 129.74 43.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 60.07 31.21 20.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.89 129.6 53.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mttt 62.43 117.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.957 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 m -119.23 24.45 10.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mt -155.49 58.99 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.94 0.4 . . . . 0.0 110.724 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -119.96 167.57 12.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.2 mtm-85 -84.5 -73.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.24 -177.96 3.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mp -142.0 -72.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -67.06 178.82 1.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.421 ' CB ' ' CD ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -178.44 -61.77 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 29' ' ' SER . 44.9 Cg_endo -68.31 145.97 67.57 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.534 2.156 . . . . 0.0 112.306 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -60.07 147.18 40.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.946 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 mp -116.78 116.35 27.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.38 -45.78 4.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -147.79 -65.64 0.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.494 ' O ' HG22 ' A' ' 36' ' ' ILE . 11.0 p -121.41 -45.61 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.051 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 35' ' ' VAL . 4.4 tp 44.19 33.34 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.47 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' O ' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -176.26 111.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.919 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -107.08 170.42 7.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.4 p -144.72 29.48 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.48 96.68 0.1 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.466 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 m -112.83 125.73 54.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -108.34 174.31 5.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.798 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.5 157.94 21.41 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.603 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 45' ' ' ARG . 2.1 mp -109.8 158.89 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.511 0.196 . . . . 0.0 110.907 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -143.31 149.77 38.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.042 0.448 . . . . 0.0 110.839 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 1.063 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -177.35 123.56 0.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.583 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -163.85 -137.6 2.23 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.592 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.66 130.42 38.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.782 0.325 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 40.0 tt0 -105.66 110.71 23.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.029 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 53' ' ' GLY . 1.9 p90 -121.06 166.99 13.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.727 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -19.95 65.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.4 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -92.14 15.86 12.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.553 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . 133.02 176.0 14.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.56 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.444 ' HD2' ' CD2' ' A' ' 83' ' ' PHE . 47.3 mtp180 -116.14 117.13 29.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.865 0.364 . . . . 0.0 111.2 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -100.36 136.36 40.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.209 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.612 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 44.0 p90 179.84 132.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.836 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . -90.34 136.65 32.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.158 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.505 ' CG2' HG21 ' A' ' 9' ' ' THR . 25.8 m -113.68 111.72 22.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.98 0.419 . . . . 0.0 111.543 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.88 124.34 29.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.148 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -101.88 155.12 18.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 111.501 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -166.43 114.92 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.48 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.0 pt -99.86 145.11 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 m 64.62 127.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.007 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.6 -177.25 5.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 66' ' ' SER . 0.2 OUTLIER 60.26 177.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 65' ' ' THR . 83.8 p -81.75 -33.58 30.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -62.04 -37.08 83.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.5 -107.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.49 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -138.02 172.99 12.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.779 0.323 . . . . 0.0 110.952 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -144.48 93.36 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mp -119.88 146.08 46.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -90.16 55.01 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.99 177.17 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.9 158.09 5.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.807 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.656 ' CG ' HG22 ' A' ' 102' ' ' VAL . 51.5 t-20 -133.41 120.67 21.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.093 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.41 ' C ' HD23 ' A' ' 76' ' ' LEU . 6.1 tt -114.94 114.99 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.443 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 120' ' ' ALA . 2.1 mp -122.45 153.79 38.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.991 0.424 . . . . 0.0 111.498 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.73 116.7 4.24 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.81 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.429 ' HB2' ' CE2' ' A' ' 56' ' ' TYR . 54.5 m -90.53 140.72 29.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.07 0.462 . . . . 0.0 111.568 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -148.34 110.78 4.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.031 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.414 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 3.9 p30 -146.36 172.18 13.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.421 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.31 118.66 35.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -97.81 167.12 11.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.665 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.494 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.1 OUTLIER -168.44 134.25 1.53 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 84' ' ' LEU . 36.9 Cg_endo -65.71 95.06 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.474 2.116 . . . . 0.0 112.102 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 86' ' ' ILE . 1.7 tt -156.42 125.43 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.14 -56.7 0.36 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.623 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.67 -53.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -177.53 -38.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.08 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 38.1 p-10 -125.59 57.53 1.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.294 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.598 HG22 HD12 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -136.63 148.48 47.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.124 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -126.64 92.31 3.53 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.078 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 6.4 tt -61.59 102.73 0.27 Allowed 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.482 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.511 ' HE1' HE22 ' A' ' 124' ' ' GLN . 15.2 p90 -113.35 154.2 27.27 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.88 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.84 130.56 1.97 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.671 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.414 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -169.65 -139.99 2.86 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.589 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -135.64 170.11 16.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 111.155 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -138.03 163.16 32.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.27 133.81 6.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -155.63 -144.31 3.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.995 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.14 130.84 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.256 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.656 HG22 ' CG ' ' A' ' 75' ' ' ASN . 14.9 t -109.65 128.84 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.225 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -127.32 131.88 50.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.853 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.4 tp -118.58 146.09 44.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -110.42 173.61 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.92 177.73 10.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.49 96.94 6.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.86 168.48 44.48 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.516 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.16 122.37 46.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 0.0 110.907 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -151.18 -48.29 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.545 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.94 163.74 26.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.53 161.55 30.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -73.47 129.41 37.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -176.35 -39.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.075 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.91 -165.77 1.42 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.982 0.42 . . . . 0.0 110.755 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.658 ' O ' HG13 ' A' ' 117' ' ' VAL . 5.3 t0 69.09 10.12 7.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.35 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 116' ' ' ASP . 3.0 m -163.32 104.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.715 0.293 . . . . 0.0 110.973 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -140.53 143.61 13.73 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.642 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -90.49 120.33 31.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.746 0.308 . . . . 0.0 110.753 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.87 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -95.04 140.05 30.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.211 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.02 134.72 0.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.72 -141.99 3.27 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.601 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 mp -149.65 162.44 40.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.89 0.376 . . . . 0.0 110.985 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.511 HE22 ' HE1' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -154.01 159.71 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 -179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 177.01 142.51 0.08 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.729 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -174.58 -125.69 0.88 Allowed Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.733 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.598 HD12 HG22 ' A' ' 91' ' ' THR . 5.3 pt -161.13 120.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 110.366 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.825 HD12 ' HB3' ' A' ' 138' ' ' GLU . 1.1 tp -95.42 114.69 26.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.971 0.415 . . . . 0.0 110.833 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 21.5 mt-30 -99.52 147.48 25.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.247 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -128.72 149.11 50.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.52 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.4 mt -109.43 -45.38 3.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.089 0.471 . . . . 0.0 110.76 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.09 -164.89 0.49 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.274 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -80.12 57.41 2.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.879 0.371 . . . . 0.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -138.72 -60.28 0.6 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.2 158.24 21.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.993 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.3 m -125.72 168.66 13.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 174' ' ' GLY . 4.0 mp -134.08 134.7 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.778 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.825 ' HB3' HD12 ' A' ' 128' ' ' LEU . 8.7 pm0 -124.21 149.99 45.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -154.76 128.8 2.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.365 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.25 -136.74 2.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.8 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -135.16 161.07 36.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.402 ' HG2' ' CG ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -147.77 146.32 29.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -112.47 145.79 39.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.85 122.56 39.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -145.52 111.99 5.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.704 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 120' ' ' ALA . 82.1 p -115.87 135.29 54.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -141.07 114.91 9.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.854 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.73 178.58 8.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.7 m 59.68 28.31 17.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 m 58.27 164.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -93.21 77.18 4.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 24.1 ttt -60.48 -52.76 63.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 153' ' ' THR . 10.6 t -79.55 114.71 47.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.22 124.52 10.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.363 2.042 . . . . 0.0 112.201 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -101.06 160.75 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 132.35 -70.03 0.52 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.536 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.68 -98.73 1.7 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.426 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -172.47 -44.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -78.79 179.72 7.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.37 138.14 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -124.62 -89.63 0.83 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.452 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.02 140.44 24.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.02 95.74 5.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -160.03 31.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.1 -66.58 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.05 40.44 3.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.16 159.14 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.2 m -107.92 148.78 29.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.0 p -107.09 122.47 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.05 155.2 49.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.3 165.16 11.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.139 0.495 . . . . 0.0 110.239 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -137.92 128.5 26.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.805 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -163.6 129.98 3.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 137' ' ' ILE . . . -179.87 -156.66 18.41 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.696 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -125.07 172.09 9.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.114 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -149.98 114.94 5.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.419 ' O ' HG12 ' A' ' 6' ' ' VAL . 39.9 m-85 -107.02 116.92 32.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.987 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -83.87 162.85 20.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 40.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.969 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.454 ' HA ' ' CD1' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.876 0.369 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -106.12 160.6 15.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.665 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -112.24 138.1 49.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.512 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 28.4 p90 -148.95 161.86 41.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.01 0.433 . . . . 0.0 111.454 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.885 HG12 ' HB1' ' A' ' 46' ' ' ALA . 34.3 m -150.33 141.18 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.02 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.1 -157.91 9.04 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 119.966 -1.112 . . . . 0.0 113.135 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -126.97 154.94 43.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.795 0.331 . . . . 0.0 110.786 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 p -128.02 149.6 50.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.437 ' CD2' ' HB3' ' A' ' 42' ' ' TRP . 1.7 t-105 -153.09 115.9 4.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.45 137.96 13.73 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -84.06 135.61 34.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 m -99.66 121.5 41.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -150.18 102.84 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.67 -60.56 2.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.954 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -65.94 114.06 4.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 tt -150.86 142.9 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -134.52 153.51 51.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.95 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -167.98 -67.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -114.69 -44.4 3.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.3 mtmm -121.88 160.2 25.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.0 t -97.41 113.85 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.81 125.6 29.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.23 135.28 50.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.8 81.59 8.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -65.28 172.74 2.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.428 ' O ' HD23 ' A' ' 27' ' ' LEU . 5.5 tt -130.26 97.61 4.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -96.45 -36.83 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.432 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.5 OUTLIER 180.0 -55.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 29' ' ' SER . 53.2 Cg_exo -52.37 178.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.488 2.126 . . . . 0.0 112.219 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -172.75 147.7 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.12 71.93 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.027 0.441 . . . . 0.0 110.745 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -113.17 -36.23 5.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.01 -57.52 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 m -71.63 73.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.2 mt -100.51 -30.52 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.123 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -110.73 -55.07 2.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.827 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.33 138.61 33.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 39' ' ' THR . 3.6 t -170.62 104.42 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.33 -175.02 30.87 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.491 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.96 149.79 38.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.437 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 68.0 p-90 -152.92 162.91 40.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.757 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.94 -165.99 35.34 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.706 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.422 HG12 ' N ' ' A' ' 45' ' ' ARG . 18.0 tt -123.56 159.84 27.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.491 0.186 . . . . 0.0 110.803 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -137.88 158.53 44.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.24 0.543 . . . . 0.0 110.669 179.639 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.885 ' HB1' HG12 ' A' ' 6' ' ' VAL . . . -177.04 123.74 0.14 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.107 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -167.02 -142.69 3.52 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.603 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 1.5 mp0 -129.78 139.39 51.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.822 0.344 . . . . 0.0 111.048 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' CD1' ' A' ' 5' ' ' PHE . 2.2 pt20 -121.25 112.33 18.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 2' ' ' ALA . 24.2 t80 -119.92 157.22 29.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.6 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.28 -22.28 29.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.255 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -95.66 21.66 8.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.257 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.67 158.85 8.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.494 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' HG3' ' HB3' ' A' ' 49' ' ' GLN . 47.5 ttm-85 -121.22 130.85 53.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.851 0.358 . . . . 0.0 111.061 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -117.67 152.52 35.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.471 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.514 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 36.2 p90 179.67 129.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.156 0.503 . . . . 0.0 111.25 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . -90.59 128.91 36.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.022 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.0 p -117.39 115.05 24.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.165 0.507 . . . . 0.0 111.486 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 75' ' ' ASN . 35.3 m-85 -92.9 130.64 38.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.116 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.9 171.73 8.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.051 0.453 . . . . 0.0 111.441 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -157.67 -176.09 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.628 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.653 HD11 ' HB2' ' A' ' 73' ' ' GLN . 4.2 mt -113.23 136.8 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 111.076 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.2 m -161.97 148.64 13.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -115.88 -41.47 3.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.943 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.767 HG23 ' H ' ' A' ' 68' ' ' GLY . 1.9 t -89.39 173.69 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.4 m -63.6 -60.91 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -67.55 -30.06 69.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.933 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.767 ' H ' HG23 ' A' ' 65' ' ' THR . . . 102.99 135.96 8.92 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.454 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -119.72 96.9 5.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.753 0.311 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt 56.66 -179.3 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.57 -168.08 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.806 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -161.51 -44.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.961 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.653 ' HB2' HD11 ' A' ' 62' ' ' ILE . 9.0 mp0 -142.64 151.99 42.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.972 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.699 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -108.24 165.02 11.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.718 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 5.6 m-80 -143.76 131.11 20.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -147.69 114.91 6.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.469 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -145.73 154.62 42.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.041 0.448 . . . . 0.0 111.472 -179.538 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.93 116.8 4.24 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.823 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.45 134.0 42.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.974 0.416 . . . . 0.0 111.447 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -124.52 110.86 14.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.061 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -130.79 166.42 20.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 111.415 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.77 118.46 35.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.396 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 55.4 p90 -97.78 166.94 11.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.574 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.68 136.14 1.65 Allowed Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.468 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.12 118.11 4.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.417 2.078 . . . . 0.0 112.377 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.475 HD12 ' CB ' ' A' ' 93' ' ' LEU . 27.8 mt -155.72 109.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.86 -95.17 0.17 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -130.57 35.44 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 110.812 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 67.06 29.87 7.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.683 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -142.34 -44.64 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.808 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.575 HG22 ' HG3' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -67.97 149.14 50.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.536 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -127.21 92.47 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 0.0 111.114 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.569 HD22 ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -59.02 103.17 0.15 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 110.319 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 40.7 p90 -110.7 157.66 19.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.053 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.98 129.96 1.61 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.835 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.3 -138.33 2.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.581 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.93 -177.82 4.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.143 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -148.99 155.98 41.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.2 132.2 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.699 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.63 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -160.52 -148.16 5.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.918 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.63 HD12 ' C ' ' A' ' 100' ' ' GLY . 5.5 mp -155.34 133.6 11.66 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.241 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 74' ' ' GLN . 12.2 p -109.35 131.31 60.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.137 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.12 121.04 28.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.966 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.9 144.38 33.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.815 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -123.3 164.47 18.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -151.41 178.02 9.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.03 -174.79 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.753 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -122.99 41.41 1.8 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -144.7 -47.26 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.58 -127.67 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.504 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -88.59 153.91 20.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.807 0.336 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -153.17 100.99 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -125.78 -65.98 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.07 119.75 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.835 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.5 p -152.54 79.77 1.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.569 ' O ' HG13 ' A' ' 117' ' ' VAL . 4.0 t70 -150.22 -67.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 116' ' ' ASP . 3.9 m -160.1 172.99 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -148.57 -157.79 7.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.428 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -116.05 115.0 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.09 144.04 37.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 141.33 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.263 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.46 -142.74 3.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.517 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mp -145.58 161.97 38.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.834 0.349 . . . . 0.0 110.771 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.675 HE21 ' HE ' ' A' ' 142' ' ' ARG . 7.7 mt-30 -149.13 160.47 43.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.794 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.75 ' HB3' ' CZ ' ' A' ' 141' ' ' TYR . . . 176.95 142.44 0.08 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.598 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.586 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -174.86 -130.69 1.33 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.748 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 126' ' ' GLY . 10.7 pt -160.94 120.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 110.492 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.693 HD11 HD22 ' A' ' 176' ' ' ASN . 0.4 OUTLIER -94.7 112.21 23.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.684 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . 0.575 ' HG3' HG22 ' A' ' 91' ' ' THR . 8.6 mp0 -103.91 124.31 48.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.75 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -86.05 149.35 25.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -104.02 -29.61 10.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.048 0.452 . . . . 0.0 110.163 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.01 -165.48 0.55 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.824 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -91.27 48.01 1.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.705 0.288 . . . . 0.0 110.596 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -155.95 -44.07 0.08 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.647 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -130.19 170.67 13.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.012 0.434 . . . . 0.0 111.566 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.7 m -156.1 -175.8 5.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.73 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.8 pt -154.18 152.61 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.701 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.87 156.56 47.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.041 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -167.54 146.4 10.63 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.95 -125.2 1.19 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.644 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.75 ' CZ ' ' HB3' ' A' ' 125' ' ' ALA . 13.7 p90 -136.09 161.2 36.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.766 0.317 . . . . 0.0 110.732 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.675 ' HE ' HE21 ' A' ' 124' ' ' GLN . 0.2 OUTLIER -162.44 140.28 8.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.246 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -119.78 162.7 18.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.54 HD21 ' CD2' ' A' ' 77' ' ' LEU . 12.1 tp -159.48 146.93 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.957 0.408 . . . . 0.0 111.306 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.6 mmm-85 -118.65 154.22 33.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.544 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.8 p -108.99 172.03 7.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -55.44 114.99 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.23 -43.94 8.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.6 m -170.75 166.12 7.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.0 p -142.35 146.35 34.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.56 86.75 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.49 -58.9 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.4 p -107.87 150.32 40.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.59 62.89 2.26 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.591 2.194 . . . . 0.0 112.241 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.13 -66.71 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 67.52 135.88 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.565 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.68 96.34 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -153.05 36.37 0.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.93 123.61 4.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.785 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.34 30.52 19.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.825 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -148.31 154.91 26.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.461 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.4 m -83.53 157.2 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.84 123.01 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.956 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.34 -178.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.3 tp -113.93 175.73 5.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.89 141.39 34.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.09 149.25 29.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.811 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.55 -177.46 3.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 30.3 t -107.11 142.41 36.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.02 155.2 35.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -102.5 165.27 11.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.2 0.524 . . . . 0.0 110.367 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -134.26 128.7 34.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.957 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 9.8 tp -163.67 129.89 3.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.588 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.77 -158.57 22.12 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.737 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.52 172.02 8.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.798 0.332 . . . . 0.0 111.046 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.693 HD22 HD11 ' A' ' 128' ' ' LEU . 39.6 t-20 -153.96 114.93 4.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -116.23 111.34 20.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 1.7 ptpt -84.43 163.17 19.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.164 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.737 0.303 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.79 129.07 3.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.25 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 1.6 t-20 -77.79 145.56 36.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.651 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 18.0 p90 -148.57 152.11 36.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.124 0.488 . . . . 0.0 111.421 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.672 HG23 ' HB2' ' A' ' 46' ' ' ALA . 9.1 p -151.29 135.64 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.158 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.86 -133.69 1.57 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mp -143.86 167.96 21.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 110.829 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -135.01 143.38 46.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.451 ' CD1' ' HB3' ' A' ' 42' ' ' TRP . 0.6 OUTLIER -134.53 117.84 16.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.708 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.2 151.2 17.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.597 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -86.24 124.28 32.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 m -81.94 135.31 35.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.14 102.81 3.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.783 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.9 m120 61.79 116.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.16 147.36 49.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 mp -74.66 110.34 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 156.99 31.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -105.93 40.83 1.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.32 105.16 15.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.982 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -64.66 0.86 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.864 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.6 m -146.36 88.37 1.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 tp -173.55 110.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 60.85 164.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.72 50.9 1.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.74 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -99.91 130.67 46.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.877 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.666 HD12 ' N ' ' A' ' 28' ' ' ASN . 1.4 pp -111.54 -34.27 6.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.666 ' N ' HD12 ' A' ' 27' ' ' LEU . 1.1 t-20 -129.18 110.22 11.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -72.39 -60.41 2.16 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.872 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 29' ' ' SER . 58.9 Cg_endo -72.07 176.43 8.45 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.538 2.158 . . . . 0.0 112.317 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -67.8 179.81 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mp -118.93 124.76 47.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.991 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -171.04 -55.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HG3' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -100.31 -65.21 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 35' ' ' VAL . 14.3 p 43.51 43.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.624 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.42 HG23 ' HG3' ' A' ' 34' ' ' LYS . 5.8 pt -85.34 87.51 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.19 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.34 121.89 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -157.83 156.07 30.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.952 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.547 HG21 ' O ' ' A' ' 63' ' ' SER . 80.0 m -108.02 -71.83 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.84 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.24 151.73 8.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.0 p -124.11 108.03 11.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TRP . . . . . 0.451 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 6.6 p-90 -126.27 164.51 20.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.691 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.61 -169.43 35.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.832 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.754 HD12 ' HB2' ' A' ' 59' ' ' TYR . 1.7 mt -107.79 163.21 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.551 0.215 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.618 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -138.92 139.82 38.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.932 0.396 . . . . 0.0 110.923 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.672 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -170.02 117.73 0.57 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.771 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -157.63 -167.25 18.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.457 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 3.9 pt20 -131.72 125.52 32.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 110.839 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.415 ' HG2' ' N ' ' A' ' 50' ' ' PHE . 5.3 tt0 -83.84 151.95 24.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' N ' ' HG2' ' A' ' 49' ' ' GLN . 0.8 OUTLIER -127.66 166.48 18.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -24.98 65.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.441 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -133.12 24.26 4.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.691 0.281 . . . . 0.0 111.475 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.99 170.96 42.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.4 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -141.5 142.68 33.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.851 0.358 . . . . 0.0 111.329 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -129.89 151.73 50.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.242 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.619 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 36.2 p90 179.49 129.19 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.191 0.52 . . . . 0.0 111.246 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.82 152.41 20.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.426 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 73.0 p -137.13 121.22 17.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 111.546 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.817 ' CE2' HD21 ' A' ' 76' ' ' LEU . 8.3 m-85 -85.67 117.62 24.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.926 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' OE2' HD11 ' A' ' 62' ' ' ILE . 5.2 tt0 -101.96 158.04 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 111.469 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -165.32 107.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.494 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.486 HD11 ' OE2' ' A' ' 60' ' ' GLU . 23.2 mm -99.87 144.26 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.205 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.547 ' O ' HG21 ' A' ' 39' ' ' THR . 14.7 m -120.98 120.45 35.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -159.19 33.99 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.581 HG21 ' HD2' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -99.06 178.73 4.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 m -74.19 -54.21 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -34.46 78.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 -45.95 1.24 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.579 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -122.88 123.02 40.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.392 . . . . 0.0 110.955 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HD2' HG21 ' A' ' 65' ' ' THR . 4.4 mtpp -112.07 -35.31 5.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.21 31.91 19.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.08 33.0 2.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -152.66 128.61 10.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.93 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.88 156.66 41.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.718 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -144.08 114.82 7.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.175 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.817 HD21 ' CE2' ' A' ' 59' ' ' TYR . 2.5 mp -107.62 131.11 54.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.397 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.446 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 1.9 mp -141.72 147.41 37.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.027 0.441 . . . . 0.0 111.565 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.99 116.75 4.21 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.072 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.566 ' OG ' HG22 ' A' ' 98' ' ' THR . 1.9 t -87.71 136.32 33.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.983 0.42 . . . . 0.0 111.259 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -133.07 110.82 10.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.258 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -147.78 172.08 14.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.031 0.444 . . . . 0.0 111.589 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.44 124.97 50.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.485 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 45.6 p90 -97.51 165.43 12.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.497 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.638 HD23 HD11 ' A' ' 86' ' ' ILE . 26.0 tp -140.52 117.85 8.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.417 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.52 108.66 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.37 2.047 . . . . 0.0 112.354 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.638 HD11 HD23 ' A' ' 84' ' ' LEU . 31.7 mm -103.76 97.73 5.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.76 62.34 2.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.534 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.483 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -122.09 -43.83 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.883 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -155.07 33.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.4 m120 60.93 66.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.643 HG22 HD12 ' A' ' 127' ' ' ILE . 0.8 OUTLIER -136.6 148.64 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.672 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -123.25 92.49 3.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.931 0.396 . . . . 0.0 110.781 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.51 103.01 0.28 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.666 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 46.6 p90 -111.37 154.59 24.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.817 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.35 132.83 2.34 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.819 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.6 -139.43 2.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.687 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.89 177.11 7.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.756 0.312 . . . . 0.0 111.183 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.566 HG22 ' OG ' ' A' ' 79' ' ' SER . 47.8 p -146.37 159.04 43.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mp -159.25 130.8 6.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.646 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -150.71 -155.91 7.1 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.124 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.9 mt -155.2 130.51 9.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.794 0.33 . . . . 0.0 110.168 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 102' ' ' VAL . 12.5 p -109.72 119.78 59.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.297 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -93.52 122.92 36.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.934 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.09 145.73 51.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.37 156.2 19.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -154.48 154.86 33.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.812 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -60.85 -42.22 97.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.75 124.74 5.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.486 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.61 -68.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.831 0.348 . . . . 0.0 110.873 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.29 -99.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.99 158.24 32.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.764 0.316 . . . . 0.0 110.947 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.8 103.75 16.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.98 163.43 20.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.04 -67.61 0.97 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.7 m -61.16 85.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.986 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.33 60.06 5.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 p -93.29 133.49 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.176 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -113.95 -177.62 19.22 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.507 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -91.71 125.44 36.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.4 137.46 51.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -171.17 140.42 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.001 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.28 -139.86 2.76 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.643 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 143' ' ' TYR . 24.9 mt -145.39 165.64 27.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.798 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 8.0 tt0 -157.14 159.27 37.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 94' ' ' PHE . . . 176.94 142.46 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -171.81 -130.69 1.26 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.656 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.643 HD12 HG22 ' A' ' 91' ' ' THR . 4.7 pt -158.68 120.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.52 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.701 HD11 ' OD1' ' A' ' 176' ' ' ASN . 8.5 tt -95.19 114.32 26.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.117 0.484 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -99.14 139.63 34.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.268 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -118.78 149.11 42.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.556 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.92 -51.22 2.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.626 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -169.11 -164.9 0.49 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.093 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -76.47 58.32 1.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.786 0.326 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -136.88 -60.17 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HB2' ' CE2' ' A' ' 177' ' ' TYR . . . -166.03 156.66 12.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.75 165.34 13.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.63 134.73 61.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.514 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.95 143.36 50.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.051 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -160.08 149.88 19.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.297 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 173.8 -133.98 2.73 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.729 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.62 161.05 23.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.82 0.343 . . . . 0.0 110.98 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.0 ttt-85 -149.91 125.27 10.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.43 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 13.1 m-85 -101.09 138.71 37.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.763 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.06 134.06 55.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.7 mmm-85 -151.64 112.14 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.1 p -118.49 129.78 55.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.987 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -140.95 115.02 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.793 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.64 116.09 17.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.3 m -88.78 153.37 21.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 61.3 p -132.55 -46.84 0.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.49 ' HB3' HG22 ' A' ' 153' ' ' THR . 8.4 mm-40 -62.37 154.21 28.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 4.1 ttp -108.78 37.26 2.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.796 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.49 HG22 ' HB3' ' A' ' 151' ' ' GLU . 2.6 t -109.77 96.23 23.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.72 96.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.519 2.146 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.92 148.35 22.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.8 161.95 32.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.51 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -175.47 -63.37 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.459 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 60.57 98.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.77 0.319 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -127.49 149.95 49.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.39 119.32 38.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 162.63 -92.27 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.524 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.3 m -160.08 142.86 13.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.27 97.34 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 62.64 126.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.007 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.6 mt -98.37 34.5 1.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -98.41 33.49 2.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.5 m -71.25 170.12 13.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.49 141.2 43.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.88 119.8 40.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -147.7 155.16 41.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -102.51 165.27 11.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.154 0.502 . . . . 0.0 110.163 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.75 129.75 30.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.113 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.4 tp -163.42 131.56 3.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.721 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 176.94 -155.17 17.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.681 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.19 172.04 13.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.986 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.701 ' OD1' HD11 ' A' ' 128' ' ' LEU . 1.1 p30 -158.05 121.81 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.544 ' CE2' ' HB2' ' A' ' 135' ' ' ALA . 36.3 m-85 -98.71 115.77 29.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.4 147.28 29.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.112 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.461 0.118 0 CA-C-O 120.809 0.337 . . . . 0.0 111.232 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.9 138.86 56.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.762 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.5 m-85 -132.48 139.88 48.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 111.103 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.605 HG12 ' CB ' ' A' ' 46' ' ' ALA . 19.6 m -154.58 127.63 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.997 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.6 -146.47 4.66 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.846 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 43' ' ' GLY . 0.5 OUTLIER -127.8 153.97 45.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 0.0 110.821 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.662 ' OG1' HG23 ' A' ' 58' ' ' THR . 1.0 OUTLIER -125.37 135.9 52.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.05 113.24 11.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.29 131.36 10.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.523 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.871 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.8 p -95.01 126.58 40.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -128.31 132.73 48.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.705 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -156.35 -167.26 17.41 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.51 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 pt -107.15 172.54 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 111.027 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.87 141.44 34.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.639 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.605 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -174.87 123.2 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.315 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -160.96 -148.74 5.38 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.698 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -136.07 126.29 26.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.01 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 1.1 tm0? -83.97 158.91 21.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.662 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -135.04 164.22 28.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.15 -24.08 65.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.365 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.32 24.38 5.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.27 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 174.61 178.21 44.32 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.202 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 54' ' ' ARG . 4.1 ptm85 -148.13 138.22 22.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 111.187 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -117.04 145.63 43.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.514 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.457 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 41.0 p90 -172.12 121.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 111.171 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.85 158.93 16.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.662 HG23 ' OG1' ' A' ' 9' ' ' THR . 68.1 m -127.95 117.06 21.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.059 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.466 ' HD2' HD23 ' A' ' 76' ' ' LEU . 28.3 t80 -100.96 127.59 47.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.754 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -141.53 176.71 8.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.029 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.742 0.306 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.431 ' OD1' HD12 ' A' ' 77' ' ' LEU . 21.7 t-20 -144.64 116.99 8.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.094 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.5 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -129.73 127.05 39.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.534 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.652 HD22 HD21 ' A' ' 144' ' ' LEU . 0.8 OUTLIER -146.32 137.72 24.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.963 0.411 . . . . 0.0 111.438 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.77 116.89 3.89 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.016 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.408 ' OG ' ' CE2' ' A' ' 56' ' ' TYR . 26.0 p -105.92 133.29 50.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.412 . . . . 0.0 111.279 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 55' ' ' TYR . 23.1 p90 -123.85 110.89 15.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.353 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.57 171.19 14.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.053 0.454 . . . . 0.0 111.383 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -117.54 120.6 38.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.919 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 42.1 p90 -97.86 164.38 12.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.133 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.721 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.2 OUTLIER -170.26 139.03 1.44 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.636 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.721 ' HD2' HD23 ' A' ' 84' ' ' LEU . 76.3 Cg_exo -49.84 119.51 4.88 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.514 2.142 . . . . 0.0 112.359 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 86' ' ' ILE . 5.0 tp . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.03 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.734 0.302 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.78 153.09 31.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.569 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 1.7 tptp -126.58 92.53 3.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.824 0.345 . . . . 0.0 110.995 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.14 102.82 0.32 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.256 0.55 . . . . 0.0 110.508 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.452 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 35.9 p90 -111.04 156.0 21.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.758 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.27 134.7 3.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.732 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.418 ' O ' HD23 ' A' ' 123' ' ' LEU . . . -177.53 -160.66 24.59 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.446 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.13 171.43 8.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 0.0 111.23 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.44 HG21 HE21 ' A' ' 124' ' ' GLN . 7.8 t -143.92 159.81 41.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.06 131.19 5.81 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.456 ' N ' HD23 ' A' ' 77' ' ' LEU . . . -152.73 -153.31 6.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.806 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.7 pp -155.28 127.94 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.656 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.2 m -109.74 130.41 62.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.206 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 117' ' ' VAL . 11.4 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.879 0.371 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.29 132.61 6.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -84.62 115.04 22.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 0.0 111.034 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -111.62 137.74 49.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.05 141.27 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.27 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.94 -139.56 2.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.603 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 96' ' ' GLY . 1.9 mt -140.37 161.16 38.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.378 . . . . 0.0 110.831 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.44 HE21 HG21 ' A' ' 98' ' ' THR . 66.8 mt-30 -150.04 157.78 43.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.796 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 178.68 142.39 0.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.371 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -168.01 -130.33 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.117 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.523 HG23 ' O ' ' A' ' 126' ' ' GLY . 11.3 pt -159.45 121.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.77 0.319 . . . . 0.0 110.377 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.13 111.61 23.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.742 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -92.58 122.13 34.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.075 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.39 149.12 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.02 -47.26 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.001 0.429 . . . . 0.0 110.518 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -164.97 0.49 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.194 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 56.71 2.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.833 0.349 . . . . 0.0 110.6 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.76 -58.96 0.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.952 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -162.68 146.18 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.978 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.03 -179.9 4.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.4 mt -136.49 134.97 49.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 141.0 46.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.97 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -161.82 117.28 0.76 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.446 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -172.64 -138.95 2.7 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.094 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -121.19 161.16 22.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 110.843 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.724 ' HD3' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -143.28 121.71 12.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.107 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -118.18 131.3 56.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.463 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.724 HD12 ' HD3' ' A' ' 142' ' ' ARG . 0.8 OUTLIER -144.29 146.96 32.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.935 0.398 . . . . 0.0 111.261 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.84 162.38 13.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.561 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.089 -179.822 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.813 0.339 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 m -106.97 117.58 34.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.816 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 155.18 51.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.724 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -103.49 165.2 11.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.21 0.528 . . . . 0.0 110.277 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.413 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -131.39 128.0 38.7 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.768 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.4 131.65 3.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.711 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.33 -152.04 15.95 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.648 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -131.61 172.01 12.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 0.0 111.058 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -152.22 115.49 4.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -109.21 113.62 26.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.94 163.56 22.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.142 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.524 -0.053 0 CA-C-O 120.643 0.258 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -109.71 128.39 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.785 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.8 OUTLIER -129.05 139.91 51.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 46' ' ' ALA . 16.4 m -154.08 126.41 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.214 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.35 -141.92 3.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.641 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.769 HD23 ' HA ' ' A' ' 44' ' ' ILE . 4.6 mt -142.93 162.01 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.749 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.412 HG21 HG21 ' A' ' 58' ' ' THR . 8.4 t -139.07 136.38 35.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 111.263 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -130.62 113.02 13.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.59 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 172' ' ' TYR . . . -118.13 169.65 13.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.064 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.79 0.329 . . . . 0.0 110.837 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.545 -0.222 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 p -138.62 107.99 6.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -125.11 137.36 54.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.707 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.15 -171.61 34.23 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.851 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.769 ' HA ' HD23 ' A' ' 8' ' ' LEU . 1.4 mp -106.95 164.05 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.578 0.227 . . . . 0.0 110.745 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 44' ' ' ILE . 4.0 ttm-85 -132.39 139.71 48.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.646 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.571 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -174.81 122.43 0.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.443 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -169.92 -128.44 1.02 Allowed Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.516 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -143.22 154.91 44.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.65 109.84 11.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -103.7 145.71 29.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.547 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.22 -21.67 24.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.208 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -124.63 24.13 7.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.073 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.75 120.49 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.513 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 129.38 53.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 110.816 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.481 ' CD1' ' CD2' ' A' ' 80' ' ' TYR . 11.4 m-85 -124.24 147.03 48.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.772 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.486 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 31.9 p90 -177.3 125.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.039 0.447 . . . . 0.0 110.979 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.69 156.13 18.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.609 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 21.2 m -133.28 119.05 19.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.495 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.509 ' CZ ' HD23 ' A' ' 76' ' ' LEU . 27.9 m-85 -89.95 118.9 29.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.324 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.92 176.72 4.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.977 0.418 . . . . 0.0 111.397 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.641 179.985 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.7 0.286 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.597 ' OD1' HG22 ' A' ' 102' ' ' VAL . 2.5 t-20 -122.71 110.87 16.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.108 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.536 ' O ' HD22 ' A' ' 77' ' ' LEU . 4.2 mp -111.42 114.96 28.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.467 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.721 HD13 ' HA3' ' A' ' 100' ' ' GLY . 4.5 mm? -123.91 142.38 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 111.297 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.96 116.89 4.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.989 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.49 ' HA ' HG22 ' A' ' 98' ' ' THR . 0.1 OUTLIER -93.18 125.43 37.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.913 0.387 . . . . 0.0 111.413 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.481 ' CD2' ' CD1' ' A' ' 55' ' ' TYR . 9.8 m-85 -127.09 110.94 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.068 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 1.6 p30 -150.26 172.18 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 111.692 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.92 122.84 47.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.623 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -97.21 169.67 9.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.641 -179.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tp -147.93 124.44 5.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.551 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.09 110.45 2.2 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.405 2.07 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.917 HD11 ' HB2' ' A' ' 93' ' ' LEU . 33.8 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.654 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 57.3 m-80 . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.63 0.252 . . . . 0.0 111.406 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.682 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -74.65 151.18 39.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.561 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.467 ' HG2' ' CD2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -130.51 93.59 3.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.052 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.917 ' HB2' HD11 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -59.81 103.08 0.18 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.595 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 44.0 p90 -111.02 153.53 25.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.913 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.72 133.84 2.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.613 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.403 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -174.75 -136.54 2.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.75 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -128.01 179.98 5.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.789 0.328 . . . . 0.0 111.353 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.775 ' O ' HD12 ' A' ' 99' ' ' LEU . 48.7 p -146.73 157.09 43.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 98' ' ' THR . 0.6 OUTLIER -158.73 131.15 6.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.678 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.721 ' HA3' HD13 ' A' ' 77' ' ' LEU . . . -150.56 -154.04 6.34 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.948 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.578 ' N ' HD23 ' A' ' 101' ' ' LEU . 2.0 pt? -155.37 130.86 9.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.853 0.359 . . . . 0.0 110.301 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.597 HG22 ' OD1' ' A' ' 75' ' ' ASN . 21.1 t -109.6 122.1 63.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.322 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.0 m . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.929 0.395 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.45 168.53 13.04 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.83 116.25 31.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.54 148.38 22.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.03 141.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.963 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.68 -140.31 2.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 97' ' ' ALA . 22.5 mt -141.02 174.33 10.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.74 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -164.2 153.3 13.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.757 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.851 ' HB3' ' CZ ' ' A' ' 141' ' ' TYR . . . 177.2 142.5 0.08 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.939 0.4 . . . . 0.0 110.633 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -172.37 -126.65 0.91 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.873 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.3 pp -160.09 120.76 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.747 0.308 . . . . 0.0 110.236 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.699 HD12 ' HG3' ' A' ' 138' ' ' GLU . 6.3 tt -94.48 110.71 22.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.054 0.454 . . . . 0.0 110.428 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.438 ' HB3' HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -91.62 161.12 15.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.058 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -120.81 146.73 46.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 19.6 mt -109.73 -30.37 7.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.743 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.62 -165.0 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.424 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.49 50.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.813 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.71 -33.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.246 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 177' ' ' TYR . . . -104.22 146.71 28.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 111.241 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.0 m -151.74 -176.81 5.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.035 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' A' ' 175' ' ' ALA . 11.8 pt -148.56 150.79 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.642 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.699 ' HG3' HD12 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -134.87 127.63 31.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.787 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 173' ' ' LEU . . . -151.84 158.34 27.72 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.583 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 171' ' ' PHE . . . 161.09 -120.71 0.97 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.657 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.851 ' CZ ' ' HB3' ' A' ' 125' ' ' ALA . 50.6 p90 -139.6 152.9 47.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.814 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.11 145.3 45.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.721 ' O ' HD22 ' A' ' 144' ' ' LEU . 8.1 m-85 -121.48 145.74 47.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.348 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.721 HD22 ' O ' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -149.64 147.19 27.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.031 0.443 . . . . 0.0 111.258 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -135.61 155.58 50.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.48 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.108 -179.809 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.416 ' O ' ' CD1' ' A' ' 143' ' ' TYR . 67.1 m . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.818 0.342 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.87 141.04 38.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -154.3 155.14 34.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 14.8 m-85 -119.68 130.88 55.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.261 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.449 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 34.5 p90 -133.23 173.9 10.95 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.712 0.768 . . . . 0.0 111.725 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.459 ' HA ' ' CA ' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -163.76 134.31 4.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.847 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -154.56 -165.61 14.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.0 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.532 ' HA ' HG22 ' A' ' 137' ' ' ILE . . . -107.73 169.73 8.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.341 . . . . 0.0 110.985 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -158.0 117.44 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -117.87 118.4 31.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -89.02 160.22 17.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.023 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.3 t80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.828 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER . . . . . 0 N--CA 1.46 0.053 0 CA-C-O 120.7 0.286 . . . . 0.0 110.858 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -112.51 141.98 45.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.678 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 28.2 p90 -146.43 167.23 24.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 111.23 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.539 HG12 ' CB ' ' A' ' 46' ' ' ALA . 35.5 m -156.33 144.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.475 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.68 -142.67 3.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mt -120.95 153.51 37.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.751 0.31 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -122.15 113.53 19.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.78 112.94 19.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.04 115.25 3.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.542 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 110.941 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.33 144.25 48.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.84 105.51 5.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.44 -164.83 10.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.513 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 45' ' ' ARG . 3.9 mt -106.69 158.95 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.695 0.283 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 44' ' ' ILE . 7.7 ttm180 -121.99 131.92 54.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.001 0.429 . . . . 0.0 110.523 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.843 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -163.75 117.82 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.97 -143.56 3.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.621 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 4.8 mt-30 -153.66 126.09 8.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.955 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 3' ' ' ASP . 19.9 pt20 -95.09 109.54 21.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.487 . . . . 0.0 111.184 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.409 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 1.7 t80 -98.82 159.43 14.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.159 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -55.41 -28.1 52.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.547 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.37 24.39 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 80' ' ' TYR . . . -174.8 132.85 2.31 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.802 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.444 ' NH1' ' CE2' ' A' ' 5' ' ' PHE . 2.7 ttt-85 -116.56 131.96 56.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 0.0 111.14 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.93 139.04 31.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.396 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.37 100.13 5.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 0.0 111.505 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -105.91 118.45 36.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.438 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 t -122.58 114.73 21.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.926 0.393 . . . . 0.0 111.224 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CD2' ' CD2' ' A' ' 76' ' ' LEU . 4.0 t80 -89.39 111.16 21.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.53 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.75 -179.91 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.104 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.882 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.854 0.359 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -127.91 110.96 13.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -105.64 116.84 32.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.651 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.445 HD21 HD21 ' A' ' 144' ' ' LEU . 0.8 OUTLIER -108.44 122.65 47.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.184 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.59 120.73 4.61 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.89 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.404 ' CB ' ' HA ' ' A' ' 98' ' ' THR . 96.5 p -129.33 145.09 51.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 0.0 111.558 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.431 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 11.2 t80 -116.56 110.87 19.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.184 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.405 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 31.1 m-20 -126.17 163.91 22.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.383 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -110.27 118.28 35.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.424 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 34.5 p90 -97.86 160.22 14.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.608 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 tp -165.85 124.69 1.14 Allowed Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.803 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' THR . 50.6 Cg_exo -55.55 108.34 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.458 2.106 . . . . 0.0 112.241 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 86' ' ' ILE . 9.1 tp . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.153 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 5.0 m120 . . . . . 0 C--O 1.232 0.142 0 N-CA-C 111.537 0.199 . . . . 0.0 111.537 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 2.6 t -79.64 153.22 29.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 7.1 mmtp -130.27 91.96 3.2 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.046 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 1.1 tt -67.79 102.81 1.29 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.886 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 82' ' ' ALA . 41.5 p90 -110.59 150.85 28.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.71 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -168.38 132.15 2.5 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.802 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.85 -144.82 4.92 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.605 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.02 158.42 17.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.404 ' HA ' ' CB ' ' A' ' 79' ' ' SER . 9.8 t -130.66 150.54 51.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.004 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.1 tt -160.07 127.01 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.729 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 120' ' ' ALA . . . -130.35 -156.97 8.84 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.612 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.64 124.83 6.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.778 0.323 . . . . 0.0 110.737 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 t -109.88 125.47 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 117' ' ' VAL . 17.6 mttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.501 HG12 ' HG2' ' A' ' 103' ' ' LYS . 8.5 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.806 0.336 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.0 -167.7 19.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.52 134.81 39.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 100' ' ' GLY . . . -106.71 142.81 35.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.075 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.78 134.3 9.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.123 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -174.38 -138.98 2.84 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.627 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 pp -155.46 160.95 41.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 6.0 pt20 -156.42 177.64 11.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.157 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 94' ' ' PHE . . . 176.84 142.53 0.08 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.46 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -155.23 -140.56 3.03 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.005 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 3.5 pt -159.43 120.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.693 0.282 . . . . 0.0 110.262 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 176' ' ' ASN . 0.4 OUTLIER -95.79 109.28 21.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.728 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 3.0 mt-30 -101.08 141.64 33.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.006 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.98 149.21 40.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.769 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 pp -110.18 -39.67 4.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.016 0.436 . . . . 0.0 110.776 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -169.2 -164.87 0.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.368 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -84.88 52.98 2.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 110.603 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.407 ' O ' ' CE1' ' A' ' 177' ' ' TYR . 0.5 OUTLIER -133.06 -55.34 0.92 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.037 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.05 150.15 7.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.156 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.582 ' OG ' HD22 ' A' ' 128' ' ' LEU . 6.4 t -106.89 169.66 8.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.785 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.463 ' O ' HD23 ' A' ' 128' ' ' LEU . 11.5 tt -132.7 134.7 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.661 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.61 152.32 35.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.984 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -161.79 118.09 0.8 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.29 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.68 -151.68 6.38 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.914 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.27 161.13 32.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 110.81 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.551 ' HD3' HD23 ' A' ' 144' ' ' LEU . 9.4 ttm180 -146.87 136.71 23.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.983 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.423 ' CD2' ' HA ' ' A' ' 169' ' ' SER . 11.5 m-85 -145.03 127.48 15.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.838 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.551 HD23 ' HD3' ' A' ' 142' ' ' ARG . 4.3 pp -156.2 162.47 40.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -103.19 157.72 16.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.8 m . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 179.964 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.849 0.357 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.423 ' HA ' ' CD2' ' A' ' 143' ' ' TYR . 15.7 m -106.87 122.98 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.64 155.15 46.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.742 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -111.71 164.1 13.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.121 0.486 . . . . 0.0 110.161 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.422 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -132.59 126.88 33.79 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.771 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.56 129.96 3.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.563 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.89 -152.94 15.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.831 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.95 172.09 10.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 111.114 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.586 ' HB2' HD21 ' A' ' 128' ' ' LEU . 23.8 m-20 -155.59 119.18 4.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.407 ' CE1' ' O ' ' A' ' 134' ' ' ASN . 13.9 t80 -120.31 115.87 24.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.081 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.39 145.93 30.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.013 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.023 -179.801 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 49' ' ' GLN . 2.0 t0 . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 120.71 0.29 . . . . 0.0 111.026 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 1.8 t30 -80.69 156.59 26.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.561 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.9 OUTLIER -156.12 164.56 38.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 111.592 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' A' ' 46' ' ' ALA . 27.4 m -158.02 128.22 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.953 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 176' ' ' ASN . . . -150.73 -146.87 4.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.596 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.38 136.9 25.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.779 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.776 HG22 ' OE2' ' A' ' 138' ' ' GLU . 35.6 p -100.58 151.2 21.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -148.69 128.69 13.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.98 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.38 138.24 13.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.43 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.362 -0.295 . . . . 0.0 112.362 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -94.99 110.08 22.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.823 0.344 . . . . 0.0 110.959 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.87 -178.96 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.567 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.602 ' HA2' ' HB2' ' A' ' 60' ' ' GLU . . . -178.17 158.17 22.78 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.081 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.793 HD12 ' CE2' ' A' ' 59' ' ' TYR . 25.7 mt -106.44 124.82 62.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.18 133.89 49.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.392 0.615 . . . . 0.0 111.084 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -163.34 111.11 1.21 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.448 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.45 -163.04 12.36 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.188 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -126.41 142.63 51.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.024 0.44 . . . . 0.0 111.298 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' ' 54' ' ' ARG . 0.7 OUTLIER -97.02 162.15 13.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.473 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.52 -169.38 1.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.977 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -32.51 73.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.509 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -127.33 -34.7 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -119.04 -166.05 13.33 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.702 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.452 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . 44.9 ptt85 -162.96 158.54 22.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.0 111.791 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.409 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 12.2 m-85 -118.84 144.26 46.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.846 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -159.12 119.09 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.963 0.411 . . . . 0.0 111.181 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.79 140.33 29.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.817 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 7.1 t -126.18 116.15 20.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.793 ' CE2' HD12 ' A' ' 44' ' ' ILE . 40.1 p90 -130.11 126.7 38.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 111.763 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.602 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -158.36 -179.91 8.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.948 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.397 179.464 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.79 0.329 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.72 ' HB2' HG12 ' A' ' 102' ' ' VAL . 8.0 p30 -146.0 119.44 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.106 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.29 145.12 50.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.642 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.402 ' CB ' ' HA3' ' A' ' 100' ' ' GLY . 0.9 OUTLIER -158.06 157.98 33.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 111.342 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.97 116.79 4.23 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.054 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.625 ' CB ' HG22 ' A' ' 98' ' ' THR . 23.3 t -98.78 133.69 42.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.97 0.414 . . . . 0.0 111.37 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.755 ' CZ ' ' HB3' ' A' ' 97' ' ' ALA . 12.7 p90 -134.13 112.06 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.185 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 6.1 p30 -139.16 172.14 13.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.188 0.518 . . . . 0.0 111.558 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.554 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -112.22 118.72 36.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.839 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 20.3 p90 -99.74 166.42 11.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.257 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 tt -167.83 134.79 1.79 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.11 118.48 4.6 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.463 2.109 . . . . 0.0 112.345 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 86' ' ' ILE . 1.1 tt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.057 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.765 0.316 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.452 HG22 HD12 ' A' ' 127' ' ' ILE . 3.3 p -136.29 151.89 50.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.547 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 5.4 mptt -122.81 92.42 3.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.906 0.384 . . . . 0.0 110.924 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tp -62.23 102.83 0.33 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.706 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 30.2 p90 -112.76 156.03 23.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.781 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.03 128.65 1.5 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.403 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -163.99 -132.75 1.38 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.65 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.755 ' HB3' ' CZ ' ' A' ' 80' ' ' TYR . . . -133.25 165.95 23.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.773 0.321 . . . . 0.0 111.235 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.625 HG22 ' CB ' ' A' ' 79' ' ' SER . 2.7 p -136.65 154.94 50.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.89 130.67 5.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.023 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 77' ' ' LEU . . . -161.92 -152.76 6.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.679 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mp -148.25 122.26 9.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.72 HG12 ' HB2' ' A' ' 75' ' ' ASN . 31.4 m -109.82 130.25 63.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.231 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.8 mttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.2 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.806 0.336 . . . . 0.0 111.098 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -137.88 170.5 23.72 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -84.31 132.68 34.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.323 . . . . 0.0 110.853 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.714 ' HB1' ' CD2' ' A' ' 144' ' ' LEU . . . -115.18 143.37 45.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -169.31 137.98 1.96 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.47 -137.86 2.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mp -146.59 157.07 43.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 110.964 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' A' ' 142' ' ' ARG . 0.0 OUTLIER -141.13 161.87 36.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.594 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 179.59 142.41 0.14 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -169.5 -135.08 1.84 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.948 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 2.8 pt -158.04 120.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.801 0.334 . . . . 0.0 110.383 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -94.82 112.99 24.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.551 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 137' ' ' ILE . 4.0 tt0 -96.45 123.94 40.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.147 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.23 149.12 32.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.572 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 tp -105.87 -47.19 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 110.542 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 m -165.72 -164.86 0.76 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -81.37 55.66 2.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.62 -59.13 0.72 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.99 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -154.89 151.36 28.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.101 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.758 ' O ' HD13 ' A' ' 137' ' ' ILE . 1.4 m -113.72 174.28 6.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.758 HD13 ' O ' ' A' ' 136' ' ' SER . 28.5 mm -134.17 134.9 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.776 ' OE2' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.96 141.52 46.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.897 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -163.07 121.41 1.02 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -174.85 -138.13 2.66 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.048 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.501 ' CE1' ' CE2' ' A' ' 171' ' ' PHE . 64.6 m-85 -132.76 161.09 34.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.756 0.312 . . . . 0.0 110.758 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.409 ' HA ' ' HG2' ' A' ' 124' ' ' GLN . 14.3 ptm180 -140.83 136.58 32.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -132.02 128.91 39.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.433 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.714 ' CD2' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -139.68 151.44 45.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.379 . . . . 0.0 111.154 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 26.5 ttt-85 -116.52 163.97 15.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.689 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.005 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.812 0.339 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.9 t -106.96 106.18 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.52 155.24 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.501 ' CE2' ' CE1' ' A' ' 141' ' ' TYR . 0.2 OUTLIER -94.2 165.36 12.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.199 0.523 . . . . 0.0 110.195 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.412 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -131.3 128.46 39.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.809 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.39 135.18 5.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.58 -142.74 6.96 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.774 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -142.88 171.99 13.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.41 ' HA ' ' HA3' ' A' ' 7' ' ' GLY . 7.8 t-20 -155.59 117.6 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -102.61 111.62 24.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.83 147.01 29.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.083 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.925 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 1.5 t0 . . . . . 0 C--O 1.227 -0.086 0 CA-C-O 120.59 0.233 . . . . 0.0 110.583 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.18 125.51 39.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.644 0.259 . . . . 0.0 110.686 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.2 OUTLIER -134.68 139.95 45.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.396 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 46' ' ' ALA . 37.9 t -150.2 131.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.982 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.36 -162.49 10.76 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.799 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -118.24 142.7 47.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 0.0 110.61 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 p -111.33 118.61 36.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.06 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -128.35 112.88 14.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.696 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -106.97 153.9 16.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.644 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 179.944 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.561 -0.215 . . . . 0.0 112.561 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 m -113.38 118.43 34.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -103.99 161.75 13.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.61 -169.36 35.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.605 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 45' ' ' ARG . 2.7 mp -134.9 160.0 41.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.602 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -138.07 139.32 39.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.95 0.405 . . . . 0.0 110.593 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.696 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -171.57 120.91 0.49 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.842 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 56' ' ' TYR . . . -167.73 -141.73 3.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.832 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 15.5 pt20 -122.3 142.18 50.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.705 0.288 . . . . 0.0 110.785 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.418 ' CG ' ' HG3' ' A' ' 54' ' ' ARG . 0.8 OUTLIER -116.81 109.68 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 111.089 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -130.57 165.01 23.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.509 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -19.2 65.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.36 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.63 24.09 12.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.31 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 80' ' ' TYR . . . 155.98 142.56 3.45 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.526 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.648 ' NH2' HD22 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -136.71 162.09 34.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.319 . . . . 0.0 110.946 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.466 ' CE1' ' CD ' ' A' ' 54' ' ' ARG . 8.9 m-85 77.05 -175.81 0.1 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 3.4 t80 178.65 -43.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.902 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -122.43 136.96 55.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 111.396 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.13 119.69 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.565 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -113.55 149.98 33.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.01 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.34 155.91 44.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.985 179.936 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.758 0.313 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.74 119.37 24.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.43 114.93 17.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.324 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.487 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.5 OUTLIER -142.93 168.87 18.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 111.399 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.97 116.74 4.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.903 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 56' ' ' TYR . 3.5 m -104.67 126.59 51.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.971 0.415 . . . . 0.0 111.484 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 63.4 t80 -136.57 110.89 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.198 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -129.21 171.87 12.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.029 0.442 . . . . 0.0 111.651 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.81 119.76 35.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.565 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 50.3 p90 -97.76 172.17 7.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.098 0.475 . . . . 0.0 111.809 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tp -165.09 135.45 3.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.391 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.54 119.26 4.89 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.548 2.165 . . . . 0.0 112.203 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.597 ' O ' HG23 ' A' ' 86' ' ' ILE . 8.9 tt . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.815 0.341 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.571 HG23 ' HG2' ' A' ' 129' ' ' GLN . 0.5 OUTLIER -67.86 145.09 54.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.348 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 3.6 mmpt? -126.63 92.32 3.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 111.272 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.585 HD13 HD13 ' A' ' 86' ' ' ILE . 1.8 tp -60.54 103.25 0.23 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.051 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 16.6 p90 -110.73 161.76 15.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.292 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.44 126.57 1.05 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.559 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.06 -134.38 1.64 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.621 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -141.06 157.81 44.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.883 0.373 . . . . 0.0 111.324 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -134.79 161.86 33.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.732 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.29 132.76 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -158.68 -144.69 4.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.986 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.21 130.09 9.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 110.388 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.63 132.84 56.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.178 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.816 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.762 0.315 . . . . 0.0 110.993 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -136.51 131.61 5.73 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.546 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -84.17 117.73 23.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.803 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.678 ' HB2' HG22 ' A' ' 146' ' ' THR . . . -109.86 145.13 37.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 141.32 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.954 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.01 -137.08 2.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.541 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 97' ' ' ALA . 3.8 mp -145.2 153.31 41.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.195 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.1 OUTLIER -133.71 172.55 12.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.622 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.89 142.49 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.054 0.454 . . . . 0.0 110.69 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.597 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -169.41 -134.33 1.72 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.721 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 126' ' ' GLY . 10.8 pt -161.22 120.48 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.318 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.648 HD22 ' NH2' ' A' ' 54' ' ' ARG . 1.8 tt -95.88 113.32 24.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 111.201 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.571 ' HG2' HG23 ' A' ' 91' ' ' THR . 30.7 mt-30 -100.31 139.27 36.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.756 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -93.34 149.15 21.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.002 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.41 -43.89 2.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 110.584 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 m -142.2 -164.72 1.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.361 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.41 28.8 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.162 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 177.84 34.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.773 0.32 . . . . 0.0 111.132 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.23 129.09 1.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.815 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.1 m -142.97 169.71 17.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.004 0.431 . . . . 0.0 111.29 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 129' ' ' GLN . 0.6 OUTLIER -132.52 134.78 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.247 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -128.18 149.19 50.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.925 0.393 . . . . 0.0 111.162 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.647 ' HA3' HD22 ' A' ' 173' ' ' LEU . . . -165.8 152.8 22.33 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.378 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.13 -131.72 2.22 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.698 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -135.82 152.56 51.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.762 0.315 . . . . 0.0 110.793 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -140.36 123.75 16.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 3.2 m-85 -116.98 124.28 48.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.0 171.39 16.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.182 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.1 ttt85 -152.39 144.32 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.765 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.678 HG22 ' HB2' ' A' ' 120' ' ' ALA . 82.5 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.408 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 10.6 t . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.798 0.332 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.83 140.65 39.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.746 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.35 155.28 33.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.081 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.58 141.57 41.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.095 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -119.84 127.51 52.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.989 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.647 HD22 ' HA3' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -163.45 129.87 3.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.465 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.76 -156.94 20.1 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.658 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.25 171.98 8.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.84 0.352 . . . . 0.0 111.159 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.451 ' ND2' ' CD1' ' A' ' 5' ' ' PHE . 2.0 t30 -150.8 114.96 5.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -115.38 122.17 45.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.162 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.93 162.91 22.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.224 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.942 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.46 0.075 0 CA-C-O 120.697 0.284 . . . . 0.0 110.667 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.82 118.53 37.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.785 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 1.7 m-85 -124.02 145.11 49.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.003 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 5' ' ' PHE . 13.3 m -158.15 125.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.181 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.02 -149.06 5.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.64 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.1 159.66 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.819 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.61 127.72 35.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 36.9 t90 -128.33 112.99 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.687 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.83 168.58 13.99 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 110.868 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 N-CA-C 112.439 -0.265 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.602 HG21 ' OE1' ' A' ' 170' ' ' GLN . 33.8 m -137.16 107.86 6.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.426 ' CE3' ' CD1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -120.35 146.55 46.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.27 -164.83 25.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.512 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.649 HD12 ' HB3' ' A' ' 59' ' ' TYR . 3.0 mp -107.0 161.16 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 110.95 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.684 HH11 HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -130.8 137.17 49.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.996 0.427 . . . . 0.0 110.693 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -174.16 122.51 0.3 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.825 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.64 -145.47 4.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.656 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -146.45 126.1 13.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.0 111.009 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -94.13 109.6 21.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.096 0.474 . . . . 0.0 111.278 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.09 155.2 19.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.474 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.38 -18.6 65.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.384 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -130.68 24.26 5.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.318 . . . . 0.0 111.172 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.72 163.62 23.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.931 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -145.0 141.04 28.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.93 0.395 . . . . 0.0 111.532 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.35 146.61 26.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.035 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CD1' ' NE ' ' A' ' 45' ' ' ARG . 6.7 m-85 -143.87 96.9 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.381 . . . . 0.0 111.683 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -90.87 139.25 30.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.099 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.684 HG23 HH11 ' A' ' 45' ' ' ARG . 0.2 OUTLIER -139.75 124.93 18.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.067 0.461 . . . . 0.0 111.714 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.649 ' HB3' HD12 ' A' ' 44' ' ' ILE . 3.3 t80 -101.5 104.67 15.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.846 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.95 153.63 19.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.086 0.47 . . . . 0.0 111.489 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.461 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.785 0.326 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.461 ' CG ' HG23 ' A' ' 102' ' ' VAL . 1.5 m-20 -124.89 111.06 15.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.002 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -118.96 116.95 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.654 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.4 ' CB ' ' HA3' ' A' ' 100' ' ' GLY . 3.9 pp -135.38 146.3 48.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 0.0 111.405 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.18 116.9 4.23 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.956 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.4 p -105.9 119.95 40.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.629 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.45 110.88 23.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.963 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.419 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 1.7 m-20 -128.08 161.11 29.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.147 0.499 . . . . 0.0 111.842 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.85 119.12 38.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.221 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 35.1 p90 -97.32 158.11 15.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.994 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.518 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -165.33 125.98 1.33 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.733 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 91' ' ' THR . 52.7 Cg_exo -52.99 100.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.614 2.209 . . . . 0.0 112.229 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 84' ' ' LEU . 18.8 tt . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.113 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 18.4 m120 . . . . . 0 CA--C 1.527 0.081 0 N-CA-C 111.539 0.2 . . . . 0.0 111.539 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 7.6 p -79.47 153.29 29.72 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -130.73 92.1 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.999 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -64.26 102.06 0.48 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.771 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 46.3 p90 -111.92 120.94 43.63 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.604 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -140.72 147.35 18.99 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.777 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.46 -139.08 3.52 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.813 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.57 176.2 5.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.891 0.377 . . . . 0.0 111.182 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 p -146.48 145.54 30.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.07 131.15 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 77' ' ' LEU . . . -154.53 -151.89 5.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.652 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.07 125.82 7.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.797 0.332 . . . . 0.0 110.746 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.461 HG23 ' CG ' ' A' ' 75' ' ' ASN . 11.1 p -110.31 142.83 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.252 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 179.874 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.9 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.815 0.341 . . . . 0.0 111.245 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -142.72 149.6 21.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.335 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -119.24 114.97 23.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.02 139.23 48.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.75 130.61 5.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -175.43 -138.19 2.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.407 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 1.7 mp -148.04 171.31 16.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -152.17 168.74 24.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.957 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . -175.15 142.06 0.6 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.96 0.41 . . . . 0.0 110.554 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -168.28 -146.74 5.08 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.783 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.8 pp -161.04 120.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.773 HD12 ' HB3' ' A' ' 138' ' ' GLU . 2.1 tt -95.95 113.41 25.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.942 0.401 . . . . 0.0 111.19 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.497 ' NE2' HD11 ' A' ' 137' ' ' ILE . 3.0 tt0 -95.17 115.84 27.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.14 149.21 24.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mp -107.66 -39.67 5.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.691 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.1 p -169.05 -164.88 0.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.395 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -83.55 55.16 3.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.865 0.364 . . . . 0.0 110.73 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -140.35 -59.99 0.53 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.002 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.47 157.33 27.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.414 ' OG ' HD21 ' A' ' 128' ' ' LEU . 51.1 p -135.4 -177.3 4.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.497 HD11 ' NE2' ' A' ' 129' ' ' GLN . 2.4 pt -129.65 134.82 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.617 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.773 ' HB3' HD12 ' A' ' 128' ' ' LEU . 1.6 pt-20 -123.86 140.62 52.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -162.46 143.94 9.2 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.392 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.07 -144.94 5.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.649 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.75 158.38 40.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.402 ' CZ ' HD21 ' A' ' 144' ' ' LEU . 4.3 ptm180 -144.67 140.26 28.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 2.8 p90 -145.06 105.06 4.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.969 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.402 HD21 ' CZ ' ' A' ' 142' ' ' ARG . 0.2 OUTLIER -139.85 153.97 47.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -108.58 147.86 31.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.839 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.961 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.805 0.336 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 72.3 p -106.94 120.55 42.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.694 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.602 ' OE1' HG21 ' A' ' 41' ' ' THR . 1.7 mt-30 -146.66 155.15 42.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.985 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -104.58 165.38 11.1 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.14 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.431 ' OH ' HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -131.47 127.27 37.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.044 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.52 129.95 3.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.471 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.84 -152.74 15.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.747 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -124.86 171.9 9.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 111.218 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.65 114.92 5.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -106.2 114.22 28.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.0 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.95 163.39 22.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.024 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 6' ' ' VAL . 4.2 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.412 ' CB ' ' HB3' ' A' ' 49' ' ' GLN . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.714 0.292 . . . . 0.0 110.862 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -112.08 132.88 54.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.801 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 8.7 m-85 -131.41 139.59 49.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.973 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 27.1 t -156.14 125.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.081 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 176' ' ' ASN . . . -170.98 -128.12 1.0 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.739 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -159.19 167.91 27.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.748 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.45 150.22 35.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.982 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -110.47 117.09 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.823 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.5 137.51 13.73 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.529 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 0.0 110.917 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.435 -0.266 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.1 p -137.72 107.99 6.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -91.6 131.22 37.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.682 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.9 -175.81 20.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.796 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.526 HG22 ' H ' ' A' ' 45' ' ' ARG . 4.0 mt -106.94 168.6 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.56 0.219 . . . . 0.0 110.698 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.526 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -138.4 142.78 39.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.051 0.453 . . . . 0.0 110.828 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -170.48 120.23 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -161.57 -156.8 8.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.577 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.46 ' HB2' ' CE2' ' A' ' 55' ' ' TYR . 5.9 mt-30 -141.44 133.39 27.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.087 0.47 . . . . 0.0 111.074 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.453 ' CG ' ' HB3' ' A' ' 54' ' ' ARG . 8.1 tt0 -83.55 162.06 20.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.849 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.02 -169.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.647 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -67.24 -40.37 86.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.237 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -123.18 -26.61 4.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.732 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -124.29 -159.83 10.56 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.689 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.453 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -171.64 168.09 6.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.632 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -141.23 166.68 24.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.424 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.613 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 41.3 p90 177.92 135.73 0.08 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.092 0.473 . . . . 0.0 110.888 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.51 155.78 18.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.257 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 77.1 p -137.58 123.78 20.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.055 0.455 . . . . 0.0 111.454 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.495 ' HD2' HD12 ' A' ' 44' ' ' ILE . 9.4 m-85 -89.89 108.69 19.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.173 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -105.99 178.68 4.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.092 0.472 . . . . 0.0 111.503 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.54 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.758 0.313 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.503 ' OD1' HG12 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -120.02 110.87 17.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.805 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.17 115.72 30.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.638 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.436 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 1.8 mp -133.12 133.66 43.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.4 . . . . 0.0 111.298 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.89 116.91 4.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.944 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.6 t -105.25 135.6 46.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 111.576 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -128.71 110.95 12.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.899 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 1.6 p30 -136.52 172.13 13.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.233 0.54 . . . . 0.0 111.866 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.508 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -115.42 121.89 44.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.547 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 18.9 p90 -97.71 164.66 12.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.737 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.664 ' CD2' HD11 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -167.04 128.15 1.23 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.389 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.57 106.92 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.445 2.097 . . . . 0.0 112.362 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.664 HD11 ' CD2' ' A' ' 84' ' ' LEU . 37.2 mt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.988 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.6 p30 . . . . . 0 CA--C 1.527 0.075 0 CA-C-O 120.659 0.266 . . . . 0.0 111.295 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.5 p -136.59 130.51 32.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.714 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -117.31 92.82 3.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.896 0.379 . . . . 0.0 110.881 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.585 HD12 HG22 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -56.17 103.02 0.09 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.596 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 22.6 p90 -110.93 156.17 21.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.802 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.43 135.21 2.94 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.712 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.404 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -168.91 -137.59 2.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.653 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -124.87 161.74 25.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.855 0.359 . . . . 0.0 111.19 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.512 ' C ' HD12 ' A' ' 99' ' ' LEU . 23.7 m -139.49 148.63 42.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.512 HD12 ' C ' ' A' ' 98' ' ' THR . 4.5 mp -157.1 130.82 8.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.667 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -141.46 -162.7 9.26 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.121 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' ' 100' ' ' GLY . 5.5 mp -155.6 142.54 19.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.885 HG22 ' HA3' ' A' ' 118' ' ' GLY . 35.0 m -109.56 145.41 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.416 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.86 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.821 0.343 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.885 ' HA3' HG22 ' A' ' 102' ' ' VAL . . . -161.11 132.4 2.86 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.275 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -113.97 114.97 26.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.876 0.37 . . . . 0.0 111.05 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.73 138.24 54.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.746 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.96 132.75 5.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.448 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.65 ' O ' HD23 ' A' ' 123' ' ' LEU . . . -173.39 -140.05 3.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.765 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 122' ' ' GLY . 13.3 mt -147.64 164.78 32.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 14.9 mt-30 -149.74 170.54 18.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.704 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.92 142.56 0.08 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.988 0.423 . . . . 0.0 110.851 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -164.53 -128.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.759 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.585 HG22 HD12 ' A' ' 93' ' ' LEU . 12.6 pt -160.59 121.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 120.794 0.33 . . . . 0.0 110.296 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 128' ' ' LEU . 5.0 tt -94.48 113.28 25.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.008 0.432 . . . . 0.0 110.857 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -95.63 124.18 39.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -111.56 149.14 31.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.7 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.6 tp -108.24 -45.9 3.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.118 0.485 . . . . 0.0 110.635 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.7 p -169.21 -164.85 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.189 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.55 54.96 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.913 0.387 . . . . 0.0 110.569 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -138.25 -58.2 0.65 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.16 171.95 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.197 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.9 m -141.03 167.73 21.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.764 HG23 ' O ' ' A' ' 174' ' ' GLY . 5.4 mt -129.26 134.87 63.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.444 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -127.95 132.09 49.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . -155.28 144.49 11.08 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.554 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 171' ' ' PHE . . . 176.14 -151.41 11.58 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.366 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 170' ' ' GLN . 0.2 OUTLIER -119.75 153.45 35.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.902 0.382 . . . . 0.0 110.916 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.424 ' HB3' ' CE1' ' A' ' 172' ' ' TYR . 29.1 ptt180 -131.89 129.99 41.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' A' ' 169' ' ' SER . 7.3 t80 -128.59 102.23 6.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.779 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.404 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 0.6 OUTLIER -150.72 164.04 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.196 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.2 153.89 18.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.718 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.3 t . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.789 0.328 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.438 ' HB3' ' CD2' ' A' ' 143' ' ' TYR . 83.4 p -107.9 122.59 47.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.805 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.407 ' O ' ' CD1' ' A' ' 141' ' ' TYR . 1.6 mt-30 -141.58 152.11 43.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 140' ' ' GLY . 2.7 t80 -100.04 120.55 40.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.265 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 142' ' ' ARG . 9.7 p90 -125.07 126.44 45.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.234 0.54 . . . . 0.0 111.428 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.612 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 1.4 pt? -147.46 155.47 41.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.858 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 137' ' ' ILE . . . -176.73 -132.73 1.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.401 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.85 169.41 16.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 0.0 111.128 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.41 ' HA ' ' HA3' ' A' ' 7' ' ' GLY . 4.3 t-20 -158.05 118.35 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.022 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -101.57 118.27 36.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -87.16 154.79 20.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.8 OUTLIER . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 110.661 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -112.28 119.19 37.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.744 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 29.0 p90 -124.05 155.29 38.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.256 0.55 . . . . 0.0 111.469 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 46' ' ' ALA . 7.5 p -151.91 128.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.732 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.74 -141.6 3.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.373 -0.917 . . . . 0.0 112.754 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.5 165.54 23.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.896 0.379 . . . . 0.0 110.799 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.632 HG23 ' HB2' ' A' ' 45' ' ' ARG . 24.1 p -129.17 143.95 51.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -140.9 112.96 7.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.689 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.88 135.24 10.98 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.6 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 110.823 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.2 p -119.2 139.43 51.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 111.028 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -148.45 139.94 23.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -177.3 -164.89 31.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.605 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 45' ' ' ARG . 3.2 mt -106.86 161.74 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.584 0.23 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.632 ' HB2' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -140.99 148.7 40.74 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.606 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.865 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -177.22 124.38 0.14 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -161.57 -163.11 13.84 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.308 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 3.4 mp0 -118.34 125.97 51.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 0.0 111.001 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.477 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 37.5 tt0 -111.79 109.97 20.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.196 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -119.41 160.11 22.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.521 179.339 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.75 -23.29 64.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.197 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -99.29 24.09 8.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.242 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 50' ' ' PHE . . . 133.4 164.57 10.83 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.337 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.401 ' NE ' ' CZ ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -139.44 146.03 39.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.918 0.39 . . . . 0.0 111.314 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -129.78 161.23 31.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.408 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.576 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 15.9 p90 -176.97 126.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.166 0.508 . . . . 0.0 111.525 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.71 139.06 31.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.284 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 51.3 m -129.57 117.29 20.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 111.529 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -94.32 117.17 29.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.319 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -111.82 175.4 5.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 111.266 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.731 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.777 0.323 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.578 ' HA ' HG12 ' A' ' 102' ' ' VAL . 4.1 m120 -114.57 112.54 23.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 tt -98.28 114.95 27.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.49 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -118.11 113.58 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.278 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.01 116.95 4.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.623 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.798 ' OG ' HG22 ' A' ' 98' ' ' THR . 12.3 m -126.41 143.02 51.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 0.0 111.831 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -131.79 110.67 11.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.502 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.451 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 15.8 m-20 -130.55 166.06 21.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.214 0.531 . . . . 0.0 112.017 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.08 127.95 53.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.045 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 45.4 p90 -97.36 168.72 10.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.143 0.497 . . . . 0.0 111.778 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 86' ' ' ILE . 7.4 tp -158.9 132.4 4.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.235 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.17 106.04 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.32 2.014 . . . . 0.0 112.401 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.704 HD11 HD23 ' A' ' 84' ' ' LEU . 42.7 mm . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.002 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.979 0.418 . . . . 0.0 110.566 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.545 HG22 HD12 ' A' ' 127' ' ' ILE . 14.5 p -136.48 142.7 43.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.463 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 13.6 mmtt -123.52 98.92 6.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 7.8 tt -55.32 104.54 0.13 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.381 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -109.42 145.88 35.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.606 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.21 140.54 6.47 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.067 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 179.45 -146.82 7.29 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.004 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.444 ' HA ' HD23 ' A' ' 123' ' ' LEU . . . -109.07 -178.02 3.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 111.257 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.798 HG22 ' OG ' ' A' ' 79' ' ' SER . 0.8 OUTLIER -145.51 161.44 39.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 12.4 mt -147.86 130.27 15.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.34 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 120' ' ' ALA . . . -130.37 123.64 4.02 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.378 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.591 HD11 ' CD2' ' A' ' 119' ' ' TYR . 2.0 tp -143.87 120.9 11.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.845 0.355 . . . . 0.0 110.743 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 75' ' ' ASN . 4.9 m -109.8 145.26 16.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.138 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.956 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.458 -0.037 0 CA-C-O 120.9 0.381 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.62 149.42 19.23 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.48 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.591 ' CD2' HD11 ' A' ' 101' ' ' LEU . 64.3 m-85 -114.25 127.93 56.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.719 ' HB1' HD12 ' A' ' 144' ' ' LEU . . . -133.86 148.82 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.11 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -171.98 134.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.85 -124.9 0.74 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.615 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 97' ' ' ALA . 86.7 mt -141.05 169.65 17.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -158.65 153.49 24.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.376 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -178.26 142.57 0.26 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.131 0.491 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -163.12 -125.0 0.74 Allowed Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.553 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.7 pt -160.79 120.62 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.708 0.29 . . . . 0.0 110.351 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 136' ' ' SER . 1.2 tt -95.0 115.21 27.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.446 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -94.58 152.97 18.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.215 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -108.13 149.08 28.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 tp -121.0 -39.1 2.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.929 0.395 . . . . 0.0 110.824 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 t -158.96 -164.57 1.44 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.353 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.41 30.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.102 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.6 p30 178.32 34.96 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.16 119.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.714 ' HB3' HD21 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -128.74 172.1 11.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.989 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 174' ' ' GLY . 3.9 mp -137.64 135.55 46.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 127.57 51.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -146.74 122.77 1.66 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.291 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.98 -147.61 5.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.885 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -135.85 161.13 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 0.0 110.922 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -133.25 149.03 52.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.667 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.76 109.97 5.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.719 HD12 ' HB1' ' A' ' 120' ' ' ALA . 1.2 pt? -151.89 164.6 36.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.068 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -112.35 146.61 37.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.846 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.762 0.315 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 11.7 m -107.0 131.23 54.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.774 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -138.68 155.2 48.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -114.21 165.17 12.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.056 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.508 ' O ' HD12 ' A' ' 173' ' ' LEU . 8.3 t80 -138.35 129.34 26.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.252 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 172' ' ' TYR . 0.3 OUTLIER -163.66 129.89 3.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.596 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 137' ' ' ILE . . . 178.35 -156.0 18.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.775 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -129.6 171.96 12.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 111.008 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -151.56 116.1 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.91 111.77 24.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.712 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 3.7 mttp -81.86 150.91 27.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.226 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.767 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.804 0.335 . . . . 0.0 110.931 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -112.13 142.03 45.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.815 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.555 ' O ' HG13 ' A' ' 6' ' ' VAL . 18.0 m-85 -131.24 142.18 50.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.773 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 5' ' ' PHE . 5.0 m -159.52 121.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.156 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.56 -140.33 2.89 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.652 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.21 146.93 49.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.2 m -116.74 129.36 56.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -124.75 112.97 17.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.682 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.1 134.41 11.71 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.719 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.834 0.349 . . . . 0.0 110.777 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.05 127.92 53.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -125.34 123.59 39.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.79 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.36 -164.85 16.09 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.553 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 pt -107.04 162.03 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 111.087 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.709 ' HG2' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -129.31 138.94 51.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.759 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.802 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -168.61 119.86 0.78 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.62 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.49 -159.33 8.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.945 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -143.26 116.67 9.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 0.0 110.74 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.413 ' HA ' ' CG ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -83.79 148.34 27.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.22 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -132.42 -166.74 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.291 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.62 -47.18 84.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.225 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -135.91 12.01 3.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.821 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -148.1 153.58 25.36 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.561 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.469 ' NH2' ' CD1' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -141.72 144.65 34.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.607 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -89.29 153.71 20.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.012 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.456 ' CE1' ' HD2' ' A' ' 54' ' ' ARG . 58.2 m-85 -133.24 103.34 5.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.362 . . . . 0.0 111.422 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -113.29 122.74 48.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.318 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.709 HG22 ' HG2' ' A' ' 45' ' ' ARG . 2.2 p -141.1 128.96 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.048 0.451 . . . . 0.0 111.268 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.639 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 3.1 m-85 -89.42 119.27 29.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.078 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -101.92 163.51 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.943 0.402 . . . . 0.0 111.54 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.637 179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.665 0.269 . . . . 0.0 110.709 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.48 HD22 HG12 ' A' ' 102' ' ' VAL . 9.6 m120 -144.65 112.6 6.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.994 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.639 HD11 ' CZ ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -82.99 136.92 34.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.601 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -118.72 142.52 47.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 111.205 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.612 ' H ' HD23 ' A' ' 77' ' ' LEU . . . -160.1 116.8 0.74 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.73 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.775 ' HB3' HG23 ' A' ' 98' ' ' THR . 49.5 p -139.25 143.21 37.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.468 . . . . 0.0 111.614 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 110.96 21.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.826 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -127.91 172.06 11.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.208 0.528 . . . . 0.0 111.787 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.53 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -119.11 118.8 32.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.44 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 21.9 p90 -97.73 161.53 13.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.086 0.47 . . . . 0.0 111.659 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.517 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -165.04 138.57 3.86 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.493 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.517 ' HD2' HD23 ' A' ' 84' ' ' LEU . 31.6 Cg_exo -58.8 117.74 4.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.38 2.053 . . . . 0.0 112.532 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 85' ' ' PRO . 37.5 mm . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.933 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 82.3 m-20 . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.75 0.31 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 p -75.85 153.13 37.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.435 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -131.5 92.49 3.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 111.047 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.418 ' CB ' HG13 ' A' ' 86' ' ' ILE . 6.3 tt -62.2 103.12 0.35 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.316 0.579 . . . . 0.0 110.497 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.459 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 24.0 p90 -110.96 154.53 23.99 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.477 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.03 139.9 4.84 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.815 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.68 -135.31 2.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.73 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.86 155.66 20.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.775 HG23 ' HB3' ' A' ' 79' ' ' SER . 6.9 m -128.34 148.34 50.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.121 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 120.99 3.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.682 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.664 ' H ' ' HB3' ' A' ' 120' ' ' ALA . . . -127.98 -155.92 8.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.63 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.19 127.0 7.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.822 0.344 . . . . 0.0 110.661 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.48 HG12 HD22 ' A' ' 75' ' ' ASN . 29.1 m -109.83 122.06 63.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HE3' HG22 ' A' ' 117' ' ' VAL . 2.1 ttmp? . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.418 HG22 ' HE3' ' A' ' 103' ' ' LYS . 21.4 t . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.826 0.346 . . . . 0.0 111.126 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.33 162.75 12.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.82 130.28 56.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.744 ' HB1' ' CD1' ' A' ' 144' ' ' LEU . . . -100.47 140.6 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.75 131.27 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -176.28 -131.03 1.41 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.605 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mp -148.93 157.72 43.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.346 . . . . 0.0 111.004 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -143.12 164.97 28.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.748 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . 179.53 142.59 0.14 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.99 0.424 . . . . 0.0 110.699 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -164.03 -136.19 1.95 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.994 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 126' ' ' GLY . 5.1 pt -161.92 120.97 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.593 HD21 ' HB3' ' A' ' 136' ' ' SER . 9.2 tt -94.46 111.31 23.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 110.745 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 36.1 tt0 -97.07 116.85 30.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.944 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.09 148.98 21.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.995 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.8 -30.02 8.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.611 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -165.34 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.491 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -89.45 52.34 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.8 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.63 -35.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.22 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.78 125.95 49.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.871 0.367 . . . . 0.0 111.216 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.593 ' HB3' HD21 ' A' ' 128' ' ' LEU . 1.2 m -126.46 163.63 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.4 mt -135.48 134.93 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.817 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.49 139.19 48.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.95 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -160.74 111.14 0.47 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.333 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -162.48 -150.18 5.92 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.07 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -139.18 161.03 38.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.433 ' HD2' HG21 ' A' ' 98' ' ' THR . 5.7 ttp-105 -137.73 140.55 40.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 142' ' ' ARG . 15.7 m-85 -140.3 115.27 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.744 ' CD1' ' HB1' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -160.53 174.01 14.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -132.82 160.38 37.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.407 HG21 HG21 ' A' ' 102' ' ' VAL . 1.1 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.2 t . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.812 0.339 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.9 t -106.93 115.9 31.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -124.01 155.09 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -126.53 140.47 52.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.447 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.431 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -122.3 126.95 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.738 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.42 130.02 3.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.62 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.02 -153.39 18.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.849 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -122.19 172.18 8.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.32 . . . . 0.0 111.065 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -155.18 117.67 4.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.152 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -107.39 111.87 24.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.694 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . 8.8 pttt -86.87 157.96 19.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.081 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.829 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 . . . . . 0 N--CA 1.46 0.062 0 CA-C-O 120.763 0.315 . . . . 0.0 111.019 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 5.3 m-80 -112.02 140.53 46.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.476 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 52.6 p90 -148.54 167.53 25.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.126 0.489 . . . . 0.0 111.661 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.673 HG13 ' HB2' ' A' ' 46' ' ' ALA . 46.2 t -155.85 137.4 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.791 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.49 -147.17 4.88 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.803 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.34 163.05 32.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.657 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.67 141.5 44.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -126.29 112.93 16.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.63 136.01 15.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.404 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 110.942 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.7 p -142.99 107.99 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -89.78 124.97 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.764 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.19 -169.24 12.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.688 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 58' ' ' THR . 13.9 tt -119.66 162.39 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.52 0.2 . . . . 0.0 110.897 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.644 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -135.1 142.69 46.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.924 0.392 . . . . 0.0 110.73 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -169.34 119.32 0.68 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.253 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -170.61 -139.06 2.65 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.673 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -150.1 143.53 25.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.805 0.336 . . . . 0.0 110.985 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 14.1 pt20 -118.13 109.84 16.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.215 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -87.69 166.83 14.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.805 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.15 -21.42 65.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.329 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.12 24.25 11.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.42 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.43 169.15 28.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.774 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 11.7 ttp180 -141.0 125.85 18.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.367 . . . . 0.0 111.231 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -117.6 150.07 39.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.346 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.525 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 28.2 p90 -177.97 127.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.079 0.466 . . . . 0.0 111.222 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.72 142.93 27.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.222 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 9.4 t -132.92 120.73 21.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 0.0 111.608 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.575 ' CD1' HD12 ' A' ' 76' ' ' LEU . 4.1 m-85 -91.14 123.97 34.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.194 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.03 170.44 7.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.951 0.405 . . . . 0.0 111.305 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.685 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.583 ' HG3' HD11 ' A' ' 76' ' ' LEU . 33.1 tp60 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.789 0.328 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.625 ' C ' HD13 ' A' ' 76' ' ' LEU . 1.4 m120 -121.91 110.93 16.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.102 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.664 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -119.31 121.01 38.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.2 OUTLIER -142.66 157.8 44.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 111.264 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.66 116.76 3.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.266 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.66 ' HB3' HG22 ' A' ' 98' ' ' THR . 0.0 OUTLIER -97.92 122.23 40.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.879 0.371 . . . . 0.0 111.065 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -117.06 110.87 18.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.475 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.61 161.42 31.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 111.289 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -113.29 120.23 40.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.376 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 48.3 p90 -97.58 161.04 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.575 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.93 122.63 1.7 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.585 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.51 116.52 3.14 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.501 2.134 . . . . 0.0 112.308 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 86' ' ' ILE . 9.6 tt . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.089 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 . . . . . 0 CA--C 1.53 0.179 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.633 HG22 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -136.35 120.95 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.551 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.617 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 17.3 mmtm -119.5 92.78 3.87 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.212 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 tp -59.54 103.34 0.19 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.344 0.592 . . . . 0.0 110.758 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 36.3 p90 -110.73 159.06 17.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.885 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.81 142.11 5.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.11 -141.07 3.7 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.725 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -129.95 169.08 15.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.865 0.364 . . . . 0.0 111.147 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.66 HG22 ' HB3' ' A' ' 79' ' ' SER . 11.6 p -138.66 150.84 46.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.806 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 98' ' ' THR . 3.3 mp -160.15 132.08 6.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -150.29 -154.54 6.5 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.822 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -155.21 128.0 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 75' ' ' ASN . 27.8 m -109.85 145.0 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.237 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.836 0.35 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.47 134.52 3.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.41 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -93.49 131.72 38.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.89 149.16 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.082 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.47 135.48 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.607 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -157.97 -140.46 2.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.573 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 122' ' ' GLY . 1.1 mp -153.06 172.02 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.906 0.384 . . . . 0.0 110.806 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -155.41 161.97 40.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.821 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.707 ' HB3' ' CE1' ' A' ' 141' ' ' TYR . . . 176.94 142.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.773 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.92 -130.41 1.25 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.736 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.633 ' HB ' HG22 ' A' ' 91' ' ' THR . 1.0 OUTLIER -156.65 120.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -94.91 115.52 27.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.191 0.52 . . . . 0.0 111.14 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -98.94 114.87 27.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.618 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.45 144.35 34.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.565 HD11 HG12 ' A' ' 137' ' ' ILE . 4.8 mp -108.75 -30.53 8.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 110.431 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.24 -170.39 1.68 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.017 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -85.96 53.78 2.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.81 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 176.31 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -122.38 143.69 49.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.982 0.42 . . . . 0.0 111.731 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.46 ' HA ' HD12 ' A' ' 131' ' ' LEU . 51.0 m -156.08 164.83 37.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.687 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.565 HG12 HD11 ' A' ' 131' ' ' LEU . 29.9 pt -143.64 136.35 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.4 ' HB3' ' CG ' ' A' ' 128' ' ' LEU . 2.2 pt-20 -126.28 176.88 6.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . -174.98 143.37 6.76 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.583 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.89 -139.35 3.95 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.016 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.707 ' CE1' ' HB3' ' A' ' 125' ' ' ALA . 19.1 p90 -120.03 161.08 21.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 0.0 111.051 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.513 ' NH2' HD12 ' A' ' 144' ' ' LEU . 0.9 OUTLIER -151.11 140.36 21.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.01 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -112.01 162.9 14.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.532 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.513 HD12 ' NH2' ' A' ' 142' ' ' ARG . 5.8 tt -153.68 145.72 23.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.3 ttm-85 -126.12 152.88 45.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.64 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 p . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.071 -179.791 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.788 0.327 . . . . 0.0 110.947 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 m -107.02 136.16 47.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -152.24 155.07 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 141' ' ' TYR . 88.5 m-85 -113.97 125.56 54.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.671 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -127.97 126.67 41.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.14 0.495 . . . . 0.0 111.263 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.548 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 3.1 pp -150.73 145.97 26.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.702 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.33 -149.02 6.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.674 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' A' ' 137' ' ' ILE . . . -121.0 168.74 11.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 111.175 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -153.89 116.14 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -99.14 114.87 27.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.038 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -81.42 153.78 26.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.063 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t70 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 179' ' ' PHE . 2.1 m120 -75.26 131.3 40.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.544 ' O ' HG13 ' A' ' 6' ' ' VAL . 10.3 t80 -126.9 139.61 52.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.802 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 5' ' ' PHE . 6.4 m -159.56 126.15 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.247 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -147.95 -144.57 4.01 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.87 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 43' ' ' GLY . 1.8 mt -126.9 158.86 35.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 m -125.61 139.28 53.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.034 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -153.1 112.98 3.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.753 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.18 131.48 9.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.516 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 0.0 110.845 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.9 m -95.18 118.62 32.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -123.51 126.24 46.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.49 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -152.02 -174.42 22.66 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.685 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.42 176.83 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.605 0.241 . . . . 0.0 111.054 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.894 ' HG3' HG22 ' A' ' 58' ' ' THR . 3.2 mtp85 -135.97 145.88 46.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.042 0.449 . . . . 0.0 110.723 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -175.37 119.95 0.18 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.075 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.82 -136.91 2.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.577 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.78 113.0 8.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.39 . . . . 0.0 110.902 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.417 ' HA ' ' HB2' ' A' ' 54' ' ' ARG . 25.2 mt-30 -134.57 128.73 33.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.081 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' O ' ' CZ ' ' A' ' 83' ' ' PHE . 1.2 t80 -105.23 -166.96 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.41 -27.48 6.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 0.0 110.945 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.416 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 4.7 mt-30 -115.27 24.16 11.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.845 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 82' ' ' ALA . . . 71.82 -155.55 52.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.274 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER 161.73 -82.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.684 0.278 . . . . 0.0 110.965 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -142.46 163.19 33.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.999 0.428 . . . . 0.0 111.23 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 79' ' ' SER . 2.3 p90 -166.01 117.86 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.743 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -90.72 147.65 23.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.709 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.894 HG22 ' HG3' ' A' ' 45' ' ' ARG . 44.9 p -139.1 123.49 18.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.965 0.412 . . . . 0.0 111.071 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -91.9 124.61 36.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.5 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -117.49 163.91 15.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 111.105 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.778 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.744 0.307 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.57 ' ND2' HG13 ' A' ' 102' ' ' VAL . 19.4 m120 -138.04 125.73 22.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.995 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mt -106.98 114.9 29.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.61 118.3 34.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.956 0.408 . . . . 0.0 111.45 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.28 116.86 3.45 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 98' ' ' THR . 66.1 m -130.91 134.16 46.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.481 . . . . 0.0 112.231 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 7.5 t80 -105.52 110.7 23.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.105 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 94' ' ' PHE . 3.5 m-20 -136.59 172.16 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.22 0.533 . . . . 0.0 112.084 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.495 ' HA ' ' HA3' ' A' ' 53' ' ' GLY . . . -137.62 124.18 20.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.637 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.477 ' HB3' ' CD1' ' A' ' 94' ' ' PHE . 55.1 p90 -97.78 162.8 13.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.344 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.549 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.2 OUTLIER -162.27 137.77 5.54 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.657 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.549 ' HD2' HD23 ' A' ' 84' ' ' LEU . 58.5 Cg_endo -71.59 112.06 3.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.462 2.108 . . . . 0.0 112.296 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.406 ' CG1' ' HB2' ' A' ' 93' ' ' LEU . 40.7 mm . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.669 0.271 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.435 ' HB ' ' HB ' ' A' ' 127' ' ' ILE . 82.5 p -136.16 144.16 44.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.783 ' CB ' HD12 ' A' ' 128' ' ' LEU . 34.5 mttp -122.38 102.05 7.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 0.0 110.729 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 7.3 tp -55.34 102.95 0.08 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.406 0.622 . . . . 0.0 110.347 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 81' ' ' ASP . 5.2 t80 -110.58 142.09 42.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.175 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.31 156.02 20.26 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.425 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 168.68 -140.57 6.25 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.732 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.85 172.94 6.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.609 0.242 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.648 HG22 ' OG ' ' A' ' 79' ' ' SER . 36.6 p -142.16 170.04 16.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.175 0.512 . . . . 0.0 111.631 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.448 ' CD1' HD23 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -154.44 131.99 11.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.982 179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.615 ' O ' HD22 ' A' ' 101' ' ' LEU . . . -127.82 123.41 4.47 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.668 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.615 HD22 ' O ' ' A' ' 100' ' ' GLY . 1.1 mm? -136.27 120.62 18.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.955 0.407 . . . . 0.0 110.304 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.57 HG13 ' ND2' ' A' ' 75' ' ' ASN . 21.3 t -109.88 142.57 21.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.271 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 mttp . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.828 -179.979 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.805 0.336 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.562 ' O ' HD13 ' A' ' 101' ' ' LEU . . . -110.38 178.28 19.92 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.52 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.75 117.86 21.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.722 ' HB1' HD13 ' A' ' 144' ' ' LEU . . . -121.44 151.23 40.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.15 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.03 131.55 0.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.038 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.506 ' C ' HD12 ' A' ' 123' ' ' LEU . . . -163.24 -124.94 0.73 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.55 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.506 HD12 ' C ' ' A' ' 122' ' ' GLY . 4.2 mp -154.36 174.33 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.8 OUTLIER -153.48 170.5 20.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.687 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . 177.0 142.48 0.08 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.991 0.424 . . . . 0.0 110.928 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.597 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -163.3 -132.27 1.32 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.726 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 126' ' ' GLY . 0.8 OUTLIER -161.78 120.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.783 HD12 ' CB ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -98.17 116.29 30.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.044 0.45 . . . . 0.0 110.979 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -95.15 143.32 26.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -110.27 149.08 30.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.69 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.92 -48.79 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.015 0.436 . . . . 0.0 110.593 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.16 -164.97 0.49 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.193 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.09 57.74 2.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.888 0.375 . . . . 0.0 110.501 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -142.12 -61.06 0.45 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.29 171.98 15.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.118 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.85 167.92 20.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.027 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.1 tt -132.74 134.67 58.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.607 ' HG2' HD23 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -130.63 172.22 12.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.018 0.437 . . . . 0.0 111.402 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.31 146.79 7.61 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.992 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.43 -147.7 5.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.057 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -126.13 146.91 49.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.96 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.55 ' HD2' HD23 ' A' ' 144' ' ' LEU . 26.9 ttp180 -125.51 132.74 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.77 116.36 20.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.722 HD13 ' HB1' ' A' ' 120' ' ' ALA . 4.3 pp -156.45 159.21 38.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.844 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.67 137.57 52.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.859 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.88 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 10.4 m . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.841 0.353 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.3 t -106.97 123.29 47.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.51 155.29 47.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.997 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -96.85 165.24 12.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.265 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.18 129.26 15.52 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.08 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.2 tt -163.42 129.99 3.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.572 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.58 -165.14 26.48 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.566 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.67 172.16 6.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.767 0.317 . . . . 0.0 111.013 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.413 ' ND2' ' CE1' ' A' ' 5' ' ' PHE . 17.4 t-20 -145.23 114.5 7.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.682 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -143.23 111.8 6.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.254 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -85.9 157.03 20.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 4' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.458 -0.045 0 CA-C-O 120.624 0.249 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -83.22 128.08 34.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 0.0 110.712 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.2 m-85 -127.52 140.0 52.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' A' ' 46' ' ' ALA . 21.9 t -152.8 128.07 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.38 -151.63 6.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.718 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 43' ' ' GLY . 5.3 mt -132.01 149.43 52.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.654 HG23 ' HD2' ' A' ' 45' ' ' ARG . 1.3 p -110.39 149.3 30.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.018 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -152.77 113.04 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.748 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.07 133.77 11.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.436 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.909 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.409 -0.276 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.7 p -119.57 107.92 13.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 110.975 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -119.29 129.88 55.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.45 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -164.94 -164.99 21.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.573 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' THR . 12.2 pt -107.67 162.48 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.66 0.267 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.654 ' HD2' HG23 ' A' ' 9' ' ' THR . 15.9 ttt85 -132.78 138.11 47.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.55 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -173.14 122.08 0.38 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.005 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.14 -137.8 2.38 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.87 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -145.48 120.4 9.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 2.3 tt0 -101.67 112.07 24.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.371 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -119.57 163.82 16.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.741 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -17.76 65.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.494 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.12 24.37 13.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.642 0.258 . . . . 0.0 111.286 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 50' ' ' PHE . . . 145.86 167.33 12.5 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.333 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.753 ' NH2' HD22 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -134.09 115.26 14.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 0.0 111.285 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.606 ' HE1' ' HB2' ' A' ' 57' ' ' ALA . 13.5 t80 -91.87 126.33 36.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.901 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.455 ' CE1' ' ND2' ' A' ' 176' ' ' ASN . 0.5 OUTLIER -133.4 103.08 5.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 0.0 111.815 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB2' ' HE1' ' A' ' 55' ' ' TYR . . . -97.32 119.62 36.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.861 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 77' ' ' LEU . 1.6 t -128.6 122.74 31.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.147 0.498 . . . . 0.0 111.438 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -86.79 124.52 33.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.474 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.04 166.96 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 0.0 111.216 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.754 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 3.1 pm0 . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.666 0.27 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.791 ' HB3' HG12 ' A' ' 102' ' ' VAL . 43.2 m-20 -143.98 111.01 5.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.139 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.426 ' HG ' ' CZ ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -85.46 145.94 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.406 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HB2' HG23 ' A' ' 58' ' ' THR . 5.5 mp -139.54 107.91 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 111.385 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.78 119.67 4.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.746 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.43 ' CB ' ' HA ' ' A' ' 98' ' ' THR . 24.3 p -130.5 150.44 51.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.869 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.51 110.86 18.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.904 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.455 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 1.8 m-20 -124.17 153.35 41.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 111.622 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -100.65 118.56 37.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.231 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 43.8 p90 -97.54 153.75 17.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.826 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.34 143.07 10.84 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.731 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' THR . 31.9 Cg_endo -63.64 91.71 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.691 2.261 . . . . 0.0 112.262 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.545 HG23 ' HB2' ' A' ' 93' ' ' LEU . 19.0 tt . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.014 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.101 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.423 HG23 ' HG3' ' A' ' 129' ' ' GLN . 0.1 OUTLIER -80.12 153.22 28.84 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -131.18 92.42 3.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.99 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' A' ' 86' ' ' ILE . 1.4 tt -61.74 102.22 0.25 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.279 0.562 . . . . 0.0 110.1 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 23.0 p90 -111.01 120.79 43.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.518 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.455 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -142.78 151.42 23.1 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.815 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.33 -140.09 4.66 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.561 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.43 150.66 47.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 0.0 111.091 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.43 ' HA ' ' CB ' ' A' ' 79' ' ' SER . 11.6 t -118.93 153.36 34.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -160.18 129.09 4.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.589 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.74 -149.18 4.97 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.856 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tt -155.21 129.21 8.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 0.0 110.49 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.791 HG12 ' HB3' ' A' ' 75' ' ' ASN . 11.2 m -109.76 128.44 65.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.245 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HA ' HG22 ' A' ' 117' ' ' VAL . 6.3 mmtt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 103' ' ' LYS . 25.1 t . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.786 0.327 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.67 -163.33 13.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.566 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -96.0 123.09 39.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.688 ' O ' HD23 ' A' ' 99' ' ' LEU . . . -94.98 146.82 23.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -168.85 140.81 2.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.941 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -163.74 -136.91 2.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.71 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.08 155.03 40.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.788 0.328 . . . . 0.0 110.882 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.44 ' NE2' ' CE2' ' A' ' 172' ' ' TYR . 0.5 OUTLIER -138.57 158.37 44.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.996 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . -176.36 141.98 0.44 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.471 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.589 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -175.08 -146.57 5.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.923 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 126' ' ' GLY . 9.5 pt -162.26 120.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 122.69 0.396 . . . . 0.0 110.01 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.753 HD22 ' NH2' ' A' ' 54' ' ' ARG . 7.8 tp -94.73 111.92 23.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.969 0.414 . . . . 0.0 110.851 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 4.3 tt0 -102.5 131.16 49.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -97.28 149.17 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.66 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.75 -45.07 4.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.98 0.419 . . . . 0.0 110.613 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -164.86 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.105 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.52 55.77 2.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.391 . . . . 0.0 110.69 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -139.06 -58.68 0.6 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.024 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.06 163.01 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.987 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.7 t -116.15 170.4 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 129' ' ' GLN . 2.1 mp -129.98 134.75 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.568 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.43 ' HG2' ' CE1' ' A' ' 94' ' ' PHE . 8.1 tt0 -123.83 147.04 47.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.961 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.62 141.66 7.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.402 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.51 -135.83 2.75 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.464 -0.875 . . . . 0.0 112.778 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -133.79 161.21 35.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 0.0 110.881 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.402 ' HG2' ' CG ' ' A' ' 124' ' ' GLN . 0.3 OUTLIER -147.72 147.49 29.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.85 140.51 50.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.643 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 tt -117.35 137.09 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.144 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.05 117.8 3.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.633 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.008 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.8 0.333 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.9 129.5 54.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -139.52 155.2 47.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.41 165.14 11.21 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.159 0.504 . . . . 0.0 110.28 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.44 ' CE2' ' NE2' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -138.29 129.47 27.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.889 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.1 tp -163.32 135.15 5.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.93 -152.69 16.74 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.64 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -130.26 171.31 13.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.455 ' ND2' ' CE1' ' A' ' 56' ' ' TYR . 14.5 m120 -151.57 114.98 4.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.082 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -116.72 117.71 30.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.674 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.86 162.41 22.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.205 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 49' ' ' GLN . 10.8 m-20 . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 120.786 0.327 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 179' ' ' PHE . 2.8 t30 -71.41 131.58 43.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.584 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.1 m-85 -123.98 139.9 53.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.684 HG13 ' HB2' ' A' ' 46' ' ' ALA . 21.4 t -150.48 122.34 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.08 -135.33 1.84 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.619 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mp -144.95 166.66 24.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.743 0.306 . . . . 0.0 110.819 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -136.83 146.52 45.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.165 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -153.0 117.54 4.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.664 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 172' ' ' TYR . . . -136.1 -176.08 14.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.466 -0.874 . . . . 0.0 113.021 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.91 -179.896 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.453 -0.259 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.9 p -140.61 107.93 5.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 0.0 111.016 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -135.15 158.32 44.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.814 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.06 -166.95 32.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.768 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 45' ' ' ARG . 9.4 mt -107.63 163.74 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.428 0.156 . . . . 0.0 110.828 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' N ' HG22 ' A' ' 44' ' ' ILE . 1.6 ttt180 -135.87 138.52 42.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.934 0.397 . . . . 0.0 110.834 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.684 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -171.05 119.8 0.51 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.255 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -162.5 -133.63 1.51 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.683 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -155.73 148.81 24.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 111.0 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.451 ' NE2' ' CZ ' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -100.7 162.57 12.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.756 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -133.29 165.78 24.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.915 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -24.65 65.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.371 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.2 24.13 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.448 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 177.77 177.49 46.61 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.447 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . 13.2 ttp-105 -143.91 140.58 29.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 111.074 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -124.43 149.44 46.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.578 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.529 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 34.0 p90 -178.28 126.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.75 162.77 14.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.527 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 49.7 p -141.05 124.46 16.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.07 0.462 . . . . 0.0 111.517 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.45 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 9.2 m-85 -92.51 116.57 29.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.957 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.06 178.37 4.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.029 0.442 . . . . 0.0 111.569 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 t30 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.51 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.834 0.349 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -120.87 114.64 21.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -98.32 128.94 44.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.496 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.634 HD11 HD11 ' A' ' 144' ' ' LEU . 2.2 mt -138.87 131.07 28.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.891 0.377 . . . . 0.0 111.183 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.76 116.82 4.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.578 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.686 ' HB3' HG22 ' A' ' 98' ' ' THR . 0.9 OUTLIER -106.65 126.28 52.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.956 0.408 . . . . 0.0 111.768 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -125.39 110.7 14.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.758 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -133.31 166.1 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.036 0.446 . . . . 0.0 111.507 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -109.63 118.33 36.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.173 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 48.5 p90 -97.85 167.62 10.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.827 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.7 tp -160.56 121.08 1.65 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.577 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.53 114.69 1.43 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.493 2.129 . . . . 0.0 112.541 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.152 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 m120 . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.786 0.326 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.04 150.71 16.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.483 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 2.4 mptm? -132.06 92.48 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.334 . . . . 0.0 111.45 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.43 ' O ' HD23 ' A' ' 93' ' ' LEU . 9.0 tt -63.23 102.96 0.44 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.137 0.494 . . . . 0.0 109.848 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 45.6 p90 -110.71 159.7 17.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.34 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.26 126.79 1.31 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.783 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.99 -140.29 2.89 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.74 178.83 6.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 111.156 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 79' ' ' SER . 44.3 p -144.08 152.13 40.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.238 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.11 131.37 5.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.59 -140.56 3.05 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.909 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.14 125.94 7.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 110.734 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.86 140.18 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.824 179.961 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.812 0.339 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -161.51 175.56 38.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.61 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.96 136.19 34.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.94 139.68 30.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.93 132.01 3.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.952 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.86 -140.83 2.97 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.628 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 mt -143.89 170.28 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.478 ' HG3' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -160.13 150.02 18.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 94' ' ' PHE . . . 178.21 142.39 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.377 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.592 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -175.32 -126.74 0.96 Allowed Glycine 0 C--O 1.229 -0.192 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.806 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.3 pp -161.07 120.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.512 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.48 HD12 ' HG3' ' A' ' 138' ' ' GLU . 2.2 tt -104.01 116.09 31.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.634 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.625 ' HG2' HG23 ' A' ' 137' ' ' ILE . 18.8 pt20 -116.85 126.22 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.775 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 136' ' ' SER . 25.2 tt0 -69.24 147.88 50.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.273 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 -30.68 7.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.338 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 t -160.93 -165.02 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.196 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -90.28 50.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.371 . . . . 0.0 110.771 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 174.14 -28.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.6 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.5 157.19 29.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.361 . . . . 0.0 111.393 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.41 ' CB ' ' HA ' ' A' ' 130' ' ' GLU . 15.2 m -155.92 169.05 25.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.994 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 129' ' ' GLN . 18.3 tt -131.49 135.0 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.417 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.48 ' HG3' HD12 ' A' ' 128' ' ' LEU . 1.3 tm-20 -133.52 167.64 20.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.544 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . 174.09 153.65 10.05 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.665 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.3 -125.95 1.26 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.971 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.444 ' CE2' ' HB3' ' A' ' 171' ' ' PHE . 5.3 m-85 -133.77 161.15 35.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.96 147.33 19.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -108.29 147.81 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.754 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.634 HD11 HD11 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -128.87 134.9 48.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.92 147.0 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.841 0.353 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.2 p -119.88 117.73 28.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -134.07 155.38 50.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.444 ' HB3' ' CE2' ' A' ' 141' ' ' TYR . 43.2 p90 -111.12 124.41 52.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.382 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.478 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 7.4 p90 -124.68 179.2 5.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.643 0.735 . . . . 0.0 111.966 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.506 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 0.4 OUTLIER -163.45 147.88 10.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.872 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.3 -162.86 21.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.809 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -123.23 171.74 9.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.861 0.363 . . . . 0.0 111.047 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.439 HD22 HD11 ' A' ' 128' ' ' LEU . 1.6 t30 -156.29 117.1 3.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.65 112.01 24.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.59 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.95 154.06 25.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.109 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 1.3 m-85 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.144 0 CA-C-O 120.763 0.316 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -63.51 137.75 58.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.826 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.3 m-85 -129.0 139.75 51.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.057 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 46' ' ' ALA . 25.7 t -154.94 124.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.012 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.98 -144.06 3.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.58 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mt -139.76 142.86 36.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.822 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.477 HG21 HG23 ' A' ' 58' ' ' THR . 9.7 t -112.15 142.4 44.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.994 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.33 114.55 13.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.74 132.54 11.01 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.426 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.6 -0.2 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -139.17 138.31 36.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.327 . . . . 0.0 110.899 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -162.03 129.42 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.44 -167.56 19.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 45' ' ' ARG . 21.0 mt -109.28 161.07 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.745 0.307 . . . . 0.0 110.964 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -129.02 133.02 47.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.665 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.524 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -169.2 120.02 0.71 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.106 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.51 -136.95 2.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.593 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -153.85 136.37 15.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 0.0 110.99 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 50' ' ' PHE . 36.5 tt0 -89.52 162.29 15.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.66 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.4 ' N ' ' HG2' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -134.95 167.21 21.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.929 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -67.11 -25.9 66.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 24.26 3.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.01 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -174.44 179.97 45.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.192 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.01 130.3 7.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 0.0 111.276 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 80' ' ' TYR . 4.1 m-85 -107.7 159.83 16.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.489 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -173.59 123.89 0.37 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.912 0.387 . . . . 0.0 111.198 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.88 153.12 20.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.602 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.477 HG23 HG21 ' A' ' 9' ' ' THR . 91.3 m -130.93 118.77 21.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.18 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 4.6 m-85 -99.23 118.34 35.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.507 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -110.82 141.85 43.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.753 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.727 0.299 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.479 ' ND2' HG13 ' A' ' 102' ' ' VAL . 6.1 m-80 -129.61 117.8 20.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.175 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.452 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 1.5 tm? -124.38 114.92 20.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.391 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -134.1 126.21 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 111.593 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.39 116.8 4.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.645 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 0.8 OUTLIER -111.72 156.71 21.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.075 0.464 . . . . 0.0 111.702 -179.248 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.434 ' HB3' ' CD2' ' A' ' 55' ' ' TYR . 23.6 p90 -130.86 110.94 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.308 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 2.4 m-20 -120.81 155.25 34.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 111.494 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.425 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -105.6 119.25 38.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.533 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 39.1 p90 -97.59 156.14 16.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.139 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tp -155.49 140.32 12.04 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.805 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.85 113.0 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.451 2.101 . . . . 0.0 112.178 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.733 HG23 ' HB ' ' A' ' 91' ' ' THR . 7.8 tp . . . . . 0 C--N 1.33 -0.247 0 CA-C-O 120.985 0.422 . . . . 0.0 111.085 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 37.3 p-10 . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.733 ' HB ' HG23 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -136.55 130.0 31.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 9.9 mttt -123.15 92.66 3.75 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.142 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.422 HD12 ' CG2' ' A' ' 127' ' ' ILE . 4.7 tp -64.88 102.72 0.63 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 17.7 p90 -115.75 155.05 28.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.404 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -172.77 142.92 7.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.558 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.73 -143.73 4.58 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.657 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.09 162.23 29.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 111.083 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.513 ' C ' HD12 ' A' ' 99' ' ' LEU . 5.2 t -129.2 155.73 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.513 HD12 ' C ' ' A' ' 98' ' ' THR . 2.9 mp -160.11 130.87 5.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.713 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.476 ' N ' HD23 ' A' ' 77' ' ' LEU . . . -156.63 -150.39 5.65 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.866 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.05 127.28 7.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.618 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.479 HG13 ' ND2' ' A' ' 75' ' ' ASN . 21.4 t -109.88 133.67 54.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.048 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 117' ' ' VAL . 5.4 mtpp . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.948 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.474 HG12 ' HG2' ' A' ' 103' ' ' LYS . 10.7 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.762 0.315 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.4 -179.27 33.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.553 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . 0.457 ' HE1' HD23 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -103.21 118.41 36.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.723 ' HA ' HG22 ' A' ' 146' ' ' THR . . . -95.31 143.41 26.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 137.94 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -165.66 -143.43 3.73 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.498 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.11 160.46 38.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.966 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -156.88 165.74 35.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.047 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.91 142.49 0.08 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.272 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -162.52 -127.0 0.85 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.263 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 14.6 pt -156.93 120.78 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -94.43 112.74 24.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.188 0.518 . . . . 0.0 111.019 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.42 HE21 HD12 ' A' ' 127' ' ' ILE . 6.4 mt-30 -102.46 115.54 30.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.024 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 136' ' ' SER . 23.6 mt-10 -73.4 149.18 42.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.872 HD13 HD11 ' A' ' 137' ' ' ILE . 8.4 tp -108.01 -31.82 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.409 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -169.04 -173.98 1.92 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.131 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -81.98 55.64 2.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.791 0.329 . . . . 0.0 110.696 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -178.45 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.277 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.79 155.87 33.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.895 0.378 . . . . 0.0 111.201 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.3 OUTLIER -140.08 -178.64 5.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.876 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.872 HD11 HD13 ' A' ' 131' ' ' LEU . 28.9 mt -138.78 134.95 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.968 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.96 131.53 54.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.708 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -155.35 124.29 1.48 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.66 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.28 -144.08 4.67 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.803 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -126.2 161.11 28.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 110.749 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -153.18 145.67 24.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.052 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.74 138.94 52.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.618 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mt -121.86 132.58 54.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.089 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.97 111.96 4.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.723 HG22 ' HA ' ' A' ' 120' ' ' ALA . 6.9 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.057 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.6 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.792 0.33 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.97 123.17 47.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.767 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -113.08 155.24 25.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -106.36 153.3 22.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.203 0.525 . . . . 0.0 110.144 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.402 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -123.57 126.78 47.27 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.583 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.52 129.91 3.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.548 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 171.66 -152.2 17.06 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.891 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.23 172.17 11.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.091 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -149.87 114.94 5.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -108.09 111.93 24.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.753 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -83.52 159.72 21.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.129 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.459 ' CB ' ' HB3' ' A' ' 49' ' ' GLN . 1.5 t0 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.797 0.332 . . . . 0.0 111.096 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -109.77 134.45 52.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.689 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 10.0 m-85 -133.47 139.99 47.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.865 0.364 . . . . 0.0 111.044 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 46' ' ' ALA . 11.1 p -155.3 122.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.199 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.31 -139.91 2.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.541 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -140.19 164.03 31.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.727 0.298 . . . . 0.0 110.759 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.656 HG21 HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -148.42 155.66 41.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.354 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -153.08 128.13 9.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.602 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.74 160.83 12.99 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.579 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.868 -179.954 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.01 131.47 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -139.6 117.69 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.82 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -151.81 -165.06 12.7 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.624 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 45' ' ' ARG . 2.0 mt -116.33 161.92 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.673 0.273 . . . . 0.0 110.956 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.656 HH11 HG21 ' A' ' 9' ' ' THR . 4.0 ttt180 -126.54 138.89 53.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.601 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.537 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -170.4 120.32 0.59 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.12 -139.32 2.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.611 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -159.14 140.19 12.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 111.128 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB3' ' CB ' ' A' ' 3' ' ' ASP . 33.0 tt0 -83.77 162.47 20.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.413 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.418 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -131.08 -166.9 1.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.88 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.85 -45.16 93.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.219 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.97 -20.47 3.83 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -118.19 179.59 17.07 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.886 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 8.4 mtt180 -142.36 143.55 32.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 111.4 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 80' ' ' TYR . 6.0 t80 -100.73 153.56 19.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.961 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 70.4 m-85 -157.66 115.44 3.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 111.585 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.09 132.52 38.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.398 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.457 HG21 ' OH ' ' A' ' 172' ' ' TYR . 16.2 p -119.28 112.18 19.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.945 0.402 . . . . 0.0 111.253 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -106.19 111.27 23.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.677 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -110.41 179.96 3.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.872 0.367 . . . . 0.0 111.132 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.792 179.942 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.688 0.28 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -130.42 119.59 22.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.177 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.04 114.97 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.431 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.618 HD13 ' OG1' ' A' ' 98' ' ' THR . 3.4 pp -145.16 152.5 40.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.399 . . . . 0.0 111.519 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.99 125.68 6.64 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.972 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -104.09 132.28 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 111.637 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.42 ' HB2' ' CE1' ' A' ' 55' ' ' TYR . 14.0 t80 -122.9 110.99 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.957 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 0.5 OUTLIER -134.43 172.05 13.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.181 0.515 . . . . 0.0 111.869 -178.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.498 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -107.99 118.77 37.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.219 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 50.4 p90 -97.38 162.97 13.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.84 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 130.7 2.12 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.444 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.54 115.94 2.95 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.446 2.097 . . . . 0.0 112.36 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.0 mt . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.089 180.0 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.7 m120 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.775 0.321 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.408 HG22 HD12 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -64.89 152.71 42.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.459 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 2.5 mttt -132.47 92.85 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 111.079 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.29 102.88 0.19 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.312 0.577 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 20.0 p90 -112.1 154.18 25.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.33 133.79 2.72 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.75 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.612 ' O ' HD23 ' A' ' 123' ' ' LEU . . . -170.14 -133.51 1.61 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.654 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -130.98 162.97 28.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 111.29 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.618 ' OG1' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -133.93 156.85 47.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.822 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -160.06 132.48 6.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.849 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.85 -149.45 5.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.825 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 mt -154.93 126.87 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.668 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 p -109.95 133.73 54.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.978 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.49 ' CD ' HG22 ' A' ' 117' ' ' VAL . 6.2 mmtt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.022 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.49 HG22 ' CD ' ' A' ' 103' ' ' LYS . 21.4 t . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.802 0.334 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -152.9 134.31 4.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.349 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -84.07 116.44 22.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.917 0.389 . . . . 0.0 111.078 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.51 ' HB1' HD22 ' A' ' 144' ' ' LEU . . . -100.23 135.8 41.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.994 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.07 142.34 1.42 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.177 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.35 -138.33 2.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.588 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 96' ' ' GLY . 5.7 mt -142.99 159.83 41.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.714 0.293 . . . . 0.0 110.688 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -157.28 173.11 17.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.14 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.87 142.67 0.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.588 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -159.52 -130.89 1.18 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.7 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.1 pt -161.13 120.38 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.0 110.67 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -94.82 115.16 27.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.672 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.415 ' N ' HD12 ' A' ' 128' ' ' LEU . 13.5 tt0 -104.31 118.15 35.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.945 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 136' ' ' SER . 1.8 pt-20 -107.82 149.3 28.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.02 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.53 -31.71 11.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.2 p -169.01 -164.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.329 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.71 56.02 3.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.886 0.374 . . . . 0.0 110.658 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -142.73 -67.5 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.061 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.68 171.49 13.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.041 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.403 ' CB ' ' HA ' ' A' ' 130' ' ' GLU . 36.3 p -156.02 173.98 16.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.942 0.401 . . . . 0.0 111.204 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 175' ' ' ALA . 5.2 pt -134.95 134.79 53.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.699 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -127.58 172.49 10.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.131 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.19 145.4 6.21 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.35 -135.96 2.53 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.657 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.85 158.04 27.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.712 0.291 . . . . 0.0 110.693 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.512 ' NH2' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.68 130.96 22.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.189 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 2.3 m-85 -122.77 133.92 54.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.453 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.51 HD22 ' HB1' ' A' ' 120' ' ' ALA . 3.7 mt -142.43 145.39 33.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 159.73 16.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.594 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.41 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.823 0.344 . . . . 0.0 110.878 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.41 136.84 51.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -156.02 155.35 32.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.022 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.9 152.58 20.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.15 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.457 ' OH ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -135.04 129.4 33.99 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.152 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.7 mt -163.56 129.87 3.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.479 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 9' ' ' THR . . . -177.79 -158.84 21.57 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.909 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -126.79 172.05 10.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.8 116.68 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.935 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -108.98 112.82 25.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.819 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 11.2 pttt -82.01 164.07 21.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.888 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -100.95 130.03 46.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.786 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.9 m-85 -132.33 139.94 48.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.379 . . . . 0.0 111.115 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.699 HG23 ' HB2' ' A' ' 46' ' ' ALA . 8.3 p -154.77 130.4 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.08 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.62 ' C ' HD22 ' A' ' 8' ' ' LEU . . . -161.22 -147.17 4.87 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.716 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.62 HD22 ' C ' ' A' ' 7' ' ' GLY . 3.9 mm? -126.41 166.72 16.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.345 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.459 HG21 HG23 ' A' ' 58' ' ' THR . 27.9 p -139.61 140.43 37.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -137.9 115.91 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.22 137.64 13.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.536 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 0.0 110.952 -179.978 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -127.81 124.05 36.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -117.75 115.47 25.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.4 -173.8 13.43 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.767 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.545 ' HA ' HD13 ' A' ' 8' ' ' LEU . 18.0 mt -106.98 162.03 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.561 0.219 . . . . 0.0 111.041 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -132.6 136.07 46.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.681 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -170.84 120.55 0.55 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.377 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -166.91 -142.34 3.41 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.755 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -131.92 130.65 41.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.681 0.277 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.439 ' NE2' ' CE1' ' A' ' 5' ' ' PHE . 32.3 tt0 -109.52 112.53 24.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.225 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -96.01 176.42 6.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.589 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -29.15 68.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.2 24.19 3.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.346 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.2 110.03 0.39 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -103.8 112.74 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 111.187 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -106.2 150.71 25.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.155 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.541 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 34.2 p90 -179.09 129.35 0.1 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.125 0.488 . . . . 0.0 111.198 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.42 148.58 22.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.15 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.459 HG23 HG21 ' A' ' 9' ' ' THR . 2.6 m -129.24 118.43 22.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.979 0.418 . . . . 0.0 111.599 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.632 ' CE2' HD12 ' A' ' 76' ' ' LEU . 14.8 m-85 -94.52 109.18 21.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.071 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -103.65 175.2 5.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.032 0.444 . . . . 0.0 111.566 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.567 179.919 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.659 0.266 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.4 110.93 20.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.632 HD12 ' CE2' ' A' ' 59' ' ' TYR . 9.3 tt -115.6 117.02 29.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.755 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.6 144.46 39.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.228 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.93 116.9 4.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.033 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.464 ' CB ' HG23 ' A' ' 98' ' ' THR . 5.2 t -99.18 134.12 42.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 111.374 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -122.41 110.89 16.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.155 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -133.11 163.39 29.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.93 0.395 . . . . 0.0 111.486 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -112.22 118.7 36.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 54.2 p90 -97.58 161.29 13.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.645 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.12 121.01 1.26 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.63 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.89 114.98 2.04 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.469 2.113 . . . . 0.0 112.329 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.859 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.741 0.305 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.531 HG22 HD12 ' A' ' 127' ' ' ILE . 16.5 p -136.55 145.08 44.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.806 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 9.0 tttt -121.31 92.69 3.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.371 . . . . 0.0 110.702 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.28 102.85 0.12 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.339 0.59 . . . . 0.0 110.772 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.451 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 32.6 p90 -112.3 153.21 27.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.862 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.12 140.66 6.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.856 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.11 -137.62 2.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.388 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.91 177.63 7.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 111.172 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.464 HG23 ' CB ' ' A' ' 79' ' ' SER . 1.2 m -146.2 151.65 37.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.978 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 130.65 5.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.775 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.35 -153.86 6.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.885 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.28 131.43 10.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 102' ' ' VAL . 12.1 p -109.59 122.83 64.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.262 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.735 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.805 0.336 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.79 118.83 2.03 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.267 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.09 131.78 34.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.966 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -123.57 145.41 48.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -170.99 140.48 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.177 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.632 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -165.6 -136.72 2.06 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.453 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.632 HD12 ' O ' ' A' ' 122' ' ' GLY . 1.7 mp -138.36 170.27 16.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 110.727 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 5.7 tt0 -159.71 152.29 21.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.881 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.94 142.48 0.08 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.612 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.596 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -169.75 -127.09 0.9 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.938 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 126' ' ' GLY . 3.4 pt -161.19 120.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.681 0.277 . . . . 0.0 110.436 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.67 HD12 ' HB3' ' A' ' 138' ' ' GLU . 1.3 tp -94.5 114.1 26.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.069 0.462 . . . . 0.0 110.725 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -98.08 122.93 41.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.09 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -95.91 149.02 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.825 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.668 HD12 HD11 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -109.78 -30.29 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.058 0.456 . . . . 0.0 110.584 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.08 -172.07 2.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.108 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.74 54.73 3.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.791 0.329 . . . . 0.0 110.833 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -177.28 -37.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.436 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.26 135.82 51.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 111.519 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.8 m -132.84 168.7 17.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.753 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.668 HD11 HD12 ' A' ' 131' ' ' LEU . 25.1 mt -138.25 135.86 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.67 ' HB3' HD12 ' A' ' 128' ' ' LEU . 13.2 pt-20 -119.5 132.64 55.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -157.1 128.41 2.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.502 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -179.86 -134.74 2.28 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.847 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.86 161.19 25.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.848 0.356 . . . . 0.0 110.859 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.11 121.96 9.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.029 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.67 139.42 49.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.648 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 mp -157.93 142.88 16.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.207 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -114.23 163.69 14.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.629 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.0 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.135 179.997 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 93.5 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.876 0.37 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.01 124.89 50.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.63 155.18 47.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -91.54 165.27 13.44 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.264 0.554 . . . . 0.0 110.29 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.24 129.98 34.5 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.78 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.6 tt -163.41 133.26 4.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.739 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.47 -156.41 18.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.613 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -124.24 172.15 9.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -150.06 114.95 5.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.982 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 6' ' ' VAL . 11.5 t80 -117.26 111.9 20.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 2.3 ptpt -82.18 161.4 22.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.773 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 2.6 m-20 . . . . . 0 N--CA 1.462 0.158 0 CA-C-O 120.828 0.346 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -60.62 140.86 57.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.0 m-85 -131.07 139.86 49.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.973 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.415 HG12 ' CB ' ' A' ' 46' ' ' ALA . 27.3 m -154.74 129.27 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.266 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.33 -143.59 3.78 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.676 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -140.14 165.42 27.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -135.05 144.86 47.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.079 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -136.73 118.58 15.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.741 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.96 143.65 16.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.683 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 0.0 110.922 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 112.563 -0.215 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.96 142.81 31.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -132.94 131.58 41.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.86 -173.26 31.36 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.665 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.35 177.12 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 111.157 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -142.55 142.73 32.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.603 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -175.68 123.06 0.2 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.255 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -163.33 -136.31 1.97 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.581 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -153.41 127.31 8.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 111.102 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 5' ' ' PHE . 1.5 tt0 -83.94 152.52 24.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.58 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -127.28 165.68 19.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.817 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -24.79 66.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.372 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -126.13 24.57 6.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.266 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 172.61 -177.29 45.25 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.357 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.748 ' NH2' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.36 122.29 7.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 111.297 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 80' ' ' TYR . 34.9 t80 -101.74 146.41 27.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.376 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.461 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 25.0 p90 -173.55 124.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.035 0.445 . . . . 0.0 111.036 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.67 162.86 14.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.584 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.4 m -139.92 125.25 18.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.221 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -102.88 100.93 10.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.295 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.94 174.95 5.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.5 m120 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.548 179.905 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.793 0.33 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.899 ' ND2' HG22 ' A' ' 102' ' ' VAL . 6.3 t-20 -131.31 116.01 17.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.821 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 68.7 tp -124.96 123.06 39.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.551 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -144.98 157.46 44.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.334 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.99 117.47 4.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.049 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.2 p -99.15 121.73 41.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.938 0.399 . . . . 0.0 111.586 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 55' ' ' TYR . 47.6 m-85 -104.25 110.86 23.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.893 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.408 ' OD1' ' CE1' ' A' ' 56' ' ' TYR . 1.9 p-10 -136.48 172.1 13.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 111.664 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.511 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -122.3 125.51 46.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.602 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 55.7 p90 -97.51 156.68 16.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 tp -158.25 135.57 6.97 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.62 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.57 116.65 3.31 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.552 2.168 . . . . 0.0 112.174 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 121.046 0.45 . . . . 0.0 110.999 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 . . . . . 0 N--CA 1.46 0.036 0 CA-C-O 120.614 0.245 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.07 153.09 51.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 9.8 mmtp -126.99 92.73 3.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 110.849 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 126' ' ' GLY . 0.7 OUTLIER -56.28 102.8 0.08 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.038 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 37.3 p90 -111.49 151.81 28.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.613 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.06 142.14 6.89 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.992 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 178.72 -142.88 5.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.685 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -125.23 179.59 5.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.802 0.334 . . . . 0.0 111.214 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.479 HG21 ' NH1' ' A' ' 142' ' ' ARG . 9.4 t -159.01 154.94 26.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.059 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 pp -160.23 131.96 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.68 -129.98 1.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.946 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.846 HD21 HG23 ' A' ' 117' ' ' VAL . 4.4 tt -155.08 128.09 8.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.393 . . . . 0.0 110.557 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.899 HG22 ' ND2' ' A' ' 75' ' ' ASN . 21.6 t -109.63 115.59 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.166 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.97 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.846 HG23 HD21 ' A' ' 101' ' ' LEU . 10.1 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.25 164.2 24.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.406 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.82 114.99 26.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.782 ' HB2' HG23 ' A' ' 102' ' ' VAL . . . -100.06 136.7 39.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.006 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -168.63 138.69 2.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.353 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.36 -140.68 2.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 143' ' ' TYR . 0.4 OUTLIER -147.66 163.95 35.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.36 . . . . 0.0 110.805 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -151.91 171.22 18.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.207 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.9 142.52 0.08 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.588 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.58 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -170.08 -134.44 1.75 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.732 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.695 ' N ' HD13 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -158.71 120.62 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.744 0.307 . . . . 0.0 110.441 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -95.07 117.69 30.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.936 0.398 . . . . 0.0 110.859 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.418 ' HB2' ' CG1' ' A' ' 137' ' ' ILE . 27.9 mt-30 -95.08 121.34 36.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -112.57 149.1 33.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.662 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mp -106.18 -42.37 5.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 110.509 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.11 -166.71 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.026 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -82.78 54.28 2.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.789 0.328 . . . . 0.0 110.44 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -141.9 -56.62 0.46 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.146 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.36 152.39 34.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.934 0.397 . . . . 0.0 111.303 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.2 t -142.17 179.12 7.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.538 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.418 ' CG1' ' HB2' ' A' ' 129' ' ' GLN . 19.2 pt -140.71 144.96 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.801 ' HB2' HD12 ' A' ' 128' ' ' LEU . 41.0 tt0 -130.54 136.25 48.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.87 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -155.82 149.98 21.2 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.547 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 172' ' ' TYR . . . 171.09 -131.24 2.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.642 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -119.9 160.76 22.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.799 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.479 ' NH1' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -142.72 123.12 13.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.198 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.864 ' O ' HD22 ' A' ' 144' ' ' LEU . 93.4 m-85 -119.55 133.91 55.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.441 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.864 HD22 ' O ' ' A' ' 143' ' ' TYR . 2.0 mm? -141.64 154.12 45.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 111.3 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -117.67 163.41 16.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.477 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 111.203 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 91.8 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.792 0.33 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 18.8 t -107.02 130.17 54.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.744 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.24 155.21 46.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -106.19 143.7 33.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.133 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -124.54 127.02 46.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.102 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.9 tt -163.66 129.73 3.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.501 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.34 -155.45 15.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.87 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -114.98 172.04 7.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -155.9 117.52 3.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 3.9 m-85 -115.98 117.19 29.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.074 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -84.58 163.98 18.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.126 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.781 0.324 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.05 132.71 54.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.708 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 13.6 m-85 -134.51 139.96 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.028 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 1.063 HG23 ' HB2' ' A' ' 46' ' ' ALA . 7.6 p -151.16 129.36 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.965 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.7 -147.85 5.31 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.843 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 4.8 mp -138.99 160.06 40.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.352 . . . . 0.0 110.903 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.505 HG21 ' CG2' ' A' ' 58' ' ' THR . 4.8 t -129.54 167.5 17.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.791 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.48 ' HB3' HD12 ' A' ' 173' ' ' LEU . 5.0 t-105 -149.11 137.18 20.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.96 122.03 5.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.474 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.853 0.359 . . . . 0.0 110.941 -179.98 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 m -112.83 125.73 54.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -108.34 174.31 5.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.798 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.5 157.94 21.41 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.603 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 45' ' ' ARG . 2.1 mp -109.8 158.89 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.511 0.196 . . . . 0.0 110.907 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -143.31 149.77 38.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.042 0.448 . . . . 0.0 110.839 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 1.063 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -177.35 123.56 0.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.583 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -163.85 -137.6 2.23 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.592 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.66 130.42 38.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.782 0.325 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 40.0 tt0 -105.66 110.71 23.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.029 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 53' ' ' GLY . 1.9 p90 -121.06 166.99 13.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.727 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -19.95 65.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.4 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -92.14 15.86 12.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.553 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . 133.02 176.0 14.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.56 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.444 ' HD2' ' CD2' ' A' ' 83' ' ' PHE . 47.3 mtp180 -116.14 117.13 29.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.865 0.364 . . . . 0.0 111.2 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -100.36 136.36 40.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.209 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.612 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 44.0 p90 179.84 132.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.836 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . -90.34 136.65 32.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.158 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.505 ' CG2' HG21 ' A' ' 9' ' ' THR . 25.8 m -113.68 111.72 22.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.98 0.419 . . . . 0.0 111.543 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.88 124.34 29.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.148 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -101.88 155.12 18.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 111.501 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.48 179.908 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.774 0.321 . . . . 0.0 110.807 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.656 ' CG ' HG22 ' A' ' 102' ' ' VAL . 51.5 t-20 -133.41 120.67 21.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.093 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.41 ' C ' HD23 ' A' ' 76' ' ' LEU . 6.1 tt -114.94 114.99 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.443 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 120' ' ' ALA . 2.1 mp -122.45 153.79 38.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.991 0.424 . . . . 0.0 111.498 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.73 116.7 4.24 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.81 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.429 ' HB2' ' CE2' ' A' ' 56' ' ' TYR . 54.5 m -90.53 140.72 29.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.07 0.462 . . . . 0.0 111.568 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -148.34 110.78 4.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.031 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.414 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 3.9 p30 -146.36 172.18 13.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.421 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.31 118.66 35.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -97.81 167.12 11.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.665 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.494 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.1 OUTLIER -168.44 134.25 1.53 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 84' ' ' LEU . 36.9 Cg_endo -65.71 95.06 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.474 2.116 . . . . 0.0 112.102 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 86' ' ' ILE . 1.7 tt . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 38.1 p-10 . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.828 0.347 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.598 HG22 HD12 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -136.63 148.48 47.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.124 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -126.64 92.31 3.53 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.078 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 6.4 tt -61.59 102.73 0.27 Allowed 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.482 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 15.2 p90 -113.35 154.2 27.27 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.88 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.84 130.56 1.97 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.671 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.414 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -169.65 -139.99 2.86 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.589 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -135.64 170.11 16.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 111.155 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -138.03 163.16 32.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.27 133.81 6.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -155.63 -144.31 3.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.995 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.14 130.84 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.256 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.656 HG22 ' CG ' ' A' ' 75' ' ' ASN . 14.9 t -109.65 128.84 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.225 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.853 179.886 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.715 0.293 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -140.53 143.61 13.73 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.642 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -90.49 120.33 31.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.746 0.308 . . . . 0.0 110.753 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.87 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -95.04 140.05 30.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.211 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.02 134.72 0.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.72 -141.99 3.27 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.601 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 mp -149.65 162.44 40.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.89 0.376 . . . . 0.0 110.985 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 5.6 tm0? -154.01 159.71 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 177.01 142.51 0.08 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.729 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -174.58 -125.69 0.88 Allowed Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.733 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.598 HD12 HG22 ' A' ' 91' ' ' THR . 5.3 pt -161.13 120.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 110.366 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.825 HD12 ' HB3' ' A' ' 138' ' ' GLU . 1.1 tp -95.42 114.69 26.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.971 0.415 . . . . 0.0 110.833 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 21.5 mt-30 -99.52 147.48 25.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.247 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -128.72 149.11 50.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.52 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.4 mt -109.43 -45.38 3.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.089 0.471 . . . . 0.0 110.76 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.09 -164.89 0.49 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.274 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -80.12 57.41 2.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.879 0.371 . . . . 0.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -138.72 -60.28 0.6 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.2 158.24 21.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.993 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.3 m -125.72 168.66 13.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 174' ' ' GLY . 4.0 mp -134.08 134.7 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.778 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.825 ' HB3' HD12 ' A' ' 128' ' ' LEU . 8.7 pm0 -124.21 149.99 45.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -154.76 128.8 2.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.365 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.25 -136.74 2.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.8 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -135.16 161.07 36.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.402 ' HG2' ' CG ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -147.77 146.32 29.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -112.47 145.79 39.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.85 122.56 39.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -145.52 111.99 5.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.704 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 120' ' ' ALA . 82.1 p . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.734 0.302 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.0 p -107.09 122.47 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.05 155.2 49.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.3 165.16 11.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.139 0.495 . . . . 0.0 110.239 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -137.92 128.5 26.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.805 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -163.6 129.98 3.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 137' ' ' ILE . . . -179.87 -156.66 18.41 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.696 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -125.07 172.09 9.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.114 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -149.98 114.94 5.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.419 ' O ' HG12 ' A' ' 6' ' ' VAL . 39.9 m-85 -107.02 116.92 32.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.987 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -83.87 162.85 20.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 40.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.969 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--O 1.228 -0.06 0 CA-C-O 120.571 0.224 . . . . 0.0 110.665 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.24 138.1 49.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.512 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 28.4 p90 -148.95 161.86 41.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.01 0.433 . . . . 0.0 111.454 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.885 HG12 ' HB1' ' A' ' 46' ' ' ALA . 34.3 m -150.33 141.18 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.02 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.1 -157.91 9.04 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 119.966 -1.112 . . . . 0.0 113.135 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -126.97 154.94 43.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.795 0.331 . . . . 0.0 110.786 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 p -128.02 149.6 50.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.437 ' CD2' ' HB3' ' A' ' 42' ' ' TRP . 1.7 t-105 -153.09 115.9 4.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.45 137.96 13.73 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 179.999 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.491 -0.243 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.96 149.79 38.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.437 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 68.0 p-90 -152.92 162.91 40.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.757 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.94 -165.99 35.34 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.706 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.422 HG12 ' N ' ' A' ' 45' ' ' ARG . 18.0 tt -123.56 159.84 27.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.491 0.186 . . . . 0.0 110.803 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -137.88 158.53 44.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.24 0.543 . . . . 0.0 110.669 179.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.885 ' HB1' HG12 ' A' ' 6' ' ' VAL . . . -177.04 123.74 0.14 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.107 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -167.02 -142.69 3.52 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.603 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 1.5 mp0 -129.78 139.39 51.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.822 0.344 . . . . 0.0 111.048 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' CD1' ' A' ' 5' ' ' PHE . 2.2 pt20 -121.25 112.33 18.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -119.92 157.22 29.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.6 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.28 -22.28 29.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.255 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -95.66 21.66 8.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.257 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.67 158.85 8.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.494 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.417 ' HG3' ' HB3' ' A' ' 49' ' ' GLN . 47.5 ttm-85 -121.22 130.85 53.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.851 0.358 . . . . 0.0 111.061 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -117.67 152.52 35.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.471 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.514 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 36.2 p90 179.67 129.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.156 0.503 . . . . 0.0 111.25 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . -90.59 128.91 36.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.022 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.0 p -117.39 115.05 24.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.165 0.507 . . . . 0.0 111.486 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 75' ' ' ASN . 35.3 m-85 -92.9 130.64 38.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.116 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.9 171.73 8.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.051 0.453 . . . . 0.0 111.441 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.628 179.833 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.699 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.724 0.297 . . . . 0.0 110.718 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 1.7 m120 -143.76 131.11 20.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -147.69 114.91 6.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.469 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -145.73 154.62 42.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.041 0.448 . . . . 0.0 111.472 -179.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.93 116.8 4.24 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.823 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.45 134.0 42.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.974 0.416 . . . . 0.0 111.447 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -124.52 110.86 14.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.061 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -130.79 166.42 20.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 111.415 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.77 118.46 35.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.396 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 55.4 p90 -97.78 166.94 11.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.574 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.68 136.14 1.65 Allowed Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.468 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.12 118.11 4.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.417 2.078 . . . . 0.0 112.377 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.475 HD12 ' CB ' ' A' ' 93' ' ' LEU . 27.8 mt . . . . . 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.788 0.327 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.575 HG22 ' HG3' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -67.97 149.14 50.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.536 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -127.21 92.47 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 0.0 111.114 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.569 HD22 ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -59.02 103.17 0.15 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 110.319 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 40.7 p90 -110.7 157.66 19.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.053 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.98 129.96 1.61 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.835 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.3 -138.33 2.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.581 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.93 -177.82 4.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.143 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -148.99 155.98 41.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.2 132.2 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.699 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.63 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -160.52 -148.16 5.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.918 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.63 HD12 ' C ' ' A' ' 100' ' ' GLY . 5.5 mp -155.34 133.6 11.66 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.241 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 74' ' ' GLN . 12.2 p -109.35 131.31 60.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.137 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.966 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.903 0.383 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -148.57 -157.79 7.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.428 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -116.05 115.0 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.09 144.04 37.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 141.33 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.263 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.46 -142.74 3.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.517 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mp -145.58 161.97 38.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.834 0.349 . . . . 0.0 110.771 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 2.1 mt-30 -149.13 160.47 43.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.794 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.75 ' HB3' ' CZ ' ' A' ' 141' ' ' TYR . . . 176.95 142.44 0.08 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.598 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.586 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -174.86 -130.69 1.33 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.748 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 126' ' ' GLY . 10.7 pt -160.94 120.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 110.492 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.693 HD11 HD22 ' A' ' 176' ' ' ASN . 0.4 OUTLIER -94.7 112.21 23.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.684 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . 0.575 ' HG3' HG22 ' A' ' 91' ' ' THR . 8.6 mp0 -103.91 124.31 48.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.75 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -86.05 149.35 25.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -104.02 -29.61 10.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.048 0.452 . . . . 0.0 110.163 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.01 -165.48 0.55 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.824 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -91.27 48.01 1.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.705 0.288 . . . . 0.0 110.596 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -155.95 -44.07 0.08 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.647 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -130.19 170.67 13.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.012 0.434 . . . . 0.0 111.566 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.7 m -156.1 -175.8 5.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.73 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.8 pt -154.18 152.61 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.701 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.87 156.56 47.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.041 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -167.54 146.4 10.63 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.95 -125.2 1.19 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.644 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.75 ' CZ ' ' HB3' ' A' ' 125' ' ' ALA . 13.7 p90 -136.09 161.2 36.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.766 0.317 . . . . 0.0 110.732 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.464 ' HB2' ' CD2' ' A' ' 172' ' ' TYR . 0.2 OUTLIER -162.44 140.28 8.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.246 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -119.78 162.7 18.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.54 HD21 ' CD2' ' A' ' 77' ' ' LEU . 12.1 tp -159.48 146.93 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.957 0.408 . . . . 0.0 111.306 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.6 mmm-85 -118.65 154.22 33.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.544 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.8 p . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 -179.823 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.734 0.302 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 30.3 t -107.11 142.41 36.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.02 155.2 35.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -102.5 165.27 11.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.2 0.524 . . . . 0.0 110.367 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -134.26 128.7 34.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.957 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 9.8 tp -163.67 129.89 3.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.588 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.77 -158.57 22.12 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.737 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.52 172.02 8.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.798 0.332 . . . . 0.0 111.046 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.693 HD22 HD11 ' A' ' 128' ' ' LEU . 39.6 t-20 -153.96 114.93 4.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -116.23 111.34 20.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 1.7 ptpt -84.43 163.17 19.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.164 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.795 0.331 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 1.6 t-20 -77.79 145.56 36.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.651 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 18.0 p90 -148.57 152.11 36.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.124 0.488 . . . . 0.0 111.421 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.672 HG23 ' HB2' ' A' ' 46' ' ' ALA . 9.1 p -151.29 135.64 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.158 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.86 -133.69 1.57 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mp -143.86 167.96 21.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 110.829 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -135.01 143.38 46.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.451 ' CD1' ' HB3' ' A' ' 42' ' ' TRP . 0.6 OUTLIER -134.53 117.84 16.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.708 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.2 151.2 17.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.597 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.847 179.993 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.0 p -124.11 108.03 11.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TRP . . . . . 0.451 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 6.6 p-90 -126.27 164.51 20.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.691 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.61 -169.43 35.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.832 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.754 HD12 ' HB2' ' A' ' 59' ' ' TYR . 1.7 mt -107.79 163.21 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.551 0.215 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.618 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -138.92 139.82 38.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.932 0.396 . . . . 0.0 110.923 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.672 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -170.02 117.73 0.57 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.771 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -157.63 -167.25 18.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.457 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 3.9 pt20 -131.72 125.52 32.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 110.839 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.415 ' HG2' ' N ' ' A' ' 50' ' ' PHE . 5.3 tt0 -83.84 151.95 24.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.415 ' N ' ' HG2' ' A' ' 49' ' ' GLN . 0.8 OUTLIER -127.66 166.48 18.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -24.98 65.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.441 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -133.12 24.26 4.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.691 0.281 . . . . 0.0 111.475 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.99 170.96 42.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.4 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -141.5 142.68 33.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.851 0.358 . . . . 0.0 111.329 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -129.89 151.73 50.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.242 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.619 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 36.2 p90 179.49 129.19 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.191 0.52 . . . . 0.0 111.246 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.82 152.41 20.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.426 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 73.0 p -137.13 121.22 17.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 111.546 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.817 ' CE2' HD21 ' A' ' 76' ' ' LEU . 8.3 m-85 -85.67 117.62 24.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.926 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -101.96 158.04 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 111.469 -179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 m120 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.494 179.884 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.713 0.292 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -144.08 114.82 7.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.175 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.817 HD21 ' CE2' ' A' ' 59' ' ' TYR . 2.5 mp -107.62 131.11 54.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.397 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.446 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 1.9 mp -141.72 147.41 37.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.027 0.441 . . . . 0.0 111.565 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.99 116.75 4.21 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.072 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.566 ' OG ' HG22 ' A' ' 98' ' ' THR . 1.9 t -87.71 136.32 33.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.983 0.42 . . . . 0.0 111.259 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -133.07 110.82 10.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.258 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -147.78 172.08 14.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.031 0.444 . . . . 0.0 111.589 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.44 124.97 50.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.485 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 45.6 p90 -97.51 165.43 12.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.497 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.638 HD23 HD11 ' A' ' 86' ' ' ILE . 26.0 tp -140.52 117.85 8.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.417 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.52 108.66 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.37 2.047 . . . . 0.0 112.354 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.638 HD11 HD23 ' A' ' 84' ' ' LEU . 31.7 mm . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.4 m120 . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.922 0.391 . . . . 0.0 111.023 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.643 HG22 HD12 ' A' ' 127' ' ' ILE . 0.8 OUTLIER -136.6 148.64 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.672 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -123.25 92.49 3.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.931 0.396 . . . . 0.0 110.781 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.51 103.01 0.28 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.666 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 46.6 p90 -111.37 154.59 24.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.817 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.35 132.83 2.34 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.819 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.6 -139.43 2.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.687 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.89 177.11 7.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.756 0.312 . . . . 0.0 111.183 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.566 HG22 ' OG ' ' A' ' 79' ' ' SER . 47.8 p -146.37 159.04 43.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mp -159.25 130.8 6.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.646 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -150.71 -155.91 7.1 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.124 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.9 mt -155.2 130.51 9.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.794 0.33 . . . . 0.0 110.168 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 102' ' ' VAL . 12.5 p -109.72 119.78 59.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.297 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 tttm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.934 -179.946 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.837 0.351 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -113.95 -177.62 19.22 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.507 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -91.71 125.44 36.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.4 137.46 51.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -171.17 140.42 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.001 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.28 -139.86 2.76 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.643 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 143' ' ' TYR . 24.9 mt -145.39 165.64 27.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.798 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 8.0 tt0 -157.14 159.27 37.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 94' ' ' PHE . . . 176.94 142.46 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -171.81 -130.69 1.26 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.656 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.643 HD12 HG22 ' A' ' 91' ' ' THR . 4.7 pt -158.68 120.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.52 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.701 HD11 ' OD1' ' A' ' 176' ' ' ASN . 8.5 tt -95.19 114.32 26.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.117 0.484 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -99.14 139.63 34.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.268 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -118.78 149.11 42.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.556 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.92 -51.22 2.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.626 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -169.11 -164.9 0.49 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.093 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -76.47 58.32 1.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.786 0.326 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -136.88 -60.17 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HB2' ' CE2' ' A' ' 177' ' ' TYR . . . -166.03 156.66 12.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.75 165.34 13.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.63 134.73 61.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.514 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.95 143.36 50.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.051 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -160.08 149.88 19.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.297 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 173.8 -133.98 2.73 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.729 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.62 161.05 23.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.82 0.343 . . . . 0.0 110.98 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.0 ttt-85 -149.91 125.27 10.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.43 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 13.1 m-85 -101.09 138.71 37.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.763 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.06 134.06 55.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.7 mmm-85 -151.64 112.14 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.987 -179.876 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.832 0.349 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.88 119.8 40.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -147.7 155.16 41.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -102.51 165.27 11.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.154 0.502 . . . . 0.0 110.163 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.75 129.75 30.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.113 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.4 tp -163.42 131.56 3.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.721 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 176.94 -155.17 17.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.681 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.19 172.04 13.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.986 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.701 ' OD1' HD11 ' A' ' 128' ' ' LEU . 1.1 p30 -158.05 121.81 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.544 ' CE2' ' HB2' ' A' ' 135' ' ' ALA . 36.3 m-85 -98.71 115.77 29.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.4 147.28 29.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.112 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.724 0.297 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -154.76 139.84 17.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.232 -179.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.9 138.86 56.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.762 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.504 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.5 m-85 -132.48 139.88 48.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.909 0.385 . . . . 0.0 111.103 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.605 HG12 ' CB ' ' A' ' 46' ' ' ALA . 19.6 m -154.58 127.63 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.997 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.6 -146.47 4.66 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.846 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.705 HD23 ' O ' ' A' ' 43' ' ' GLY . 0.5 OUTLIER -127.8 153.97 45.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.806 0.336 . . . . 0.0 110.821 -179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.662 ' OG1' HG23 ' A' ' 58' ' ' THR . 1.0 OUTLIER -125.37 135.9 52.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -135.05 113.24 11.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.84 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -104.29 131.36 10.6 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.523 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.61 119.46 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.37 . . . . 0.0 110.871 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 t -122.49 105.59 10.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.984 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 36.3 p -150.05 102.79 3.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -88.59 -46.14 9.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.551 ' O ' HD13 ' A' ' 17' ' ' ILE . 19.2 p-10 -86.6 140.53 29.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.915 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.551 HD13 ' O ' ' A' ' 16' ' ' ASN . 29.5 mm -128.39 97.69 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.113 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -144.03 171.05 14.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.77 144.18 51.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.6 p -140.77 165.99 26.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.904 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -148.89 132.26 16.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.77 127.52 45.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 63.46 129.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.954 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -106.34 -31.4 8.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.863 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -58.41 -23.6 57.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 62.33 105.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.962 0.411 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -148.55 -47.04 0.15 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.811 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -93.51 128.22 39.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.858 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.4 t -140.95 87.34 11.02 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.027 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.86 -174.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.581 2.187 . . . . 0.0 112.228 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -127.1 68.79 1.27 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.81 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 mt -138.2 101.31 4.36 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.994 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -140.76 90.97 2.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.715 ' HD2' HG22 ' A' ' 35' ' ' VAL . 0.2 OUTLIER 178.46 -34.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.036 179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.715 HG22 ' HD2' ' A' ' 34' ' ' LYS . 15.5 m -152.2 92.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.174 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mp -130.72 103.99 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.092 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -136.47 -167.88 2.15 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.716 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -146.09 -47.55 0.2 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.867 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -120.45 140.04 51.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.77 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 156.87 134.55 1.79 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.53 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.8 p -95.01 126.58 40.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.743 0.306 . . . . 0.0 110.82 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 57.2 p-90 -128.31 132.73 48.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.873 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.705 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -156.35 -167.26 17.41 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.51 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 pt -107.15 172.54 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.753 0.311 . . . . 0.0 111.027 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.87 141.44 34.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.639 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.605 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -174.87 123.2 0.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.315 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -160.96 -148.74 5.38 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.698 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -136.07 126.29 26.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.86 0.362 . . . . 0.0 111.01 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 1.1 tm0? -83.97 158.91 21.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.662 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -135.04 164.22 28.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.883 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.15 -24.08 65.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.365 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -128.32 24.38 5.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.27 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 174.61 178.21 44.32 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.202 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 54' ' ' ARG . 4.1 ptm85 -148.13 138.22 22.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.972 0.415 . . . . 0.0 111.187 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 80' ' ' TYR . 0.1 OUTLIER -117.04 145.63 43.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.514 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.457 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 41.0 p90 -172.12 121.94 0.47 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 111.171 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.85 158.93 16.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.769 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.662 HG23 ' OG1' ' A' ' 9' ' ' THR . 68.1 m -127.95 117.06 21.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.059 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.466 ' HD2' HD23 ' A' ' 76' ' ' LEU . 28.3 t80 -100.96 127.59 47.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.754 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -141.53 176.71 8.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.029 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -137.29 -78.41 0.39 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.991 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.685 HG21 ' HB3' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -159.99 137.45 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.081 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.0 126.02 25.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -73.91 153.46 39.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.001 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.8 172.8 16.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -81.05 -35.86 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 p -105.1 27.16 8.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.025 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.612 ' HA3' HD11 ' A' ' 71' ' ' LEU . . . -70.82 111.15 3.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.517 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -111.77 128.35 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.836 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 15.5 mmtt 60.55 82.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.902 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.685 ' HB3' HG21 ' A' ' 62' ' ' ILE . 3.1 mt -130.58 115.25 16.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.964 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -176.91 106.57 0.06 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.95 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -162.25 -178.8 6.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.861 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -128.41 150.24 50.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.835 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.431 ' OD1' HD12 ' A' ' 77' ' ' LEU . 21.7 t-20 -144.64 116.99 8.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.094 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.5 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -129.73 127.05 39.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.534 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.652 HD22 HD21 ' A' ' 144' ' ' LEU . 0.8 OUTLIER -146.32 137.72 24.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.963 0.411 . . . . 0.0 111.438 -179.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.77 116.89 3.89 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.016 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.408 ' OG ' ' CE2' ' A' ' 56' ' ' TYR . 26.0 p -105.92 133.29 50.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.412 . . . . 0.0 111.279 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 55' ' ' TYR . 23.1 p90 -123.85 110.89 15.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.353 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.57 171.19 14.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.053 0.454 . . . . 0.0 111.383 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -117.54 120.6 38.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.919 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 42.1 p90 -97.86 164.38 12.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.133 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.721 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.2 OUTLIER -170.26 139.03 1.44 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.636 179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.721 ' HD2' HD23 ' A' ' 84' ' ' LEU . 76.3 Cg_exo -49.84 119.51 4.88 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.514 2.142 . . . . 0.0 112.359 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.621 ' O ' HG23 ' A' ' 86' ' ' ILE . 5.0 tp -119.71 104.85 16.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.03 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.88 -75.53 0.26 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.489 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -139.55 -68.64 0.43 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 110.868 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 t30 179.71 37.17 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.959 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -121.48 -59.98 1.65 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.81 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -78.78 153.09 31.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.569 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 1.7 tptp -126.58 92.53 3.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.824 0.345 . . . . 0.0 110.995 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 tp -62.14 102.82 0.32 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.256 0.55 . . . . 0.0 110.508 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.452 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 35.9 p90 -111.04 156.0 21.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.758 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -168.27 134.7 3.32 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.732 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.418 ' O ' HD23 ' A' ' 123' ' ' LEU . . . -177.53 -160.66 24.59 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.446 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -118.13 171.43 8.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 0.0 111.23 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.44 HG21 HE21 ' A' ' 124' ' ' GLN . 7.8 t -143.92 159.81 41.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.906 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.06 131.19 5.81 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.456 ' N ' HD23 ' A' ' 77' ' ' LEU . . . -152.73 -153.31 6.27 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.806 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.472 ' O ' HD12 ' A' ' 101' ' ' LEU . 2.7 pp -155.28 127.94 7.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.656 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.2 m -109.74 130.41 62.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.206 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -104.63 126.95 52.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.93 127.14 47.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.87 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -122.94 143.65 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -131.64 170.95 14.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.862 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -83.29 115.31 21.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.95 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -140.41 -46.06 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.656 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 61.24 116.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.841 0.353 . . . . 0.0 110.905 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.65 -78.02 1.62 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.454 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -97.4 104.79 16.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 110.845 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.56 122.93 28.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 4.8 ttm180 -87.99 -52.14 5.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -63.02 136.65 57.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.43 ' HB2' HG12 ' A' ' 117' ' ' VAL . 23.5 p -83.63 -22.19 32.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.19 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 64.24 31.84 12.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 0.0 110.738 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 117' ' ' VAL . 11.4 p -148.94 110.81 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.011 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -133.29 132.61 6.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.499 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -84.62 115.04 22.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.848 0.356 . . . . 0.0 111.034 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -111.62 137.74 49.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.05 141.27 1.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.27 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.94 -139.56 2.69 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.603 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 96' ' ' GLY . 1.9 mt -140.37 161.16 38.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.893 0.378 . . . . 0.0 110.831 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.44 HE21 HG21 ' A' ' 98' ' ' THR . 66.8 mt-30 -150.04 157.78 43.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.796 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 178.68 142.39 0.11 Allowed 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.371 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.523 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -168.01 -130.33 1.17 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.117 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.523 HG23 ' O ' ' A' ' 126' ' ' GLY . 11.3 pt -159.45 121.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.77 0.319 . . . . 0.0 110.377 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.13 111.61 23.35 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.742 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -92.58 122.13 34.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.075 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -106.39 149.12 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.769 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.02 -47.26 3.46 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.001 0.429 . . . . 0.0 110.518 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -164.97 0.49 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.194 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 56.71 2.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.833 0.349 . . . . 0.0 110.6 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.76 -58.96 0.67 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.952 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -162.68 146.18 11.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.978 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.03 -179.9 4.08 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.846 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.4 mt -136.49 134.97 49.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.05 141.0 46.26 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.97 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -161.82 117.28 0.76 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.446 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -172.64 -138.95 2.7 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.369 -0.919 . . . . 0.0 113.094 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -121.19 161.16 22.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.747 0.308 . . . . 0.0 110.843 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.724 ' HD3' HD12 ' A' ' 144' ' ' LEU . 0.0 OUTLIER -143.28 121.71 12.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.107 -179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -118.18 131.3 56.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.463 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.724 HD12 ' HD3' ' A' ' 142' ' ' ARG . 0.8 OUTLIER -144.29 146.96 32.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.935 0.398 . . . . 0.0 111.261 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -106.84 162.38 13.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.561 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.6 p -108.91 172.04 7.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.089 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -56.17 115.56 2.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.079 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -148.32 80.0 1.45 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 t -116.98 119.97 36.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.959 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 3.3 m 59.38 162.47 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.908 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -115.63 159.36 21.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -88.33 -63.51 1.29 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.923 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.2 p -110.88 99.04 40.88 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.837 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.59 116.38 4.22 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.447 2.098 . . . . 0.0 112.328 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -87.21 -63.01 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.925 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 80.84 130.97 1.04 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.524 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -141.26 -108.58 0.73 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.548 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -155.18 161.75 41.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.9 0.381 . . . . 0.0 110.846 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -101.88 80.22 1.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.932 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.6 mp -87.65 108.26 19.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.68 -127.48 39.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.534 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.58 162.51 38.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.804 0.335 . . . . 0.0 110.896 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.6 pp -156.53 162.37 39.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -76.69 139.29 40.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.403 ' C ' HD12 ' A' ' 165' ' ' LEU . 0.5 OUTLIER -56.54 176.86 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.054 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -93.78 100.16 12.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.926 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -126.69 160.85 29.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.87 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.69 150.56 22.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.791 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 m -106.97 117.58 34.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.816 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.21 155.18 51.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.724 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -103.49 165.2 11.18 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 121.21 0.528 . . . . 0.0 110.277 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.413 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -131.39 128.0 38.7 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.768 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -163.4 131.65 3.74 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.711 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.33 -152.04 15.95 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.648 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -131.61 172.01 12.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.844 0.354 . . . . 0.0 111.058 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 23.6 m-80 -152.22 115.49 4.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.046 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -109.21 113.62 26.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.883 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.504 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.94 163.56 22.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.142 -179.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--N 1.331 -0.229 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.93 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.85 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.79 0.329 . . . . 0.0 110.92 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.92 168.12 9.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.863 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -109.71 128.39 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.785 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.8 OUTLIER -129.05 139.91 51.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.571 HG12 ' CB ' ' A' ' 46' ' ' ALA . 16.4 m -154.08 126.41 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.214 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.35 -141.92 3.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.641 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.769 HD23 ' HA ' ' A' ' 44' ' ' ILE . 4.6 mt -142.93 162.01 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.694 0.283 . . . . 0.0 110.749 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.412 HG21 HG21 ' A' ' 58' ' ' THR . 8.4 t -139.07 136.38 35.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 111.263 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.5 t90 -130.62 113.02 13.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.59 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 172' ' ' TYR . . . -118.13 169.65 13.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.064 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.97 133.84 54.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.79 0.329 . . . . 0.0 110.837 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.6 p -135.67 110.04 8.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.2 p -150.17 102.76 3.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.848 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -65.51 -69.02 0.32 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.874 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -62.95 162.84 10.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.908 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.43 142.32 14.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.088 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.92 101.98 0.24 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.875 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -72.85 136.68 45.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.917 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.8 p -143.65 137.39 28.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -106.71 -64.8 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.892 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.99 166.19 19.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.859 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.57 -44.89 69.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -78.81 179.68 7.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.881 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -145.71 -176.96 5.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.5 t30 65.96 80.45 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.24 -62.15 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.796 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -127.38 -46.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.84 163.6 27.13 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.22 -179.75 3.35 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.6 2.2 . . . . 0.0 112.344 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -107.38 31.51 5.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.97 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.8 tp -168.35 153.3 6.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.941 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 60.26 76.73 0.35 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.816 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.2 tptt -79.46 -43.76 22.63 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.499 HG23 HG13 ' A' ' 36' ' ' ILE . 13.2 m -147.83 -46.22 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.074 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.499 HG13 HG23 ' A' ' 35' ' ' VAL . 2.6 pp -155.29 -175.22 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.726 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -131.69 120.12 22.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.866 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -150.2 146.32 26.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.5 p -114.72 -61.73 1.71 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.803 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 153.12 -142.28 9.11 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.545 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 p -138.62 107.99 6.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.864 0.364 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -125.11 137.36 54.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.707 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.15 -171.61 34.23 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.851 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.769 ' HA ' HD23 ' A' ' 8' ' ' LEU . 1.4 mp -106.95 164.05 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.578 0.227 . . . . 0.0 110.745 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.5 ' N ' HG22 ' A' ' 44' ' ' ILE . 4.0 ttm-85 -132.39 139.71 48.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.948 0.404 . . . . 0.0 110.646 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.571 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -174.81 122.43 0.24 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.443 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -169.92 -128.44 1.02 Allowed Glycine 0 C--N 1.33 0.205 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.516 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 26.7 mm100 -143.22 154.91 44.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 110.917 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.65 109.84 11.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.087 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.85 ' CD2' ' HB2' ' A' ' 2' ' ' ALA . 0.6 OUTLIER -103.7 145.71 29.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.547 179.757 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.22 -21.67 24.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.208 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -124.63 24.13 7.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.073 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 171.75 120.49 0.55 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.513 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 129.38 53.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.776 0.322 . . . . 0.0 110.816 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.481 ' CD1' ' CD2' ' A' ' 80' ' ' TYR . 11.4 m-85 -124.24 147.03 48.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.772 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.486 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 31.9 p90 -177.3 125.53 0.14 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.039 0.447 . . . . 0.0 110.979 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.69 156.13 18.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.609 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 21.2 m -133.28 119.05 19.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.495 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.509 ' CZ ' HD23 ' A' ' 76' ' ' LEU . 27.9 m-85 -89.95 118.9 29.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.324 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.92 176.72 4.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.977 0.418 . . . . 0.0 111.397 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.595 ' OD1' HD21 ' A' ' 71' ' ' LEU . 1.1 t-20 -150.47 -165.87 2.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.641 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.513 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.9 mp -129.48 111.11 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.097 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.1 t -118.76 113.24 20.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -140.49 -50.17 0.46 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.864 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -70.08 115.6 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.0 m -68.68 -34.42 75.65 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 99.2 p -66.5 -31.44 72.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.883 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.73 61.83 1.83 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.569 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -122.22 129.09 51.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 110.909 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 61.8 116.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.935 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.595 HD21 ' OD1' ' A' ' 61' ' ' ASN . 2.2 tt -163.09 100.85 0.97 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.62 83.54 1.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.846 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.465 ' CB ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -151.73 157.91 42.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.994 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -146.44 131.81 18.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.796 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.597 ' OD1' HG22 ' A' ' 102' ' ' VAL . 2.5 t-20 -122.71 110.87 16.04 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.108 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.536 ' O ' HD22 ' A' ' 77' ' ' LEU . 4.2 mp -111.42 114.96 28.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.467 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.721 HD13 ' HA3' ' A' ' 100' ' ' GLY . 4.5 mm? -123.91 142.38 51.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 111.297 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.96 116.89 4.26 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.989 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.49 ' HA ' HG22 ' A' ' 98' ' ' THR . 0.1 OUTLIER -93.18 125.43 37.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.913 0.387 . . . . 0.0 111.413 -179.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.481 ' CD2' ' CD1' ' A' ' 55' ' ' TYR . 9.8 m-85 -127.09 110.94 13.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.068 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 1.6 p30 -150.26 172.18 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.102 0.477 . . . . 0.0 111.692 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.92 122.84 47.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.623 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -97.21 169.67 9.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.641 -179.349 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tp -147.93 124.44 5.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.551 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.09 110.45 2.2 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.405 2.07 . . . . 0.0 112.296 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.917 HD11 ' HB2' ' A' ' 93' ' ' LEU . 33.8 mt -99.89 97.82 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.654 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.09 74.81 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.77 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -148.05 -47.34 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.909 0.385 . . . . 0.0 110.63 179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -149.37 30.96 0.75 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.614 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 57.3 m-80 62.85 15.9 8.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.406 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.682 HG23 ' HB ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -74.65 151.18 39.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.561 179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.467 ' HG2' ' CD2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -130.51 93.59 3.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 111.052 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.917 ' HB2' HD11 ' A' ' 86' ' ' ILE . 0.3 OUTLIER -59.81 103.08 0.18 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.595 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 44.0 p90 -111.02 153.53 25.46 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.913 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.72 133.84 2.86 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.613 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.403 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -174.75 -136.54 2.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.75 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -128.01 179.98 5.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.789 0.328 . . . . 0.0 111.353 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.775 ' O ' HD12 ' A' ' 99' ' ' LEU . 48.7 p -146.73 157.09 43.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 98' ' ' THR . 0.6 OUTLIER -158.73 131.15 6.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.678 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.721 ' HA3' HD13 ' A' ' 77' ' ' LEU . . . -150.56 -154.04 6.34 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.948 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.578 ' N ' HD23 ' A' ' 101' ' ' LEU . 2.0 pt? -155.37 130.86 9.72 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.853 0.359 . . . . 0.0 110.301 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.597 HG22 ' OD1' ' A' ' 75' ' ' ASN . 21.1 t -109.6 122.1 63.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.322 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.48 138.12 53.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -134.73 132.33 38.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.9 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -136.66 164.27 28.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.906 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -138.3 169.3 18.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -158.22 150.16 21.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.898 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 141.03 -152.61 23.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 106.71 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 111.45 88.83 1.85 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.531 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -76.11 122.91 24.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.901 0.381 . . . . 0.0 110.832 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.84 139.51 21.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.961 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.17 82.45 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.16 106.06 18.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.833 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.4 t -150.86 124.75 9.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -144.74 85.1 1.75 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.0 m -84.56 118.08 31.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.189 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.45 168.53 13.04 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.411 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -105.83 116.25 31.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.843 0.354 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -96.54 148.38 22.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.115 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.03 141.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.963 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.68 -140.31 2.86 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.477 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 97' ' ' ALA . 22.5 mt -141.02 174.33 10.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.905 0.383 . . . . 0.0 110.74 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.437 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -164.2 153.3 13.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.757 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.851 ' HB3' ' CZ ' ' A' ' 141' ' ' TYR . . . 177.2 142.5 0.08 Allowed 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 120.939 0.4 . . . . 0.0 110.633 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.544 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -172.37 -126.65 0.91 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.873 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.544 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.3 pp -160.09 120.76 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-O 120.747 0.308 . . . . 0.0 110.236 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.699 HD12 ' HG3' ' A' ' 138' ' ' GLU . 6.3 tt -94.48 110.71 22.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.054 0.454 . . . . 0.0 110.428 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.438 ' HB3' HD11 ' A' ' 137' ' ' ILE . 0.2 OUTLIER -91.62 161.12 15.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.058 -179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -120.81 146.73 46.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 19.6 mt -109.73 -30.37 7.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.743 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.62 -165.0 1.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.424 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.49 50.04 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.813 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.71 -33.15 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.246 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.406 ' HB2' ' CZ ' ' A' ' 177' ' ' TYR . . . -104.22 146.71 28.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.825 0.345 . . . . 0.0 111.241 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 5.0 m -151.74 -176.81 5.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.035 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' A' ' 175' ' ' ALA . 11.8 pt -148.56 150.79 13.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.642 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.699 ' HG3' HD12 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -134.87 127.63 31.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.787 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.459 ' CA ' ' HA ' ' A' ' 173' ' ' LEU . . . -151.84 158.34 27.72 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.583 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 171' ' ' PHE . . . 161.09 -120.71 0.97 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.657 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.851 ' CZ ' ' HB3' ' A' ' 125' ' ' ALA . 50.6 p90 -139.6 152.9 47.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.856 0.36 . . . . 0.0 110.814 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.11 145.3 45.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.215 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.721 ' O ' HD22 ' A' ' 144' ' ' LEU . 8.1 m-85 -121.48 145.74 47.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.348 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.721 HD22 ' O ' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -149.64 147.19 27.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.031 0.443 . . . . 0.0 111.258 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -135.61 155.58 50.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.48 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 p -108.89 123.76 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.108 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -141.14 114.85 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.823 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.99 -33.57 7.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.066 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 71.7 m -159.02 -75.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 59.31 101.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.035 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -173.47 -44.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.929 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 8.9 mtt -64.88 95.82 0.17 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.873 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 80.8 p -117.22 97.6 50.95 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.02 -61.69 0.53 Allowed 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.479 2.119 . . . . 0.0 112.411 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -178.06 38.13 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.901 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 87.03 -141.91 17.96 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.455 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 170.74 178.82 41.64 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.46 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -78.98 110.88 14.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.841 0.353 . . . . 0.0 110.899 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mttt -76.2 -25.42 55.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.024 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 mt 69.51 -66.84 0.24 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.953 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -166.63 -135.92 1.94 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.574 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.2 p -68.01 127.41 32.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.829 0.347 . . . . 0.0 110.943 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.1 tp -148.1 105.89 3.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -113.84 108.34 16.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -156.35 84.7 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.857 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.05 -49.27 0.74 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.81 148.64 40.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.416 ' O ' ' CD1' ' A' ' 143' ' ' TYR . 67.1 m -109.66 147.22 33.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.87 141.04 38.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.841 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -154.3 155.14 34.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.06 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 140' ' ' GLY . 14.8 m-85 -119.68 130.88 55.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.261 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.449 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 34.5 p90 -133.23 173.9 10.95 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.712 0.768 . . . . 0.0 111.725 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.459 ' HA ' ' CA ' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -163.76 134.31 4.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.847 179.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -154.56 -165.61 14.15 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.0 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.532 ' HA ' HG22 ' A' ' 137' ' ' ILE . . . -107.73 169.73 8.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.341 . . . . 0.0 110.985 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -158.0 117.44 3.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.941 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.406 ' CZ ' ' HB2' ' A' ' 135' ' ' ALA . 0.2 OUTLIER -117.87 118.4 31.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.9 OUTLIER -89.02 160.22 17.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.023 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.3 t80 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.828 -179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.9 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.676 0.274 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 49' ' ' GLN . 0.1 OUTLIER -132.05 163.1 29.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.858 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -112.51 141.98 45.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.678 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 28.2 p90 -146.43 167.23 24.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 111.23 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.539 HG12 ' CB ' ' A' ' 46' ' ' ALA . 35.5 m -156.33 144.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.475 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.68 -142.67 3.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mt -120.95 153.51 37.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.751 0.31 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -122.15 113.53 19.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.979 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -119.78 112.94 19.88 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.813 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.04 115.25 3.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.542 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.73 120.03 35.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.789 0.328 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 13' ' ' THR . 3.9 t -92.85 103.58 15.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.7 m -150.12 102.76 3.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -93.59 76.01 4.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.91 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -86.9 118.93 26.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 17' ' ' ILE . 2.0 tp -72.75 65.01 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.022 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.77 -173.87 0.14 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.879 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.03 -178.53 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 m -139.09 125.43 20.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.882 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -88.58 159.13 18.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.3 m -147.28 143.9 28.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.883 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mt -116.81 31.14 6.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.937 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -74.72 -167.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.814 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.14 42.73 1.09 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -177.23 158.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.859 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.1 mt -144.03 -51.76 0.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -95.63 79.19 3.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -160.64 137.59 6.63 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.846 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.41 158.28 7.83 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.537 2.158 . . . . 0.0 112.317 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -133.06 149.32 52.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.876 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 tp -111.03 49.49 0.87 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.817 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -110.59 78.55 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.479 ' O ' HG12 ' A' ' 35' ' ' VAL . 0.1 OUTLIER -142.67 -49.31 0.35 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.83 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 35' ' ' VAL . 12.3 p 44.38 29.59 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.763 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 mm 62.43 143.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.159 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -161.82 118.08 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.947 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -133.24 129.18 37.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.953 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.3 t -178.17 150.71 0.6 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 152.27 -136.71 5.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.485 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.33 144.25 48.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.878 0.37 . . . . 0.0 111.01 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -136.84 105.51 5.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.752 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.44 -164.83 10.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.513 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 45' ' ' ARG . 3.9 mt -106.69 158.95 6.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.695 0.283 . . . . 0.0 110.898 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.483 ' N ' HG22 ' A' ' 44' ' ' ILE . 7.7 ttm180 -121.99 131.92 54.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.001 0.429 . . . . 0.0 110.523 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.843 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -163.75 117.82 1.53 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.779 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.97 -143.56 3.8 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.621 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 4.8 mt-30 -153.66 126.09 8.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.955 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' N ' ' O ' ' A' ' 3' ' ' ASP . 19.9 pt20 -95.09 109.54 21.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.122 0.487 . . . . 0.0 111.184 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.9 ' CE2' ' HB2' ' A' ' 2' ' ' ALA . 1.7 t80 -98.82 159.43 14.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.159 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -55.41 -28.1 52.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.547 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -135.37 24.39 3.48 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.431 ' HA3' ' CE1' ' A' ' 80' ' ' TYR . . . -174.8 132.85 2.31 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.802 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.444 ' NH1' ' CE2' ' A' ' 5' ' ' PHE . 2.7 ttt-85 -116.56 131.96 56.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 0.0 111.14 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.93 139.04 31.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.396 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -130.37 100.13 5.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.918 0.389 . . . . 0.0 111.505 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -105.91 118.45 36.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.438 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.5 t -122.58 114.73 21.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.926 0.393 . . . . 0.0 111.224 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.454 ' CD2' ' CD2' ' A' ' 76' ' ' LEU . 4.0 t80 -89.39 111.16 21.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.53 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -140.75 -179.91 6.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.104 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.499 ' O ' HG23 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -149.97 -75.49 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.882 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.605 HD13 HG22 ' A' ' 65' ' ' THR . 1.8 pp -158.61 140.48 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.133 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 34.1 t -106.16 -32.48 8.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.884 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -115.39 134.23 55.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.605 HG22 HD13 ' A' ' 62' ' ' ILE . 30.6 p -121.93 31.71 6.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 m -69.53 -31.38 69.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.26 -36.0 76.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.955 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.58 -134.12 2.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.447 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -113.62 132.94 55.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.816 0.341 . . . . 0.0 110.916 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.0 mttt -154.78 158.81 40.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.802 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp -170.77 -66.49 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.841 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.54 92.4 1.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.736 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.41 ' OE1' HD11 ' A' ' 104' ' ' LEU . 12.2 tt0 -153.15 144.67 23.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -138.41 125.15 20.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.91 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -127.91 110.96 13.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.454 ' CD2' ' CD2' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -105.64 116.84 32.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.651 179.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.445 HD21 HD21 ' A' ' 144' ' ' LEU . 0.8 OUTLIER -108.44 122.65 47.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.184 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -120.59 120.73 4.61 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.89 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.404 ' CB ' ' HA ' ' A' ' 98' ' ' THR . 96.5 p -129.33 145.09 51.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.014 0.435 . . . . 0.0 111.558 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.431 ' CE1' ' HA3' ' A' ' 53' ' ' GLY . 11.2 t80 -116.56 110.87 19.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.184 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.405 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 31.1 m-20 -126.17 163.91 22.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.383 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -110.27 118.28 35.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.424 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 34.5 p90 -97.86 160.22 14.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.608 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 tp -165.85 124.69 1.14 Allowed Pre-proline 0 CA--C 1.531 0.234 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.803 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 91' ' ' THR . 50.6 Cg_exo -55.55 108.34 0.31 Allowed 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 122.458 2.106 . . . . 0.0 112.241 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.41 ' O ' HG23 ' A' ' 86' ' ' ILE . 9.1 tp -157.07 127.23 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.153 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.7 -96.71 0.41 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.809 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.39 -74.39 0.35 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.804 0.335 . . . . 0.0 111.016 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -173.15 -39.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 5.0 m120 -116.22 15.1 15.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.537 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 2.6 t -79.64 153.22 29.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.529 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 7.1 mmtp -130.27 91.96 3.2 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.333 -0.547 . . . . 0.0 111.046 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 1.1 tt -67.79 102.81 1.29 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.886 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 82' ' ' ALA . 41.5 p90 -110.59 150.85 28.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.71 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.405 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -168.38 132.15 2.5 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.802 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.85 -144.82 4.92 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.605 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.02 158.42 17.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.404 ' HA ' ' CB ' ' A' ' 79' ' ' SER . 9.8 t -130.66 150.54 51.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.004 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 4.1 tt -160.07 127.01 4.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.729 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 120' ' ' ALA . . . -130.35 -156.97 8.84 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.612 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.64 124.83 6.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.778 0.323 . . . . 0.0 110.737 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.5 t -109.88 125.47 67.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.993 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 117' ' ' VAL . 17.6 mttt -140.12 144.98 37.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.41 HD11 ' OE1' ' A' ' 73' ' ' GLN . 0.0 OUTLIER -121.26 158.35 28.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.13 127.84 43.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.13 159.41 19.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -162.84 133.26 4.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.935 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 159.49 -88.16 0.11 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.466 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -179.83 -37.05 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.773 0.32 . . . . 0.0 110.889 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -54.53 -100.34 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.661 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -92.5 136.18 33.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.58 174.07 11.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.784 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 60.49 -175.27 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.9 t0 70.38 -64.68 0.36 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 6.4 p 62.88 150.37 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.84 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -95.92 65.01 2.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.983 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.501 HG12 ' HG2' ' A' ' 103' ' ' LYS . 8.5 m -88.31 153.69 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.077 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.0 -167.7 19.29 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.484 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -135.52 134.81 39.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 110.871 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 100' ' ' GLY . . . -106.71 142.81 35.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.075 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -157.78 134.3 9.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.123 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -174.38 -138.98 2.84 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.627 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.1 pp -155.46 160.95 41.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.768 0.318 . . . . 0.0 110.875 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 6.0 pt20 -156.42 177.64 11.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.157 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 94' ' ' PHE . . . 176.84 142.53 0.08 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.46 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -155.23 -140.56 3.03 Favored Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.005 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.529 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 3.5 pt -159.43 120.01 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-O 120.693 0.282 . . . . 0.0 110.262 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 176' ' ' ASN . 0.4 OUTLIER -95.79 109.28 21.62 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.728 179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 3.0 mt-30 -101.08 141.64 33.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.006 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -116.98 149.21 40.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.769 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.1 pp -110.18 -39.67 4.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.016 0.436 . . . . 0.0 110.776 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -169.2 -164.87 0.48 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.368 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.8 mmtt -84.88 52.98 2.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.791 0.329 . . . . 0.0 110.603 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.407 ' O ' ' CE1' ' A' ' 177' ' ' TYR . 0.5 OUTLIER -133.06 -55.34 0.92 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.037 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.05 150.15 7.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.156 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.582 ' OG ' HD22 ' A' ' 128' ' ' LEU . 6.4 t -106.89 169.66 8.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.785 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.463 ' O ' HD23 ' A' ' 128' ' ' LEU . 11.5 tt -132.7 134.7 58.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.661 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -117.61 152.32 35.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.984 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -161.79 118.09 0.8 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.29 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.68 -151.68 6.38 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.302 -0.951 . . . . 0.0 112.914 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -131.27 161.13 32.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 110.81 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.551 ' HD3' HD23 ' A' ' 144' ' ' LEU . 9.4 ttm180 -146.87 136.71 23.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.983 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.423 ' CD2' ' HA ' ' A' ' 169' ' ' SER . 11.5 m-85 -145.03 127.48 15.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.838 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.551 HD23 ' HD3' ' A' ' 142' ' ' ARG . 4.3 pp -156.2 162.47 40.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.001 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -103.19 157.72 16.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.9 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.8 m -109.0 129.13 55.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.838 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -128.8 151.15 49.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -131.49 -46.16 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.012 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.1 m -128.66 -175.78 3.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.871 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -141.39 -66.23 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.927 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -79.34 89.91 4.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.938 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.0 -47.17 86.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 25.6 p -116.22 144.86 33.76 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.19 -43.72 0.68 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.468 2.112 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -116.47 159.25 22.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.37 -28.5 12.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.6 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 100.93 -163.51 18.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.584 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.34 131.24 56.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -127.11 -70.69 0.7 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.875 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.59 90.73 5.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 167.92 41.99 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.463 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 8.1 t -163.45 164.11 24.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.816 0.341 . . . . 0.0 110.894 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 68.03 -70.28 0.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -66.24 77.62 0.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 mt -109.92 -35.01 6.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.859 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 61.22 154.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.875 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.81 154.12 46.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.902 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.0 168.37 10.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.846 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.423 ' HA ' ' CD2' ' A' ' 143' ' ' TYR . 15.7 m -106.87 122.98 47.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.772 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.64 155.15 46.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.742 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -111.71 164.1 13.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.121 0.486 . . . . 0.0 110.161 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.422 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -132.59 126.88 33.79 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.771 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.56 129.96 3.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.563 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.89 -152.94 15.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.831 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -126.95 172.09 10.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.823 0.344 . . . . 0.0 111.114 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.586 ' HB2' HD21 ' A' ' 128' ' ' LEU . 23.8 m-20 -155.59 119.18 4.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.407 ' CE1' ' O ' ' A' ' 134' ' ' ASN . 13.9 t80 -120.31 115.87 24.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.081 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.39 145.93 30.56 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.013 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 9.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.023 -179.801 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.842 0.353 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 49' ' ' GLN . 2.0 t0 -163.06 138.92 6.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 1.8 t30 -80.69 156.59 26.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.561 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.9 OUTLIER -156.12 164.56 38.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.19 0.519 . . . . 0.0 111.592 179.873 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' A' ' 46' ' ' ALA . 27.4 m -158.02 128.22 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.953 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 176' ' ' ASN . . . -150.73 -146.87 4.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.596 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.38 136.9 25.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.779 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.776 HG22 ' OE2' ' A' ' 138' ' ' GLU . 35.6 p -100.58 151.2 21.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 t90 -148.69 128.69 13.53 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.98 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.38 138.24 13.81 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.43 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 109.97 17.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.82 0.343 . . . . 0.0 110.88 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.8 p -110.26 147.05 34.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.821 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.11 102.89 3.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.9 m-20 62.35 94.66 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.891 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -92.52 150.14 20.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.926 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 21.0 pt -139.19 31.09 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -105.61 -57.65 2.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.75 151.34 31.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 m 60.54 110.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.84 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.3 tttp -121.87 -54.89 1.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.1 m 61.15 155.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.3 156.86 40.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.411 ' OD1' HD13 ' A' ' 27' ' ' LEU . 1.3 m-80 -115.01 -177.23 3.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.823 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.71 -45.42 1.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.854 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -131.9 -69.69 0.6 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.411 HD13 ' OD1' ' A' ' 24' ' ' ASN . 12.4 tp 61.05 101.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.844 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -111.9 46.62 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.865 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.7 m -131.85 95.9 21.6 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.846 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.01 -41.8 7.04 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.435 2.09 . . . . 0.0 112.356 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -84.06 58.22 4.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.44 -48.9 0.18 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.83 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -146.3 87.27 1.72 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.935 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -74.97 -73.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.461 HG23 ' N ' ' A' ' 36' ' ' ILE . 15.1 m -134.27 -46.67 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.152 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.461 ' N ' HG23 ' A' ' 35' ' ' VAL . 5.0 mt -121.98 103.25 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.023 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -126.76 -63.24 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -116.73 30.92 7.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 39' ' ' THR . 9.6 t -118.71 117.94 30.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.78 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 133.75 138.86 4.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.362 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -94.99 110.08 22.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.823 0.344 . . . . 0.0 110.959 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.87 -178.96 6.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.567 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.602 ' HA2' ' HB2' ' A' ' 60' ' ' GLU . . . -178.17 158.17 22.78 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.081 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.793 HD12 ' CE2' ' A' ' 59' ' ' TYR . 25.7 mt -106.44 124.82 62.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.18 133.89 49.19 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 121.392 0.615 . . . . 0.0 111.084 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -163.34 111.11 1.21 Allowed 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.448 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.45 -163.04 12.36 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 119.959 -1.115 . . . . 0.0 113.188 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -126.41 142.63 51.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.024 0.44 . . . . 0.0 111.298 -179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' ' 54' ' ' ARG . 0.7 OUTLIER -97.02 162.15 13.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.473 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -125.52 -169.38 1.99 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.977 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -32.51 73.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.509 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -127.33 -34.7 2.26 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -119.04 -166.05 13.33 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.702 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.452 ' HB3' ' HG2' ' A' ' 49' ' ' GLN . 44.9 ptt85 -162.96 158.54 22.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.089 0.471 . . . . 0.0 111.791 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.409 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 12.2 m-85 -118.84 144.26 46.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.846 179.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -159.12 119.09 3.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.963 0.411 . . . . 0.0 111.181 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.79 140.33 29.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.817 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 7.1 t -126.18 116.15 20.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.668 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.793 ' CE2' HD12 ' A' ' 44' ' ' ILE . 40.1 p90 -130.11 126.7 38.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.918 0.39 . . . . 0.0 111.763 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.602 ' HB2' ' HA2' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -158.36 -179.91 8.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.948 179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -93.26 -166.22 1.48 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.397 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 62' ' ' ILE . 9.0 tp -137.38 121.53 22.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 0.0 111.196 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 65.2 m 57.72 91.79 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.999 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -163.84 177.24 8.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.3 p -107.83 -177.65 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.6 t -89.8 -42.44 11.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.05 27.07 5.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.991 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -93.46 -151.79 28.47 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.493 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -146.01 141.71 27.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.778 0.323 . . . . 0.0 110.901 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 14.6 mttp -70.99 168.59 16.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.888 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.3 -67.71 0.73 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.958 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -176.7 37.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.959 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -134.89 142.68 46.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.991 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.49 159.91 10.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.842 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.72 ' HB2' HG12 ' A' ' 102' ' ' VAL . 8.0 p30 -146.0 119.44 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.106 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.29 145.12 50.9 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.642 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.402 ' CB ' ' HA3' ' A' ' 100' ' ' GLY . 0.9 OUTLIER -158.06 157.98 33.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.935 0.398 . . . . 0.0 111.342 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.97 116.79 4.23 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.054 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.625 ' CB ' HG22 ' A' ' 98' ' ' THR . 23.3 t -98.78 133.69 42.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.97 0.414 . . . . 0.0 111.37 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.755 ' CZ ' ' HB3' ' A' ' 97' ' ' ALA . 12.7 p90 -134.13 112.06 10.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.185 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 6.1 p30 -139.16 172.14 13.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.188 0.518 . . . . 0.0 111.558 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.554 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -112.22 118.72 36.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.839 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 20.3 p90 -99.74 166.42 11.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.257 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 tt -167.83 134.79 1.79 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.768 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -52.11 118.48 4.6 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.463 2.109 . . . . 0.0 112.345 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.616 ' O ' HG23 ' A' ' 86' ' ' ILE . 1.1 tt -121.24 105.45 16.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.057 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.9 -96.43 0.74 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -147.59 51.67 1.05 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.896 0.379 . . . . 0.0 110.827 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.0 m120 60.27 29.44 19.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -108.13 -24.03 11.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.452 HG22 HD12 ' A' ' 127' ' ' ILE . 3.3 p -136.29 151.89 50.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.547 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 5.4 mptt -122.81 92.42 3.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.906 0.384 . . . . 0.0 110.924 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.9 tp -62.23 102.83 0.33 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.706 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 30.2 p90 -112.76 156.03 23.55 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.781 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.03 128.65 1.5 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.654 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.403 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -163.99 -132.75 1.38 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.65 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.755 ' HB3' ' CZ ' ' A' ' 80' ' ' TYR . . . -133.25 165.95 23.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.773 0.321 . . . . 0.0 111.235 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.625 HG22 ' CB ' ' A' ' 79' ' ' SER . 2.7 p -136.65 154.94 50.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.89 130.67 5.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.023 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 77' ' ' LEU . . . -161.92 -152.76 6.82 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.679 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.5 mp -148.25 122.26 9.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.839 0.352 . . . . 0.0 110.648 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.72 HG12 ' HB2' ' A' ' 75' ' ' ASN . 31.4 m -109.82 130.25 63.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.231 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -114.55 134.93 54.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.3 mt -131.74 142.66 49.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -109.39 147.92 31.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.858 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -119.24 151.74 37.87 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -171.49 35.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.899 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -154.42 73.46 0.25 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.499 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -63.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.83 0.347 . . . . 0.0 110.841 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.43 -74.49 0.35 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.429 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.08 162.47 24.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.825 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.8 mmtm -83.61 96.15 8.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.968 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -88.42 168.77 12.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.72 116.91 12.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.817 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.72 88.97 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -147.98 -68.66 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.2 p -163.64 137.21 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.098 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -137.88 170.5 23.72 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -84.31 132.68 34.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.777 0.323 . . . . 0.0 110.853 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.714 ' HB1' ' CD2' ' A' ' 144' ' ' LEU . . . -115.18 143.37 45.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -169.31 137.98 1.96 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.47 -137.86 2.36 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.491 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mp -146.59 157.07 43.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.928 0.394 . . . . 0.0 110.964 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.409 ' HG2' ' HA ' ' A' ' 142' ' ' ARG . 0.0 OUTLIER -141.13 161.87 36.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.594 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . 179.59 142.41 0.14 Allowed 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.48 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -169.5 -135.08 1.84 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.948 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 2.8 pt -158.04 120.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 120.801 0.334 . . . . 0.0 110.383 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -94.82 112.99 24.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.551 179.89 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 137' ' ' ILE . 4.0 tt0 -96.45 123.94 40.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.147 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -112.23 149.12 32.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.572 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 tp -105.87 -47.19 3.93 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.051 0.453 . . . . 0.0 110.542 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.8 m -165.72 -164.86 0.76 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 16.2 mttp -81.37 55.66 2.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -136.62 -59.13 0.72 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.99 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -154.89 151.36 28.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.101 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.758 ' O ' HD13 ' A' ' 137' ' ' ILE . 1.4 m -113.72 174.28 6.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.932 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.758 HD13 ' O ' ' A' ' 136' ' ' SER . 28.5 mm -134.17 134.9 55.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.776 ' OE2' HG22 ' A' ' 9' ' ' THR . 0.0 OUTLIER -112.96 141.52 46.7 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.897 -179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -163.07 121.41 1.02 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -174.85 -138.13 2.66 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.048 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.501 ' CE1' ' CE2' ' A' ' 171' ' ' PHE . 64.6 m-85 -132.76 161.09 34.98 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.756 0.312 . . . . 0.0 110.758 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.409 ' HA ' ' HG2' ' A' ' 124' ' ' GLN . 14.3 ptm180 -140.83 136.58 32.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.201 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -132.02 128.91 39.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.433 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.714 ' CD2' ' HB1' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -139.68 151.44 45.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.379 . . . . 0.0 111.154 -179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.596 HH21 HD22 ' A' ' 165' ' ' LEU . 26.5 ttt-85 -116.52 163.97 15.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.689 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.3 m -108.83 134.29 51.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.005 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -135.01 153.23 52.16 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -170.54 -50.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.04 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 61.02 91.5 0.06 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 p -107.74 -47.17 3.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.804 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -106.47 121.38 44.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.23 -43.18 8.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.94 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.52 139.61 31.71 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.27 145.66 30.81 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.468 2.112 . . . . 0.0 112.287 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -169.47 149.21 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 96.73 164.87 32.95 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.441 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -105.26 46.72 1.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.458 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.07 135.47 16.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.81 0.338 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 12.4 mmtp -114.61 150.18 35.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.6 -35.15 16.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.87 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 129.18 114.09 1.72 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.497 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.5 p -118.15 163.35 16.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.789 0.328 . . . . 0.0 110.972 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 59.59 20.81 9.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.094 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.3 t70 178.79 82.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.856 0.36 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.596 HD22 HH21 ' A' ' 145' ' ' ARG . 1.0 OUTLIER -111.14 151.2 28.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.955 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -79.96 175.27 10.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.889 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.45 173.22 11.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.84 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.95 119.72 37.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 8.9 t -106.96 106.18 16.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.52 155.24 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.501 ' CE2' ' CE1' ' A' ' 141' ' ' TYR . 0.2 OUTLIER -94.2 165.36 12.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.199 0.523 . . . . 0.0 110.195 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.412 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.2 OUTLIER -131.3 128.46 39.81 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.809 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.39 135.18 5.0 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.58 -142.74 6.96 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.774 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -142.88 171.99 13.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.828 0.347 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.41 ' HA ' ' HA3' ' A' ' 7' ' ' GLY . 7.8 t-20 -155.59 117.6 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -102.61 111.62 24.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.018 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.83 147.01 29.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.083 179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.925 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.805 0.336 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 1.5 t0 -113.48 168.18 9.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.583 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.18 125.51 39.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.644 0.259 . . . . 0.0 110.686 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.631 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 0.2 OUTLIER -134.68 139.95 45.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.968 0.413 . . . . 0.0 111.396 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 46' ' ' ALA . 37.9 t -150.2 131.03 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.982 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.36 -162.49 10.76 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.799 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 tt -118.24 142.7 47.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.771 0.32 . . . . 0.0 110.61 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.2 p -111.33 118.61 36.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.06 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 84.1 t90 -128.35 112.88 14.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.696 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -106.97 153.9 16.74 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.644 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -94.84 133.2 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.815 0.341 . . . . 0.0 110.91 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.26 108.58 20.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.971 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -150.07 102.84 3.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.853 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -93.62 125.31 38.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 -65.79 138.38 57.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 18' ' ' GLN . 1.7 pp -146.12 -46.81 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.175 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.504 ' N ' HD12 ' A' ' 17' ' ' ILE . 0.0 OUTLIER 55.68 89.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.039 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.5 tttm -140.94 116.12 9.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.017 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.7 m -124.97 83.64 2.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.976 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -96.64 97.8 9.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.0 m -102.1 82.74 2.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.918 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.94 -64.68 1.21 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -130.03 161.01 31.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.871 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.27 110.79 18.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.912 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -104.76 132.01 51.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.863 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.78 -71.02 0.68 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.866 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 61.22 83.25 0.15 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.3 p 62.17 148.64 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.042 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.24 -19.39 22.54 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.599 2.199 . . . . 0.0 112.529 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 63.02 89.12 0.09 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.928 0.394 . . . . 0.0 110.957 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -95.72 -39.88 9.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.89 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -71.44 -30.08 65.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.0 mtmt 62.37 105.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 m -61.69 -26.44 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.212 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.4 mt 67.39 138.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -103.68 -27.71 12.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.975 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.22 91.72 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 m -117.92 95.51 4.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 174.02 141.1 3.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.561 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.739 HG23 ' CG1' ' A' ' 62' ' ' ILE . 7.8 m -113.38 118.43 34.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.781 0.324 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -103.99 161.75 13.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.899 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.61 -169.36 35.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.605 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 45' ' ' ARG . 2.7 mp -134.9 160.0 41.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.765 0.317 . . . . 0.0 111.026 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.602 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -138.07 139.32 39.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.95 0.405 . . . . 0.0 110.593 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.696 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -171.57 120.91 0.49 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.842 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 56' ' ' TYR . . . -167.73 -141.73 3.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.832 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 15.5 pt20 -122.3 142.18 50.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.705 0.288 . . . . 0.0 110.785 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.418 ' CG ' ' HG3' ' A' ' 54' ' ' ARG . 0.8 OUTLIER -116.81 109.68 17.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.035 0.445 . . . . 0.0 111.089 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -130.57 165.01 23.66 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.509 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -19.2 65.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.36 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.63 24.09 12.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.31 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.411 ' HA3' ' CZ ' ' A' ' 80' ' ' TYR . . . 155.98 142.56 3.45 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.526 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.648 ' NH2' HD22 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -136.71 162.09 34.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.771 0.319 . . . . 0.0 110.946 -179.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.466 ' CE1' ' CD ' ' A' ' 54' ' ' ARG . 8.9 m-85 77.05 -175.81 0.1 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.416 ' CB ' ' HA3' ' A' ' 47' ' ' GLY . 3.4 t80 178.65 -43.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.902 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -122.43 136.96 55.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 111.396 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.13 119.69 12.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.565 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -113.55 149.98 33.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.01 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.34 155.91 44.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.856 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -166.8 124.92 1.35 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.985 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.739 ' CG1' HG23 ' A' ' 41' ' ' THR . 3.5 mt -126.91 134.85 65.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.129 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.82 -67.99 0.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.852 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.3 -74.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.979 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 t -69.55 147.11 51.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.2 m -86.03 -24.57 26.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -95.71 26.93 3.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.119 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.7 91.31 0.11 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.476 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -119.01 138.07 53.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 110.943 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.91 27.68 16.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.981 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.8 tp -177.84 85.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.94 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.528 ' NH2' HD21 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -170.1 -42.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.894 -179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -142.2 124.87 15.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.992 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -118.75 130.5 55.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.689 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -128.74 119.37 24.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.125 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mp -128.43 114.93 17.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.324 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.487 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.5 OUTLIER -142.93 168.87 18.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.011 0.434 . . . . 0.0 111.399 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.97 116.74 4.21 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.903 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 56' ' ' TYR . 3.5 m -104.67 126.59 51.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.971 0.415 . . . . 0.0 111.484 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' CZ ' ' HA3' ' A' ' 53' ' ' GLY . 63.4 t80 -136.57 110.89 8.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.198 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -129.21 171.87 12.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.029 0.442 . . . . 0.0 111.651 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.81 119.76 35.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.565 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 50.3 p90 -97.76 172.17 7.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.098 0.475 . . . . 0.0 111.809 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 tp -165.09 135.45 3.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.391 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.54 119.26 4.89 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.548 2.165 . . . . 0.0 112.203 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.597 ' O ' HG23 ' A' ' 86' ' ' ILE . 8.9 tt -128.13 108.74 18.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.166 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.2 -57.57 0.57 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.525 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -166.57 -59.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.754 0.311 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 176.74 38.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.793 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -129.77 -68.01 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.733 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.571 HG23 ' HG2' ' A' ' 129' ' ' GLN . 0.5 OUTLIER -67.86 145.09 54.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.348 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 3.6 mmpt? -126.63 92.32 3.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.9 0.381 . . . . 0.0 111.272 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.585 HD13 HD13 ' A' ' 86' ' ' ILE . 1.8 tp -60.54 103.25 0.23 Allowed 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.051 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 16.6 p90 -110.73 161.76 15.44 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.292 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -179.44 126.57 1.05 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.559 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -161.06 -134.38 1.64 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.621 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -141.06 157.81 44.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.883 0.373 . . . . 0.0 111.324 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.6 t -134.79 161.86 33.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.732 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -160.29 132.76 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.009 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -158.68 -144.69 4.02 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.986 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.21 130.09 9.35 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.83 0.347 . . . . 0.0 110.388 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 21.7 t -109.63 132.84 56.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.178 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.12 130.22 52.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.816 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.528 HD21 ' NH2' ' A' ' 72' ' ' ARG . 6.8 tp -114.5 136.14 53.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.906 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -161.17 136.34 7.61 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -137.17 129.81 30.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.39 110.61 2.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.872 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -152.34 157.5 27.3 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.441 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.6 tmtm? -114.98 89.86 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.827 0.346 . . . . 0.0 110.906 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 155.93 -65.19 0.32 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -90.16 171.76 9.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.756 0.312 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -140.87 159.06 43.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.927 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.14 170.01 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.163 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 27.0 p30 -135.19 27.65 3.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 3.3 p -167.75 -78.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.851 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.639 ' O ' HG13 ' A' ' 117' ' ' VAL . 1.0 OUTLIER 79.89 -8.73 1.51 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.777 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 116' ' ' ASP . 2.8 m -162.77 117.87 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-O 120.762 0.315 . . . . 0.0 110.993 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -136.51 131.61 5.73 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.546 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -84.17 117.73 23.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.349 . . . . 0.0 110.803 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.678 ' HB2' HG22 ' A' ' 146' ' ' THR . . . -109.86 145.13 37.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 141.32 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.954 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.01 -137.08 2.19 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.541 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 97' ' ' ALA . 3.8 mp -145.2 153.31 41.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 111.195 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.1 OUTLIER -133.71 172.55 12.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.622 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.89 142.49 0.08 Allowed 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.054 0.454 . . . . 0.0 110.69 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.597 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -169.41 -134.33 1.72 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.721 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 126' ' ' GLY . 10.8 pt -161.22 120.48 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-O 120.744 0.307 . . . . 0.0 110.318 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.648 HD22 ' NH2' ' A' ' 54' ' ' ARG . 1.8 tt -95.88 113.32 24.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.97 0.414 . . . . 0.0 111.201 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.571 ' HG2' HG23 ' A' ' 91' ' ' THR . 30.7 mt-30 -100.31 139.27 36.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.756 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -93.34 149.15 21.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.002 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.41 -43.89 2.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.017 0.437 . . . . 0.0 110.584 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.3 m -142.2 -164.72 1.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.361 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.41 28.8 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.162 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 177.84 34.73 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.773 0.32 . . . . 0.0 111.132 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.23 129.09 1.97 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.815 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 4.1 m -142.97 169.71 17.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.004 0.431 . . . . 0.0 111.29 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.402 ' CG2' ' HB2' ' A' ' 129' ' ' GLN . 0.6 OUTLIER -132.52 134.78 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.247 179.728 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -128.18 149.19 50.55 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.925 0.393 . . . . 0.0 111.162 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.647 ' HA3' HD22 ' A' ' 173' ' ' LEU . . . -165.8 152.8 22.33 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.378 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 172.13 -131.72 2.22 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.698 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -135.82 152.56 51.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.762 0.315 . . . . 0.0 110.793 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -140.36 123.75 16.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.428 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 3.2 m-85 -116.98 124.28 48.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 pp -150.0 171.39 16.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.887 0.375 . . . . 0.0 111.182 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 3.1 ttt85 -152.39 144.32 23.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.765 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.678 HG22 ' HB2' ' A' ' 120' ' ' ALA . 82.5 p -108.99 128.88 55.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.922 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.93 115.62 9.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -104.04 -176.58 3.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.079 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 77.6 p -99.2 175.25 5.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.9 t -61.93 172.11 1.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.992 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.94 -31.38 7.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 12.4 ptt? -172.74 -47.46 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.943 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.5 p -126.82 148.59 65.86 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.995 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.95 152.95 63.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.294 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -174.36 -42.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.847 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -80.92 97.86 1.79 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.515 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -139.46 117.51 1.37 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.465 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -138.93 133.04 31.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.804 0.335 . . . . 0.0 110.891 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -105.21 164.96 11.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.9 92.99 1.3 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.854 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -116.21 32.54 5.55 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.496 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 81.2 p -147.51 167.88 23.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.892 0.377 . . . . 0.0 110.845 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.1 mt -101.99 31.59 3.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -131.13 122.07 26.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.88 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.5 tp -61.55 158.13 15.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.932 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 -96.71 92.88 6.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.3 m -140.89 152.47 45.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.838 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.408 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 10.6 t -107.4 150.85 26.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.953 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -106.83 140.65 39.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.746 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -155.35 155.28 33.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.081 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -109.58 141.57 41.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.095 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -119.84 127.51 52.81 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.989 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.647 HD22 ' HA3' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -163.45 129.87 3.28 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.465 179.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 178.76 -156.94 20.1 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.658 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.25 171.98 8.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.84 0.352 . . . . 0.0 111.159 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.451 ' ND2' ' CD1' ' A' ' 5' ' ' PHE . 2.0 t30 -150.8 114.96 5.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -115.38 122.17 45.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.162 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.93 162.91 22.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.224 -179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.942 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.888 0.375 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.4 OUTLIER -97.29 168.47 10.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.667 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -108.82 118.53 37.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.785 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.512 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 1.7 m-85 -124.02 145.11 49.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.003 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.486 HG13 ' O ' ' A' ' 5' ' ' PHE . 13.3 m -158.15 125.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.181 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -160.02 -149.06 5.44 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.64 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 mp -125.1 159.66 30.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.825 0.345 . . . . 0.0 110.819 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.61 127.72 35.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.426 ' CD1' ' CE3' ' A' ' 42' ' ' TRP . 36.9 t90 -128.33 112.99 15.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.687 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.83 168.58 13.99 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -110.48 130.61 55.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 0.0 110.868 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.502 ' O ' HG23 ' A' ' 13' ' ' THR . 9.8 t -102.21 113.82 27.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.973 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.08 102.88 3.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.746 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -105.36 101.64 11.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.829 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -92.27 134.38 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.855 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 pp -138.28 173.94 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.65 108.78 1.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.4 mmtp -131.34 -46.57 0.99 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.7 t -82.53 161.46 22.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.53 132.46 10.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.1 t 61.48 30.5 18.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 mp -117.38 -39.55 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -140.67 -177.97 5.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.822 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -166.3 163.74 17.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -99.77 34.8 2.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.31 73.94 1.43 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.888 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -176.67 -66.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 p -148.25 95.08 4.14 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -50.14 98.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.469 2.113 . . . . 0.0 112.313 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -92.89 -73.19 0.57 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.92 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 64.77 -78.64 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.926 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.37 97.44 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.815 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -128.04 -71.1 0.67 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 36' ' ' ILE . 10.5 p -176.21 -41.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.08 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.781 HD11 ' OG1' ' A' ' 39' ' ' THR . 1.7 pt -156.76 27.77 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.257 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 57.82 64.49 1.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m120 60.71 156.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.781 ' OG1' HD11 ' A' ' 36' ' ' ILE . 0.9 OUTLIER -134.31 -67.41 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.879 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.407 ' HA2' HG22 ' A' ' 13' ' ' THR . . . 129.38 -161.77 22.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.439 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.602 HG21 ' OE1' ' A' ' 170' ' ' GLN . 33.8 m -137.16 107.86 6.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.943 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.426 ' CE3' ' CD1' ' A' ' 10' ' ' TRP . 0.2 OUTLIER -120.35 146.55 46.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.822 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -169.27 -164.83 25.65 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.512 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.649 HD12 ' HB3' ' A' ' 59' ' ' TYR . 3.0 mp -107.0 161.16 6.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.765 0.317 . . . . 0.0 110.95 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.684 HH11 HG23 ' A' ' 58' ' ' THR . 0.0 OUTLIER -130.8 137.17 49.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.996 0.427 . . . . 0.0 110.693 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -174.16 122.51 0.3 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.825 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.64 -145.47 4.14 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.656 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.506 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -146.45 126.1 13.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.805 0.336 . . . . 0.0 111.009 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -94.13 109.6 21.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.096 0.474 . . . . 0.0 111.278 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 2' ' ' ALA . 0.2 OUTLIER -105.09 155.2 19.22 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.474 179.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.38 -18.6 65.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.384 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -130.68 24.26 5.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.769 0.318 . . . . 0.0 111.172 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 168.72 163.62 23.03 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.931 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -145.0 141.04 28.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.93 0.395 . . . . 0.0 111.532 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.35 146.61 26.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.035 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CD1' ' NE ' ' A' ' 45' ' ' ARG . 6.7 m-85 -143.87 96.9 2.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.901 0.381 . . . . 0.0 111.683 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.657 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -90.87 139.25 30.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.099 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.684 HG23 HH11 ' A' ' 45' ' ' ARG . 0.2 OUTLIER -139.75 124.93 18.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.067 0.461 . . . . 0.0 111.714 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.649 ' HB3' HD12 ' A' ' 44' ' ' ILE . 3.3 t80 -101.5 104.67 15.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.846 179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.95 153.63 19.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.086 0.47 . . . . 0.0 111.489 -179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.99 -164.78 1.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.461 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.491 HG23 ' CB ' ' A' ' 73' ' ' GLN . 1.2 pt -109.34 108.92 26.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.148 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.6 m 58.94 -84.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.067 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -179.65 -176.93 0.39 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.9 t -101.31 33.85 2.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.911 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.0 t -90.93 -11.45 39.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.393 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t -96.08 27.02 3.83 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.717 0.294 . . . . 0.0 111.131 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 57.41 -142.87 42.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.606 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.56 121.68 41.54 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.783 0.325 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.2 tttt -176.7 -39.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.928 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mt -137.1 146.67 45.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.92 123.75 6.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.803 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.491 ' CB ' HG23 ' A' ' 62' ' ' ILE . 0.8 OUTLIER -131.54 155.09 48.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -140.81 121.06 13.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.461 ' CG ' HG23 ' A' ' 102' ' ' VAL . 1.5 m-20 -124.89 111.06 15.03 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.002 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.416 ' HB3' ' CE1' ' A' ' 59' ' ' TYR . 0.4 OUTLIER -118.96 116.95 27.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.654 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.4 ' CB ' ' HA3' ' A' ' 100' ' ' GLY . 3.9 pp -135.38 146.3 48.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.983 0.421 . . . . 0.0 111.405 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.18 116.9 4.23 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.956 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 56.4 p -105.9 119.95 40.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.882 0.372 . . . . 0.0 111.629 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -98.45 110.88 23.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.963 179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.419 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 1.7 m-20 -128.08 161.11 29.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.147 0.499 . . . . 0.0 111.842 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -107.85 119.12 38.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.221 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.576 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 35.1 p90 -97.32 158.11 15.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.994 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.518 ' O ' HG22 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -165.33 125.98 1.33 Allowed Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.733 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 91' ' ' THR . 52.7 Cg_exo -52.99 100.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.614 2.209 . . . . 0.0 112.229 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.518 HG22 ' O ' ' A' ' 84' ' ' LEU . 18.8 tt -157.28 127.1 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.113 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.0 -83.25 0.2 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.786 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -109.95 -63.13 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.803 0.335 . . . . 0.0 110.991 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -169.44 -40.76 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.986 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 18.4 m120 -121.86 17.98 11.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.539 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 85' ' ' PRO . 7.6 p -79.47 153.29 29.72 Favored 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -130.73 92.1 3.18 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.999 -179.63 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.576 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -64.26 102.06 0.48 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.771 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 46.3 p90 -111.92 120.94 43.63 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.604 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.419 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -140.72 147.35 18.99 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.777 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -179.46 -139.08 3.52 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.813 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -114.57 176.2 5.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.891 0.377 . . . . 0.0 111.182 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.0 p -146.48 145.54 30.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.976 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.07 131.15 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.837 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 77' ' ' LEU . . . -154.53 -151.89 5.95 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.652 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.07 125.82 7.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.797 0.332 . . . . 0.0 110.746 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.461 HG23 ' CG ' ' A' ' 75' ' ' ASN . 11.1 p -110.31 142.83 21.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.252 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? -153.48 138.23 17.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.97 146.01 50.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.945 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.28 133.48 14.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.83 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.56 138.59 43.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.938 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.2 p30 -176.73 -178.16 0.86 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -114.27 -39.59 1.02 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.498 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 3.7 mtmp? -126.01 -63.01 1.14 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -154.52 37.22 0.68 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.465 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -89.12 173.05 8.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.887 0.375 . . . . 0.0 110.855 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.48 132.64 9.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -134.13 -65.93 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.939 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -114.43 102.85 10.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.952 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.6 t -177.41 133.82 0.18 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.847 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.676 ' O ' HG13 ' A' ' 117' ' ' VAL . 0.4 OUTLIER -149.78 -83.59 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.012 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 116' ' ' ASP . 1.9 m -164.04 169.32 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.815 0.341 . . . . 0.0 111.245 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -142.72 149.6 21.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.335 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -119.24 114.97 23.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.773 0.321 . . . . 0.0 110.925 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.02 139.23 48.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.75 130.61 5.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -175.43 -138.19 2.73 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.464 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.407 ' HB2' ' CE2' ' A' ' 143' ' ' TYR . 1.7 mp -148.04 171.31 16.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -152.17 168.74 24.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.957 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . -175.15 142.06 0.6 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.96 0.41 . . . . 0.0 110.554 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -168.28 -146.74 5.08 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.783 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.8 pp -161.04 120.55 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.773 HD12 ' HB3' ' A' ' 138' ' ' GLU . 2.1 tt -95.95 113.41 25.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.942 0.401 . . . . 0.0 111.19 -179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.497 ' NE2' HD11 ' A' ' 137' ' ' ILE . 3.0 tt0 -95.17 115.84 27.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -103.14 149.21 24.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mp -107.66 -39.67 5.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.998 0.428 . . . . 0.0 110.691 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.1 p -169.05 -164.88 0.49 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.395 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -83.55 55.16 3.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.865 0.364 . . . . 0.0 110.73 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -140.35 -59.99 0.53 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.002 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.47 157.33 27.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.931 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.414 ' OG ' HD21 ' A' ' 128' ' ' LEU . 51.1 p -135.4 -177.3 4.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.128 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.497 HD11 ' NE2' ' A' ' 129' ' ' GLN . 2.4 pt -129.65 134.82 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.617 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.773 ' HB3' HD12 ' A' ' 128' ' ' LEU . 1.6 pt-20 -123.86 140.62 52.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.408 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -162.46 143.94 9.2 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.392 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.07 -144.94 5.52 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.649 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.75 158.38 40.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.782 0.325 . . . . 0.0 110.862 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.402 ' CZ ' HD21 ' A' ' 144' ' ' LEU . 4.3 ptm180 -144.67 140.26 28.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.421 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 2.8 p90 -145.06 105.06 4.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.969 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.402 HD21 ' CZ ' ' A' ' 142' ' ' ARG . 0.2 OUTLIER -139.85 153.97 47.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.001 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -108.58 147.86 31.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.839 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.84 126.7 50.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.961 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -141.04 115.12 9.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -106.73 157.68 17.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.118 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.7 t -82.92 79.49 9.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.889 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -112.94 -64.7 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -161.56 152.44 18.1 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -67.44 167.49 12.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.803 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.6 t -117.59 132.71 23.46 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.871 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.33 164.88 1.72 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.427 2.084 . . . . 0.0 112.284 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -139.72 130.92 26.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -136.16 -117.0 1.63 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.471 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -134.52 -147.25 5.55 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.497 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -145.77 -178.74 6.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 110.92 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -130.36 -54.57 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.1 167.13 22.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -95.94 37.2 3.5 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.483 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.2 m -152.28 153.49 33.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.754 0.311 . . . . 0.0 110.878 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.78 -173.23 4.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.869 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.94 100.65 2.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.852 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.785 HD23 ' HB2' ' A' ' 167' ' ' SER . 1.2 tp -59.41 130.58 47.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -99.9 30.39 3.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.785 ' HB2' HD23 ' A' ' 165' ' ' LEU . 2.0 m -78.4 175.39 10.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.898 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.61 125.16 50.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.964 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 72.3 p -106.94 120.55 42.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.694 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.602 ' OE1' HG21 ' A' ' 41' ' ' THR . 1.7 mt-30 -146.66 155.15 42.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.985 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -104.58 165.38 11.1 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.14 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.431 ' OH ' HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -131.47 127.27 37.02 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.044 -179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -163.52 129.95 3.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.471 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.84 -152.74 15.66 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.747 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -124.86 171.9 9.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.856 0.36 . . . . 0.0 111.218 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.65 114.92 5.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.815 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -106.2 114.22 28.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.0 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.95 163.39 22.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.024 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 6' ' ' VAL . 4.2 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.818 0.342 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.412 ' CB ' ' HB3' ' A' ' 49' ' ' GLN . 0.5 OUTLIER -94.2 168.17 11.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.862 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -112.08 132.88 54.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.801 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 8.7 m-85 -131.41 139.59 49.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.973 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 27.1 t -156.14 125.91 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.081 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 176' ' ' ASN . . . -170.98 -128.12 1.0 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.739 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -159.19 167.91 27.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.814 0.34 . . . . 0.0 110.748 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.45 150.22 35.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.982 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -110.47 117.09 32.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.823 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.5 137.51 13.73 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.529 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.05 116.94 32.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.842 0.354 . . . . 0.0 110.917 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.517 HG22 ' OE1' ' A' ' 170' ' ' GLN . 73.3 p -121.9 106.43 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.962 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.11 102.87 3.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.84 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -117.24 136.97 52.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.793 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -91.23 124.6 35.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.67 ' N ' HD13 ' A' ' 17' ' ' ILE . 0.2 OUTLIER -131.12 -37.75 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.374 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -164.17 -176.81 4.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.794 0.331 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -107.79 153.72 22.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.3 p -151.41 177.09 10.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.815 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.63 133.31 16.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.9 t -109.99 92.11 3.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.2 tp -100.95 31.54 3.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.808 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -99.49 -67.14 0.86 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.818 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -77.14 114.99 16.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.942 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.65 -68.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.833 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.405 HD23 ' H ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER 60.58 161.83 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.405 ' H ' HD23 ' A' ' 27' ' ' LEU . 13.4 m-80 -131.3 102.67 6.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.978 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.7 t -149.55 137.98 12.1 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.734 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.62 -49.85 15.86 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.406 2.071 . . . . 0.0 112.297 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.49 -179.77 6.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 60.81 91.86 0.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -177.53 -45.62 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -97.04 -14.03 21.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.329 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.5 m -96.07 28.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.312 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.614 ' O ' HD12 ' A' ' 36' ' ' ILE . 1.3 pp -143.94 84.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.126 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -103.16 -76.06 0.59 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -105.72 115.02 29.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 m -72.71 -54.22 9.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 135.68 -138.49 9.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.435 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.1 p -137.72 107.99 6.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.834 0.35 . . . . 0.0 110.901 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -91.6 131.22 37.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.682 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.9 -175.81 20.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.796 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.526 HG22 ' H ' ' A' ' 45' ' ' ARG . 4.0 mt -106.94 168.6 3.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.56 0.219 . . . . 0.0 110.698 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.526 ' H ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -138.4 142.78 39.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.051 0.453 . . . . 0.0 110.828 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . . . -170.48 120.23 0.58 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.965 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -161.57 -156.8 8.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.577 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.46 ' HB2' ' CE2' ' A' ' 55' ' ' TYR . 5.9 mt-30 -141.44 133.39 27.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.087 0.47 . . . . 0.0 111.074 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.453 ' CG ' ' HB3' ' A' ' 54' ' ' ARG . 8.1 tt0 -83.55 162.06 20.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.849 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.02 -169.45 1.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.647 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -67.24 -40.37 86.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.237 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -123.18 -26.61 4.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.732 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.508 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -124.29 -159.83 10.56 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.689 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.453 ' HB3' ' CG ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -171.64 168.09 6.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.95 0.405 . . . . 0.0 111.632 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.489 ' CD1' ' N ' ' A' ' 55' ' ' TYR . 0.2 OUTLIER -141.23 166.68 24.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.424 179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.613 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 41.3 p90 177.92 135.73 0.08 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.092 0.473 . . . . 0.0 110.888 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.51 155.78 18.65 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.257 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 77.1 p -137.58 123.78 20.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.055 0.455 . . . . 0.0 111.454 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.495 ' HD2' HD12 ' A' ' 44' ' ' ILE . 9.4 m-85 -89.89 108.69 19.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.173 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -105.99 178.68 4.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.092 0.472 . . . . 0.0 111.503 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -164.36 -164.67 0.87 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.54 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.578 HD11 ' OE1' ' A' ' 73' ' ' GLN . 1.3 pt -121.47 117.65 53.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.801 0.334 . . . . 0.0 111.199 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -105.82 82.9 1.85 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.84 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -90.84 -65.19 1.04 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.7 t -99.09 140.56 33.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.97 -31.95 34.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.835 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.24 -29.82 24.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -92.48 46.47 2.57 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.467 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -76.65 122.13 24.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.861 0.363 . . . . 0.0 110.895 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -161.84 147.54 13.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.939 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -91.8 87.18 6.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -105.27 -30.39 9.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.977 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.578 ' OE1' HD11 ' A' ' 62' ' ' ILE . 2.7 mt-30 -116.49 169.09 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.936 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -151.21 131.34 13.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.503 ' OD1' HG12 ' A' ' 102' ' ' VAL . 0.5 OUTLIER -120.02 110.87 17.19 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.805 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.17 115.72 30.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.638 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.436 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 1.8 mp -133.12 133.66 43.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.939 0.4 . . . . 0.0 111.298 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.89 116.91 4.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.929 -0.653 . . . . 0.0 111.944 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 11.6 t -105.25 135.6 46.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 0.0 111.576 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -128.71 110.95 12.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.899 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 1.6 p30 -136.52 172.13 13.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.233 0.54 . . . . 0.0 111.866 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.508 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -115.42 121.89 44.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.547 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 18.9 p90 -97.71 164.66 12.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.737 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.664 ' CD2' HD11 ' A' ' 86' ' ' ILE . 0.5 OUTLIER -167.04 128.15 1.23 Allowed Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.389 179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.57 106.92 0.21 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.445 2.097 . . . . 0.0 112.362 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.664 HD11 ' CD2' ' A' ' 84' ' ' LEU . 37.2 mt -150.23 120.49 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.988 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 149.22 -78.72 0.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.422 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.02 -72.99 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.794 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -170.43 31.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.144 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -172.31 31.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.295 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 71.5 p -136.59 130.51 32.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.714 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -117.31 92.82 3.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.896 0.379 . . . . 0.0 110.881 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.585 HD12 HG22 ' A' ' 127' ' ' ILE . 0.4 OUTLIER -56.17 103.02 0.09 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.596 -179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 22.6 p90 -110.93 156.17 21.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.802 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.43 135.21 2.94 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.712 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.404 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -168.91 -137.59 2.29 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.653 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -124.87 161.74 25.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.855 0.359 . . . . 0.0 111.19 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.512 ' C ' HD12 ' A' ' 99' ' ' LEU . 23.7 m -139.49 148.63 42.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.512 HD12 ' C ' ' A' ' 98' ' ' THR . 4.5 mp -157.1 130.82 8.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.523 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.667 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -141.46 -162.7 9.26 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.121 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.667 HD12 ' C ' ' A' ' 100' ' ' GLY . 5.5 mp -155.6 142.54 19.04 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.885 HG22 ' HA3' ' A' ' 118' ' ' GLY . 35.0 m -109.56 145.41 16.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.416 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -138.88 145.06 39.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.86 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.553 HD21 ' HG2' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -118.84 103.63 9.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.883 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -114.31 166.39 11.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.911 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.65 177.98 7.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -140.39 158.16 44.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.84 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 107.77 46.11 1.06 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.497 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 12.4 mtmm 59.52 32.44 21.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.846 0.355 . . . . 0.0 110.971 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -109.55 111.26 3.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.448 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -103.77 149.71 24.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.808 0.337 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -149.72 155.39 40.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -87.59 -63.79 1.25 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.814 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -65.66 118.46 9.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.808 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 4.5 p -173.87 154.14 2.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.1 t0 61.73 76.67 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.955 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -152.58 100.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.192 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.885 ' HA3' HG22 ' A' ' 102' ' ' VAL . . . -161.11 132.4 2.86 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.275 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -113.97 114.97 26.9 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.876 0.37 . . . . 0.0 111.05 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.73 138.24 54.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.746 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.96 132.75 5.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.448 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.65 ' O ' HD23 ' A' ' 123' ' ' LEU . . . -173.39 -140.05 3.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.765 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.65 HD23 ' O ' ' A' ' 122' ' ' GLY . 13.3 mt -147.64 164.78 32.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 0.0 110.858 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 14.9 mt-30 -149.74 170.54 18.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.704 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.92 142.56 0.08 Allowed 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.988 0.423 . . . . 0.0 110.851 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -164.53 -128.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.759 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.585 HG22 HD12 ' A' ' 93' ' ' LEU . 12.6 pt -160.59 121.99 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 120.794 0.33 . . . . 0.0 110.296 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.654 HD23 ' O ' ' A' ' 128' ' ' LEU . 5.0 tt -94.48 113.28 25.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.008 0.432 . . . . 0.0 110.857 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -95.63 124.18 39.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.857 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -111.56 149.14 31.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.7 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 11.6 tp -108.24 -45.9 3.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.118 0.485 . . . . 0.0 110.635 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 54.7 p -169.21 -164.85 0.48 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.189 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.55 54.96 2.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.913 0.387 . . . . 0.0 110.569 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -138.25 -58.2 0.65 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.088 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -147.16 171.95 14.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.197 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.9 m -141.03 167.73 21.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.764 HG23 ' O ' ' A' ' 174' ' ' GLY . 5.4 mt -129.26 134.87 63.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.444 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -127.95 132.09 49.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.941 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . -155.28 144.49 11.08 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.554 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' O ' ' CD1' ' A' ' 171' ' ' PHE . . . 176.14 -151.41 11.58 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.366 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.407 ' CD1' ' O ' ' A' ' 170' ' ' GLN . 0.2 OUTLIER -119.75 153.45 35.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.902 0.382 . . . . 0.0 110.916 -179.564 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.424 ' HB3' ' CE1' ' A' ' 172' ' ' TYR . 29.1 ptt180 -131.89 129.99 41.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.906 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' A' ' 169' ' ' SER . 7.3 t80 -128.59 102.23 6.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.779 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.404 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 0.6 OUTLIER -150.72 164.04 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.196 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -100.2 153.89 18.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.718 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.3 t -108.89 172.12 7.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.004 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -56.15 115.21 2.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.84 95.57 8.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.419 ' OG ' HG22 ' A' ' 153' ' ' THR . 0.2 OUTLIER 60.83 172.77 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.914 179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.7 p -135.95 -55.25 0.77 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.908 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -150.71 135.71 17.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.906 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.99 104.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.419 HG22 ' OG ' ' A' ' 149' ' ' SER . 44.3 p -108.25 91.87 8.79 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.97 92.78 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.484 2.122 . . . . 0.0 112.317 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.28 153.24 43.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.856 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -76.18 -65.82 1.96 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.53 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 107.33 98.96 2.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.459 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -76.31 -179.32 5.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.64 30.83 6.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.852 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.8 mt -147.07 -49.72 0.19 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.958 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 176.48 177.78 45.74 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.491 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 54.2 p -152.28 129.44 11.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.762 0.315 . . . . 0.0 110.892 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 60.52 178.71 0.1 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.876 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -145.69 -64.26 0.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.88 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.1 tp -128.71 143.87 51.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.93 33.57 4.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.431 ' HB3' ' CE1' ' A' ' 143' ' ' TYR . 4.6 m -110.05 176.05 5.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.807 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.5 m -157.53 132.48 8.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.438 ' HB3' ' CD2' ' A' ' 143' ' ' TYR . 83.4 p -107.9 122.59 47.13 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.805 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.517 ' OE1' HG22 ' A' ' 13' ' ' THR . 1.6 mt-30 -141.58 152.11 43.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.159 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.415 ' CD1' ' O ' ' A' ' 140' ' ' GLY . 2.7 t80 -100.04 120.55 40.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.265 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 142' ' ' ARG . 9.7 p90 -125.07 126.44 45.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.234 0.54 . . . . 0.0 111.428 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.612 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 1.4 pt? -147.46 155.47 41.94 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.858 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.764 ' O ' HG23 ' A' ' 137' ' ' ILE . . . -176.73 -132.73 1.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.401 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -132.85 169.41 16.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.807 0.337 . . . . 0.0 111.128 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.41 ' HA ' ' HA3' ' A' ' 7' ' ' GLY . 4.3 t-20 -158.05 118.35 3.36 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.022 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -101.57 118.27 36.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -87.16 154.79 20.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.099 179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.824 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.798 0.333 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.8 OUTLIER -110.06 151.53 27.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.661 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -112.28 119.19 37.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.506 -0.316 . . . . 0.0 110.744 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 29.0 p90 -124.05 155.29 38.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.256 0.55 . . . . 0.0 111.469 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.865 HG23 ' HB2' ' A' ' 46' ' ' ALA . 7.5 p -151.91 128.3 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.732 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.74 -141.6 3.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.373 -0.917 . . . . 0.0 112.754 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -131.5 165.54 23.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.896 0.379 . . . . 0.0 110.799 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.632 HG23 ' HB2' ' A' ' 45' ' ' ARG . 24.1 p -129.17 143.95 51.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.978 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -140.9 112.96 7.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.689 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -119.88 135.24 10.98 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.6 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -79.93 125.42 29.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 110.823 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -110.75 119.16 38.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -150.12 102.79 3.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.717 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -104.06 -64.53 1.09 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -74.51 131.9 41.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 pp -139.11 124.54 22.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.072 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -173.39 164.29 4.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.857 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.21 124.69 45.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.94 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -136.54 31.57 2.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.5 129.22 19.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.3 m -90.17 118.09 29.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.975 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.708 ' N ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -125.65 173.78 8.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.973 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -120.77 138.14 54.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 mtt-85 -115.51 -178.37 3.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -176.83 -52.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 tt -162.92 -44.83 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.923 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -88.78 115.58 26.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.6 116.19 60.38 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.801 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.06 93.39 0.4 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.341 2.027 . . . . 0.0 112.306 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -118.07 127.54 53.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.939 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.1 mm? 60.78 74.39 0.45 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -110.81 -49.89 3.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -158.1 78.07 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.663 ' C ' HD12 ' A' ' 36' ' ' ILE . 21.4 t -121.92 -66.15 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.176 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.663 HD12 ' C ' ' A' ' 35' ' ' VAL . 3.3 mp 69.18 -67.17 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.22 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.3 153.29 0.93 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -136.94 -56.87 0.72 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -141.73 142.72 33.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.31 -159.18 23.73 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.465 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.2 p -119.2 139.43 51.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.88 0.371 . . . . 0.0 111.028 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 76.9 t90 -148.45 139.94 23.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -177.3 -164.89 31.67 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.605 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.521 HG22 ' N ' ' A' ' 45' ' ' ARG . 3.2 mt -106.86 161.74 5.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.584 0.23 . . . . 0.0 111.027 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.632 ' HB2' HG23 ' A' ' 9' ' ' THR . 0.0 OUTLIER -140.99 148.7 40.74 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.029 0.442 . . . . 0.0 110.606 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.865 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -177.22 124.38 0.14 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.039 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.576 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -161.57 -163.11 13.84 Favored Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 120.388 -0.911 . . . . 0.0 113.308 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 3.4 mp0 -118.34 125.97 51.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.861 0.362 . . . . 0.0 111.001 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.477 ' HB2' ' CE1' ' A' ' 5' ' ' PHE . 37.5 tt0 -111.79 109.97 20.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.196 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 0.5 OUTLIER -119.41 160.11 22.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.521 179.339 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.75 -23.29 64.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.197 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -99.29 24.09 8.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.242 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' ' CG ' ' A' ' 50' ' ' PHE . . . 133.4 164.57 10.83 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.337 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.401 ' NE ' ' CZ ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -139.44 146.03 39.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.918 0.39 . . . . 0.0 111.314 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -129.78 161.23 31.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.408 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.576 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 15.9 p90 -176.97 126.42 0.15 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.166 0.508 . . . . 0.0 111.525 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.71 139.06 31.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.284 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 77' ' ' LEU . 51.3 m -129.57 117.29 20.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 111.529 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -94.32 117.17 29.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.319 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -111.82 175.4 5.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.901 0.381 . . . . 0.0 111.266 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.08 -166.85 1.35 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.731 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.7 mt -100.1 118.86 47.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.101 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.0 m -82.86 -55.17 4.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.913 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.87 137.71 46.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 65' ' ' THR . 3.5 t -128.25 106.43 9.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.0 t -68.65 -40.24 80.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.861 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -61.0 -36.96 80.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.29 42.37 83.16 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.561 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -100.05 171.76 7.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -102.83 81.52 2.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.743 HD21 HD21 ' A' ' 104' ' ' LEU . 4.1 tt -163.86 136.43 5.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 tpp180 -135.89 151.9 50.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.999 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -127.25 -178.43 4.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -121.38 139.53 53.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.578 ' HA ' HG12 ' A' ' 102' ' ' VAL . 4.1 m120 -114.57 112.54 23.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.829 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.0 tt -98.28 114.95 27.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.49 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 58' ' ' THR . 0.5 OUTLIER -118.11 113.58 21.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.278 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -112.01 116.95 4.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.623 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.798 ' OG ' HG22 ' A' ' 98' ' ' THR . 12.3 m -126.41 143.02 51.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 0.0 111.831 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -131.79 110.67 11.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.502 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.451 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 15.8 m-20 -130.55 166.06 21.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.214 0.531 . . . . 0.0 112.017 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -119.08 127.95 53.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.045 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 45.4 p90 -97.36 168.72 10.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.143 0.497 . . . . 0.0 111.778 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 86' ' ' ILE . 7.4 tp -158.9 132.4 4.85 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.235 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -65.17 106.04 0.77 Allowed 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.32 2.014 . . . . 0.0 112.401 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.704 HD11 HD23 ' A' ' 84' ' ' LEU . 42.7 mm -119.08 103.39 14.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.002 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 119.29 -95.08 0.59 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.537 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -169.5 59.83 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.902 0.382 . . . . 0.0 110.872 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 64.23 25.2 13.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.938 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -106.63 -36.37 6.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.545 HG22 HD12 ' A' ' 127' ' ' ILE . 14.5 p -136.48 142.7 43.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.463 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 13.6 mmtt -123.52 98.92 6.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.037 0.446 . . . . 0.0 111.191 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 7.8 tt -55.32 104.54 0.13 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.381 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -109.42 145.88 35.41 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.606 -179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -165.21 140.54 6.47 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.364 -0.922 . . . . 0.0 113.067 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 179.45 -146.82 7.29 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.004 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.444 ' HA ' HD23 ' A' ' 123' ' ' LEU . . . -109.07 -178.02 3.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.888 0.375 . . . . 0.0 111.257 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.798 HG22 ' OG ' ' A' ' 79' ' ' SER . 0.8 OUTLIER -145.51 161.44 39.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.024 -179.916 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.41 ' O ' ' HA ' ' A' ' 77' ' ' LEU . 12.4 mt -147.86 130.27 15.73 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.34 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 120' ' ' ALA . . . -130.37 123.64 4.02 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.378 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.591 HD11 ' CD2' ' A' ' 119' ' ' TYR . 2.0 tp -143.87 120.9 11.4 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.845 0.355 . . . . 0.0 110.743 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 75' ' ' ASN . 4.9 m -109.8 145.26 16.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.138 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.24 137.18 52.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.956 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.743 HD21 HD21 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -118.09 131.44 56.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -145.01 149.74 35.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 31.0 tp60 -113.88 155.21 26.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.83 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -106.57 -173.87 2.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 68.22 159.99 1.59 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.508 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.83 148.85 39.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 146.44 -165.51 28.28 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -92.54 124.97 36.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.903 0.382 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.88 102.86 4.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -124.83 -40.5 2.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.87 161.9 1.05 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.161 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 80.0 p -169.74 154.81 5.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.819 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.63 83.3 2.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.56 106.58 20.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -97.62 149.42 19.23 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.48 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.591 ' CD2' HD11 ' A' ' 101' ' ' LEU . 64.3 m-85 -114.25 127.93 56.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.834 0.35 . . . . 0.0 110.878 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.719 ' HB1' HD12 ' A' ' 144' ' ' LEU . . . -133.86 148.82 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.11 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -171.98 134.5 0.76 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.85 -124.9 0.74 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.615 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 97' ' ' ALA . 86.7 mt -141.05 169.65 17.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 0.0 110.972 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -158.65 153.49 24.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.376 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . -178.26 142.57 0.26 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.131 0.491 . . . . 0.0 111.058 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.569 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -163.12 -125.0 0.74 Allowed Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.553 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.569 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.7 pt -160.79 120.62 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 CA-C-O 120.708 0.29 . . . . 0.0 110.351 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.714 HD21 ' HB3' ' A' ' 136' ' ' SER . 1.2 tt -95.0 115.21 27.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.038 0.446 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -94.58 152.97 18.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.215 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -108.13 149.08 28.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.2 tp -121.0 -39.1 2.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.929 0.395 . . . . 0.0 110.824 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.1 t -158.96 -164.57 1.44 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.353 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.41 30.66 0.78 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.102 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.6 p30 178.32 34.96 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.803 0.335 . . . . 0.0 110.939 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -166.16 119.41 1.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.714 ' HB3' HD21 ' A' ' 128' ' ' LEU . 0.4 OUTLIER -128.74 172.1 11.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.989 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 174' ' ' GLY . 3.9 mp -137.64 135.55 46.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.764 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.35 127.57 51.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -146.74 122.77 1.66 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.291 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.98 -147.61 5.25 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.436 -0.888 . . . . 0.0 112.885 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -135.85 161.13 36.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.855 0.36 . . . . 0.0 110.922 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -133.25 149.03 52.0 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.667 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -144.76 109.97 5.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.719 HD12 ' HB1' ' A' ' 120' ' ' ALA . 1.2 pt? -151.89 164.6 36.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.068 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 8.7 mtt180 -112.35 146.61 37.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.846 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.28 130.39 55.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -141.14 125.16 17.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.26 95.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.132 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.46 174.87 10.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.3 t -141.55 -50.35 0.41 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.826 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -96.33 89.46 5.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.884 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 8.5 mmt -97.91 140.3 32.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.922 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 40.1 p -94.67 105.9 21.24 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.92 132.85 27.54 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.383 2.055 . . . . 0.0 112.374 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -95.8 144.92 25.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 166.79 -79.71 0.11 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.547 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.07 28.38 18.1 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.527 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -172.92 -44.17 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.851 0.358 . . . . 0.0 110.921 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.3 tmtt? -147.99 118.85 7.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.927 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.4 147.32 36.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -155.48 161.1 30.34 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.436 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 1.3 t -73.45 142.15 46.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 0.0 110.889 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.36 -178.7 7.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -87.01 130.51 34.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.6 tp -158.27 -178.3 7.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.817 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -131.84 156.74 45.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 24.4 m -111.35 174.81 5.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.813 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.1 m -128.16 157.24 41.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.958 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 11.7 m -107.0 131.23 54.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.774 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -138.68 155.2 48.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.077 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -114.21 165.17 12.95 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.056 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.508 ' O ' HD12 ' A' ' 173' ' ' LEU . 8.3 t80 -138.35 129.34 26.97 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.252 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 172' ' ' TYR . 0.3 OUTLIER -163.66 129.89 3.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.596 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 137' ' ' ILE . . . 178.35 -156.0 18.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.775 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -129.6 171.96 12.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.781 0.324 . . . . 0.0 111.008 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -151.56 116.1 5.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.91 111.77 24.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.712 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.558 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 3.7 mttp -81.86 150.91 27.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.226 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.767 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.874 0.369 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.52 168.09 10.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.931 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -112.13 142.03 45.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.815 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.555 ' O ' HG13 ' A' ' 6' ' ' VAL . 18.0 m-85 -131.24 142.18 50.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.773 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.555 HG13 ' O ' ' A' ' 5' ' ' PHE . 5.0 m -159.52 121.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.156 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.56 -140.33 2.89 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.652 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -126.21 146.93 49.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 110.907 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 85.2 m -116.74 129.36 56.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -124.75 112.97 17.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.682 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.1 134.41 11.71 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.719 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.02 117.57 31.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.834 0.349 . . . . 0.0 110.777 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.9 m -113.96 147.09 39.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.9 m -150.05 102.86 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.779 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -155.22 146.89 23.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.868 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -78.54 103.18 8.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.878 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.2 pt -113.59 30.86 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -155.62 110.74 2.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.32 146.74 52.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.838 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 74.4 m -143.82 172.4 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -92.06 -32.94 14.99 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.57 136.19 35.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.1 mt -151.74 167.73 27.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.924 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -141.18 147.64 38.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.23 35.19 3.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.914 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -147.54 -56.87 0.24 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.878 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -97.06 136.32 37.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -97.16 139.5 33.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.423 ' N ' ' HD2' ' A' ' 30' ' ' PRO . 0.1 OUTLIER -71.19 -58.84 3.7 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 29' ' ' SER . 59.8 Cg_endo -72.68 114.85 4.13 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.426 2.084 . . . . 0.0 112.342 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -106.57 156.63 18.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.942 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.11 82.31 7.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.979 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -136.5 26.86 3.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.87 43.5 18.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.034 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 13.3 t -120.09 -66.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.05 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.9 mt -118.62 90.63 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.158 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -107.24 -55.97 2.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -177.31 -178.64 0.8 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.4 HG22 ' H ' ' A' ' 40' ' ' GLY . 0.2 OUTLIER -84.58 -170.32 3.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.846 179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' H ' HG22 ' A' ' 39' ' ' THR . . . 176.91 144.85 5.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.57 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.05 127.92 53.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -125.34 123.59 39.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.79 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.36 -164.85 16.09 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.553 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.8 pt -107.04 162.03 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 0.0 111.087 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.709 ' HG2' HG22 ' A' ' 58' ' ' THR . 0.0 OUTLIER -129.31 138.94 51.88 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.759 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.802 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -168.61 119.86 0.78 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.62 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.49 -159.33 8.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.945 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -143.26 116.67 9.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.825 0.345 . . . . 0.0 110.74 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.413 ' HA ' ' CG ' ' A' ' 54' ' ' ARG . 0.2 OUTLIER -83.79 148.34 27.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.22 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.403 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -132.42 -166.74 1.78 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.291 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.62 -47.18 84.88 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.225 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -135.91 12.01 3.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.821 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.53 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -148.1 153.58 25.36 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.561 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.469 ' NH2' ' CD1' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -141.72 144.65 34.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.909 0.385 . . . . 0.0 111.607 -179.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -89.29 153.71 20.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.012 179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.456 ' CE1' ' HD2' ' A' ' 54' ' ' ARG . 58.2 m-85 -133.24 103.34 5.94 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.861 0.362 . . . . 0.0 111.422 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -113.29 122.74 48.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.318 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.709 HG22 ' HG2' ' A' ' 45' ' ' ARG . 2.2 p -141.1 128.96 21.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.048 0.451 . . . . 0.0 111.268 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.639 ' CZ ' HD11 ' A' ' 76' ' ' LEU . 3.1 m-85 -89.42 119.27 29.73 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.078 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -101.92 163.51 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.943 0.402 . . . . 0.0 111.54 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -145.08 -171.04 3.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.637 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.526 HD11 ' HG3' ' A' ' 73' ' ' GLN . 33.1 mm -100.1 118.26 46.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.179 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.7 t -102.23 107.1 18.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -153.87 125.05 7.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -109.55 -28.9 8.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.949 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.8 p -56.73 -31.62 64.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.079 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.3 p -107.92 -30.7 8.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 125.44 140.25 5.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.465 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -59.5 97.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.831 0.348 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.74 84.93 2.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -79.34 81.51 5.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.873 179.941 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.28 -32.35 11.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.922 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.526 ' HG3' HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -110.66 167.47 10.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.99 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.16 163.19 35.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.709 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.48 HD22 HG12 ' A' ' 102' ' ' VAL . 9.6 m120 -144.65 112.6 6.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.994 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.639 HD11 ' CZ ' ' A' ' 59' ' ' TYR . 0.2 OUTLIER -82.99 136.92 34.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.601 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -118.72 142.52 47.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 111.205 -179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.612 ' H ' HD23 ' A' ' 77' ' ' LEU . . . -160.1 116.8 0.74 Allowed Glycine 0 N--CA 1.452 -0.296 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.73 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.775 ' HB3' HG23 ' A' ' 98' ' ' THR . 49.5 p -139.25 143.21 37.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.468 . . . . 0.0 111.614 -179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -111.67 110.96 21.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.826 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -127.91 172.06 11.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.208 0.528 . . . . 0.0 111.787 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.53 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -119.11 118.8 32.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.44 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 21.9 p90 -97.73 161.53 13.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.086 0.47 . . . . 0.0 111.659 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.517 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.4 OUTLIER -165.04 138.57 3.86 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.493 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.517 ' HD2' HD23 ' A' ' 84' ' ' LEU . 31.6 Cg_exo -58.8 117.74 4.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.38 2.053 . . . . 0.0 112.532 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.467 HD13 ' O ' ' A' ' 85' ' ' PRO . 37.5 mm -123.0 105.76 16.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.933 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 126.11 -47.67 1.01 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.411 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -175.64 -67.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.706 0.289 . . . . 0.0 111.003 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -179.68 37.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.773 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 82.3 m-20 -124.27 -63.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.786 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 35.1 p -75.85 153.13 37.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.435 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -131.5 92.49 3.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.873 0.368 . . . . 0.0 111.047 -179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.418 ' CB ' HG13 ' A' ' 86' ' ' ILE . 6.3 tt -62.2 103.12 0.35 Allowed 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.316 0.579 . . . . 0.0 110.497 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.459 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 24.0 p90 -110.96 154.53 23.99 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.477 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.03 139.9 4.84 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.434 -0.888 . . . . 0.0 112.815 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.68 -135.31 2.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.617 -0.802 . . . . 0.0 112.73 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.86 155.66 20.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.296 . . . . 0.0 111.046 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.775 HG23 ' HB3' ' A' ' 79' ' ' SER . 6.9 m -128.34 148.34 50.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.121 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 120.99 3.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.682 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.664 ' H ' ' HB3' ' A' ' 120' ' ' ALA . . . -127.98 -155.92 8.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.63 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.19 127.0 7.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.822 0.344 . . . . 0.0 110.661 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.48 HG12 HD22 ' A' ' 75' ' ' ASN . 29.1 m -109.83 122.06 63.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.093 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HE3' HG22 ' A' ' 117' ' ' VAL . 2.1 ttmp? -141.13 144.64 34.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.926 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.499 HD23 ' CB ' ' A' ' 73' ' ' GLN . 0.6 OUTLIER -130.95 160.69 33.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.847 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -129.48 135.13 48.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.88 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.8 tm0? -107.37 146.87 31.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.58 110.66 4.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -161.08 -171.2 26.75 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.477 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 7.9 tttt -145.51 97.8 3.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 173.77 -159.09 28.57 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.493 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.73 91.18 6.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.843 0.354 . . . . 0.0 110.876 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -118.25 140.52 49.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.6 mmt180 -144.24 -47.83 0.27 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -114.03 128.53 56.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.86 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 5.9 t -137.85 -60.6 0.64 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.964 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.89 46.39 1.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.418 HG22 ' HE3' ' A' ' 103' ' ' LYS . 21.4 t -74.59 109.37 7.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.126 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -110.33 162.75 12.49 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.488 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -113.82 130.28 56.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.828 0.347 . . . . 0.0 110.919 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.744 ' HB1' ' CD1' ' A' ' 144' ' ' LEU . . . -100.47 140.6 34.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.75 131.27 5.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -176.28 -131.03 1.41 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.605 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.9 mp -148.93 157.72 43.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.828 0.346 . . . . 0.0 111.004 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 -143.12 164.97 28.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.748 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . 179.53 142.59 0.14 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.99 0.424 . . . . 0.0 110.699 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.6 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -164.03 -136.19 1.95 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.994 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 126' ' ' GLY . 5.1 pt -161.92 120.97 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.593 HD21 ' HB3' ' A' ' 136' ' ' SER . 9.2 tt -94.46 111.31 23.06 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.982 0.42 . . . . 0.0 110.745 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 36.1 tt0 -97.07 116.85 30.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.944 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -94.09 148.98 21.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.995 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.8 -30.02 8.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.611 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.88 -165.34 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.491 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.6 mmmt -89.45 52.34 2.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.8 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.63 -35.47 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.22 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -102.78 125.95 49.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.871 0.367 . . . . 0.0 111.216 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.593 ' HB3' HD21 ' A' ' 128' ' ' LEU . 1.2 m -126.46 163.63 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 23.4 mt -135.48 134.93 52.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.817 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.49 139.19 48.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.95 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -160.74 111.14 0.47 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.333 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -162.48 -150.18 5.92 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.07 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -139.18 161.03 38.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.721 0.296 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.433 ' HD2' HG21 ' A' ' 98' ' ' THR . 5.7 ttp-105 -137.73 140.55 40.75 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 142' ' ' ARG . 15.7 m-85 -140.3 115.27 9.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.744 ' CD1' ' HB1' ' A' ' 120' ' ' ALA . 0.6 OUTLIER -160.53 174.01 14.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -132.82 160.38 37.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.829 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.407 HG21 HG21 ' A' ' 102' ' ' VAL . 1.1 m -109.01 127.37 54.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.862 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -140.98 132.1 26.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.931 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.92 -62.38 1.65 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.068 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 150' ' ' THR . 42.7 t -157.93 -49.22 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.961 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 149' ' ' SER . 4.5 p -158.46 163.18 37.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -153.73 -69.05 0.14 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.927 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.24 31.27 20.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 154' ' ' PRO . 81.0 p -83.36 154.55 66.26 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.897 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 153' ' ' THR . 52.2 Cg_endo -69.33 -179.53 2.78 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.605 2.203 . . . . 0.0 112.339 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.01 -55.84 0.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.947 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 59.69 77.11 0.19 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.559 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -64.16 -50.1 62.44 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.485 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -123.31 -69.84 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.793 0.33 . . . . 0.0 110.918 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -138.3 -53.77 0.62 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.73 125.13 2.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 91.22 35.51 7.01 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.517 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.9 132.22 26.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 1.1 mp -120.49 -52.09 2.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.84 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.7 t0 60.52 -179.63 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 62.62 119.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.943 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -117.37 -44.31 2.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 9.2 t -154.63 175.38 13.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 31.2 t -98.73 162.39 13.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.9 t -106.93 115.9 31.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.818 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -124.01 155.09 38.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -126.53 140.47 52.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.447 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.431 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -122.3 126.95 49.21 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.738 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -163.42 130.02 3.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.62 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 173.02 -153.39 18.22 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.849 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -122.19 172.18 8.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.773 0.32 . . . . 0.0 111.065 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -155.18 117.67 4.25 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.152 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -107.39 111.87 24.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.694 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 5' ' ' PHE . 8.8 pttt -86.87 157.96 19.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.081 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.829 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.463 ' HB2' ' CD2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.743 0.306 . . . . 0.0 111.056 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -138.22 159.69 41.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.019 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 5.3 m-80 -112.02 140.53 46.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.476 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 52.6 p90 -148.54 167.53 25.14 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.126 0.489 . . . . 0.0 111.661 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.673 HG13 ' HB2' ' A' ' 46' ' ' ALA . 46.2 t -155.85 137.4 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.791 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.49 -147.17 4.88 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.803 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -138.34 163.05 32.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.784 0.326 . . . . 0.0 110.657 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.67 141.5 44.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -126.29 112.93 16.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -81.63 136.01 15.29 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.404 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.0 110.01 21.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.774 0.321 . . . . 0.0 110.942 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 60.3 m -83.63 131.72 34.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 t -150.05 102.76 3.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.31 32.39 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.862 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.8 p30 -83.06 163.12 21.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.905 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 mt 66.21 89.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.153 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -165.34 35.39 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.05 171.82 7.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.871 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.3 p -91.42 137.08 32.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.94 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.1 mmtm -75.48 178.03 6.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.7 t -154.48 151.78 29.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.73 118.04 6.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.913 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -122.25 -59.93 1.6 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -138.94 -65.28 0.49 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -135.84 150.06 49.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.93 151.72 46.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 50.5 m-20 -104.44 146.03 29.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.85 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.5 t -112.34 85.31 6.88 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.71 174.51 10.21 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.464 2.11 . . . . 0.0 112.336 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.655 ' O ' HD22 ' A' ' 32' ' ' LEU . 78.3 m-20 -83.36 -55.52 4.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.655 HD22 ' O ' ' A' ' 31' ' ' ASN . 0.8 OUTLIER -139.35 111.7 7.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -94.17 -31.45 14.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.8 mtmp? -100.25 81.4 2.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.854 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.6 t -105.84 79.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.074 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 pt -148.36 129.39 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -95.11 -34.68 12.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 m120 60.05 160.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.1 p -135.76 -76.5 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.957 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.46 -141.4 14.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.465 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.7 p -142.99 107.99 4.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.889 0.376 . . . . 0.0 110.913 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -89.78 124.97 35.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.764 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.19 -169.24 12.38 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.688 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 58' ' ' THR . 13.9 tt -119.66 162.39 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.52 0.2 . . . . 0.0 110.897 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.644 ' O ' HG13 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -135.1 142.69 46.31 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.924 0.392 . . . . 0.0 110.73 -179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.673 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -169.34 119.32 0.68 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.253 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -170.61 -139.06 2.65 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.673 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -150.1 143.53 25.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.805 0.336 . . . . 0.0 110.985 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 54' ' ' ARG . 14.1 pt20 -118.13 109.84 16.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.215 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.463 ' CD2' ' HB2' ' A' ' 2' ' ' ALA . 73.8 m-85 -87.69 166.83 14.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.805 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -67.15 -21.42 65.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.329 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.12 24.25 11.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.627 -0.26 . . . . 0.0 111.42 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 165.43 169.15 28.67 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.498 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.774 ' CZ ' HD13 ' A' ' 128' ' ' LEU . 11.7 ttp180 -141.0 125.85 18.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.872 0.367 . . . . 0.0 111.231 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -117.6 150.07 39.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.346 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.525 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 28.2 p90 -177.97 127.43 0.13 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.079 0.466 . . . . 0.0 111.222 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.72 142.93 27.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.222 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 9.4 t -132.92 120.73 21.84 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.035 0.445 . . . . 0.0 111.608 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.575 ' CD1' HD12 ' A' ' 76' ' ' LEU . 4.1 m-85 -91.14 123.97 34.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.194 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.03 170.44 7.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.951 0.405 . . . . 0.0 111.305 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.05 -164.94 1.81 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.685 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.446 ' O ' HD12 ' A' ' 62' ' ' ILE . 2.0 pp -115.99 118.91 60.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.12 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.46 62.85 5.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.827 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.12 -170.46 3.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.02 162.48 29.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.898 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 t -68.62 -51.33 43.53 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 t -87.43 -31.03 20.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.74 68.89 1.85 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.498 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.66 159.34 31.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.296 . . . . 0.0 110.884 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -170.17 -42.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.812 HD21 HD21 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -112.62 175.71 5.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.997 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.12 137.6 8.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.855 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -141.62 163.71 32.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.003 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.583 ' HG3' HD11 ' A' ' 76' ' ' LEU . 33.1 tp60 -130.32 131.56 45.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.697 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.625 ' C ' HD13 ' A' ' 76' ' ' LEU . 1.4 m120 -121.91 110.93 16.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.102 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.664 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -119.31 121.01 38.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 0.2 OUTLIER -142.66 157.8 44.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 111.264 -179.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -114.66 116.76 3.86 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.266 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.66 ' HB3' HG22 ' A' ' 98' ' ' THR . 0.0 OUTLIER -97.92 122.23 40.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.879 0.371 . . . . 0.0 111.065 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -117.06 110.87 18.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.475 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.61 161.42 31.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.014 0.435 . . . . 0.0 111.289 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -113.29 120.23 40.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.376 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 48.3 p90 -97.58 161.04 13.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.575 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.93 122.63 1.7 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.585 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.51 116.52 3.14 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.501 2.134 . . . . 0.0 112.308 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 86' ' ' ILE . 9.6 tt -148.54 120.59 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.089 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 125.5 -43.71 1.34 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.457 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -178.26 -62.29 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 110.905 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 175.56 -30.96 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -89.58 18.5 5.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.668 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.633 HG22 ' HB ' ' A' ' 127' ' ' ILE . 0.2 OUTLIER -136.35 120.95 18.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.759 -0.2 . . . . 0.0 110.551 179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.617 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 17.3 mmtm -119.5 92.78 3.87 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.212 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.7 tp -59.54 103.34 0.19 Allowed 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 121.344 0.592 . . . . 0.0 110.758 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 36.3 p90 -110.73 159.06 17.97 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.885 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.81 142.11 5.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -176.11 -141.07 3.7 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.725 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -129.95 169.08 15.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.865 0.364 . . . . 0.0 111.147 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.66 HG22 ' HB3' ' A' ' 79' ' ' SER . 11.6 p -138.66 150.84 46.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.806 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 98' ' ' THR . 3.3 mp -160.15 132.08 6.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -150.29 -154.54 6.5 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.822 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.3 tt -155.21 128.0 8.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.821 0.343 . . . . 0.0 110.531 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 75' ' ' ASN . 27.8 m -109.85 145.0 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.237 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.06 145.03 51.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.812 HD21 HD21 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -108.1 148.85 29.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.959 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -131.54 158.83 39.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.849 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.93 155.09 37.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -143.71 124.16 13.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.911 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 147.47 -93.7 0.16 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 ttpp -163.59 109.25 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 94.13 114.71 2.55 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.503 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -96.64 99.13 10.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.895 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.86 86.14 2.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.76 161.02 34.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.03 30.61 1.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.781 ' O ' HG12 ' A' ' 117' ' ' VAL . 0.3 OUTLIER -116.02 -77.22 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.9 179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.4 p30 44.3 31.04 0.52 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.455 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 115' ' ' SER . 11.5 p -170.01 151.47 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -170.47 134.52 3.17 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.41 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -93.49 131.72 38.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 0.0 110.927 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -121.89 149.16 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.082 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.47 135.48 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.118 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.607 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -157.97 -140.46 2.93 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.573 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.607 HD12 ' O ' ' A' ' 122' ' ' GLY . 1.1 mp -153.06 172.02 17.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.906 0.384 . . . . 0.0 110.806 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -155.41 161.97 40.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.821 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.707 ' HB3' ' CE1' ' A' ' 141' ' ' TYR . . . 176.94 142.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.773 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.92 -130.41 1.25 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.736 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.633 ' HB ' HG22 ' A' ' 91' ' ' THR . 1.0 OUTLIER -156.65 120.37 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.774 HD13 ' CZ ' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -94.91 115.52 27.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.191 0.52 . . . . 0.0 111.14 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -98.94 114.87 27.7 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.618 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -79.45 144.35 34.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.902 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.565 HD11 HG12 ' A' ' 137' ' ' ILE . 4.8 mp -108.75 -30.53 8.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.074 0.464 . . . . 0.0 110.431 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.24 -170.39 1.68 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.017 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -85.96 53.78 2.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.81 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 6.6 p-10 176.31 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -122.38 143.69 49.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.982 0.42 . . . . 0.0 111.731 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.46 ' HA ' HD12 ' A' ' 131' ' ' LEU . 51.0 m -156.08 164.83 37.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.687 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.565 HG12 HD11 ' A' ' 131' ' ' LEU . 29.9 pt -143.64 136.35 24.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.4 ' HB3' ' CG ' ' A' ' 128' ' ' LEU . 2.2 pt-20 -126.28 176.88 6.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.85 0.357 . . . . 0.0 111.176 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . -174.98 143.37 6.76 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.583 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.89 -139.35 3.95 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.016 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.707 ' CE1' ' HB3' ' A' ' 125' ' ' ALA . 19.1 p90 -120.03 161.08 21.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.886 0.374 . . . . 0.0 111.051 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.513 ' NH2' HD12 ' A' ' 144' ' ' LEU . 0.9 OUTLIER -151.11 140.36 21.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.01 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -112.01 162.9 14.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.532 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.513 HD12 ' NH2' ' A' ' 142' ' ' ARG . 5.8 tt -153.68 145.72 23.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 2.3 ttm-85 -126.12 152.88 45.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.64 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.5 p -108.84 124.88 51.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.071 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -140.96 151.49 44.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.807 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -154.26 166.29 33.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.163 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.79 77.49 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.832 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.7 p -111.74 175.47 5.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.97 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.9 -46.59 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.83 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.06 -32.61 56.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.834 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.94 91.97 19.62 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.82 -175.82 1.3 Allowed 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.528 2.152 . . . . 0.0 112.335 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 65.5 m80 -124.91 -47.63 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.952 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 126.34 144.08 6.04 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.504 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -148.96 59.55 0.45 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.464 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.78 -172.39 2.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.836 0.351 . . . . 0.0 110.892 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.9 34.12 2.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.46 89.14 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.848 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 102.76 46.88 1.44 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.471 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 4.6 p -103.03 152.32 21.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 0.0 110.841 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.13 161.7 32.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.838 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.421 ' C ' HD12 ' A' ' 165' ' ' LEU . 4.5 t0 -66.76 -42.13 86.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.98 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.421 HD12 ' C ' ' A' ' 164' ' ' ASP . 7.8 mp -125.9 179.86 5.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.971 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -129.39 31.13 4.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.926 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 12.0 t -117.09 175.26 5.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 1.4 m -151.44 166.75 30.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 m -107.02 136.16 47.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.838 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -152.24 155.07 37.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 141' ' ' TYR . 88.5 m-85 -113.97 125.56 54.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.671 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -127.97 126.67 41.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.14 0.495 . . . . 0.0 111.263 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.548 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 3.1 pp -150.73 145.97 26.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.702 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.33 -149.02 6.05 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.674 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.522 ' HA ' HG22 ' A' ' 137' ' ' ILE . . . -121.0 168.74 11.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 111.175 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -153.89 116.14 4.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.938 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -99.14 114.87 27.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.038 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -81.42 153.78 26.74 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.063 -179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.96 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.837 0.351 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -121.72 168.02 12.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.403 ' HB2' ' CB ' ' A' ' 179' ' ' PHE . 2.1 m120 -75.26 131.3 40.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.544 ' O ' HG13 ' A' ' 6' ' ' VAL . 10.3 t80 -126.9 139.61 52.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.802 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 5' ' ' PHE . 6.4 m -159.56 126.15 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.247 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -147.95 -144.57 4.01 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.289 -0.958 . . . . 0.0 112.87 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 43' ' ' GLY . 1.8 mt -126.9 158.86 35.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.745 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.5 m -125.61 139.28 53.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.034 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -153.1 112.98 3.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.753 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.18 131.48 9.76 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.516 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.43 109.96 19.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 0.0 110.845 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 m -105.26 128.42 53.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.9 t -150.06 102.81 3.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -160.98 -55.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.851 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -96.13 94.95 7.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.831 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.58 99.53 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.097 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -104.8 -177.47 3.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 60.58 94.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.836 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -123.72 -63.05 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 tppm? -115.71 38.28 3.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.6 m 61.22 164.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.05 61.47 0.69 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.89 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m120 60.05 -175.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.843 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -117.95 138.5 52.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -155.64 153.87 30.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.2 177.07 8.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 59.87 31.63 20.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.6 p -129.64 101.47 18.68 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -49.15 120.14 5.23 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.562 2.175 . . . . 0.0 112.376 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -98.03 133.43 42.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.6 tp -149.85 -59.59 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -170.32 -69.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.46 82.69 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.858 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.548 HG12 ' O ' ' A' ' 35' ' ' VAL . 14.2 t -117.6 34.62 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.027 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -126.61 118.68 51.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.13 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 60.16 100.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -93.01 173.38 7.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.44 111.04 8.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.911 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 142.21 135.3 3.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.462 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.9 m -95.18 118.62 32.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.789 0.328 . . . . 0.0 110.897 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -123.51 126.24 46.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.49 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -152.02 -174.42 22.66 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.685 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.2 pp -117.42 176.83 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.605 0.241 . . . . 0.0 111.054 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.894 ' HG3' HG22 ' A' ' 58' ' ' THR . 3.2 mtp85 -135.97 145.88 46.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.042 0.449 . . . . 0.0 110.723 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -175.37 119.95 0.18 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.075 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -167.82 -136.91 2.13 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.577 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.78 113.0 8.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.92 0.39 . . . . 0.0 110.902 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.417 ' HA ' ' HB2' ' A' ' 54' ' ' ARG . 25.2 mt-30 -134.57 128.73 33.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.081 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' O ' ' CZ ' ' A' ' 83' ' ' PHE . 1.2 t80 -105.23 -166.96 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.439 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -50.41 -27.48 6.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.835 0.35 . . . . 0.0 110.945 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.416 ' O ' ' HB1' ' A' ' 82' ' ' ALA . 4.7 mt-30 -115.27 24.16 11.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.845 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 82' ' ' ALA . . . 71.82 -155.55 52.03 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.274 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' GLY . 0.1 OUTLIER 161.73 -82.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.684 0.278 . . . . 0.0 110.965 179.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -142.46 163.19 33.49 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.999 0.428 . . . . 0.0 111.23 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 79' ' ' SER . 2.3 p90 -166.01 117.86 1.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.743 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 46' ' ' ALA . . . -90.72 147.65 23.11 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.709 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.894 HG22 ' HG3' ' A' ' 45' ' ' ARG . 44.9 p -139.1 123.49 18.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.965 0.412 . . . . 0.0 111.071 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -91.9 124.61 36.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.5 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -117.49 163.91 15.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 111.105 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -149.17 -178.18 6.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.778 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 pp -124.86 122.2 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.19 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 62.2 m 61.15 96.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.066 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.42 81.37 0.53 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.757 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 30.5 m -150.03 -61.8 0.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.9 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.3 p -83.97 -45.42 13.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -62.23 -35.03 77.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 84.53 -58.51 4.99 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.481 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -111.79 151.5 28.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.8 0.334 . . . . 0.0 110.934 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -174.53 159.07 2.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mt -160.14 81.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.793 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.9 -38.23 3.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.886 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -172.67 148.59 1.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.48 167.53 10.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.57 ' ND2' HG13 ' A' ' 102' ' ' VAL . 19.4 m120 -138.04 125.73 22.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.995 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.5 mt -106.98 114.9 29.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.39 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.61 118.3 34.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.956 0.408 . . . . 0.0 111.45 -179.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -119.28 116.86 3.45 Favored Glycine 0 N--CA 1.451 -0.357 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 98' ' ' THR . 66.1 m -130.91 134.16 46.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.481 . . . . 0.0 112.231 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CG ' ' O ' ' A' ' 54' ' ' ARG . 7.5 t80 -105.52 110.7 23.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.105 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 94' ' ' PHE . 3.5 m-20 -136.59 172.16 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.22 0.533 . . . . 0.0 112.084 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.495 ' HA ' ' HA3' ' A' ' 53' ' ' GLY . . . -137.62 124.18 20.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.637 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.477 ' HB3' ' CD1' ' A' ' 94' ' ' PHE . 55.1 p90 -97.78 162.8 13.09 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.344 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.549 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.2 OUTLIER -162.27 137.77 5.54 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.657 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.549 ' HD2' HD23 ' A' ' 84' ' ' LEU . 58.5 Cg_endo -71.59 112.06 3.27 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.462 2.108 . . . . 0.0 112.296 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.406 ' CG1' ' HB2' ' A' ' 93' ' ' LEU . 40.7 mm -117.11 102.75 13.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.082 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.54 -60.43 0.67 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.355 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -177.25 -65.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.835 0.35 . . . . 0.0 110.674 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -177.61 36.88 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.812 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.13 -30.53 5.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.11 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.435 ' HB ' ' HB ' ' A' ' 127' ' ' ILE . 82.5 p -136.16 144.16 44.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.783 ' CB ' HD12 ' A' ' 128' ' ' LEU . 34.5 mttp -122.38 102.05 7.87 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.951 0.405 . . . . 0.0 110.729 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.472 ' O ' ' HA ' ' A' ' 83' ' ' PHE . 7.3 tp -55.34 102.95 0.08 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.406 0.622 . . . . 0.0 110.347 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 81' ' ' ASP . 5.2 t80 -110.58 142.09 42.89 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.175 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -176.31 156.02 20.26 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.425 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 168.68 -140.57 6.25 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.732 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.85 172.94 6.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.609 0.242 . . . . 0.0 110.891 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.648 HG22 ' OG ' ' A' ' 79' ' ' SER . 36.6 p -142.16 170.04 16.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.175 0.512 . . . . 0.0 111.631 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.448 ' CD1' HD23 ' A' ' 101' ' ' LEU . 0.2 OUTLIER -154.44 131.99 11.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.982 179.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.615 ' O ' HD22 ' A' ' 101' ' ' LEU . . . -127.82 123.41 4.47 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.668 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.615 HD22 ' O ' ' A' ' 100' ' ' GLY . 1.1 mm? -136.27 120.62 18.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.955 0.407 . . . . 0.0 110.304 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.57 HG13 ' ND2' ' A' ' 75' ' ' ASN . 21.3 t -109.88 142.57 21.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.271 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -125.61 132.67 52.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.828 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.4 tt -98.12 148.09 23.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -115.45 147.05 41.05 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -78.05 143.98 36.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.882 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.15 -50.91 17.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 126.62 -27.76 4.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.477 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.4 141.07 52.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.362 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.04 127.85 3.48 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.531 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -87.07 93.96 9.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -126.09 177.71 6.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.862 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.72 97.37 7.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.822 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -93.46 -176.1 4.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.1 m 63.39 125.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.975 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -168.47 78.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.875 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.6 p -96.12 132.68 39.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.145 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.562 ' O ' HD13 ' A' ' 101' ' ' LEU . . . -110.38 178.28 19.92 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.52 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.75 117.86 21.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.722 ' HB1' HD13 ' A' ' 144' ' ' LEU . . . -121.44 151.23 40.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.15 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.03 131.55 0.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.038 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.506 ' C ' HD12 ' A' ' 123' ' ' LEU . . . -163.24 -124.94 0.73 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.55 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.506 HD12 ' C ' ' A' ' 122' ' ' GLY . 4.2 mp -154.36 174.33 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.961 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.8 OUTLIER -153.48 170.5 20.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.687 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . 177.0 142.48 0.08 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.991 0.424 . . . . 0.0 110.928 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.597 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -163.3 -132.27 1.32 Allowed Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.726 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.597 HG23 ' O ' ' A' ' 126' ' ' GLY . 0.8 OUTLIER -161.78 120.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 -179.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.783 HD12 ' CB ' ' A' ' 92' ' ' LYS . 0.2 OUTLIER -98.17 116.29 30.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.044 0.45 . . . . 0.0 110.979 -179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -95.15 143.32 26.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -110.27 149.08 30.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.69 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.92 -48.79 3.03 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.015 0.436 . . . . 0.0 110.593 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.16 -164.97 0.49 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.193 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.09 57.74 2.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.888 0.375 . . . . 0.0 110.501 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -142.12 -61.06 0.45 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.083 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.29 171.98 15.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.118 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.85 167.92 20.28 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.027 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.1 tt -132.74 134.67 58.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.447 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.607 ' HG2' HD23 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -130.63 172.22 12.19 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.018 0.437 . . . . 0.0 111.402 -179.6 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.31 146.79 7.61 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.992 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.43 -147.7 5.66 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.057 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -126.13 146.91 49.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.804 0.335 . . . . 0.0 110.96 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.55 ' HD2' HD23 ' A' ' 144' ' ' LEU . 26.9 ttp180 -125.51 132.74 52.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.726 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -126.77 116.36 20.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.722 HD13 ' HB1' ' A' ' 120' ' ' ALA . 4.3 pp -156.45 159.21 38.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.844 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.67 137.57 52.57 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.859 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.9 t -118.85 134.27 55.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.88 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -139.49 117.12 11.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -109.28 32.2 5.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.066 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.6 t -159.7 168.22 26.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -147.98 118.84 7.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.834 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -161.47 158.06 26.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -88.82 -36.31 16.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.697 HG22 ' HD2' ' A' ' 154' ' ' PRO . 0.2 OUTLIER -86.33 145.02 39.12 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.909 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.697 ' HD2' HG22 ' A' ' 153' ' ' THR . 51.3 Cg_exo -53.13 165.79 1.23 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.513 2.142 . . . . 0.0 112.325 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -142.9 35.87 1.4 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 116.74 146.52 8.48 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.448 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 162.89 156.28 8.47 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -107.43 -53.24 2.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.819 0.342 . . . . 0.0 110.944 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -79.44 -177.57 5.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.625 HD12 ' N ' ' A' ' 161' ' ' GLY . 1.5 pp -134.95 -46.34 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.973 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.625 ' N ' HD12 ' A' ' 160' ' ' LEU . . . -128.94 48.46 0.97 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.508 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.483 ' CB ' HD23 ' A' ' 165' ' ' LEU . 32.2 t -79.42 176.08 10.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.351 . . . . 0.0 110.825 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 6.5 tt -112.47 -40.37 4.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.97 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.98 40.56 1.14 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.863 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.483 HD23 ' CB ' ' A' ' 162' ' ' SER . 0.5 OUTLIER -105.92 -43.67 4.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.887 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -69.04 -52.37 29.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.828 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.2 m -94.25 159.59 15.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 10.4 m -123.64 158.91 30.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.3 t -106.97 123.29 47.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.837 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.51 155.29 47.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.997 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -96.85 165.24 12.2 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.265 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -147.18 129.26 15.52 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.08 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.2 tt -163.42 129.99 3.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.572 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.58 -165.14 26.48 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.579 -0.82 . . . . 0.0 112.566 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -106.67 172.16 6.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.767 0.317 . . . . 0.0 111.013 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.413 ' ND2' ' CE1' ' A' ' 5' ' ' PHE . 17.4 t-20 -145.23 114.5 7.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.682 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -143.23 111.8 6.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.254 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -85.9 157.03 20.27 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.87 179.741 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.403 ' CB ' ' HB2' ' A' ' 4' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.881 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.833 0.349 . . . . 0.0 111.043 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -107.64 149.79 27.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.775 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -83.22 128.08 34.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.794 0.33 . . . . 0.0 110.712 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.2 m-85 -127.52 140.0 52.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.451 HG13 ' HB2' ' A' ' 46' ' ' ALA . 21.9 t -152.8 128.07 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.067 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -158.38 -151.63 6.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.529 -0.844 . . . . 0.0 112.718 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.45 HD23 ' O ' ' A' ' 43' ' ' GLY . 5.3 mt -132.01 149.43 52.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.89 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.654 HG23 ' HD2' ' A' ' 45' ' ' ARG . 1.3 p -110.39 149.3 30.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.018 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 23.6 t-105 -152.77 113.04 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.748 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.07 133.77 11.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.436 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.498 ' HG3' HG23 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -104.97 109.94 22.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.878 0.37 . . . . 0.0 110.909 179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.519 HG23 HG22 ' A' ' 39' ' ' THR . 2.2 t -121.5 128.58 52.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -150.12 102.77 3.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.776 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -155.26 -46.52 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.867 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.74 126.03 25.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.832 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.58 112.66 41.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.158 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -102.65 36.74 2.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -146.95 121.41 9.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.79 26.29 0.44 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.84 -30.33 6.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 1.4 p -92.63 46.44 1.24 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.959 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.2 mt 58.41 177.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.066 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -85.42 171.57 11.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.868 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -167.42 131.83 1.88 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.838 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -139.0 -46.84 0.48 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.3 mp -89.13 83.48 6.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -106.43 -43.04 4.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 85.4 p -176.48 139.85 0.5 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -73.77 -29.08 10.88 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.428 2.086 . . . . 0.0 112.334 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.63 158.32 33.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 32' ' ' LEU . 2.0 pp -112.53 101.58 9.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.848 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -112.17 -41.62 3.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.853 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mttm -115.7 89.55 3.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.5 t -88.27 -56.92 4.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.498 HG23 ' HG3' ' A' ' 12' ' ' GLU . 3.6 pt -107.81 101.8 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -71.34 -68.45 0.44 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.877 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -134.11 33.52 3.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.939 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.519 HG22 HG23 ' A' ' 13' ' ' THR . 2.5 m -137.66 156.39 48.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 144.58 165.98 11.32 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.409 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.7 p -119.57 107.92 13.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.753 0.311 . . . . 0.0 110.975 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -119.29 129.88 55.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.81 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.45 ' O ' HD23 ' A' ' 8' ' ' LEU . . . -164.94 -164.99 21.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.573 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 58' ' ' THR . 12.2 pt -107.67 162.48 5.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.66 0.267 . . . . 0.0 111.068 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.654 ' HD2' HG23 ' A' ' 9' ' ' THR . 15.9 ttt85 -132.78 138.11 47.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.55 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 57' ' ' ALA . . . -173.14 122.08 0.38 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.005 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -157.14 -137.8 2.38 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.87 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -145.48 120.4 9.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.881 0.372 . . . . 0.0 110.901 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 2.3 tt0 -101.67 112.07 24.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.371 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 0.9 OUTLIER -119.57 163.82 16.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.741 179.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -17.76 65.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.494 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.12 24.37 13.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.642 0.258 . . . . 0.0 111.286 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 50' ' ' PHE . . . 145.86 167.33 12.5 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.333 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.753 ' NH2' HD22 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -134.09 115.26 14.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.965 0.412 . . . . 0.0 111.285 -179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.606 ' HE1' ' HB2' ' A' ' 57' ' ' ALA . 13.5 t80 -91.87 126.33 36.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.901 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.455 ' CE1' ' ND2' ' A' ' 176' ' ' ASN . 0.5 OUTLIER -133.4 103.08 5.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 0.0 111.815 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB2' ' HE1' ' A' ' 55' ' ' TYR . . . -97.32 119.62 36.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.861 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.438 HG23 ' HB2' ' A' ' 77' ' ' LEU . 1.6 t -128.6 122.74 31.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.147 0.498 . . . . 0.0 111.438 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -86.79 124.52 33.12 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.474 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -102.04 166.96 10.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.944 0.402 . . . . 0.0 111.216 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.42 -166.33 1.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.754 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.876 HD11 ' HB3' ' A' ' 73' ' ' GLN . 3.6 mp -100.16 113.29 35.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.147 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.6 -43.25 12.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.24 87.76 6.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.4 t -78.43 142.57 37.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.833 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.9 t -90.95 -54.06 4.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 63.4 m -108.55 -35.88 6.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 114.23 49.06 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.504 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -143.17 137.36 28.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.746 0.307 . . . . 0.0 110.833 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -149.01 120.3 7.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -139.6 -60.64 0.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.8 mtt180 -105.85 53.83 0.7 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.876 ' HB3' HD11 ' A' ' 62' ' ' ILE . 3.7 mm-40 -132.64 122.37 24.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.973 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 3.1 pm0 -162.97 153.75 16.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.799 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.791 ' HB3' HG12 ' A' ' 102' ' ' VAL . 43.2 m-20 -143.98 111.01 5.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.139 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.426 ' HG ' ' CZ ' ' A' ' 59' ' ' TYR . 0.5 OUTLIER -85.46 145.94 27.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.406 179.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HB2' HG23 ' A' ' 58' ' ' THR . 5.5 mp -139.54 107.91 5.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 111.385 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.78 119.67 4.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.746 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.43 ' CB ' ' HA ' ' A' ' 98' ' ' THR . 24.3 p -130.5 150.44 51.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.077 0.465 . . . . 0.0 111.869 -179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -117.51 110.86 18.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.904 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.455 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 1.8 m-20 -124.17 153.35 41.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 111.622 -179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -100.65 118.56 37.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.231 179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 93' ' ' LEU . 43.8 p90 -97.54 153.75 17.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.826 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -159.34 143.07 10.84 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.731 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 91' ' ' THR . 31.9 Cg_endo -63.64 91.71 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.691 2.261 . . . . 0.0 112.262 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.545 HG23 ' HB2' ' A' ' 93' ' ' LEU . 19.0 tt -157.12 126.57 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.014 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 157.76 -56.87 0.36 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.539 -0.838 . . . . 0.0 112.719 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -154.01 -46.63 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.754 0.311 . . . . 0.0 111.067 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -169.33 -46.72 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.254 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 0.7 OUTLIER -126.17 20.82 7.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.651 -179.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.423 HG23 ' HG3' ' A' ' 129' ' ' GLN . 0.1 OUTLIER -80.12 153.22 28.84 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.415 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.1 OUTLIER -131.18 92.42 3.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.99 -179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' A' ' 86' ' ' ILE . 1.4 tt -61.74 102.22 0.25 Allowed 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 121.279 0.562 . . . . 0.0 110.1 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 125' ' ' ALA . 23.0 p90 -111.01 120.79 43.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.518 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.455 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -142.78 151.42 23.1 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.815 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 177.33 -140.09 4.66 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.561 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -125.43 150.66 47.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.761 0.315 . . . . 0.0 111.091 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.43 ' HA ' ' CB ' ' A' ' 79' ' ' SER . 11.6 t -118.93 153.36 34.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.277 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 120' ' ' ALA . 0.2 OUTLIER -160.18 129.09 4.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.589 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -150.74 -149.18 4.97 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.856 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.7 tt -155.21 129.21 8.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 0.0 110.49 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.791 HG12 ' HB3' ' A' ' 75' ' ' ASN . 11.2 m -109.76 128.44 65.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.245 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.455 ' HA ' HG22 ' A' ' 117' ' ' VAL . 6.3 mmtt -122.89 127.34 48.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.833 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.593 HD12 ' HB2' ' A' ' 116' ' ' ASP . 3.3 mt -132.15 131.79 42.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.66 140.59 21.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.879 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -89.52 169.83 11.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.07 135.25 28.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.846 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.81 -137.74 6.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.468 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.45 105.7 0.98 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.82 0.343 . . . . 0.0 110.969 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.51 -76.75 0.25 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.475 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.68 172.23 1.72 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.832 0.349 . . . . 0.0 110.856 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.8 -179.95 7.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.79 146.35 30.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.91 161.18 23.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.879 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 m -153.77 70.4 0.83 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.593 ' HB2' HD12 ' A' ' 104' ' ' LEU . 1.8 m-20 -108.31 31.02 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 103' ' ' LYS . 25.1 t -84.45 125.08 40.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -160.67 -163.33 13.69 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.566 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -96.0 123.09 39.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.789 0.328 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.688 ' O ' HD23 ' A' ' 99' ' ' LEU . . . -94.98 146.82 23.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -168.85 140.81 2.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.941 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -163.74 -136.91 2.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.71 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.08 155.03 40.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.788 0.328 . . . . 0.0 110.882 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.44 ' NE2' ' CE2' ' A' ' 172' ' ' TYR . 0.5 OUTLIER -138.57 158.37 44.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.996 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 94' ' ' PHE . . . -176.36 141.98 0.44 Allowed 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.471 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.589 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -175.08 -146.57 5.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.923 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 126' ' ' GLY . 9.5 pt -162.26 120.59 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 122.69 0.396 . . . . 0.0 110.01 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.753 HD22 ' NH2' ' A' ' 54' ' ' ARG . 7.8 tp -94.73 111.92 23.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.969 0.414 . . . . 0.0 110.851 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 4.3 tt0 -102.5 131.16 49.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.131 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 59.9 tt0 -97.28 149.17 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.66 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.75 -45.07 4.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.98 0.419 . . . . 0.0 110.613 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.11 -164.86 0.49 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.105 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.52 55.77 2.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.922 0.391 . . . . 0.0 110.69 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -139.06 -58.68 0.6 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.024 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -160.06 163.01 34.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.987 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.7 t -116.15 170.4 8.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.401 ' O ' ' N ' ' A' ' 129' ' ' GLN . 2.1 mp -129.98 134.75 62.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.568 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.43 ' HG2' ' CE1' ' A' ' 94' ' ' PHE . 8.1 tt0 -123.83 147.04 47.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.961 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.62 141.66 7.23 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.402 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 178.51 -135.83 2.75 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.464 -0.875 . . . . 0.0 112.778 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -133.79 161.21 35.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.868 0.366 . . . . 0.0 110.881 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.402 ' HG2' ' CG ' ' A' ' 124' ' ' GLN . 0.3 OUTLIER -147.72 147.49 29.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.85 140.51 50.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.643 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 tt -117.35 137.09 52.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.144 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.05 117.8 3.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.633 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -108.95 131.84 54.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.008 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.08 114.86 9.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.79 -72.51 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.09 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 150' ' ' THR . 3.6 m -162.26 160.66 27.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.856 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 149' ' ' SER . 18.0 p -159.63 39.17 0.2 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.872 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -132.79 -46.62 0.87 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 7.0 mmt -76.76 -25.44 53.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.136 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 60.5 p -111.61 93.25 19.11 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.937 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.97 174.54 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 59.48 -175.22 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.932 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -153.71 -109.19 0.36 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.545 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 107.22 147.9 14.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.51 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -135.26 103.66 5.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.803 0.335 . . . . 0.0 110.947 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -178.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 2.5 mt -92.33 168.9 11.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 150.54 -48.79 0.57 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.478 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 75.3 m -131.16 176.04 8.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.851 0.357 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 16.9 mt -99.6 -51.25 3.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.859 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.58 159.96 15.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.868 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -175.26 106.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.848 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -174.22 -63.81 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.876 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 96.4 p -155.38 161.73 40.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 4.6 t -118.02 160.57 21.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.9 129.5 54.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.906 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -139.52 155.2 47.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.842 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -103.41 165.14 11.21 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.159 0.504 . . . . 0.0 110.28 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.44 ' CE2' ' NE2' ' A' ' 124' ' ' GLN . 0.1 OUTLIER -138.29 129.47 27.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.889 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.1 tp -163.32 135.15 5.04 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.782 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 172.93 -152.69 16.74 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.64 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -130.26 171.31 13.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.455 ' ND2' ' CE1' ' A' ' 56' ' ' TYR . 14.5 m120 -151.57 114.98 4.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.082 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -116.72 117.71 30.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.674 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.86 162.41 22.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.205 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.71 0.29 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 49' ' ' GLN . 10.8 m-20 -152.18 137.82 17.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.194 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 179' ' ' PHE . 2.8 t30 -71.41 131.58 43.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.584 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 2.1 m-85 -123.98 139.9 53.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.684 HG13 ' HB2' ' A' ' 46' ' ' ALA . 21.4 t -150.48 122.34 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.122 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.08 -135.33 1.84 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.619 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mp -144.95 166.66 24.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.743 0.306 . . . . 0.0 110.819 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -136.83 146.52 45.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.165 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -153.0 117.54 4.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.664 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 172' ' ' TYR . . . -136.1 -176.08 14.16 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.466 -0.874 . . . . 0.0 113.021 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.571 ' OE2' HG21 ' A' ' 35' ' ' VAL . 2.0 tm-20 -98.15 149.02 22.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.863 0.363 . . . . 0.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.453 HG22 HD21 ' A' ' 15' ' ' ASN . 0.9 OUTLIER -92.08 131.42 37.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.893 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.3 p -150.14 102.79 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.453 HD21 HG22 ' A' ' 13' ' ' THR . 3.0 p30 -157.75 142.74 16.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.923 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -88.13 97.23 10.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.4 pp -142.55 151.39 17.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.133 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -104.29 138.21 41.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.875 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.9 mttt -74.84 -31.79 61.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.901 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.51 136.17 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -76.22 134.1 39.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 84.1 p -114.7 111.5 21.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -48.53 23.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -149.02 102.85 3.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.88 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.41 165.3 7.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.5 164.13 23.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.831 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.49 83.86 2.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -122.11 78.04 1.45 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.69 156.17 55.93 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.948 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.23 -45.34 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.533 2.155 . . . . 0.0 112.283 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -149.37 149.32 30.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mt -142.53 32.29 1.47 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.852 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.16 -74.18 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' O ' HG13 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -162.78 -72.82 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.571 HG21 ' OE2' ' A' ' 12' ' ' GLU . 8.8 m -156.85 82.82 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.728 HD12 ' N ' ' A' ' 37' ' ' ASP . 2.5 pp -63.74 -47.99 88.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.355 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.728 ' N ' HD12 ' A' ' 36' ' ' ILE . 0.4 OUTLIER 176.29 40.22 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.838 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -144.5 38.78 1.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.976 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.4 HG22 ' CB ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -161.9 143.01 10.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.933 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.97 156.37 17.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.453 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.9 p -140.61 107.93 5.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.851 0.358 . . . . 0.0 111.016 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 37.0 p-90 -135.15 158.32 44.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.814 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.06 -166.95 32.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.768 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.509 HG22 ' N ' ' A' ' 45' ' ' ARG . 9.4 mt -107.63 163.74 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.428 0.156 . . . . 0.0 110.828 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' N ' HG22 ' A' ' 44' ' ' ILE . 1.6 ttt180 -135.87 138.52 42.55 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.934 0.397 . . . . 0.0 110.834 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.684 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -171.05 119.8 0.51 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.255 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -162.5 -133.63 1.51 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.683 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -155.73 148.81 24.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.017 0.437 . . . . 0.0 111.0 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.451 ' NE2' ' CZ ' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -100.7 162.57 12.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.756 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -133.29 165.78 24.03 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.915 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.16 -24.65 65.9 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.371 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.2 24.13 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.448 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 177.77 177.49 46.61 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.447 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . 13.2 ttp-105 -143.91 140.58 29.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.855 0.359 . . . . 0.0 111.074 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -124.43 149.44 46.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.578 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.529 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 34.0 p90 -178.28 126.57 0.12 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.892 0.377 . . . . 0.0 111.038 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.75 162.77 14.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.527 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 49.7 p -141.05 124.46 16.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.07 0.462 . . . . 0.0 111.517 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.45 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 9.2 m-85 -92.51 116.57 29.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.957 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -110.06 178.37 4.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.029 0.442 . . . . 0.0 111.569 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -164.98 154.4 12.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.51 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.6 tt -100.02 130.28 49.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.176 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 33.1 t -96.68 108.71 21.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -116.43 -66.14 1.11 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 46.1 p -85.72 89.9 7.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.2 t -69.63 -33.07 72.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 p -112.63 -35.86 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.822 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -69.57 -146.12 0.23 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.623 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -114.0 130.07 56.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.785 0.326 . . . . 0.0 110.901 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 136.59 34.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 mp -78.66 162.41 26.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.944 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.4 mtm-85 -67.06 124.95 24.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.828 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -155.79 160.76 40.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.918 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.21 135.88 3.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.779 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -120.87 114.64 21.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.577 HD13 ' N ' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -98.32 128.94 44.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.496 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.634 HD11 HD11 ' A' ' 144' ' ' LEU . 2.2 mt -138.87 131.07 28.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.891 0.377 . . . . 0.0 111.183 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.76 116.82 4.27 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.578 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.686 ' HB3' HG22 ' A' ' 98' ' ' THR . 0.9 OUTLIER -106.65 126.28 52.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.956 0.408 . . . . 0.0 111.768 -179.066 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -125.39 110.7 14.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.758 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -133.31 166.1 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.036 0.446 . . . . 0.0 111.507 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -109.63 118.33 36.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.173 179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 48.5 p90 -97.85 167.62 10.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.827 -179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 11.7 tp -160.56 121.08 1.65 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.577 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -49.53 114.69 1.43 Allowed 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.493 2.129 . . . . 0.0 112.541 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.6 OUTLIER -156.29 123.74 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.152 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.46 -95.64 0.3 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.658 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.6 33.23 5.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.812 0.339 . . . . 0.0 110.87 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.2 m-20 63.56 24.82 14.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.711 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -141.36 -44.58 0.37 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.732 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.04 150.71 16.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.483 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 2.4 mptm? -132.06 92.48 3.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.334 . . . . 0.0 111.45 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.43 ' O ' HD23 ' A' ' 93' ' ' LEU . 9.0 tt -63.23 102.96 0.44 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 121.137 0.494 . . . . 0.0 109.848 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 45.6 p90 -110.71 159.7 17.38 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.34 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.26 126.79 1.31 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.783 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.99 -140.29 2.89 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -128.74 178.83 6.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.844 0.354 . . . . 0.0 111.156 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.686 HG22 ' HB3' ' A' ' 79' ' ' SER . 44.3 p -144.08 152.13 40.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.238 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.11 131.37 5.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.59 -140.56 3.05 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.909 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.14 125.94 7.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.871 0.367 . . . . 0.0 110.734 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 28.6 m -109.86 140.18 29.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.163 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -141.76 136.94 31.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.824 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.488 HD23 ' H ' ' A' ' 105' ' ' GLU . 0.3 OUTLIER -148.96 158.45 44.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.959 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.488 ' H ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -122.2 172.65 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.26 163.14 33.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -130.64 37.52 3.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.847 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -66.52 -156.82 0.47 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.592 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.9 tmtt? -123.15 88.81 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.813 0.34 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.74 -176.93 33.91 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.486 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -75.65 96.58 3.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.777 0.322 . . . . 0.0 110.838 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -101.55 138.18 38.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.95 -59.33 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.918 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -119.09 110.04 16.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.5 m -80.93 -64.14 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -149.43 80.91 1.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 31.3 t -130.38 120.89 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 148' ' ' ALA . . . -161.51 175.56 38.08 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.61 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -83.96 136.19 34.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.812 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -94.94 139.68 30.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -164.93 132.01 3.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.952 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -164.86 -140.83 2.97 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.628 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 15.9 mt -143.89 170.28 16.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.845 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.478 ' HG3' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -160.13 150.02 18.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 94' ' ' PHE . . . 178.21 142.39 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.377 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.592 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -175.32 -126.74 0.96 Allowed Glycine 0 C--O 1.229 -0.192 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.806 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.592 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.3 pp -161.07 120.68 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 120.793 0.33 . . . . 0.0 110.512 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.48 HD12 ' HG3' ' A' ' 138' ' ' GLU . 2.2 tt -104.01 116.09 31.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.634 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.625 ' HG2' HG23 ' A' ' 137' ' ' ILE . 18.8 pt20 -116.85 126.22 52.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.775 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' CB ' ' A' ' 136' ' ' SER . 25.2 tt0 -69.24 147.88 50.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.273 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.27 -30.68 7.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.338 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.7 t -160.93 -165.02 1.28 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.196 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -90.28 50.0 1.78 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.371 . . . . 0.0 110.771 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 174.14 -28.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.6 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.5 157.19 29.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.857 0.361 . . . . 0.0 111.393 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.41 ' CB ' ' HA ' ' A' ' 130' ' ' GLU . 15.2 m -155.92 169.05 25.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.994 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.625 HG23 ' HG2' ' A' ' 129' ' ' GLN . 18.3 tt -131.49 135.0 60.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.417 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.48 ' HG3' HD12 ' A' ' 128' ' ' LEU . 1.3 tm-20 -133.52 167.64 20.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.544 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 173' ' ' LEU . . . 174.09 153.65 10.05 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.665 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 171.3 -125.95 1.26 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.123 -1.037 . . . . 0.0 112.971 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.444 ' CE2' ' HB3' ' A' ' 171' ' ' PHE . 5.3 m-85 -133.77 161.15 35.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.888 0.375 . . . . 0.0 111.065 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.96 147.33 19.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.857 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -108.29 147.81 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.754 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.634 HD11 HD11 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -128.87 134.9 48.45 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.92 147.0 28.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.8 t -121.98 125.86 47.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.923 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -140.79 115.67 9.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.406 ' HB2' ' HA2' ' A' ' 118' ' ' GLY . . . -153.2 31.24 0.48 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.107 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 93.5 p -86.11 162.7 18.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.12 81.55 1.89 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -137.7 122.95 19.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.956 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 4.7 ptt? -121.6 -43.01 2.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 16.7 p -86.71 149.26 48.05 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.923 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.68 176.04 8.01 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.552 2.168 . . . . 0.0 112.311 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 60.31 110.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 149.42 84.85 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.558 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -174.4 -42.02 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.585 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 34.3 m120 59.83 29.45 19.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.82 0.343 . . . . 0.0 110.97 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -178.14 125.37 0.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.907 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.0 mt -88.57 129.11 35.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -116.82 113.13 2.69 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.503 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.9 165.29 6.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.775 0.321 . . . . 0.0 110.892 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 3.0 tt -59.74 109.47 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -134.04 170.31 15.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.999 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.465 HD23 ' N ' ' A' ' 166' ' ' HIS . 9.5 tt 64.54 -77.95 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.019 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.465 ' N ' HD23 ' A' ' 165' ' ' LEU . 1.2 t60 65.87 -70.39 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.778 0.323 . . . . 0.0 111.124 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 165' ' ' LEU . 0.6 OUTLIER -162.07 166.6 25.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.707 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 62.2 m -127.44 136.99 52.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.977 -179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.2 p -119.88 117.73 28.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.826 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -134.07 155.38 50.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.888 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.444 ' HB3' ' CE2' ' A' ' 141' ' ' TYR . 43.2 p90 -111.12 124.41 52.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.382 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.478 ' HA ' ' HA2' ' A' ' 11' ' ' GLY . 7.4 p90 -124.68 179.2 5.07 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.643 0.735 . . . . 0.0 111.966 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.506 ' HA ' ' HA2' ' A' ' 139' ' ' GLY . 0.4 OUTLIER -163.45 147.88 10.84 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.872 179.915 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -168.3 -162.86 21.22 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.207 -0.997 . . . . 0.0 112.809 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -123.23 171.74 9.13 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.861 0.363 . . . . 0.0 111.047 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.439 HD22 HD11 ' A' ' 128' ' ' LEU . 1.6 t30 -156.29 117.1 3.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -106.65 112.01 24.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.59 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.95 154.06 25.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.109 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 4' ' ' ASN . 1.3 m-85 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.904 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.895 0.379 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.62 123.82 13.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.112 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -63.51 137.75 58.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.826 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.3 m-85 -129.0 139.75 51.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.057 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.524 HG13 ' HB2' ' A' ' 46' ' ' ALA . 25.7 t -154.94 124.64 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.012 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -159.98 -144.06 3.85 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.58 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mt -139.76 142.86 36.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.844 0.354 . . . . 0.0 110.822 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.477 HG21 HG23 ' A' ' 58' ' ' THR . 9.7 t -112.15 142.4 44.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.994 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -134.33 114.55 13.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -97.74 132.54 11.01 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.426 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -88.25 110.0 20.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 110.856 -179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.64 135.33 31.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.82 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.4 t -150.06 102.88 3.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.862 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.84 -39.24 24.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.859 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -85.6 162.09 19.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.884 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 16.1 pt -115.35 165.74 10.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.149 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -145.42 109.76 4.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.8 33.04 3.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.938 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.9 m -153.18 110.77 3.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.962 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.51 -48.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.83 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.4 p -157.28 129.8 7.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.965 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 mp -119.08 -68.43 0.92 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -95.94 123.73 39.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.01 150.61 49.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -141.99 146.92 36.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.9 tp -117.34 90.5 3.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.87 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -145.96 -52.25 0.25 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.867 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.479 ' CB ' ' CD ' ' A' ' 30' ' ' PRO . 1.5 t -114.48 -68.54 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.479 ' CD ' ' CB ' ' A' ' 29' ' ' SER . 60.6 Cg_endo -72.42 -178.18 3.17 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.136 1.89 . . . . 0.0 112.393 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -133.47 -173.08 3.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.49 103.21 15.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -75.11 -30.96 61.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.987 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 mmtt 61.29 92.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.875 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 35' ' ' VAL . 7.9 p -102.93 56.24 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.058 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' O ' HD12 ' A' ' 36' ' ' ILE . 1.8 pp -107.05 111.59 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.117 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -148.72 134.91 19.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.973 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -144.3 157.16 44.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.929 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.5 p -108.04 130.74 55.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.76 -68.57 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.6 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 m -139.17 138.31 36.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.327 . . . . 0.0 110.899 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -162.03 129.42 3.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.825 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -158.44 -167.56 19.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.524 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.49 HG22 ' N ' ' A' ' 45' ' ' ARG . 21.0 mt -109.28 161.07 7.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.745 0.307 . . . . 0.0 110.964 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.49 ' N ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -129.02 133.02 47.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.665 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.524 ' HB2' HG13 ' A' ' 6' ' ' VAL . . . -169.2 120.02 0.71 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.106 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -159.51 -136.95 2.13 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.593 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -153.85 136.37 15.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.951 0.405 . . . . 0.0 110.99 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HG2' ' N ' ' A' ' 50' ' ' PHE . 36.5 tt0 -89.52 162.29 15.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.66 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.4 ' N ' ' HG2' ' A' ' 49' ' ' GLN . 0.6 OUTLIER -134.95 167.21 21.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.929 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -67.11 -25.9 66.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.074 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.67 24.26 3.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.01 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -174.44 179.97 45.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.192 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.01 130.3 7.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 0.0 111.276 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.434 ' CD2' ' HB3' ' A' ' 80' ' ' TYR . 4.1 m-85 -107.7 159.83 16.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.489 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -173.59 123.89 0.37 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.912 0.387 . . . . 0.0 111.198 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.88 153.12 20.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.602 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.477 HG23 HG21 ' A' ' 9' ' ' THR . 91.3 m -130.93 118.77 21.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.18 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.452 ' CE2' ' CD2' ' A' ' 76' ' ' LEU . 4.6 m-85 -99.23 118.34 35.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.507 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -110.82 141.85 43.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 111.157 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.25 -69.54 0.24 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.753 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 19.1 mt -151.89 127.64 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.109 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 86.7 p -87.66 55.17 3.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -153.45 152.22 30.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.8 p -109.19 -35.79 6.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.925 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.82 -48.66 17.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.943 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.5 p -112.27 27.11 9.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.994 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -107.61 75.37 0.22 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.495 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -132.59 177.02 7.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 0.0 110.883 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt 60.59 163.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.89 88.92 3.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.826 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -87.39 -30.63 20.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -143.58 139.67 29.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.988 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.55 135.6 53.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.71 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.479 ' ND2' HG13 ' A' ' 102' ' ' VAL . 6.1 m-80 -129.61 117.8 20.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.175 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 1.5 tm? -124.38 114.92 20.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.391 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 99' ' ' LEU . 0.5 OUTLIER -134.1 126.21 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.962 0.411 . . . . 0.0 111.593 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -113.39 116.8 4.04 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.645 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 98' ' ' THR . 0.8 OUTLIER -111.72 156.71 21.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.075 0.464 . . . . 0.0 111.702 -179.248 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.434 ' HB3' ' CD2' ' A' ' 55' ' ' TYR . 23.6 p90 -130.86 110.94 11.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.308 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB3' ' N ' ' A' ' 95' ' ' GLY . 2.4 m-20 -120.81 155.25 34.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.974 0.416 . . . . 0.0 111.494 -179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.425 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -105.6 119.25 38.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.533 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 39.1 p90 -97.59 156.14 16.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.139 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 tp -155.49 140.32 12.04 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.805 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.85 113.0 1.12 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.451 2.101 . . . . 0.0 112.178 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.733 HG23 ' HB ' ' A' ' 91' ' ' THR . 7.8 tp -119.12 97.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.985 0.422 . . . . 0.0 111.085 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 115.02 -73.68 0.25 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.614 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -153.77 -49.6 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.648 0.261 . . . . 0.0 111.233 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 174.62 -27.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.391 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 37.3 p-10 -73.99 3.06 7.4 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.733 ' HB ' HG23 ' A' ' 86' ' ' ILE . 0.2 OUTLIER -136.55 130.0 31.77 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.477 -0.194 . . . . 0.0 110.477 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 9.9 mttt -123.15 92.66 3.75 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.556 -0.458 . . . . 0.0 111.142 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.422 HD12 ' CG2' ' A' ' 127' ' ' ILE . 4.7 tp -64.88 102.72 0.63 Allowed 'General case' 0 N--CA 1.45 -0.475 0 CA-C-O 121.319 0.581 . . . . 0.0 110.253 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 17.7 p90 -115.75 155.05 28.5 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.404 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -172.77 142.92 7.02 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.558 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -174.73 -143.73 4.58 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.657 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.09 162.23 29.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.772 0.32 . . . . 0.0 111.083 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.513 ' C ' HD12 ' A' ' 99' ' ' LEU . 5.2 t -129.2 155.73 45.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.513 HD12 ' C ' ' A' ' 98' ' ' THR . 2.9 mp -160.11 130.87 5.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.713 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.476 ' N ' HD23 ' A' ' 77' ' ' LEU . . . -156.63 -150.39 5.65 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.866 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.05 127.28 7.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.618 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.479 HG13 ' ND2' ' A' ' 75' ' ' ASN . 21.4 t -109.88 133.67 54.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.048 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 117' ' ' VAL . 5.4 mtpp -120.98 129.97 53.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.948 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 105' ' ' GLU . 6.6 tt -121.45 153.67 37.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.828 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.666 ' N ' HD23 ' A' ' 104' ' ' LEU . 4.5 pt-20 -169.61 172.09 7.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.943 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -100.71 156.01 17.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.928 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -114.02 104.43 12.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -135.74 -55.48 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.471 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -111.03 -33.13 6.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.817 0.341 . . . . 0.0 110.843 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.46 33.87 1.68 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.555 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -78.36 106.45 10.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.831 0.348 . . . . 0.0 110.842 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.4 ttmm -73.11 83.26 1.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.65 112.22 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -100.89 126.69 47.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.971 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.34 -29.02 8.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.02 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -81.68 59.95 4.41 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.474 HG12 ' HG2' ' A' ' 103' ' ' LYS . 10.7 m -98.66 161.76 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.067 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -158.4 -179.27 33.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.553 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . 0.457 ' HE1' HD23 ' A' ' 99' ' ' LEU . 0.7 OUTLIER -103.21 118.41 36.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.917 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.723 ' HA ' HG22 ' A' ' 146' ' ' THR . . . -95.31 143.41 26.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.087 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 137.94 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -165.66 -143.43 3.73 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.498 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -157.11 160.46 38.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.76 0.314 . . . . 0.0 110.966 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -156.88 165.74 35.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.047 179.93 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.406 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.91 142.49 0.08 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.272 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -162.52 -127.0 0.85 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.263 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 92' ' ' LYS . 14.6 pt -156.93 120.78 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -94.43 112.74 24.53 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.188 0.518 . . . . 0.0 111.019 -179.469 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.42 HE21 HD12 ' A' ' 127' ' ' ILE . 6.4 mt-30 -102.46 115.54 30.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.024 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 136' ' ' SER . 23.6 mt-10 -73.4 149.18 42.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.872 HD13 HD11 ' A' ' 137' ' ' ILE . 8.4 tp -108.01 -31.82 7.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.076 0.465 . . . . 0.0 110.409 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.1 m -169.04 -173.98 1.92 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.131 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.0 pttt -81.98 55.64 2.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.791 0.329 . . . . 0.0 110.696 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -178.45 -37.42 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.277 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -120.79 155.87 33.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.895 0.378 . . . . 0.0 111.201 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 0.3 OUTLIER -140.08 -178.64 5.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.876 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.872 HD11 HD13 ' A' ' 131' ' ' LEU . 28.9 mt -138.78 134.95 43.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.968 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.96 131.53 54.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.708 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -155.35 124.29 1.48 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.66 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.28 -144.08 4.67 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.803 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 35.4 p90 -126.2 161.11 28.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.742 0.306 . . . . 0.0 110.749 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.5 ttm180 -153.18 145.67 24.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.052 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.74 138.94 52.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.618 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.7 mt -121.86 132.58 54.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.089 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.97 111.96 4.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.695 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.723 HG22 ' HA ' ' A' ' 120' ' ' ALA . 6.9 p -111.75 142.78 43.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.057 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -141.02 115.16 9.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -100.76 -69.6 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.171 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.17 149.55 41.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.911 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 24.7 p -132.89 -177.94 4.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.944 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.18 56.26 3.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.82 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 69.15 -65.63 0.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.935 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.71 108.94 45.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.877 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -61.02 -45.71 18.66 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.509 2.139 . . . . 0.0 112.112 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 9.7 t60 -104.86 175.52 5.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 102.96 117.27 4.31 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.495 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 80.56 36.9 21.91 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.537 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -91.5 88.24 6.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.37 -46.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 160' ' ' LEU . 3.4 pp -137.59 127.96 26.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 135.15 162.92 9.91 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.512 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 30.2 t -62.55 157.42 20.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.83 0.347 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -127.05 102.54 7.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.93 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -60.39 -46.18 90.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.53 130.13 37.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.87 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -160.93 93.14 0.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.95 171.88 2.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.866 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 51.6 p -149.24 179.76 7.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.929 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -106.97 123.17 47.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.767 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.4 mm100 -113.08 155.24 25.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -106.36 153.3 22.41 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.203 0.525 . . . . 0.0 110.144 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.402 ' O ' ' HA2' ' A' ' 139' ' ' GLY . 0.1 OUTLIER -123.57 126.78 47.27 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.583 -179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.52 129.91 3.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.548 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 171.66 -152.2 17.06 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.891 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -128.23 172.17 11.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.091 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -149.87 114.94 5.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.991 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -108.09 111.93 24.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.753 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -83.52 159.72 21.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.129 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.778 0.323 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' CB ' ' HB3' ' A' ' 49' ' ' GLN . 1.5 t0 -112.03 168.57 9.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.096 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -109.77 134.45 52.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.689 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 10.0 m-85 -133.47 139.99 47.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.865 0.364 . . . . 0.0 111.044 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 46' ' ' ALA . 11.1 p -155.3 122.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.199 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -157.31 -139.91 2.82 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.541 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -140.19 164.03 31.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.727 0.298 . . . . 0.0 110.759 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.656 HG21 HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -148.42 155.66 41.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.908 0.385 . . . . 0.0 111.354 -179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -153.08 128.13 9.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.602 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -114.74 160.83 12.99 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.579 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -98.65 115.55 28.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.815 0.341 . . . . 0.0 110.868 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.9 p -140.75 113.01 7.89 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.83 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 t -150.12 102.87 3.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.769 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -102.89 90.64 3.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -64.01 123.84 20.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.915 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.519 ' H ' HD12 ' A' ' 17' ' ' ILE . 3.9 mp -91.93 130.93 40.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.17 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 90.4 mt-30 -104.19 100.84 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -137.89 84.62 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.959 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.82 107.42 18.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.7 -49.64 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.72 156.53 35.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.862 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.33 49.42 2.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.887 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -98.04 -61.23 1.41 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.5 ttt180 -105.43 128.01 53.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.877 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.41 ' C ' HD23 ' A' ' 27' ' ' LEU . 8.4 t-20 -176.04 143.74 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.828 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.41 HD23 ' C ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -169.69 36.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.869 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.3 m-20 -129.94 153.05 48.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.918 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -152.55 131.82 6.84 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.91 -41.13 77.46 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.427 2.085 . . . . 0.0 112.23 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.704 ' O ' HD22 ' A' ' 32' ' ' LEU . 97.8 m-20 61.11 86.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.953 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.704 HD22 ' O ' ' A' ' 31' ' ' ASN . 4.4 mm? -130.22 120.37 24.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.846 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.503 ' OD1' HG22 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -136.13 -66.61 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.011 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 179.56 45.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.014 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.503 HG22 ' OD1' ' A' ' 33' ' ' ASP . 17.3 m -145.41 -46.33 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.153 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.61 HG23 ' O ' ' A' ' 36' ' ' ILE . 2.2 tt -129.89 106.76 13.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.036 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.631 ' O ' HG22 ' A' ' 39' ' ' THR . 1.5 t0 -71.03 -57.53 4.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.022 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.71 29.9 19.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.987 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 37' ' ' ASP . 2.5 t -177.08 94.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 179.52 -134.69 2.33 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -143.01 131.47 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.939 0.4 . . . . 0.0 110.929 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 2.1 m95 -139.6 117.69 11.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.82 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -151.81 -165.06 12.7 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.624 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.507 HG22 ' N ' ' A' ' 45' ' ' ARG . 2.0 mt -116.33 161.92 14.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.673 0.273 . . . . 0.0 110.956 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.656 HH11 HG21 ' A' ' 9' ' ' THR . 4.0 ttt180 -126.54 138.89 53.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.104 0.478 . . . . 0.0 110.601 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.537 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -170.4 120.32 0.59 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.918 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.12 -139.32 2.76 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.611 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -159.14 140.19 12.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.902 0.382 . . . . 0.0 111.128 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB3' ' CB ' ' A' ' 3' ' ' ASP . 33.0 tt0 -83.77 162.47 20.63 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.413 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.418 ' N ' ' CG ' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -131.08 -166.9 1.76 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.88 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.85 -45.16 93.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.219 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.97 -20.47 3.83 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . -118.19 179.59 17.07 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.886 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HB3' ' CE2' ' A' ' 56' ' ' TYR . 8.4 mtt180 -142.36 143.55 32.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.921 0.391 . . . . 0.0 111.4 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 80' ' ' TYR . 6.0 t80 -100.73 153.56 19.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.961 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 54' ' ' ARG . 70.4 m-85 -157.66 115.44 3.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.925 0.393 . . . . 0.0 111.585 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -94.09 132.52 38.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.398 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.457 HG21 ' OH ' ' A' ' 172' ' ' TYR . 16.2 p -119.28 112.18 19.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.945 0.402 . . . . 0.0 111.253 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -106.19 111.27 23.81 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.677 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -110.41 179.96 3.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.872 0.367 . . . . 0.0 111.132 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 17.3 m-20 -162.09 -74.33 0.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.792 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.553 HD13 ' HB2' ' A' ' 70' ' ' LYS . 7.3 pt -142.81 125.77 13.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.091 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -95.54 -32.54 12.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.986 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -59.28 -49.84 76.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.986 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.3 p 49.57 78.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.234 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -84.82 -52.05 6.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 m -104.46 -31.1 9.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 137.23 -75.82 0.38 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.467 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.58 124.59 44.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.775 0.321 . . . . 0.0 110.843 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.553 ' HB2' HD13 ' A' ' 62' ' ' ILE . 15.0 mtpt -146.26 82.64 1.6 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.883 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.406 ' H ' HD12 ' A' ' 71' ' ' LEU . 4.7 mp -71.96 72.79 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.775 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -118.99 -39.47 2.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.013 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.409 ' HG3' HD12 ' A' ' 104' ' ' LEU . 1.1 tt0 -130.38 143.16 50.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.893 0.378 . . . . 0.0 111.109 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -141.68 134.55 28.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.675 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -130.42 119.59 22.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.177 -179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -133.04 114.97 14.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.431 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.618 HD13 ' OG1' ' A' ' 98' ' ' THR . 3.4 pp -145.16 152.5 40.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.939 0.399 . . . . 0.0 111.519 -179.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -116.99 125.68 6.64 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.972 179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 35.2 p -104.09 132.28 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.984 0.421 . . . . 0.0 111.637 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.42 ' HB2' ' CE1' ' A' ' 55' ' ' TYR . 14.0 t80 -122.9 110.99 16.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.957 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.404 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 0.5 OUTLIER -134.43 172.05 13.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.181 0.515 . . . . 0.0 111.869 -178.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.498 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -107.99 118.77 37.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.219 179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 50.4 p90 -97.38 162.97 13.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.84 -179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -164.8 130.7 2.12 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.444 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.54 115.94 2.95 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.446 2.097 . . . . 0.0 112.36 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 23.0 mt -153.9 122.12 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.089 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 138.97 -90.38 0.2 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.632 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -131.24 35.91 3.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.804 0.335 . . . . 0.0 110.836 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 65.13 29.02 12.15 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.654 -179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -143.58 -45.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.735 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.408 HG22 HD12 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -64.89 152.71 42.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.459 179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 2.5 mttt -132.47 92.85 3.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.83 0.348 . . . . 0.0 111.079 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.29 102.88 0.19 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.312 0.577 . . . . 0.0 110.296 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 20.0 p90 -112.1 154.18 25.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.876 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -173.33 133.79 2.72 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.75 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.612 ' O ' HD23 ' A' ' 123' ' ' LEU . . . -170.14 -133.51 1.61 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.654 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -130.98 162.97 28.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.879 0.371 . . . . 0.0 111.29 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.618 ' OG1' HD13 ' A' ' 77' ' ' LEU . 0.8 OUTLIER -133.93 156.85 47.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.822 179.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 99' ' ' LEU . 1.0 OUTLIER -160.06 132.48 6.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.849 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.85 -149.45 5.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.825 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 13.1 mt -154.93 126.87 7.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 0.0 110.668 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 10.5 p -109.95 133.73 54.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.978 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.49 ' CD ' HG22 ' A' ' 117' ' ' VAL . 6.2 mmtt -131.4 145.07 51.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.409 HD12 ' HG3' ' A' ' 73' ' ' GLN . 4.0 tp -127.01 127.05 44.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.78 133.72 20.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.908 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -85.33 160.98 19.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -70.27 -48.2 57.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.93 -99.97 0.23 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mmtm -71.37 178.72 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.84 0.352 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -179.21 71.38 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -84.84 163.13 19.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.846 0.355 . . . . 0.0 110.844 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.6 mmmt -90.89 78.3 6.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.79 31.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -154.53 73.85 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.11 -79.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.4 t0 75.37 -58.79 0.55 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.49 HG22 ' CD ' ' A' ' 103' ' ' LYS . 21.4 t -135.37 141.1 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.124 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -152.9 134.31 4.41 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.349 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -84.07 116.44 22.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.917 0.389 . . . . 0.0 111.078 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.51 ' HB1' HD22 ' A' ' 144' ' ' LEU . . . -100.23 135.8 41.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.994 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.07 142.34 1.42 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.177 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -170.35 -138.33 2.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.588 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.612 HD23 ' O ' ' A' ' 96' ' ' GLY . 5.7 mt -142.99 159.83 41.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.714 0.293 . . . . 0.0 110.688 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -157.28 173.11 17.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.14 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.87 142.67 0.08 Allowed 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.648 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.588 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -159.52 -130.89 1.18 Allowed Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.7 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 126' ' ' GLY . 1.1 pt -161.13 120.38 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.791 0.329 . . . . 0.0 110.67 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 128' ' ' LEU . 0.3 OUTLIER -94.82 115.16 27.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.672 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.415 ' N ' HD12 ' A' ' 128' ' ' LEU . 13.5 tt0 -104.31 118.15 35.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.945 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 136' ' ' SER . 1.8 pt-20 -107.82 149.3 28.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.02 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.53 -31.71 11.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.406 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 53.2 p -169.01 -164.96 0.5 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.329 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.71 56.02 3.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.886 0.374 . . . . 0.0 110.658 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -142.73 -67.5 0.37 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.061 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -142.68 171.49 13.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.041 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.403 ' CB ' ' HA ' ' A' ' 130' ' ' GLU . 36.3 p -156.02 173.98 16.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.942 0.401 . . . . 0.0 111.204 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 175' ' ' ALA . 5.2 pt -134.95 134.79 53.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.699 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -127.58 172.49 10.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.131 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.19 145.4 6.21 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.514 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.35 -135.96 2.53 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.657 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -119.85 158.04 27.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.712 0.291 . . . . 0.0 110.693 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.512 ' NH2' HD21 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -142.68 130.96 22.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.189 -179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 143' ' ' TYR . 2.3 m-85 -122.77 133.92 54.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.453 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.51 HD22 ' HB1' ' A' ' 120' ' ' ALA . 3.7 mt -142.43 145.39 33.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 0.0 111.114 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 159.73 16.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.594 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.82 152.14 25.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -131.93 163.27 28.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.725 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 65.19 -176.12 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.885 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 61.59 80.71 0.21 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.1 p -109.94 80.19 1.29 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.891 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.89 108.23 16.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.938 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -107.8 143.39 36.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.6 p -114.47 148.2 39.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.0 -30.37 16.62 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.558 2.172 . . . . 0.0 112.284 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -92.01 85.92 5.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.782 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -124.89 -178.64 15.4 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 150.01 -148.2 19.22 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.555 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -137.36 142.47 41.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.99 -46.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.866 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 11.0 mt -81.18 -36.01 30.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.817 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 139.6 -118.81 1.56 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.501 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 42.8 t -120.52 128.37 53.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -77.99 145.89 35.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.18 111.13 17.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.87 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.71 123.93 13.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.908 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -136.6 -55.64 0.74 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.862 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.7 m -145.49 176.04 9.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.971 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.41 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 0.3 OUTLIER -115.98 165.6 12.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.878 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.41 136.84 51.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -156.02 155.35 32.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.022 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.9 152.58 20.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.15 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.457 ' OH ' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -135.04 129.4 33.99 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.152 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 5.7 mt -163.56 129.87 3.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.479 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 9' ' ' THR . . . -177.79 -158.84 21.57 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.909 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -126.79 172.05 10.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.778 0.323 . . . . 0.0 111.125 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -154.8 116.68 4.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.935 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -108.98 112.82 25.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.819 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 11.2 pttt -82.01 164.07 21.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.888 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.724 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.484 1.274 0 CA-C-O 120.805 0.336 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -111.37 168.16 9.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -100.95 130.03 46.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.786 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.9 m-85 -132.33 139.94 48.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.379 . . . . 0.0 111.115 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.699 HG23 ' HB2' ' A' ' 46' ' ' ALA . 8.3 p -154.77 130.4 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.08 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.62 ' C ' HD22 ' A' ' 8' ' ' LEU . . . -161.22 -147.17 4.87 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.716 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.62 HD22 ' C ' ' A' ' 7' ' ' GLY . 3.9 mm? -126.41 166.72 16.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.345 . . . . 0.0 110.909 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.459 HG21 HG23 ' A' ' 58' ' ' THR . 27.9 p -139.61 140.43 37.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -137.9 115.91 11.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.914 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.22 137.64 13.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.536 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -111.65 134.21 53.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 0.0 110.952 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.7 125.68 35.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 m -150.02 102.89 3.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.825 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -136.53 40.95 2.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.895 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -85.6 120.0 26.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.3 pt -111.77 -30.55 2.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.238 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -166.43 176.07 7.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.016 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.2 mttt 60.84 156.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.13 -177.88 3.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.836 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.97 85.08 2.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.903 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.2 m -114.2 -175.44 2.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.779 HD12 ' HB2' ' A' ' 24' ' ' ASN . 1.6 pp -168.3 -43.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.779 ' HB2' HD12 ' A' ' 23' ' ' LEU . 1.4 t30 -123.94 -61.9 1.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.84 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.55 87.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.902 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -136.94 125.31 23.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.971 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -168.01 33.58 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.816 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.76 -69.09 0.69 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.968 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -91.54 138.93 25.05 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.01 -43.67 0.24 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.522 2.148 . . . . 0.0 112.428 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -103.83 -37.19 7.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.976 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.69 89.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -157.6 73.96 0.73 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.6 ttmt -100.1 -46.21 5.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.87 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.7 t 69.48 -66.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.214 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.49 HG23 ' N ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -144.18 -45.15 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.254 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.49 ' N ' HG23 ' A' ' 36' ' ' ILE . 3.2 t70 76.05 111.76 0.07 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.963 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -157.05 29.09 0.3 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.895 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.9 m -118.87 137.31 53.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.901 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.0 172.66 12.71 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.582 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.6 p -127.81 124.05 36.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.879 0.371 . . . . 0.0 110.861 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 10.6 p-90 -117.75 115.47 25.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.846 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -132.4 -173.8 13.43 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.767 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.545 ' HA ' HD13 ' A' ' 8' ' ' LEU . 18.0 mt -106.98 162.03 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.561 0.219 . . . . 0.0 111.041 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.578 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.0 OUTLIER -132.6 136.07 46.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.869 0.366 . . . . 0.0 110.681 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.699 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -170.84 120.55 0.55 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.377 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.541 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -166.91 -142.34 3.41 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.755 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -131.92 130.65 41.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.681 0.277 . . . . 0.0 110.891 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.439 ' NE2' ' CE1' ' A' ' 5' ' ' PHE . 32.3 tt0 -109.52 112.53 24.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.225 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.724 ' CE2' ' HB2' ' A' ' 2' ' ' ALA . 4.2 m-85 -96.01 176.42 6.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.589 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.09 -29.15 68.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.172 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.2 24.19 3.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.346 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -165.2 110.03 0.39 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.385 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -103.8 112.74 25.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 111.187 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -106.2 150.71 25.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.155 179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.541 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 34.2 p90 -179.09 129.35 0.1 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 121.125 0.488 . . . . 0.0 111.198 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.42 148.58 22.71 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.15 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.459 HG23 HG21 ' A' ' 9' ' ' THR . 2.6 m -129.24 118.43 22.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.979 0.418 . . . . 0.0 111.599 -179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.632 ' CE2' HD12 ' A' ' 76' ' ' LEU . 14.8 m-85 -94.52 109.18 21.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.071 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -103.65 175.2 5.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.032 0.444 . . . . 0.0 111.566 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -149.1 171.9 15.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.567 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.586 HG21 HG22 ' A' ' 65' ' ' THR . 29.3 mt -99.97 119.51 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.228 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.3 m -91.03 -35.86 14.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -146.94 126.05 12.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.586 HG22 HG21 ' A' ' 62' ' ' ILE . 46.2 p -100.16 109.81 22.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.3 t -87.3 -38.52 16.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.89 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 p -101.91 -34.28 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.0 -178.97 29.09 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.518 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -102.3 145.14 29.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -73.34 123.58 24.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.8 tp -158.12 -67.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -177.39 158.28 1.41 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.463 ' HB2' HD12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -176.71 159.33 1.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.874 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -142.5 122.97 14.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.4 110.93 20.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.919 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.632 HD12 ' CE2' ' A' ' 59' ' ' TYR . 9.3 tt -115.6 117.02 29.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.755 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.6 144.46 39.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.228 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.93 116.9 4.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.033 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.464 ' CB ' HG23 ' A' ' 98' ' ' THR . 5.2 t -99.18 134.12 42.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.942 0.401 . . . . 0.0 111.374 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -122.41 110.89 16.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.155 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -133.11 163.39 29.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.93 0.395 . . . . 0.0 111.486 -179.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' PHE . . . -112.22 118.7 36.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.282 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.418 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 54.2 p90 -97.58 161.29 13.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.645 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -163.12 121.01 1.26 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.63 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.89 114.98 2.04 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.469 2.113 . . . . 0.0 112.329 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.7 pt -108.08 97.97 6.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 120.47 -58.24 0.57 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.44 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -169.19 -75.02 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.843 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -169.46 34.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.66 -30.18 9.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.531 HG22 HD12 ' A' ' 127' ' ' ILE . 16.5 p -136.55 145.08 44.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.806 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 9.0 tttt -121.31 92.69 3.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.878 0.371 . . . . 0.0 110.702 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.28 102.85 0.12 Allowed 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.339 0.59 . . . . 0.0 110.772 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.451 ' CE1' ' N ' ' A' ' 126' ' ' GLY . 32.6 p90 -112.3 153.21 27.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.862 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -170.12 140.66 6.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.856 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -178.11 -137.62 2.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.388 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -129.91 177.63 7.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 111.172 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.464 HG23 ' CB ' ' A' ' 79' ' ' SER . 1.2 m -146.2 151.65 37.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.978 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.03 130.65 5.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.775 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -148.35 -153.86 6.11 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.885 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -155.28 131.43 10.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.834 0.349 . . . . 0.0 110.351 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.459 HG22 HE22 ' A' ' 73' ' ' GLN . 12.1 p -109.59 122.83 64.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.262 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.01 145.07 50.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.735 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.6 tt -105.16 131.16 53.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.814 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.43 150.6 34.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.899 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -175.68 172.09 2.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -161.74 95.9 1.01 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.901 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -106.43 -80.82 1.36 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.437 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.6 mttt -126.66 -68.38 0.81 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -110.77 -117.01 3.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.453 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -110.42 169.09 8.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.777 0.322 . . . . 0.0 110.897 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.13 149.39 32.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.862 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.93 125.79 43.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.885 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -150.43 -71.07 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.888 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 1.2 p -121.46 -61.52 1.52 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 76.68 -57.91 0.53 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.118 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.6 t -140.33 123.88 17.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.298 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.79 118.83 2.03 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.267 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -88.09 131.78 34.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.854 0.359 . . . . 0.0 110.966 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -123.57 145.41 48.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.0 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -170.99 140.48 1.56 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.177 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.632 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -165.6 -136.72 2.06 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.453 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.632 HD12 ' O ' ' A' ' 122' ' ' GLY . 1.7 mp -138.36 170.27 16.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.935 0.398 . . . . 0.0 110.727 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 5.7 tt0 -159.71 152.29 21.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.881 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.94 142.48 0.08 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.612 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.596 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -169.75 -127.09 0.9 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.938 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 126' ' ' GLY . 3.4 pt -161.19 120.89 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.681 0.277 . . . . 0.0 110.436 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.67 HD12 ' HB3' ' A' ' 138' ' ' GLU . 1.3 tp -94.5 114.1 26.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.069 0.462 . . . . 0.0 110.725 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -98.08 122.93 41.81 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.09 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -95.91 149.02 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.825 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.668 HD12 HD11 ' A' ' 137' ' ' ILE . 0.3 OUTLIER -109.78 -30.29 7.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.058 0.456 . . . . 0.0 110.584 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -165.08 -172.07 2.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.108 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.74 54.73 3.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.791 0.329 . . . . 0.0 110.833 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -177.28 -37.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.436 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -111.26 135.82 51.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 111.519 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 3.8 m -132.84 168.7 17.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.753 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.668 HD11 HD12 ' A' ' 131' ' ' LEU . 25.1 mt -138.25 135.86 44.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.86 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.67 ' HB3' HD12 ' A' ' 128' ' ' LEU . 13.2 pt-20 -119.5 132.64 55.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -157.1 128.41 2.15 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.502 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.412 ' HA3' ' HA3' ' A' ' 126' ' ' GLY . . . -179.86 -134.74 2.28 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.847 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.86 161.19 25.82 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.848 0.356 . . . . 0.0 110.859 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.11 121.96 9.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.029 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -114.67 139.42 49.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.648 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.5 mp -157.93 142.88 16.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.207 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -114.23 163.69 14.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.629 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.0 m -119.39 123.88 45.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.135 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -141.15 114.87 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.816 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.03 -33.83 63.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.133 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.1 m 61.19 167.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 82.0 p -112.77 -73.7 0.66 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.974 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -131.03 42.03 3.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.794 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 3.6 mmt 59.99 31.98 20.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.933 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 2.2 t -89.73 147.42 37.6 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.802 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.14 145.67 79.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.465 2.11 . . . . 0.0 112.244 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -179.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -80.79 138.76 19.93 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.565 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -153.37 71.47 0.28 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.458 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -144.33 95.98 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.792 0.33 . . . . 0.0 110.865 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.5 tttm 68.38 -69.73 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.941 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.56 176.73 9.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.927 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -134.9 -144.31 4.97 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.652 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.7 m -103.36 162.25 13.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.794 0.331 . . . . 0.0 110.964 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.6 mt -135.03 31.74 3.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.81 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -146.59 102.41 3.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.964 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 6.6 mt -77.08 97.85 4.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -89.87 60.67 5.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -146.08 150.45 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.823 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 93.5 p -144.04 163.09 34.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.897 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.01 124.89 50.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.69 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -130.63 155.18 47.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -91.54 165.27 13.44 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.264 0.554 . . . . 0.0 110.29 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.24 129.98 34.5 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.78 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 8.6 tt -163.41 133.26 4.24 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.739 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.47 -156.41 18.24 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.613 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -124.24 172.15 9.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -150.06 114.95 5.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.982 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.4 ' O ' HG12 ' A' ' 6' ' ' VAL . 11.5 t80 -117.26 111.9 20.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.915 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 2.3 ptpt -82.18 161.4 22.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.155 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.7 t80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.773 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.797 0.332 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.402 ' O ' ' HB3' ' A' ' 49' ' ' GLN . 2.6 m-20 -163.09 136.34 5.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.199 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -60.62 140.86 57.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.549 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 3.0 m-85 -131.07 139.86 49.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.973 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.415 HG12 ' CB ' ' A' ' 46' ' ' ALA . 27.3 m -154.74 129.27 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.266 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.33 -143.59 3.78 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.498 -0.858 . . . . 0.0 112.676 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -140.14 165.42 27.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.81 0.338 . . . . 0.0 110.851 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -135.05 144.86 47.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.079 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 5.8 m-90 -136.73 118.58 15.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.741 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -93.96 143.65 16.66 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.683 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -114.6 110.41 19.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.832 0.349 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.1 p -102.29 117.94 35.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.969 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -150.14 102.82 3.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.807 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.04 -56.6 2.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.841 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -75.27 124.27 26.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.866 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pt -82.56 -178.98 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.143 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 64.72 111.46 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.13 -35.24 5.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.884 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m 61.9 157.43 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.894 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -143.12 -176.36 4.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 13.4 m -88.16 166.57 14.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.715 HD13 ' H ' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -88.37 148.07 24.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.715 ' H ' HD13 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -159.51 -43.36 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.031 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.6 ttt-85 68.82 94.36 0.07 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.968 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -162.87 117.65 1.74 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.946 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.07 -51.47 13.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -92.74 80.68 4.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.85 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.6 t -99.98 100.26 11.03 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.83 60.1 3.58 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.487 2.124 . . . . 0.0 112.43 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 179.11 102.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mt -80.4 103.94 10.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -129.08 87.4 2.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.5 21.92 9.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 37' ' ' ASP . 16.0 t 61.96 117.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.217 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mt -63.58 -27.18 42.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.053 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.405 ' H ' HG12 ' A' ' 35' ' ' VAL . 3.8 m-20 63.6 87.76 0.11 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.014 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 m120 58.3 171.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.047 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.8 p -102.46 -73.57 0.66 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.58 -92.27 0.41 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.563 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -142.96 142.81 31.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.892 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -132.94 131.58 41.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.864 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.86 -173.26 31.36 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.665 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.1 pp -114.35 177.12 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 111.157 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.9 ttm-85 -142.55 142.73 32.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.603 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.415 ' CB ' HG12 ' A' ' 6' ' ' VAL . . . -175.68 123.06 0.2 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.255 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.461 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -163.33 -136.31 1.97 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.581 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -153.41 127.31 8.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.94 0.4 . . . . 0.0 111.102 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 5' ' ' PHE . 1.5 tt0 -83.94 152.52 24.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.58 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -127.28 165.68 19.21 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.817 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.02 -24.79 66.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.372 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -126.13 24.57 6.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.266 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 82' ' ' ALA . . . 172.61 -177.29 45.25 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.357 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.748 ' NH2' HD13 ' A' ' 128' ' ' LEU . 0.0 OUTLIER -152.36 122.29 7.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.915 0.388 . . . . 0.0 111.297 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.499 ' CD1' ' CZ ' ' A' ' 80' ' ' TYR . 34.9 t80 -101.74 146.41 27.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.376 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.461 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 25.0 p90 -173.55 124.44 0.38 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.035 0.445 . . . . 0.0 111.036 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.67 162.86 14.75 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.584 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.4 m -139.92 125.25 18.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.013 0.435 . . . . 0.0 111.221 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -102.88 100.93 10.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.295 179.509 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.94 174.95 5.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.987 0.422 . . . . 0.0 111.46 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -151.77 -164.84 2.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.548 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.528 HG22 ' HB2' ' A' ' 73' ' ' GLN . 1.5 tp -114.3 123.45 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.182 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.9 p -78.44 102.18 7.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -107.31 -169.99 1.63 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.974 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.5 p -68.03 144.26 55.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.43 -33.0 72.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.984 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.0 m -72.28 -31.9 66.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -75.7 -174.41 36.14 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.441 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -77.07 131.72 38.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.873 0.368 . . . . 0.0 110.88 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 mtmp? -78.95 -68.67 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.977 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.18 81.82 0.13 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.828 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.81 -53.72 2.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.528 ' HB2' HG22 ' A' ' 62' ' ' ILE . 3.5 mt-30 -107.11 166.61 10.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.841 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -162.25 125.12 2.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.899 ' ND2' HG22 ' A' ' 102' ' ' VAL . 6.3 t-20 -131.31 116.01 17.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.821 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.447 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 68.7 tp -124.96 123.06 39.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.551 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -144.98 157.46 44.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.334 -179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.99 117.47 4.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.049 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.2 p -99.15 121.73 41.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.938 0.399 . . . . 0.0 111.586 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.499 ' CZ ' ' CD1' ' A' ' 55' ' ' TYR . 47.6 m-85 -104.25 110.86 23.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.893 179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.408 ' OD1' ' CE1' ' A' ' 56' ' ' TYR . 1.9 p-10 -136.48 172.1 13.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 111.664 -179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.511 ' HA ' ' HA2' ' A' ' 53' ' ' GLY . . . -122.3 125.51 46.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.602 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 55.7 p90 -97.51 156.68 16.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.353 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 tp -158.25 135.57 6.97 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.62 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -55.57 116.65 3.31 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.552 2.168 . . . . 0.0 112.174 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.638 ' O ' HG23 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -117.43 103.45 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.046 0.45 . . . . 0.0 110.999 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 112.91 -66.42 0.25 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.49 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -162.25 -75.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.84 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -169.33 33.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.7 m-20 -112.65 -22.62 10.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.19 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.07 153.09 51.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.712 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.521 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 9.8 mmtp -126.99 92.73 3.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.99 0.424 . . . . 0.0 110.849 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 126' ' ' GLY . 0.7 OUTLIER -56.28 102.8 0.08 Allowed 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.038 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 37.3 p90 -111.49 151.81 28.18 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.613 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.06 142.14 6.89 Favored Glycine 0 C--N 1.329 0.155 0 C-N-CA 120.306 -0.949 . . . . 0.0 112.992 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 81' ' ' ASP . . . 178.72 -142.88 5.61 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.685 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 123' ' ' LEU . . . -125.23 179.59 5.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.802 0.334 . . . . 0.0 111.214 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.479 HG21 ' NH1' ' A' ' 142' ' ' ARG . 9.4 t -159.01 154.94 26.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.059 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.2 pp -160.23 131.96 6.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.799 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.442 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -154.68 -129.98 1.33 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.946 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.846 HD21 HG23 ' A' ' 117' ' ' VAL . 4.4 tt -155.08 128.09 8.2 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.393 . . . . 0.0 110.557 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.899 HG22 ' ND2' ' A' ' 75' ' ' ASN . 21.6 t -109.63 115.59 50.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.166 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.15 130.79 55.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.97 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.415 HD22 ' OG ' ' A' ' 115' ' ' SER . 0.4 OUTLIER -116.91 165.6 13.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.51 135.29 55.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -99.58 141.56 32.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -126.01 114.34 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 105.93 154.7 21.33 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -103.59 31.21 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.868 0.366 . . . . 0.0 110.857 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.37 -98.09 2.4 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.541 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.78 138.04 58.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.846 0.355 . . . . 0.0 110.907 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.76 143.32 28.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 67.4 mtm180 -146.41 168.86 20.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -92.26 86.85 5.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.88 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.415 ' OG ' HD22 ' A' ' 104' ' ' LEU . 67.3 m -129.56 95.04 3.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -161.47 -74.33 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.846 HG23 HD21 ' A' ' 101' ' ' LEU . 10.1 p -160.76 122.14 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.127 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -134.25 164.2 24.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.406 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -88.82 114.99 26.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.81 0.338 . . . . 0.0 110.831 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.782 ' HB2' HG23 ' A' ' 102' ' ' VAL . . . -100.06 136.7 39.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.006 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -168.63 138.69 2.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.353 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -166.36 -140.68 2.94 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.407 HD12 ' CD2' ' A' ' 143' ' ' TYR . 0.4 OUTLIER -147.66 163.95 35.05 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.36 . . . . 0.0 110.805 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 0.0 OUTLIER -151.91 171.22 18.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.207 -179.899 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 176.9 142.52 0.08 Allowed 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.588 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.58 ' O ' HD22 ' A' ' 93' ' ' LEU . . . -170.08 -134.44 1.75 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.732 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.695 ' N ' HD13 ' A' ' 127' ' ' ILE . 0.1 OUTLIER -158.71 120.62 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-O 120.744 0.307 . . . . 0.0 110.441 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.801 HD12 ' HB2' ' A' ' 138' ' ' GLU . 0.4 OUTLIER -95.07 117.69 30.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.936 0.398 . . . . 0.0 110.859 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.418 ' HB2' ' CG1' ' A' ' 137' ' ' ILE . 27.9 mt-30 -95.08 121.34 36.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.939 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -112.57 149.1 33.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.662 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.7 mp -106.18 -42.37 5.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 110.509 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.11 -166.71 0.65 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.701 -0.682 . . . . 0.0 110.026 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 30.3 mttt -82.78 54.28 2.64 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.789 0.328 . . . . 0.0 110.44 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -141.9 -56.62 0.46 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.146 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -150.36 152.39 34.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.934 0.397 . . . . 0.0 111.303 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 29.2 t -142.17 179.12 7.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.538 179.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.418 ' CG1' ' HB2' ' A' ' 129' ' ' GLN . 19.2 pt -140.71 144.96 26.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.977 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.801 ' HB2' HD12 ' A' ' 128' ' ' LEU . 41.0 tt0 -130.54 136.25 48.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.87 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -155.82 149.98 21.2 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.634 -0.794 . . . . 0.0 112.547 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 172' ' ' TYR . . . 171.09 -131.24 2.15 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.642 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -119.9 160.76 22.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.799 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.479 ' NH1' HG21 ' A' ' 98' ' ' THR . 0.0 OUTLIER -142.72 123.12 13.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.198 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.864 ' O ' HD22 ' A' ' 144' ' ' LEU . 93.4 m-85 -119.55 133.91 55.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.441 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.864 HD22 ' O ' ' A' ' 143' ' ' TYR . 2.0 mm? -141.64 154.12 45.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.911 0.386 . . . . 0.0 111.3 -179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 16.1 ttt180 -117.67 163.41 16.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.477 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.86 172.07 7.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 111.203 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -56.65 117.23 3.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.142 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -113.75 113.29 24.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.077 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 7.9 p 62.58 146.41 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.031 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.1 p -147.24 65.48 1.15 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 62.51 128.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.118 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 41.0 mtm -99.22 -178.78 4.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 63.5 p -114.93 135.44 22.44 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.992 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 153' ' ' THR . 52.0 Cg_exo -54.19 -62.3 0.32 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.515 2.144 . . . . 0.0 112.323 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -75.86 137.6 40.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.912 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 83.22 174.98 50.77 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.493 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 176.8 165.4 32.23 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.443 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -128.12 -178.56 4.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.0 110.802 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 89.52 0.15 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -77.31 155.68 31.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.933 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 109.18 60.18 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.473 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 48.7 m -134.41 129.42 35.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.805 0.336 . . . . 0.0 110.908 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.37 97.58 2.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 17.0 p30 -150.84 33.89 0.6 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.44 -52.34 9.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 3.5 m170 60.31 166.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 57.9 m -91.35 167.69 12.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 91.8 p -115.16 157.34 23.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.997 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 18.8 t -107.02 130.17 54.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.744 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.24 155.21 46.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.104 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -106.19 143.7 33.95 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.133 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.406 ' O ' ' N ' ' A' ' 140' ' ' GLY . 0.1 OUTLIER -124.54 127.02 46.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.102 -179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.9 tt -163.66 129.73 3.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.501 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.34 -155.45 15.92 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.87 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 137' ' ' ILE . . . -114.98 172.04 7.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.844 0.354 . . . . 0.0 111.119 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -155.9 117.52 3.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 177' ' ' TYR . 3.9 m-85 -115.98 117.19 29.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.074 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -84.58 163.98 18.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.126 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.922 0.391 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -123.07 168.11 12.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -112.05 132.71 54.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.708 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 13.6 m-85 -134.51 139.96 45.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.028 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 1.063 HG23 ' HB2' ' A' ' 46' ' ' ALA . 7.6 p -151.16 129.36 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.965 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -165.7 -147.85 5.31 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.843 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 4.8 mp -138.99 160.06 40.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.84 0.352 . . . . 0.0 110.903 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.505 HG21 ' CG2' ' A' ' 58' ' ' THR . 4.8 t -129.54 167.5 17.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.791 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.48 ' HB3' HD12 ' A' ' 173' ' ' LEU . 5.0 t-105 -149.11 137.18 20.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -112.96 122.03 5.73 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.474 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -87.26 122.83 31.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.853 0.359 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.09 137.84 52.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 66.0 m -150.06 102.83 3.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -138.27 36.52 2.3 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -67.24 150.87 48.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.5 pt -140.33 31.07 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.155 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.14 129.74 43.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.86 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 60.07 31.21 20.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -120.89 129.6 53.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.5 mttt 62.43 117.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.957 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.1 m -119.23 24.45 10.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mt -155.49 58.99 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.94 0.4 . . . . 0.0 110.724 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -119.96 167.57 12.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.2 mtm-85 -84.5 -73.26 0.43 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -102.24 -177.96 3.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mp -142.0 -72.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.825 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -67.06 178.82 1.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.856 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.421 ' CB ' ' CD ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -178.44 -61.77 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.949 179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 29' ' ' SER . 44.9 Cg_endo -68.31 145.97 67.57 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.534 2.156 . . . . 0.0 112.306 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.6 m-20 -60.07 147.18 40.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.946 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.0 mp -116.78 116.35 27.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -105.38 -45.78 4.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -147.79 -65.64 0.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.876 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.494 ' O ' HG22 ' A' ' 36' ' ' ILE . 11.0 p -121.41 -45.61 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.051 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 35' ' ' VAL . 4.4 tp 44.19 33.34 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.47 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.439 ' O ' HG22 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -176.26 111.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.919 179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -107.08 170.42 7.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.946 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.4 p -144.72 29.48 1.23 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 175.48 96.68 0.1 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.466 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 m -112.83 125.73 54.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.889 0.376 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . . . . . . . . . 67.5 p-90 -108.34 174.31 5.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.798 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -179.5 157.94 21.41 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.603 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.466 HG22 ' N ' ' A' ' 45' ' ' ARG . 2.1 mp -109.8 158.89 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.511 0.196 . . . . 0.0 110.907 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -143.31 149.77 38.27 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 121.042 0.448 . . . . 0.0 110.839 179.74 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 1.063 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -177.35 123.56 0.13 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.583 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -163.85 -137.6 2.23 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.592 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.66 130.42 38.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.782 0.325 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 5' ' ' PHE . 40.0 tt0 -105.66 110.71 23.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.029 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 53' ' ' GLY . 1.9 p90 -121.06 166.99 13.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.727 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.25 -19.95 65.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.4 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -92.14 15.86 12.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.553 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.401 ' O ' ' CD1' ' A' ' 50' ' ' PHE . . . 133.02 176.0 14.21 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.56 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.444 ' HD2' ' CD2' ' A' ' 83' ' ' PHE . 47.3 mtp180 -116.14 117.13 29.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.865 0.364 . . . . 0.0 111.2 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -100.36 136.36 40.37 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.209 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.612 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 44.0 p90 179.84 132.33 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.142 0.496 . . . . 0.0 110.836 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.499 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . -90.34 136.65 32.92 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.158 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.505 ' CG2' HG21 ' A' ' 9' ' ' THR . 25.8 m -113.68 111.72 22.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.98 0.419 . . . . 0.0 111.543 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.88 124.34 29.02 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.148 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -101.88 155.12 18.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 111.501 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -166.43 114.92 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.48 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.0 pt -99.86 145.11 11.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.277 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 m 64.62 127.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.007 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.6 -177.25 5.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.508 HG22 ' H ' ' A' ' 66' ' ' SER . 0.2 OUTLIER 60.26 177.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 65' ' ' THR . 83.8 p -81.75 -33.58 30.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.846 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.9 m -62.04 -37.08 83.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.823 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.5 -107.94 0.2 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.49 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -138.02 172.99 12.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.779 0.323 . . . . 0.0 110.952 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -144.48 93.36 2.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.939 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mp -119.88 146.08 46.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -90.16 55.01 2.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.99 177.17 5.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -170.9 158.09 5.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.807 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.656 ' CG ' HG22 ' A' ' 102' ' ' VAL . 51.5 t-20 -133.41 120.67 21.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.093 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.41 ' C ' HD23 ' A' ' 76' ' ' LEU . 6.1 tt -114.94 114.99 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.443 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 120' ' ' ALA . 2.1 mp -122.45 153.79 38.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.991 0.424 . . . . 0.0 111.498 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.73 116.7 4.24 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.81 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.429 ' HB2' ' CE2' ' A' ' 56' ' ' TYR . 54.5 m -90.53 140.72 29.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.07 0.462 . . . . 0.0 111.568 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -148.34 110.78 4.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.031 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.414 ' HB3' ' N ' ' A' ' 96' ' ' GLY . 3.9 p30 -146.36 172.18 13.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.421 -179.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -113.31 118.66 35.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.674 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 0.0 OUTLIER -97.81 167.12 11.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.665 -179.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.494 HD23 ' HD2' ' A' ' 85' ' ' PRO . 0.1 OUTLIER -168.44 134.25 1.53 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.621 179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 84' ' ' LEU . 36.9 Cg_endo -65.71 95.06 0.28 Allowed 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.474 2.116 . . . . 0.0 112.102 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.42 ' O ' HG23 ' A' ' 86' ' ' ILE . 1.7 tt -156.42 125.43 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.127 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 158.14 -56.7 0.36 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.623 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.67 -53.06 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.78 0.324 . . . . 0.0 110.889 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -177.53 -38.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.08 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 129' ' ' GLN . 38.1 p-10 -125.59 57.53 1.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.294 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.598 HG22 HD12 ' A' ' 127' ' ' ILE . 0.6 OUTLIER -136.63 148.48 47.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.124 179.432 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -126.64 92.31 3.53 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.078 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 6.4 tt -61.59 102.73 0.27 Allowed 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.482 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 15.2 p90 -113.35 154.2 27.27 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.88 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -171.84 130.56 1.97 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.671 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.414 ' N ' ' HB3' ' A' ' 81' ' ' ASP . . . -169.65 -139.99 2.86 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.589 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -135.64 170.11 16.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.789 0.328 . . . . 0.0 111.155 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.4 t -138.03 163.16 32.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -160.27 133.81 6.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.89 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -155.63 -144.31 3.89 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.995 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -155.14 130.84 9.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.256 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.656 HG22 ' CG ' ' A' ' 75' ' ' ASN . 14.9 t -109.65 128.84 65.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.225 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -127.32 131.88 50.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.853 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.4 tp -118.58 146.09 44.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.891 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -110.42 173.61 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.92 177.73 10.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.49 96.94 6.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 87.86 168.48 44.48 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.516 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.16 122.37 46.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 0.0 110.907 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -151.18 -48.29 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.545 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.94 163.74 26.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.53 161.55 30.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.907 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -73.47 129.41 37.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -176.35 -39.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.075 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.91 -165.77 1.42 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.982 0.42 . . . . 0.0 110.755 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.658 ' O ' HG13 ' A' ' 117' ' ' VAL . 5.3 t0 69.09 10.12 7.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.35 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 116' ' ' ASP . 3.0 m -163.32 104.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.715 0.293 . . . . 0.0 110.973 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -140.53 143.61 13.73 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.642 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -90.49 120.33 31.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.746 0.308 . . . . 0.0 110.753 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.87 ' HB1' HD21 ' A' ' 77' ' ' LEU . . . -95.04 140.05 30.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.211 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.02 134.72 0.77 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.015 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.72 -141.99 3.27 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.601 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 mp -149.65 162.44 40.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.89 0.376 . . . . 0.0 110.985 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.423 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 5.6 tm0? -154.01 159.71 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.898 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 124' ' ' GLN . . . 177.01 142.51 0.08 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.729 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.59 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -174.58 -125.69 0.88 Allowed Glycine 0 CA--C 1.517 0.177 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.733 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.598 HD12 HG22 ' A' ' 91' ' ' THR . 5.3 pt -161.13 120.46 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 120.747 0.308 . . . . 0.0 110.366 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.825 HD12 ' HB3' ' A' ' 138' ' ' GLU . 1.1 tp -95.42 114.69 26.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.971 0.415 . . . . 0.0 110.833 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 90' ' ' ASN . 21.5 mt-30 -99.52 147.48 25.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.247 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -128.72 149.11 50.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.52 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 12.4 mt -109.43 -45.38 3.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.089 0.471 . . . . 0.0 110.76 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.09 -164.89 0.49 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.274 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -80.12 57.41 2.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.879 0.371 . . . . 0.0 110.736 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -138.72 -60.28 0.6 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -163.2 158.24 21.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.993 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 19.3 m -125.72 168.66 13.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.587 HG23 ' O ' ' A' ' 174' ' ' GLY . 4.0 mp -134.08 134.7 55.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.778 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.825 ' HB3' HD12 ' A' ' 128' ' ' LEU . 8.7 pm0 -124.21 149.99 45.75 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -154.76 128.8 2.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.365 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.25 -136.74 2.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.8 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -135.16 161.07 36.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.402 ' HG2' ' CG ' ' A' ' 124' ' ' GLN . 0.0 OUTLIER -147.77 146.32 29.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.889 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -112.47 145.79 39.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -121.85 122.56 39.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.983 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 17.4 ttt180 -145.52 111.99 5.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.704 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 120' ' ' ALA . 82.1 p -115.87 135.29 54.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.035 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -141.07 114.91 9.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.854 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -79.73 178.58 8.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.163 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 58.7 m 59.68 28.31 17.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.994 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.6 m 58.27 164.97 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -93.21 77.18 4.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 24.1 ttt -60.48 -52.76 63.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 153' ' ' THR . 10.6 t -79.55 114.71 47.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.85 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.22 124.52 10.97 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.363 2.042 . . . . 0.0 112.201 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -101.06 160.75 14.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 132.35 -70.03 0.52 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.536 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 79.68 -98.73 1.7 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.426 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -172.47 -44.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.855 0.359 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.3 mttm -78.79 179.72 7.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -168.37 138.14 2.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -124.62 -89.63 0.83 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.452 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.02 140.44 24.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.02 95.74 5.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.836 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -160.03 31.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.1 -66.58 1.04 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.86 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.05 40.44 3.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.16 159.14 30.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 3.2 m -107.92 148.78 29.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.0 p -107.09 122.47 46.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -133.05 155.2 49.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.3 165.16 11.82 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.139 0.495 . . . . 0.0 110.239 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -137.92 128.5 26.6 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.805 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.48 HD12 ' HB3' ' A' ' 10' ' ' TRP . 0.4 OUTLIER -163.6 129.98 3.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.637 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 137' ' ' ILE . . . -179.87 -156.66 18.41 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.696 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -125.07 172.09 9.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.855 0.359 . . . . 0.0 111.114 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -149.98 114.94 5.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.903 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.419 ' O ' HG12 ' A' ' 6' ' ' VAL . 39.9 m-85 -107.02 116.92 32.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.987 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.5 OUTLIER -83.87 162.85 20.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.091 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 40.5 t80 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.969 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.454 ' HA ' ' CD1' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.876 0.369 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.436 ' O ' ' HA ' ' A' ' 48' ' ' GLN . 0.2 OUTLIER -106.12 160.6 15.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.665 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.24 138.1 49.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.512 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.587 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 28.4 p90 -148.95 161.86 41.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.01 0.433 . . . . 0.0 111.454 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.885 HG12 ' HB1' ' A' ' 46' ' ' ALA . 34.3 m -150.33 141.18 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.02 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.1 -157.91 9.04 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 119.966 -1.112 . . . . 0.0 113.135 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 44' ' ' ILE . 0.2 OUTLIER -126.97 154.94 43.92 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.795 0.331 . . . . 0.0 110.786 179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.6 p -128.02 149.6 50.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.951 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.437 ' CD2' ' HB3' ' A' ' 42' ' ' TRP . 1.7 t-105 -153.09 115.9 4.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.881 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.45 137.96 13.73 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.505 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -84.06 135.61 34.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.4 m -99.66 121.5 41.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.9 t -150.18 102.84 3.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -83.67 -60.56 2.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.954 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.4 p-10 -65.94 114.06 4.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.1 tt -150.86 142.9 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.068 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -134.52 153.51 51.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.95 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -167.98 -67.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.9 t -114.69 -44.4 3.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.3 mtmm -121.88 160.2 25.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.867 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 12.0 t -97.41 113.85 25.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.917 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.81 125.6 29.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.914 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -69.23 135.28 50.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.859 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -84.8 81.59 8.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -65.28 172.74 2.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.428 ' O ' HD23 ' A' ' 27' ' ' LEU . 5.5 tt -130.26 97.61 4.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -96.45 -36.83 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.9 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.432 ' CB ' ' HD3' ' A' ' 30' ' ' PRO . 0.5 OUTLIER 180.0 -55.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.919 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' HD3' ' CB ' ' A' ' 29' ' ' SER . 53.2 Cg_exo -52.37 178.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.488 2.126 . . . . 0.0 112.219 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -172.75 147.7 1.78 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.12 71.93 9.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.027 0.441 . . . . 0.0 110.745 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -113.17 -36.23 5.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.01 -57.52 2.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.9 m -71.63 73.55 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.2 mt -100.51 -30.52 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.123 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -110.73 -55.07 2.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.827 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.33 138.61 33.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.846 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 39' ' ' THR . 3.6 t -170.62 104.42 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.892 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.33 -175.02 30.87 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.491 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -142.96 149.79 38.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.748 0.309 . . . . 0.0 110.904 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.437 ' HB3' ' CD2' ' A' ' 10' ' ' TRP . 68.0 p-90 -152.92 162.91 40.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.757 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.94 -165.99 35.34 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.706 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.422 HG12 ' N ' ' A' ' 45' ' ' ARG . 18.0 tt -123.56 159.84 27.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.491 0.186 . . . . 0.0 110.803 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.43 ' HA ' ' O ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -137.88 158.53 44.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.24 0.543 . . . . 0.0 110.669 179.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.885 ' HB1' HG12 ' A' ' 6' ' ' VAL . . . -177.04 123.74 0.14 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.107 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -167.02 -142.69 3.52 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.6 -0.809 . . . . 0.0 112.603 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 3' ' ' ASP . 1.5 mp0 -129.78 139.39 51.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.822 0.344 . . . . 0.0 111.048 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' CD1' ' A' ' 5' ' ' PHE . 2.2 pt20 -121.25 112.33 18.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 2' ' ' ALA . 24.2 t80 -119.92 157.22 29.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.6 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -56.28 -22.28 29.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.255 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -95.66 21.66 8.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.257 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.67 158.85 8.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.494 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.417 ' HG3' ' HB3' ' A' ' 49' ' ' GLN . 47.5 ttm-85 -121.22 130.85 53.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.851 0.358 . . . . 0.0 111.061 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -117.67 152.52 35.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.471 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.514 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 36.2 p90 179.67 129.5 0.08 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.156 0.503 . . . . 0.0 111.25 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 45' ' ' ARG . . . -90.59 128.91 36.74 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.022 179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 37.0 p -117.39 115.05 24.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.165 0.507 . . . . 0.0 111.486 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 75' ' ' ASN . 35.3 m-85 -92.9 130.64 38.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.116 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.9 171.73 8.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.051 0.453 . . . . 0.0 111.441 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -157.67 -176.09 5.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.628 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.653 HD11 ' HB2' ' A' ' 73' ' ' GLN . 4.2 mt -113.23 136.8 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 111.076 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 17.2 m -161.97 148.64 13.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -115.88 -41.47 3.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.943 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.767 HG23 ' H ' ' A' ' 68' ' ' GLY . 1.9 t -89.39 173.69 8.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.4 m -63.6 -60.91 2.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.4 p -67.55 -30.06 69.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.933 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.767 ' H ' HG23 ' A' ' 65' ' ' THR . . . 102.99 135.96 8.92 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.454 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -119.72 96.9 5.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.753 0.311 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 44.8 mmtt 56.66 -179.3 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.57 -168.08 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.806 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -161.51 -44.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.961 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.653 ' HB2' HD11 ' A' ' 62' ' ' ILE . 9.0 mp0 -142.64 151.99 42.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.972 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.699 ' O ' HG23 ' A' ' 102' ' ' VAL . 0.0 OUTLIER -108.24 165.02 11.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.718 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.406 ' O ' ' HA ' ' A' ' 59' ' ' TYR . 1.7 m120 -143.76 131.11 20.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 76' ' ' LEU . 0.8 OUTLIER -147.69 114.91 6.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.469 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.559 HD12 ' N ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -145.73 154.62 42.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.041 0.448 . . . . 0.0 111.472 -179.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.93 116.8 4.24 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.823 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.45 134.0 42.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.974 0.416 . . . . 0.0 111.447 -179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -124.52 110.86 14.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.061 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -130.79 166.42 20.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.057 0.456 . . . . 0.0 111.415 -179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.77 118.46 35.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.396 179.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 55.4 p90 -97.78 166.94 11.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.574 -179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.68 136.14 1.65 Allowed Pre-proline 0 C--N 1.332 -0.19 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.468 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.12 118.11 4.79 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.417 2.078 . . . . 0.0 112.377 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.475 HD12 ' CB ' ' A' ' 93' ' ' LEU . 27.8 mt -155.72 109.7 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 144.86 -95.17 0.17 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.481 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -130.57 35.44 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.776 0.322 . . . . 0.0 110.812 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 67.06 29.87 7.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.683 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -142.34 -44.64 0.33 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.808 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.575 HG22 ' HG3' ' A' ' 129' ' ' GLN . 1.0 OUTLIER -67.97 149.14 50.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.536 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 128' ' ' LEU . 0.0 OUTLIER -127.21 92.47 3.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.907 0.384 . . . . 0.0 111.114 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.569 HD22 ' O ' ' A' ' 126' ' ' GLY . 0.6 OUTLIER -59.02 103.17 0.15 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 121.308 0.575 . . . . 0.0 110.319 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 40.7 p90 -110.7 157.66 19.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.053 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.98 129.96 1.61 Allowed Glycine 0 CA--C 1.518 0.222 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.835 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -168.3 -138.33 2.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.581 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -130.93 -177.82 4.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.78 0.324 . . . . 0.0 111.143 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 m -148.99 155.98 41.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.061 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -160.2 132.2 6.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.699 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.63 ' C ' HD12 ' A' ' 101' ' ' LEU . . . -160.52 -148.16 5.17 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.918 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.63 HD12 ' C ' ' A' ' 100' ' ' GLY . 5.5 mp -155.34 133.6 11.66 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.896 0.379 . . . . 0.0 110.241 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 74' ' ' GLN . 12.2 p -109.35 131.31 60.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.137 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.12 121.04 28.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.966 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.9 144.38 33.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.815 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -123.3 164.47 18.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -151.41 178.02 9.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.9 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.03 -174.79 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.753 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -122.99 41.41 1.8 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.459 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.3 mtpp -144.7 -47.26 0.24 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 0.0 110.907 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.58 -127.67 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.504 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -88.59 153.91 20.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.807 0.336 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -153.17 100.99 2.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.8 tpp85 -125.78 -65.98 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.07 119.75 22.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.835 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 10.5 p -152.54 79.77 1.22 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.569 ' O ' HG13 ' A' ' 117' ' ' VAL . 4.0 t70 -150.22 -67.23 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 116' ' ' ASP . 3.9 m -160.1 172.99 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -148.57 -157.79 7.71 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.428 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -116.05 115.0 25.33 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 110.92 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -109.09 144.04 37.65 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.984 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.01 141.33 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.263 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -161.46 -142.74 3.47 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.517 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.2 mp -145.58 161.97 38.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.834 0.349 . . . . 0.0 110.771 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 2.1 mt-30 -149.13 160.47 43.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.794 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.75 ' HB3' ' CZ ' ' A' ' 141' ' ' TYR . . . 176.95 142.44 0.08 Allowed 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.598 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.586 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -174.86 -130.69 1.33 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.748 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 126' ' ' GLY . 10.7 pt -160.94 120.81 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-O 120.782 0.325 . . . . 0.0 110.492 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.693 HD11 HD22 ' A' ' 176' ' ' ASN . 0.4 OUTLIER -94.7 112.21 23.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.684 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . 0.575 ' HG3' HG22 ' A' ' 91' ' ' THR . 8.6 mp0 -103.91 124.31 48.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.75 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -86.05 149.35 25.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.895 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.517 HD13 ' O ' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -104.02 -29.61 10.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.048 0.452 . . . . 0.0 110.163 179.564 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.01 -165.48 0.55 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.824 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -91.27 48.01 1.45 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.705 0.288 . . . . 0.0 110.596 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -155.95 -44.07 0.08 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.647 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -130.19 170.67 13.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.012 0.434 . . . . 0.0 111.566 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 2.7 m -156.1 -175.8 5.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.73 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 6.8 pt -154.18 152.61 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.701 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.87 156.56 47.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.041 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 172' ' ' TYR . . . -167.54 146.4 10.63 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.507 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 170.95 -125.2 1.19 Allowed Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.644 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.75 ' CZ ' ' HB3' ' A' ' 125' ' ' ALA . 13.7 p90 -136.09 161.2 36.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.766 0.317 . . . . 0.0 110.732 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.464 ' HB2' ' CD2' ' A' ' 172' ' ' TYR . 0.2 OUTLIER -162.44 140.28 8.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.246 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -119.78 162.7 18.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.221 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.54 HD21 ' CD2' ' A' ' 77' ' ' LEU . 12.1 tp -159.48 146.93 17.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.957 0.408 . . . . 0.0 111.306 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 5.6 mmm-85 -118.65 154.22 33.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.544 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.8 p -108.99 172.03 7.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.077 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -55.44 114.99 2.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.055 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -94.23 -43.94 8.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.6 m -170.75 166.12 7.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 8.0 p -142.35 146.35 34.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.56 86.75 7.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -138.49 -58.9 0.63 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 13.4 p -107.87 150.32 40.15 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.932 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.59 62.89 2.26 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.591 2.194 . . . . 0.0 112.241 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -109.13 -66.71 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.868 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 67.52 135.88 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.565 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -76.68 96.34 1.16 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.475 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -153.05 36.37 0.48 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 0.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.93 123.61 4.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.785 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 60.34 30.52 19.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.825 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -148.31 154.91 26.16 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.461 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.4 m -83.53 157.2 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 2.1 pp -68.84 123.01 19.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.956 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 61.34 -178.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 2.3 tp -113.93 175.73 5.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.877 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.89 141.39 34.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.837 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.09 149.25 29.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.811 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.55 -177.46 3.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 30.3 t -107.11 142.41 36.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.931 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.02 155.2 35.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -102.5 165.27 11.19 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.2 0.524 . . . . 0.0 110.367 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.464 ' CD2' ' HB2' ' A' ' 142' ' ' ARG . 0.1 OUTLIER -134.26 128.7 34.39 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.957 -179.911 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 9.8 tp -163.67 129.89 3.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.588 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -179.77 -158.57 22.12 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.737 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -120.52 172.02 8.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.798 0.332 . . . . 0.0 111.046 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.693 HD22 HD11 ' A' ' 128' ' ' LEU . 39.6 t-20 -153.96 114.93 4.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -116.23 111.34 20.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.001 0.429 . . . . 0.0 110.885 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 1.7 ptpt -84.43 163.17 19.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.164 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.737 0.303 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.79 129.07 3.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.25 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 48' ' ' GLN . 1.6 t-20 -77.79 145.56 36.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.651 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.652 ' HA ' ' HA ' ' A' ' 178' ' ' LYS . 18.0 p90 -148.57 152.11 36.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.124 0.488 . . . . 0.0 111.421 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.672 HG23 ' HB2' ' A' ' 46' ' ' ALA . 9.1 p -151.29 135.64 9.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.158 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.86 -133.69 1.57 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.528 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 mp -143.86 167.96 21.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.758 0.313 . . . . 0.0 110.829 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 t -135.01 143.38 46.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.451 ' CD1' ' HB3' ' A' ' 42' ' ' TRP . 0.6 OUTLIER -134.53 117.84 16.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.708 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -111.2 151.2 17.82 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.597 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -86.24 124.28 32.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.5 m -81.94 135.31 35.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.14 102.81 3.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.783 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.9 m120 61.79 116.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.898 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.16 147.36 49.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.841 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 3.0 mp -74.66 110.34 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.186 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.95 156.99 31.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.4 pttt -105.93 40.83 1.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.827 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.32 105.16 15.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.982 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -64.66 0.86 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.864 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.6 m -146.36 88.37 1.78 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 tp -173.55 110.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 60.85 164.68 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.963 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.72 50.9 1.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.74 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -99.91 130.67 46.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.877 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.666 HD12 ' N ' ' A' ' 28' ' ' ASN . 1.4 pp -111.54 -34.27 6.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.666 ' N ' HD12 ' A' ' 27' ' ' LEU . 1.1 t-20 -129.18 110.22 11.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.947 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 30' ' ' PRO . 0.3 OUTLIER -72.39 -60.41 2.16 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.872 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 29' ' ' SER . 58.9 Cg_endo -72.07 176.43 8.45 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.538 2.158 . . . . 0.0 112.317 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -67.8 179.81 1.34 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.6 mp -118.93 124.76 47.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.991 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -171.04 -55.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' HG3' HG23 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -100.31 -65.21 0.98 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.588 HG22 ' O ' ' A' ' 35' ' ' VAL . 14.3 p 43.51 43.42 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.624 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.42 HG23 ' HG3' ' A' ' 34' ' ' LYS . 5.8 pt -85.34 87.51 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.19 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -164.34 121.89 1.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.841 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -157.83 156.07 30.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.952 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.547 HG21 ' O ' ' A' ' 63' ' ' SER . 80.0 m -108.02 -71.83 0.74 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.84 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.24 151.73 8.62 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.0 p -124.11 108.03 11.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.881 0.372 . . . . 0.0 110.939 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TRP . . . . . 0.451 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 6.6 p-90 -126.27 164.51 20.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.691 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.61 -169.43 35.93 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.832 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.754 HD12 ' HB2' ' A' ' 59' ' ' TYR . 1.7 mt -107.79 163.21 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.551 0.215 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.618 ' O ' HG23 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -138.92 139.82 38.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.932 0.396 . . . . 0.0 110.923 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.672 ' HB2' HG23 ' A' ' 6' ' ' VAL . . . -170.02 117.73 0.57 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.771 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 56' ' ' TYR . . . -157.63 -167.25 18.36 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.457 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 4' ' ' ASN . 3.9 pt20 -131.72 125.52 32.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.885 0.374 . . . . 0.0 110.839 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.415 ' HG2' ' N ' ' A' ' 50' ' ' PHE . 5.3 tt0 -83.84 151.95 24.85 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.7 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.415 ' N ' ' HG2' ' A' ' 49' ' ' GLN . 0.8 OUTLIER -127.66 166.48 18.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.8 -179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -24.98 65.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.441 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -133.12 24.26 4.19 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.691 0.281 . . . . 0.0 111.475 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 179.99 170.96 42.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.4 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -141.5 142.68 33.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.851 0.358 . . . . 0.0 111.329 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -129.89 151.73 50.13 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.242 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.619 ' HA ' ' HA3' ' A' ' 47' ' ' GLY . 36.2 p90 179.49 129.19 0.08 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.191 0.52 . . . . 0.0 111.246 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.82 152.41 20.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.426 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 44' ' ' ILE . 73.0 p -137.13 121.22 17.81 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.948 0.404 . . . . 0.0 111.546 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.817 ' CE2' HD21 ' A' ' 76' ' ' LEU . 8.3 m-85 -85.67 117.62 24.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.926 179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' OE2' HD11 ' A' ' 62' ' ' ILE . 5.2 tt0 -101.96 158.04 16.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.972 0.415 . . . . 0.0 111.469 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -165.32 107.58 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.494 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.486 HD11 ' OE2' ' A' ' 60' ' ' GLU . 23.2 mm -99.87 144.26 12.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.205 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.547 ' O ' HG21 ' A' ' 39' ' ' THR . 14.7 m -120.98 120.45 35.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.855 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -159.19 33.99 0.2 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.581 HG21 ' HD2' ' A' ' 70' ' ' LYS . 0.7 OUTLIER -99.06 178.73 4.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.865 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 m -74.19 -54.21 8.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.15 -34.46 78.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 108.95 -45.95 1.24 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.579 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -122.88 123.02 40.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.392 . . . . 0.0 110.955 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HD2' HG21 ' A' ' 65' ' ' THR . 4.4 mtpp -112.07 -35.31 5.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.916 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.21 31.91 19.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.08 33.0 2.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.432 ' NE2' HD23 ' A' ' 104' ' ' LEU . 66.9 mt-30 -152.66 128.61 10.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.93 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.88 156.66 41.66 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.718 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -144.08 114.82 7.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.175 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.817 HD21 ' CE2' ' A' ' 59' ' ' TYR . 2.5 mp -107.62 131.11 54.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.397 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.446 ' HA ' ' HA3' ' A' ' 100' ' ' GLY . 1.9 mp -141.72 147.41 37.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.027 0.441 . . . . 0.0 111.565 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -111.99 116.75 4.21 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.072 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.566 ' OG ' HG22 ' A' ' 98' ' ' THR . 1.9 t -87.71 136.32 33.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.983 0.42 . . . . 0.0 111.259 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -133.07 110.82 10.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.258 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -147.78 172.08 14.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.031 0.444 . . . . 0.0 111.589 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -117.44 124.97 50.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.485 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 94' ' ' PHE . 45.6 p90 -97.51 165.43 12.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.497 -179.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.638 HD23 HD11 ' A' ' 86' ' ' ILE . 26.0 tp -140.52 117.85 8.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.417 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.52 108.66 1.06 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.37 2.047 . . . . 0.0 112.354 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.638 HD11 HD23 ' A' ' 84' ' ' LEU . 31.7 mm -103.76 97.73 5.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.858 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.76 62.34 2.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.534 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.483 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.7 OUTLIER -122.09 -43.83 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 0.0 110.883 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -155.07 33.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.4 m120 60.93 66.35 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.023 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.643 HG22 HD12 ' A' ' 127' ' ' ILE . 0.8 OUTLIER -136.6 148.64 47.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.672 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 127' ' ' ILE . 0.0 OUTLIER -123.25 92.49 3.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.931 0.396 . . . . 0.0 110.781 179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.51 103.01 0.28 Allowed 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.666 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.574 ' HA ' ' HA ' ' A' ' 83' ' ' PHE . 46.6 p90 -111.37 154.59 24.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.817 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -174.35 132.83 2.34 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.417 -0.897 . . . . 0.0 112.819 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -173.6 -139.43 2.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.687 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -127.89 177.11 7.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.756 0.312 . . . . 0.0 111.183 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.566 HG22 ' OG ' ' A' ' 79' ' ' SER . 47.8 p -146.37 159.04 43.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 1.3 mp -159.25 130.8 6.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.646 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.446 ' HA3' ' HA ' ' A' ' 77' ' ' LEU . . . -150.71 -155.91 7.1 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.124 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 85.9 mt -155.2 130.51 9.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.794 0.33 . . . . 0.0 110.168 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 102' ' ' VAL . 12.5 p -109.72 119.78 59.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.297 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -93.52 122.92 36.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.934 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.432 HD23 ' NE2' ' A' ' 73' ' ' GLN . 0.5 OUTLIER -132.09 145.73 51.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.835 179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -108.37 156.2 19.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.959 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -154.48 154.86 33.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.812 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -60.85 -42.22 97.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.874 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 102.75 124.74 5.5 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.486 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.61 -68.04 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.831 0.348 . . . . 0.0 110.873 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.29 -99.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.439 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.99 158.24 32.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.764 0.316 . . . . 0.0 110.947 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.8 103.75 16.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.868 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.98 163.43 20.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.04 -67.61 0.97 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.903 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 16.7 m -61.16 85.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.986 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -83.33 60.06 5.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.84 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 p -93.29 133.49 34.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.176 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -113.95 -177.62 19.22 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.507 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -91.71 125.44 36.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.851 0.358 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -113.4 137.46 51.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.105 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -171.17 140.42 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.001 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -160.28 -139.86 2.76 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.643 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.43 ' HB2' ' CD1' ' A' ' 143' ' ' TYR . 24.9 mt -145.39 165.64 27.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.389 . . . . 0.0 110.798 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . 0.427 ' O ' ' HB2' ' A' ' 125' ' ' ALA . 8.0 tt0 -157.14 159.27 37.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.794 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 94' ' ' PHE . . . 176.94 142.46 0.08 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.678 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 127' ' ' ILE . . . -171.81 -130.69 1.26 Allowed Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.656 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.643 HD12 HG22 ' A' ' 91' ' ' THR . 4.7 pt -158.68 120.43 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 120.879 0.371 . . . . 0.0 110.52 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.701 HD11 ' OD1' ' A' ' 176' ' ' ASN . 8.5 tt -95.19 114.32 26.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.117 0.484 . . . . 0.0 110.766 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -99.14 139.63 34.5 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.268 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -118.78 149.11 42.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.556 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.92 -51.22 2.9 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.988 0.423 . . . . 0.0 110.626 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 8.4 t -169.11 -164.9 0.49 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.093 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? -76.47 58.32 1.32 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.786 0.326 . . . . 0.0 110.735 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -136.88 -60.17 0.7 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.937 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HB2' ' CE2' ' A' ' 177' ' ' TYR . . . -166.03 156.66 12.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.882 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.75 165.34 13.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.881 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.63 134.73 61.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.514 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.95 143.36 50.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.051 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -160.08 149.88 19.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.297 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 173.8 -133.98 2.73 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.729 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -121.62 161.05 23.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.82 0.343 . . . . 0.0 110.98 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 11.0 ttt-85 -149.91 125.27 10.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.43 ' CD1' ' HB2' ' A' ' 123' ' ' LEU . 13.1 m-85 -101.09 138.71 37.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.763 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -118.06 134.06 55.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 13.7 mmm-85 -151.64 112.14 4.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 31.1 p -118.49 129.78 55.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.987 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -140.95 115.02 9.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.793 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -77.64 116.09 17.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 6.3 m -88.78 153.37 21.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.825 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 61.3 p -132.55 -46.84 0.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.843 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.49 ' HB3' HG22 ' A' ' 153' ' ' THR . 8.4 mm-40 -62.37 154.21 28.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' MET . . . . . . . . . . . . . 4.1 ttp -108.78 37.26 2.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.796 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.49 HG22 ' HB3' ' A' ' 151' ' ' GLU . 2.6 t -109.77 96.23 23.27 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.878 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.72 96.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.519 2.146 . . . . 0.0 112.473 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -91.92 148.35 22.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -158.8 161.95 32.22 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.51 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -175.47 -63.37 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.459 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 60.57 98.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.77 0.319 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -127.49 149.95 49.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -103.39 119.32 38.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 162.63 -92.27 0.11 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.524 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.3 m -160.08 142.86 13.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.847 0.356 . . . . 0.0 110.888 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.27 97.34 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 62.64 126.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.007 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 11.6 mt -98.37 34.5 1.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.941 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -98.41 33.49 2.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.893 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 1.5 m -71.25 170.12 13.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.49 141.2 43.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.88 119.8 40.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -147.7 155.16 41.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -102.51 165.27 11.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.154 0.502 . . . . 0.0 110.163 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.75 129.75 30.97 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.113 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.4 tp -163.42 131.56 3.7 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.721 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 176.94 -155.17 17.64 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.513 -0.851 . . . . 0.0 112.681 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -135.19 172.04 13.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.845 0.355 . . . . 0.0 110.986 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.701 ' OD1' HD11 ' A' ' 128' ' ' LEU . 1.1 p30 -158.05 121.81 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.874 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.544 ' CE2' ' HB2' ' A' ' 135' ' ' ALA . 36.3 m-85 -98.71 115.77 29.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.833 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -81.4 147.28 29.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.112 -179.674 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.022 -179.867 . . . . . . . . 1 1 . 1 stop_ save_